DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2008-06-16	17934461	Broderick P	2007-10-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17934461	A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk.	Colorectal cancer	930 European ancestry cases, 960 European ancestry controls	7,473 European ancestry cases, 5,984 European ancestry controls	18q21.1	18	48927093	SMAD7	SMAD7			4092			rs4939827-T	rs4939827	0	4939827	intron_variant	0	0.52	1E-12	12.0		1.16	[1.09-1.27]	Illumina [547647]	N
2010-12-09	20972440	Houlston RS	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972440	Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.	Colorectal cancer	3,334 European ancestry cases, 4,628 European ancestry controls	14,851 European ancestry cases, 15,569 European ancestry controls	1q41	1	221872104	DUSP10	LOC105372950			105372950			rs6691170-T	rs6691170	0	6691170	intergenic_variant	0	NR	1E-9	9.0		1.06	[1.03-1.09]	Illumina [up to 550000] (imputed)	N
2010-12-09	20972440	Houlston RS	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972440	Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.	Colorectal cancer	3,334 European ancestry cases, 4,628 European ancestry controls	14,851 European ancestry cases, 15,569 European ancestry controls	3q26.2	3	169774313	MYNN	MYNN			55892			rs10936599-C	rs10936599	0	10936599	synonymous_variant	0	NR	3E-8	7.522878745280337		1.04	[1.04-1.10]	Illumina [up to 550000] (imputed)	N
2010-12-09	20972440	Houlston RS	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972440	Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.	Colorectal cancer	3,334 European ancestry cases, 4,628 European ancestry controls	14,851 European ancestry cases, 15,569 European ancestry controls	20q13.33	20	62345988	LAMA5	LAMA5			3911			rs4925386-C	rs4925386	0	4925386	intron_variant	0	NR	2E-10	9.698970004336019		1.08	[1.05-1.10]	Illumina [up to 550000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	18q21.1	18	48927678	SMAD7	SMAD7			4092			rs7226855-A	rs7226855	0	7226855	intron_variant	0	0.55	4E-23	22.397940008672037		1.25	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	20p12.3	20	6399697	BMP2	FGFR3P3 - CASC20	100462816	101929244		178952	27035	rs57046232-T	rs57046232	1	34033947	intergenic_variant	1	0.37	5E-7	6.301029995663981		1.11	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	20p12.3	20	6709454	BMP2	CASC20 - LOC105372516	101929244	105372516		180995	21293	rs1015563-T	rs1015563	0	1015563	intergenic_variant	1	0.35	2E-6	5.698970004336019		1.12	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	20q13.33	20	62394395	LAMA5	CABLES2			81928			rs2427308-C	rs2427308	0	2427308	intron_variant	0	0.78	3E-11	10.522878745280337		1.19	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	1p36.12	1	22261235	WNT4, CDC42	LOC107985377 - MIR4418	107985377	100616433		3268	5004	rs72647484-?	rs72647484	0	72647484	intergenic_variant	1	0.91	1E-8	8.0		1.24	[1.15-1.33]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	5q15	5	96794170	ERAP1	ERAP1			51752			rs202110856-?	rs202110856	0	202110856	intron_variant	0	0.99	7E-8	7.154901959985743		1.51	[1.23-1.86]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	10p13	10	16955267	CUBN	CUBN			8029			rs10904849-?	rs10904849	0	10904849	intron_variant	0	0.68	7E-8	7.154901959985743		1.13	[1.08-1.19]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	16p13.2	16	9203955	C16orf72	RPL21P119 - LOC101927026	653737	101927026		47034	82384	rs79900961-?	rs79900961	0	79900961	intergenic_variant	1	0.98	5E-8	7.301029995663981		1.49	[1.26-1.76]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	16q24.1	16	86662114	FOXL1	FOXL1 - LOC101928614	2300	101928614		80416	58570	rs16941835-?	rs16941835	0	16941835	intron_variant	1	0.21	5E-8	7.301029995663981		1.16	[1.09-1.22]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	1q41	1	221887680	DUSP10	LOC105372950			105372950			rs11118883-A	rs11118883	0	11118883	intron_variant	0	0.35	5E-6	5.301029995663981		1.12	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	8q24.11	8	116836068	EIF3H	UTP23 - RAD21	84294	5885		61384	9866	rs76316943-A	rs76316943	0	76316943	intron_variant	1	0.01	2E-11	10.698970004336019		1.58	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	8q24.21	8	127412547	MYC	CASC8			727677			rs7014346-A	rs7014346	0	7014346	intron_variant	0	0.34	6E-15	14.221848749616356		1.19	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	10p14	10	8697617	GATA3	LOC105376400 - LOC105755953	105376400	105755953		27815	200372	rs11255841-T	rs11255841	0	11255841	intergenic_variant	1	0.68	4E-13	12.397940008672037		1.18	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	10q24.2	10	99591947	SLC25A28, NKX2-3	NKX2-3 - SLC25A28	159296	81894		55423	18571	rs11190164-G	rs11190164	0	11190164	intergenic_variant	1	0.29	8E-7	6.096910013008056		1.13	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	11q13.4	11	74634505	POLD3	POLD3			10714			rs3824999-C	rs3824999	0	3824999	intron_variant	0	0.47	8E-11	10.096910013008056		1.15	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	11q23.1	11	111300984	FLJ45803	COLCA1, COLCA2			399948, 120376			rs3802842-C	rs3802842	0	3802842	intron_variant	0	0.27	2E-6	5.698970004336019		1.13	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	12q13.12	12	50651666	DIP2B, ATF1	DIP2B			57609			rs4768903-A	rs4768903	0	4768903	intron_variant	0	0.61	4E-8	7.3979400086720375		1.1	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	14q22.2	14	53952388	BMP4	BMP4			652			rs35107139-C	rs35107139	0	35107139	intron_variant	0	0.4	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-12-06	27207650	Schmit SL	2016-04-18	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/27207650	Genome-wide association study of colorectal cancer in Hispanics.	Colorectal cancer	1,611 Hispanic cases, 4,330 Hispanic controls	NA	1p34.3	1	39344315	MACF1	MACF1			23499			rs7528276-T	rs7528276	0	7528276	intron_variant	0	0.03	3E-7	6.522878745280337		1.86	[1.47-2.36]	Illumina [9875636] (imputed)	N
2016-12-06	27207650	Schmit SL	2016-04-18	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/27207650	Genome-wide association study of colorectal cancer in Hispanics.	Colorectal cancer	1,611 Hispanic cases, 4,330 Hispanic controls	NA	2q23.3	2	153074663	NR	LOC105373691 - ATP5F1P4	105373691	100422514		46377	84275	rs1367374-C	rs1367374	0	1367374	intergenic_variant	1	0.13	4E-7	6.3979400086720375		1.37	[1.21-1.55]	Illumina [9875636] (imputed)	N
2016-12-06	27207650	Schmit SL	2016-04-18	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/27207650	Genome-wide association study of colorectal cancer in Hispanics.	Colorectal cancer	1,611 Hispanic cases, 4,330 Hispanic controls	NA	14q24.2	14	70937530	NR	PCNX, LOC105370557			22990, 105370557			rs143046984-TA	rs143046984	0	143046984	intron_variant	0	0.04	4E-7	6.3979400086720375		1.65	[1.36-2.01]	Illumina [9875636] (imputed)	N
2016-12-06	27207650	Schmit SL	2016-04-18	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/27207650	Genome-wide association study of colorectal cancer in Hispanics.	Colorectal cancer	1,611 Hispanic cases, 4,330 Hispanic controls	NA	16q12.2	16	55504828	NR	MMP2			4313			rs142319636-G	rs142319636	0	142319636	intron_variant	0	0.04	8E-7	6.096910013008056		1.69	[1.37-2.08]	Illumina [9875636] (imputed)	N
2016-12-06	27207650	Schmit SL	2016-04-18	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/27207650	Genome-wide association study of colorectal cancer in Hispanics.	Colorectal cancer	1,611 Hispanic cases, 4,330 Hispanic controls	NA	1p34.3	1	39458103	NR	MACF1			23499			rs658191-G	rs658191	0	658191	non_coding_transcript_exon_variant	0	0.03	4E-7	6.3979400086720375		1.86	[1.46-2.36]	Illumina [9875636] (imputed)	N
2016-12-06	27207650	Schmit SL	2016-04-18	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/27207650	Genome-wide association study of colorectal cancer in Hispanics.	Colorectal cancer	1,611 Hispanic cases, 4,330 Hispanic controls	NA	14q24.2	14	71047446	NR	PCNX			22990			rs2286313-G	rs2286313	0	2286313	intron_variant	0	0.04	4E-7	6.3979400086720375		1.66	[1.36-2.02]	Illumina [9875636] (imputed)	N
2016-12-06	27207650	Schmit SL	2016-04-18	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/27207650	Genome-wide association study of colorectal cancer in Hispanics.	Colorectal cancer	1,611 Hispanic cases, 4,330 Hispanic controls	NA	18q21.1	18	48926786	NR	SMAD7			4092			rs11874392-A	rs11874392	0	11874392	intron_variant	0	0.49	7E-8	7.154901959985743		1.27	[1.17-1.39]	Illumina [9875636] (imputed)	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	2q37.2	2	234706553	ARL4C	LINC01173			106144537			rs6736997-A	rs6736997	0	6736997	intron_variant	0	0.33	6E-6	5.221848749616356	(recessive)	1.57	[1.29-1.91]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	7q36.2	7	153928758	DPP6	DPP6			1804			rs6464375-A	rs6464375	0	6464375	intron_variant	0	0.10	4E-7	6.3979400086720375	(recessive)	3.73	[2.24-6.21]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	8q24.13	8	123753462	FAM91A1	LOC105375739			105375739			rs10088262-A	rs10088262	0	10088262	intergenic_variant	0	0.34	4E-6	5.3979400086720375	(dominant)	1.4	[1.21-1.61]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	6p25.3	6	1339954	FOXQ1	LINC01394 - LOC105374880	106144586	105374880		3590	43838	rs9502893-G	rs9502893	0	9502893	intergenic_variant	1	0.35	3E-7	6.522878745280337	(allelic)	1.29	[1.17-1.43]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	2q12.1	2	104762499	LOC284998	LINC01114 - HMGB3P11	284998	644442		4780	8692	rs12615966-A	rs12615966	0	12615966	upstream_gene_variant	1	0.10	7E-6	5.154901959985743	(recessive)	3.15	[1.91-5.21]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	13q21.32	13	65907683	LOC387933	LOC105370243			105370243			rs1585440-C	rs1585440	0	1585440	regulatory_region_variant	0	0.71	9E-6	5.045757490560675	(allelic)	1.3	[1.16-1.45]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	13q22.1	13	73357977	LOC730242	RNY1P8 - MARK2P12	100873807	100421565		130717	49812	rs1886449-A	rs1886449	0	1886449	intergenic_variant	1	0.38	9E-6	5.045757490560675	(recessive)	1.51	[1.26-1.80]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	5p15.33	5	2109787	LOC731559	LOC105374618			105374618			rs6879627-G	rs6879627	0	6879627	intergenic_variant	0	0.52	8E-6	5.096910013008056	(allelic)	1.25	[1.14-1.39]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	17q11.2	17	32550640	MYO1D	MYO1D			4642			rs225190-G	rs225190	0	225190	intron_variant	0	0.36	6E-6	5.221848749616356	(allelic)	1.26	[1.14-1.39]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	13q31.1	13	79725587	NDFIP2	LINC01068 - LINC01038	103724388	102724076		154141	78799	rs2039553-A	rs2039553	0	2039553	intergenic_variant	1	0.27	7E-6	5.154901959985743	(recessive)	1.73	[1.36-2.19]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	6q26	6	161815043	PARK2	PARK2			5071			rs3016539-A	rs3016539	0	3016539	intron_variant	0	0.87	7E-6	5.154901959985743	(dominant)	1.5	[1.26-1.79]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	17p11.2	17	18850557	PRPSAP2	LOC101929141 - PRPSAP2	101929141	5636		8189	5742	rs4924935-G	rs4924935	0	4924935	intron_variant	1	0.23	8E-6	5.096910013008056	(dominant)	1.37	[1.19-1.58]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	2q11.2	2	101305708	RNF149	RNF149			284996			rs6711606-A	rs6711606	0	6711606	intron_variant	0	0.12	4E-6	5.3979400086720375	(recessive)	2.81	[1.81-4.37]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	17q22	17	58370936	RNF43	RNF43			54894			rs2257205-A	rs2257205	0	2257205	missense_variant	0	0.33	8E-6	5.096910013008056	(dominant)	1.38	[1.20-1.59]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	8p11.22	8	38611785	RNF5P1	RNF5P1 - TACC1	286140	6867		10528	116401	rs7832232-A	rs7832232	0	7832232	intergenic_variant	1	0.45	5E-6	5.301029995663981	(recessive)	1.45	[1.24-1.71]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	2q22.1	2	136797654	THSD7B	THSD7B			80731			rs1427593-A	rs1427593	0	1427593	intron_variant	0	0.08	7E-6	5.154901959985743	(dominant)	1.49	[1.25-1.77]	Illumina [420236]	N
2010-09-10	20686608	Low SK	2010-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/20686608	Genome-wide association study of pancreatic cancer in Japanese population.	Pancreatic cancer	991 Japanese ancestry cases, 5,209 Japanese ancestry controls	NA	12p11.21	12	32283475	BICD1	BICD1			636			rs708224-A	rs708224	0	708224	intron_variant	0	0.66	3E-7	6.522878745280337	(allelic)	1.32	[1.19-1.47]	Illumina [420236]	N
2010-09-23	20729852	Abnet CC	2010-08-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20729852	A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.	Esophageal cancer and gastric cancer	1,625 Chinese ancestry gastric cancer cases, 1,898 Chinese ancestry ESCC cases, 2,100 Chinese ancestry controls	NA	10q23.33	10	94298541	PLCE1, NOC3L	PLCE1			51196			rs3765524-T	rs3765524	0	3765524	missense_variant	0	0.207	2E-9	8.698970004336019	(ESCC)	1.35	[1.22-1.49]	Illumina [551152]	N
2010-09-23	20729852	Abnet CC	2010-08-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20729852	A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.	Esophageal cancer and gastric cancer	1,625 Chinese ancestry gastric cancer cases, 1,898 Chinese ancestry ESCC cases, 2,100 Chinese ancestry controls	NA	22q12.1	22	28734024	HSCB, CHEK2	CHEK2			11200			rs738722-T	rs738722	0	738722	intron_variant	0	0.25	1E-8	8.0	(ESCC)	1.3	[1.19-1.43]	Illumina [551152]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	2q36.3	2	227644742	intergenic	C2orf83 - LOC100420667	56918	100420667		11422	3100	rs997363-C	rs997363	0	997363	intron_variant	1	0.4032	1E-6	6.0		1.986	[1.50-2.62]	Affymetrix [556045]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	7q11.23	7	77433395	intergenic	LOC101927243 - GCNT1P5	101927243	100421598		7951	27761	rs7780883-A	rs7780883	0	7780883	intergenic_variant	1	0.05376	2E-6	5.698970004336019		3.28	[1.956-5.50]	Affymetrix [556045]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	2q14.2	2	118131653	intergenic	INSIG2 - LOC100506797	51141	100506797		21622	51274	rs6726538-A	rs6726538	0	6726538	downstream_gene_variant	1	0.3871	3E-6	5.522878745280337		1.946	[1.471-2.573]	Affymetrix [556045]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	18q22.3	18	72259522	intergenic	LOC105372189 - CBLN2	105372189	147381		86657	274198	rs8088832-C	rs8088832	0	8088832	intergenic_variant	1	0.508	4E-6	5.3979400086720375		1.94	[1.46-2.57]	Affymetrix [556045]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	1q23.3	1	160773959	intergenic	LOC105371470			105371470			rs12068654-T	rs12068654	0	12068654	downstream_gene_variant	0	0.885	5E-6	5.301029995663981		3.23	[2.06-6.93]	Affymetrix [556045]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	16p13.2	16	9232128	intergenic	RPL21P119 - LOC101927026	653737	101927026		75207	54211	rs4782151-C	rs4782151	0	4782151	intergenic_variant	1	0.4677	5E-6	5.301029995663981		1.91	[1.44-2.52]	Affymetrix [556045]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	8p21.3	8	20734998	intergenic	LOC105379315			105379315			rs11985951-T	rs11985951	0	11985951	intergenic_variant	0	0.871	6E-6	5.221848749616356		3.36	[1.94-5.83]	Affymetrix [556045]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	7q21.13	7	88970471	ZNF804B	ZNF804B			219578			rs3899697-A	rs3899697	0	3899697	intron_variant	0	0.2787	9E-6	5.045757490560675		1.949	[1.449-2.621]	Affymetrix [556045]	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212052	MTX1	MTX1			4580			rs2974935-T	rs2974935	0	2974935	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155216951	GBAP1	GBAP1			2630			rs1057941-A	rs1057941	0	1057941	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q32.2	1	210816167	KCNH1	KCNH1			3756			rs11119608-T	rs11119608	0	11119608	intron_variant	0	NR	1E-7	7.0		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3q26.2	3	169043635	Intergenic	LOC107986051			107986051			rs75316749-G	rs75316749	0	75316749	intergenic_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	387117	100129192		10865	39737	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	LOC105375015 - HLA-B	105375015	3106		38409	6862	rs115392158-G	rs115392158	1	2507997	intron_variant	1	NR	9E-6	5.045757490560675		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	3119	404026		33007	6448	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	5E-7	6.301029995663981		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6q14.1	6	80398959	Intergenic	BCKDHB			594			rs4604234-C	rs4604234	0	4604234	intergenic_variant	0	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	21951903	Intergenic	ERVFRD-3 - CDKN2A-AS1	100533725	51198		20630	15236	rs12349081-A	rs12349081	0	12349081	intron_variant	1	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	SH2B3			10019			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32398489	BRCA2	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	NR	8E-12	11.096910013008056		1.6	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B			6928			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	1E-9	9.0		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	BABAM1 - ANKLE1	29086	126549		129	2163	rs4808075-C	rs4808075	0	4808075	intron_variant	1	NR	4E-7	6.3979400086720375		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	140755	434		8649	54502	rs11907546-C	rs11907546	0	11907546	regulatory_region_variant	1	NR	3E-9	8.522878745280337		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32265853	FRY	FRY			10129			rs56404467-A	rs56404467	0	56404467	non_coding_transcript_exon_variant	0	NR	1E-7	7.0		1.2	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			22913			rs2300206-G	rs2300206	0	2300206	intron_variant	0	NR	2E-8	7.698970004336019		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1p36.33	1	1351675	Intergenic	DVL1 - MXRA8	1855	54587		2533	1014	rs186507655-A	rs186507655	0	186507655	upstream_gene_variant	1	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212373	MTX1	MTX1			4580			rs2075570-T	rs2075570	0	2075570	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3p24.1	3	27285723	NEK10	NEK10			152110			rs481519-T	rs481519	0	481519	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	4q24	4	105140377	Intergenic	LOC100288146 - TET2	100288146	54790		36383	5498	rs7679673-A	rs7679673	0	7679673	intron_variant	1	NR	1E-10	10.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5p15.33	5	1282299	TERT	TERT			7015			rs7725218-A	rs7725218	0	7725218	intron_variant	0	NR	2E-10	9.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5q11.2	5	56737113	Intergenic	LOC101928448 - LOC105378979	101928448	105378979		130881	29282	rs1862626-T	rs1862626	0	1862626	regulatory_region_variant	1	NR	4E-12	11.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	29785031	Intergenic	3.8-1.5 - HCG4	353010	54435		18735	6000	rs147680653-G	rs147680653	1	9258375	regulatory_region_variant	1	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	387117	100129192		10865	39737	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	5E-7	6.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	LOC105375015 - HLA-B	105375015	3106		38409	6862	rs115392158-G	rs115392158	1	2507997	intron_variant	1	NR	3E-7	6.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	3119	404026		33007	6448	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	6E-8	7.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	10q26.13	10	121575416	FGFR2	FGFR2			2263			rs11200014-A	rs11200014	0	11200014	intron_variant	0	NR	8E-35	34.096910013008056	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q13.3	11	69227030	Intergenic	LOC105369366 - LOC105369367	105369366	105369367		49023	1719	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	NR	4E-14	13.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103813371	Intergenic	LOC105369463 - LOC102723862	105369463	102723862		162091	29401	rs148883465-G	rs148883465	0	148883465	intron_variant	1	NR	3E-8	7.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.12	12	49251457	TUBA1C	TUBA1C			84790			rs11168936-C	rs11168936	0	11168936	intron_variant	0	NR	9E-7	6.045757490560675	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.13	12	52918828	KRT8	KRT8			3856			rs73110464-T	rs73110464	0	73110464	intron_variant	0	NR	2E-15	14.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	SH2B3			10019			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32394673	BRCA2	BRCA2			675			rs11571818-C	rs11571818	0	11571818	intron_variant	0	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	14q24.1	14	68559662	RAD51B	RAD51B			5890			rs11844632-A	rs11844632	0	11844632	intron_variant	0	NR	3E-10	9.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B			6928			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	7E-28	27.154901959985743	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	BABAM1 - ANKLE1	29086	126549		129	2163	rs4808075-C	rs4808075	0	4808075	intron_variant	1	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	140755	434		8649	54502	rs11907546-T	rs11907546	0	11907546	regulatory_region_variant	1	NR	3E-6	5.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103745837	Intergenic	LOC105369463 - LOC102723862	105369463	102723862		94557	96935	rs141752671-G	rs141752671	0	141752671	intron_variant	1	NR	1E-7	7.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111621753	Intergenic	ATXN2 - BRAP	6311	8315		22077	20393	rs11065979-T	rs11065979	0	11065979	intergenic_variant	1	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			22913			rs2300206-C	rs2300206	0	2300206	intron_variant	0	NR	6E-6	5.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32295727	FRY	FRY			10129			rs56084662-A	rs56084662	0	56084662	3_prime_UTR_variant	0	NR	4E-9	8.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-03-16	27579533	Zhang M	2016-08-01	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27579533	Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.	Pancreatic cancer	5,107 European ancestry cases, 8,845 European ancestry controls	6,076 cases, 7,555 controls	8q24.21	8	127707639	MYC	CASC11			100270680			rs10094872-T	rs10094872	0	10094872	intron_variant	0	0.350	3E-9	8.522878745280337		1.15	[1.10-1.20]	Illumina [9132527] (imputed)	N
2017-03-16	27579533	Zhang M	2016-08-01	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27579533	Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.	Pancreatic cancer	5,107 European ancestry cases, 8,845 European ancestry controls	6,076 cases, 7,555 controls	5p15.33	5	1295258	CLPTM1L, TERT	TERT			7015			rs35226131-C	rs35226131	0	35226131	upstream_gene_variant	0	0.959	2E-8	7.698970004336019		1.4084507	[1.25-1.59]	Illumina [9132527] (imputed)	N
2009-09-09	19698717	Cui R	2009-08-18	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/19698717	Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk.	Esophageal cancer	182 Japanese ancestry cases, 927 Japanese ancestry controls	782 Japanese ancestry cases, 1,898 Japanese ancestry controls	12q24.12	12	111803962	BRAP, ALDH2	ALDH2			217			rs671-A	rs671	0	671	missense_variant	0	NR	3E-24	23.522878745280337		1.67	[1.58-1.76]	Illumina [359195]	N
2009-09-09	19698717	Cui R	2009-08-18	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/19698717	Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk.	Esophageal cancer	182 Japanese ancestry cases, 927 Japanese ancestry controls	782 Japanese ancestry cases, 1,898 Japanese ancestry controls	4q23	4	99318162	ADH6, ADH1B	ADH1B			125			rs1229984-G	rs1229984	0	1229984	missense_variant	0	NR	8E-24	23.096910013008056		1.79	[1.69-1.88]	Illumina [359195]	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	2q31.1	2	176177905	HOXD1, HOXD3	HAGLR			401022			rs2072590-T	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	NR	5E-14	13.301029995663981		1.16	[1.12-1.21]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	3q25.31	3	156679960	TIPARP	TIPARP, LOC107986148			25976, 107986148			rs2665390-C	rs2665390	0	2665390	intron_variant	0	NR	3E-7	6.522878745280337		1.19	[1.11-1.27]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	8q24.21	8	128531703	MYC, THEM75	LINC00824			101927774			rs10088218-G	rs10088218	0	10088218	intron_variant	0	NR	3E-9	8.522878745280337		1.19	[1.12-1.25]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	17q21.32	17	48334138	SKAP1	SKAP1			8631			rs9303542-G	rs9303542	0	9303542	intron_variant	0	NR	1E-6	6.0		1.11	[1.06-1.16]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	1p36.12	1	22164231	NR	LOC105376850			105376850			rs7521902-?	rs7521902	0	7521902	intergenic_variant	0	NR	5E-6	5.301029995663981		1.12	[1.07-1.18]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	11p14.3	11	25186158	NR	LOC100130747 - RPL36AP40	100130747	554234		44957	402207	rs12794435-?	rs12794435	0	12794435	intergenic_variant	1	NR	5E-6	5.301029995663981		1.16	[1.09-1.23]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	17q21.32	17	48279758	NR	SKAP1			8631			rs2084881-?	rs2084881	0	2084881	intron_variant	0	NR	2E-6	5.698970004336019		1.12	[1.07-1.18]	Illumina [2056878] (imputed)	N
2011-02-25	21242260	Cui R	2011-01-17	Gut	www.ncbi.nlm.nih.gov/pubmed/21242260	Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population.	Colorectal cancer	1,583 Japanese ancestry cases, 1,898 Japanese ancestry controls	4,584 Japanese ancestry cases, 225 Korean ancestry distal cases, 2,973 East Asian ancestry controls	6q25.3	6	160419220	SLC22A3	SLC22A3			6581			rs7758229-T	rs7758229	0	7758229	intron_variant	0	NR	8E-9	8.096910013008056	(distal colon cancer)	1.28	[1.18-1.39]	Illumina [391749]	N
2011-02-25	21242260	Cui R	2011-01-17	Gut	www.ncbi.nlm.nih.gov/pubmed/21242260	Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population.	Colorectal cancer	1,583 Japanese ancestry cases, 1,898 Japanese ancestry controls	4,584 Japanese ancestry cases, 225 Korean ancestry distal cases, 2,973 East Asian ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.34	2E-8	7.698970004336019	(colorectal cancer)	1.18	[1.11-1.25]	Illumina [391749]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	6,911 European ancestry cases, 11,818 European ancestry controls	801 cases, 1,307 controls	8q21.13	8	81074718	NR	PAG1			55824			rs5003154-?	rs5003154	0	5003154	intron_variant	0	NR	1E-6	6.0		1.11	[1.06-1.16]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	6,911 European ancestry cases, 11,818 European ancestry controls	801 cases, 1,307 controls	13q34	13	113004794	NR	LOC107984591, MCF2L			107984591, 23263			rs4907479-?	rs4907479	0	4907479	intron_variant	0	NR	3E-6	5.522878745280337		1.13	[1.07-1.18]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	6,911 European ancestry cases, 11,818 European ancestry controls	801 cases, 1,307 controls	6p22.3	6	20751084	NR	CDKAL1			54901			rs7747724-?	rs7747724	0	7747724	intron_variant	0	NR	1E-6	6.0		1.11	[1.06-1.16]	Illumina [462190]	N
2014-10-03	24448986	Zhang B	2014-01-21	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/24448986	Genome-wide association study identifies a new SMAD7 risk variant associated with colorectal cancer risk in East Asians.	Colorectal cancer	1,773 East Asian ancestry cases, 2,642 East Asian ancestry controls	6,902 East Asian ancestry cases, 7,862 East Asian ancestry controls	18q21.1	18	48924606	SMAD7	SMAD7			4092			rs7229639-A	rs7229639	0	7229639	intron_variant	0	0.145	3E-11	10.522878745280337		1.22	[1.15-1.29]	Affymetrix, Illumina [1695815] (imputed)	N
2013-04-23	23350875	Fernandez-Rozadilla C	2013-01-26	BMC Genomics	www.ncbi.nlm.nih.gov/pubmed/23350875	A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12.	Colorectal cancer	882 European ancestry cases, 473 European ancestry controls	1,436 European ancestry cases, 1,780 European ancestry controls	3p21.31	3	47347457	NR	KLHL18 - PTPN23	23276	25930		641	33525	rs8180040-?	rs8180040	0	8180040	non_coding_transcript_exon_variant	1	NR	2E-6	5.698970004336019		1.28	[1.15-1.41]	Affymetrix [674718]	N
2013-04-23	23350875	Fernandez-Rozadilla C	2013-01-26	BMC Genomics	www.ncbi.nlm.nih.gov/pubmed/23350875	A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12.	Colorectal cancer	882 European ancestry cases, 473 European ancestry controls	1,436 European ancestry cases, 1,780 European ancestry controls	8p12	8	29486945	NR	LOC105379349 - LOC107986883	105379349	107986883		113553	24475	rs12548021-?	rs12548021	0	12548021	intergenic_variant	1	NR	3E-6	5.522878745280337		1.28	[1.155-1.418]	Affymetrix [674718]	N
2013-04-23	23350875	Fernandez-Rozadilla C	2013-01-26	BMC Genomics	www.ncbi.nlm.nih.gov/pubmed/23350875	A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12.	Colorectal cancer	882 European ancestry cases, 473 European ancestry controls	1,436 European ancestry cases, 1,780 European ancestry controls	8q22.1	8	95583508	NR	C8orf37-AS1			100616530			rs3104964-?	rs3104964	0	3104964	intron_variant	0	NR	4E-6	5.3979400086720375		1.265	[1.144-1.398]	Affymetrix [674718]	N
2015-06-22	25192705	Du M	2014-09-05	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25192705	No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk.	Colorectal cancer (calcium intake interaction)	9,006 European ancestry cases, 9,503 European ancestry controls	NA	6q23.1	6	130604622	EPB41L2, TMEM200A	TMEM200A - LOC105378002	114801	105378002		161198	114608	rs1933755-T	rs1933755	0	1933755	intergenic_variant	1	0.9	2E-6	5.698970004336019	(Total calcium intake)	1.19	[1.11-1.28]	NR [~ 2700000] (imputed)	N
2015-06-22	25192705	Du M	2014-09-05	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25192705	No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk.	Colorectal cancer (calcium intake interaction)	9,006 European ancestry cases, 9,503 European ancestry controls	NA	4q22.1	4	91117856	FAM190A	CCSER1			401145			rs6855885-A	rs6855885	0	6855885	intron_variant	0	0.5	2E-6	5.698970004336019	(Dietary calcium intake)	1.11	[1.06-1.16]	NR [~ 2700000] (imputed)	N
2015-06-22	25192705	Du M	2014-09-05	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25192705	No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk.	Colorectal cancer (calcium intake interaction)	9,006 European ancestry cases, 9,503 European ancestry controls	NA	4q34.3	4	181892145	TENM3, AGA	TENM3			55714			rs1028166-G	rs1028166	0	1028166	intron_variant	0	0.31	7E-7	6.154901959985743	(Supplemental calcium intake)	1.49	[1.27-1.74]	NR [~ 2700000] (imputed)	N
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	5q14.3	5	87315172	RASA1, CCNH	RASA1, CCNH			5921, 902			rs35148638-C	rs35148638	0	35148638	intron_variant	0	0.255	6E-9	8.221848749616356		0.088	[0.059-0.117] unit increase	Illumina [1531807] (imputed)	N
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	3q26.31	3	175534948	NAALADL2	NAALADL2			254827			rs78943174-C	rs78943174	0	78943174	intron_variant	0	0.987	4E-8	7.3979400086720375		0.289	[0.19-0.39] unit increase	Illumina [1531807] (imputed)	N
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	19q13.33	19	50857584	KLK3	KLK3			354			rs62113212-T	rs62113212	0	62113212	non_coding_transcript_exon_variant	0	0.061	6E-9	8.221848749616356		0.138	[0.091-0.185] unit increase	Illumina [1531807] (imputed)	N
2014-02-10	21964575	Rafnar T	2011-10-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21964575	Mutations in BRIP1 confer high risk of ovarian cancer.	Ovarian cancer	640 European ancestry cases, 41,607 European ancestry controls	NA	17q23.2	17	61803285	BRIP1	BRIP1			83990			rs34289250-C	rs34289250	0	34289250	intron_variant	0	0.0089	6E-13	12.221848749616356		7.95	[NR]	Illumina [15957390] (imputed)	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	6,911 European ancestry cases, 11,818 European ancestry controls	801 cases, 1,307 controls	3q26.2	3	169774313	ACTRT3, MYNN, TERC, LRRC34	MYNN			55892			rs10936599-C	rs10936599	0	10936599	synonymous_variant	0	0.76	5E-9	8.301029995663981		1.1765	[1.11-1.23]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	6,911 European ancestry cases, 11,818 European ancestry controls	801 cases, 1,307 controls	11p15.5	11	1852842	LSP1	LOC107984299 - LSP1	107984299	4046		6190	128	rs907611-A	rs907611	0	907611	upstream_gene_variant	1	0.31	4E-8	7.3979400086720375		1.15	[1.09-1.21]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	6,911 European ancestry cases, 11,818 European ancestry controls	801 cases, 1,307 controls	20p12.2	20	11007451	C20orf187, LOC339593	C20orf187			728434			rs6104690-A	rs6104690	0	6104690	intergenic_variant	0	0.56	7E-7	6.154901959985743		1.1236	[1.08-1.18]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	6,911 European ancestry cases, 11,818 European ancestry controls	801 cases, 1,307 controls	6p22.3	6	20766466	CDKAL1	CDKAL1			54901			rs4510656-C	rs4510656	0	4510656	intron_variant	0	0.55	7E-7	6.154901959985743		1.1236	[1.08-1.18]	Illumina [462190]	N
2017-06-14	28295283	Wang H	2017-03-13	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/28295283	Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.	Colorectal cancer	1,894 African American ancestry cases, 4,703 African American ancestry controls.	891 African American ancestry cases, 1,150 African American ancestry controls, 1,611 Hispanic ancestry cases, 4,330 Hispanic ancestry controls.	19q13.11	19	33084158	GPATCH1	GPATCH1			55094			rs7252505-G	rs7252505	0	7252505	intron_variant	0	0.38	4E-8	7.3979400086720375		1.19	[1.12-1.27]	Illumina [10050748] (imputed)	N
2017-06-14	28295283	Wang H	2017-03-13	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/28295283	Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.	Colorectal cancer	1,894 African American ancestry cases, 4,703 African American ancestry controls.	891 African American ancestry cases, 1,150 African American ancestry controls, 1,611 Hispanic ancestry cases, 4,330 Hispanic ancestry controls.	19q13.32	19	45818249	SYMPK	SYMPK			8189			rs56848936-A	rs56848936	0	56848936	intron_variant	0	0.94	9E-7	6.045757490560675	(AA)	1.45	[1.25-1.69]	Illumina [10050748] (imputed)	N
2013-01-18	23103227	Jin G	2012-10-25	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23103227	Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	2,331 Han Chinese ancestry lung cancer cases, 1,006 Han Chinese ancestry non-cardia gastric cancer cases, 2,031 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 4,006 Han Chinese ancestry controls	2,665 Han Chinese ancestry lung cancer cases, 3,330 Han Chinese ancestry non-cardia gastric cancer cases, 3,006 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 11,436 Han Chinese ancestry controls	6p21.1	6	40568389	LRFN2	LRFN2			57497			rs2494938-A	rs2494938	0	2494938	intron_variant	0	0.23	2E-6	5.698970004336019	(Lung Cancer)	1.15	[1.08-1.22]	Affymetrix [NR]	N
2013-01-18	23103227	Jin G	2012-10-25	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23103227	Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	2,331 Han Chinese ancestry lung cancer cases, 1,006 Han Chinese ancestry non-cardia gastric cancer cases, 2,031 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 4,006 Han Chinese ancestry controls	2,665 Han Chinese ancestry lung cancer cases, 3,330 Han Chinese ancestry non-cardia gastric cancer cases, 3,006 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 11,436 Han Chinese ancestry controls	7p15.3	7	21544470	DNAH11, SP4	DNAH11			8701			rs2285947-A	rs2285947	0	2285947	intron_variant	0	0.26	2E-8	7.698970004336019	(Lung Cancer)	1.17	[1.11-1.24]	Affymetrix [NR]	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity and pharyngeal cancer	2,717 European ancestry oral cavity cancer cases, 273 oral cavity cancer cases, 2,506 European ancestry oropharynx cancer cases, 135 oropharynx cancer cases, 305 European and unknown ancestry hypopharynx cancer cases, 73 European and unknown ancestry overlapping cases, 25 European and unknown ancestry cases, 5,984 European ancestry controls, 601 controls	NA	4q23	4	99318162	ADH1B, ADH1C, METAP1, LOC100507053	ADH1B			125			rs1229984-G	rs1229984	0	1229984	missense_variant	0	0.94	2E-15	14.698970004336019		1.7898692		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity and pharyngeal cancer	2,717 European ancestry oral cavity cancer cases, 273 oral cavity cancer cases, 2,506 European ancestry oropharynx cancer cases, 135 oropharynx cancer cases, 305 European and unknown ancestry hypopharynx cancer cases, 73 European and unknown ancestry overlapping cases, 25 European and unknown ancestry cases, 5,984 European ancestry controls, 601 controls	NA	5p14.3	5	19108581	intergenic	RPL32P14 - HSPD1P15	100270994	646273		67213	124721	rs79767424-C	rs79767424	0	79767424	intron_variant	1	0.97	4E-10	9.397940008672037		1.812908		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity and pharyngeal cancer	2,717 European ancestry oral cavity cancer cases, 273 oral cavity cancer cases, 2,506 European ancestry oropharynx cancer cases, 135 oropharynx cancer cases, 305 European and unknown ancestry hypopharynx cancer cases, 73 European and unknown ancestry overlapping cases, 25 European and unknown ancestry cases, 5,984 European ancestry controls, 601 controls	NA	11p15.4	11	5807854	OR52N2	OR52N2			390077			rs1453414-C	rs1453414	0	1453414	intron_variant	0	0.2	5E-8	7.301029995663981		1.1945		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity and pharyngeal cancer	2,717 European ancestry oral cavity cancer cases, 273 oral cavity cancer cases, 2,506 European ancestry oropharynx cancer cases, 135 oropharynx cancer cases, 305 European and unknown ancestry hypopharynx cancer cases, 73 European and unknown ancestry overlapping cases, 25 European and unknown ancestry cases, 5,984 European ancestry controls, 601 controls	NA	6p21.32	6	32668343	HLA-DQB1	HLA-DQB1 - MTCO3P1	3119	404026		1654	37801	rs3828805-C	rs3828805	0	3828805	5_prime_UTR_variant	1	0.72	3E-13	12.522878745280337		1.2759		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity and pharyngeal cancer	2,717 European ancestry oral cavity cancer cases, 273 oral cavity cancer cases, 2,506 European ancestry oropharynx cancer cases, 135 oropharynx cancer cases, 305 European and unknown ancestry hypopharynx cancer cases, 73 European and unknown ancestry overlapping cases, 25 European and unknown ancestry cases, 5,984 European ancestry controls, 601 controls	NA	9q34.12	9	131087186	LAMC3	LAMC3			10319			rs77452476-C	rs77452476	0	77452476	intron_variant	0	0.16	3E-7	6.522878745280337		1.24		Illumina [7574753] (imputed)	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	3p22.2	3	37954986	CTDSPL	CTDSPL			10217			rs9311171-?	rs9311171	0	9311171	splice_region_variant	0	NR	2E-6	5.698970004336019				Affymetrix [70897]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	13q33.1	13	103275657	intergenic	SLC10A2 - LOC105370338	6555	105370338		208811	15312	rs1529276-?	rs1529276	0	1529276	intergenic_variant	1	NR	2E-6	5.698970004336019				Affymetrix [70897]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	6p12.2	6	51801833	PKHD1	PKHD1			5314			rs10498792-?	rs10498792	0	10498792	intron_variant	0	NR	3E-6	5.522878745280337				Affymetrix [70897]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	5q14.3	5	83689920	HAPLN1	HAPLN1			1404			rs4466137-?	rs4466137	0	4466137	intron_variant	0	NR	3E-6	5.522878745280337				Affymetrix [70897]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	3q24	3	145456001	intergenic	LOC105374141 - LARP7P4	105374141	100421509		559760	67525	rs345013-?	rs345013	0	345013	intergenic_variant	1	NR	5E-6	5.301029995663981				Affymetrix [70897]	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA				NR							kgp1923988-C	kgp1923988	0			1	0.192	3E-8	7.522878745280337		1.41	[1.25-1.59]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA				NR							kgp9645322-A	kgp9645322	0			1	0.044	8E-10	9.096910013008056		2.39	[1.81-3.16]	Illumina [~ 9400000] (imputed)	N
2010-09-11	20676096	Zhang H	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676096	Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.	Hepatocellular carcinoma	348 Chinese ancestry cases, 359 Chinese ancestry controls	2,121 Chinese ancestry cases, 1,748 Chinese ancestry controls	1p36.22	1	10325413	UBE4B, KIF1B, PGD	KIF1B			23095			rs17401966-A	rs17401966	0	17401966	intron_variant	0	0.72	2E-18	17.69897000433602		1.64	[1.49-1.82]	Affymetrix [294566]	N
2011-01-10	21105107	Clifford RJ	2010-12-01	Hepatology	www.ncbi.nlm.nih.gov/pubmed/21105107	Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.	Hepatocellular carcinoma	180 Korean ancestry cases, 271 Korean ancestry controls	206 Korean ancestry cases, 416 East Asian ancestry controls,	3p22.3	3	32978543	GLB1	LOC105377022 - LOC107986072	105377022	107986072		1329	13381	rs4678680-?	rs4678680	0	4678680	intergenic_variant	1	0.07	2E-7	6.698970004336019		2.27	[1.68-3.08]	Affymetrix [658897]	N
2011-01-10	21105107	Clifford RJ	2010-12-01	Hepatology	www.ncbi.nlm.nih.gov/pubmed/21105107	Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.	Hepatocellular carcinoma	180 Korean ancestry cases, 271 Korean ancestry controls	206 Korean ancestry cases, 416 East Asian ancestry controls,	6p21.33	6	31915902	C2	C2			717			rs9267673-?	rs9267673	0	9267673	intron_variant	0	0.08	2E-6	5.698970004336019		1.97	[1.47-2.64]	Affymetrix [658897]	N
2011-01-10	21105107	Clifford RJ	2010-12-01	Hepatology	www.ncbi.nlm.nih.gov/pubmed/21105107	Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.	Hepatocellular carcinoma	180 Korean ancestry cases, 271 Korean ancestry controls	206 Korean ancestry cases, 416 East Asian ancestry controls,	14q32.11	14	89834691	C14orf143	EFCAB11			90141			rs12100561-?	rs12100561	0	12100561	intron_variant	0	0.39	4E-6	5.3979400086720375		1.52	[1.26-1.83]	Affymetrix [658897]	N
2011-05-11	21499248	Kumar V	2011-04-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21499248	Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.	Hepatocellular carcinoma	721 Japanese ancestry cases, 2,890 Japanese ancestry controls	673 Japanese ancestry cases, 2,596 Japanese ancestry controls	6p21.32	6	32711222	HLA-DQ, HLA-DR	MTCO3P1 - LOC102725019	404026	102725019		4419	6945	rs9275572-A	rs9275572	0	9275572	upstream_gene_variant	1	0.36	6E-9	8.221848749616356		1.3	[1.19-1.42]	Illumina [432703]	N
2011-05-11	21499248	Kumar V	2011-04-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21499248	Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.	Hepatocellular carcinoma	721 Japanese ancestry cases, 2,890 Japanese ancestry controls	673 Japanese ancestry cases, 2,596 Japanese ancestry controls	6p21.33	6	31398818	MICA	LOC101929072 - MICA	101929072	100507436		310	966	rs2596542-A	rs2596542	0	2596542	upstream_gene_variant	1	0.33	4E-13	12.397940008672037		1.39	[1.27-1.52]	Illumina [432703]	N
2012-09-20	22807686	Li S	2012-07-12	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22807686	GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.	Hepatocellular carcinoma	1,538 Han Chinese ancestry HBV-positive HCC cases, 1,465 Han Chinese ancestry chronic HBV carriers	4,431 Han Chinese ancestry HBV-positive HCC cases, 4,725 Han Chinese ancestry chronic HBV carriers	21q21.3	21	29773850	GRIK1	GRIK1			2897			rs455804-C	rs455804	0	455804	intron_variant	0	0.66	5E-10	9.301029995663981		1.19	[1.12-1.25]	NR [523663]	N
2013-03-11	23242368	Jiang DK	2012-12-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23242368	Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	1,161 Chinese ancestry cases, 1,353 Chinese ancestry controls	4,319 Chinese ancestry cases, 4,966 Chinese ancestry controls	2q32.2	2	191099907	STAT4	STAT4			6775			rs7574865-G	rs7574865	0	7574865	intron_variant	0	0.67	2E-10	9.698970004336019		1.21	[1.14-1.28]	Illumina [1672517] (imputed)	N
2017-03-28	27764800	Cox DG	2016-10-14	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27764800	GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.	Estrogen receptor status in breast cancer	6,211 French ancestry estrogen receptor positive cases, 2,516 French ancestry estrogen receptor negative cases	NA	10q26.13	10	121594355	FGFR2	FGFR2			2263			rs3135718-?	rs3135718	0	3135718	intron_variant	0	NR	6E-12	11.221848749616356		1.33	[1.23 - 1.45]	Illumina [914144] (imputed)	N
2008-06-16	18372901	Tenesa A	2008-03-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18372901	Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.	Colorectal cancer	981 European ancestry cases, 1,002 European ancestry controls	10,287 European ancestry cases, 10,401 European ancestry controls, 4,400 Japanese ancestry cases, 3,179 Japanese ancestry controls, 1,789 cases, 1,771 controls	8q24.21	8	127412547	POU5FIP1, HsG57825, DQ515897	CASC8			727677			rs7014346-A	rs7014346	0	7014346	intron_variant	0	0.18	9E-26	25.045757490560675		1.19	[1.15-1.23]	Illumina [541628]	N
2008-06-16	18372901	Tenesa A	2008-03-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18372901	Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.	Colorectal cancer	981 European ancestry cases, 1,002 European ancestry controls	10,287 European ancestry cases, 10,401 European ancestry controls, 4,400 Japanese ancestry cases, 3,179 Japanese ancestry controls, 1,789 cases, 1,771 controls	11q23.1	11	111300984	intergenic	COLCA1, COLCA2			399948, 120376			rs3802842-C	rs3802842	0	3802842	intron_variant	0	0.43	6E-10	9.221848749616356		1.11	[1.08-1.15]	Illumina [541628]	N
2008-06-16	18372901	Tenesa A	2008-03-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18372901	Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.	Colorectal cancer	981 European ancestry cases, 1,002 European ancestry controls	10,287 European ancestry cases, 10,401 European ancestry controls, 4,400 Japanese ancestry cases, 3,179 Japanese ancestry controls, 1,789 cases, 1,771 controls	18q21.1	18	48927093	SMAD7	SMAD7			4092			rs4939827-T	rs4939827	0	4939827	intron_variant	0	0.52	8E-28	27.096910013008056		1.2	[1.16-1.24]	Illumina [541628]	N
2008-06-16	18372905	Tomlinson IP	2008-03-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18372905	A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.	Colorectal cancer	922 European ancestry cases, 927 European ancestry controls	17,089 European ancestry cases, 16,862 European ancestry controls, 783 cases, 664 controls	10p14	10	8659256	intergenic	LOC105376400			105376400			rs10795668-A	rs10795668	0	10795668	upstream_gene_variant	0	0.67	3E-13	12.522878745280337		1.12	[1.10-1.16]	Illumina [547647]	N
2008-06-16	18372905	Tomlinson IP	2008-03-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18372905	A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.	Colorectal cancer	922 European ancestry cases, 927 European ancestry controls	17,089 European ancestry cases, 16,862 European ancestry controls, 783 cases, 664 controls	8q23.3	8	116618444	EIF3H	LOC105375712 - EIF3H	105375712	8667		3110	26372	rs16892766-A	rs16892766	0	16892766	regulatory_region_variant	1	0.07	3E-18	17.522878745280337		1.27	[1.20-1.34]	Illumina [547647]	N
2008-06-16	17618284	Tomlinson I	2007-07-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17618284	A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21.	Colorectal cancer	930 European ancestry cases, 960 European ancestry controls	7,334 European ancestry cases, 5,246 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.49	1E-14	14.0		1.27	[1.16-1.39]	Illumina [547647]	N
2008-06-16	17618283	Zanke BW	2007-07-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17618283	Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24.	Colorectal cancer	1,257 cases, 1,336 controls	5,084 European ancestry cases, 5,388 European ancestry controls, 1,139 cases, 1,055 controls	8q24.21	8	127395198	ORF DQ515897	CASC8			727677			rs10505477-A	rs10505477	0	10505477	intron_variant	0	0.50	3E-11	10.522878745280337		1.17	[1.12-1.23]	Affymetrix, Illumina [99632]	N
2008-06-16	18372905	Tomlinson IP	2008-03-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18372905	A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.	Colorectal cancer	922 European ancestry cases, 927 European ancestry controls	17,089 European ancestry cases, 16,862 European ancestry controls, 783 cases, 664 controls	8q24.21	8	127401060	intergenic	CCAT2, CASC8			101805488, 727677			rs6983267-?	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.48	7E-11	10.154901959985743		1.24	[1.17-1.33]	Illumina [547647]	N
2008-06-16	18372905	Tomlinson IP	2008-03-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18372905	A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.	Colorectal cancer	922 European ancestry cases, 927 European ancestry controls	17,089 European ancestry cases, 16,862 European ancestry controls, 783 cases, 664 controls	18q21.1	18	48927093	SMAD7	SMAD7			4092			rs4939827-?	rs4939827	0	4939827	intron_variant	0	0.53	2E-6	5.698970004336019		1.18	[1.10-1.25]	Illumina [547647]	N
2008-06-16	18372905	Tomlinson IP	2008-03-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18372905	A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.	Colorectal cancer	922 European ancestry cases, 927 European ancestry controls	17,089 European ancestry cases, 16,862 European ancestry controls, 783 cases, 664 controls	15q13.3	15	32702555	intergenic	SCG5 - GREM1	6447	26585		5458	15385	rs4779584-?	rs4779584	0	4779584	intergenic_variant	1	0.19	5E-7	6.301029995663981		1.23	[1.14-1.34]	Illumina [547647]	N
2008-12-01	19011631	Houlston RS	2008-11-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19011631	Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.	Colorectal cancer	1,902 European ancestry cases, 1,929 European ancestry controls	18,284 European ancestry cases, 18,926 European ancestry controls	19q13.11	19	33041394	RHPN2	RHPN2			85415			rs10411210-C	rs10411210	0	10411210	intron_variant	0	0.90	5E-9	8.301029995663981		1.15	[1.10-1.20]	Illumina [up to 548586]	N
2008-12-01	19011631	Houlston RS	2008-11-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19011631	Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.	Colorectal cancer	1,902 European ancestry cases, 1,929 European ancestry controls	18,284 European ancestry cases, 18,926 European ancestry controls	20p12.3	20	6423634	intergenic	FGFR3P3 - CASC20	100462816	101929244		202889	3098	rs961253-A	rs961253	0	961253	intergenic_variant	1	0.36	2E-10	9.698970004336019		1.12	[1.08-1.16]	Illumina [up to 548586]	N
2008-12-01	19011631	Houlston RS	2008-11-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19011631	Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.	Colorectal cancer	1,902 European ancestry cases, 1,929 European ancestry controls	18,284 European ancestry cases, 18,926 European ancestry controls	16q22.1	16	68787043	CDH1	CDH1			999			rs9929218-G	rs9929218	0	9929218	intron_variant	0	0.29	1E-8	8.0		1.1	[1.06-1.12]	Illumina [up to 548586]	N
2008-12-01	19011631	Houlston RS	2008-11-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19011631	Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.	Colorectal cancer	1,902 European ancestry cases, 1,929 European ancestry controls	18,284 European ancestry cases, 18,926 European ancestry controls	14q22.2	14	53944201	BMP4	LOC107984676 - MIR5580	107984676	100847076		27304	4226	rs4444235-C	rs4444235	0	4444235	downstream_gene_variant	1	0.46	8E-10	9.096910013008056		1.11	[1.08-1.15]	Illumina [up to 548586]	N
2011-08-15	21761138	Peters U	2011-07-15	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21761138	Meta-analysis of new genome-wide association studies of colorectal cancer risk.	Colorectal cancer	2,906 European ancestry cases, 3,416 European ancestry controls	8,161 European ancestry cases, 9,101 European ancestry controls	18q21.1	18	48927093	SMAD7	SMAD7			4092			rs4939827-?	rs4939827	0	4939827	intron_variant	0	0.51	1E-7	7.0		1.14	[1.08-1.18]	Illumina [378739]	N
2011-08-15	21761138	Peters U	2011-07-15	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21761138	Meta-analysis of new genome-wide association studies of colorectal cancer risk.	Colorectal cancer	2,906 European ancestry cases, 3,416 European ancestry controls	8,161 European ancestry cases, 9,101 European ancestry controls	15q13.3	15	32702555	GREM1, SCG5	SCG5 - GREM1	6447	26585		5458	15385	rs4779584-?	rs4779584	0	4779584	intergenic_variant	1	0.19	2E-8	7.698970004336019		1.18	[1.11-1.24]	Illumina [378739]	N
2011-08-15	21761138	Peters U	2011-07-15	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21761138	Meta-analysis of new genome-wide association studies of colorectal cancer risk.	Colorectal cancer	2,906 European ancestry cases, 3,416 European ancestry controls	8,161 European ancestry cases, 9,101 European ancestry controls	8q23.3	8	116618444	EIF3H	LOC105375712 - EIF3H	105375712	8667		3110	26372	rs16892766-?	rs16892766	0	16892766	regulatory_region_variant	1	0.08	4E-7	6.3979400086720375		1.24	[1.14-1.34]	Illumina [378739]	N
2011-08-15	21761138	Peters U	2011-07-15	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21761138	Meta-analysis of new genome-wide association studies of colorectal cancer risk.	Colorectal cancer	2,906 European ancestry cases, 3,416 European ancestry controls	8,161 European ancestry cases, 9,101 European ancestry controls	11q23.1	11	111300984	LOC120376	COLCA1, COLCA2			399948, 120376			rs3802842-?	rs3802842	0	3802842	intron_variant	0	0.28	4E-7	6.3979400086720375		1.14	[1.08-1.20]	Illumina [378739]	N
2011-08-15	21761138	Peters U	2011-07-15	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21761138	Meta-analysis of new genome-wide association studies of colorectal cancer risk.	Colorectal cancer	2,906 European ancestry cases, 3,416 European ancestry controls	8,161 European ancestry cases, 9,101 European ancestry controls	12q24.21	12	115453598	MED13L	LOC105370003			105370003			rs7315438-?	rs7315438	0	7315438	intergenic_variant	0	0.58	6E-6	5.221848749616356		1.11	[1.06-1.15]	Illumina [378739]	N
2010-12-09	20972440	Houlston RS	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972440	Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.	Colorectal cancer	3,334 European ancestry cases, 4,628 European ancestry controls	14,851 European ancestry cases, 15,569 European ancestry controls	12q13.12	12	50761880	DIP2B, ATF1	DIP2B - ATF1	57609	466		13213	1802	rs11169552-C	rs11169552	0	11169552	upstream_gene_variant	1	NR	2E-10	9.698970004336019		1.09	[1.05-1.11]	Illumina [up to 550000] (imputed)	N
2010-12-09	20972440	Houlston RS	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972440	Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.	Colorectal cancer	3,334 European ancestry cases, 4,628 European ancestry controls	14,851 European ancestry cases, 15,569 European ancestry controls	1q41	1	221991606	DUSP10	LOC105372950 - LOC107985307	105372950	107985307		72894	50098	rs6687758-G	rs6687758	0	6687758	regulatory_region_variant	1	NR	2E-9	8.698970004336019		1.09	[1.06-1.12]	Illumina [up to 550000] (imputed)	N
2012-07-17	22634755	Dunlop MG	2012-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22634755	Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.	Colorectal cancer	8,323 European ancestry cases, 9,457 European ancestry controls	19,513 European ancestry cases, 17,657 European ancestry controls, 1,583 Japanese ancestry cases, 1,898 Japanese ancestry controls	6p21.2	6	36655123	CDKN1A	LOC105375038 - PANDAR	105375038	101154753		13103	18498	rs1321311-?	rs1321311	0	1321311	regulatory_region_variant	1	NR	1E-10	10.0		1.1	[1.07-1.13]	Illumina [NR] (imputed)	N
2012-07-17	22634755	Dunlop MG	2012-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22634755	Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.	Colorectal cancer	8,323 European ancestry cases, 9,457 European ancestry controls	19,513 European ancestry cases, 17,657 European ancestry controls, 1,583 Japanese ancestry cases, 1,898 Japanese ancestry controls	11q13.4	11	74634505	POLD3	POLD3			10714			rs3824999-?	rs3824999	0	3824999	intron_variant	0	NR	4E-10	9.397940008672037		1.08	[1.05-1.10]	Illumina [NR] (imputed)	N
2012-07-17	22634755	Dunlop MG	2012-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22634755	Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.	Colorectal cancer	8,323 European ancestry cases, 9,457 European ancestry controls	19,513 European ancestry cases, 17,657 European ancestry controls, 1,583 Japanese ancestry cases, 1,898 Japanese ancestry controls	Xp22.2	X	9783434	SHROOM2	GPR143 - SHROOM2	4935	357		17469	2972	rs5934683-?	rs5934683	0	5934683	intron_variant	1	NR	7E-10	9.154901959985743		1.07	[1.04-1.10]	Illumina [NR] (imputed)	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	1q32.1	1	204549714	MDM4	MDM4			4194			rs4245739-C	rs4245739	0	4245739	3_prime_UTR_variant	0		4E-6	5.3979400086720375		1.19	[1.11-1.29]	Illumina [NR] (imputed)	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-A	rs10069690	0	10069690	intron_variant	0		1E-7	7.0		1.24	[1.14-1.34]	Illumina [NR] (imputed)	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	6q25.1	6	151592978	ESR1	CCDC170			80129			rs3757318-A	rs3757318	0	3757318	intron_variant	0		9E-6	5.045757490560675		1.33	[1.17-1.51]	Illumina [NR] (imputed)	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	19p13.11	19	17283315	intergenic	ANKLE1			126549			rs2363956-C	rs2363956	0	2363956	missense_variant	0		2E-8	7.698970004336019		1.2195	[1.14-1.3]	Illumina [NR] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	10q24.2	10	99585609	SLC25A28, ABCC2, MRP2, NKX2-3	NKX2-3 - SLC25A28	159296	81894		49085	24909	rs1035209-T	rs1035209	0	1035209	intergenic_variant	1	0.195	5E-11	10.301029995663981		1.12	[1.08-1.16]	Illumina [NR] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	10p14	10	8047173	GATA3, GATA-AS1	GATA3			2625			rs4143094-T	rs4143094	0	4143094	upstream_gene_variant	0	0.21-0.27	9E-9	8.045757490560675	(Processed meat)	1.17	[1.11-1.23]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	2p14	2	66738934	MEIS1, DNMT3AP1	LOC101927577 - DNMT3AP1	101927577	130802		35707	80991	rs2901879-?	rs2901879	0	2901879	intergenic_variant	1	0.41-0.49	7E-7	6.154901959985743	(Red meat)	1.11	[1.06-1.16]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	15q26.1	15	92316651	NPM1P5, ST8SIA2	NPM1P5 - ST8SIA2	4874	8128		29417	77259	rs1871438-?	rs1871438	0	1871438	intron_variant	1	0.51-0.56	8E-7	6.096910013008056	(Red meat)	1.11	[1.07-1.16]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	7p12.3	7	47199109	MRPL42P4, TNS3	LOC105375268 - LOC107986793	105375268	107986793		119300	52991	rs1370916-?	rs1370916	0	1370916	intergenic_variant	1	0.46-0.52	2E-6	5.698970004336019	(Red meat)	1.11	[1.06-1.15]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	2q13	2	110970905	ACOXL	ACOXL			55289			rs4849303-?	rs4849303	0	4849303	intron_variant	0	0.47-0.54	1E-6	6.0	(Vegetable)	1.12	[1.08-1.18]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	4p15.31	4	18793707	LCORL, RPL21P46	LOC105374510			105374510			rs4147045-?	rs4147045	0	4147045	intergenic_variant	0	0.08-0.12	1E-6	6.0	(Vegetable)	1.2	[1.11-1.3]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	8p22	8	12915246	KIAA1456, LONRF1	LOC105379289 - KIAA1456	105379289	57604		24510	30428	rs6989010-?	rs6989010	0	6989010	intergenic_variant	1	0.98-0.99	2E-6	5.698970004336019	(Vegetable)	1.64	[1.33-2]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	13q14.2	13	47795595	RPL27AP8, SUCLA2	RPL27AP8 - LOC107984570	100271605	107984570		28497	108211	rs7999699-?	rs7999699	0	7999699	regulatory_region_variant	1	0.38-0.47	3E-6	5.522878745280337	(Fruit)	1.32	[1.18-1.47]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	19p12	19	22611884	VN1R86P, ZNF492	LOC100420273 - LOC374890	100420273	374890		1090	3673	rs11671104-?	rs11671104	0	11671104	downstream_gene_variant	1	0.89-0.94	4E-6	5.3979400086720375	(Fruit)	1.25	[1.13-1.37]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	19q13.32	19	46470746	PNMAL1	PNMAL1			55228			rs7248888-?	rs7248888	0	7248888	missense_variant	0	0.93-0.97	5E-6	5.301029995663981	(Fruit)	1.37	[1.19-1.56]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	3q13.13	3	108984178	MORC1	MORC1			27136			rs2593957-?	rs2593957	0	2593957	intron_variant	0	0.40-0.46	2E-6	5.698970004336019	(Fiber)	1.15	[1.09-1.2]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	7q36.2	7	154889200	DPP6	DPP6			1804			rs12534701-?	rs12534701	0	12534701	intron_variant	0	0.54-0.62	2E-6	5.698970004336019	(Fiber)	1.17	[1.09-1.24]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-07	24743840	Figueiredo JC	2014-04-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/24743840	Genome-wide diet-gene interaction analyses for risk of colorectal cancer.	Colorectal cancer (diet interaction)	9,287 European ancestry cases, 9,117 European ancestry controls	NA	3q13.13	3	109132637	MORC1, FLJ22763	MORC1 - FLJ22763	27136	401081		14491	4077	rs4855695-?	rs4855695	0	4855695	intron_variant	1	0.51-0.58	2E-6	5.698970004336019	(Fiber)	1.14	[1.08-1.20]	Affymetrix, Illumina [> 2700000] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	8q23.3	8	116562277	EIF3H	LOC105375711 - LOC105375712	105375711	105375712		87874	42242	rs140355816-G	rs140355816	0	140355816	intergenic_variant	1	0.017	2E-8	7.698970004336019		1.591	[NR]	Illumina [NR] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	8q24.21	8	127395198	MYC	CASC8			727677			rs10505477-T	rs10505477	0	10505477	intron_variant	0	0.54	8E-13	12.096910013008056		1.198	[NR]	Illumina [NR] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	10p14	10	8697617	GATA3	LOC105376400 - LOC105755953	105376400	105755953		27815	200372	rs11255841-T	rs11255841	0	11255841	intergenic_variant	1	0.68	7E-11	10.154901959985743		1.19	[NR]	Illumina [NR] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	12q13.12	12	50179650	DIP2B, ATF1	LIMA1			51474			rs34245511-C	rs34245511	0	34245511	intron_variant	0	0.346	3E-8	7.522878745280337		1.144	[NR]	Illumina [NR] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	15q13.3	15	32720301	GREM1, SCG5	GREM1			26585			rs73376930-G	rs73376930	0	73376930	intron_variant	0	0.207	1E-11	11.0		1.246	[NR]	Illumina [NR] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	19q13.11	19	33036982	GPATCH1, RHPN2	RHPN2			85415			rs13343954-T	rs13343954	0	13343954	intron_variant	0	0.857	7E-8	7.154901959985743		1.183	[NR]	Illumina [NR] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	20p12.3	20	6399697	BMP2	FGFR3P3 - CASC20	100462816	101929244		178952	27035	rs57046232-T	rs57046232	1	34033947	intergenic_variant	1	0.369	3E-6	5.522878745280337		1.107	[NR]	Illumina [NR] (imputed)	N
2014-11-08	24737748	Whiffin N	2014-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24737748	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	Colorectal cancer	5,626 European ancestry cases, 7,817 European ancestry controls	14,037 European ancestry cases, 15,937 European ancestry controls	20q13.33	20	62394395	LAMA5	CABLES2			81928			rs2427308-C	rs2427308	0	2427308	intron_variant	0	0.78	3E-11	10.522878745280337		1.235	[NR]	Illumina [NR] (imputed)	N
2016-02-13	25990418	Al-Tassan NA	2015-05-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/25990418	A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.	Colorectal cancer	7,577 European ancestry cases, 9,979 European ancestry controls	NA	15q13.3	15	32718211	GREM1, SCG5	LOC100131315, GREM1			100131315, 26585			rs2293582-A	rs2293582	0	2293582	non_coding_transcript_exon_variant	0	0.21	3E-11	10.522878745280337		1.21	[NR]	Affymetrix, Illumina [~ 10000000] (imputed)	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	4q31.23	4	149751362	intergenic	LOC285423			285423			rs17026425-?	rs17026425	0	17026425	intron_variant	0		7E-7	6.154901959985743	(overall survival)	5.06	[2.67-9.60]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	4q13.3	4	74821455	intergenic	BTC - LOC105377278	685	105377278		26737	9672	rs6854845-?	rs6854845	0	6854845	intergenic_variant	1		9E-7	6.045757490560675	(overall survival)	4.12	[2.34-7.26]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	5q13.1	5	67999079	intergenic	LOC107986420 - RNU6-1232P	107986420	106480105		17296	159982	rs157411-?	rs157411	0	157411	regulatory_region_variant	1		2E-6	5.698970004336019	(overall survival)	2.89	[1.86-4.47]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	8q24.22	8	131922291	EFR3A	EFR3A			23167			rs7004484-?	rs7004484	0	7004484	intron_variant	0		2E-6	5.698970004336019	(overall survival)	2.79	[1.83-4.25]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	15q23	15	67967670	intergenic	RNU6-1 - LOC100286942	26827	100286942		127625	6147	rs338389-?	rs338389	0	338389	intergenic_variant	1		3E-6	5.522878745280337	(overall survival)	3.4	[2.04-5.67]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	10p15.3	10	791467	intergenic	DIP2C - LARP4B	22982	23185		101757	15447	rs1555895-?	rs1555895	0	1555895	intergenic_variant	1		3E-6	5.522878745280337	(overall survival)	2.94	[1.85-4.55]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	2q31.3	2	180594207	intergenic	LOC105373770 - SCHLAP1	105373770	101669767		22386	97897	rs16867335-?	rs16867335	0	16867335	intron_variant	1		4E-6	5.3979400086720375	(overall survival)	3.27	[1.98-5.42]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	6p25.1	6	6786192	intergenic	LOC101928004			101928004			rs1573948-?	rs1573948	0	1573948	intergenic_variant	0		4E-6	5.3979400086720375	(overall survival)	2.71	[1.77-4.15]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	15q14	15	37837578	intergenic	LOC105370773 - TMCO5A	105370773	145942		156849	97029	rs10152207-?	rs10152207	0	10152207	regulatory_region_variant	1		5E-6	5.301029995663981	(overall survival)	3.06	[1.90-4.93]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	10q25.3	10	113528742	intergenic	LOC107984270 - HABP2	107984270	3026		36548	22089	rs1570271-?	rs1570271	0	1570271	intergenic_variant	1		1E-7	7.0	(disease-free survival)	3.66	[2.26-5.94]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	5q33.3	5	159821007	AC011343.1	LOC101927766			101927766			rs17057166-?	rs17057166	0	17057166	intron_variant	0		2E-7	6.698970004336019	(disease-free survival)	5.56	[2.91-10.64]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	5q35.2	5	173704454	intergenic	LOC105377736			105377736			rs4868304-?	rs4868304	0	4868304	intron_variant	0		3E-7	6.522878745280337	(disease-free survival)	2.91	[1.94-4.37]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	4q13.3	4	74821455	intergenic	BTC - LOC105377278	685	105377278		26737	9672	rs6854845-?	rs6854845	0	6854845	intergenic_variant	1		6E-7	6.221848749616356	(disease-free survival)	3.31	[2.07-5.30]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	6p25.2	6	3294794	SLC22A23	PSMG4, SLC22A23			389362, 63027			rs4959799-?	rs4959799	0	4959799	intron_variant	0		5E-6	5.301029995663981	(disease-free survival)	3.5	[2.05-5.99]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	9q21.31	9	79445613	intergenic	CHCHD2P9 - LOC102723932	645345	102723932		53578	72260	rs11138220-?	rs11138220	0	11138220	intergenic_variant	1		8E-6	5.096910013008056	(disease-free survival)	2.76	[1.77-4.31]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	7p21.1	7	19121274	intergenic	TWIST1 - FERD3L	7291	222894		3602	23508	rs10275272-?	rs10275272	0	10275272	intron_variant	1		8E-6	5.096910013008056	(disease-free survival)	3.19	[1.92-5.31]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	11q13.3	11	70153146	ANO1	ANO1			55107			rs3781663-?	rs3781663	0	3781663	intron_variant	0		8E-6	5.096910013008056	(disease-free survival)	2.24	[1.57-3.19]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in rectal cancer	171 European ancestry cases	NA	10q26.3	10	131698817	intergenic	LOC101927461 - LINC01164	101927461	399827		383127	73581	rs9419702-?	rs9419702	0	9419702	intergenic_variant	1		9E-6	5.045757490560675	(disease-free survival)	2.54	[1.68-3.83]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	6q25.3	6	156266886	LOC101928923	LOC101928923			101928923			rs17087282-?	rs17087282	0	17087282	intergenic_variant	0		2E-6	5.698970004336019	(overall survival)	2.47	[1.71-3.56]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	2q14.1	2	114456179	DPP10	DPP10			57628			rs17048372-?	rs17048372	0	17048372	intron_variant	0		2E-6	5.698970004336019	(overall survival)	1.91	[1.46-2.48]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	9p23	9	13704540	intergenic	LOC105375977 - LOC101929507	105375977	101929507		217391	107142	rs1998584-?	rs1998584	0	1998584	intergenic_variant	1		2E-6	5.698970004336019	(overall survival)	1.76	[1.39-2.22]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	2p21	2	45181130	LINC01121	LINC01121			400952			rs6720296-?	rs6720296	0	6720296	intron_variant	0		3E-6	5.522878745280337	(overall survival)	1.74	[1.38-2.19]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	5q34	5	163158639	intergenic	LOC105377700			105377700			rs12187751-?	rs12187751	0	12187751	intron_variant	0		3E-6	5.522878745280337	(overall survival)	2.48	[1.70-3.64]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	6p25.1	6	6786192	intergenic	LOC101928004			101928004			rs1573948-?	rs1573948	0	1573948	intergenic_variant	0		5E-6	5.301029995663981	(overall survival)	1.93	[1.46-2.57]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	5p15.31	5	6353702	intergenic	LOC105374638			105374638			rs10040610-?	rs10040610	0	10040610	intergenic_variant	0		8E-6	5.096910013008056	(overall survival)	1.96	[1.46-2.63]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	5q33.2	5	153611838	GRIA1	GRIA1			2890			rs1493383-?	rs1493383	0	1493383	intron_variant	0		8E-6	5.096910013008056	(overall survival)	1.81	[1.39-2.35]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	5p12	5	45265666	HCN1	HCN1			348980			rs13180087-?	rs13180087	0	13180087	intron_variant	0		9E-6	5.045757490560675	(overall survival)	2.06	[1.50-2.83]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	2p21	2	45181130	LINC01121	LINC01121			400952			rs6720296-?	rs6720296	0	6720296	intron_variant	0		5E-7	6.301029995663981	(disease-free survival)	1.74	[1.40-2.16]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	9q22.33	9	98882256	intergenic	LOC102724684 - LOC100288125	102724684	100288125		4923	8173	rs1407508-?	rs1407508	0	1407508	regulatory_region_variant	1		9E-7	6.045757490560675	(disease-free survival)	2.53	[1.75-3.66]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in microsatellite instability low/stable colorectal cancer	431 European ancestry cases	NA	13q12.3	13	31124157	intergenic	WDR95P - HSPH1	100873795	10808		8458	10817	rs912294-?	rs912294	0	912294	intergenic_variant	1		5E-6	5.301029995663981	(disease-free survival)	1.67	[1.34-2.08]	Illumina [729737]	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	3p22.1	3	40883471	CTNNB1	LOC105377043 - LOC105377045	105377043	105377045		7059	166986	rs3536032-A	rs35360328	0	35360328	intergenic_variant	1	0.16	2E-8	7.698970004336019	(EA)	1.14	[1.09–1.19]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	3p14.1	3	66392011	SLC25A26, LRIG1	LRIG1			26018			rs812481-G	rs812481	0	812481	intron_variant	0	0.58	3E-8	7.522878745280337	(EA)	1.09	[1.05–1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	10q24.2	10	99591947	ENTPD7, COX15, CUTC, ABCC2, SLC25A28	NKX2-3 - SLC25A28	159296	81894		55423	18571	rs11190164-G	rs11190164	0	11190164	intergenic_variant	1	0.29	8E-7	6.096910013008056	(EA)	1.1	[1.05–1.14]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	12q24.12	12	111446804	CUX2, BRAP, ACAD10, SH2B3	SH2B3			10019			rs3184504-C	rs3184504	0	3184504	missense_variant	0	0.53	2E-8	7.698970004336019	(EA)	1.09	[1.06–1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	12q24.22	12	117309785	NOS1	NOS1			4842			rs73208120-G	rs73208120	0	73208120	intron_variant	0	0.11	3E-8	7.522878745280337	(EA)	1.16	[1.11–1.23]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	6q22.1	6	117501830	NR	DCBLD1			285761			rs4946260-T	rs4946260	0	4946260	intron_variant	0	0.53	5E-7	6.301029995663981	(EA)	1.08	[1.05–1.11]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-10-12	26586795	Phipps AI	2015-11-19	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/26586795	Common Genetic Variation and Survival after Colorectal Cancer Diagnosis: A Genome-Wide Analysis.	Survival in colorectal cancer (non-distant metastatic)	up to 2,843 European ancestry cases	up to 3,205 European ancestry cases	15q13.3	15	31449013	OTUD7A	KLF13 - LOC400347	51621	400347		13348	4188	rs1075232-A	rs1075232	0	1075232	downstream_gene_variant	1	0.05	3E-6	5.522878745280337	(Overall Survival)	1.49	[1.26-1.76]	Illumina [~ 2700000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	3p22.1	3	40883471	CTNNB1	LOC105377043 - LOC105377045	105377043	105377045		7059	166986	rs35360328-A	rs35360328	0	35360328	intergenic_variant	1	0.16	3E-9	8.522878745280337		1.14	[1.09-1.19]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	3p14.1	3	66392011	SLC25A26, LRIG1	LRIG1			26018			rs812481-G	rs812481	0	812481	intron_variant	0	0.58	2E-8	7.698970004336019		1.09	[1.05-1.11]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	10q24.2	10	99591947	ENTPD7, COX15, CUTC, ABCC2, SLC25A28	NKX2-3 - SLC25A28	159296	81894		55423	18571	rs11190164-G	rs11190164	0	11190164	intergenic_variant	1	0.29	4E-8	7.3979400086720375		1.09	[1.06-1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	12q24.12	12	111446804	SH2B3, CUX2, BRAP, ACAD10	SH2B3			10019			rs3184504-C	rs3184504	0	3184504	missense_variant	0	0.53	2E-8	7.698970004336019		1.09	[1.06-1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	12q24.22	12	117309785	NOS1	NOS1			4842			rs73208120-G	rs73208120	0	73208120	intron_variant	0	0.11	3E-8	7.522878745280337		1.16	[1.11-1.23]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	20q13.13	20	48723580	PREX1	PREX1			57580			rs6066825-A	rs6066825	0	6066825	intron_variant	0	0.64	4E-9	8.397940008672037		1.09	[1.06-1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	6q22.1	6	117501830	NR	DCBLD1			285761			rs4946260-T	rs4946260	0	4946260	intron_variant	0	0.53	6E-8	7.221848749616356		1.07	[1.05-1.10]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	8q23.3	8	116618444	EIF3H	LOC105375712 - EIF3H	105375712	8667		3110	26372	rs16892766-C	rs16892766	0	16892766	regulatory_region_variant	1	0.1	3E-12	11.522878745280337		1.2048193	[1.15-1.26]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	8q24.21	8	127401060	MYC	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.5	4E-14	13.397940008672037		1.1235955	[1.09-1.15]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	11q13.4	11	74634505	POLD3	POLD3			10714			rs3824999-G	rs3824999	0	3824999	intron_variant	0	0.53	1E-6	6.0		1.0752687	[1.05-1.1]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	11q23.1	11	111300984	C11orf93	COLCA1, COLCA2			399948, 120376			rs3802842-C	rs3802842	0	3802842	intron_variant	0	0.28	1E-10	10.0		1.1235955	[1.09-1.16]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	12p13.32	12	4296223	CCND2	CCND2			894			rs3217901-G	rs3217901	0	3217901	intron_variant	0	0.41	2E-6	5.698970004336019		1.0869565	[1.05-1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	14q22.2	14	53944201	BMP4	LOC107984676 - MIR5580	107984676	100847076		27304	4226	rs4444235-C	rs4444235	0	4444235	downstream_gene_variant	1	0.49	5E-8	7.301029995663981		1.0869565	[1.06-1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	15q13.3	15	32702555	CRAC1, HMPS, GREM1	SCG5 - GREM1	6447	26585		5458	15385	rs4779584-T	rs4779584	0	4779584	intergenic_variant	1	0.81	1E-8	8.0		1.12	[1.08-1.16]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	18q21.1	18	48927093	SMAD7	SMAD7			4092			rs4939827-T	rs4939827	0	4939827	intron_variant	0	0.54	2E-15	14.698970004336019		1.13	[1.1-1.16]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-06-10	26151821	Schumacher FR	2015-07-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26151821	Genome-wide association study of colorectal cancer identifies six new susceptibility loci.	Colorectal cancer	18,299 European ancestry cases, 19,656 European ancestry controls	4,725 East Asian ancestry cases, 9,969 East Asian ancestry controls	20p12.3	20	6423634	BMP2	FGFR3P3 - CASC20	100462816	101929244		202889	3098	rs961253-A	rs961253	0	961253	intergenic_variant	1	0.37	1E-7	7.0		1.09	[1.06-1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-04-01	25023989	Schmit SL	2014-07-14	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/25023989	A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study.	Colorectal cancer	485 Ashkenazi Jewish cases, 498 Ashkenazi Jewish controls, 1,977 European ancestry cases, 999 European ancestry controls	1,131 Ashkenazi Jewish cases, 831 Ashkenazi Jewish controls	4q32.2	4	162412253	FSTL5, NAF1	MTHFD2P4 - TOMM22P4	100131135	100874517		88349	109449	rs35509282-A	rs35509282	0	35509282	intergenic_variant	1	NR	8E-9	8.096910013008056		1.53	[1.39-1.67]	Illumina [up to 9177523] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	20p11.1	20	25995038	NANP	LOC101926955 - LOC100134868	101926955	100134868		25750	14761	rs6051080-A	rs6051080	0	6051080	intergenic_variant	1	0.649	1E-7	7.0	(same direction)	1.12	[1.08-1.17]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	19p12	19	21569009	ZNF429	ZNF429 - LOC101929007	353088	101929007		27852	893	rs11085466-G	rs11085466	0	11085466	intron_variant	1	0.782	2E-7	6.698970004336019	(same direction)	1.15	[1.09-1.22]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	6q15	6	88856018	RNGTT	RNGTT			8732			rs17503919-A	rs17503919	0	17503919	intron_variant	0	0.862	2E-7	6.698970004336019	(same direction)	1.17	[1.11-1.25]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	10p12.31	10	19031157	ARL5B	LOC107984180 - MALRD1	107984180	340895		100480	15774	rs76225372-A	rs76225372	0	76225372	intergenic_variant	1	0.912	2E-7	6.698970004336019	(same direction)	1.21	[1.13-1.31]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	6q25.2	6	154800125	SCAF8	SCAF8			22828			rs7740797-G	rs7740797	0	7740797	intron_variant	0	0.513	2E-7	6.698970004336019	(same direction)	1.12	[1.07-1.16]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	6p22.3	6	24651092	TDP2	TDP2			51567			rs3181245-C	rs3181245	0	3181245	intron_variant	0	0.514	2E-7	6.698970004336019	(same direction)	1.12	[1.07-1.16]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	17q21.2	17	42603793	PSMC3IP	FAM134C			162427			rs9901225-T	rs9901225	0	9901225	intron_variant	0	0.55	1E-6	6.0	(same direction)	1.11	[1.06-1.16]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	12p11.22	12	29680396	TMTC1	TMTC1			83857			rs2052678-?	rs2052678	0	2052678	intron_variant	0	0.139	1E-7	7.0	(same direction)	1.1627907	[1.1-1.23]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	2q24.3	2	165696408	CSRNP3	CSRNP3 - GALNT3	80034	2591		7001	51395	rs34462569-G	rs34462569	0	34462569	intergenic_variant	1	0.934	4E-6	5.3979400086720375	(opposite direction)	1.22	[1.12-1.33]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	7q36.1	7	149043401	EZH2	RNU6-650P - COX6B1P1	106481387	140603		10235	10466	rs4727012-C	rs4727012	0	4727012	intergenic_variant	1	0.891	1E-6	6.0	(opposite direction)	1.18	[1.10-1.26]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	9q22.32	9	94720876	FBP1	LOC107987101 - C9orf3	107987101	84909		20717	5728	rs112541862-A	rs112541862	0	112541862	intergenic_variant	1	0.962	4E-6	5.3979400086720375	(opposite direction)	1.3	[1.16-1.45]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	11q13.5	11	75537412	GDPD5	GDPD5 - SERPINH1	81544	871		11496	24644	rs606460-G	rs606460	0	606460	regulatory_region_variant	1	0.725	4E-6	5.3979400086720375	(opposite direction)	1.11	[1.06-1.17]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	11q14.1	11	82100187	PRCP	LOC101928989			101928989			rs11607499-T	rs11607499	0	11607499	non_coding_transcript_exon_variant	0	0.954	2E-6	5.698970004336019	(opposite direction)	1.27	[1.15-1.40]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	12q13.12	12	50185615	LIMA1	LIMA1			51474			rs12817211-C	rs12817211	0	12817211	non_coding_transcript_exon_variant	0	0.767	3E-6	5.522878745280337	(opposite direction)	1.12	[1.07-1.18]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	16q23.1	16	78042662	CLEC3A	CLEC3A - KRT8P22	10143	342419		10556	5575	rs11150038-G	rs11150038	0	11150038	intron_variant	1	0.944	1E-6	6.0	(opposite direction)	1.27	[1.15-1.39]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	NA	21q21.2	21	23048180	NCAM2	LOC107985494 - MIR6130	107985494	102466967		487604	31104	rs4816890-?	rs4816890	0	4816890	intergenic_variant	1	0.363	2E-6	5.698970004336019	(opposite direction)	1.1111112	[1.06-1.16]	Illumina [up to 6000000] (imputed)	N
2016-10-12	26586795	Phipps AI	2015-11-19	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/26586795	Common Genetic Variation and Survival after Colorectal Cancer Diagnosis: A Genome-Wide Analysis.	Survival in colorectal cancer (distant metastatic)	up to 462 European ancestry cases	up to 435 European ancestry cases	6p12.1	6	53312880	ELOVL5	ELOVL5			60481			rs209489-C	rs209489	0	209489	intron_variant	0	0.08	4E-9	8.397940008672037	(Overall Survival)	1.77	[1.46-2.14]	Illumina [~ 2700000] (imputed)	N
2016-10-12	26586795	Phipps AI	2015-11-19	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/26586795	Common Genetic Variation and Survival after Colorectal Cancer Diagnosis: A Genome-Wide Analysis.	Survival in colorectal cancer (distant metastatic)	up to 462 European ancestry cases	up to 435 European ancestry cases	18q21.2	18	53590462	DCC	LOC102724651			102724651			rs1372474-G	rs1372474	0	1372474	intron_variant	0	0.1	2E-6	5.698970004336019	(Overall Survival)	1.53	[1.28-1.83]	Illumina [~ 2700000] (imputed)	N
2016-10-12	26586795	Phipps AI	2015-11-19	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/26586795	Common Genetic Variation and Survival after Colorectal Cancer Diagnosis: A Genome-Wide Analysis.	Survival in colorectal cancer (distant metastatic)	up to 462 European ancestry cases	up to 435 European ancestry cases	6p12.1	6	53312880	ELOVL5	ELOVL5			60481			rs209489-C	rs209489	0	209489	intron_variant	0	0.08	8E-10	9.096910013008056	(Disease-Specific Survival)	1.83	[1.51-2.22]	Illumina [~ 2700000] (imputed)	N
2016-10-12	26586795	Phipps AI	2015-11-19	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/26586795	Common Genetic Variation and Survival after Colorectal Cancer Diagnosis: A Genome-Wide Analysis.	Survival in colorectal cancer (distant metastatic)	up to 462 European ancestry cases	up to 435 European ancestry cases	18q21.2	18	53580709	DCC	LOC102724651, LOC101928167			102724651, 101928167			rs1442089-C	rs1442089	0	1442089	non_coding_transcript_exon_variant	0	0.09	2E-6	5.698970004336019	(Disease-Specific Survival)	1.56	[1.3-1.87]	Illumina [~ 2700000] (imputed)	N
2017-04-01	27723779	Gong J	2016-10-10	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/27723779	Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer.	Colorectal cancer (alcohol consumption interaction)	8,058 European ancestry non/occasional, light-to-moderate, and heavy drinker cases, 8,765 European ancestry non/occasional, light-to-moderate, and heavy drinker controls	NA	9q22.32	9	94488752	HIATL1, FBP2	LOC107987100			107987100			rs9409565-C	rs9409565	0	9409565	intergenic_variant	0	NR	2E-8	7.698970004336019	(Light-to-moderate drinkers)	1.35	[1.21-1.49]	Affymetrix, Illumina [~ 2700000] (imputed)	N
2017-04-01	27723779	Gong J	2016-10-10	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/27723779	Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer.	Colorectal cancer (alcohol consumption interaction)	8,058 European ancestry non/occasional, light-to-moderate, and heavy drinker cases, 8,765 European ancestry non/occasional, light-to-moderate, and heavy drinker controls	NA	9q22.32	9	94488752	HIATL1, FBP2	LOC107987100			107987100			rs9409565-C	rs9409565	0	9409565	intergenic_variant	0	NR	1E-7	7.0	(light/moderate and heavy drinkers)	1.23	[1.04-1.45]	Affymetrix, Illumina [~ 2700000] (imputed)	N
2016-12-21	27145994	Wang M	2016-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27145994	Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.	Colorectal cancer	1,023 Han Chinese ancestry cases and 1,306 Han Chinese ancestry controls	5,317 Han Chinese ancestry cases, 6,887 Han Chinese ancestry controls, 1,046 European ancestry cases, 1,076 European ancestry controls	12p13.2	12	11856807	ETV6	ETV6			2120			rs2238126-G	rs2238126	0	2238126	intron_variant	0		3E-11	10.522878745280337		1.17	[1.12-1.23]	Illumina [691326]	N
2016-12-21	27145994	Wang M	2016-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27145994	Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.	Colorectal cancer	1,023 Han Chinese ancestry cases and 1,306 Han Chinese ancestry controls	5,317 Han Chinese ancestry cases, 6,887 Han Chinese ancestry controls, 1,046 European ancestry cases, 1,076 European ancestry controls	17p13.3	17	897353	NXN	NXN			64359			rs12603526-C	rs12603526	0	12603526	intron_variant	0	0.184	3E-6	5.522878745280337	Han Chinese	1.44	[1.24-1.68]	Illumina [691326]	N
2016-12-21	27145994	Wang M	2016-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27145994	Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.	Colorectal cancer	1,023 Han Chinese ancestry cases and 1,306 Han Chinese ancestry controls	5,317 Han Chinese ancestry cases, 6,887 Han Chinese ancestry controls, 1,046 European ancestry cases, 1,076 European ancestry controls	19q13.2	19	41354391	TGFB1	TGFB1 - B9D2	7040	80776		458	26	rs1800469-A	rs1800469	0	1800469	intron_variant	1	0.456	4E-7	6.3979400086720375	Han Chinese	1.36	[1.21-1.53]	Illumina [691326]	N
2016-12-21	27145994	Wang M	2016-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27145994	Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.	Colorectal cancer	1,023 Han Chinese ancestry cases and 1,306 Han Chinese ancestry controls	5,317 Han Chinese ancestry cases, 6,887 Han Chinese ancestry controls, 1,046 European ancestry cases, 1,076 European ancestry controls	12p13.2	12	11856807	ETV6	ETV6			2120			rs2238126-G	rs2238126	0	2238126	intron_variant	0	0.477	3E-10	9.522878745280337	Han Chinese	1.17	1.11-1.23	Illumina [691326]	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	3q12.3	3	101881880	NR	NFKBIZ - LOC152225	64332	152225		20855	58979	rs651907-C	rs651907	0	651907	intergenic_variant	1	0.54	9E-6	5.045757490560675		1.0752687	[1.04-1.1]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	6p21.1	6	41725074	TFEB	TFEB			7942			rs4711689-A	rs4711689	0	4711689	intron_variant	0	0.85	4E-8	7.3979400086720375		1.11	[1.07-1.15]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	8q23.3	8	116611854	EIF3H	LOC105375712			105375712			rs2450115-T	rs2450115	0	2450115	intergenic_variant	0	0.58	1E-12	12.0		1.12	[1.08-1.15]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	8q23.3	8	116635549	EIF3H	LOC105375712 - EIF3H	105375712	8667		20215	9267	rs6469656-A	rs6469656	0	6469656	intergenic_variant	1	0.67	2E-12	11.698970004336019		1.11	[1.08-1.14]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	10q21.1	10	58811675	NR	BICC1			80114			rs4948317-C	rs4948317	0	4948317	intron_variant	0	0.27	2E-7	6.698970004336019		1.0869565	[1.05-1.12]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	10q24.2	10	99529178	NR	LINC01475			101927324			rs12412391-G	rs12412391	0	12412391	intron_variant	0	0.4	4E-7	6.3979400086720375		1.0752687	[1.04-1.1]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	10q24.32	10	102835491	CYP17A1	CYP17A1			1586			rs4919687-G	rs4919687	0	4919687	non_coding_transcript_exon_variant	0	0.8	8E-12	11.096910013008056		1.14	[1.10-1.19]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	10q25.2	10	112559621	VTI1A	VTI1A			143187			rs10506868-T	rs10506868	0	10506868	intron_variant	0	0.28	4E-9	8.397940008672037		1.1	[1.06-1.13]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	12p13.31	12	6872998	SPSB2	SPSB2			84727			rs11064437-C	rs11064437	0	11064437	splice_acceptor_variant	0	0.75	4E-11	10.397940008672037		1.12	[1.08-1.16]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	17p12	17	10806436	NR	TMEM220-AS1			101101775			rs17817050-A	rs17817050	0	17817050	intron_variant	0	0.9	3E-6	5.522878745280337		1.12	[1.07-1.18]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	20q13.33	20	62381861	RPS21	LOC105372708 - RPS21	105372708	6227		2877	5204	rs6061231-C	rs6061231	0	6061231	downstream_gene_variant	1	0.91	8E-11	10.096910013008056		1.18	[1.13-1.25]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	5q31.1	5	135163402	NR	C5orf66			100996485			rs647161-A	rs647161	0	647161	intron_variant	0	0.31	2E-14	13.698970004336019		1.15	[1.11-1.19]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	10q22.3	10	79059375	NR	ZMIZ1-AS1			283050			rs704017-G	rs704017	0	704017	intron_variant	0	0.32	2E-8	7.698970004336019		1.1	[1.06-1.13]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	10q25.2	10	112967084	NR	TCF7L2			6934			rs11196172-A	rs11196172	0	11196172	intron_variant	0	0.68	1E-12	12.0		1.14	[1.10-1.18]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	11q12.2	11	61785208	NR	MYRF			745			rs174537-G	rs174537	0	174537	non_coding_transcript_exon_variant	0	0.59	9E-21	20.045757490560675		1.16	[1.12-1.19]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	12p13.31	12	6276561	NR	LOC105369625			105369625			rs10849432-T	rs10849432	0	10849432	intergenic_variant	0	0.82	4E-10	9.397940008672037		1.14	[1.09-1.18]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	12p13.32	12	4259186	NR	CCND2-AS1			103752584			rs10774214-T	rs10774214	0	10774214	intron_variant	0	0.37	1E-10	10.0		1.14	[1.09-1.18]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	17p13.3	17	897353	NR	NXN			64359			rs12603526-C	rs12603526	0	12603526	intron_variant	0	0.3	3E-8	7.522878745280337		1.1	[1.06-1.14]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	18q21.1	18	48924606	NR	SMAD7			4092			rs7229639-A	rs7229639	0	7229639	intron_variant	0	0.16	3E-15	14.522878745280337		1.2	[1.16-1.25]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	19q13.2	19	41354391	NR	TGFB1 - B9D2	7040	80776		458	26	rs1800469-G	rs1800469	0	1800469	intron_variant	1	0.48	1E-8	8.0		1.09	[1.06-1.12]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	20p12.3	20	7831703	NR	SRSF10P2			171472			rs2423279-C	rs2423279	0	2423279	downstream_gene_variant	0	0.31	3E-12	11.522878745280337		1.13	[1.09-1.17]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	1q41	1	221991606	NR	LOC105372950 - LOC107985307	105372950	107985307		72894	50098	rs6687758-G	rs6687758	0	6687758	regulatory_region_variant	1	0.24	9E-9	8.045757490560675		1.12	[1.08-1.17]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	8q24.21	8	127395198	NR	CASC8			727677			rs10505477-A	rs10505477	0	10505477	intron_variant	0	0.38	3E-13	12.522878745280337		1.15	[1.11-1.20]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	8q24.21	8	127401060	NR	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.38	5E-14	13.301029995663981		1.14	[1.10-1.18]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	8q24.21	8	127412547	NR	CASC8			727677			rs7014346-A	rs7014346	0	7014346	intron_variant	0	0.27	2E-8	7.698970004336019		1.13	[1.08-1.17]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	10p14	10	8659256	NR	LOC105376400			105376400			rs10795668-G	rs10795668	0	10795668	upstream_gene_variant	0	0.6	5E-15	14.301029995663981		1.15	[1.11-1.19]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	11q23.1	11	111300984	NR	COLCA1, COLCA2			399948, 120376			rs3802842-C	rs3802842	0	3802842	intron_variant	0	0.38	3E-7	6.522878745280337		1.09	[1.05-1.12]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	18q21.1	18	48927093	NR	SMAD7			4092			rs4939827-T	rs4939827	0	4939827	intron_variant	0	0.24	2E-8	7.698970004336019		1.12	[1.08-1.16]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	19q13.11	19	33041394	NR	RHPN2			85415			rs10411210-C	rs10411210	0	10411210	intron_variant	0	0.82	3E-6	5.522878745280337		1.12	[1.07-1.17]	Affymetrix, Illumina [~ 4000000] (imputed)	N
2017-03-24	26965516	Zeng C	2016-03-08	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/26965516	Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.	Colorectal cancer	4,508 East Asian ancestry cases, 16,588 East Asian ancestry controls	11,044 East Asian ancestry cases, 18,036 East Asian ancestry controls	8q23.3	8;8	116635549;116611854	EIF3H	LOC105375712 - EIF3H; LOC105375712						rs6469656-A; rs2450115-T	rs6469656; rs2450115	0		intergenic_variant; intergenic_variant		NR	1E-15	15.0		1.2	NR	Affymetrix, Illumina [~ 4000000] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	15q21.1	15	46737708	SEMA6D	LOC729316			729316			rs16958536-?	rs16958536	0	16958536	intron_variant	0	0.22	4E-6	5.3979400086720375	(Breast cancer, telangiectasia, multivariable analysis)	1.66		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10p12.31	10	21147293	C10orf113	NEBL			10529			rs12243039-?	rs12243039	0	12243039	intron_variant	0	0.01	8E-6	5.096910013008056	(Breast cancer, overall toxicity, multivariable analysis)	3.28		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	17q12	17	35565049	SLFN14	SLFN14 - RPL39P32	342618	100131387		4208	1411	rs2840044-?	rs2840044	0	2840044	upstream_gene_variant	1	0.33	8E-6	5.096910013008056	(Breast cancer, overal toxicity, multivariable analysis)	1.56		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	5q21.1	5	101043689	ST8SIA4	LOC107986437 - LOC107986438	107986437	107986438		99140	201910	rs575018-?	rs575018	0	575018	intergenic_variant	1	0.34	7E-7	6.154901959985743	(Breast cancer, overall toxicity, univariable analysis)	0.13	[NR] unit decrease	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	6p25.1	6	6550516	LY86-AS1	LY86-AS1			285780			rs17142289-?	rs17142289	0	17142289	intron_variant	0	0.02	4E-6	5.3979400086720375	(Breast cancer, overall toxicity, univariable analysis)	0.35	[NR] unit increase	Illumina [2417493] (imputed)	N
2013-01-15	23108145	Wang LE	2012-10-29	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23108145	Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer.	Lung Cancer (DNA repair capacity)	914 European ancestry non-small cell lung cancer cases, 860 European ancestry controls	679 European ancestry ancestry non-small cell lung cancer cases, 695 European ancestry controls	19q13.32	19	45351661	ERCC2, XPD	ERCC2			2068			rs13181-C	rs13181	0	13181	missense_variant	0	0.3613	9E-7	6.045757490560675				Illumina [303669]	N
2013-01-15	23108145	Wang LE	2012-10-29	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23108145	Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer.	Lung Cancer (DNA repair capacity)	914 European ancestry non-small cell lung cancer cases, 860 European ancestry controls	679 European ancestry ancestry non-small cell lung cancer cases, 695 European ancestry controls	6q24.2	6	143622177	PHACTR2	PHACTR2			9749			rs9390123-A	rs9390123	0	9390123	intron_variant	0	0.3957	7E-6	5.154901959985743				Illumina [303669]	N
2012-03-08	22318345	Cha PC	2012-02-09	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22318345	A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population.	Gallbladder cancer	41 Japanese ancestry cases, 866 Japanese ancestry controls	30 Japanese ancestry cases, 898 Japanese ancestry controls	18q21.2	18	52991406	DCC	DCC			1630			rs7504990-A	rs7504990	0	7504990	intron_variant	0	0.21	7E-8	7.154901959985743		6.95	[3.43-14.08]	Illumina [425706] (imputed)	N
2012-03-08	22318345	Cha PC	2012-02-09	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22318345	A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population.	Gallbladder cancer	41 Japanese ancestry cases, 866 Japanese ancestry controls	30 Japanese ancestry cases, 898 Japanese ancestry controls	3p26.2	3	2804632	NR	CNTN4			152330			rs975334-C	rs975334	0	975334	intron_variant	0	0.16	9E-7	6.045757490560675		8.3	[3.57-19.26]	Illumina [425706] (imputed)	N
2012-03-08	22318345	Cha PC	2012-02-09	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22318345	A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population.	Gallbladder cancer	41 Japanese ancestry cases, 866 Japanese ancestry controls	30 Japanese ancestry cases, 898 Japanese ancestry controls	9p21.2	9	26694890	NR	LOC105369289 - LOC105376000	105369289	105376000		13881	20529	rs13294589-G	rs13294589	0	13294589	intergenic_variant	1	0.11	2E-6	5.698970004336019		12.78	[4.43-36.83]	Illumina [425706] (imputed)	N
2012-03-08	22318345	Cha PC	2012-02-09	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22318345	A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population.	Gallbladder cancer	41 Japanese ancestry cases, 866 Japanese ancestry controls	30 Japanese ancestry cases, 898 Japanese ancestry controls	5q15	5	94474503	NR	KIAA0825			285600			rs6869388-C	rs6869388	0	6869388	intron_variant	0	0.04	7E-6	5.154901959985743		72.7	[11.19-472.10]	Illumina [425706] (imputed)	N
2012-03-08	22318345	Cha PC	2012-02-09	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22318345	A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population.	Gallbladder cancer	41 Japanese ancestry cases, 866 Japanese ancestry controls	30 Japanese ancestry cases, 898 Japanese ancestry controls	7q31.1	7	109512654	NR	LOC646614 - LOC100421901	646614	100421901		517594	251027	rs10953615-C	rs10953615	0	10953615	intergenic_variant	1	0.11	9E-6	5.045757490560675		7.51	[3.08-18.30]	Illumina [425706] (imputed)	N
2012-01-06	22142827	Innocenti F	2011-12-05	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22142827	A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.	Response to gemcitabine in pancreatic cancer	294 European ancestry cases	NA	6p12.2	6	52236941	IL17F	IL17F			112744			rs763780-G	rs763780	0	763780	missense_variant	0	NR	3E-8	7.522878745280337		3.3	[2.10-5.10]	Illumina [330690]	N
2012-01-06	22142827	Innocenti F	2011-12-05	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22142827	A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.	Response to gemcitabine in pancreatic cancer	294 European ancestry cases	NA	12p13.2	12	11394598	PRB2	PRB2			653247			rs2900174-G	rs2900174	0	2900174	intron_variant	0	NR	1E-6	6.0		3.3	[2.00-5.50]	Illumina [330690]	N
2012-01-06	22142827	Innocenti F	2011-12-05	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22142827	A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.	Response to gemcitabine in pancreatic cancer	294 European ancestry cases	NA	12p13.33	12	1982091	DCP1B	CACNA1C, DCP1B			775, 196513			rs11062040-A	rs11062040	0	11062040	intron_variant	0	NR	8E-6	5.096910013008056		1.4	[1.20-1.70]	Illumina [330690]	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	1p13.2	1	111873741	KCND3	KCND3			3752			rs2788612-?	rs2788612	0	2788612	intron_variant	0	0.05	6E-16	15.221848749616356	(Prostate cancer, rectal incontinence, univariable analysis)	0.18	[NR] unit increase	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10q24.31	10	100170652	ERLIN1	ERLIN1			10613			rs11595238-?	rs11595238	0	11595238	intron_variant	0	0.04	2E-6	5.698970004336019	(Prostate cancer, rectal incontinence, multivariable analysis)	6.61		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	3p24.1	3	29287529	RBMS3	RBMS3			27303			rs9832625-?	rs9832625	0	9832625	intron_variant	0	0.08	3E-6	5.522878745280337	(Prostate cancer, rectal incontinence, univariable analysis)	0.07	[NR] unit increase	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	21q21.1	21	16396204	CNTNAP2	MIR99AHG			388815			rs2823779-?	rs2823779	0	2823779	intron_variant	0	0.09	7E-6	5.154901959985743	(Prostate cancer, urine incontinence, univariable analysis)	0.1	[NR] unit increase	Illumina [2417493] (imputed)	N
2013-07-01	23482656	Chen D	2013-03-12	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23482656	Genome-wide association study of susceptibility loci for cervical cancer.	Cervical cancer	1,034 European ancestry cases, 3,948 European ancestry controls	1,140 European ancestry cases, 1,058 European ancestry controls	6p21.33	6	31422633	MICA	MICA - HLA-X	100507436	267016		7318	39213	rs2516448-?	rs2516448	0	2516448	intron_variant	1	NR	4E-18	17.397940008672037		1.42	[1.31-1.54]	Illumina [632668]	N
2013-07-01	23482656	Chen D	2013-03-12	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23482656	Genome-wide association study of susceptibility loci for cervical cancer.	Cervical cancer	1,034 European ancestry cases, 3,948 European ancestry controls	1,140 European ancestry cases, 1,058 European ancestry controls	6p21.32	6	32633026	HLA-DRB1, HLA-DQA1	HLA-DRB1 - LOC107986589	3123	107986589		43190	4162	rs9272143-?	rs9272143	0	9272143	intron_variant	1	NR	3E-22	21.522878745280337		1.49	[1.37-1.61]	Illumina [632668]	N
2013-07-01	23482656	Chen D	2013-03-12	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23482656	Genome-wide association study of susceptibility loci for cervical cancer.	Cervical cancer	1,034 European ancestry cases, 3,948 European ancestry controls	1,140 European ancestry cases, 1,058 European ancestry controls	6p21.32	6	33121846	HLA-DPB2	HLA-DPB2			3116			rs3117027-?	rs3117027	0	3117027	intron_variant	0	NR	1E-7	7.0		1.25	[1.15-1.36]	Illumina [632668]	N
2013-07-01	23482656	Chen D	2013-03-12	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23482656	Genome-wide association study of susceptibility loci for cervical cancer.	Cervical cancer	1,034 European ancestry cases, 3,948 European ancestry controls	1,140 European ancestry cases, 1,058 European ancestry controls				HLA-B							HLA-B*0702-?	HLA-B*0702	0			1	0.14	8E-8	7.096910013008056		1.42	[1.25-1.61]	Illumina [632668]	N
2013-07-01	23482656	Chen D	2013-03-12	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23482656	Genome-wide association study of susceptibility loci for cervical cancer.	Cervical cancer	1,034 European ancestry cases, 3,948 European ancestry controls	1,140 European ancestry cases, 1,058 European ancestry controls				HLA							DRB1*1301-DQA1*0103-DQB1*0603-?	DRB1*1301-DQA1*0103-DQB1*0603	0			1	NR	9E-10	9.045757490560675		2.13	[1.67-2.70]	Illumina [632668]	N
2013-07-01	23482656	Chen D	2013-03-12	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23482656	Genome-wide association study of susceptibility loci for cervical cancer.	Cervical cancer	1,034 European ancestry cases, 3,948 European ancestry controls	1,140 European ancestry cases, 1,058 European ancestry controls				HLA							DRB1*1501-DQB1*0602-?	DRB1*1501-DQB1*0602	0			1	0.15	4E-7	6.3979400086720375		1.39	[1.23-1.58]	Illumina [632668]	N
2017-01-27	27285765	Chen D	2016-06-07	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27285765	Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus.	Cervical cancer	1,553 Swedish ancestry cervical intraepithelial neoplasia grade 3 cases, 81 Swedish ancestry cervical cancer cases,  4,442 Swedish ancestry controls	827 Swedish ancestry cervical intraepithelial neoplasia grade 3 cases, 123 Swedish ancestry cervical cancer cases, 1,715 European ancestry controls	6p21.32	6	32616804	intergenic	HLA-DRB1 - LOC107986589	3123	107986589		26968	20384	rs73730372	rs73730372	0	73730372	intergenic_variant	1		3E-19	18.522878745280337		1.67	[1.49-1.85]	Illumina [5471179]	N
2009-02-26	19117981	Sun J	2009-01-01	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19117981	Sequence variants at 22q13 are associated with prostate cancer risk.	Prostate cancer	1,235 European ancestry aggressive cases, 1,599 European ancestry controls	1,215 European ancestry aggressive cases, 2,213 European ancestry non-aggressive cases, 1,208 European ancestry controls, 1,034 aggressive cases, 921 non-aggressive cases, 2,231 controls	22q13.1	22	40056115	TNRC6B	TNRC6B			23112			rs9623117-C	rs9623117	0	9623117	intron_variant	0	0.21	5E-7	6.301029995663981		1.18	[1.11-1.26]	Affymetrix, Illumina [~ 2000000] (imputed)	N
2012-01-11	22130093	Nam RK	2011-12-01	Cancer Biol Ther	www.ncbi.nlm.nih.gov/pubmed/22130093	New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.	Prostate cancer	316 cases, 229 controls	55 Asian ancestry cases, 134 Asian ancestry controls, 1,382 European ancestry cases, 1,428 European ancestry controls, 184 Black cases, 127 Black controls, 42 cases, 87 controls	10q26.12	10	121273005	intergenic	LINC01153 - LOC105378523	101927889	105378523		87039	18603	rs11199874-?	rs11199874	0	11199874	intergenic_variant	1	NR	3E-10	9.522878745280337				Affymetrix [443816]	N
2012-01-11	22130093	Nam RK	2011-12-01	Cancer Biol Ther	www.ncbi.nlm.nih.gov/pubmed/22130093	New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.	Prostate cancer	316 cases, 229 controls	55 Asian ancestry cases, 134 Asian ancestry controls, 1,382 European ancestry cases, 1,428 European ancestry controls, 184 Black cases, 127 Black controls, 42 cases, 87 controls	15q21.1	15	46347610	intergenic	LOC100419366 - LOC105370803	100419366	105370803		247236	260140	rs4775302-?	rs4775302	0	4775302	downstream_gene_variant	1	NR	4E-8	7.3979400086720375				Affymetrix [443816]	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127401060	SRRM1P1, POU5F1B	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0		4E-15	14.397940008672037		0.29	[0.22-0.36] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127472793	MYC	CASC8			727677			rs1447295-A	rs1447295	0	1447295	intron_variant	0		6E-18	17.221848749616356		0.51	[0.40-0.63] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1		3E-26	25.522878745280337		0.4	[0.33-0.47] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	17q24.3	17	71122495	SOX9, CALM2P1	CASC17			101928165			rs4793529-T	rs4793529	0	4793529	intron_variant	0		2E-13	12.698970004336019		0.28	[0.20-0.35] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	19q13.33	19	50858501	KLK3	KLK3			354			rs17632542-T	rs17632542	0	17632542	missense_variant	0		2E-28	27.69897000433602		0.73	[0.60-0.86] unit increase	Illumina [514432] (imputed)	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	5p15.33	5	1895715	NR	CTD-2194D22.4			101929081			rs12653946-T	rs12653946	0	12653946	intron_variant	0	0.43	3E-7	6.522878745280337	(Japanese)	1.39	[1.22-1.57]	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8p21.2	8	23668950	NR	LOC107986930			107986930			rs1512268-T	rs1512268	0	1512268	intergenic_variant	0	0.36	5E-6	5.301029995663981	(Japanese)	1.35	[1.19-1.53]	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127094635	NR	PRNCR1 - LOC105375752	101867536	105375752		2040	45423	rs6983561-C	rs6983561	0	6983561	downstream_gene_variant	1	0.18	4E-13	12.397940008672037	(Japanese)	1.87	[1.58-2.22]	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127519892	NR	CASC8 - LOC105375754	727677	105375754		37753	144647	rs10090154-T	rs10090154	0	10090154	intergenic_variant	1	0.08	3E-6	5.522878745280337	(Latin American)	1.68	[1.35-2.09]	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127112950	NR	PRNCR1 - LOC105375752	101867536	105375752		20355	27108	rs10505483-T	rs10505483	0	10505483	intergenic_variant	1	NR	7E-15	14.154901959985743	(Japanese and Latin American)	1.73	NR	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	3p12.1	3	87085650	NR	LOC285232 - LINC00506	285232	100846978		32781	3630	rs17023900-G	rs17023900	0	17023900	upstream_gene_variant	1	NR	6E-8	7.221848749616356	(Japanese and Latin American)	1.41	NR	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8p21.2	8	23676505	NR	LOC107986930			107986930			rs10503733-T	rs10503733	0	10503733	downstream_gene_variant	0	NR	8E-8	7.096910013008056	(Japanese and Latin American)	1.29	NR	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127092098	NR	PRNCR1			101867536			rs13254738-C	rs13254738	0	13254738	non_coding_transcript_exon_variant	0	0.54	4E-10	9.397940008672037	(Japanese)	1.59	[1.38-1.84]	Illumina [528023]	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127094539	SRRM1P1, POU5F1B	PRNCR1 - LOC105375752	101867536	105375752		1944	45519	rs12682344-G	rs12682344	0	12682344	downstream_gene_variant	1		5E-12	11.301029995663981		0.67	[0.48-0.86] unit increase	Illumina [514432] (imputed)	N
2015-12-07	25890600	Guo Q	2015-04-18	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases		11q24.2	11	125389528	HEPACAM, HEPN1, CCDC15, SLC37A2, TMEM218, FEZ1, MGC39545, STT3A, CHEK1, ACRV1, PATE1, PATE2, PATE3, PATE4, HYLS1, PKNOX2, ROBO4	PKNOX2			63876			rs2059614-?	rs2059614	0	2059614	intron_variant	0	0.06	1E-9	9.0	(ER -ve)	1.9	[1.54-2.33]	Affymetrix, Illumina [9000000] (imputed)	N
2015-12-07	25890600	Guo Q	2015-04-18	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases		14q24.1	14	67599772	NR	GPHN, PIGH			10243, 5283			rs7149859-?	rs7149859	0	7149859	intron_variant	0		7E-7	6.154901959985743	(ER +ve)	1.22	[1.13-1.33]	Affymetrix, Illumina [9000000] (imputed)	N
2016-02-24	25963547	Wilson CL	2015-05-11	Cancer	www.ncbi.nlm.nih.gov/pubmed/25963547	Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.	Obesity in adult survivors of childhood cancer exposed to cranial radiation	365 obese individuals, 411 non-obese individuals	NA	2p25.2	2	4847728	SOX11	LINC01249 - RNU6-649P	727982	106479854		191506	97549	rs4971486-G	rs4971486	0	4971486	intergenic_variant	1	0.23	8E-8	7.096910013008056		1.99	(1.54-2.57)	Affymetrix [NR] (imputed)	N
2016-02-24	25963547	Wilson CL	2015-05-11	Cancer	www.ncbi.nlm.nih.gov/pubmed/25963547	Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.	Obesity in adult survivors of childhood cancer exposed to cranial radiation	365 obese individuals, 411 non-obese individuals	NA	4q34.1	4	174701439	GLRA3	GLRA3			8001			rs12646911-A	rs12646911	0	12646911	intron_variant	0	0.78	1E-6	6.0		1.89	[1.45-2.44]	Affymetrix [NR] (imputed)	N
2016-02-24	25963547	Wilson CL	2015-05-11	Cancer	www.ncbi.nlm.nih.gov/pubmed/25963547	Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.	Obesity in adult survivors of childhood cancer exposed to cranial radiation	365 obese individuals, 411 non-obese individuals	NA	5p15.1	5	18186318	CDH18, BASP1	RPL36AP21 - RN7SL58P	100271332	106479245		136403	360994	rs140236920-?	rs140236920	0	140236920	intergenic_variant	1	0.46	1E-7	7.0		1.77	(1.43-2.20)	Affymetrix [NR] (imputed)	N
2016-02-24	25963547	Wilson CL	2015-05-11	Cancer	www.ncbi.nlm.nih.gov/pubmed/25963547	Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.	Obesity in adult survivors of childhood cancer exposed to cranial radiation	365 obese individuals, 411 non-obese individuals	NA	13q33.3	13	107138053	FAM155A	LOC105370350 - FAM155A	105370350	728215		5129	30478	rs35669975-C	rs35669975	0	35669975	intergenic_variant	1	0.61	3E-8	7.522878745280337		1.92	[1.52-2.44]	Affymetrix [NR] (imputed)	N
2016-02-24	25963547	Wilson CL	2015-05-11	Cancer	www.ncbi.nlm.nih.gov/pubmed/25963547	Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	359 obese individuals, 861 non-obese individuals	NA	1q21.2	1	150036820	VPS45	LOC105371427			105371427			rs12073359-?	rs12073359	0	12073359	intergenic_variant	0	NR	5E-6	5.301029995663981		1.7	(1.4-2.1)	Affymetrix [NR] (imputed)	N
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-Wide Association Study of Prostate Cancer-Specific Survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	2p23.1	2	30399958	NR	LOC285043 - LCLAT1	285043	253558		49800	47268	rs114997855-A	rs114997855	0	114997855	intergenic_variant	1	0.02	1E-7	7.0		1.67	[1.38-2.03]	Affymetrix, Illumina [up to 9536409] (imputed)	N
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-Wide Association Study of Prostate Cancer-Specific Survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	3p14.1	3	67392218	NR	SUCLG2			8801			rs76010824-A	rs76010824	0	76010824	intron_variant	0	0.07	1E-7	7.0		1.26	[1.16-1.38]	Affymetrix, Illumina [up to 9536409] (imputed)	N
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-Wide Association Study of Prostate Cancer-Specific Survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	Xp11.22	X	50451939	NR	DGKK			139189			rs140659849-A	rs140659849	0	140659849	intron_variant	0	0.01	1E-7	7.0		2.61	[1.83-3.73]	Affymetrix, Illumina [up to 9536409] (imputed)	N
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-Wide Association Study of Prostate Cancer-Specific Survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	Xq25	X	127519376	NR	LOC105373332 - LOC100420320	105373332	100420320		19688	209345	rs723557-G	rs723557	0	723557	intergenic_variant	1	0.08	6E-7	6.221848749616356		1.15	[1.09-1.22]	Affymetrix, Illumina [up to 9536409] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10p12.31	10	21147293	C10orf113	NEBL			10529			rs12243039-?	rs12243039	0	12243039	intron_variant	0	0.01	6E-6	5.221848749616356	(All samples, overall toxicity, multivariable analysis)	3.39		Illumina [2417493] (imputed)	N
2008-09-25	18780872	Liu P	2008-09-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/18780872	Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.	Lung cancer	194 European ancestry cases, 219 European ancestry controls	3,878 cases, 4,831 controls	15q25.1	15	78513681	CHRNA5, PSMA4, CHRNA3, LOC123688, CHRNB4	HYKK			123688			rs8034191-G	rs8034191	0	8034191	intron_variant	0	NR	1E-8	8.0		1.38	[1.17-1.64]	Affymetrix [up to 722376]	N
2009-09-04	19648918	Amundadottir L	2009-08-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19648918	Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.	Pancreatic cancer	1,771 European ancestry cases, 1,805 European ancestry controls	2,120 European ancestry cases, 2,127 European ancestry controls				ABO							rs505922-C	rs505922	0	505922		1	0.35	5E-8	7.301029995663981		1.2	[1.12-1.28]	Illumina [558542]	N
2009-09-14	19654303	Broderick P	2009-08-04	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19654303	Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.	Lung cancer	1,952 European ancestry cases, 1,438 European ancestry controls	2,465 European ancestry cases, 3,005 European ancestry controls, 3,143 individuals, 3,762 individuals	15q25.1	15	78513681	CHRNA3	HYKK			123688			rs8034191-?	rs8034191	0	8034191	intron_variant	0	NR	3E-26	25.522878745280337		1.29	[1.23-1.35]	Illumina [511919]	N
2009-09-14	19654303	Broderick P	2009-08-04	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19654303	Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.	Lung cancer	1,952 European ancestry cases, 1,438 European ancestry controls	2,465 European ancestry cases, 3,005 European ancestry controls, 3,143 individuals, 3,762 individuals	5p15.33	5	1315545	CLPTM1L	MIR4457 - CLPTM1L	100616235	81037		6168	2199	rs4975616-?	rs4975616	0	4975616	downstream_gene_variant	1	NR	3E-9	8.522878745280337		1.15	[1.10-1.20]	Illumina [511919]	N
2009-09-14	19654303	Broderick P	2009-08-04	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19654303	Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.	Lung cancer	1,952 European ancestry cases, 1,438 European ancestry controls	2,465 European ancestry cases, 3,005 European ancestry controls, 3,143 individuals, 3,762 individuals	6p21.33	6	31652743	BAT3	APOM, BAG6			55937, 7917			rs3117582-?	rs3117582	0	3117582	intron_variant	0	NR	4E-10	9.397940008672037		1.24	[1.16-1.33]	Illumina [511919]	N
2009-09-14	19654303	Broderick P	2009-08-04	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19654303	Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.	Lung cancer	1,952 European ancestry cases, 1,438 European ancestry controls	2,465 European ancestry cases, 3,005 European ancestry controls, 3,143 individuals, 3,762 individuals	15q15.2	15	43267033	TGM5	TGM5 - ATP5HP1	9333	390581		176	798	rs748404-?	rs748404	0	748404	upstream_gene_variant	1	NR	1E-6	6.0		1.15	[1.09-1.20]	Illumina [511919]	N
2009-09-14	19654303	Broderick P	2009-08-04	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19654303	Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.	Lung cancer	1,952 European ancestry cases, 1,438 European ancestry controls	2,465 European ancestry cases, 3,005 European ancestry controls, 3,143 individuals, 3,762 individuals	10q23.31	10	88967577	NR	ACTA2			59			rs1926203-?	rs1926203	0	1926203	intron_variant	0	NR	1E-6	6.0		1.12	[NR]	Illumina [511919]	N
2009-09-14	19654303	Broderick P	2009-08-04	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19654303	Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.	Lung cancer	1,952 European ancestry cases, 1,438 European ancestry controls	2,465 European ancestry cases, 3,005 European ancestry controls, 3,143 individuals, 3,762 individuals	3p24.1	3	29533972	NR	RBMS3			27303			rs1530057-?	rs1530057	0	1530057	intron_variant	0	NR	3E-6	5.522878745280337		1.26	[NR]	Illumina [511919]	N
2009-09-14	19654303	Broderick P	2009-08-04	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19654303	Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.	Lung cancer	1,952 European ancestry cases, 1,438 European ancestry controls	2,465 European ancestry cases, 3,005 European ancestry controls, 3,143 individuals, 3,762 individuals	2p13.3	2	68971256	NR	GKN2 - GKN1	200504	56287		18286	3317	rs4254535-?	rs4254535	0	4254535	upstream_gene_variant	1	NR	5E-6	5.301029995663981		1.12	[NR]	Illumina [511919]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	21q21.3	21	29345416	BACH1	BACH1			571			rs372883-T	rs372883	0	372883	3_prime_UTR_variant	0	NR	2E-13	12.698970004336019		1.27	[1.19-1.33]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	5p13.1	5	39394887	DAB2	DAB2			1601			rs2255280-T	rs2255280	0	2255280	intron_variant	0	NR	4E-10	9.397940008672037		1.23	[1.15-1.32]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	10q26.11	10	118519432	PRLHR	LOC105378507 - SLC25A18P1	105378507	106480776		11671	53439	rs12413624-T	rs12413624	0	12413624	regulatory_region_variant	1	0.37	5E-11	10.301029995663981		1.23	[1.16-1.31]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	21q22.3	21	42358786	TFF1	LOC105372815			105372815			rs1547374-A	rs1547374	0	1547374	downstream_gene_variant	0	NR	4E-13	12.397940008672037		1.27	[1.19-1.35]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	13q22.1	13	73334709	NR	RNY1P8 - MARK2P12	100873807	100421565		107449	73080	rs9573163-G	rs9573163	0	9573163	intergenic_variant	1	0.43	5E-13	12.301029995663981		1.26	[1.18-1.34]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	22q13.32	22	48533757	FAM19A5	FAM19A5			25817			rs5768709-G	rs5768709	0	5768709	intron_variant	0	0.23	1E-10	10.0		1.25	[1.17-1.34]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	1q43	1	238745053	MIPEPP2	KRT18P32 - MIPEPP2	391179	100130099		252352	32072	rs2689154-G	rs2689154	0	2689154	regulatory_region_variant	1	0.17	6E-6	5.221848749616356		1.2	[1.11-1.29]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	6q12	6	68432116	BAI3	LOC101928280 - LOC101928307	101928280	101928307		102217	200547	rs9363918-A	rs9363918	0	9363918	intergenic_variant	1	NR	1E-6	6.0		1.27	[1.15-1.39]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	9p24.2	9	4426631	SLC1A1	RNU6-694P - SLC1A1	106479872	6505		40075	63796	rs10974531-A	rs10974531	0	10974531	intergenic_variant	1	NR	5E-6	5.301029995663981		1.24	[1.13-1.35]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	6q25.3	6	155876368	ARID1B	LOC101928923, LOC105378072			101928923, 105378072			rs4269383-C	rs4269383	0	4269383	intergenic_variant	0	NR	7E-7	6.154901959985743		1.2	[1.12-1.30]	Affymetrix [666141]	N
2015-05-06	22158540	Wu C	2011-12-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22158540	Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.	Pancreatic cancer	981 Han Chinese ancestry cases, 1,991 Han Chinese ancestry controls	2,603 Han Chinese ancestry cases, 2,877 Han Chinese ancestry controls	3q29	3	196024759	TFRC	LOC105374300			105374300			rs4927850-A	rs4927850	0	4927850	downstream_gene_variant	0	NR	2E-7	6.698970004336019		1.24	[1.14-1.35]	Affymetrix [666141]	N
2012-03-23	22293537	Kiyotani K	2012-01-29	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/22293537	A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.	Response to gemcitabine in pancreatic cancer	21 Japanese ancestry adverse reaction cases, 58 Japanese ancestry non-adverse reaction individuals	33 Japanese ancestry adverse reaction cases, 62 Japanese ancestry non-adverse reaction individuals	9q21.33	9	87620879	DAPK1	DAPK1			1612			rs11141915-T	rs11141915	0	11141915	intron_variant	0	0.62	1E-6	6.0	(Allelic)	4.1	[2.21-7.62]	Illumina [470064]	N
2012-03-23	22293537	Kiyotani K	2012-01-29	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/22293537	A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.	Response to gemcitabine in pancreatic cancer	21 Japanese ancestry adverse reaction cases, 58 Japanese ancestry non-adverse reaction individuals	33 Japanese ancestry adverse reaction cases, 62 Japanese ancestry non-adverse reaction individuals	2q21.2	2	133680388	intergenic	NCKAP5 - LOC105373627	344148	105373627		5207	246688	rs1901440-C	rs1901440	0	1901440	intergenic_variant	1	0.20	3E-6	5.522878745280337	(Recessive)	34.0	[4.29-269.48]	Illumina [470064]	N
2010-02-28	20101243	Petersen GM	2010-01-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20101243	A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.	Pancreatic cancer	3,851 European, Chinese and other ancestry cases, 3,934 European, Chinese and other ancestry controls	NA	13q22.1	13	73342491	KLF12, KLF5	RNY1P8 - MARK2P12	100873807	100421565		115231	65298	rs9543325-C	rs9543325	0	9543325	intergenic_variant	1	0.37	3E-11	10.522878745280337		1.26	[1.18-1.35]	Illumina [551766]	N
2010-02-28	20101243	Petersen GM	2010-01-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20101243	A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.	Pancreatic cancer	3,851 European, Chinese and other ancestry cases, 3,934 European, Chinese and other ancestry controls	NA	1q32.1	1	200038304	NR5A2	NR5A2			2494			rs3790844-T	rs3790844	0	3790844	intron_variant	0	0.76	2E-10	9.698970004336019		1.3	[1.19-1.41]	Illumina [551766]	N
2010-02-28	20101243	Petersen GM	2010-01-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20101243	A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.	Pancreatic cancer	3,851 European, Chinese and other ancestry cases, 3,934 European, Chinese and other ancestry controls	NA	5p15.33	5	1321972	CLPTM1L	CLPTM1L			81037			rs401681-T	rs401681	0	401681	intron_variant	0	0.45	7E-7	6.154901959985743		1.19	[1.11-1.27]	Illumina [551766]	N
2013-12-12	23817570	Shi Y	2013-06-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23817570	A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.	Cervical cancer	Up to 1,364 Han Chinese ancestry cases, up to 3,028 Han Chinese ancestry controls	4,167 Han Chinese ancestry cases, 7,196 Han Chinese ancestry controls	4q12	4	55885574	EXOC1	EXOC1			55763			rs13117307-T	rs13117307	0	13117307	intron_variant	0	0.10	3E-10	9.522878745280337	(Matched)	1.28	[1.19-1.38]	Affymetrix [563339]	N
2013-12-12	23817570	Shi Y	2013-06-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23817570	A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.	Cervical cancer	Up to 1,364 Han Chinese ancestry cases, up to 3,028 Han Chinese ancestry controls	4,167 Han Chinese ancestry cases, 7,196 Han Chinese ancestry controls	6p21.32	6	33104395	HLA-DPB2	COL11A2P1			394214			rs4282438-?	rs4282438	0	4282438	intron_variant	0	0.56	5E-27	26.30102999566398	(Stringently Matched)	1.35	[1.27-1.41]	Affymetrix [563339]	N
2013-12-12	23817570	Shi Y	2013-06-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23817570	A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.	Cervical cancer	Up to 1,364 Han Chinese ancestry cases, up to 3,028 Han Chinese ancestry controls	4,167 Han Chinese ancestry cases, 7,196 Han Chinese ancestry controls	17q21.1	17	39895095	GSDMB	ZPBP2 - GSDMB	124626	55876		17199	9500	rs8067378-G	rs8067378	0	8067378	intergenic_variant	1	0.22	9E-10	9.045757490560675	(Matched)	1.19	[1.13-1.26]	Affymetrix [563339]	N
2013-12-12	23817570	Shi Y	2013-06-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23817570	A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.	Cervical cancer	Up to 1,364 Han Chinese ancestry cases, up to 3,028 Han Chinese ancestry controls	4,167 Han Chinese ancestry cases, 7,196 Han Chinese ancestry controls	6p21.32	6	33236497	intergenic	ZNF70P1 - LOC105375022	100419609	105375022		20314	9578	rs9277952-?	rs9277952	0	9277952	upstream_gene_variant	1	0.53	2E-9	8.698970004336019	(Matched)	1.18	[1.12-1.23]	Affymetrix [563339]	N
2014-11-08	24700089	Miura K	2014-04-04	J Med Virol	www.ncbi.nlm.nih.gov/pubmed/24700089	Genome-wide association study of HPV-associated cervical cancer in Japanese women.	Cervical cancer	226 Japanese ancestry cases, 186 Japanese ancestry controls	NA	8p23.3	8	2021565	intergenic	KBTBD11 - MYOM2	9920	9172		14622	23478	rs6558578-G	rs6558578	0	6558578	regulatory_region_variant	1	0.7608	7E-6	5.154901959985743		2.31	[1.59-3.34]	Affymetrix [556045]	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	17q24.3	17	72404025	LINC00673	LINC00673			100499467			rs11655237-T	rs11655237	0	11655237	non_coding_transcript_exon_variant	0	0.11	1E-14	14.0		1.26	[1.19-1.34]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	2p14	2	67412637	ETAA1	ETAA1 - LOC107985891	54465	107985891		2226	30942	rs1486134-G	rs1486134	0	1486134	downstream_gene_variant	1	0.275	3E-9	8.522878745280337		1.14	[1.09-1.19]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	7p14.1	7	40827064	SUGCT	SUGCT			79783			rs17688601-C	rs17688601	0	17688601	intron_variant	0	0.737	1E-8	8.0		1.1363636	[1.09-1.19]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	3q28	3	189790682	TP63	TP63			8626			rs9854771-G	rs9854771	0	9854771	intron_variant	0	0.638	2E-8	7.698970004336019		1.1235955	[1.08-1.18]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	13q12.2	13	27902841	PDX1-AS1	LOC105370130, PDX1-AS1			105370130, 100861550			rs9554197-T	rs9554197	0	9554197	intron_variant	0	0.399	9E-11	10.045757490560675		1.14	[1.1-1.19]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	2p14	2	67366671	intergenic	LOC102800447 - ETAA1	102800447	54465		77427	30639	rs962856-C	rs962856	0	962856	intergenic_variant	1	0.379	2E-8	7.698970004336019		1.12	[1.08-1.17]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	18q21.32	18	59211042	GRP	LOC100286992 - GRP	100286992	2922		41699	8146	rs1517037-C	rs1517037	0	1517037	intergenic_variant	1	0.818	3E-7	6.522878745280337		1.1494253	[1.09-1.2]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	12q24.31	12	120987058	HNF1A	HNF1A			6927			rs7310409-A	rs7310409	0	7310409	intron_variant	0	0.386	6E-7	6.221848749616356		1.11	[1.06-1.15]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	1p13.2	1	112503773	WNT2B	WNT2B			7482			rs351365-C	rs351365	0	351365	intron_variant	0	0.743	7E-7	6.154901959985743		1.1235955	[1.08-1.18]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	20q13.12	20	44458008	intergenic	C20orf62			140834			rs6073450-A	rs6073450	0	6073450	intron_variant	0	0.381	9E-7	6.045757490560675		1.11	[1.06-1.15]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	1p31.3	1	64073289	ROR1	ROR1			4919			rs1747924-A	rs1747924	0	1747924	intron_variant	0	0.767	7E-6	5.154901959985743		1.1111112	[1.06-1.16]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls				ABO							rs505922-?	rs505922	0	505922		1	NR	2E-13	12.698970004336019		1.27	[1.19-1.35]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	13q22.1	13	73342491	KLF5, KLF12	RNY1P8 - MARK2P12	100873807	100421565		115231	65298	rs9543325-?	rs9543325	0	9543325	intergenic_variant	1	NR	2E-10	9.698970004336019		1.24	[1.16-1.32]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	1q32.1	1	200038304	NR5A2	NR5A2			2494			rs3790844-?	rs3790844	0	3790844	intron_variant	0	NR	3E-6	5.522878745280337		1.2048193	[1.11-1.3]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	5p15.33	5	1321972	CLPTM1L	CLPTM1L			81037			rs401681-?	rs401681	0	401681	intron_variant	0	NR	3E-8	7.522878745280337		1.2	[1.13-1.28]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	7q32.3	7	130995762	LINC-PINT	LINC-PINT			378805			rs6971499-?	rs6971499	0	6971499	intron_variant	0	NR	7E-6	5.154901959985743		1.2345679	[1.14-1.35]	Illumina [866891] (imputed)	N
2016-06-21	26098869	Childs EJ	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098869	Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.	Pancreatic cancer	7,638 cases, 7,364 controls	2,287 cases, 4,205 controls	13q12.2	13	27919860	PDX1	PDX1-AS1			100861550			rs9581943-?	rs9581943	0	9581943	intron_variant	0	NR	2E-7	6.698970004336019		1.17	[1.10-1.24]	Illumina [866891] (imputed)	N
2016-11-30	27206850	Wang M	2016-03-29	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27206850	Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.	Bladder cancer	578 Han Chinese ancestry cases, 1,006 Han Chinese ancestry controls	2,828 Han Chinese ancestry cases, 3,639 Han Chinese ancestry controls	5q12.3	5	64771925	CWC27	CWC27			10283			rs2042329-T	rs2042329	0	2042329	intron_variant	0	0.098	5E-11	10.301029995663981		1.4	[1.27–1.55]	Illumina [478403] (imputed)	N
2015-01-21	24880342	Wang Y	2014-06-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24880342	Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.	Lung cancer	3,442 European ancestry adenocarcinoma cases, 3,275 European ancestry squamous cell carcinoma cases, 4,631 cases, up to 15,861 controls	3,589 European ancestry adenocarcinoma cases, 3,202 European ancestry squamous cell carcinoma cases, 3,455 cases, up to 38,295 controls	13q13.1	13	32398489	BRCA2, FRY	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.011	2E-19	18.69897000433602	(All lung cancer)	1.83	[1.61-2.09]	Illumina [8900000] (imputed)	N
2015-01-21	24880342	Wang Y	2014-06-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24880342	Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.	Lung cancer	3,442 European ancestry adenocarcinoma cases, 3,275 European ancestry squamous cell carcinoma cases, 4,631 cases, up to 15,861 controls	3,589 European ancestry adenocarcinoma cases, 3,202 European ancestry squamous cell carcinoma cases, 3,455 cases, up to 38,295 controls	22q12.1	22	28725099	CHEK2	CHEK2			11200			rs17879961-A	rs17879961	0	17879961	missense_variant	0	0.9975	3E-11	10.522878745280337	(All lung cancer)	1.67	[1.43-1.92]	Illumina [8900000] (imputed)	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	5p15.33	5	1293971	ZDHHC11, BRD9, TRIP13, LOC100506688, NKD2, SLC12A7, MIR4635, SLC6A19, SLC6A18, MIR4457, TERT, SLC6A3, LPCAT1, CLPTM1L, SDHAP3, LOC728613, MIR4277	TERT			7015			rs2736098-C	rs2736098	0	2736098	synonymous_variant	0	0.716	1E-13	13.0		1.25	[1.18-1.32]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	7q32.3	7	130995762	COPG2, TSGA13, KLF14, MIR29A, MIR29B1, LOC646329, LINC-PINT, MKLN1	LINC-PINT			378805			rs6971499-T	rs6971499	0	6971499	intron_variant	0	0.853	3E-12	11.522878745280337		1.27	[1.19-1.35]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	16q23.1	16	75229763	ZFP1, CTRB1, CFDP1, TMEM170A, CHST6, CHST5, TMEM231, GABARAPL2, ADAT1, KARS, TERF21P, LDHD, BCAR1, CTRB2, FA2H, WDR59, ZNFR1	BCAR1			9564			rs7190458-A	rs7190458	0	7190458	synonymous_variant	0	0.039	1E-10	10.0		1.46	[1.30–1.65]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	13q12.2	13	27919860	URAD, FLT3, PAN3-AS1, PAN3, GSX1, PDX1-AS1, PDX1, ATP5EP2, CDX2	PDX1-AS1			100861550			rs9581943-A	rs9581943	0	9581943	intron_variant	0	0.406	2E-9	8.698970004336019		1.15	[1.10–1.20]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	22q12.1	22	28904318	SNORD125, RHBDD3, EWSR1, CHEK2, TTC28, HSCB, CCDC117, XBP1, ZNRF3, KREMEN1, ZNRF3-AS1, C22orf31, EMID1, GAS2L1, RASL10A, AP1B1, MIR3653	ZNRF3			84133			rs16986825-T	rs16986825	0	16986825	intron_variant	0	0.149	1E-8	8.0		1.18	[1.12–1.25]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	8q24.21	8	128555832	LINC00977, MIR1208, PVT1, MYC	LINC00824			101927774			rs1561927-T	rs1561927	0	1561927	intron_variant	0	0.721	1E-7	7.0		1.15	[1.09-1.2]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls				ADAMTS13, ABO							rs687289-?	rs687289	0	687289		1	NR	2E-16	15.698970004336019		1.27	[1.20–1.35]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	13q22.1	13	73342491	KLF12, KLF5	RNY1P8 - MARK2P12	100873807	100421565		115231	65298	rs9543325-?	rs9543325	0	9543325	intergenic_variant	1	NR	4E-14	13.397940008672037		1.23	[1.18-1.30]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	1q32.1	1	199996040	NR5A2	LOC105371682 - RNU6-716P	105371682	106479883		36581	12465	rs10919791-?	rs10919791	0	10919791	intergenic_variant	1	NR	1E-11	11.0		1.27	[1.18-1.33]	Illumina [608202]	N
2015-07-08	25086665	Wolpin BM	2014-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25086665	Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.	Pancreatic cancer	1,582 European ancestry cases, 5,203 European ancestry controls	6,101 European ancestry cases, 9,194 European ancestry controls	5p15.33	5	1344343	CLPTM1L	CLPTM1L			81037			rs31490-?	rs31490	0	31490	splice_region_variant	0	NR	2E-11	10.698970004336019		1.2	[1.14-1.27]	Illumina [608202]	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Lung cancer	1,737 African American cases, 3,602 African American controls	866 African American cases, 796  African American controls	15q25.1	15	78565644	PSMA4, CHRNA5	CHRNA5			1138			rs55781567-?	rs55781567	0	55781567	5_prime_UTR_variant	0	NR	1E-9	9.0		1.3169	[1.2049-1.4394]	Illumina [1024001]	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Lung cancer	1,737 African American cases, 3,602 African American controls	866 African American cases, 796  African American controls	5p15.33	5	1287079	TERT	TERT			7015			rs2853677-C	rs2853677	0	2853677	intron_variant	0	0.273	3E-9	8.522878745280337		1.2818	[1.1810-1.3911]	Illumina [1024001]	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Lung cancer	1,737 African American cases, 3,602 African American controls	866 African American cases, 796  African American controls	8q24.11	8	117013406	SLC30A8	SLC30A8			169026			rs3019885-G	rs3019885	0	3019885	intron_variant	0	0.2817	3E-6	5.522878745280337		1.2394	[1.1323-1.3565]	Illumina [1024001]	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Lung cancer	1,737 African American cases, 3,602 African American controls	866 African American cases, 796  African American controls	12q13.11	12	48016734	intergenic	LOC105369750			105369750			rs6580649-?	rs6580649	0	6580649	intron_variant	0	NR	5E-6	5.301029995663981		1.2169892	[1.12-1.32]	Illumina [1024001]	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Lung cancer	1,737 African American cases, 3,602 African American controls	866 African American cases, 796  African American controls	10p12.1	10	28348731	intergenic	ZNF101P1 - LOC105376468	100419867	105376468		7666	84277	rs7900823-?	rs7900823	0	7900823	intergenic_variant	1	NR	2E-6	5.698970004336019		1.7850769	[1.41-2.27]	Illumina [1024001]	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Lung cancer	1,737 African American cases, 3,602 African American controls	866 African American cases, 796  African American controls	6q25.1	6	149598007	C6orf72, KATNA1	KATNA1			11104			rs9322193-?	rs9322193	0	9322193	intron_variant	0	NR	1E-7	7.0		1.2508	[1.1508-1.3596]	Illumina [1024001]	N
2017-03-16	27579533	Zhang M	2016-08-01	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27579533	Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.	Pancreatic cancer	5,107 European ancestry cases, 8,845 European ancestry controls	6,076 cases, 7,555 controls	1q32.1	1	200016240	NR5A2	RNU6-609P - NR5A2	106481906	2494		1445	11362	rs2816938-A	rs2816938	0	2816938	upstream_gene_variant	1	0.216	5E-15	14.301029995663981		1.2	[1.15-1.25]	Illumina [9132527] (imputed)	N
2017-05-26	28120872	Li X	2017-01-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28120872	Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	66 Han Chinese ancestry non-responder cases, 160 Han Chinese ancestry responder cases	79 Han Chinese ancestry non-responder cases, 291 Han Chinese ancestry responder cases	4q34.3	4	179391655	intergenic	LOC105377563 - LOC105377564	105377563	105377564		574329	572791	rs6812281-T	rs6812281	0	6812281	intron_variant	1	0.18	9E-9	8.045757490560675		2.37	[1.77-3.18]	Affymetrix [657178]	N
2017-05-26	28120872	Li X	2017-01-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28120872	Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	66 Han Chinese ancestry non-responder cases, 160 Han Chinese ancestry responder cases	79 Han Chinese ancestry non-responder cases, 291 Han Chinese ancestry responder cases	14q32.11	14	90698719	CALM1, TTC7B, NRDE2, PSMC1, RPS18P2, RPS6KA5, RNU7- 30P, C14orf159, SNORA11B	TTC7B, LOC105370622			145567, 105370622			rs1742101-G	rs1742101	0	1742101	non_coding_transcript_exon_variant	0	0.5	7E-6	5.154901959985743		1.92	[1.45-2.56]	Affymetrix [657178]	N
2017-05-26	28120872	Li X	2017-01-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28120872	Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	66 Han Chinese ancestry non-responder cases, 160 Han Chinese ancestry responder cases	79 Han Chinese ancestry non-responder cases, 291 Han Chinese ancestry responder cases	16q23.3	16	83706502	MIR3182, HSBP1, MLYCO, OSGIN1, NECAB2, SLC38A8, RNA5SP432, MBTPS1, HSDL1, CDH13, DNAAF1, TAF1C, ADAD2	CDH13, LOC105371366			1012, 105371366			rs1364121-A	rs1364121	0	1364121	intron_variant	0	0.25	3E-6	5.522878745280337		1.98	[1.49-2.64]	Affymetrix [657178]	N
2012-09-20	22807686	Li S	2012-07-12	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22807686	GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.	Hepatocellular carcinoma	1,538 Han Chinese ancestry HBV-positive HCC cases, 1,465 Han Chinese ancestry chronic HBV carriers	4,431 Han Chinese ancestry HBV-positive HCC cases, 4,725 Han Chinese ancestry chronic HBV carriers	6p21.32	6	32632222	HLA-DRB1, HLA-DQA1	HLA-DRB1 - LOC107986589	3123	107986589		42386	4966	rs9272105-A	rs9272105	0	9272105	intron_variant	1	0.45	5E-22	21.30102999566398		1.28	[1.22-1.35]	NR [523663]	N
2012-09-20	22807686	Li S	2012-07-12	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22807686	GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.	Hepatocellular carcinoma	1,538 Han Chinese ancestry HBV-positive HCC cases, 1,465 Han Chinese ancestry chronic HBV carriers	4,431 Han Chinese ancestry HBV-positive HCC cases, 4,725 Han Chinese ancestry chronic HBV carriers	6p21.32	6	32632222	HLA_DRB1, HLA_DQA1	No mapped genes; HLA-DRB1 - LOC107986589; No mapped genes						HLA_DRB1_0901-?; rs9272105-A; HLA_DRB1_0405-?	HLA_DRB1_0901; rs9272105; HLA_DRB1_0405	0		intron_variant		NR	2E-7	6.698970004336019		1.32	[1.19-1.46]	NR [523663]	N
2013-03-11	23242368	Jiang DK	2012-12-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23242368	Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	1,161 Chinese ancestry cases, 1,353 Chinese ancestry controls	4,319 Chinese ancestry cases, 4,966 Chinese ancestry controls	6p21.32	6	32698518	HLA-DQ	HLA-DQB1 - MTCO3P1	3119	404026		31829	7626	rs9275319-A	rs9275319	0	9275319	intergenic_variant	1	0.88	3E-17	16.522878745280337		1.49	[1.36-1.63]	Illumina [1672517] (imputed)	N
2016-10-05	26870257	Qu LS	2015-11-23	Oncol Lett	www.ncbi.nlm.nih.gov/pubmed/26870257	Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study.	Hepatocellular carcinoma in hepatitis B infection	50 Han Chinese ancestry seropositive cases, 50 Han Chinese ancestry seropositive controls	282 Han Chinese ancestry seropositive cases, 278 Han Chinese ancestry seropositive controls	3q25.32	3	157429779	VEPH1	VEPH1			79674			rs2120243-?	rs2120243	0	2120243	intron_variant	0	NR	2E-6	5.698970004336019		1.76	1.39-2.22	Affymetrix [279757]	N
2016-10-05	26870257	Qu LS	2015-11-23	Oncol Lett	www.ncbi.nlm.nih.gov/pubmed/26870257	Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study.	Hepatocellular carcinoma in hepatitis B infection	50 Han Chinese ancestry seropositive cases, 50 Han Chinese ancestry seropositive controls	282 Han Chinese ancestry seropositive cases, 278 Han Chinese ancestry seropositive controls	11q14.2	11	86933347	FZD4	LOC107984428, PRSS23			107984428, 11098			rs1350171-?	rs1350171	0	1350171	non_coding_transcript_exon_variant	0	NR	6E-6	5.221848749616356		1.66	[1.33-2.07]	Affymetrix [279757]	N
2017-03-28	27764800	Cox DG	2016-10-14	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27764800	GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.	Estrogen receptor status in HER2 negative breast cancer	4,267 French ancestry estrogen receptor positive cases,  1,185 French ancestry estrogen receptor negative cases	NA	10q26.13	10	121592706	FGFR2	FGFR2			2263			rs3135724-?	rs3135724	0	3135724	intron_variant	0	NR	5E-11	10.301029995663981		1.79	[1.49 - 2.13] 	Illumina [914144] (imputed)	N
2017-06-12	28163062	Matsuura K	2017-02-02	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/28163062	Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	123 Japanese ancestry hepatocellular carcinoma cases, 333 Japanese ancestry 5-yr hepatocellular carcinoma-free controls	130 Japanese ancestry hepatocellular carcinoma cases, 210 Japanese ancestry 5-yr hepatocellular carcinoma-free controls	4q32.3	4	166008836	TLL1	TLL1			7092			rs17047200-T	rs17047200	0	17047200	intron_variant	0		3E-8	7.522878745280337		2.37	[1.74-3.23]	Affymetrix [443299]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.40	9E-29	28.045757490560675		1.25	[1.17-1.34]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	19q13.33	19	50861367	KLK3	KLK3 - KLK2	354	3817		603	12066	rs2735839-G	rs2735839	0	2735839	upstream_gene_variant	1	0.85	2E-18	17.69897000433602		1.2	[1.10-1.33]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	11q13.3	11	69227030	intergenic	LOC105369366 - LOC105369367	105369366	105369367		49023	1719	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	0.51	2E-12	11.698970004336019		1.19	[1.11-1.27]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	6q25.3	6	160412632	SLC22A3	SLC22A3			6581			rs9364554-T	rs9364554	0	9364554	intron_variant	0	0.29	6E-10	9.221848749616356		1.17	[1.08-1.26]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	7q21.3	7	98187015	LMTK2	LMTK2			22853			rs6465657-C	rs6465657	0	6465657	intron_variant	0	0.46	1E-9	9.0		1.12	[1.05-1.20]	Illumina [541129]	N
2008-06-16	18264098	Gudmundsson J	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264098	Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.	Prostate cancer	1,854 European ancestry cases, 21,372 European ancestry controls	8,239 European ancestry cases, 7,590 European ancestry controls	Xp11.22	X	51486831	LOC340602, NUDT10, NUDT11	CXorf67 - NUDT11	340602	55190		77993	3180	rs5945572-A	rs5945572	0	5945572	downstream_gene_variant	1	0.35	4E-13	12.397940008672037		1.23	[1.16-1.30]	Illumina [310520]	N
2008-06-16	18264098	Gudmundsson J	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264098	Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.	Prostate cancer	1,854 European ancestry cases, 21,372 European ancestry controls	8,239 European ancestry cases, 7,590 European ancestry controls	2p15	2	62904596	EHBP1	EHBP1			23301			rs721048-A	rs721048	0	721048	intron_variant	0	0.19	8E-9	8.096910013008056		1.15	[1.10-1.21]	Illumina [310520]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.40	7E-13	12.154901959985743		1.16	[1.04-1.29]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	10q26.13	10	125008303	CTBP2	CTBP2			1488			rs4962416-C	rs4962416	0	4962416	intron_variant	0	0.27	2E-7	6.698970004336019		1.17	[1.05-1.30]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	11q13.3	11	69227200	intergenic	LOC105369366 - LOC105369367	105369366	105369367		49193	1549	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1	0.52	2E-9	8.698970004336019		1.1	[0.98-1.23]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	7p15.1	7	27936944	JAZF1	JAZF1			221895			rs10486567-G	rs10486567	0	10486567	intron_variant	0	0.77	2E-6	5.698970004336019		1.12	[1.02-1.25]	Illumina [527869]	N
2008-06-16	17603485	Gudmundsson J	2007-07-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17603485	Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.	Prostate cancer	1,501 European ancestry cases, 11,290 European ancestry controls	1,992 European ancestry cases, 3,058 European ancestry controls	17q12	17	37738049	TCF2	HNF1B			6928			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.49	1E-11	11.0		1.22	[1.15-1.30]	Illumina [310520]	N
2008-06-16	17603485	Gudmundsson J	2007-07-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17603485	Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.	Prostate cancer	1,501 European ancestry cases, 11,290 European ancestry controls	1,992 European ancestry cases, 3,058 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			101928165			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.46	3E-10	9.522878745280337		1.2	[1.14-1.27]	Illumina [310520]	N
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8	127112671	intergenic	PRNCR1 - LOC105375752	101867536	105375752		20076	27387	rs16901979-A	rs16901979	0	16901979	intergenic_variant	1	0.03	1E-12	12.0	(EA)	1.79	[1.53-2.11]	Illumina [316515]	N
2008-06-16	17401363	Yeager M	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401363	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,124 European ancestry cases, 3,142 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.50	9E-13	12.045757490560675		1.26	[1.13-1.41]	Illumina [538548]	N
2008-06-16	17401363	Yeager M	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401363	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,124 European ancestry cases, 3,142 European ancestry controls	8q24.21	8	127472793	intergenic	CASC8			727677			rs1447295-A	rs1447295	0	1447295	intron_variant	0	0.11	2E-14	13.698970004336019		1.43	[1.29-1.59]	Illumina [538548]	N
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8	127472793	intergenic	CASC8			727677			rs1447295-A	rs1447295	0	1447295	intron_variant	0	0.09	6E-18	17.221848749616356		1.6	[1.43-1.77]	Illumina [316515]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	3p12.1	3	87061524	intergenic	LOC285232 - LINC00506	285232	100846978		8655	27756	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1	0.11	3E-8	7.522878745280337		1.18	[1.06-1.31]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	Xp11.22	X	51498820	NUDT10, NUDT11	NUDT11 - LINC01496	55190	102723426		2213	1089	rs5945619-C	rs5945619	0	5945619	upstream_gene_variant	1	0.36	2E-9	8.698970004336019		1.19	[1.07-1.31]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.49	9E-13	12.045757490560675		1.42	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127081052	intergenic	PRNCR1, PCAT2			101867536, 103164619			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0	0.18	1E-7	7.0		1.37	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127506309	intergenic	CASC8 - LOC105375754	727677	105375754		24170	158230	rs4242384-C	rs4242384	0	4242384	intergenic_variant	1	0.09	3E-16	15.522878745280337		1.88	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	17q12	17	37741165	HNF1B	HNF1B			6928			rs7501939-C	rs7501939	0	7501939	intron_variant	0	0.57	9E-12	11.045757490560675		1.41	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			101928165			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.46	1E-6	6.0		1.26	[NR]	Illumina [541129]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.53	7E-12	11.154901959985743		1.28	[1.15-1.45]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	8q24.21	8	127505328	intergenic	CASC8 - LOC105375754	727677	105375754		23189	159211	rs4242382-A	rs4242382	0	4242382	intergenic_variant	1	0.12	3E-19	18.522878745280337		1.66	[1.47-1.87]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	17q12	17	37738049	HNF1B	HNF1B			6928			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.54	1E-9	9.0		1.18	[1.04-1.32]	Illumina [527869]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	3q21.3	3	128319530	intergenic	EEFSEC			60678			rs10934853-A	rs10934853	0	10934853	intron_variant	0	0.28	3E-10	9.522878745280337		1.12	[1.08-1.16]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127310936	intergenic	CASC21, CASC8			103021164, 727677			rs445114-T	rs445114	0	445114	intron_variant	0	0.64	5E-10	9.301029995663981		1.14	[1.10-1.19]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	19q13.2	19	38244973	intergenic	DPF1 - PPP1R14A	8193	94274		15259	6264	rs8102476-C	rs8102476	0	8102476	intron_variant	1	0.54	2E-11	10.698970004336019		1.12	[1.08-1.15]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	11q13.3	11	69211113	intergenic	LOC105369366 - LOC105369367	105369366	105369367		33106	17636	rs11228565-A	rs11228565	0	11228565	intergenic_variant	1	0.20	7E-12	11.154901959985743		1.23	[1.16-1.31]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127112671	intergenic	PRNCR1 - LOC105375752	101867536	105375752		20076	27387	rs16901979-A	rs16901979	0	16901979	intergenic_variant	1	0.04	3E-14	13.522878745280337		1.8	[1.55-2.09]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	17q12	17	37738049	intergenic	HNF1B			6928			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.52	8E-6	5.096910013008056		1.19	[1.10-1.28]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127308101	intergenic	CASC21, CASC8			103021164, 727677			rs16902094-G	rs16902094	0	16902094	intron_variant	0	0.15	6E-15	14.221848749616356		1.21	[1.15-1.26]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127472793	intergenic	CASC8			727677			rs1447295-A	rs1447295	0	1447295	intron_variant	0	0.11	2E-19	18.69897000433602		1.58	[1.43-1.74]	Illumina [310520]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	NR	9E-6	5.045757490560675		1.2	[1.11-1.32]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127506309	intergenic	CASC8 - LOC105375754	727677	105375754		24170	158230	rs4242384-C	rs4242384	0	4242384	intergenic_variant	1	NR	3E-16	15.522878745280337		1.56	[1.40-1.73]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	NR	5E-6	5.301029995663981		1.18	[1.10-1.27]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	11q13.3	11	69228491	intergenic	LOC105369366 - LOC105369367	105369366	105369367		50484	258	rs7130881-G	rs7130881	0	7130881	intergenic_variant	1	NR	9E-9	8.045757490560675		1.31	[1.20-1.44]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	17q12	17	37741165	TCF2	HNF1B			6928			rs7501939-C	rs7501939	0	7501939	intron_variant	0	NR	2E-6	5.698970004336019		1.19	[1.11-1.28]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			101928165			rs1859962-G	rs1859962	0	1859962	intron_variant	0	NR	3E-11	10.522878745280337		1.27	[1.18-1.37]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127081052	intergenic	PRNCR1, PCAT2			101867536, 103164619			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0	NR	4E-10	9.397940008672037		1.31	[1.20-1.42]	Illumina [571243]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	2p24.1	2	20688505	C2orf43	C2orf43			60526			rs13385191-G	rs13385191	0	13385191	intron_variant	0	0.44	8E-8	7.096910013008056		1.15	[1.10-1.21]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	5p15.33	5	1895715	intergenic	CTD-2194D22.4			101929081			rs12653946-T	rs12653946	0	12653946	intron_variant	0	0.44	4E-18	17.397940008672037		1.26	[1.20-1.33]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	6p21.1	6	41568689	FOXP4	FOXP4			116113			rs1983891-T	rs1983891	0	1983891	intron_variant	0	0.41	8E-8	7.096910013008056		1.15	[1.09-1.21]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	6q22.1	6	116888889	GPRC6A, RFX6	RFX6			222546			rs339331-T	rs339331	0	339331	intron_variant	0	0.37	2E-12	11.698970004336019		1.22	[1.15-1.28]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	13q22.1	13	73154002	intergenic	RNU6-66P - RNU7-89P	100873770	100873844		40984	14087	rs9600079-T	rs9600079	0	9600079	intergenic_variant	1	0.38	3E-9	8.522878745280337		1.18	[1.12-1.24]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8q24.21	8	127527115	intergenic	CASC8 - LOC105375754	727677	105375754		44976	137424	rs7837688-?	rs7837688	0	7837688	intergenic_variant	1	NR	1E-25	25.0				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8q24.21	8	127091692	intergenic	PRNCR1			101867536			rs1456315-?	rs1456315	0	1456315	non_coding_transcript_exon_variant	0	NR	2E-29	28.69897000433602				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	3p11.2	3	87103019	intergenic	LINC00506			100846978			rs9284813-?	rs9284813	0	9284813	intron_variant	0	NR	5E-9	8.301029995663981				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8p21.2	8	23668950	NKX3.1	LOC107986930			107986930			rs1512268-?	rs1512268	0	1512268	intergenic_variant	0	NR	4E-11	10.397940008672037				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-?	rs10993994	0	10993994	upstream_gene_variant	1	NR	3E-8	7.522878745280337				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	17q12	17	37741165	HNF1B	HNF1B			6928			rs7501939-?	rs7501939	0	7501939	intron_variant	0	NR	1E-12	12.0				Illumina [510687]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	2q37.3	2	237534583	MLPH	MLPH			79083			rs2292884-G	rs2292884	0	2292884	missense_variant	0	0.25	4E-8	7.3979400086720375		1.14	[1.09-1.19]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	12q13.13	12	52880120	KRT8, EIF4B, TENC1	KRT78 - RPL7P41	196374	100271222		31126	5639	rs902774-A	rs902774	0	902774	TF_binding_site_variant	1	0.17	5E-9	8.301029995663981		1.17	[1.11-1.24]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	3p11.2	3	87192347	intergenic	LINC00506 - MIR4795	100846978	100616161		35278	33842	rs7629490-T	rs7629490	0	7629490	intergenic_variant	1	NR	1E-7	7.0	(conditioned on rs2660753)	1.06	[1.04-1.09]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	6q25.3	6	160160342	SLC22A1	SLC22A1 - SLC22A2	6580	6582		1141	56420	rs651164-G	rs651164	0	651164	downstream_gene_variant	1	NR	2E-10	9.698970004336019	(conditioned on rs9364554)	1.15	[1.10-1.20]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127082911	intergenic	PRNCR1			101867536			rs13252298-A	rs13252298	0	13252298	non_coding_transcript_exon_variant	0	NR	4E-6	5.3979400086720375	(conditioned on 5 SNPs)	1.12	[1.05-1.18]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	22q13.2	22	43122269	BIK	BIK			638			rs742134-G	rs742134	0	742134	intron_variant	0	NR	6E-6	5.221848749616356	(conditioned on rs5759167)	1.16	[1.01-1.23]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127310936	intergenic	CASC21, CASC8			103021164, 727677			rs445114-T	rs445114	0	445114	intron_variant	0	NR	5E-7	6.301029995663981		1.22	[1.12-1.32]	Illumina [571243]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2p21	2	43326810	THADA	THADA			63892			rs1465618-?	rs1465618	0	1465618	intron_variant	0	0.23	2E-8	7.698970004336019		1.08	[1.03-1.12]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2q31.1	2	172446825	ITGA6	ITGA6			3655			rs12621278-?	rs12621278	0	12621278	intron_variant	0	0.94	9E-23	22.045757490560675		1.33	[1.25-1.43]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q22.3	4	94641726	PDLIM5	PDLIM5			10611			rs17021918-?	rs17021918	0	17021918	intron_variant	0	0.65	4E-15	14.397940008672037		1.11	[1.08-1.15]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q24	4	105140377	TET2	LOC100288146 - TET2	100288146	54790		36383	5498	rs7679673-?	rs7679673	0	7679673	intron_variant	1	0.55	3E-14	13.522878745280337		1.1	[1.06-1.14]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	7p15.3	7	20954872	NR	LINC01162			104355138			rs12155172-?	rs12155172	0	12155172	intron_variant	0	0.20	9E-6	5.045757490560675		1.05	[1.00-1.10]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	8p21.2	8	23668950	NKX3.1	LOC107986930			107986930			rs1512268-?	rs1512268	0	1512268	intergenic_variant	0	0.45	3E-30	29.522878745280337		1.18	[1.14-1.22]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	11p15.5	11	2212344	IGF2, INS, TH, IGF2AS	TH - ASCL2	7054	430		38263	56154	rs7127900-?	rs7127900	0	7127900	intergenic_variant	1	0.20	3E-33	32.52287874528034		1.22	[1.17-1.27]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	22q13.2	22	43104206	NR	RPS25P10 - BIK	100271372	638		11618	6542	rs5759167-?	rs5759167	0	5759167	regulatory_region_variant	1	0.53	6E-29	28.221848749616356		1.16	[1.14-1.20]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q22.3	4	94593458	PDLIM5	PDLIM5			10611			rs12500426-?	rs12500426	0	12500426	intron_variant	0	0.46	1E-11	11.0		1.08	[1.05-1.12]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2p15	2	63074029	EHBP1	LOC107985769			107985769			rs6545977-?	rs6545977	0	6545977	intergenic_variant	0	NR	5E-7	6.301029995663981				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	3p11.2	3	87124174	NR	LINC00506			100846978			rs17181170-?	rs17181170	0	17181170	intron_variant	0	NR	3E-8	7.522878745280337				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	6q25.3	6	160160342	NR	SLC22A1 - SLC22A2	6580	6582		1141	56420	rs651164-?	rs651164	0	651164	downstream_gene_variant	1	NR	2E-9	8.698970004336019				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	7q21.3	7	98187015	NR	LMTK2			22853			rs6465657-?	rs6465657	0	6465657	intron_variant	0	NR	2E-8	7.698970004336019				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	8q24.21	8	127506309	NR	CASC8 - LOC105375754	727677	105375754		24170	158230	rs4242384-?	rs4242384	0	4242384	intergenic_variant	1	NR	2E-24	23.69897000433602				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	10q11.22	10	46070851	NR	RPL23AP61 - AGAP7P	728484	653268		7131	38644	rs3123078-?	rs3123078	0	3123078	intergenic_variant	1	NR	1E-19	19.0				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	11q13.3	11	69228491	NR	LOC105369366 - LOC105369367	105369366	105369367		50484	258	rs7130881-?	rs7130881	0	7130881	intergenic_variant	1	NR	8E-13	12.096910013008056				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	17q12	17	37741165	NR	HNF1B			6928			rs7501939-?	rs7501939	0	7501939	intron_variant	0	NR	3E-18	17.522878745280337				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	17q24.3	17	71112612	NR	CASC17			101928165			rs1859962-?	rs1859962	0	1859962	intron_variant	0	NR	2E-16	15.698970004336019				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	Xp11.22	X	51467205	NR	CXorf67 - NUDT11	340602	55190		58367	22806	rs1327301-?	rs1327301	0	1327301	downstream_gene_variant	1	NR	2E-10	9.698970004336019				Illumina [541129]	N
2015-05-15	23104005	Gudmundsson J	2012-10-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23104005	A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer.	Prostate cancer	5,141 European ancestry cases, 54,444 European ancestry controls	Up to 5,470 European ancestry cases, up to 7,583 European ancestry controls	8q24.21	8	127179427	HOXB13	LOC105375752 - CASC19	105375752	103021165		9909	8358	rs188140481-A	rs188140481	0	188140481	intergenic_variant	1	0.054	6E-34	33.221848749616356		2.9	[2.44-3.44]	Illumina [~ 32500000] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	8q24.21	8	127401060	NR	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	NR	1E-8	8.0		1.36	[NR]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.42	2E-7	6.698970004336019		1.32	[1.21-1.43]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11p15.5	11	2212344	NR	TH - ASCL2	7054	430		38263	56154	rs7127900-A	rs7127900	0	7127900	intergenic_variant	1	NR	1E-7	7.0		1.4	[NR]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11q13.3	11	69227030	NR	LOC105369366 - LOC105369367	105369366	105369367		49023	1719	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	NR	1E-6	6.0		1.3	[NR]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	17q12	17	37736310	TCF2	HNF1B			6928			rs2005705-G	rs2005705	0	2005705	intron_variant	0	0.56	1E-6	6.0		1.35	[1.23-1.47]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	8q24.21	8	127395198	MYC	CASC8			727677			rs10505477-A	rs10505477	0	10505477	intron_variant	0	0.49	9E-9	8.045757490560675		1.39	[1.28-1.50]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11q13.3	11	69241647	MYEOV	LOC105369367 - LOC105369368	105369367	105369368		6711	6354	rs11228583-T	rs11228583	0	11228583	intergenic_variant	1	0.52	2E-7	6.698970004336019		1.33	[1.22-1.44]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	19q13.33	19	50858501	KLK3	KLK3			354			rs17632542-T	rs17632542	0	17632542	missense_variant	0	0.92	1E-7	7.0		1.85	[1.61-2.09]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11p15.5	11	2207722	TH	TH - ASCL2	7054	430		33641	60776	rs7126629-C	rs7126629	0	7126629	regulatory_region_variant	1	0.21	2E-8	7.698970004336019		1.44	[1.31-1.57]	Illumina [2639562] (imputed)	N
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	9q31.2	9	107394019	KLF4, RAD23B	LOC107987111 - LINC01509	107987111	101928720		10562	26265	rs817826-C	rs817826	0	817826	intergenic_variant	1	0.084	5E-14	13.301029995663981		1.41	[1.29-1.54]	Illumina [587294]	N
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	19q13.42	19	54293995	LILRA3	MIR4752 - LILRA5	100616171	353514		11815	13075	rs103294-C	rs103294	0	103294	3_prime_UTR_variant	1	0.238	5E-16	15.301029995663981		1.28	[1.21-1.36]	Illumina [587294]	N
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	8q24.21	8	127091692	intergenic	PRNCR1			101867536			rs1456315-?	rs1456315	0	1456315	non_coding_transcript_exon_variant	0	NR	1E-12	12.0				Illumina [587294]	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	10p14	10	9602837	intergenic	LOC105376402			105376402			rs4749884-C	rs4749884	0	4749884	intergenic_variant	0	0.533	7E-6	5.154901959985743		1.12	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	11p15.4	11	7535346	PPFIBP2	PPFIBP2			8495			rs12791447-C	rs12791447	0	12791447	intron_variant	0	0.136	4E-8	7.3979400086720375		1.23	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	12q23.1	12	97483128	RMST	RMST			196475			rs75718479-C	rs75718479	0	75718479	intron_variant	0	0.877	1E-6	6.0		1.22	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	14q23.2	14	64227194	ESR2	ESR2			2100			rs58262369-T	rs58262369	0	58262369	3_prime_UTR_variant	0	0.072	6E-10	9.221848749616356		1.28	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	2p24.1	2	20688505	C2orf43	C2orf43			60526			rs13385191-G	rs13385191	0	13385191	intron_variant	0	NR	5E-6	5.301029995663981		1.17	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	3p12.1	3	87061524	VGLL3	LOC285232 - LINC00506	285232	100846978		8655	27756	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1	NR	6E-6	5.221848749616356		1.1904762	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	5p15.33	5	1895715	IRX4	CTD-2194D22.4			101929081			rs12653946-A	rs12653946	0	12653946	intron_variant	0	NR	2E-12	11.698970004336019		1.2820514	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	6q22.1	6	116888889	RFX6	RFX6			222546			rs339331-T	rs339331	0	339331	intron_variant	0	NR	4E-11	10.397940008672037		1.2820514	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8p21.2	8	23668950	NKX3-1	LOC107986930			107986930			rs1512268-T	rs1512268	0	1512268	intergenic_variant	0	NR	1E-13	13.0		1.3157895	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8q24.21	8	127112671	POU5F1B	PRNCR1 - LOC105375752	101867536	105375752		20076	27387	rs16901979-A	rs16901979	0	16901979	intergenic_variant	1	NR	1E-16	16.0		1.3888888	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8q24.21	8	127472793	LOC727677, POU5F1B	CASC8			727677			rs1447295-A	rs1447295	0	1447295	intron_variant	0	NR	4E-23	22.397940008672037		1.5384616	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	NR	4E-8	7.3979400086720375		1.2048193	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	13q22.1	13	73154002	KLF5	RNU6-66P - RNU7-89P	100873770	100873844		40984	14087	rs9600079-T	rs9600079	0	9600079	intergenic_variant	1	NR	1E-6	6.0		1.1904762	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	17q12	17	37738049	HNF1B	HNF1B			6928			rs4430796-A	rs4430796	0	4430796	intron_variant	0	NR	6E-8	7.221848749616356		1.2345679	[NR]	Illumina [4550396] (imputed)	N
2016-02-05	25855579	Mancikova V	2015-04-22	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/25855579	Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.	Thyroid cancer	398 European ancestry cases , 502 European ancestry controls	1,422 European ancestry cases, 1,908 European ancestry controls	9q22.33	9	97865986	FOXE1	FOXE1 - C9orf156	2304	51531		9271	10335	rs10122541-G	rs10122541	0	10122541	regulatory_region_variant	1	0.33	1E-17	17.0		1.54	[1.40-1.70]	Affymetrix [474624]	N
2016-02-05	25855579	Mancikova V	2015-04-22	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/25855579	Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.	Thyroid cancer	398 European ancestry cases , 502 European ancestry controls	1,422 European ancestry cases, 1,908 European ancestry controls	9q22.33	9	97896036	FOXE1	C9orf156			51531			rs7037324-A	rs7037324	0	7037324	regulatory_region_variant	0	0.34	1E-17	17.0		1.54	[1.39-1.70]	Affymetrix [474624]	N
2016-02-05	25855579	Mancikova V	2015-04-22	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/25855579	Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.	Thyroid cancer	398 European ancestry cases , 502 European ancestry controls	1,422 European ancestry cases, 1,908 European ancestry controls	9q22.33	9	97793827	FOXE-1	KRT18P13 - FOXE1	392371	2304		93026	59428	rs965513-A	rs965513	0	965513	intergenic_variant	1	0.34	3E-23	22.522878745280337		1.65	[1.49-1.82]	Affymetrix [474624]	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	16q22.2	16	71997071	PKD1L3	PKD1L3			342372			rs12597458-G	rs12597458	0	12597458	intron_variant	0	0.56	1E-7	7.0		1.11	[1.06‐1.15]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	6p22.3	6	21330062	CDKAL1	CDKAL1 - LINC00581	54901	100874531		97658	155999	rs12198220-T	rs12198220	0	12198220	intergenic_variant	1	0.74	2E-7	6.698970004336019		1.12	[1.07‐1.17]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127505328	LOC727677, CASC8	CASC8 - LOC105375754	727677	105375754		23189	159211	rs4242382-A	rs4242382	0	4242382	intergenic_variant	1	0.1	1E-34	34.0		1.45	[1.35-1.54]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	17q12	17	37741595	HNF1B	HNF1B			6928			rs8064454-C	rs8064454	0	8064454	intron_variant	0	0.52	8E-29	28.096910013008056		1.24	[1.19‐1.29]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	17q24.3	17	71110733	BC039327, CASC17	CASC17			101928165			rs17765344-A	rs17765344	0	17765344	intron_variant	0	0.48	4E-21	20.397940008672037		1.19	[1.15-1.23]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	22q13.2	22	43104206	BIK	RPS25P10 - BIK	100271372	638		11618	6542	rs5759167-G	rs5759167	0	5759167	regulatory_region_variant	1	0.5	1E-16	16.0		1.18	[1.12-1.22]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	10q11.22	10	46046326	PARG, TIMM23, MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.39	1E-15	15.0		1.16	[1.12-1.20]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	3q26.2	3	170281428	PRKCI	PRKCI			5584			rs71277158-T	rs71277158	0	71277158	non_coding_transcript_exon_variant	0	0.82	8E-14	13.096910013008056		1.22	[1.15-1.28]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	11q13.3	11	69218116	LOC338694, MYEOV	LOC105369366 - LOC105369367	105369366	105369367		40109	10633	rs7929962-T	rs7929962	0	7929962	intergenic_variant	1	0.51	2E-13	12.698970004336019		1.15	[1.11‐1.19]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	6q25.3	6	160419220	SLC22A3	SLC22A3			6581			rs7758229-T	rs7758229	0	7758229	intron_variant	0	0.31	4E-12	11.397940008672037		1.15	[1.10‐1.20]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	2p15	2	62950976	EHBP1	EHBP1			23301			rs2430386-T	rs2430386	0	2430386	intron_variant	0	0.5	9E-12	11.045757490560675		1.14	[1.10‐1.18]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	3p12.1	3	87085650	LINC00506, BC050344	LOC285232 - LINC00506	285232	100846978		32781	3630	rs17023900-G	rs17023900	0	17023900	upstream_gene_variant	1	0.07	1E-11	11.0		1.26	[1.18‐1.34]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	5p15.33	5	1282299	TERT, hTERT	TERT			7015			rs7725218-G	rs7725218	0	7725218	intron_variant	0	0.64	3E-11	10.522878745280337		1.15	[1.10-1.19]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	12q24.21	12	114228397	TBX5	LOC105369995 - LOC105369996	105369995	105369996		114908	9825	rs10774740-G	rs10774740	0	10774740	intergenic_variant	1	0.6	3E-10	9.522878745280337		1.14	[1.09-1.18]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	4q24	4	105140377	TET2	LOC100288146 - TET2	100288146	54790		36383	5498	rs7679673-C	rs7679673	0	7679673	intron_variant	1	0.58	4E-9	8.397940008672037		1.12	[1.08-1.16]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	Xp11.22	X	52867918	NR	XAGE3			170626			rs2807031-C	rs2807031	0	2807031	intron_variant	0	0.161	4E-6	5.3979400086720375		1.15	[1.09-1.22]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127401060	NR	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.499	4E-10	9.397940008672037		1.23	[1.15-1.32]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127112671	NR	PRNCR1 - LOC105375752	101867536	105375752		20076	27387	rs16901979-A	rs16901979	0	16901979	intergenic_variant	1	0.029	5E-9	8.301029995663981		1.65	[1.39-1.95]	Illumina [1531807] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	5q31.2	5	138428109	FAM53C, CDC25C, KDM3B	KDM3B			51780			rs17599026-T	rs17599026	0	17599026	intron_variant	0	0.08	4E-8	7.3979400086720375		3.12	[2.08-4.69]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	12q13.13	12	53200654	intergenic	ITGB7			3695			rs11574532-T	rs11574532	0	11574532	intron_variant	0	0.07	2E-7	6.698970004336019		3.25	[2.08-5.07]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	4q22.1	4	87150076	intergenic	AFF1 - KLHL8	4299	57563		9022	10027	rs342442-?	rs342442	0	342442	intergenic_variant	1	0.62	4E-7	6.3979400086720375		1.9607843	[1.52-2.56]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	12p13.31	12	8514205	intergenic	CLEC4D			338339			rs4534636-A	rs4534636	0	4534636	intron_variant	0	0.20	2E-6	5.698970004336019		1.96	[1.49-2.59]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	18q21.1	18	45971047	intergenic	EPG5 - PSTPIP2	57724	9050		3708	12489	rs8098701-T	rs8098701	0	8098701	upstream_gene_variant	1	0.07	2E-6	5.698970004336019		2.41	[1.68-3.47]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	1q41	1	214606084	intergenic	CENPF, ABHD17AP3			1063, 648359			rs7366282-C	rs7366282	0	7366282	splice_region_variant	0	0.06	2E-6	5.698970004336019		3.2	[1.98-5.16]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	2q36.1	2	221684477	intergenic	LOC105373899			105373899			rs10209697-A	rs10209697	0	10209697	intergenic_variant	0	0.07	2E-6	5.698970004336019		2.66	[1.77-3.99]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	6q14.1	6	82698067	intergenic	LOC105377876 - LOC105377877	105377876	105377877		9653	120921	rs4997823-?	rs4997823	0	4997823	intergenic_variant	1	0.65	2E-6	5.698970004336019		2.0408163	[1.52-2.78]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	6p24.1	6	12217189	intergenic	HIVEP1 - EDN1	3096	1906		5155	39275	rs7356945-T	rs7356945	0	7356945	intergenic_variant	1	0.33	4E-6	5.3979400086720375		1.74	[1.38-2.21]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	22q11.23	22	23942638	intergenic	LOC100652871			100652871			rs6003982-?	rs6003982	0	6003982	non_coding_transcript_exon_variant	0	0.56	4E-6	5.3979400086720375		1.9607843	[1.47-2.63]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	8q24.3	8	141800605	intergenic	MIR1302-7 - LOC100131146	100302147	100131146		14292	167289	rs10101158-A	rs10101158	0	10101158	regulatory_region_variant	1	0.44	4E-6	5.3979400086720375		1.8	[1.40-2.31]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	5p15.2	5	13858219	DNAH5	DNAH5			1767			rs7720298-G	rs7720298	0	7720298	intron_variant	0	0.24	3E-8	7.522878745280337		2.71	[1.90-3.86]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	8p23.2	8	5689302	intergenic	LOC105377794 - LOC392180	105377794	392180		92404	159395	rs17362923-G	rs17362923	0	17362923	intergenic_variant	1	0.18	7E-7	6.154901959985743		2.7	[1.83-4.00]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	1q32.1	1	198705436	intergenic	PTPRC			5788			rs76273496-C	rs76273496	0	76273496	intron_variant	0	0.07	3E-6	5.522878745280337		3.68	[2.13-6.33]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	Xq21.1	X	80753384	intergenic	BRWD3			254065			rs2203205-C	rs2203205	0	2203205	intron_variant	0	0.29	3E-6	5.522878745280337		1.74	[1.38-2.20]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	3q28	3	190286521	intergenic	LOC107986170			107986170			rs144596911-A	rs144596911	0	144596911	intergenic_variant	0	0.09	3E-6	5.522878745280337		3.6	[2.11-6.17]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	18p11.32	18	514471	intergenic	LOC105376854			105376854			rs62091368-A	rs62091368	0	62091368	intron_variant	0	0.07	4E-6	5.3979400086720375		4.36	[2.33-8.14]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	5q23.3	5	128745323	intergenic	LOC105379168			105379168			rs141342719-T	rs141342719	0	141342719	intron_variant	0	0.12	4E-6	5.3979400086720375		3.5	[2.05-5.95]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	18p11.32	18	2825420	intergenic	SMCHD1 - EMILIN2	23347	84034		20403	21610	rs673783-G	rs673783	0	673783	intron_variant	1	0.31	4E-6	5.3979400086720375		2.49	[1.69-3.67]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	3p12.3	3	76667643	intergenic	ROBO2			6092			rs12497518-?	rs12497518	0	12497518	intron_variant	0	0.53	1E-6	6.0		1.6666665	[1.35-2.08]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	Xq23	X	115688155	intergenic	ASS1P5 - EEF1GP5	450	642357		21816	14636	rs141044160-C	rs141044160	0	141044160	intergenic_variant	1	0.05	2E-6	5.698970004336019		2.68	[1.78-4.04]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	3q26.1	3	162481716	intergenic	LOC107986049 - TOMM22P6	107986049	100287573		265296	4803	rs7432328-A	rs7432328	0	7432328	downstream_gene_variant	1	0.06	3E-6	5.522878745280337		3.36	[2.05-5.59]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	8q21.13	8	79779234	intergenic	LOC101927067, LOC101927040			101927067, 101927040			rs6999859-G	rs6999859	0	6999859	intron_variant	0	0.28	3E-6	5.522878745280337		1.73	[1.37-2.17]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	19p13.2	19	10457843	intergenic	PDE4A			5141			rs4804134-?	rs4804134	0	4804134	intron_variant	0	0.69	3E-6	5.522878745280337		1.6666665	[1.35-2.08]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	1q42.12	1	225904035	intergenic	LEFTY1 - PYCR2	10637	29920		14889	15842	rs360071-T	rs360071	0	360071	intron_variant	1	0.49	4E-6	5.3979400086720375		1.61	[1.32-1.97]	NR [~ 38000000] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	8q21.13 x 9q33.2	8 x 9	78044423 x 121665094	PKIA x DAB2IC	LOC102724874 - LOC105375911 x DAB2IP						rs2219968-? x rs1571801-?	rs2219968 x rs1571801	0		intergenic_variant x intron_variant		NR	6E-7	6.221848749616356		1.3	[1.17-1.43]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	10p14 x 19q13.2	10 x 19	12009817 x 38244973	UPF2 x NR	UPF2 x DPF1 - PPP1R14A						rs10795917-? x rs8102476-?	rs10795917 x rs8102476	0		intron_variant x intron_variant		NR	7E-7	6.154901959985743		1.24	[1.14-1.36]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	12q13.11 x 17q12	12 x 17	48417317 x 37738049	ANP32D x HNF1B	OR8S21P, C12orf54 x HNF1B						rs4489787-? x rs4430796-?	rs4489787 x rs4430796	0		non_coding_transcript_exon_variant x intron_variant		NR	1E-6	6.0		1.47	[1.25-1.72]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p14.3 x 11q13.3	3 x 11	57409039 x 69167951	DNAH12 x MYEOV	DNAH12 x LOC338694, LOC105369366						rs1916284-? x rs12418451-?	rs1916284 x rs12418451	0		intron_variant x intron_variant		NR	1E-6	6.0		1.2658	[1.15-1.41]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	7q21.3 x 10q26.13	7 x 10	98391899 x 125008303	BAIAP2L1 x CTBP2	BAIAP2L1 x CTBP2						rs9649213-? x rs4962416-?	rs9649213 x rs4962416	0		intron_variant x intron_variant		NR	1E-6	6.0		1.28	[1.16-1.42]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	14q11.2 x 11q13.3	14 x 11	20556460 x 69167951	RNASE9 x MYEOV	RNASE9 x LOC338694, LOC105369366						rs1243647-? x rs12418451-?	rs1243647 x rs12418451	0		missense_variant x intron_variant		NR	1E-6	6.0		1.3333	[1.19-1.49]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	9q22.2 x 4q24	9 x 4	90793457 x 105140377	SYK x TET2	OR7E108P - SYK x LOC100288146 - TET2						rs290258-? x rs7679673-?	rs290258 x rs7679673	0		intergenic_variant x intron_variant		NR	1E-6	6.0		1.3333	[1.19-1.49]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	9p24.1 x 8q24.21	9 x 8	8012418 x 127472793	C9orf123 x NR	LOC105375971 - PTPRD x CASC8						rs12682851-? x rs1447295-?	rs12682851 x rs1447295	0		intergenic_variant x intron_variant		NR	2E-6	5.698970004336019		1.3889	[1.22-1.59]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	6q22.31 x 17q12	6 x 17	122961796 x 37714971	CLVS2 x HNF1B	ATP5LP2 - CLVS2 x LOC105371754, HNF1B						rs13192613-? x rs11649743-?	rs13192613 x rs11649743	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.37	[1.20-1.56]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	2q31.3 x 17q24.3	2 x 17	180176559 x 71112612	CWC22 x NR	LOC105373767 - LOC105373768 x CASC17						rs16867225-? x rs1859962-?	rs16867225 x rs1859962	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.5625	[1.3-1.89]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	20q13.33 x 19q13.33	20 x 19	63037684 x 50861367	LOC63930 x KLK3	LOC63930 x KLK3 - KLK2						rs6089829-? x rs2735839-?	rs6089829 x rs2735839	0		intron_variant x upstream_gene_variant		NR	3E-6	5.522878745280337		1.3514	[1.19-1.54]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	7p14.1 x 8q24.21	7 x 8	40925528 x 127472793	INHBA x NR	LOC105375242 - LINC01450 x CASC8						rs7789197-? x rs1447295-?	rs7789197 x rs1447295	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.5152	[1.27-1.79]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	5q13.1 x 3p12.1	5 x 3	67537429 x 87061524	CD180 x NR	LOC101928819 - RPL21P55 x LOC285232 - LINC00506						rs7717572-? x rs2660753-?	rs7717572 x rs2660753	0		intron_variant x intergenic_variant		NR	3E-6	5.522878745280337		1.94	[1.47-2.56]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	5p15.2 x 19q13.2	5 x 19	13505322 x 41479716	DNAH5 x PPP1R14A	LOC105374660 x PCAT19						rs4463179-? x rs887391-?	rs4463179 x rs887391	0		intergenic_variant x intron_variant		NR	2E-6	5.698970004336019		1.5625	[1.3-1.89]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	14q32.31 x 3q21.3	14 x 3	101260770 x 128319530	MIR656 x EEFSEC	LOC100128373 - LOC107984697 x EEFSEC						rs2400997-? x rs10934853-?	rs2400997 x rs10934853	0		intron_variant x intron_variant		NR	3E-6	5.522878745280337		1.25	[1.14-1.38]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p26.3 x 7q21.3	3 x 7	108303 x 98187015	CHL1 x LMTK2	LOC107986040 - LOC101927174 x LMTK2						rs12485321-? x rs6465657-?	rs12485321 x rs6465657	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.2346	[1.14-1.35]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	22q13.1 x 11p15.5	22 x 11	40258272 x 2212344	TNRC6B x IGF2, IGF2AS, INS, TH	TNRC6B x TH - ASCL2						rs12628051-? x rs7127900-?	rs12628051 x rs7127900	0		intron_variant x intergenic_variant		NR	3E-6	5.522878745280337		1.3	[1.17-1.46]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	8q21.13 x 9q33.2	8 x 9	82161594 x 121665094	SNX16 x DAB2IC	LOC105375930 x DAB2IP						rs13264970-? x rs1571801-?	rs13264970 x rs1571801	0		upstream_gene_variant x intron_variant		NR	4E-6	5.3979400086720375		1.2987	[1.16-1.45]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	8q24.13 x 11p15.5	8 x 11	123702482 x 2212344	ANXA13 x IGF2, IGF2AS, INS, TH	ANXA13 x TH - ASCL2						rs13258681-? x rs7127900-?	rs13258681 x rs7127900	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.32	[1.17-1.48]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	6p22.1 x 8p21.2	6 x 8	29734733 x 23668950	LOC285830 x NKX3.1	HLA-F, HLA-F-AS1 x LOC107986930						rs2523395-? x rs1512268-?	rs2523395 x rs1512268	0		intron_variant x intergenic_variant		NR	2E-6	5.698970004336019		1.24	[1.14-1.35]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	4q25 x 8q24.21	4 x 8	113079800 x 126999692	ANK2 x NR	ANK2 x LOC105375751						rs7694725-? x rs10086908-?	rs7694725 x rs10086908	0		intron_variant x intron_variant		NR	2E-6	5.698970004336019		1.36	[1.20-1.55]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	15q26.2 x 8q24.21	15 x 8	96459423 x 127472793	NR2F2 x NR	RPL31P55 - RN7SKP254 x CASC8						rs11637980-? x rs1447295-?	rs11637980 x rs1447295	0		intergenic_variant x intron_variant		NR	2E-6	5.698970004336019		1.4706	[1.27-1.72]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p25.2 x 10q11.22	3 x 10	12510308 x 46046326	TSEN2 x MSMB	TSEN2 x MSMB - RPL23AP61						rs6766510-? x rs10993994-?	rs6766510 x rs10993994	0		intron_variant x upstream_gene_variant		NR	2E-6	5.698970004336019		1.58	[1.31-1.91]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	4p16.2 x 19q13.2	4 x 19	5757142 x 41479716	EVC x PPP1R14A	EVC x PCAT19						rs735172-? x rs887391-?	rs735172 x rs887391	0		intron_variant x intron_variant		NR	2E-6	5.698970004336019		1.31	[1.17-1.46]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	12q13.11 x 22q13.2	12 x 22	46978487 x 43104206	AMIGO2 x TTLL1, BIK, MCAT, PACSIN2	LOC107984466 - AMIGO2 x RPS25P10 - BIK						rs2711721-? x rs5759167-?	rs2711721 x rs5759167	0		intergenic_variant x regulatory_region_variant		NR	2E-6	5.698970004336019		1.28	[1.16-1.42]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3q13.2 x 2q31.1	3 x 2	112779033 x 172446825	CD200R1L x ITAGA6	LOC101929694 - LOC100129297 x ITGA6						rs1002979-? x rs12621278-?	rs1002979 x rs12621278	0		regulatory_region_variant x intron_variant		NR	3E-6	5.522878745280337		1.5873	[1.32-1.92]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	13q31.3 x 8p21.2	13 x 8	90213292 x 23668950	MIR622 x NKX3.1	FAR1P1 - KRT18P27 x LOC107986930						rs16944141-? x rs1512268-?	rs16944141 x rs1512268	0		intergenic_variant x intergenic_variant		NR	3E-6	5.522878745280337		1.5385	[1.28-1.85]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	15q21.1 x 11q13.3	15 x 11	48747600 x 69167951	CEP152 x MYEOV	CEP152 x LOC338694, LOC105369366						rs784411-? x rs12418451-?	rs784411 x rs12418451	0		intron_variant x intron_variant		NR	1E-7	7.0		1.42	[1.25-1.61]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	18q12.3 x 3q21.3	18 x 3	45145697 x 128319530	MIR4319 x EEFSEC	LOC105372091 x EEFSEC						rs998124-? x rs10934853-?	rs998124 x rs10934853	0		intron_variant x intron_variant		NR	5E-6	5.301029995663981		1.33	[1.18-1.51]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	2q33.1 x 11q13.3	2 x 11	198304372 x 69227200	PLCL1 x MYEOV	LOC101927619 x LOC105369366 - LOC105369367						rs13398206-? x rs10896449-?	rs13398206 x rs10896449	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.24	[1.13-1.36]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	10q25.3 x 8q24.21	10 x 8	114567791 x 127472793	ABLIM1 x NR	ABLIM1 x CASC8						rs10885582-? x rs1447295-?	rs10885582 x rs1447295	0		intron_variant x intron_variant		NR	4E-6	5.3979400086720375		1.3699	[1.20-1.59]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	12q21.31 x 8q24.21	12 x 8	82770777 x 127112671	TMTC2 x NR	TMTC2 x PRNCR1 - LOC105375752						rs12317459-? x rs16901979-?	rs12317459 x rs16901979	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		2.06	[1.52-2.80]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	5q11.2 x 10q26.13	5 x 10	57834991 x 125008303	ACTBL2 x CTBP2	LOC101928505 - LOC101928539 x CTBP2						rs10940579-? x rs4962416-?	rs10940579 x rs4962416	0		regulatory_region_variant x intron_variant		NR	4E-6	5.3979400086720375		1.32	[1.18-1.49]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	7q31.1 x 17q24.3	7 x 17	109363517 x 71112612	C7orf66 x NR	LOC646614 - LOC100421901 x CASC17						rs10277209-? x rs1859962-?	rs10277209 x rs1859962	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.36	[1.19-1.55]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	9q33.1 x 3q21.3	9 x 3	115068533 x 128319530	TNC x EEFSEC	TNC x EEFSEC						rs7847271-? x rs10934853-?	rs7847271 x rs10934853	0		intron_variant x intron_variant		NR	4E-6	5.3979400086720375		1.4925	[1.27-1.79]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p26.3 x 22q13.1	3 x 22	1470903 x 40056115	CNTN6 x TNRC6B	CNTN6 - RPL23AP38 x TNRC6B						rs6763848-? x rs9623117-?	rs6763848 x rs9623117	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.3	[1.16-1.45]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	13q14.11 x 2p21	13 x 2	44063269 x 43326810	NCRNA00284 x THADA	LINC00284 - LOC105370183 x THADA						rs9567349-? x rs1465618-?	rs9567349 x rs1465618	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.6393	[1.33-2.04]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	15q14 x 8q24.21	15 x 8	34776108 x 127401060	ACTC1 x NR	LOC101928174 x CCAT2, CASC8						rs543686-? x rs6983267-?	rs543686 x rs6983267	0		intron_variant x non_coding_transcript_exon_variant		NR	4E-6	5.3979400086720375		1.24	[1.13-1.35]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	22q12.1 x 8q24.21	22 x 8	27456222 x 127310936	MN1 x NR	LOC105372980 - LOC105372981 x CASC21, CASC8						rs6005451-? x rs445114-?	rs6005451 x rs445114	0		downstream_gene_variant x intron_variant		NR	4E-6	5.3979400086720375		1.42	[1.22-1.65]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	22q11.22 x 4q24	22 x 4	22490916 x 105140377	ZNF280B x TET2	ZNF280B, IGL x LOC100288146 - TET2						rs5751168-? x rs7679673-?	rs5751168 x rs7679673	0		intron_variant x intron_variant		NR	4E-6	5.3979400086720375		1.44	[1.23-1.67]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	18q12.1 x Xp11.22	18 x X	33347811 x 51498820	C18orf34 x NUDT10	CCDC178 x NUDT11 - LINC01496						rs6507016-? x rs5945619-?	rs6507016 x rs5945619	0		intron_variant x upstream_gene_variant		NR	4E-6	5.3979400086720375		1.2821	[1.15-1.41]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	22q13.1 x 11p15.5	22 x 11	40279087 x 2212344	TNRC6B x IGF2, IGF2AS, INS, TH	TNRC6B x TH - ASCL2						rs4821941-? x rs7127900-?	rs4821941 x rs7127900	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.3	[1.16-1.46]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	2q13 x 11p15.5	2 x 11	111039954 x 2212344	ACOXL x IGF2, IGF2AS, INS, TH	ACOXL x TH - ASCL2						rs3789080-? x rs7127900-?	rs3789080 x rs7127900	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.4085	[1.22-1.64]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	11p15.2 x 4q24	11 x 4	15333700 x 105140377	INSC x TET2	INSC - LOC105376569 x LOC100288146 - TET2						rs11605083-? x rs7679673-?	rs11605083 x rs7679673	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.28	[1.15-1.43]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	1p34.3 x 17q12	1 x 17	37731169 x 37738049	EPHA10 x HNF1B	EPHA10 x HNF1B						rs731174-? x rs4430796-?	rs731174 x rs4430796	0		intron_variant x intron_variant		NR	5E-6	5.301029995663981		1.27	[1.15-1.40]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	16q12.1 x 7q21.3	16 x 7	49360365 x 98187015	C16orf78 x LMTK2	LOC105371243 - C16orf78 x LMTK2						rs8057939-? x rs6465657-?	rs8057939 x rs6465657	0		intergenic_variant x intron_variant		NR	5E-6	5.301029995663981		1.37	[1.20-1.57]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p12.1 x 4q22.3	3 x 4	86845328 x 94641726	VGLL3 x PDLIM5	LOC101927518 - LOC105377196 x PDLIM5						rs9757252-? x rs17021918-?	rs9757252 x rs17021918	0		intergenic_variant x intron_variant		NR	5E-6	5.301029995663981		1.25	[1.13-1.37]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	6p22.3 x 8q24.21	6 x 8	17813594 x 126999692	KIF13A x NR	KIF13A x LOC105375751						rs10456809-? x rs10086908-?	rs10456809 x rs10086908	0		intron_variant x intron_variant		NR	5E-6	5.301029995663981		1.25	[1.14-1.38]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3q26.31 x 7p15.1	3 x 7	173125487 x 27936944	SPATA16 x JAZF1	SPATA16, LOC105374220 x JAZF1						rs11720607-? x rs10486567-?	rs11720607 x rs10486567	0		intron_variant x intron_variant		NR	5E-6	5.301029995663981		1.3699	[1.20-1.59]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	6q12 x 6q25.3	6 x 6	68584593 x 160412632	BAI3 x NR	LOC101928280 - LOC101928307 x SLC22A3						rs9351730-? x rs9364554-?	rs9351730 x rs9364554	0		intergenic_variant x intron_variant		NR	5E-6	5.301029995663981		1.25	[1.13-1.37]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	1p35.3 x 19q13.2	1 x 19	29712815 x 38244973	PTPRU x NR	LOC107984934 - LOC101929406 x DPF1 - PPP1R14A						rs1866967-? x rs8102476-?	rs1866967 x rs8102476	0		upstream_gene_variant x intron_variant		NR	5E-6	5.301029995663981		1.2195	[1.12-1.33]	Affymetrix, Illumina [1117531] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	6q25.3	6	160421505	SLC22A3	SLC22A3			6581			rs3123636-C	rs3123636	0	3123636	intron_variant	0	0.356	3E-9	8.522878745280337		1.37	[1.23-1.51]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	10q11.22	10	46057653	TIMM23	MSMB - RPL23AP61	4477	728484		11384	5597	rs10763567-A	rs10763567	0	10763567	regulatory_region_variant	1	0.489	6E-10	9.221848749616356		1.31	[1.19-1.44]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	11q13.3	11	69244777	MYEOV	LOC105369367 - LOC105369368	105369367	105369368		9841	3224	rs12270641-T	rs12270641	0	12270641	intergenic_variant	1	0.45	1E-11	11.0		1.4	[1.27-1.55]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	17q12	17	37742390	HNF1B	HNF1B			6928			rs11651052-A	rs11651052	0	11651052	intron_variant	0	0.435	3E-10	9.522878745280337		1.37	[1.24-1.51]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	8q24.21	8	127101181	PRNCR1	PRNCR1 - LOC105375752	101867536	105375752		8586	38877	rs56005245-T	rs56005245	0	56005245	intergenic_variant	1	0.225	1E-8	8.0		1.41	[1.25-1.59]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	8q24.21	8	127196124	CASC19	CASC19			103021165			rs138042437-G	rs138042437	0	138042437	intron_variant	0	0.015	2E-8	7.698970004336019		13.25	[5.37-32.69]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	8q24.21	8	127311646	CASC8, CASC21	CASC21, CASC8			103021164, 727677			rs4506170-C	rs4506170	0	4506170	intron_variant	0	0.166	2E-9	8.698970004336019		1.51	[1.32-1.73]	Illumina [~ 9400000] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	1p36.22	1	10503552	PEX14	PEX14			5195			rs10864459-?	rs10864459	0	10864459	intron_variant	0	0.6799999999999999	2E-9	8.698970004336019		1.1111112	[1.08-1.15]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	1q32.1	1	202209914	LGR6	LGR6			59352			rs17489300-?	rs17489300	0	17489300	intron_variant	0	0.6	9E-10	9.045757490560675		1.1111112	[1.08-1.15]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	1q32.1	1	204549714	MDM4	MDM4			4194			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.26	6E-15	14.221848749616356		1.13	[1.11-1.19]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	2p24.1	2	19121042	Intergenic	LOC105373455 - MIR4757	105373455	100616307		54972	227387	rs12710696-?	rs12710696	0	12710696	intron_variant	1	0.36	2E-8	7.698970004336019		1.1	[1.06-1.13]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	2q14.2	2	120330606	INHBB	LOC105373584 - LOC105373989	105373584	105373989		11282	11844	rs11903787-?	rs11903787	0	11903787	downstream_gene_variant	1	0.75	9E-7	6.045757490560675		1.1111112	[1.06-1.16]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	5p15.33	5	1279913	TERT	TERT			7015			rs2242652-?	rs2242652	0	2242652	intron_variant	0	0.2	3E-14	13.522878745280337		1.18	[1.13-1.23]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	5p15.33	5	1282204	TERT	TERT			7015			rs7726159-?	rs7726159	0	7726159	intron_variant	0	0.34	2E-6	5.698970004336019		1.09	[1.05-1.13]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	5p15.33	5	1297373	TERT	TERT - MIR4457	7015	100616235		1747	11937	rs2736108-?	rs2736108	0	2736108	upstream_gene_variant	1	0.71	1E-8	8.0		1.1235955	[1.08-1.16]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	6q25.1	6	151597721	ESR1	CCDC170			80129			rs12662670-?	rs12662670	0	12662670	intron_variant	0	0.08	9E-15	14.045757490560675		1.2	[1.18-1.32]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	6q25.1	6	151625017	ESR1	CCDC170 - ESR1	80129	2099		3824	29131	rs11155804-?	rs11155804	0	11155804	downstream_gene_variant	1	0.34	8E-18	17.096910013008056		1.16	[1.12-1.19]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-?	rs10995190	0	10995190	intron_variant	0	0.84	4E-8	7.3979400086720375		1.1235955	[1.08-1.18]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	11p15.5	11	1880867	LSP1	LSP1			4046			rs4980383-?	rs4980383	0	4980383	non_coding_transcript_exon_variant	0	0.44	3E-6	5.522878745280337		1.08	[1.05-1.12]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	12p11.22	12	28021884	PTHLH	PTHLH - LOC105369710	5744	105369710		47697	39757	rs7297051-?	rs7297051	0	7297051	regulatory_region_variant	1	0.76	1E-14	14.0		1.1627907	[1.12-1.2]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-?	rs10771399	0	10771399	intergenic_variant	1	0.88	4E-13	12.397940008672037		1.2658228	[1.15-1.28]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	16q12.1	16	52565276	TOX3	CASC16			643714			rs4784227-?	rs4784227	0	4784227	intron_variant	0	0.24	1E-14	14.0		1.15	[1.11-1.19]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	16q12.2	16	53779455	FTO	FTO			79068			rs17817449-?	rs17817449	0	17817449	intron_variant	0	0.5900000000000001	3E-7	6.522878745280337		1.098901	[1.05-1.12]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	16q12.2	16	53821379	FTO	FTO			79068			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	3E-8	7.522878745280337		1.11	[1.07-1.15]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	19p13.11	19	17283116	ADHB8	ANKLE1			126549			rs56069439-?	rs56069439	0	56069439	non_coding_transcript_exon_variant	0	0.3	8E-19	18.096910013008056		1.16	[1.13-1.20]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	19p13.11	19	17278895	MERIT40	BABAM1			29086			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	1E-12	12.0		1.15	[1.11-1.20]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	2p23.2	2	28896719	WDR43	WDR43			23160			rs67073037-?	rs67073037	0	67073037	intron_variant	0	0.76	3E-6	5.522878745280337		1.0869565	[1.05-1.14]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	2q33.1	2	200878871	PPIL3, CLK1, FAM126B, NDUFB3	PPIL3			53938			rs115635831-?	rs115635831	0	115635831	intron_variant	0	0.015	1E-6	6.0		1.36	[1.20-1.54]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	13q22.1	13	73232845	KLF5, KLF12	RNY1P8 - MARK2P12	100873807	100421565		5585	174944	rs12870942-?	rs12870942	0	12870942	intergenic_variant	1	0.32	3E-7	6.522878745280337		1.09	[1.05-1.13]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	9p21.3	9	22062135	NR	CDKN2B-AS1			100048912			rs1011970-?	rs1011970	0	1011970	intron_variant	0	0.17	2E-6	5.698970004336019		1.11	[1.06-1.15]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	12q22	12	95633983	NR	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-?	rs17356907	0	17356907	intron_variant	1	0.7	3E-6	5.522878745280337		1.098901	[1.69-1.14]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	13q13.1	13	32398489	NR	BRCA2			675			rs11571833-?	rs11571833	0	11571833	stop_gained	0	0.01	6E-6	5.221848749616356		1.32	[1.20-1.43]	Illumina [10909381] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	11q12.2	11	60441351	Intergenic	MS4A5			64232			rs11230328-G	rs11230328	0	11230328	intron_variant	0	0.27	6E-10	9.221848749616356		0.31	[0.21-0.41] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	10p14	10	10074911	Intergenic	LOC101928298 - TCEB1P3	101928298	644540		11409	99269	rs147596965-T	rs147596965	0	147596965	regulatory_region_variant	1	0.07	6E-8	7.221848749616356		0.67	[0.43-0.91] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	2q31.1	2	174729547	Intergenic	H3F3AP4 - CHRNA1	440926	1134		8689	18045	rs77530448-G	rs77530448	0	77530448	intron_variant	1	0.09	7E-8	7.154901959985743		0.36	[0.23-0.49] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	15q12	15	25730061	Intergenic	ATP10A			57194			rs4906759-T	rs4906759	0	4906759	intron_variant	0	0.06	2E-7	6.698970004336019		0.55	[0.34-0.75] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	4p15.2	4	26002024	Intergenic	SMIM20 - LOC105374540	389203	105374540		72145	68738	rs71610881-A	rs71610881	0	71610881	intergenic_variant	1	0.06	5E-7	6.301029995663981		0.6	[0.36-0.83] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	19q13.2	19	40682173	Intergenic	NUMBL			9253			rs141799618-G	rs141799618	0	141799618	intron_variant	0	0.06	1E-6	6.0		0.44	[0.26-0.62] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	10q26.2	10	126642144	Intergenic	C10orf90			118611			rs2842169-C	rs2842169	0	2842169	intron_variant	0	0.1	1E-6	6.0		0.28	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	11q24.1	11	123204711	Intergenic	LOC105369540			105369540			rs11219068-A	rs11219068	0	11219068	intron_variant	0	0.15	2E-6	5.698970004336019		0.28	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	17p13.2	17	6384826	Intergenic	LOC105371509 - AIPL1	105371509	23746		9779	38911	rs8075565-T	rs8075565	0	8075565	intergenic_variant	1	0.13	2E-6	5.698970004336019		0.28	[0.16-0.39] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	4q28.3	4	134616564	Intergenic	LOC105377436			105377436			rs6535028-T	rs6535028	0	6535028	intergenic_variant	0	0.1	3E-6	5.522878745280337		0.29	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	15q21.1	15	46564730	Intergenic	LOC100419366 - LOC105370803	100419366	105370803		464356	43020	rs4775602-C	rs4775602	0	4775602	intergenic_variant	1	0.16	3E-6	5.522878745280337		0.23	[0.13-0.32] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	1p13.3	1	109165601	Intergenic	KIAA1324			57535			rs60481745-A	rs60481745	0	60481745	intron_variant	0	0.1	4E-6	5.3979400086720375		0.37	[0.22-0.53] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	8p23.2	8	3289837	Intergenic	CSMD1			64478			rs7829759-A	rs7829759	0	7829759	intron_variant	0	0.11	4E-6	5.3979400086720375		0.33	[0.19-0.47] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	15q24.2	15	75637650	Intergenic	SNUPN - IMP3	10073	55272		11272	1435	rs79604958-C	rs79604958	0	79604958	intron_variant	1	0.07	4E-6	5.3979400086720375		0.47	[0.27-0.68] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	12p13.31	12	8552873	Intergenic	CLEC4E - LOC105369645	26253	105369645		11545	10322	rs10770857-A	rs10770857	0	10770857	intron_variant	1	0.37	5E-6	5.301029995663981		0.17	[0.10-0.25] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	15q25.1	15	79696844	Intergenic	LOC390618 - TRC-GCA5-1	390618	100189155		27749	47811	rs12591436-G	rs12591436	0	12591436	intergenic_variant	1	0.34	6E-6	5.221848749616356		0.18	[0.10-0.26] unit increase	NR [~ 38000000] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer (estrogen-receptor negative)	1349 African American cases, 42 African ancestry cases, 4,150 African American controls, 624 African ancestry controls	573 African American cases, 2,939 African American controls	3q26.31	3	172550013	TNFSF10	TNFSF10 - LOC105374219	8743	105374219		26506	42844	rs13074711-T	rs13074711	0	13074711	intergenic_variant	1	0.69	2E-8	7.698970004336019		1.29	[1.18-1.40]	Illumina [16147413] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer (estrogen-receptor negative)	1349 African American cases, 42 African ancestry cases, 4,150 African American controls, 624 African ancestry controls	573 African American cases, 2,939 African American controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.6	2E-10	9.698970004336019		1.3	[1.20-1.41]	Illumina [16147413] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer (estrogen-receptor positive)	1795 African American cases, 99 African ancestry cases, 4,150 African American controls, 624 African ancestry controls	1093 African American cases, 2939 African American controls	2q35	2	217029040	intergenic	LOC101928278			101928278			rs12998806-G	rs12998806	0	12998806	intergenic_variant	0	0.86	2E-8	7.698970004336019		1.34	[1.21-1.48]	Illumina [16147413] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	2p23.3	2	27633057	GPN1, C2orf16, ZNF512, CCDC121	GPN1			11321			rs6547741-G	rs6547741	0	6547741	intron_variant	0	0.46	4E-8	7.3979400086720375		1.1983223	NR	Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	4q23	4	99318162	ADH1B	ADH1B			125			rs1229984-G	rs1229984	0	1229984	missense_variant	0	0.94	1E-9	9.0		1.7436792	NR	Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	5p15.33	5	1343679	CLPTM1L	CLPTM1L			81037			rs10462706-C	rs10462706	0	10462706	intron_variant	0	0.85	6E-10	9.221848749616356		1.3594345	NR	Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	9p21.3	9	22064466	CDKN2B-AS1	CDKN2B-AS1			100048912			rs8181047-A	rs8181047	0	8181047	intron_variant	0	0.24	4E-9	8.397940008672037		1.24	NR	Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	9q34.12	9	131076637	LAMC3, LOC105376298	LAMC3			10319			rs928674-G	rs928674	0	928674	intron_variant	0	0.12	2E-8	7.698970004336019		1.3252	NR	Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	15q21.2	15	49536822	LOC105370811	LOC105370811, FAM227B			105370811, 196951			rs10851478-G	rs10851478	0	10851478	intron_variant	0	0.36	4E-7	6.3979400086720375		1.1865	NR	Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	15q26.2	15	96319940	NR2F2-AS1	NR2F2-AS1			644192			rs2398180-T	rs2398180	0	2398180	intron_variant	0	0.53	3E-7	6.522878745280337		1.201	NR	Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	6p21.32	6	32679924	intergenic	HLA-DQB1 - MTCO3P1	3119	404026		13235	26220	rs3129780-A	rs3129780	0	3129780	intergenic_variant	1	0.64	6E-8	7.221848749616356		1.2373	NR	Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oral cavity cancer	2,717 European ancestry cases, 273 cases, 5,984 European ancestry controls, 601 controls	NA	6p21.33	6	31579073	MICB, AIF1	TNF - LTB	7124	4050		737	1485	rs1800628-A	rs1800628	0	1800628	downstream_gene_variant	1	0.07	7E-8	7.154901959985743		1.3962	NR	Illumina [7574753] (imputed)	N
2008-06-16	18385676	Amos CI	2008-04-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18385676	Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.	Lung cancer	1,154 European ancestry cases, 1,137 European ancestry controls	2,724 European ancestry cases, 3,694 European ancestry controls	15q25.1	15	78513681	CHRNA5, CHRNA3, PSMA4, LOC123688	HYKK			123688			rs8034191-G	rs8034191	0	8034191	intron_variant	0	NR	3E-18	17.522878745280337		1.3	[1.15-1.47]	Illumina [317498]	N
2008-06-16	18385676	Amos CI	2008-04-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18385676	Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.	Lung cancer	1,154 European ancestry cases, 1,137 European ancestry controls	2,724 European ancestry cases, 3,694 European ancestry controls	1q23.2	1	159711078	CRP	CRPP1 - CRP	171422	1401		5482	1211	rs2808630-G	rs2808630	0	2808630	downstream_gene_variant	1	NR	7E-6	5.154901959985743		1.22	[1.10-1.35]	Illumina [317498]	N
2008-06-16	18385676	Amos CI	2008-04-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18385676	Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.	Lung cancer	1,154 European ancestry cases, 1,137 European ancestry controls	2,724 European ancestry cases, 3,694 European ancestry controls	3q28	3	190632672	IL1RAP	IL1RAP			3556			rs7626795-G	rs7626795	0	7626795	intron_variant	0	NR	8E-6	5.096910013008056		1.16	[1.05-1.28]	Illumina [317498]	N
2008-09-25	18794855	Kiemeney LA	2008-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18794855	Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.	Urinary bladder cancer	1,803 European ancestry cases, 34,336 European ancestry controls	2,165 European ancestry cases, 3,800 European ancestry controls	8q24.21	8	127705823	MYC, BC042052	CASC11			100270680			rs9642880-T	rs9642880	0	9642880	intron_variant	0	0.45	9E-12	11.045757490560675		1.22	[1.15-1.29]	Illumina [302140]	N
2008-09-25	18794855	Kiemeney LA	2008-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18794855	Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.	Urinary bladder cancer	1,803 European ancestry cases, 34,336 European ancestry controls	2,165 European ancestry cases, 3,800 European ancestry controls	3q28	3	189928144	TP63	TP63 - P3H2	8626	55214		30865	28584	rs710521-A	rs710521	0	710521	intergenic_variant	1	0.73	1E-7	7.0		1.19	[1.12-1.27]	Illumina [302140]	N
2008-11-12	18978787	Wang Y	2008-11-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18978787	Common 5p15.33 and 6p21.33 variants influence lung cancer risk.	Lung cancer	5,095 European ancestry cases, 5,200 European ancestry controls	2,448 European ancestry cases, 2,983 European ancestry controls	6p21.33	6	31652743	BAT3, MSH5	APOM, BAG6			55937, 7917			rs3117582-C	rs3117582	0	3117582	intron_variant	0	NR	5E-10	9.301029995663981		1.24	[1.16-1.33]	Illumina [223891]	N
2008-11-12	18978787	Wang Y	2008-11-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18978787	Common 5p15.33 and 6p21.33 variants influence lung cancer risk.	Lung cancer	5,095 European ancestry cases, 5,200 European ancestry controls	2,448 European ancestry cases, 2,983 European ancestry controls	5p15.33	5	1321972	CLPTM1L	CLPTM1L			81037			rs401681-G	rs401681	0	401681	intron_variant	0	NR	8E-9	8.096910013008056		1.15	[1.09-1.19]	Illumina [223891]	N
2008-11-12	18978787	Wang Y	2008-11-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18978787	Common 5p15.33 and 6p21.33 variants influence lung cancer risk.	Lung cancer	5,095 European ancestry cases, 5,200 European ancestry controls	2,448 European ancestry cases, 2,983 European ancestry controls	15q25.1	15	78615690	NR	CHRNA3			1136			rs8042374-?	rs8042374	0	8042374	intron_variant	0	NR	8E-12	11.096910013008056				Illumina [223891]	N
2008-12-09	18978790	McKay JD	2008-11-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18978790	Lung cancer susceptibility locus at 5p15.33.	Lung cancer	2,971 European ancestry cases, 3,746 European ancestry controls	2,899 European ancestry cases, 5,573 European ancestry controls	5p15.33	5	1320607	TERT, CLPTM1L	CLPTM1L			81037			rs402710-C	rs402710	0	402710	non_coding_transcript_exon_variant	0	NR	4E-6	5.3979400086720375		1.18	[1.12-1.24]	Illumina [315194]	N
2008-12-09	18978790	McKay JD	2008-11-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18978790	Lung cancer susceptibility locus at 5p15.33.	Lung cancer	2,971 European ancestry cases, 3,746 European ancestry controls	2,899 European ancestry cases, 5,573 European ancestry controls	15q25.1	15	78601997	intergenic	CHRNA3			1136			rs1051730-A	rs1051730	0	1051730	synonymous_variant	0	NR	1E-15	15.0		1.35	[1.25-1.45]	Illumina [315194]	N
2009-06-14	19483682	Kanetsky PA	2009-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19483682	Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer.	Testicular cancer	277 European ancestry cases, 919 European ancestry controls	371 European ancestry  cases with their 408 parents, 860 European ancestry controls	12q21.32	12	88560182	KITLG	KITLG			4254			rs4474514-A	rs4474514	0	4474514	intron_variant	0	NR	6E-15	14.221848749616356		3.07	[2.29-4.13]	Affymetrix [611254]	N
2009-07-12	19578367	Shete S	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578367	Genome-wide association study identifies five susceptibility loci for glioma.	Glioma	1,878 European ancestry cases, 3,670 European ancestry controls	2,545 European ancestry cases, 2,953 European ancestry controls	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-G	rs2736100	0	2736100	intron_variant	0	0.49	2E-17	16.69897000433602		1.27	[1.19-1.37]	Illumina [454576]	N
2009-07-12	19578367	Shete S	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578367	Genome-wide association study identifies five susceptibility loci for glioma.	Glioma	1,878 European ancestry cases, 3,670 European ancestry controls	2,545 European ancestry cases, 2,953 European ancestry controls	5p15.33	5	1288432	TERT	TERT			7015			rs2853676-A	rs2853676	0	2853676	intron_variant	0	0.73	4E-14	13.397940008672037		1.26	[1.20-1.32]	Illumina [454576]	N
2009-07-12	19578367	Shete S	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578367	Genome-wide association study identifies five susceptibility loci for glioma.	Glioma	1,878 European ancestry cases, 3,670 European ancestry controls	2,545 European ancestry cases, 2,953 European ancestry controls	8q24.21	8	129479506	CCDC26	CCDC26			137196			rs891835-G	rs891835	0	891835	intron_variant	0	0.79	8E-11	10.096910013008056		1.24	[1.17-1.30]	Illumina [454576]	N
2009-07-12	19578367	Shete S	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578367	Genome-wide association study identifies five susceptibility loci for glioma.	Glioma	1,878 European ancestry cases, 3,670 European ancestry controls	2,545 European ancestry cases, 2,953 European ancestry controls	8q24.21	8	129673211	CCDC26	CCDC26			137196			rs4295627-G	rs4295627	0	4295627	intron_variant	0	0.83	2E-18	17.69897000433602		1.36	[1.29-1.43]	Illumina [454576]	N
2009-07-12	19578367	Shete S	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578367	Genome-wide association study identifies five susceptibility loci for glioma.	Glioma	1,878 European ancestry cases, 3,670 European ancestry controls	2,545 European ancestry cases, 2,953 European ancestry controls	9p21.3	9	22068653	CDKN2A, CDKN2B	CDKN2B-AS1			100048912			rs4977756-G	rs4977756	0	4977756	intron_variant	0	0.60	7E-15	14.154901959985743		1.24	[1.19-1.30]	Illumina [454576]	N
2009-07-12	19578367	Shete S	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578367	Genome-wide association study identifies five susceptibility loci for glioma.	Glioma	1,878 European ancestry cases, 3,670 European ancestry controls	2,545 European ancestry cases, 2,953 European ancestry controls	11q23.3	11	118606652	PHLDB1	PHLDB1			23187			rs498872-T	rs498872	0	498872	5_prime_UTR_variant	0	0.69	1E-8	8.0		1.18	[1.13-1.24]	Illumina [454576]	N
2009-07-12	19578367	Shete S	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578367	Genome-wide association study identifies five susceptibility loci for glioma.	Glioma	1,878 European ancestry cases, 3,670 European ancestry controls	2,545 European ancestry cases, 2,953 European ancestry controls	20q13.33	20	63678486	RTEL1	RTEL1-TNFRSF6B, RTEL1			100533107, 51750			rs6010620-G	rs6010620	0	6010620	intron_variant	0	0.23	3E-12	11.522878745280337		1.28	[1.21-1.35]	Illumina [454576]	N
2009-07-12	19578366	Wrensch M	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578366	Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.	Glioma (high-grade)	692 European ancestry cases, 3,992 European ancestry controls	176 cases, 174 controls	9p21.3	9	22043927	intergenic	CDKN2B-AS1			100048912			rs1412829-C	rs1412829	0	1412829	intron_variant	0	0.39	2E-10	9.698970004336019		1.42	[1.27-1.58]	Illumina [326506]	N
2009-07-12	19578366	Wrensch M	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578366	Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.	Glioma (high-grade)	692 European ancestry cases, 3,992 European ancestry controls	176 cases, 174 controls	20q13.33	20	63678486	RTEL1	RTEL1-TNFRSF6B, RTEL1			100533107, 51750			rs6010620-G	rs6010620	0	6010620	intron_variant	0	0.77	3E-9	8.522878745280337		1.52	[1.32-1.75]	Illumina [326506]	N
2009-07-12	19578366	Wrensch M	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578366	Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.	Glioma (high-grade)	692 European ancestry cases, 3,992 European ancestry controls	176 cases, 174 controls	20q13.33	20	63686867	RTEL1	RTEL1-TNFRSF6B, RTEL1			100533107, 51750			rs4809324-C	rs4809324	0	4809324	non_coding_transcript_exon_variant	0	0.10	2E-9	8.698970004336019		1.6	[1.37-1.87]	Illumina [326506]	N
2009-09-04	19648919	Song H	2009-08-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19648919	A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.	Ovarian cancer	1,817 European ancestry cases, 2,353 European ancestry controls	6,944 European ancestry cases, 9,477 European ancestry controls	9p22.2	9	16915023	BNC2, LOC648570, CNTLN	BNC2 - LOC105375983	54796	105375983		44185	99049	rs3814113-T	rs3814113	0	3814113	intergenic_variant	1	0.68	5E-19	18.30102999566398		1.22	[1.16-1.27]	Illumina [up to 2000000] (imputed)	N
2009-08-21	19648920	Wu X	2009-08-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19648920	Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.	Bladder cancer	969 European ancestry cases, 957 European ancestry controls	5,698 European ancestry cases, 38,633 European ancestry controls	8q24.3	8	142680513	PSCA	PSCA			8000			rs2294008-T	rs2294008	0	2294008	5_prime_UTR_variant	0	0.46	2E-10	9.698970004336019		1.15	[1.10-1.20]	Illumina [556429]	N
2011-09-17	21824976	Garcia-Closas M	2011-08-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21824976	A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.	Bladder cancer	4,501 European ancestry cases, 6,076 European ancestry controls	1,382 European ancestry cases, 2,201 European ancestry controls	18q12.3	18	45737001	SLC14A1	SLC14A1, LOC105372093			6563, 105372093			rs7238033-?	rs7238033	0	7238033	intron_variant	0		9E-9	8.045757490560675		1.2	[1.13-1.28]	Illumina [555912]	N
2011-09-21	21827660	Yang TH	2011-08-09	BMC Med Genomics	www.ncbi.nlm.nih.gov/pubmed/21827660	Combinations of newly confirmed Glioma-Associated loci link regions on chromosomes 1 and 9 to increased disease risk.	Glioma	781 European ancestry cases, 3,992 European ancestry controls	NA	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-?	rs2736100	0	2736100	intron_variant	0	NR	7E-9	8.154901959985743				Illumina [489781]	N
2011-11-24	22020760	Won HH	2011-10-21	Cancer	www.ncbi.nlm.nih.gov/pubmed/22020760	Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.	Response to platinum-based agents	96 colon cancer cases	247 colon cancer cases	7q21.3	7	97600466	TAC1	RN7SKP104 - TAC1	106480865	6863		1206	131493	rs10486003-?	rs10486003	0	10486003	upstream_gene_variant	1	NR	5E-7	6.301029995663981		3.13	[1.92-5.26]	Affymetrix [656843]	N
2011-11-24	22020760	Won HH	2011-10-21	Cancer	www.ncbi.nlm.nih.gov/pubmed/22020760	Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.	Response to platinum-based agents	96 colon cancer cases	247 colon cancer cases	6p25.3	6	1573378	FOXC1, GMDS	LOC107986555			107986555			rs2338-?	rs2338	0	2338	intergenic_variant	0	NR	5E-6	5.301029995663981		2.27	[1.58-3.26]	Affymetrix [656843]	N
2011-11-24	22020760	Won HH	2011-10-21	Cancer	www.ncbi.nlm.nih.gov/pubmed/22020760	Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.	Response to platinum-based agents	96 colon cancer cases	247 colon cancer cases	5q11.2	5	52724562	ITGA1, PELO	LOC105378964			105378964			rs830884-?	rs830884	0	830884	intron_variant	0	NR	2E-6	5.698970004336019		3.13	[1.85-5.26]	Affymetrix [656843]	N
2010-10-07	20852633	Bolton KL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852633	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	Ovarian cancer	1,768 European ancestry cases, 2,353 European ancestry controls	8,739 European ancestry cases, 10,831 European ancestry controls	19p13.11	19	17278895	C19orf62, MERIT40	BABAM1			29086			rs8170-T	rs8170	0	8170	synonymous_variant	0	NR	4E-6	5.3979400086720375	(Susceptibility)	1.12	[1.07-1.17]	Illumina [540573]	N
2010-10-07	20852633	Bolton KL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852633	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	Ovarian cancer	1,768 European ancestry cases, 2,353 European ancestry controls	8,739 European ancestry cases, 10,831 European ancestry controls	19p13.11	19	17283315	ANKLE1	ANKLE1			126549			rs2363956-T	rs2363956	0	2363956	missense_variant	0	NR	1E-7	7.0	(Susceptibility)	1.1	[1.06-1.15]	Illumina [540573]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	22q13.1	22	38936618	CBX6, APOBEC3A	LOC105373032 - APOBEC3A	105373032	200315		10159	20904	rs1014971-?	rs1014971	0	1014971	intergenic_variant	1	0.62	8E-12	11.096910013008056		1.18	[1.10-1.18]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	19q12	19	29805946	CCNE1	LOC107985345 - CCNE1	107985345	898		69844	6048	rs8102137-C	rs8102137	0	8102137	regulatory_region_variant	1	0.33	2E-11	10.698970004336019		1.13	[1.09-1.17]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	2q37.1	2	233656637	UGT1A	UGT1A, UGT1A10, UGT1A8			7361, 54575, 54576			rs11892031-?	rs11892031	0	11892031	intron_variant	0	0.92	1E-7	7.0		1.19	[1.12-1.27]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	8p22	8	18415371	NAT2	NAT2 - PSD3	10	23362		14152	111932	rs1495741-?	rs1495741	0	1495741	intergenic_variant	1	0.80	4E-11	10.397940008672037		1.15	[1.10-1.20]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	8q24.21	8	127705823	MYC	CASC11			100270680			rs9642880-T	rs9642880	0	9642880	intron_variant	0	0.45	2E-18	17.69897000433602		1.21	[1.16-1.27]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	8q24.3	8	142680513	PSCA	PSCA			8000			rs2294008-T	rs2294008	0	2294008	5_prime_UTR_variant	0	0.46	4E-11	10.397940008672037		1.13	[1.09-1.17]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	5p15.33	5	1321972	TERT, CLPTM1L	CLPTM1L			81037			rs401681-C	rs401681	0	401681	intron_variant	0	0.54	5E-7	6.301029995663981		1.11	[1.07-1.16]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	4p16.3	4	1732512	TMEM129, TACC3, FGFR3	TACC3			10460			rs798766-T	rs798766	0	798766	intron_variant	0	0.19	4E-13	12.397940008672037		1.2	[1.14-1.26]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls				GSTM1							Deletion assay	NR	0			1	0.51	5E-31	30.30102999566398		1.47	[1.38-1.57]	Illumina [589299]	N
2010-12-08	20972438	Rothman N	2010-10-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20972438	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	Bladder cancer	3,532 European ancestry cases, 5,120 European ancestry controls	8,381 cases, 48,275 controls	3q28	3	189928144	TP63	TP63 - P3H2	8626	55214		30865	28584	rs710521-A	rs710521	0	710521	intergenic_variant	1	0.73	2E-10	9.698970004336019		1.18	[1.12-1.24]	Illumina [589299]	N
2011-06-01	21531791	Sanson M	2011-04-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21531791	Chromosome 7p11.2 (EGFR) variation influences glioma risk.	Glioma	4,147 European ancestry cases, 7,435 European ancestry controls	NA	7p11.2	7	55091656	EGFR	EGFR			1956			rs11979158-A	rs11979158	0	11979158	intron_variant	0	0.83	7E-8	7.154901959985743		1.23	[1.15-1.35]	Illumina [424460]	N
2011-06-01	21531791	Sanson M	2011-04-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21531791	Chromosome 7p11.2 (EGFR) variation influences glioma risk.	Glioma	4,147 European ancestry cases, 7,435 European ancestry controls	NA	8q24.21	8	129673211	CCDC26	CCDC26			137196			rs4295627-?	rs4295627	0	4295627	intron_variant	0	NR	5E-21	20.30102999566398		1.4	[NR]	Illumina [424460]	N
2011-06-01	21531791	Sanson M	2011-04-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21531791	Chromosome 7p11.2 (EGFR) variation influences glioma risk.	Glioma	4,147 European ancestry cases, 7,435 European ancestry controls	NA	9p21.3	9	22033367	CDKN2A, CDKN2B	CDKN2B-AS1			100048912			rs2157719-?	rs2157719	0	2157719	intron_variant	0	NR	5E-16	15.301029995663981		1.26	[NR]	Illumina [424460]	N
2011-06-01	21531791	Sanson M	2011-04-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21531791	Chromosome 7p11.2 (EGFR) variation influences glioma risk.	Glioma	4,147 European ancestry cases, 7,435 European ancestry controls	NA	11q23.3	11	118606652	PHLDB1	PHLDB1			23187			rs498872-?	rs498872	0	498872	5_prime_UTR_variant	0	NR	5E-11	10.301029995663981		1.22	[NR]	Illumina [424460]	N
2011-06-01	21531791	Sanson M	2011-04-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21531791	Chromosome 7p11.2 (EGFR) variation influences glioma risk.	Glioma	4,147 European ancestry cases, 7,435 European ancestry controls	NA	20q13.33	20	63678486	RTEL1	RTEL1-TNFRSF6B, RTEL1			100533107, 51750			rs6010620-?	rs6010620	0	6010620	intron_variant	0	NR	2E-9	8.698970004336019		1.24	[NR]	Illumina [424460]	N
2011-06-01	21531791	Sanson M	2011-04-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21531791	Chromosome 7p11.2 (EGFR) variation influences glioma risk.	Glioma	4,147 European ancestry cases, 7,435 European ancestry controls	NA	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-?	rs2736100	0	2736100	intron_variant	0	NR	1E-14	14.0		1.25	[NR]	Illumina [424460]	N
2011-06-01	21531791	Sanson M	2011-04-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21531791	Chromosome 7p11.2 (EGFR) variation influences glioma risk.	Glioma	4,147 European ancestry cases, 7,435 European ancestry controls	NA	7p11.2	7	54911231	EGFR	LOC100996654 - LOC643168	100996654	643168		106262	22150	rs2252586-T	rs2252586	0	2252586	intergenic_variant	1	0.296	8E-8	7.096910013008056		1.18	[1.11-1.25]	Illumina [424460]	N
2011-08-03	21725308	Hu Z	2011-07-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21725308	A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.	Lung cancer	2,331 Han Chinese ancestry cases, 3,077 Han Chinese ancestry controls	6,313 Han Chinese ancestry cases, 6,409 Han Chinese ancestry controls	3q28	3	189638472	TP63	TP63			8626			rs4488809-C	rs4488809	0	4488809	intron_variant	0	0.47	7E-26	25.154901959985743		1.26	[1.21-1.32]	Affymetrix [906703]	N
2011-08-03	21725308	Hu Z	2011-07-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21725308	A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.	Lung cancer	2,331 Han Chinese ancestry cases, 3,077 Han Chinese ancestry controls	6,313 Han Chinese ancestry cases, 6,409 Han Chinese ancestry controls	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-C	rs2736100	0	2736100	intron_variant	0	0.41	1E-27	27.0		1.27	[1.22-1.33]	Affymetrix [906703]	N
2011-08-03	21725308	Hu Z	2011-07-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21725308	A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.	Lung cancer	2,331 Han Chinese ancestry cases, 3,077 Han Chinese ancestry controls	6,313 Han Chinese ancestry cases, 6,409 Han Chinese ancestry controls	13q12.12	13	23719720	MIPEP	LOC105370113			105370113			rs753955-G	rs753955	0	753955	intergenic_variant	0	0.29	2E-12	11.698970004336019		1.18	[1.13-1.24]	Affymetrix [906703]	N
2011-08-03	21725308	Hu Z	2011-07-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21725308	A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.	Lung cancer	2,331 Han Chinese ancestry cases, 3,077 Han Chinese ancestry controls	6,313 Han Chinese ancestry cases, 6,409 Han Chinese ancestry controls	22q12.2	22	29941597	MTMR3	MTMR3			8897			rs36600-A	rs36600	0	36600	intron_variant	0	0.09	6E-13	12.221848749616356		1.29	[1.20-1.38]	Affymetrix [906703]	N
2011-08-05	21750109	Rafnar T	2011-07-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21750109	European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.	Bladder cancer	2,234 European ancestry cases, 41,603 European ancestry controls	3,371 European ancestry cases, 10,261 European ancestry controls, 269 Iranian ancestry cases, 246 Iranian ancestry controls	18q12.3	18	45729946	SLC14A1	LOC105372093, SLC14A1			105372093, 6563			rs17674580-T	rs17674580	0	17674580	5_prime_UTR_variant	0	0.33	8E-11	10.096910013008056		1.17	[1.11-1.22]	Illumina [5340737] (imputed)	N
2012-04-28	22452962	Kim HC	2012-03-27	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22452962	A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study.	Breast cancer	2,273 Korean ancestry cases, 2,052 Korean ancestry controls	4,049 Korean ancestry cases, 3,845 Korean ancestry controls	2q34	2	212432139	ERBB4	ERBB4			2066			rs13393577-T	rs13393577	0	13393577	intron_variant	0	0.051	9E-14	13.045757490560675		1.53	[1.37-1.70]	Affymetrix [555525]	N
2012-07-17	22637743	Wei S	2012-05-27	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22637743	Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility.	Lung cancer (asbestos exposure interaction)	1,154 European ancestry cases, 1,137 European ancestry controls	NA	2q34	2	208713876	PTHR2	LOC101927960			101927960			rs13383928-C	rs13383928	0	13383928	intron_variant	0	0.04	2E-6	5.698970004336019				Illumina [307944]	N
2012-07-17	22637743	Wei S	2012-05-27	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22637743	Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility.	Lung cancer (asbestos exposure interaction)	1,154 European ancestry cases, 1,137 European ancestry controls	NA	16p13.3	16	4951379	PPL	PPL - SEC14L5	5493	9717		14244	6938	rs9635542-G	rs9635542	0	9635542	intron_variant	1	0.10	4E-6	5.3979400086720375				Illumina [307944]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	2q37.1	2	233656637	UGT1A	UGT1A, UGT1A10, UGT1A8			7361, 54575, 54576			rs11892031-A	rs11892031	0	11892031	intron_variant	0	0.92	1E-7	7.0		1.17	[1.11-1.25]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	3q28	3	189928144	TP63	TP63 - P3H2	8626	55214		30865	28584	rs710521-A	rs710521	0	710521	intergenic_variant	1	0.73	2E-11	10.698970004336019		1.14	[1.10-1.19]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	4p16.3	4	1732512	TMEM129, TACC3, FGFR3	TACC3			10460			rs798766-T	rs798766	0	798766	intron_variant	0	0.19	7E-25	24.154901959985743		1.22	[1.18-1.27]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	5p15.33	5	1321972	TERT, CLPTML	CLPTM1L			81037			rs401681-C	rs401681	0	401681	intron_variant	0	0.54	4E-11	10.397940008672037		1.12	[1.08-1.16]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	8p22	8	18415371	NAT2	NAT2 - PSD3	10	23362		14152	111932	rs1495741-A	rs1495741	0	1495741	intergenic_variant	1	0.8	2E-10	9.698970004336019		1.14	[1.09-1.18]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	12q12	12	38045401	PSCA	LOC105369729 - LOC100128817	105369729	100128817		467884	32778	rs2294008-T	rs2204008	0	2204008	intergenic_variant	1	0.46	3E-15	14.522878745280337		1.13	[1.10-1.16]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	8q24.21	8	127705823	intergenic	CASC11			100270680			rs9642880-T	rs9642880	0	9642880	intron_variant	0	0.45	4E-38	37.39794000867204		1.24	[1.20-1.28]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	18q12.3	18	45737317	SLC14A2	SLC14A1, LOC105372093			6563, 105372093			rs10775480-T	rs10775480	0	10775480	intron_variant	0	0.43	6E-8	7.221848749616356		1.13	[1.08-1.19]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	19q12	19	29805946	CCNE1	LOC107985345 - CCNE1	107985345	898		69844	6048	rs8102137-C	rs8102137	0	8102137	regulatory_region_variant	1	0.33	1E-11	11.0		1.13	[1.09-1.17]	Illumina [462190]	N
2014-05-01	24163127	Figueroa JD	2013-10-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24163127	Genome-wide association study identifies multiple loci associated with bladder cancer risk.	Bladder cancer	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls	up to 13,298 cases, up to 54,535 controls	22q13.1	22	38936618	CBX6, APOBEC3A	LOC105373032 - APOBEC3A	105373032	200315		10159	20904	rs1014971-T	rs1014971	0	1014971	intergenic_variant	1	0.62	1E-11	11.0		1.13	[1.09-1.17]	Illumina [462190]	N
2010-03-29	20304703	Li Y	2010-03-19	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/20304703	Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.	Lung cancer	364 European ancestry cases, 364 European ancestry controls, 13 cases, 13 controls	446 European ancestry cases, 853 European ancestry controls, 65 cases, 154 controls	13q31.3	13	91792975	GPC5	GPC5			2262			rs2352028-A	rs2352028	0	2352028	intron_variant	0	0.26	6E-6	5.221848749616356		1.46	[1.26-1.70]	Illumina [331918]	N
2010-04-14	20348956	Kiemeney LA	2010-03-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20348956	A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.	Urinary bladder cancer	1,889 European ancestry cases, 39,310 European ancestry controls	2,850 European ancestry cases, 6,239 European ancestry controls	4p16.3	4	1732512	TMEM129, SLBP, TACC3, FGFR3	TACC3			10460			rs798766-T	rs798766	0	798766	intron_variant	0	0.19	1E-11	11.0		1.24	[1.17-1.32]	Illumina [304703]	N
2010-04-14	20348956	Kiemeney LA	2010-03-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20348956	A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.	Urinary bladder cancer	1,889 European ancestry cases, 39,310 European ancestry controls	2,850 European ancestry cases, 6,239 European ancestry controls	8q24.21	8	127705823	MYC	CASC11			100270680			rs9642880-T	rs9642880	0	9642880	intron_variant	0	0.44	7E-12	11.154901959985743		1.21	[1.15-1.28]	Illumina [304703]	N
2010-04-14	20348956	Kiemeney LA	2010-03-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20348956	A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.	Urinary bladder cancer	1,889 European ancestry cases, 39,310 European ancestry controls	2,850 European ancestry cases, 6,239 European ancestry controls	3q28	3	189928144	TP63	TP63 - P3H2	8626	55214		30865	28584	rs710521-A	rs710521	0	710521	intergenic_variant	1	0.73	6E-8	7.221848749616356		1.19	[1.12-1.27]	Illumina [304703]	N
2010-07-12	20543847	Turnbull C	2010-06-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20543847	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.	Testicular germ cell cancer	979 European ancestry cases, 4,947 European ancestry controls	664 European ancestry cases, 3,456 European ancestry controls	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-T	rs2736100	0	2736100	intron_variant	0	0.49	8E-15	14.096910013008056		1.33	[1.18-1.50]	Illumina [298782]	N
2010-07-12	20543847	Turnbull C	2010-06-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20543847	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.	Testicular germ cell cancer	979 European ancestry cases, 4,947 European ancestry controls	664 European ancestry cases, 3,456 European ancestry controls	5p15.33	5	1308437	TERT, CLPTM1L	TERT - MIR4457	7015	100616235		12811	873	rs4635969-T	rs4635969	0	4635969	downstream_gene_variant	1	0.19	1E-23	23.0		1.54	[1.33-1.79]	Illumina [298782]	N
2010-07-12	20543847	Turnbull C	2010-06-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20543847	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.	Testicular germ cell cancer	979 European ancestry cases, 4,947 European ancestry controls	664 European ancestry cases, 3,456 European ancestry controls	9p24.3	9	863635	DMRT1	DMRT1			1761			rs755383-T	rs755383	0	755383	intron_variant	0	0.62	1E-23	23.0		1.37	[1.21-1.55]	Illumina [298782]	N
2010-07-12	20543847	Turnbull C	2010-06-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20543847	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.	Testicular germ cell cancer	979 European ancestry cases, 4,947 European ancestry controls	664 European ancestry cases, 3,456 European ancestry controls	12p13.1	12	14500933	ATF7IP	ATF7IP			55729			rs2900333-C	rs2900333	0	2900333	3_prime_UTR_variant	0	0.62	6E-10	9.221848749616356		1.27	[1.12-1.44]	Illumina [298782]	N
2010-07-12	20543847	Turnbull C	2010-06-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20543847	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.	Testicular germ cell cancer	979 European ancestry cases, 4,947 European ancestry controls	664 European ancestry cases, 3,456 European ancestry controls	5q31.3	5	142302223	SPRY4	LOC107986455 - SPRY4	107986455	81848		109105	8204	rs4624820-?	rs4624820	0	4624820	intergenic_variant	1	0.54	1E-14	14.0		1.47	[1.33-1.64]	Illumina [298782]	N
2010-07-12	20543847	Turnbull C	2010-06-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20543847	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.	Testicular germ cell cancer	979 European ancestry cases, 4,947 European ancestry controls	664 European ancestry cases, 3,456 European ancestry controls	12q21.32	12	88559784	KITLG	KITLG			4254			rs3782181-?	rs3782181	0	3782181	intron_variant	0	0.78	2E-26	25.69897000433602		2.22	[1.89-2.56]	Illumina [298782]	N
2012-10-09	22886559	Rajaraman P	2012-08-11	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22886559	Genome-wide association study of glioma and meta-analysis.	Glioma	1,856 European ancestry cases, 4,955 European ancestry controls	5,015 European ancestry cases, 11,601 European ancestry controls	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-G	rs2736100	0	2736100	intron_variant	0	0.494	4E-9	8.397940008672037		1.3	[1.19-1.41]	Illumina [559977]	N
2012-10-09	22886559	Rajaraman P	2012-08-11	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22886559	Genome-wide association study of glioma and meta-analysis.	Glioma	1,856 European ancestry cases, 4,955 European ancestry controls	5,015 European ancestry cases, 11,601 European ancestry controls	9p21.3	9	22068653	CDKN2BAS	CDKN2B-AS1			100048912			rs4977756-G	rs4977756	0	4977756	intron_variant	0	.423	1E-8	8.0		1.283	[1.177-1.398]	Illumina [559977]	N
2012-10-09	22886559	Rajaraman P	2012-08-11	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22886559	Genome-wide association study of glioma and meta-analysis.	Glioma	1,856 European ancestry cases, 4,955 European ancestry controls	5,015 European ancestry cases, 11,601 European ancestry controls	20q13.33	20	63678486	TNFRSF6B, RTEL1	RTEL1-TNFRSF6B, RTEL1			100533107, 51750			rs6010620-G	rs6010620	0	6010620	intron_variant	0	.771	1E-10	10.0		1.43	[1.28-1.59]	Illumina [559977]	N
2012-11-22	22899653	Timofeeva MN	2012-08-16	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22899653	Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.	Lung cancer	up to 14,900 European ancestry cases, up to 29,485 European ancestry controls	2,338 Han Chinese ancestry cases, 3,077 Han Chinese ancestry controls	12p13.33	12	955272	RAD52	RAD52			5893			rs10849605-?	rs10849605	0	10849605	intron_variant	0	0.51	6E-7	6.221848749616356		1.08	[1.04-1.11]	Illumina [up to 536008]	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	45439036	intergenic	PLEKHM1			9842			rs17631303-G	rs17631303	0	17631303	intron_variant	0	0.19	1E-8	8.0		1.27	[1.17-1.38]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	46710944	intergenic	NSF			4905			rs183211-A	rs183211	0	183211	intron_variant	0	0.23	3E-8	7.522878745280337		1.25	[1.16-1.35]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	4q32.3	4	164987569	intergenic	TRIM61 - LOC391713	391712	391713		9903	22890	rs4691139-G	rs4691139	0	4691139	non_coding_transcript_exon_variant	1	0.48	3E-8	7.522878745280337		1.2	[1.17-1.38]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	9p22.2	9	16915023	intergenic	BNC2 - LOC105375983	54796	105375983		44185	99049	rs3814113-A	rs3814113	0	3814113	intergenic_variant	1	0.66	6E-11	10.221848749616356		1.3	[1.2-1.41]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	3q25.31	3	156679960	intergenic	TIPARP, LOC107986148			25976, 107986148			rs2665390-C	rs2665390	0	2665390	intron_variant	0	0.043	7E-6	5.154901959985743		1.46	[1.25-1.71]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	45439036	NR	PLEKHM1			9842			rs17631303-?	rs17631303	0	17631303	intron_variant	0	NR	1E-8	8.0				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	46710944	NR	NSF			4905			rs183211-?	rs183211	0	183211	intron_variant	0	NR	3E-8	7.522878745280337				Illumina [2568349] (imputed)	N
2014-11-02	24658283	Zhang R	2014-03-22	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24658283	A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility.	Lung cancer (smoking interaction)	1,506 Han Chinese ancestry smoker cases, 825 Han Chinese ancestry non-smoker cases, 1,309 Han Chinese ancestry smoker controls, 1,768 Han Chinese ancestry non-smoker controls	912 Han Chinese ancestry smoker cases, 622 Han Chinese ancestry non-smoker cases, 572 Han Chinese ancestry smoker controls, 917 Han Chinese ancestry non-smoker controls	14q22.1	14	51899056	GNG2, NID2, FRMD6	GNG2			54331			rs1316298-T	rs1316298	0	1316298	intron_variant	0		7E-6	5.154901959985743		1.41	[1.2-1.71]	Affymetrix [591370]	N
2014-11-02	24658283	Zhang R	2014-03-22	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24658283	A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility.	Lung cancer (smoking interaction)	1,506 Han Chinese ancestry smoker cases, 825 Han Chinese ancestry non-smoker cases, 1,309 Han Chinese ancestry smoker controls, 1,768 Han Chinese ancestry non-smoker controls	912 Han Chinese ancestry smoker cases, 622 Han Chinese ancestry non-smoker cases, 572 Han Chinese ancestry smoker controls, 917 Han Chinese ancestry non-smoker controls	15q22.31	15	66862731	SMAD6, SMAD3	LOC105376718			105376718			rs4589502-T	rs4589502	0	4589502	non_coding_transcript_exon_variant	0		4E-6	5.3979400086720375		1.55	[1.29-1.87]	Affymetrix [591370]	N
2014-11-27	24861552	Rafnar T	2014-05-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24861552	Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.	Urinary bladder cancer	1,670 European ancestry cases, 90,180 European ancestry controls	5,241 European ancestry cases, 10,456 European ancestry controls	20p12.2	20	10981287	JAG1	C20orf187			728434			rs62185668-A	rs62185668	0	62185668	intron_variant	0	0.236	2E-11	10.698970004336019		1.19	[1.13-1.26]	Illumina [34200000] (imputed)	N
2014-11-02	24662972	Figueroa JD	2014-03-24	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24662972	Genome-wide interaction study of smoking and bladder cancer risk.	Bladder cancer (smoking interaction)	560 European ancestry never smoker cases, 2,442 European ancestry ever smoker cases, 1,406 European ancestry never smoker controls, 3,005 European ancestry ever smoker controls	494 European ancestry never smoker cases, 1,927 European ancestry ever smoker cases, 2,257 European ancestry never smoker controls, 3,490 European ancestry ever smoker controls	6p25.3	6	1402302	FOXF2	FOXF2 - LOC102723944	2295	102723944		6705	50985	rs1711973-?	rs1711973	0	1711973	intergenic_variant	1	NR	3E-6	5.522878745280337	(multiplicative, prospective analysis)			Illumina [491011]	N
2014-11-02	24662972	Figueroa JD	2014-03-24	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24662972	Genome-wide interaction study of smoking and bladder cancer risk.	Bladder cancer (smoking interaction)	560 European ancestry never smoker cases, 2,442 European ancestry ever smoker cases, 1,406 European ancestry never smoker controls, 3,005 European ancestry ever smoker controls	494 European ancestry never smoker cases, 1,927 European ancestry ever smoker cases, 2,257 European ancestry never smoker controls, 3,490 European ancestry ever smoker controls	7q36.2	7	155109147	HTR5A, PAXIP1, INSIG1	HTR5A - LOC105375584	3361	105375584		21755	60189	rs2969540-?	rs2969540	0	2969540	upstream_gene_variant	1	NR	2E-6	5.698970004336019	(multiplicative, retrospective analysis)			Illumina [491011]	N
2014-11-02	24662972	Figueroa JD	2014-03-24	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24662972	Genome-wide interaction study of smoking and bladder cancer risk.	Bladder cancer (smoking interaction)	560 European ancestry never smoker cases, 2,442 European ancestry ever smoker cases, 1,406 European ancestry never smoker controls, 3,005 European ancestry ever smoker controls	494 European ancestry never smoker cases, 1,927 European ancestry ever smoker cases, 2,257 European ancestry never smoker controls, 3,490 European ancestry ever smoker controls	7q22.3	7	107142238	PRKAR2B	PRKAR2B			5577			rs3752645-?	rs3752645	0	3752645	intron_variant	0	NR	6E-6	5.221848749616356	(multiplicative, prospective analysis)			Illumina [491011]	N
2014-11-02	24662972	Figueroa JD	2014-03-24	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24662972	Genome-wide interaction study of smoking and bladder cancer risk.	Bladder cancer (smoking interaction)	560 European ancestry never smoker cases, 2,442 European ancestry ever smoker cases, 1,406 European ancestry never smoker controls, 3,005 European ancestry ever smoker controls	494 European ancestry never smoker cases, 1,927 European ancestry ever smoker cases, 2,257 European ancestry never smoker controls, 3,490 European ancestry ever smoker controls	6q25.3	6	158947492	TAGAP, RSPH3, EZR	RSPH3			83861			rs12216499-?	rs12216499	0	12216499	intergenic_variant	0	NR	1E-6	6.0	(additive, prospective analysis)			Illumina [491011]	N
2014-11-02	24662972	Figueroa JD	2014-03-24	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24662972	Genome-wide interaction study of smoking and bladder cancer risk.	Bladder cancer (smoking interaction)	560 European ancestry never smoker cases, 2,442 European ancestry ever smoker cases, 1,406 European ancestry never smoker controls, 3,005 European ancestry ever smoker controls	494 European ancestry never smoker cases, 1,927 European ancestry ever smoker cases, 2,257 European ancestry never smoker controls, 3,490 European ancestry ever smoker controls	15q13.3	15	32834253	FMN1	FMN1			342184			rs1258767-?	rs1258767	0	1258767	intron_variant	0	NR	7E-7	6.154901959985743	(additive, retrospective analysis)			Illumina [491011]	N
2014-12-11	24908248	Walsh KM	2014-06-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24908248	Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.	Glioma (high-grade)	1,013 European ancestry cases, 6,595 European ancestry controls	631 European ancestry cases, 1,141 European ancestry controls	3q26.2	3	169862183	TERC	LRRC31			79782			rs1920116-G	rs1920116	0	1920116	intron_variant	0	0.72	8E-9	8.096910013008056		1.3	[1.19-1.42]	Affymetrix, Illumina [2362330] (imputed)	N
2014-12-11	24908248	Walsh KM	2014-06-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24908248	Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.	Glioma (high-grade)	1,013 European ancestry cases, 6,595 European ancestry controls	631 European ancestry cases, 1,141 European ancestry controls	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-C	rs2736100	0	2736100	intron_variant	0	0.51	1E-15	15.0		1.39	[1.28-1.50]	Affymetrix, Illumina [2362330] (imputed)	N
2014-12-11	24908248	Walsh KM	2014-06-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24908248	Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.	Glioma (high-grade)	1,013 European ancestry cases, 6,595 European ancestry controls	631 European ancestry cases, 1,141 European ancestry controls	20q13.33	20	63678486	RTEL1	RTEL1-TNFRSF6B, RTEL1			100533107, 51750			rs6010620-G	rs6010620	0	6010620	intron_variant	0	0.76	5E-19	18.30102999566398		1.56	[1.42-1.72]	Affymetrix, Illumina [2362330] (imputed)	N
2013-01-18	23103227	Jin G	2012-10-25	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23103227	Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	2,331 Han Chinese ancestry lung cancer cases, 1,006 Han Chinese ancestry non-cardia gastric cancer cases, 2,031 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 4,006 Han Chinese ancestry controls	2,665 Han Chinese ancestry lung cancer cases, 3,330 Han Chinese ancestry non-cardia gastric cancer cases, 3,006 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 11,436 Han Chinese ancestry controls	6p21.1	6	40568389	LRFN2	LRFN2			57497			rs2494938-A	rs2494938	0	2494938	intron_variant	0	0.23	1E-12	12.0	(All Cancers)	1.15	[1.10-1.19]	Affymetrix [NR]	N
2013-01-18	23103227	Jin G	2012-10-25	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23103227	Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	2,331 Han Chinese ancestry lung cancer cases, 1,006 Han Chinese ancestry non-cardia gastric cancer cases, 2,031 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 4,006 Han Chinese ancestry controls	2,665 Han Chinese ancestry lung cancer cases, 3,330 Han Chinese ancestry non-cardia gastric cancer cases, 3,006 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 11,436 Han Chinese ancestry controls	7p15.3	7	21544470	SP4, DNAH11	DNAH11			8701			rs2285947-A	rs2285947	0	2285947	intron_variant	0	0.27	1E-16	16.0	(All Cancers)	1.17	[1.12-1.21]	Affymetrix [NR]	N
2013-02-01	23143601	Lan Q	2012-11-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23143601	Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.	Lung cancer	5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls	1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls	3q28	3	189638472	TP63	TP63			8626			rs4488809-C	rs4488809	0	4488809	intron_variant	0	0.42	4E-9	8.397940008672037		1.19	[1.12-1.26]	Illumina [596032]	N
2013-02-01	23143601	Lan Q	2012-11-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23143601	Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.	Lung cancer	5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls	1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls	5p15.33	5	1286401	TERT, hTERT	TERT			7015			rs2736100-G	rs2736100	0	2736100	intron_variant	0	0.40	4E-27	26.397940008672037		1.38	[1.30-1.47]	Illumina [596032]	N
2013-02-01	23143601	Lan Q	2012-11-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23143601	Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.	Lung cancer	5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls	1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls	17q24.2	17	67902693	BPTF	BPTF			2186			rs7216064-A	rs7216064	0	7216064	intron_variant	0	0.63	7E-6	5.154901959985743		1.16	[1.09-1.25]	Illumina [596032]	N
2013-02-01	23143601	Lan Q	2012-11-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23143601	Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.	Lung cancer	5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls	1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls	2q23.3	2	151397404	TNFAIP6, RIF1	TNFAIP6 - RIF1	7130	55183		17356	12479	rs10197940-T	rs10197940	0	10197940	intergenic_variant	1	0.52	5E-6	5.301029995663981		1.12	[1.06-1.18]	Illumina [596032]	N
2013-02-01	23143601	Lan Q	2012-11-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23143601	Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.	Lung cancer	5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls	1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls	10q25.2	10	112738717	VTI1A	VTI1A			143187			rs7086803-A	rs7086803	0	7086803	intron_variant	0	0.27	4E-18	17.397940008672037		1.28	[1.21-.1.35]	Illumina [596032]	N
2013-02-01	23143601	Lan Q	2012-11-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23143601	Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.	Lung cancer	5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls	1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls	6q22.1	6	117465017	ROS1, DCBLD1	RNU6-253P - DCBLD1	106480697	285761		7179	15329	rs9387478-C	rs9387478	0	9387478	intron_variant	1	0.50	4E-10	9.397940008672037		1.18	[1.11-1.23]	Illumina [596032]	N
2013-02-01	23143601	Lan Q	2012-11-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23143601	Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.	Lung cancer	5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls	1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls	6p21.32	6	32465390	HLA class II	HLA-DRB9 - HLA-DRB5	3132	3127		5301	51953	rs2395185-T	rs2395185	0	2395185	intron_variant	1	0.35	1E-8	8.0		1.17	[1.11-1.23]	Illumina [596032]	N
2013-02-13	23180869	Wu C	2012-11-24	Gut	www.ncbi.nlm.nih.gov/pubmed/23180869	Genome-wide association study of survival in patients with pancreatic adenocarcinoma.	Pancreatic cancer	642 European ancestry cases	363 Chinese ancestry cases	11p15.4	11	9951515	SBF2	SBF2			81846			rs10500715-T	rs10500715	0	10500715	intron_variant	0	0.63	2E-7	6.698970004336019		1.32	[1.19-1.47]	Illumina [2731086] (imputed)	N
2013-02-13	23180869	Wu C	2012-11-24	Gut	www.ncbi.nlm.nih.gov/pubmed/23180869	Genome-wide association study of survival in patients with pancreatic adenocarcinoma.	Pancreatic cancer	642 European ancestry cases	363 Chinese ancestry cases	18p11.21	18	13366863	c18orf1	LDLRAD4			753			rs12456874-G	rs12456874	0	12456874	intron_variant	0	0.25	6E-7	6.221848749616356		1.38	[1.22-1.57]	Illumina [2731086] (imputed)	N
2013-02-13	23180869	Wu C	2012-11-24	Gut	www.ncbi.nlm.nih.gov/pubmed/23180869	Genome-wide association study of survival in patients with pancreatic adenocarcinoma.	Pancreatic cancer	642 European ancestry cases	363 Chinese ancestry cases	3p26.2	3	3314490	intergenic	LOC100130207			100130207			rs9874556-A	rs9874556	0	9874556	intron_variant	0	0.46	4E-6	5.3979400086720375		1.31	[1.17-1.46]	Illumina [2731086] (imputed)	N
2013-02-13	23180869	Wu C	2012-11-24	Gut	www.ncbi.nlm.nih.gov/pubmed/23180869	Genome-wide association study of survival in patients with pancreatic adenocarcinoma.	Pancreatic cancer	642 European ancestry cases	363 Chinese ancestry cases	9q33.1	9	115288135	intergenic	DEC1			50514			rs7853844-A	rs7853844	0	7853844	intron_variant	0	0.17	2E-6	5.698970004336019		1.43	[1.23-1.65]	Illumina [2731086] (imputed)	N
2013-02-13	23180869	Wu C	2012-11-24	Gut	www.ncbi.nlm.nih.gov/pubmed/23180869	Genome-wide association study of survival in patients with pancreatic adenocarcinoma.	Pancreatic cancer	642 European ancestry cases	363 Chinese ancestry cases	10q23.1	10	85980996	GRID1	GRID1			2894			rs10788473-T	rs10788473	0	10788473	intron_variant	0	0.38	3E-6	5.522878745280337		1.27	[1.15-1.41]	Illumina [2731086] (imputed)	N
2013-02-13	23180869	Wu C	2012-11-24	Gut	www.ncbi.nlm.nih.gov/pubmed/23180869	Genome-wide association study of survival in patients with pancreatic adenocarcinoma.	Pancreatic cancer	642 European ancestry cases	363 Chinese ancestry cases	11p15.1	11	18363391	GTF2H1	GTF2H1			2965			rs9783347-A	rs9783347	0	9783347	intron_variant	0	0.30	9E-6	5.045757490560675		1.36	[1.19-1.56]	Illumina [2731086] (imputed)	N
2013-02-13	23180869	Wu C	2012-11-24	Gut	www.ncbi.nlm.nih.gov/pubmed/23180869	Genome-wide association study of survival in patients with pancreatic adenocarcinoma.	Pancreatic cancer	642 European ancestry cases	363 Chinese ancestry cases	13q21.31	13	63567780	intergenic	LINC00376 - LOC105370237	104355293	105370237		239686	17738	rs1000589-T	rs1000589	0	1000589	intergenic_variant	1	0.53	3E-6	5.522878745280337		1.27	[1.15-1.39]	Illumina [2731086] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Lung cancer	6,877 East Asian ancestry never smoker cases, 6,277 East Asian ancestry never smoker controls	5,878 East Asian ancestry never smoker cases, 7,046 East Asian ancestry never smoker controls	6p21.1	6	41525674	DQ141194	FOXP4-AS1			101060264			rs7741164-A	rs7741164	0	7741164	intron_variant	0	0.309	6E-13	12.221848749616356		1.17	[1.12-1.22]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Lung cancer	6,877 East Asian ancestry never smoker cases, 6,277 East Asian ancestry never smoker controls	5,878 East Asian ancestry never smoker cases, 7,046 East Asian ancestry never smoker controls	9p21.3	9	22160088	Intergenic	CDKN2B-AS1 - DMRTA1	100048912	63951		38991	286753	rs72658409-?	rs72658409	0	72658409	intergenic_variant	1	0.927	1E-10	10.0		1.2987013	[1.19-1.39]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Lung cancer	6,877 East Asian ancestry never smoker cases, 6,277 East Asian ancestry never smoker controls	5,878 East Asian ancestry never smoker cases, 7,046 East Asian ancestry never smoker controls	12q13.13	12	51955287	ACVR1B	ACVR1B			91			rs11610143-?	rs11610143	0	11610143	intron_variant	0	0.685	5E-9	8.301029995663981		1.1235955	[1.09-1.18]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Lung cancer	6,877 East Asian ancestry never smoker cases, 6,277 East Asian ancestry never smoker controls	5,878 East Asian ancestry never smoker cases, 7,046 East Asian ancestry never smoker controls	17q25.3	17	78169467	SYNGR2	SYNGR2			9144			rs3794742-?	rs3794742	0	3794742	intron_variant	0	0.483	4E-7	6.3979400086720375		1.098901	[1.06-1.14]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Lung cancer	6,877 East Asian ancestry never smoker cases, 6,277 East Asian ancestry never smoker controls	5,878 East Asian ancestry never smoker cases, 7,046 East Asian ancestry never smoker controls	8p22	8	17650455	Intergenic	MTUS1			57509			rs4921799-?	rs4921799	0	4921799	intron_variant	0	0.171	3E-6	5.522878745280337		1.1235955	[1.06-1.18]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Lung cancer	6,877 East Asian ancestry never smoker cases, 6,277 East Asian ancestry never smoker controls	5,878 East Asian ancestry never smoker cases, 7,046 East Asian ancestry never smoker controls	9p24.3	9	310970	Intergenic	DOCK8			81704			rs10969557-G	rs10969557	0	10969557	intron_variant	0	0.227	6E-6	5.221848749616356		1.11	[1.06-1.16]	Affymetrix, Illumina [7564751] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	12q24.33	12	132799954	VTl1A	GOLGA3			2802			rs111696067-A	rs111696067	0	111696067	intron_variant	0	0.59	4E-6	5.3979400086720375		1.1235955	[1.08-1.20]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	12q21.2	12	75848895	intergenic	LOC105369846 - RN7SL734P	105369846	106479490		66698	108938	rs12230172-G	rs12230172	0	12230172	intron_variant	1	0.54	2E-6	5.698970004336019		1.1363636	[1.08-1.19]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	12q23.3	12	106419124	POLR3B	POLR3B			55703			rs3851634-T	rs3851634	0	3851634	intron_variant	0	0.7	4E-7	6.3979400086720375		1.15	[1.09-1.22]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	5p15.33	5	1279675	NR	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	NR	4E-20	19.397940008672037		1.4	[1.30-1.50]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	7p11.2	7	55080382	NR	EGFR			1956			rs59060240-T	rs59060240	0	59060240	intron_variant	0	NR	2E-8	7.698970004336019		1.2820514	[1.18-1.39]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	7p11.2	7	54848587	NR	LOC100996654 - LOC643168	100996654	643168		43618	84794	rs75061358-G	rs75061358	0	75061358	intergenic_variant	1	NR	2E-11	10.698970004336019		1.42	[1.28-1.57]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	8q24.21	8	129633446	NR	CCDC26			137196			rs55705857-G	rs55705857	0	55705857	intron_variant	0	NR	6E-37	36.221848749616356		2.19	[1.94-2.47]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	9p21.3	9	22033367	NR	CDKN2B-AS1			100048912			rs2157719-C	rs2157719	0	2157719	intron_variant	0	NR	3E-17	16.522878745280337		1.28	[1.21-1.35]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	11q23.3	11	118609400	NR	PHLDB1			23187			rs12803321-G	rs12803321	0	12803321	intron_variant	0	NR	2E-16	15.698970004336019		1.2820514	[1.22-1.37]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	17p13.1	17	7675353	NR	TP53			7157			rs35850753-T	rs35850753	0	35850753	5_prime_UTR_variant	0	NR	9E-20	19.045757490560675		2.53	[2.07-3.08]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioma	1,783 Northern European ancestry glioblastoma cases,  2,364 Northern European ancestry non-glioblastoma cases, 7,435 Northern European ancestry controls	1,490 European ancestry cases, 1,723 European ancestry control	20q13.33	20	63691653	NR	RTEL1, RTEL1-TNFRSF6B			51750, 100533107			rs2236507-C	rs2236507	0	2236507	intron_variant	0	NR	9E-11	10.045757490560675		1.2658228	[1.18-1.35]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	12q24.33	12	132799954	VTI1A	GOLGA3			2802			rs111696067-A	rs111696067	0	111696067	intron_variant	0	0.59	4E-8	7.3979400086720375		1.1904762	[1.12-1.27]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	11q23.2	11	114160077	ZBTB16	ZBTB16			7704			rs648044-T	rs648044	0	648044	intron_variant	0	0.38	6E-11	10.221848749616356		1.25	[1.17-1.34]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	12q21.2	12	75848895	intergenic	LOC105369846 - RN7SL734P	105369846	106479490		66698	108938	rs12230172-G	rs12230172	0	12230172	intron_variant	1	0.54	8E-11	10.096910013008056		1.2345679	[1.16-1.32]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	15q24.2	15	76286421	ETFA	ETFA			2108			rs1801591-A	rs1801591	0	1801591	missense_variant	0	0.09	6E-9	8.221848749616356		1.36	[1.23–1.51]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	7p11.2	7	54848587	NR	LOC100996654 - LOC643168	100996654	643168		43618	84794	rs75061358-G	rs75061358	0	75061358	intergenic_variant	1	NR	3E-6	5.522878745280337		1.36	[1.20-1.55]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	8q24.21	8	129633446	NR	CCDC26			137196			rs55705857-G	rs55705857	0	55705857	intron_variant	0	NR	1E-62	62.0		3.6	[3.10-4.19]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	9p21.3	9	22033367	NR	CDKN2B-AS1			100048912			rs2157719-C	rs2157719	0	2157719	intron_variant	0	NR	2E-11	10.698970004336019		1.27	[1.19-1.36]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	11q23.3	11	118609400	NR	PHLDB1			23187			rs12803321-G	rs12803321	0	12803321	intron_variant	0	NR	4E-25	24.397940008672037		1.4705882	[1.37-1.59]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	17p13.1	17	7514323	NR	POLR2A			5430			rs8753-T	rs8753	0	8753	3_prime_UTR_variant	0	NR	8E-18	17.096910013008056		3.09	[2.39-4.00]	Illumina [at least 8427548] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	10q24.2	10	99096696	NR	HPSE2			60495			rs12780046-T	rs12780046	0	12780046	intron_variant	0	0.09	4E-6	5.3979400086720375		1.29	[1.16-1.44]	Illumina [at least 8427548] (imputed)	N
2016-11-30	26766742	Garcia-Albeniz X	2016-01-14	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/26766742	CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk.	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	554 European ancestry postmenopausal cases, 729 European ancestry postmenopausal controls	NA	20q13.2	20	54200178	CYP24A1	LOC105372675 - PFDN4	105372675	5203		10230	7785	rs964293-?	rs964293	0	964293	intergenic_variant	1	NR	5E-9	8.301029995663981	(Empirical Bayes)	1.6393442	[1.39-1.92]	Affymetrix, Illumina [~ 2700000] (imputed)	N
2014-11-27	24861552	Rafnar T	2014-05-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24861552	Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.	Urinary bladder cancer	1,670 European ancestry cases, 90,180 European ancestry controls	5,241 European ancestry cases, 10,456 European ancestry controls	8q24.21	8	127707639	MYC, POU5F1B, PVT1	CASC11			100270680			rs10094872-T	rs10094872	0	10094872	intron_variant	0	0.411	2E-7	6.698970004336019		1.26		Illumina [34200000] (imputed)	N
2015-05-23	25281661	Matsuda K	2014-10-03	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25281661	Genome wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.	Bladder cancer	531 Japanese ancestry cases, 5,581 Japanese ancestry conrols	592 Japanese ancestry cases, 6,964 Japanese ancestry controls, 3,508 European ancestry cases, 5,101 European ancestry controls	15q24.1	15	74619987	CLK3, CYP1A2	CLK3			1198			rs11543198-G	rs11543198	0	11543198	missense_variant	0	0.78	4E-9	8.397940008672037	(Japanese)	1.41	[1.26-1.59]	Illumina [554389]	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	4q21.21	4	78088155	FRAS1	FRAS1			80144			rs150303591-?	rs150303591	0	150303591	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [6243550] (imputed)	N
2016-10-12	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Non-glioblastoma glioma	2,364 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	5p15.33	5	1279675	NR	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0		8E-7	6.096910013008056		1.25	[1.15-1.37]	Illumina [at least 8427548] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	18q21.1	18	48561565	CTIF	CTIF			9811			rs8091660-?	rs8091660	0	8091660	intron_variant	0	NR	9E-6	5.045757490560675				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	3q24	3	143384827	SLC9A9	SLC9A9			285195			rs201023017-?	rs201023017	0	201023017	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	10q26.11	10	119607441	TIAL1	LOC105378512 - RAD1P1	105378512	100128880		7635	13434	rs66696671-?	rs66696671	0	66696671	intergenic_variant	1	NR	7E-7	6.154901959985743				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	1q44	1	247193430	ZNF731P	ZNF731P - MIR3916	729806	100500849		2413	8537	rs12025262-?	rs12025262	0	12025262	intron_variant	1	NR	7E-7	6.154901959985743				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	13q21.2	13	61317943	PCDH20	MIR3169 - PCDH20	100422973	64881		118063	91020	rs10674174-?	rs10674174	0	10674174	intergenic_variant	1	NR	8E-7	6.096910013008056				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	2p23.2	2	28097166	BRE	BRE			9577			rs7572644-?	rs7572644	0	7572644	intron_variant	0	NR	6E-6	5.221848749616356				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	4p15.33	4	13607505	BOD1L1	BOD1L1			259282			rs185229225-?	rs185229225	0	185229225	intron_variant	0	NR	2E-7	6.698970004336019				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	6q12	6	65027022	EYS	EYS			346007			rs201083182-?	rs201083182	0	201083182	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	5q23.2	5	122442912	MGC32805, SNCAIP	SNCAIP, MGC32805			9627, 153163			rs3842595-?	rs3842595	0	3842595	intron_variant	0	NR	3E-7	6.522878745280337				Illumina [6243550] (imputed)	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in lung cancer	112 cases	NA	14q21.2	14	44734273	C14orf28	LOC105370472 - LOC101927351	105370472	101927351		138539	30985	rs712419-?	rs712419	0	712419	intergenic_variant	1		2E-6	5.698970004336019		0.076	[0.047-0.105] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in lung cancer	112 cases	NA	6q23.2	6	131740280	ENPP3	ENPP3			5169			rs17601580-?	rs17601580	0	17601580	missense_variant	0		2E-6	5.698970004336019		0.112	[0.069-0.155] unit decrease	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in lung cancer	112 cases	NA	12p11.21	12	32962886	PKP2	PKP2 - ASS1P14	5318	459		66040	22852	rs4346053-?	rs4346053	0	4346053	intergenic_variant	1		4E-6	5.3979400086720375		0.1033	[0.062-0.144] unit decrease	Affymetrix [418365]	N
2016-04-28	25964295	Khan S	2015-05-11	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/25964295	Polymorphism at 19q13.41 predicts breast cancer survival specifically after endocrine therapy.	Survival in endocrine treated breast cancer (estrogen-receptor positive)	352 European ancestry cases with endocrine therapy, 254 European ancestry cases without endocrine therapy, 597 European ancestry controls	3,330 European ancestry cases with endocrine therapy, 42 European ancestry cases without endocrine therapy, 1,351 European ancestry controls	19q13.41	19	51942133	ZNF613	ZNF613			79898			rs8113308-G	rs8113308	0	8113308	intron_variant	0	0.152	6E-7	6.221848749616356		1.69	[1.37-2.07]	Illumina [486478]	N
2008-10-14	18463975	Kibriya MG	2008-05-08	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/18463975	A pilot genome-wide association study of early-onset breast cancer.	Breast cancer	26 European ancestry cases, 3 Hispanic cases, 1 African American case, 26 European ancestry controls, 3 Hispanic controls, 1 African American control	NA	16q23.1	16	74438798	GLG1	LOC107984827 - GLG1	107984827	2734		3372	8629	3-SNP haplotype 1	rs10871290	0	10871290	downstream_gene_variant	1	0.34	4E-7	6.3979400086720375				Affymetrix [200220]	N
2011-09-30	21908515	Cai Q	2011-09-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21908515	Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.	Breast cancer	2,062 East Asian ancestry cases, 2,066 East Asian ancestry controls	15,091 East Asian ancestry cases, 14,877 East Asian ancestry controls	7q32.3	7	130969092	NR	LINC-PINT			378805			rs2048672-C	rs2048672	0	2048672	intron_variant	0	0.45	6E-6	5.221848749616356		1.11	[1.05-1.17]	Affymetrix [684457]	N
2011-09-30	21908515	Cai Q	2011-09-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21908515	Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.	Breast cancer	2,062 East Asian ancestry cases, 2,066 East Asian ancestry controls	15,091 East Asian ancestry cases, 14,877 East Asian ancestry controls	10q21.2	10	62492218	ZNF365	ZNF365			22891			rs10822013-T	rs10822013	0	10822013	intron_variant	0	0.47	6E-9	8.221848749616356		1.12	[1.06-1.18]	Affymetrix [684457]	N
2010-10-07	20852631	Antoniou AC	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852631	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.	Breast cancer	1,193 European ancestry cases, 1,190 European ancestry controls	2,974 European ancestry cases, 3,012 European ancestry controls	19p13.11	19	17278895	ANKLE1, C19orf62, ABHD8	BABAM1			29086			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.17	2E-9	8.698970004336019		1.26	[1.17-1.35]	Illumina [555616]	N
2010-10-15	20872241	Li J	2010-09-26	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	2,702 European ancestry female cases, 5,726 European ancestry controls	Up to 7,386 cases, 7,576 controls	10q26.13	10	121586676	FGFR2	FGFR2			2263			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.42	2E-13	12.698970004336019		1.32	[1.22-1.42]	Illumina [285984]	N
2010-10-15	20872241	Li J	2010-09-26	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	2,702 European ancestry female cases, 5,726 European ancestry controls	Up to 7,386 cases, 7,576 controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.30	4E-7	6.3979400086720375		1.22	[1.13-1.32]	Illumina [285984]	N
2010-10-15	20872241	Li J	2010-09-26	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	2,702 European ancestry female cases, 5,726 European ancestry controls	Up to 7,386 cases, 7,576 controls	5p12	5	44874903	MRPS30	MRPS30 - HCN1	10884	348980		59389	380047	rs7716600-A	rs7716600	0	7716600	intergenic_variant	1	0.23	7E-7	6.154901959985743		1.24	[1.14-1.34]	Illumina [285984]	N
2010-10-15	20872241	Li J	2010-09-26	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	2,702 European ancestry female cases, 5,726 European ancestry controls	Up to 7,386 cases, 7,576 controls	2q35	2	217041109	intergenic	LOC101928278, LOC105373874			101928278, 105373874			rs13387042-?	rs13387042	0	13387042	intergenic_variant	0	0.53	9E-6	5.045757490560675		1.18	[1.10-1.27]	Illumina [285984]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	2q35	2	217041109	intergenic	LOC101928278, LOC105373874			101928278, 105373874			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.52	2E-10	9.698970004336019		1.16	[1.11-1.22]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	3p24.1	3	27374522	SLC4A7	SLC4A7			9497			rs4973768-C	rs4973768	0	4973768	3_prime_UTR_variant	0	0.49	2E-8	7.698970004336019		1.14	[1.09-1.19]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	5p12	5	44662413	intergenic	LOC102723839 - RN7SL383P	102723839	106479363		152131	53780	rs4415084-T	rs4415084	0	4415084	intergenic_variant	1	0.42	8E-11	10.096910013008056		1.17	[1.11-1.22]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	8q24.21	8	127375606	intergenic	CASC21, CASC8			103021164, 727677			rs1562430-A	rs1562430	0	1562430	intron_variant	0	0.60	3E-11	10.522878745280337		1.16	[1.11-1.22]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	10q26.13	10	121586676	FGFR2	FGFR2			2263			rs1219648-?	rs1219648	0	1219648	intron_variant	0	0.42	1E-30	30.0		1.31	[1.25-1.37]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	16q12.2	16	52601252	TOX3	CASC16			643714			rs3112612-T	rs3112612	0	3112612	intron_variant	0	0.43	4E-10	9.397940008672037		1.15	[1.10-1.21]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	9q31.2	9	108126198	KLF4, ACTL7A, RAD23B	LOC105376214			105376214			rs865686-T	rs865686	0	865686	intergenic_variant	0	0.61	2E-10	9.698970004336019		1.12	[1.09-1.18]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	6q25.1	6	151618215	ESR1	CCDC170			80129			rs3734805-C	rs3734805	0	3734805	3_prime_UTR_variant	0	0.08	1E-7	7.0		1.19	[1.11-1.27]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	10q26.13	10	121865675	FGFR2	ATE1			11101			rs10510102-G	rs10510102	0	10510102	intron_variant	0	0.17	2E-6	5.698970004336019		1.12	[1.07-1.17]	Illumina [~ 296114]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	12q24.13	12	112379979	RPL6	HECTD4			283450			rs11066280-A	rs11066280	0	11066280	intron_variant	0	0.21	2E-15	14.698970004336019		1.3	[1.22-1.38]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	12q24.13	12	112207597	C12orf51	HECTD4			283450			rs2074356-T	rs2074356	0	2074356	intron_variant	0	0.13	2E-31	30.69897000433602		1.56	[1.45-1.68]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	5q32	5	149524529	CSNK1A1	CSNK1A1			1452			rs10058728-T	rs10058728	0	10058728	intron_variant	0	0.98	5E-9	8.301029995663981		2.04	[1.61-2.56]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	3q26.31	3	175929377	TBL1XR1	NAALADL2 - ACTG1P23	254827	442097		119867	48109	rs6772209-G	rs6772209	0	6772209	intergenic_variant	1	0.97	3E-7	6.522878745280337		1.49	[1.28-1.75]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	3q21.1	3	123012063	SEMA5B	SEMA5B			54437			rs9868873-G	rs9868873	0	9868873	intron_variant	0	0.82	1E-7	7.0		1.19	[1.11-1.27]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	15q23	15	68766745	ANP32A	CARSP1 - ANP32A	100420042	8125		16516	11790	rs8030672-A	rs8030672	0	8030672	intergenic_variant	1	0.03	1E-11	11.0		1.56	[1.37-1.78]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	10q23.33	10	94306584	PLCE1	PLCE1			51196			rs2274223-G	rs2274223	0	2274223	missense_variant	0	0.21	4E-20	19.397940008672037		1.34	[1.26-1.42]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	5q11.2	5	59111944	PDE4D	PDE4D			5144			rs10052657-C	rs10052657	0	10052657	intron_variant	0	0.78	2E-19	18.69897000433602		1.49	[1.37-1.61]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	12q24.12	12	111730205	ACAD10	ACAD10			80724			rs11066015-A	rs11066015	0	11066015	intron_variant	0	0.19	7E-21	20.154901959985743		1.38	[1.29-1.48]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	21q22.12	21	34985564	RUNX1	RUNX1			861			rs2014300-G	rs2014300	0	2014300	intron_variant	0	0.83	8E-22	21.096910013008056		1.43	[1.33-1.54]	Affymetrix [666141]	N
2011-06-16	21642993	Wu C	2011-06-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21642993	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.	Esophageal cancer	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	3,986 Han Chinese ancestry cases, 4,157 Han Chinese ancestry controls	6p21.1	6	40834522	UNC5CL	LOC105375053 - LOC101929555	105375053	101929555		9179	44364	rs10484761-G	rs10484761	0	10484761	intergenic_variant	1	0.09	7E-12	11.154901959985743		1.33	[1.23-1.45]	Affymetrix [666141]	N
2012-02-14	22232737	Shu XO	2012-01-09	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	1,950 Chinese ancestry cases	4,160 Chinese ancestry cases	14q24.1	14	68283210	RAD51L1	RAD51B			5890			rs3784099-A	rs3784099	0	3784099	intron_variant	0	NR	1E-7	7.0	(Total Mortality)	1.49	[1.28-1.72]	Affymetrix [613031]	N
2012-02-14	22232737	Shu XO	2012-01-09	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	1,950 Chinese ancestry cases	4,160 Chinese ancestry cases	14q24.1	14	68283210	RAD51L1	RAD51B			5890			rs3784099-A	rs3784099	0	3784099	intron_variant	0	NR	3E-7	6.522878745280337	(Recurrence)	1.43	[1.25-1.64]	Affymetrix [613031]	N
2012-02-14	22232737	Shu XO	2012-01-09	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	1,950 Chinese ancestry cases	4,160 Chinese ancestry cases	16q22.3	16	73405456	intergenic	LINC01568, C16orf47			100506172, 388289			rs9934948-C	rs9934948	0	9934948	intron_variant	0	NR	6E-6	5.221848749616356	(Total Mortality)	1.29	[1.16-1.44]	Affymetrix [613031]	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-G	rs10771399	0	10771399	intergenic_variant	1		2E-8	7.698970004336019		1.3889	[1.25-1.56]	Illumina [NR] (imputed)	N
2010-07-12	20585626	Long J	2010-06-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20585626	Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.	Breast cancer	2,073 Chinese ancestry cases, 2,084 Chinese ancestry controls	15,159 East Asian ancestry cases, 12,993 East Asian ancestry controls, 2,797 European ancestry cases, 2,662 European ancestry controls	16q12.1	16	52565276	TOX3	CASC16			643714			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.24	1E-28	28.0	(all races combined)	1.24	[1.20-1.29]	Affymetrix [684457]	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	1q25.3	1	183004356	NR	KRT18P28 - LAMC1	343326	3915		43944	19104	rs10752881-A	rs10752881	0	10752881	intergenic_variant	1	0.39	5E-6	5.301029995663981	(East Asian)	1.07	[1.04-1.10]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	8q23.3	8	116635549	NR	LOC105375712 - EIF3H	105375712	8667		20215	9267	rs6469656-A	rs6469656	0	6469656	intergenic_variant	1	0.65	5E-8	7.301029995663981	(East Asian)	1.09	[1.06-1.13]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	10q21.1	10	58811675	NR	BICC1			80114			rs4948317-C	rs4948317	0	4948317	intron_variant	0	0.27	7E-8	7.154901959985743	(East Asian)	1.1	[1.06-1.13]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	10q22.3	10	79059375	AS1, ZMIZ1	ZMIZ1-AS1			283050			rs704017-G	rs704017	0	704017	intron_variant	0	0.32	2E-8	7.698970004336019	(East Asian)	1.1	[1.06-1.13]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	10q24.2	10	99529178	NR	LINC01475			101927324			rs12412391-G	rs12412391	0	12412391	intron_variant	0	0.42	7E-7	6.154901959985743	(East Asian)	1.08	[1.05-1.11]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	10q25.2	10	112967084	TCF7L2	TCF7L2			6934			rs11196172-A	rs11196172	0	11196172	intron_variant	0	0.68	1E-12	12.0	(East Asian)	1.14	[1.10-1.18]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	11q12.2	11	61785208	MYRF, FADS1, FADS2, FEN1	MYRF			745			rs174537-G	rs174537	0	174537	non_coding_transcript_exon_variant	0	0.59	9E-21	20.045757490560675	(East Asian)	1.16	[1.12-1.19]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	12p13.33	12	866782	NR	WNK1			65125			rs12309274-T	rs12309274	0	12309274	intron_variant	0	0.85	3E-6	5.522878745280337	(East Asian)	1.11	[1.06-1.16]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	12p13.31	12	6276561	PLEKHG6, TNFRSF1A, CD9	LOC105369625			105369625			rs10849432-T	rs10849432	0	10849432	intergenic_variant	0	0.82	6E-10	9.221848749616356	(East Asian)	1.14	[1.09-1.18]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	17p13.3	17	897353	NXN	NXN			64359			rs12603526-C	rs12603526	0	12603526	intron_variant	0	0.3	3E-8	7.522878745280337	(East Asian)	1.1	[1.06-1.14]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	19q13.2	19	41354391	TGFB1, B9D2	TGFB1 - B9D2	7040	80776		458	26	rs1800469-G	rs1800469	0	1800469	intron_variant	1	0.48	1E-8	8.0	(East Asian)	1.09	[1.06-1.12]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	1q41	1	221991606	DUSP10	LOC105372950 - LOC107985307	105372950	107985307		72894	50098	rs6687758-G	rs6687758	0	6687758	regulatory_region_variant	1	0.24	9E-9	8.045757490560675	(East Asian)	1.12	[1.08-1.17]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	5q31.1	5	135163402	PITX1	C5orf66			100996485			rs647161-A	rs647161	0	647161	intron_variant	0	0.31	2E-14	13.698970004336019	(East Asian)	1.15	[1.11-1.19]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.38	5E-14	13.301029995663981	(East Asian)	1.14	[1.10-1.18]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	10p14	10	8659256	intergenic	LOC105376400			105376400			rs10795668-G	rs10795668	0	10795668	upstream_gene_variant	0	0.6	5E-15	14.301029995663981	(East Asian)	1.15	[1.11-1.19]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	11q23.1	11	111300984	intergenic	COLCA1, COLCA2			399948, 120376			rs3802842-C	rs3802842	0	3802842	intron_variant	0	0.38	3E-7	6.522878745280337	(East Asian)	1.09	[1.05-1.12]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	12p13.32	12	4259186	CCND2	CCND2-AS1			103752584			rs10774214-T	rs10774214	0	10774214	intron_variant	0	0.37	1E-10	10.0	(East Asian)	1.14	[1.09-1.18]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	18q21.1	18	48924606	SMAD7	SMAD7			4092			rs7229639-A	rs7229639	0	7229639	intron_variant	0	0.16	2E-8	7.698970004336019	(East Asian)	1.2	[1.16-1.25]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	19q13.11	19	33041394	RHPN2	RHPN2			85415			rs10411210-C	rs10411210	0	10411210	intron_variant	0	0.82	3E-6	5.522878745280337	(East Asian)	1.12	[1.07-1.17]	Affymetrix, Illumina [2400000] (imputed)	N
2014-11-29	24836286	Zhang B	2014-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24836286	Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.	Colorectal cancer	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls	12,865 East Asian ancestry cases, 25,773 East Asian ancestry controls, up to 16,984 European ancestry cases, up to 18,262 European ancestry controls	20p12.3	20	7831703	HAO1	SRSF10P2			171472			rs2423279-C	rs2423279	0	2423279	downstream_gene_variant	0	0.31	3E-12	11.522878745280337	(East Asian)	1.13	[1.09-1.17]	Affymetrix, Illumina [2400000] (imputed)	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	5q14.3	5	91979496	ARRDC3	PCBP2P3 - LOC105379080	100131236	105379080		134968	347656	rs421379-?	rs421379	0	421379	intergenic_variant	1	0.05	1E-6	6.0		1.61	[1.33-1.96]	Illumina [487496]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	15q22.2	15	61410580	RORa	LOC105370847			105370847			rs3884558-?	rs3884558	0	3884558	intron_variant	0	0.07	4E-6	5.3979400086720375		1.46	[1.24-1.72]	Illumina [487496]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	17p13.1	17	9186907	NTN1	NTN1			9423			rs3785982-?	rs3785982	0	3785982	intron_variant	0	0.12	8E-6	5.096910013008056		1.4	[1.21-1.62]	Illumina [487496]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	1p13.2	1	114128347	SYT6	SYT6			148281			rs2774307-?	rs2774307	0	2774307	intron_variant	0	0.26	8E-6	5.096910013008056		1.3	[1.16-1.47]	Illumina [487496]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	1q23.3	1	164720525	PBX1	PBX1			5087			rs1387389-?	rs1387389	0	1387389	intron_variant	0	0.36	4E-6	5.3979400086720375		1.28	[1.16-1.43]	Illumina [487496]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer  (alcohol interaction)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	4q23	4	99307309	ADH1B	ADH1B			125			rs1042026-?	rs1042026	0	1042026	3_prime_UTR_variant	0	0.22	3E-7	6.522878745280337		1.27	[1.16-1.38]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer  (alcohol interaction)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	4q23	4	99135847	ADH4	ADH4, LOC100507053			127, 100507053			rs3805322-?	rs3805322	0	3805322	intron_variant	0	0.51	6E-7	6.221848749616356		1.23	[1.14-1.33]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer  (alcohol interaction)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	2q35	2	216616548	IGFB2	PSMB3P2 - IGFBP2	130700	3485		5487	16280	rs9288520-?	rs9288520	0	9288520	intergenic_variant	1	0.34	4E-11	10.397940008672037		1.33	[1.22-1.45]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer  (alcohol interaction)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	13q33.2	13	104386796	SLC10A2	LOC105370340 - LOC107984624	105370340	107984624		252508	309325	rs17450420-?	rs17450420	0	17450420	intergenic_variant	1	0.04	5E-8	7.301029995663981		1.7	[1.41-2.06]	NR [NR]	N
2013-03-05	23263487	Jia WH	2012-12-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23263487	Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.	Colorectal cancer	2,098 East Asian ancestry cases, 5,749 East Asian ancestry controls	5,358 East Asian ancestry cases, 5,922 East Asian ancestry controls, 26,060 European ancestry individuals	12p13.32	12	4259186	C12orf5, CCND2, FGF6, RAD51AP1, FGF23, PARP11	CCND2-AS1			103752584			rs10774214-T	rs10774214	0	10774214	intron_variant	0	0.379	3E-8	7.522878745280337		1.09	[1.06-1.13]	Affymetrix, Illumina [1636380] (imputed)	N
2013-03-05	23263487	Jia WH	2012-12-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23263487	Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.	Colorectal cancer	2,098 East Asian ancestry cases, 5,749 East Asian ancestry controls	5,358 East Asian ancestry cases, 5,922 East Asian ancestry controls, 26,060 European ancestry individuals	5q31.1	5	135163402	CATSPER3, PCBD2, MIR4461 and H2AFY, PITX1	C5orf66			100996485			rs647161-A	rs647161	0	647161	intron_variant	0	0.667	1E-10	10.0		1.11	[1.08-1.15]	Affymetrix, Illumina [1636380] (imputed)	N
2013-03-05	23263487	Jia WH	2012-12-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23263487	Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.	Colorectal cancer	2,098 East Asian ancestry cases, 5,749 East Asian ancestry controls	5,358 East Asian ancestry cases, 5,922 East Asian ancestry controls, 26,060 European ancestry individuals	20p12.3	20	7831703	PLCB1, HAO1	SRSF10P2			171472			rs2423279-C	rs2423279	0	2423279	downstream_gene_variant	0	0.252	7E-9	8.154901959985743		1.1	[1.06-1.14]	Affymetrix, Illumina [1636380] (imputed)	N
2013-03-05	23263487	Jia WH	2012-12-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23263487	Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.	Colorectal cancer	2,098 East Asian ancestry cases, 5,749 East Asian ancestry controls	5,358 East Asian ancestry cases, 5,922 East Asian ancestry controls, 26,060 European ancestry individuals	12p13.32	12	4259186	C12orf5, CCND2, FGF6, RAD51AP1, FGF23, PARP11	CCND2-AS1			103752584			rs10774214-T	rs10774214	0	10774214	intron_variant	0	0.352	5E-10	9.301029995663981	(East Asian)	1.17	[1.11-1.23]	Affymetrix, Illumina [1636380] (imputed)	N
2013-03-05	23263487	Jia WH	2012-12-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23263487	Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.	Colorectal cancer	2,098 East Asian ancestry cases, 5,749 East Asian ancestry controls	5,358 East Asian ancestry cases, 5,922 East Asian ancestry controls, 26,060 European ancestry individuals	5q31.1	5	135163402	CATSPER3, PCBD2, MIR4461 and H2AFY, PITX1	C5orf66			100996485			rs647161-A	rs647161	0	647161	intron_variant	0	0.313	4E-10	9.397940008672037	(East Asian)	1.17	[1.11-1.22]	Affymetrix, Illumina [1636380] (imputed)	N
2013-03-05	23263487	Jia WH	2012-12-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23263487	Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.	Colorectal cancer	2,098 East Asian ancestry cases, 5,749 East Asian ancestry controls	5,358 East Asian ancestry cases, 5,922 East Asian ancestry controls, 26,060 European ancestry individuals	20p12.3	20	7831703	PLCB1, HAO1	SRSF10P2			171472			rs2423279-C	rs2423279	0	2423279	downstream_gene_variant	0	0.302	2E-7	6.698970004336019	(East Asian)	1.14	[1.08-1.19]	Affymetrix, Illumina [1636380] (imputed)	N
2013-03-05	23263487	Jia WH	2012-12-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23263487	Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.	Colorectal cancer	2,098 East Asian ancestry cases, 5,749 East Asian ancestry controls	5,358 East Asian ancestry cases, 5,922 East Asian ancestry controls, 26,060 European ancestry individuals	10q25.3	10	116727589	HSPA12A	HSPA12A			259217			rs1665650-T	rs1665650	0	1665650	intron_variant	0	0.315	9E-7	6.045757490560675	(East Asian)	1.13	[1.08-1.19]	Affymetrix, Illumina [1636380] (imputed)	N
2016-01-27	25781442	Nan H	2015-03-17	JAMA	www.ncbi.nlm.nih.gov/pubmed/25781442	Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.	Colorectal cancer (aspirin and/or NSAID use interaction)	8,634 European ancestry cases, 8,553 European ancestry controls	NA	12p12.3	12	17291799	MGST1, PIK3C2G	RPL7P40 - PSMC1P8	100271220	390297		169339	91318	rs2965667-?	rs2965667	0	2965667	intergenic_variant	1	NR	5E-9	8.301029995663981				Affymetrix, Illumina [2700000] (imputed)	N
2016-01-27	25781442	Nan H	2015-03-17	JAMA	www.ncbi.nlm.nih.gov/pubmed/25781442	Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.	Colorectal cancer (aspirin and/or NSAID use interaction)	8,634 European ancestry cases, 8,553 European ancestry controls	NA	15q25.2	15	81937658	IL16	LOC102724001			102724001			rs16973225-?	rs16973225	0	16973225	intergenic_variant	0	NR	8E-9	8.096910013008056	(Case only)			Affymetrix, Illumina [2700000] (imputed)	N
2015-12-07	25890600	Guo Q	2015-04-18	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases		2q24.3	2	162922103	KCNH7, BC042876	KCNH7 - RPL7P61	90134	101929589		83356	230148	rs148760487-?	rs148760487	0	148760487	intergenic_variant	1	0.01	2E-8	7.698970004336019		1.88	[1.51-2.34]	Affymetrix, Illumina [9000000] (imputed)	N
2016-02-12	25956309	Palomba G	2015-05-10	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/25956309	Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.	Breast cancer	1,367 Sardinian cases, 1,658 Sardinian controls	201 Sardinian cases, 1,467 Sardinian controls, 61,485 European ancestry cases, 60,860 European ancestry controls	10q26.13	10	121577603	FGFR2	FGFR2			2263			rs2912780-?	rs2912780	0	2912780	intron_variant	0	0.506	4E-6	5.3979400086720375		1.302	(1.164-1.456)	Affymetrix [2067645] (imputed)	N
2016-02-12	25956309	Palomba G	2015-05-10	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/25956309	Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.	Breast cancer	1,367 Sardinian cases, 1,658 Sardinian controls	201 Sardinian cases, 1,467 Sardinian controls, 61,485 European ancestry cases, 60,860 European ancestry controls	16q12.1	16	52532542	TOX3	TOX3			27324			rs2193094-?	rs2193094	0	2193094	intron_variant	0	0.478	2E-7	6.698970004336019		1.337	(1.198-1.491)	Affymetrix [2067645] (imputed)	N
2016-10-12	26586795	Phipps AI	2015-11-19	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/26586795	Common Genetic Variation and Survival after Colorectal Cancer Diagnosis: A Genome-Wide Analysis.	Survival in colorectal cancer	up to 2,843 European ancestry cases without distant metastases, up to 462 European ancestry cases with distant metastases, up to 189 European ancestry cases of unknown stage	up to 3,205 European ancestry cases without distant metastases, up to 435 European ancestry cases with distant metastases, up to 124 European ancestry cases of unknown stage	11p12	11	41047350	LRRC4C	LRRC4C			57689			rs12224794-?	rs12224794	0	12224794	intron_variant	0	0.55	3E-6	5.522878745280337	(Overall Survival)	1.1494253	[1.09-1.22]	Illumina [~ 2700000] (imputed)	N
2015-10-26	25824743	Haryono SJ	2015-01-01	Asian Pac J Cancer Prev	www.ncbi.nlm.nih.gov/pubmed/25824743	A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia.	Breast cancer	89 Indonesian ancestry cases, 46 Indonesian ancestry controls	NA	18p11.22	18	8716323	SOGA2	MTCL1			23255			rs2111836-G	rs2111836	0	2111836	intron_variant	0	0.22	7E-6	5.154901959985743		1.32	[1.17-1.44]	Affymetrix [292887]	N
2015-10-26	25824743	Haryono SJ	2015-01-01	Asian Pac J Cancer Prev	www.ncbi.nlm.nih.gov/pubmed/25824743	A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia.	Breast cancer	89 Indonesian ancestry cases, 46 Indonesian ancestry controls	NA	2p12	2	79716982	CTNNA2	CTNNA2			1496			rs13025833-A	rs13025833	0	13025833	intron_variant	0	0.52	1E-7	7.0		1.2	[1.13-1.33]	Affymetrix [292887]	N
2015-04-23	25105248	Wang H	2014-08-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25105248	Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.	Colorectal cancer	2,627 Japanese ancestry cases, 3,797 Japanese ancestry controls, 1,893 African American cases, 4,703 African American controls	16,823 European ancestry cases, 18,211 European ancestry controls	10q25.2	10	112520943	VTI1A	VTI1A			143187			rs12241008-C	rs12241008	0	12241008	intron_variant	0	0.090	1E-9	9.0		1.13	[1.09–1.18]	Illumina [4276079] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	6q24.1	6	138801103	ECT2L	ECT2L			345930			rs10457678-A	rs10457678	0	10457678	intron_variant	0	0.773	4E-7	6.3979400086720375	(same direction)	1.1	[1.06-1.14]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	4q24	4	105143597	TET2	LOC100288146 - TET2	100288146	54790		39603	2278	rs17035310-C	rs17035310	0	17035310	upstream_gene_variant	1	0.876	6E-7	6.221848749616356	(same direction)	1.13	[1.08-1.18]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	12q24.12	12	111446804	SH2B3	SH2B3			10019			rs3184504-C	rs3184504	0	3184504	missense_variant	0	0.52	8E-9	8.096910013008056	(same direction)	1.1	[1.06-1.13]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	11q22.3	11	106436144	GUCY1A2	LOC105369474 - GUCY1A2	105369474	2977		26960	237868	rs1512436-?	rs1512436	0	1512436	intergenic_variant	1	0.447	1E-6	6.0	(same direction)	1.0752687	[1.05-1.11]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	9p21.3	9	22121350	CDKN2B-AS1	CDKN2B-AS1 - DMRTA1	100048912	63951		253	325491	rs10217586-?	rs10217586	0	10217586	downstream_gene_variant	1	0.461	2E-6	5.698970004336019	(same direction)	1.0752687	[1.04-1.11]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	2p13.3	2	69832692	GMCL1	GMCL1			64395			rs4853036-?	rs4853036	0	4853036	intron_variant	0	0.264	6E-6	5.221848749616356	(same direction)	1.0869565	[1.05-1.12]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	17q25.2	17	76934284	MGAT5B	MGAT5B			146664			rs4789378-?	rs4789378	0	4789378	intron_variant	0	0.352	9E-6	5.045757490560675	(same direction)	1.0752687	[1.04-1.11]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	16p13.13	16	11626210	LITAF	LITAF, LOC107984880			9516, 107984880			rs12446552-?	rs12446552	0	12446552	intron_variant	0	0.277	3E-6	5.522878745280337	(same direction)	1.0869565	[1.05-1.12]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	3q13.31	3	115931601	LSAMP	LSAMP			4045			rs4378954-C	rs4378954	0	4378954	intron_variant	0	0.898	4E-7	6.3979400086720375	(same direction)	1.15	[1.09-1.21]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	9q31.2	9	108297916	KLF4	LOC105376214			105376214			rs77922938-?	rs77922938	0	77922938	intergenic_variant	0	0.047	8E-6	5.096910013008056	(opposite direction)	1.1764705	[1.1-1.27]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	14q13.1	14	33820232	NPAS3	NPAS3 - EGLN3	64067	112399		16056	103983	rs1952157-C	rs1952157	0	1952157	intergenic_variant	1	0.69	6E-6	5.221848749616356	(opposite direction)	1.08	[1.05-1.12]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	17q21.32	17	48536888	HOXB1	HOXB1 - HOXB2	3211	3212		5978	5767	rs76525880-A	rs76525880	0	76525880	downstream_gene_variant	1	0.929	7E-6	5.154901959985743	(opposite direction)	1.16	[1.09-1.24]	Illumina [up to 6000000] (imputed)	N
2016-10-06	26621817	Cheng TH	2015-12-01	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26621817	Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.	Colorectal or endometrial cancer	5,725 European ancestry colorectal carcinoma cases, 2,212 European ancestry endometrial carcinoma cases, 13,396 European ancestry controls	4,330 European ancestry endometrial carcinoma cases, 26,849 European ancestry controls	18q22.3	18	75305279	TSHZ1	TSHZ1 - LOC105372200	10194	105372200		15329	100167	rs12970291-T	rs12970291	0	12970291	intergenic_variant	1	0.965	5E-8	7.301029995663981	(opposite direction)	1.27	[1.16-1.38]	Illumina [up to 6000000] (imputed)	N
2013-04-05	23300701	Jiao S	2012-12-26	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23300701	Genome-wide search for gene-gene interactions in colorectal cancer.	Colorectal cancer (interaction)	8,380 European ancestry cases, 10,558 European ancestry controls	2,527 European ancestry cases, 2,628 European ancestry controls	12q21.1 x 20p12.3	12 x 20	72020783 x 6389406	intergenic x intergenic	TPH2 x FGFR3P3 - CASC20						rs10879357-? x rs1571218-?	rs10879357 x rs1571218	0		intron_variant x intergenic_variant		0.62	3E-6	5.522878745280337		1.25	[1.14-1.39]	Illumina [2011668]	N
2013-04-05	23300701	Jiao S	2012-12-26	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23300701	Genome-wide search for gene-gene interactions in colorectal cancer.	Colorectal cancer (interaction)	8,380 European ancestry cases, 10,558 European ancestry controls	2,527 European ancestry cases, 2,628 European ancestry controls	5q21.3 x 10p14	5 x 10	109613236 x 8659256	intergenic x intergenic	KRT18P42 - LOC105379118 x LOC105376400						rs367615-? x rs10795668-?	rs367615 x rs10795668	0		intergenic_variant x upstream_gene_variant		0.73	4E-8	7.3979400086720375		1.35	[1.20-1.49]	Illumina [2011668]	N
2013-04-05	23300701	Jiao S	2012-12-26	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23300701	Genome-wide search for gene-gene interactions in colorectal cancer.	Colorectal cancer (interaction)	8,380 European ancestry cases, 10,558 European ancestry controls	2,527 European ancestry cases, 2,628 European ancestry controls	9q22.31 x 15q13.3	9 x 15	93868852 x 32702555	intergenic x CRAC1	LOC101928014 - BARX1 x SCG5 - GREM1						rs10114408-? x rs4779584-?	rs10114408 x rs4779584	0		intergenic_variant x intergenic_variant		0.76	3E-6	5.522878745280337		1.37	[1.20-1.56]	Illumina [2011668]	N
2013-04-05	23300701	Jiao S	2012-12-26	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23300701	Genome-wide search for gene-gene interactions in colorectal cancer.	Colorectal cancer (interaction)	8,380 European ancestry cases, 10,558 European ancestry controls	2,527 European ancestry cases, 2,628 European ancestry controls	6q25.3 x 1q41	6 x 1	158014540 x 221991606	intergenic x intergenic	SYNJ2 x LOC105372950 - LOC107985307						rs9365723-? x rs6687758-?	rs9365723 x rs6687758	0		intron_variant x regulatory_region_variant		0.57	4E-6	5.3979400086720375		1.27	[1.15-1.41]	Illumina [2011668]	N
2013-04-05	23300701	Jiao S	2012-12-26	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23300701	Genome-wide search for gene-gene interactions in colorectal cancer.	Colorectal cancer (interaction)	8,380 European ancestry cases, 10,558 European ancestry controls	2,527 European ancestry cases, 2,628 European ancestry controls	7p15.3 x 1q41	7 x 1	25094230 x 221991606	intergenic x intergenic	OSBPL3 - CYCS x LOC105372950 - LOC107985307						rs39453-? x rs6687758-?	rs39453 x rs6687758	0		regulatory_region_variant x regulatory_region_variant		0.63	2E-6	5.698970004336019		1.28	[1.16-1.43]	Illumina [2011668]	N
2013-04-05	23300701	Jiao S	2012-12-26	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23300701	Genome-wide search for gene-gene interactions in colorectal cancer.	Colorectal cancer (interaction)	8,380 European ancestry cases, 10,558 European ancestry controls	2,527 European ancestry cases, 2,628 European ancestry controls	4q13.2 x 12q13.12	4 x 12	66491736 x 50486433	intergenic x intergenic	RPS23P3 - LOC105377262 x LARP4 - DIP2B						rs17730929-? x rs7136702	rs17730929 x rs7136702	0		intergenic_variant x intergenic_variant		0.9	3E-6	5.522878745280337		1.47	[1.25-1.72]	Illumina [2011668]	N
2013-04-05	23300701	Jiao S	2012-12-26	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23300701	Genome-wide search for gene-gene interactions in colorectal cancer.	Colorectal cancer (interaction)	8,380 European ancestry cases, 10,558 European ancestry controls	2,527 European ancestry cases, 2,628 European ancestry controls	3p24.3 x 20q13.33	3 x 20	23101556 x 62345988	intergenic x intergenic	SALL4P5 - RPL24P7 x LAMA5						rs4591517-? x rs4925386-?	rs4591517 x rs4925386	0		intergenic_variant x intron_variant		0.28	3E-6	5.522878745280337		1.06	[0.88-1.29]	Illumina [2011668]	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	4q23	4	99318162	ADH1B	ADH1B			125			rs1229984-G	rs1229984	0	1229984	missense_variant	0	0.9401455463215125	9E-9	8.045757490560675		1.832173		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	16q23.2	16	79768943	LINC01229	MAFTRR			102467146			rs4284656-T	rs4284656	0	4284656	intron_variant	0	0.04403901382978104	2E-6	5.698970004336019		1.7409471		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	2q33.1	2	199223244	intergenic	LOC100419513 - SATB2	100419513	23314		113156	46256	rs62178732-G	rs62178732	0	62178732	intergenic_variant	1	0.9168610229735275	2E-6	5.698970004336019		1.3898541		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	1p13.3	1	110235437	KCNC4	KCNC4			3749			rs17358800-A	rs17358800	0	17358800	3_prime_UTR_variant	0	0.762545890181155	1E-6	6.0		1.2551776		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	11q24.3	11	130558363	LOC105369574	LOC105369574			105369574			rs1021455-C	rs1021455	0	1021455	intergenic_variant	0	0.811067491812841	4E-6	5.3979400086720375		1.2520347		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	2p15	2	61645668	intergenic	RNU6-1145P - LOC647077	106481541	647077		39947	64929	rs111510828-G	rs111510828	0	111510828	intergenic_variant	1	0.824176006877976	2E-6	5.698970004336019		1.2493753		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	4q35.1	4	182335224	TENM3	TENM3			55714			rs112500619-C	rs112500619	0	112500619	intron_variant	0	0.797527099008316	5E-6	5.301029995663981		1.2391574		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	5p15.31	5	7439973	ADCY2	ADCY2			108			rs76122614-G	rs76122614	0	76122614	intron_variant	0	0.740588266296706	4E-6	5.3979400086720375		1.206127		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	9p24.1	9	4970909	intergenic	HNRNPA1P41 - JAK2	100128701	3717		24947	14177	rs7870381-A	rs7870381	0	7870381	intergenic_variant	1	0.577259990144875	3E-6	5.522878745280337		1.1848341		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	8p21.3	8	19513087	CSGALNACT1	CSGALNACT1			55790			rs9644630-C	rs9644630	0	9644630	intron_variant	0	0.403417288993538	3E-6	5.522878745280337		1.1837121		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	4q21.23	4	84811016	WDFY3	WDFY3			23001			rs6847067-A	rs6847067	0	6847067	intron_variant	0	0.404213487423565	1E-6	6.0		1.1861		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	2q36.1	2	223036938	intergenic	LOC100419511 - KCNE4	100419511	23704		90298	14992	rs1837494-G	rs1837494	0	1837494	intergenic_variant	1	0.631347603998295	3E-6	5.522878745280337		1.1912		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	2q36.1	2	223040390	intergenic	LOC100419511 - KCNE4	100419511	23704		93750	11540	rs1961637-T	rs1961637	0	1961637	intergenic_variant	1	0.601490382710969	3E-7	6.522878745280337		1.2057		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	11p15.4	11	5807854	intergenic	OR52N2			390077			rs1453414-C	rs1453414	0	1453414	intron_variant	0	0.200985866449642	4E-6	5.3979400086720375		1.2157		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	2p23.1	2	30871379	LOC105374446	LOC105374435 - GALNT14	105374435	79623		35949	17139	rs2216824-A	rs2216824	0	2216824	intergenic_variant	1	0.0907245595473838	3E-6	5.522878745280337		1.3186		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	6p21.32	6	32668343	HLA-DQB1	HLA-DQB1 - MTCO3P1	3119	404026		1654	37801	rs3828805-C	rs3828805	0	3828805	5_prime_UTR_variant	1	0.720208999141883	2E-12	11.698970004336019		1.3699		Illumina [7574753] (imputed)	N
2017-03-31	27749845	Lesseur C	2016-10-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27749845	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.	Oropharynx cancer	2,506 European ancestry cases, 135 cases, 5,984 European ancestry controls, 601 controls	NA	12q23.3	12	107582831	BTBD11	BTBD11			121551			rs35189640-T	rs35189640	0	35189640	intron_variant	0	0.0175638236703023	2E-6	5.698970004336019		1.7533		Illumina [7574753] (imputed)	N
2009-02-28	19198613	Gudmundsson J	2009-02-06	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19198613	Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.	Thyroid cancer	192 European ancestry cases, 37,196 European ancestry controls	432 European ancestry cases, 1,727 European ancestry controls	9q22.33	9	97793827	FOXE1	KRT18P13 - FOXE1	392371	2304		93026	59428	rs965513-A	rs965513	0	965513	intergenic_variant	1	0.34	2E-27	26.69897000433602		1.75	[1.59-1.94]	Illumina [304083]	N
2009-02-28	19198613	Gudmundsson J	2009-02-06	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19198613	Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.	Thyroid cancer	192 European ancestry cases, 37,196 European ancestry controls	432 European ancestry cases, 1,727 European ancestry controls	14q13.3	14	36180040	NKX2-1	PTCSC3 - RN7SKP21	100886964	106480839		3389	51515	rs944289-T	rs944289	0	944289	upstream_gene_variant	1	0.57	2E-9	8.698970004336019		1.37	[1.24-1.52]	Illumina [304083]	N
2010-09-23	20729852	Abnet CC	2010-08-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20729852	A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.	Esophageal cancer and gastric cancer	1,625 Chinese ancestry gastric cancer cases, 1,898 Chinese ancestry ESCC cases, 2,100 Chinese ancestry controls	NA	10q23.33	10	94310618	PLCE1, NOC3L	PLCE1			51196			rs3781264-C	rs3781264	0	3781264	intron_variant	0	0.15	4E-9	8.397940008672037	(Total gastric)	1.36	[1.23-1.50]	Illumina [551152]	N
2010-09-23	20729852	Abnet CC	2010-08-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20729852	A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.	Esophageal cancer and gastric cancer	1,625 Chinese ancestry gastric cancer cases, 1,898 Chinese ancestry ESCC cases, 2,100 Chinese ancestry controls	NA	1q22	1	155192276	NR	MUC1			4582			rs4072037-A	rs4072037	0	4072037	splice_acceptor_variant	0	0.84	4E-7	6.3979400086720375	(Total gastric)	1.33	[1.19-1.49]	Illumina [551152]	N
2012-02-09	22267200	Gudmundsson J	2012-01-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22267200	Discovery of common variants associated with low TSH levels and thyroid cancer risk.	Thyroid cancer	27,758 European ancestry individuals	1,156 European ancestry cases, up to 42,617 European ancestry controls	2q35	2	217445617	DIRC3	DIRC3			729582			rs966423-C	rs966423	0	966423	intron_variant	0	0.442	1E-9	9.0		1.34	[1.22-1.47]	Illumina [~ 16000000] (imputed)	N
2012-02-09	22267200	Gudmundsson J	2012-01-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22267200	Discovery of common variants associated with low TSH levels and thyroid cancer risk.	Thyroid cancer	27,758 European ancestry individuals	1,156 European ancestry cases, up to 42,617 European ancestry controls	8p12	8	32574851	NRG1	NRG1			3084			rs2439302-G	rs2439302	0	2439302	intron_variant	0	0.351	2E-9	8.698970004336019		1.36	[1.23-1.50]	Illumina [~ 16000000] (imputed)	N
2012-02-09	22267200	Gudmundsson J	2012-01-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22267200	Discovery of common variants associated with low TSH levels and thyroid cancer risk.	Thyroid cancer	27,758 European ancestry individuals	1,156 European ancestry cases, up to 42,617 European ancestry controls	14q13.3	14	36269155	MBIP	RN7SKP21 - LOC107984003	106480839	107984003		37381	4160	rs116909374-T	rs116909374	0	116909374	intergenic_variant	1	0.017	5E-11	10.301029995663981		2.09	[1.68-2.60]	Illumina [~ 16000000] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	19p13.11	19	17791525	B3GNT3	FCHO1 - B3GNT3	23149	10331		2957	3303	rs265548-C	rs265548	0	265548	upstream_gene_variant	1	0.26	1E-13	13.0	(CA19-9)	0.072	[0.029-0.115] U/ml decrease	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	9q34.2	9	133255801	ABO	ABO			28			rs8176749-T	rs8176749	0	8176749	synonymous_variant	0	0.18	7E-105	104.15490195998575	(CEA)	0.205	[0.18-0.23] ng/ml increase	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	19p13.3	19	5841345	FUT6	FUT6 - FUT3	2528	2525		1592	1543	rs3760775-T	rs3760775	0	3760775	upstream_gene_variant	1	0.33	1E-35	35.0	(CEA)	0.073	[0.048-0.098] ng/ml increase	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	19q13.33	19	48703374	FUT2	FUT2, LOC105447645			2524, 105447645			rs1047781-T	rs1047781	0	1047781	missense_variant	0	0.46	6E-209	208.22184874961636	(CEA)	0.238	[0.21-0.26] ng/ml increase	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	21q22.3	21	41326980	FAM3B	FAM3B			54097			rs441810-G	rs441810	0	441810	intron_variant	0	0.24	3E-22	21.522878745280337	(CEA)	0.069	[0.040-0.098] ng/ml increase	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	4q13.3	4	73453566	AFP	AFP			174			rs12506899-G	rs12506899	0	12506899	non_coding_transcript_exon_variant	0	0.32	3E-18	17.522878745280337	(AFP)	0.065	[0.032-0.098] ng/ml decrease	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	15q15.3	15	43544280	HISPPD2A	PPIP5K1			9677			rs2251844-C	rs2251844	0	2251844	intron_variant	0	0.42	1E-14	14.0	(AFP)	0.087	[0.056-0.118] ng/ml increase	Affymetrix, Illumina [NR] (imputed)	N
2015-12-02	25823930	Xu L	2015-03-30	Cancer	www.ncbi.nlm.nih.gov/pubmed/25823930	Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.	Salivary gland carcinoma	266 European ancestry cases, 453 European ancestry controls	43 Hispanic cases, 82 Hispanic controls				CHRNA2							exm2258812-A	exm2258812	0			1	0.015	2E-12	11.698970004336019		8.95	[4.86-16.48]	Illumina [244351]	N
2015-12-02	25823930	Xu L	2015-03-30	Cancer	www.ncbi.nlm.nih.gov/pubmed/25823930	Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.	Salivary gland carcinoma	266 European ancestry cases, 453 European ancestry controls	43 Hispanic cases, 82 Hispanic controls				ZN343F							exm1519918-G	exm1519918	0			1	0.04	3E-8	7.522878745280337		3.24	[2.14-4.91]	Illumina [244351]	N
2015-12-02	25823930	Xu L	2015-03-30	Cancer	www.ncbi.nlm.nih.gov/pubmed/25823930	Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.	Salivary gland carcinoma	266 European ancestry cases, 453 European ancestry controls	43 Hispanic cases, 82 Hispanic controls				PARP4							exm1057993-A	exm1057993	0			1	0.2	7E-9	8.154901959985743		2.09	[1.63-2.68]	Illumina [244351]	N
2015-12-02	25823930	Xu L	2015-03-30	Cancer	www.ncbi.nlm.nih.gov/pubmed/25823930	Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.	Salivary gland carcinoma	266 European ancestry cases, 453 European ancestry controls	43 Hispanic cases, 82 Hispanic controls				ELL2							exm2265979-G	exm2265979	0			1	0.29	1E-7	7.0		1.86	[1.48-2.34]	Illumina [244351]	N
2015-12-02	25823930	Xu L	2015-03-30	Cancer	www.ncbi.nlm.nih.gov/pubmed/25823930	Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.	Salivary gland carcinoma	266 European ancestry cases, 453 European ancestry controls	43 Hispanic cases, 82 Hispanic controls				OR4F15							exm1194739-A	exm1194739	0			1	0.029	4E-10	9.397940008672037	(EA)	5.26	[3.13-8.83]	Illumina [244351]	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	19p13.3	19	5841345	FUT6	FUT6 - FUT3	2528	2525		1592	1543	rs3760775-T	rs3760775	0	3760775	upstream_gene_variant	1	0.33	3E-290	289.52287874528037	(CA19-9)	0.481	[0.44-0.52] U/ml decrease	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	19q13.33	19	48703374	FUT2, CA11	FUT2, LOC105447645			2524, 105447645			rs1047781-T	rs1047781	0	1047781	missense_variant	0	0.46	8E-176	175.09691001300806	(CA19-9)	0.444	[0.41-0.48] U/ml increase	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	19p13.3	19	5834201	FUT6	FUT6			2528			rs17271883-G	rs17271883	0	17271883	intron_variant	0	0.38	5E-132	131.30102999566398	(CA19-9)	0.282	[0.20-0.37] U/ml increase	Affymetrix, Illumina [NR] (imputed)	N
2013-04-11	23300138	He M	2013-01-07	Gut	www.ncbi.nlm.nih.gov/pubmed/23300138	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and &#x000ce;&#x000b1; fetoprotein and their associations with cancer risk.	Tumor biomarkers	3,451 Han Chinese ancestry individuals	10,326 Chinese ancestry individuals	19p13.3	19	5839735	FUT6	FUT6			2528			rs3760776-T	rs3760776	0	3760776	upstream_gene_variant	0	0.20	2E-56	55.69897000433602	(CA19-9)	0.169	[0.11-0.22] U/ml decrease	Affymetrix, Illumina [NR] (imputed)	N
2014-02-25	23894154	Kohler A	2013-07-26	J Clin Endocrinol Metab	www.ncbi.nlm.nih.gov/pubmed/23894154	Genome-wide association study on differentiated thyroid cancer.	Thyroid cancer	690 European ancestry cases, 497 European ancestry controls	2,958 European ancestry cases, 3,727 European ancestry controls	2q35	2	217406996	DIRC3	DIRC3			729582			rs6759952-T	rs6759952	0	6759952	intron_variant	0	0.43	6E-10	9.221848749616356		1.25	[1.16-1.34]	Illumina [572042]	N
2014-02-25	23894154	Kohler A	2013-07-26	J Clin Endocrinol Metab	www.ncbi.nlm.nih.gov/pubmed/23894154	Genome-wide association study on differentiated thyroid cancer.	Thyroid cancer	690 European ancestry cases, 497 European ancestry controls	2,958 European ancestry cases, 3,727 European ancestry controls	9q22.33	9	97793827	FOXE1	KRT18P13 - FOXE1	392371	2304		93026	59428	rs965513-A	rs965513	0	965513	intergenic_variant	1	NR	3E-10	9.522878745280337		1.78	[NR]	Illumina [572042]	N
2014-12-17	24974847	Fachal L	2014-06-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24974847	A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.	Response to radiotherapy in prostate cancer (toxicity)	Up to 652 European ancestry cases	849 European ancestry cases	2q24.2	2	159042977	TANC1, BTF3L4P2, GSTM3P2	TANC1			85461			rs7582141-T	rs7582141	0	7582141	intron_variant	0	0.04	5E-11	10.301029995663981	(late toxicity)	0.37	[NR] unit increase	Affymetrix [552597]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	9q22.33	9	98998959	TGFBR1, COL15A1	COL15A1			1306			rs1413299-C	rs1413299	0	1413299	intron_variant	0	0.38	2E-8	7.698970004336019		1.2	[1.03-1.41]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	10p11.21	10	36880367	NAMPTL, ANKRD30A	NAMPTP1 - LOC105376496	646309	105376496		356131	36909	rs1192691-C	rs1192691	0	1192691	intergenic_variant	1	0.54	3E-8	7.522878745280337		1.23	[1.05-1.43]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	12q14.2	12	63871057	SRGAP1	SRGAP1			57522			rs11175194-G	rs11175194	0	11175194	intron_variant	0	0.59	1E-7	7.0		1.19	[1.02-1.39]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	9q34.2	9	133279871	SURF6, ABO	ABO - LCN1P2	28	653163		4657	37634	rs633862-A	rs633862	0	633862	upstream_gene_variant	1	0.54	9E-7	6.045757490560675		1.19	[1.02-1.39]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	1q44	1	244077146	ZNF238, ADSS	LOC440742 - RN7SL148P	440742	106479275		9243	26786	rs2500488-C	rs2500488	0	2500488	intron_variant	1	0.33	4E-6	5.3979400086720375		1.472	[1.246-1.739]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	7q21.11	7	83667946	SEMA3E, ABCB4	RAD23BP2 - LOC107986745	100130572	107986745		3123	250489	rs6976769-C	rs6976769	0	6976769	downstream_gene_variant	1	.05	4E-6	5.3979400086720375		1.458	[1.056-2.012]	Illumina [710714]	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.275	3E-7	6.522878745280337		1.2	1.12-1.29	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	2q35	2	217427435	NR	DIRC3			729582			rs11693806-C	rs11693806	0	11693806	non_coding_transcript_exon_variant	0	0.319	2E-24	23.69897000433602		1.43	1.33-1.54	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	8p12	8	32575278	NR	NRG1			3084			rs2466076-G	rs2466076	0	2466076	intron_variant	0	0.484	2E-17	16.69897000433602		1.32	1.23-1.41	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	9q22.33	9	97775520	NR	KRT18P13 - FOXE1	392371	2304		74719	77735	rs1588635-A	rs1588635	0	1588635	intergenic_variant	1	0.396	2E-58	57.69897000433602		1.69	1.59-1.82	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	14q13.2	14	36063370	NR	LOC105370452			105370452			rs368187-G	rs368187	0	368187	non_coding_transcript_exon_variant	0	0.581	5E-23	22.30102999566398		1.39	1.30-1.47	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	14q13.3	14	36269155	NR	RN7SKP21 - LOC107984003	106480839	107984003		37381	4160	rs116909374-T	rs116909374	0	116909374	intergenic_variant	1	0.034	1E-16	16.0		1.81	1.57-2.08	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	1q42.2	1	233276815	PCNXL2	PCNXL2			80003			rs12129938-A	rs12129938	0	12129938	intron_variant	0	0.795	4E-11	10.397940008672037		1.32	1.20-1.43	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	3q26.2	3	169800667	LRRC34, TERC	LRRC34			151827			rs6793295-T	rs6793295	0	6793295	missense_variant	0	0.759	3E-8	7.522878745280337		1.23	1.15-1.33	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	5q22.1	5	112150207	NREP, EPB41L4A	EPB41L4A			64097			rs73227498-A	rs73227498	0	73227498	intron_variant	0	0.872	3E-10	9.522878745280337		1.37	1.23-1.49	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	10q24.33	10	103934543	OBFC1	OBFC1 - LOC102724351	79991	102724351		16256	3104	rs7902587-T	rs7902587	0	7902587	intergenic_variant	1	0.109	5E-11	10.301029995663981		1.41	1.27-1.56	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	15q22.33	15	67165147	SMAD3	SMAD3			4088			rs2289261-C	rs2289261	0	2289261	intron_variant	0	0.683	3E-9	8.522878745280337		1.23	1.15-1.32	Illumina [7100000] (imputed)	N
2017-06-06	28195142	Gudmundsson J	2017-02-14	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28195142	A genome-wide association study yields five novel thyroid cancer risk loci.	Thyroid cancer	2,637 European ancestry cases, 364 non-array typed, familial imputed Icelandic ancestry cases, 134,811 European ancestry controls, 152,739 non-array typed, familial imputed Icelandic ancestry controls.	NA	15q22.33	15	67163292	SMAD3	SMAD3			4088			rs56062135-T	rs56062135	0	56062135	intron_variant	0	0.253	5E-9	8.301029995663981		1.24	1.16.1.34	Illumina [7100000] (imputed)	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in cancer	1,085 cases	NA	16q22.2	16	72128203	PMFBP1	PMFBP1			83449			rs8044868-?	rs8044868	0	8044868	intron_variant	0		5E-6	5.301029995663981		0.031	[0.018-0.044] unit increase	Affymetrix [418365]	N
2017-06-20	28274756	Mhatre S	2017-03-03	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/28274756	Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.	Gallbladder cancer	1,042 Indian ancestry cases, 1,709 Indian ancestry controls	428 Indian ancestry cases, 420 Indian ancestry controls	7q21.12	7	87449753	ABCB4	ABCB4			5244			rs1558375-A	rs1558375	0	1558375	intron_variant	0	0.74	2E-10	9.698970004336019		1.47	[1.30-1.66]	Illumina [10400000] (imputed)	N
2017-06-20	28274756	Mhatre S	2017-03-03	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/28274756	Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.	Gallbladder cancer	1,042 Indian ancestry cases, 1,709 Indian ancestry controls	428 Indian ancestry cases, 420 Indian ancestry controls	7q21.12	7	87495506	ABCB1	ABCB4 - ABCB1	5244	5243		19642	8357	rs17209837-A	rs17209837	0	17209837	intergenic_variant	1	0.85	2E-9	8.698970004336019		1.61	[1.38-1.89]	Illumina [10400000] (imputed)	N
2017-06-14	28295283	Wang H	2017-03-13	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/28295283	Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.	Colon cancer	1,451 African American ancestry cases, 4,703 African American ancestry controls.	607 African American ancestry cases, 1,146 African American ancestry controls.	19q13.32	19	45818249	SYMPK	SYMPK			8189			rs56848936-A	rs56848936	0	56848936	intron_variant	0	0.94	2E-8	7.698970004336019		1.64	[1.37-1.92]	Illumina [10050748] (imputed)	N
2017-06-14	28295283	Wang H	2017-03-13	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/28295283	Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.	Colon cancer	1,451 African American ancestry cases, 4,703 African American ancestry controls.	607 African American ancestry cases, 1,146 African American ancestry controls.	19q13.32	19	45818249	SYMPK	SYMPK			8189			rs56848936-A	rs56848936	0	56848936	intron_variant	0	0.94	5E-7	6.301029995663981	(right-sided colon tumor)	1.79	[1.43-2.22]	Illumina [10050748] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	3p24.1	3	27302153	SLC4A7	NEK10			152110			rs653465-?	rs653465	0	653465	intron_variant	0	0.54	5E-12	11.301029995663981		1.18	[1.12-1.23]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56872885	MAP3K1	MAP3K1			4214			rs2229882-?	rs2229882	0	2229882	synonymous_variant	0	0.06	1E-14	14.0		1.45	[1.32-1.60]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	8q24.21	8	127375779	intergenic	CASC8, CASC21			727677, 103021164			rs2392780-?	rs2392780	0	2392780	intron_variant	0	0.6	1E-8	8.0		1.15	[1.10-1.20]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	10q26.13	10	121589148	FGFR2	FGFR2			2263			rs2912774-?	rs2912774	0	2912774	intron_variant	0	0.44	3E-27	26.522878745280337		1.29	[1.23-1.35]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	11q13.3	11	69492927	CCND1	LINC01488			101928292			rs537626-?	rs537626	0	537626	intergenic_variant	0	0.18	2E-15	14.698970004336019		1.29	[1.21-1.37]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	16q12.1	16	52541995	TOX3	TOX3			27324			rs4784223-?	rs4784223	0	4784223	intron_variant	0	0.29	6E-21	20.221848749616356		1.27	[1.21-1.34]	Illumina [1265548] (imputed)	N
2013-09-20	23644492	Wu C	2013-05-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23644492	Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma.	Esophageal squamous cell cancer (length of survival)	1,331 Chinese ancestry cases	1,062 Chinese ancestry individuals	18q12.2	18	36114157	SLC39A6	SLC39A6			25800			rs1050631-T	rs1050631	0	1050631	synonymous_variant	0	0.18	4E-8	7.3979400086720375		1.3	[1.19-1.43]	Affymetrix [665999]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer (squamous cell)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	16q12.1	16	50069823	HEATR3	HEATR3			55027			rs4785204-T	rs4785204	0	4785204	intron_variant	0	0.26	2E-20	19.69897000433602		1.24	[1.18-1.29]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer (squamous cell)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	17q21.2	17	41741012	HAP1	HAP1 - JUP	9001	3728		6366	13595	rs6503659-A	rs6503659	0	6503659	intergenic_variant	1	0.13	3E-16	15.522878745280337		1.27	[1.20-1.34]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer (squamous cell)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	22q12.1	22	28796682	XBP1	XBP1			7494			rs2239815-T	rs2239815	0	2239815	non_coding_transcript_exon_variant	0	0.37	4E-15	14.397940008672037		1.18	[1.13-1.23]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer (squamous cell)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	3q27.3	3	187075454	ST6GAL1	ST6GAL1			6480			rs2239612-T	rs2239612	0	2239612	intron_variant	0	0.19	6E-14	13.221848749616356		1.21	[1.15-1.27]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer (squamous cell)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	17p13.3	17	2268343	SMG6	SMG6			23293			rs17761864-A	rs17761864	0	17761864	intron_variant	0	0.14	2E-11	10.698970004336019		1.21	[1.14-1.28]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer (squamous cell)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	18p11.21	18	12821594	PTPN2	PTPN2			5771			rs2847281-C	rs2847281	0	2847281	intron_variant	0	0.16	2E-11	10.698970004336019		1.2	[1.14-1.26]	NR [NR]	N
2012-12-11	22960999	Wu C	2012-09-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22960999	Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.	Esophageal cancer (squamous cell)	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls	8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls	22q12.1	22	28719078	CHEK2	CHEK2			11200			rs4822983-T	rs4822983	0	4822983	intron_variant	0	0.20	2E-22	21.69897000433602		1.27	[1.21-1.34]	NR [NR]	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56733416	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		127184	32979	rs16886181-?	rs16886181	0	16886181	intergenic_variant	1	0.18	9E-14	13.045757490560675		1.26	[1.18-1.34]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56874986	MAP3K1	MAP3K1			4214			rs16886448-?	rs16886448	0	16886448	intron_variant	0	0.07	2E-12	11.698970004336019		1.37	[1.25-1.49]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56838449	MAP3K1	MAP3K1			4214			rs16886397-?	rs16886397	0	16886397	intron_variant	0	0.07	4E-12	11.397940008672037		1.36	[1.25-1.49]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56882284	MAP3K1	MAP3K1			4214			rs3822625-?	rs3822625	0	3822625	synonymous_variant	0	0.07	5E-12	11.301029995663981		1.36	[1.24-1.48]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56826517	MAP3K1	MAP3K1			4214			rs16886364-?	rs16886364	0	16886364	intron_variant	0	0.07	5E-12	11.301029995663981		1.36	[1.25-1.48]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56699208	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		92976	67187	rs16886113-?	rs16886113	0	16886113	intergenic_variant	1	0.08	4E-11	10.397940008672037		1.35	[1.23-1.47]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56857565	MAP3K1	MAP3K1			4214			rs1017226-?	rs1017226	0	1017226	intron_variant	0	0.08	6E-11	10.221848749616356		1.33	[1.22-1.45]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56960656	MAP3K1	MIER3 - LOC100130001	166968	100130001		8526	14828	rs7726354-?	rs7726354	0	7726354	intron_variant	1	0.06	7E-11	10.154901959985743		1.37	[1.24-1.50]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56899963	MAP3K1	LOC105378980			105378980			rs12655019-?	rs12655019	0	12655019	downstream_gene_variant	0	0.1	3E-10	9.522878745280337		1.27	[1.18-1.37]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56688029	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		81797	78366	rs16886034-?	rs16886034	0	16886034	regulatory_region_variant	1	0.08	2E-9	8.698970004336019		1.36	[1.23-1.51]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56736057	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-?	rs889312	0	889312	regulatory_region_variant	1	0.29	1E-8	8.0		1.29	[NR]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	11q13.3	11	69513996	CCND1	LINC01488 - CCND1	101928292	595		20453	127109	rs614367-?	rs614367	0	614367	intergenic_variant	1	0.16	1E-8	8.0		1.34	[NR]	Illumina [1265548] (imputed)	N
2008-06-16	18326623	Gold B	2008-03-11	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/18326623	Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.	Breast cancer	249 Ashkenazi Jewish non-BRCA1/2 carriers cases, 299 Ashkenazi Jewish non-BRCA1/2 carriers controls	1,193 Ashkenazi Jewish non-BRCA1/2 carriers  cases,1,166 Ashkenazi Jewish non-BRCA1/2 carriers controls	6q22.33	6	127279485	ECHDC1, RNF146	RNF146			81847			rs2180341-G	rs2180341	0	2180341	intron_variant	0	0.21	3E-8	7.522878745280337		1.41	[1.25-1.59]	Affymetrix [150080]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	17q21.33	17	50196930	COL1A1	COL1A1			1277			rs2075555-?	rs2075555	0	2075555	intron_variant	0	NR	8E-8	7.096910013008056				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	5q34	5	164462274	intergenic	LOC105377703, LOC101927835			105377703, 101927835			rs6556756-?	rs6556756	0	6556756	intron_variant	0	NR	5E-7	6.301029995663981				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	12q21.1	12	73596057	intergenic	LOC105369839 - RPL31P48	105369839	645654		253086	52583	rs1154865-?	rs1154865	0	1154865	intergenic_variant	1	NR	7E-7	6.154901959985743				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	18q21.2	18	55997051	intergenic	LOC101927273 - LOC107985164	101927273	107985164		76852	1108	rs1978503-?	rs1978503	0	1978503	intron_variant	1	NR	1E-6	6.0				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	13q32.1	13	95222702	ABCC4	ABCC4			10257			rs1926657-?	rs1926657	0	1926657	intron_variant	0	NR	2E-6	5.698970004336019				Affymetrix [70897]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	10q26.13	10	121592803	FGFR2	FGFR2			2263			rs2981582-A	rs2981582	0	2981582	intron_variant	0	0.38	2E-76	75.69897000433602		1.26	[1.23-1.30]	Perlegen [205586]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	16q12.1	16	52552429	TNRC9, LOC643714	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.25	1E-36	36.0		1.2	[1.16-1.24]	Perlegen [205586]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	5q11.2	5	56736057	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-C	rs889312	0	889312	regulatory_region_variant	1	0.28	7E-20	19.154901959985743		1.13	[1.10-1.16]	Perlegen [205586]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	8q24.21	8	127343372	intergenic	CASC21, CASC8			103021164, 727677			rs13281615-C	rs13281615	0	13281615	intron_variant	0	0.40	5E-12	11.301029995663981		1.08	[1.05-1.11]	Perlegen [205586]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	11p15.5	11	1887776	LSP1	LSP1			4046			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.30	3E-9	8.522878745280337		1.07	[1.04-1.11]	Perlegen [205586]	N
2008-06-16	17529973	Hunter DJ	2007-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529973	A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	874 European ancestry cases, 1,478 European ancestry controls, 302 cases, 594 controls	10q26.13	10	121586676	FGFR2	FGFR2			2263			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.40	1E-10	10.0		1.2	[1.07-1.42]	Illumina [528173]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	5p12	5	45285616	intergenic	HCN1			348980			rs981782-C	rs981782	0	981782	intron_variant	0	0.53	9E-6	5.045757490560675		1.04	[1.01-1.08]	Perlegen [205586]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	7q11.22	7	67594280	intergenic	LOC105375340			105375340			rs10263639-?	rs10263639	0	10263639	intergenic_variant	0	NR	3E-6	5.522878745280337				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	2p16.1	2	59272212	intergenic	LOC101927285, LOC105374754			101927285, 105374754			rs10490113-?	rs10490113	0	10490113	intron_variant	0	NR	5E-6	5.301029995663981				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	21q21.3	21	29805194	GRIK1	GRIK1			2897			rs458685-?	rs458685	0	458685	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	15q21.1	15	48608389	FBN1	FBN1			2200			rs1876206-?	rs1876206	0	1876206	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix [70897]	N
2009-02-28	19219042	Zheng W	2009-02-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19219042	Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.	Breast cancer	1,505 Chinese ancestry cases, 1,522 Chinese ancestry controls	5,026 Chinese ancestry cases, 2,476 Chinese ancestry controls, 1,591 European ancestry cases, 1,466 European ancestry controls	6q25.1	6	151627231	ESR1, C6orf97	CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-A	rs2046210	0	2046210	intergenic_variant	1	0.37	2E-15	14.698970004336019		1.29	[1.21-1.37]	Affymetrix [up to 607728]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	10q26.13	10	121577821	FGFR2	FGFR2			2263			rs2981579-T	rs2981579	0	2981579	intron_variant	0	0.41	2E-10	9.698970004336019		1.17	[1.07-1.27] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.27	1E-9	9.0		1.16	[1.07-1.27] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	5q11.2	5	56727256	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		121024	39139	rs16886165-G	rs16886165	0	16886165	intergenic_variant	1	0.15	5E-7	6.301029995663981		1.23	[1.12-1.35] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	2q35	2	217041109	intergenic	LOC101928278, LOC105373874			101928278, 105373874			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.51	2E-8	7.698970004336019		1.25	[1.15-1.37] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	1p11.2	1	121538815	intergenic	EMBP1			647121			rs11249433-C	rs11249433	0	11249433	intron_variant	0	0.39	7E-10	9.154901959985743		1.16	[1.09-1.24] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	14q24.1	14	68567965	RAD51L1	RAD51B			5890			rs999737-C	rs999737	0	999737	intron_variant	0	0.76	2E-7	6.698970004336019		1.06	[1.01-1.14] (Het)	Illumina [528173]	N
2010-12-09	21060860	Gaudet MM	2010-10-28	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21060860	Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.	Breast cancer in BRCA2 mutation carriers	899 European ancestry cases, 804 European ancestry controls	1,264 European ancestry cases, 1,222 European ancestry controls	10q26.13	10	121586602	FGFR2	FGFR2			2263			rs2981575-?	rs2981575	0	2981575	intron_variant	0	0.42	1E-8	8.0		1.28	[1.18-1.39]	Affymetrix [592163]	N
2010-12-09	21118971	Wu C	2010-11-30	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/21118971	Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.	Small-cell lung cancer (survival)	245 Han Chinese ancestry cases	305 Han Chinese ancestry cases	11q22.3	11	103547430	DYNC2H1	DYNC2H1 - LOC105369463	79659	105369463		67567	47830	rs716274-G	rs716274	0	716274	intergenic_variant	1	NR	9E-8	7.045757490560675	(AG genotype)	1.83	[1.47-2.29]	Affymetrix [265996]	N
2011-04-13	21424380	Sehrawat B	2011-03-19	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21424380	Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.	Breast cancer	302 European ancestry female cases, 321 European ancestry female controls	1,153 European ancestry female cases, 1,215 European ancestry female controls	5p15.2	5	10467590	ROPN1L	ROPN1L			83853			rs1092913-T	rs1092913	0	1092913	intron_variant	0	0.13	2E-6	5.698970004336019		1.45	[1.24-1.69]	Affymetrix [782838]	N
2011-04-13	21424380	Sehrawat B	2011-03-19	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21424380	Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.	Breast cancer	302 European ancestry female cases, 321 European ancestry female controls	1,153 European ancestry female cases, 1,215 European ancestry female controls	19q13.41	19	51869723	ZNF577	ZNF577			84765			rs10411161-T	rs10411161	0	10411161	intron_variant	0	0.13	7E-6	5.154901959985743		1.42	[1.22-1.65]	Affymetrix [782838]	N
2012-03-17	22383897	Long J	2012-02-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls	up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls	6q25.1	6	149287738	TAB2	TAB2			23118			rs9485372-G	rs9485372	0	9485372	intron_variant	0	0.55	4E-12	11.397940008672037		1.11	[1.09-1.15]	Affymetrix [690947]	N
2012-03-17	22383897	Long J	2012-02-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls	up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls	6q25.1	6	151974478	ESR1	ESR1			2099			rs9383951-G	rs9383951	0	9383951	intron_variant	0	0.90	2E-6	5.698970004336019		1.14	[1.08-1.19]	Affymetrix [690947]	N
2012-03-17	22383897	Long J	2012-02-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls	up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls	11q24.3	11	129603795	TMEM45B, BARX2	RPS27P20 - LINC01395	100271581	101929557		65622	8321	rs7107217-C	rs7107217	0	7107217	intron_variant	1	0.36	5E-7	6.301029995663981		1.08	[1.05-1.11]	Affymetrix [690947]	N
2012-07-19	22664479	Han JY	2012-06-05	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/22664479	A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer.	Response to irinotecan in non-small-cell lung cancer	101 non-small-cell lung cancer cases	146 non-small-cell lung cancer cases	8q13.2	8	68476982	C8orf34	C8orf34			116328			rs1517114-C	rs1517114	0	1517114	intron_variant	0	0.12	9E-6	5.045757490560675	(G3D)	4.1	[2.10-8.00]	Affymetrix [312230]	N
2012-07-19	22664479	Han JY	2012-06-05	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/22664479	A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer.	Response to irinotecan in non-small-cell lung cancer	101 non-small-cell lung cancer cases	146 non-small-cell lung cancer cases	20p12.3	20	8297296	PLCB1	PLCB1			23236			rs2745761-C	rs2745761	0	2745761	intron_variant	0	0.072	6E-6	5.221848749616356	(G3D)	4.8	[2.30-10.0]	Affymetrix [312230]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	10q26.13	10	121577821	FGFR2	FGFR2			2263			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.42	4E-31	30.397940008672037		1.43	[1.35-1.53]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	3E-15	14.522878745280337		1.3	[1.22-1.39]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	5q11.2	5	56736057	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-C	rs889312	0	889312	regulatory_region_variant	1	0.28	5E-9	8.301029995663981		1.22	[1.14-1.30]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	8q24.21	8	127375606	intergenic	CASC21, CASC8			103021164, 727677			rs1562430-T	rs1562430	0	1562430	intron_variant	0	0.58	6E-7	6.221848749616356		1.17	[1.10-1.25]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	2q35	2	217041109	intergenic	LOC101928278, LOC105373874			101928278, 105373874			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.49	2E-10	9.698970004336019		1.21	[1.14-1.29]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	11p15.5	11	1920716	LSP1	TNNT3			7140			rs909116-T	rs909116	0	909116	intron_variant	0	0.53	7E-7	6.154901959985743		1.17	[1.10-1.24]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	6q25.1	6	151592978	ESR1, C6orf97	CCDC170			80129			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.07	3E-6	5.522878745280337		1.3	[1.17-1.46]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	3p24.1	3	27374522	SLC4A7	SLC4A7			9497			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	6E-7	6.221848749616356		1.16	[1.10-1.24]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	9p21.3	9	22062135	CDKN2A, CDKN2B	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.17	3E-8	7.522878745280337		1.09	[1.04-1.14]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	10p15.1	10	5844771	ANKRD16, FBXO18	GDI2 - TRV-TAC3-1	2665	100189342		31222	8940	rs2380205-C	rs2380205	0	2380205	upstream_gene_variant	1	0.57	5E-7	6.301029995663981		1.06	[1.02-1.10]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-G	rs10995190	0	10995190	intron_variant	0	0.85	5E-15	14.301029995663981		1.16	[1.10-1.22]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	10q22.3	10	79081391	ZMIZ1	ZMIZ1			57178			rs704010-A	rs704010	0	704010	intron_variant	0	0.39	4E-9	8.397940008672037		1.07	[1.03-1.11]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	11q13.3	11	69513996	FGF3, MYEOV, CCND1, ORAOV1, FGF19, FGF4	LINC01488 - CCND1	101928292	595		20453	127109	rs614367-T	rs614367	0	614367	intergenic_variant	1	0.15	3E-15	14.522878745280337		1.15	[1.10-1.20]	Illumina [582886]	N
2012-10-13	22923054	Chen F	2012-08-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22923054	A genome-wide association study of breast cancer in women of African ancestry.	Breast cancer	3,016 African American cases, 2,745 African American controls	3,533 African ancestry cases, 11,046 African ancestry controls	14q31.3	14	87829256	GALC	LOC105370611 - GALC	105370611	2581		173962	103758	rs4322600-G	rs4322600	0	4322600	intron_variant	1	0.78	4E-6	5.3979400086720375		1.18	[1.10-1.27]	Illumina [2067098] (imputed)	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.321	5E-12	11.301029995663981		1.15	[1.11-1.20]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	6q14.1	6	81483392	intergenic	LOC105377871			105377871			rs17530068-C	rs17530068	0	17530068	intergenic_variant	0	0.237	3E-6	5.522878745280337		1.09	[1.05-1.13]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	6q25.1	6	151627231	ESR1	CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-A	rs2046210	0	2046210	intergenic_variant	1	0.423	5E-16	15.301029995663981		1.15	[1.11-1.19]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-G	rs10995190	0	10995190	intron_variant	0	0.846	1E-7	7.0		1.12	[1.08-1.18]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-T	rs10771399	0	10771399	intergenic_variant	1	0.895	2E-12	11.698970004336019		1.2	[1.15-1.27]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.267	6E-13	12.221848749616356		1.14	[1.10-1.18]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	19p13.11	19	17278895	MERIT40	BABAM1			29086			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.191	9E-13	12.045757490560675		1.15	[1.11-1.20]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	1p36.22	1	10506158	PEX14	PEX14			5195			rs616488-A	rs616488	0	616488	intron_variant	0	0.665	1E-8	8.0		1.1	[1.06-1.14]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	5q33.3	5	158817075	EBF1	EBF1			1879			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.435	7E-6	5.154901959985743		1.08	[1.04-1.11]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	12q22	12	95633983	NTN4	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-A	rs17356907	0	17356907	intron_variant	1	0.702	9E-6	5.045757490560675		1.09	[1.04-1.12]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	13q13.1	13	32398489	BRCA2, N4BP2L1	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.496	6E-6	5.221848749616356		1.52	[1.31-1.77]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	16q12.2	16	53779455	FTO, MIR1972-2	FTO			79068			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.526	6E-7	6.221848749616356		1.09	[1.05-1.12]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	22q13.1	22	40480230	MKL1	MKL1			57591			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.107	2E-6	5.698970004336019		1.14	[1.08-1.20]	Illumina [NR]	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	1q32.1	1	204546897	MDM4	MDM4			4194			rs2290854-A	rs2290854	0	2290854	intron_variant	0	0.31	1E-7	7.0		1.13	[1.08-1.18]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	10q25.2	10	112974337	TCF7L2	TCF7L2			6934			rs11196174-G	rs11196174	0	11196174	intron_variant	0	0.28	8E-7	6.096910013008056		1.13	[1.07-1.18]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	7p21.3	7	8512984	NR	NXPH1			30010			rs765855-?	rs765855	0	765855	intron_variant	0		4E-6	5.3979400086720375				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	19p13.11	19	17278895	intergenic	BABAM1			29086			rs8170-G	rs8170	0	8170	synonymous_variant	0	0.48	4E-13	12.397940008672037		1.19	[1.14-1.25]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	6q25.1	6	151627231	intergenic	CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-C	rs2046210	0	2046210	intergenic_variant	1	0.08	5E-9	8.301029995663981		1.28	[1.18-1.39]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	12p11.22	12	28002147	intergenic	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.86	8E-6	5.096910013008056		1.18	[1.1-1.27]	Illumina [2568349] (imputed)	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	10q22.3	10	79295869		ZMIZ1			57178			rs12355688-T	rs12355688	0	12355688	non_coding_transcript_exon_variant	0	0.22	6E-6	5.221848749616356		1.24	[1.13-1.36]	Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	1p36.23	1;1	8326670;8335500		SLC45A1; SLC45A1						rs9628987-?; rs7535752-?	rs9628987; rs7535752	0		intron_variant; missense_variant		NR	5E-6	5.301029995663981				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	3p26.1	3;3	7220327;7242282		GRM7; GRM7						rs6797852-?; rs1810320-?	rs6797852; rs1810320	0		intron_variant; intron_variant		NR	3E-6	5.522878745280337				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	4q27	4;4	121185138;121205653		TNIP3; TNIP3						rs17051310-?; rs13116936-?	rs17051310; rs13116936	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	4q27	4;4	121215608;121189820		TNIP3; TNIP3						rs4455437-?; rs921551-?	rs4455437; rs921551	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	4q27	4;4	121222509;121200339		TNIP3; TNIP3						rs6835704-?; rs17435444-?	rs6835704; rs17435444	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	5p15.32	5;5	5320143;5324870		ADAMTS16; LOC101929200; LOC101929200						rs3806872-?; rs16875333-?	rs3806872; rs16875333	0		3_prime_UTR_variant; downstream_gene_variant		NR	3E-6	5.522878745280337				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	12q22	12;12	94138989;94149730		LOC105369913 - LOC441644; PLXNC1						rs11613298-?; rs2230754-?	rs11613298; rs2230754	0		upstream_gene_variant; synonymous_variant		NR	5E-6	5.301029995663981				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	17q23.2	17;17	61319088;61314018		BCAS3; BCAS3						rs10853029-?; rs3785856-?	rs10853029; rs3785856	0		intron_variant; intron_variant		NR	8E-6	5.096910013008056	(Haplotype-?????)			Illumina [1006480]	N
2012-11-06	22951594	Elgazzar S	2012-09-06	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22951594	A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.	Breast cancer	1,086 Japanese ancestry cases, 1,816 Japanese ancestry controls	1,653 Japanese ancestry cases, 2,797 Japanese ancestry controls	3q25.1	3	150750021	SIAH2	SIAH2			6478			rs6788895-G	rs6788895	0	6788895	intron_variant	0	0.65	9E-8	7.045757490560675		1.22	[1.13-1.31]	Illumina [453627]	N
2012-11-06	22951594	Elgazzar S	2012-09-06	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22951594	A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.	Breast cancer	1,086 Japanese ancestry cases, 1,816 Japanese ancestry controls	1,653 Japanese ancestry cases, 2,797 Japanese ancestry controls	10q26.13	10	121573063	FGFR2	FGFR2			2263			rs3750817-T	rs3750817	0	3750817	intron_variant	0	0.49	8E-8	7.096910013008056		1.22	[NR]	Illumina [453627]	N
2012-12-02	23001122	Orr N	2012-09-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	823 European ancestry cases, 2,795 European ancestry controls	438 European ancestry cases, 474 European ancestry controls	1p31.1	1	84156830	PRKACB	PRKACB, LOC107985046			5567, 107985046			rs903263-?	rs903263	0	903263	intron_variant	0	NR	1E-6	6.0		1.27	[1.10-1.34]	Illumina [447760]	N
2012-12-02	23001122	Orr N	2012-09-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	823 European ancestry cases, 2,795 European ancestry controls	438 European ancestry cases, 474 European ancestry controls	14q24.1	14	68232877	RAD51B	RAD51B			5890			rs1314913-?	rs1314913	0	1314913	intron_variant	0	NR	3E-13	12.522878745280337		1.57	[1.39-1.77]	Illumina [447760]	N
2012-12-02	23001122	Orr N	2012-09-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	823 European ancestry cases, 2,795 European ancestry controls	438 European ancestry cases, 474 European ancestry controls	16q12.1	16	52552429	LOC643174, TOX3	CASC16			643714			rs3803662-?	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	NR	4E-15	14.397940008672037		1.5	[1.35-1.66]	Illumina [447760]	N
2013-04-24	23354978	Rinella ES	2013-01-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls	203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols	6p22.3	6	19443704	intergenic	RNA5SP205 - LOC105374960	100873466	105374960		5286	6117	rs16882214-?	rs16882214	0	16882214	intron_variant	1	0.81	2E-6	5.698970004336019	(Meta P value)	1.43	[NR]	Affymetrix [435632]	N
2013-04-24	23354978	Rinella ES	2013-01-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls	203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols	15q24.3	15	77977130	intergenic	ADAMTS7P3			400406			rs12906542-?	rs12906542	0	12906542	intron_variant	0	0.93	7E-7	6.154901959985743	(Meta P value)	2.0	[NR]	Affymetrix [435632]	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	8q24.21	8	127401060	MYC	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.5	1E-11	11.0		1.13	[1.09-1.18]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	11q23.1	11	111300984	intergenic	COLCA1, COLCA2			399948, 120376			rs3802842-?	rs3802842	0	3802842	intron_variant	0	0.29	4E-7	6.3979400086720375		1.11	[1.06-1.15]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	15q13.3	15	32702555	CRAC1, HMPS, GREM1	SCG5 - GREM1	6447	26585		5458	15385	rs4779584-?	rs4779584	0	4779584	intergenic_variant	1	0.18	5E-7	6.301029995663981		1.12	[1.08-1.19]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	18q21.1	18	48927093	SMAD7	SMAD7			4092			rs4939827-?	rs4939827	0	4939827	intron_variant	0	0.52	2E-10	9.698970004336019		1.12	[1.09-1.16]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	20p12.3	20	6718948	BMP2	CASC20 - LOC105372516	101929244	105372516		190489	11799	rs4813802-G	rs4813802	0	4813802	intergenic_variant	1	0.34	7E-6	5.154901959985743		1.1	[1.05-1.14]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	2q32.3	2	191722478	NABP1	LOC105747689 - LOC105373811	105747689	105373811		12009	13687	rs11903757-C	rs11903757	0	11903757	intergenic_variant	1	0.16	4E-8	7.3979400086720375		1.16	[1.10-1.22]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	1q25.3	1	183112059	LAMC1	LAMC1			3915			rs10911251-A	rs10911251	0	10911251	intron_variant	0	0.57	9E-8	7.045757490560675		1.09	[1.06-1.13]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	12p13.32	12	4279105	CCND2	CCND2			894			rs3217810-T	rs3217810	0	3217810	intron_variant	0	0.16	6E-8	7.221848749616356		1.2	[1.12-1.28]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	12p13.32	12	4296223	CCND2	CCND2			894			rs3217901-G	rs3217901	0	3217901	intron_variant	0	0.41	3E-7	6.522878745280337		1.1	[1.06-1.14]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	12q24.21	12	114678547	TBX3	TBX3			6926			rs59336-T	rs59336	0	59336	intron_variant	0	0.48	4E-7	6.3979400086720375		1.09	[1.06-1.13]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	1q23.3	1	162851501	C1orf110	C1orf110			339512			rs1912453-?	rs1912453	0	1912453	3_prime_UTR_variant	0	0.41	9E-6	5.045757490560675		1.07	[1.04-1.11]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	4q22.2	4	93965880	intergenic	ATOH1 - LOC101929210	474	101929210		135889	151940	rs13130787-?	rs13130787	0	13130787	intergenic_variant	1	0.43	3E-7	6.522878745280337		1.09	[1.06-1.13]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	6q22.1	6	117498194	DCBLD1, GOPC	DCBLD1			285761			rs2057314-?	rs2057314	0	2057314	intron_variant	0	0.50	3E-6	5.522878745280337		1.08	[1.04-1.11]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	8q24.21	8	129807793	intergenic	GSDMC - FAM49B	56169	51571		20905	31800	rs2128382-?	rs2128382	0	2128382	intergenic_variant	1	0.82	8E-6	5.096910013008056		1.11	[1.06-1.16]	Affymetrix, Illumina [2708280] (imputed)	N
2013-02-19	23266556	Peters U	2012-12-21	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/23266556	Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.	Colorectal cancer	12,696 European ancestry colorectal tumor cases, 15,113 European ancestry controls	958 European ancestry colorectal tumor cases, 909 European ancestry controls, up to 2,098 East Asian ancestry colorectal tumor cases, up to 5,749 East Asian ancestry controls	14q23.1	14	58722643	intergenic	DACT1 - LOC102723725	51339	102723725		74322	26107	rs17094983-?	rs17094983	0	17094983	regulatory_region_variant	1	0.13	3E-6	5.522878745280337		1.13	[1.08-1.20]	Affymetrix, Illumina [2708280] (imputed)	N
2015-05-16	25327703	Fejerman L	2014-10-20	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25327703	Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.	Breast cancer	1,497 Latino cases, 3,213 Latino controls	1,643 Latino cases, 4,971 Latino controls	6q25.1	6	151633699	ESR1	CCDC170 - ESR1	80129	2099		12506	20449	rs140068132-A	rs140068132	0	140068132	intergenic_variant	1	0.93	9E-18	17.045757490560675		1.67	[1.49-1.89]	Affymetrix, Illumina [7229558] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		5q13.3	5	76143375	SV2C	SV2C			22987			rs6453204-?	rs6453204	0	6453204	intron_variant	0	NR	6E-8	7.221848749616356		3.3	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		5q13.3	5	76143375	SV2C	SV2C			22987			rs6453204-?	rs6453204	0	6453204	intron_variant	0	NR	5E-8	7.301029995663981		2.2	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		22q13.31	22	44080184	PARVB	PARVB			29780			rs130318-?	rs130318	0	130318	intron_variant	0	NR	4E-6	5.3979400086720375		1.72	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		11q24.1	11	123393934	intergenic	GRAMD1B			57476			rs1943466-?	rs1943466	0	1943466	intron_variant	0	NR	1E-6	6.0		1.82	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		22q13.31	22	44080184	PARVB	PARVB			29780			rs130318-?	rs130318	0	130318	intron_variant	0	NR	4E-7	6.3979400086720375		1.7	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		11q24.1	11	123393934	intergenic	GRAMD1B			57476			rs1943466-?	rs1943466	0	1943466	intron_variant	0	NR	6E-7	6.221848749616356		1.69	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		2q14.2	2	119990995	intergenic	PTPN4 - RPL27P7	5775	100129234		6096	2173	rs11685222-?	rs11685222	0	11685222	downstream_gene_variant	1	NR	4E-6	5.3979400086720375		1.98	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		2p24.2	2	18106253	intergenic	KCNS3 - LOC105373451	3790	105373451		173292	161785	rs12467348-?	rs12467348	0	12467348	intron_variant	1	NR	9E-6	5.045757490560675		2.05	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		3p24.1	3	30677040	TGFBR2	TGFBR2			7048			rs3773651-?	rs3773651	0	3773651	intron_variant	0	NR	7E-6	5.154901959985743		2.15	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		12p12.3	12	19774866	intergenic	RNU1-146P - LOC105369682	106480198	105369682		50267	68881	rs2731620-?	rs2731620	0	2731620	upstream_gene_variant	1	NR	7E-6	5.154901959985743		1.59	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		5q35.2	5	174280232	intergenic	LOC105377737 - LINC01411	105377737	101928176		36731	56122	rs6878584-?	rs6878584	0	6878584	intergenic_variant	1	NR	7E-6	5.154901959985743		2.27	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		6q24.2	6	143412439	intergenic	LOC100288558 - ADAT2	100288558	134637		22901	10393	rs2496589-?	rs2496589	0	2496589	intergenic_variant	1	NR	5E-6	5.301029995663981		1.7	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		8p23.1	8	10403043	MSRA	MSRA			4482			rs1962073-?	rs1962073	0	1962073	intron_variant	0	NR	2E-6	5.698970004336019		1.69	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		8p23.1	8	9932039	intergenic	MIR124-1 - LOC105379235	406907	105379235		28567	51270	rs11786541-?	rs11786541	0	11786541	intergenic_variant	1	NR	2E-6	5.698970004336019		1.65	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		10p15.1	10	6195193	PFKFB3	PFKFB3			5209			rs11257188-?	rs11257188	0	11257188	intron_variant	0	NR	9E-6	5.045757490560675		2.19	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		11q21	11	96198321	MAML2	MAML2			84441			rs479825-?	rs479825	0	479825	intron_variant	0	NR	6E-6	5.221848749616356		1.64	[NR]	Illumina [up to 810372] (imputed)	N
2015-05-16	25327703	Fejerman L	2014-10-20	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25327703	Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.	Breast cancer	1,497 Latino cases, 3,213 Latino controls	1,643 Latino cases, 4,971 Latino controls	16q12.1	16	52565276	TOX3	CASC16			643714			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.31	3E-9	8.522878745280337		1.38	[1.24-1.54]	Affymetrix, Illumina [7229558] (imputed)	N
2015-09-22	25526632	Rafiq S	2014-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	1,341 European ancestry cases	1,523 European ancestry cases	10p14	10	11806793	C10orf47, ECHDC3	LOC105376415 - PROSER2	105376415	254427		21461	16548	rs12358475-?	rs12358475	0	12358475	intergenic_variant	1	NR	2E-6	5.698970004336019		1.33	[1.19-1.49]	Illumina [6500000] (imputed)	N
2015-09-22	25526632	Rafiq S	2014-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	1,341 European ancestry cases	1,523 European ancestry cases	16q24.1	16	86400840	LOC732275, FOXF1	LINC00917 - LOC401864	732275	401864		55161	34004	rs1728400-?	rs1728400	0	1728400	intergenic_variant	1	NR	6E-6	5.221848749616356		1.25	[1.13-1.39]	Illumina [6500000] (imputed)	N
2015-09-22	25526632	Rafiq S	2014-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	1,341 European ancestry cases	1,523 European ancestry cases	5q14.3	5	91979496	ARRDC3	PCBP2P3 - LOC105379080	100131236	105379080		134968	347656	rs421379-?	rs421379	0	421379	intergenic_variant	1	NR	1E-6	6.0		1.49	[1.27-1.75]	Illumina [6500000] (imputed)	N
2016-02-05	25867717	Song N	2015-04-13	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25867717	Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes.	Disease-free survival in breast cancer	1,732 Korean ancestry cases	1,494 Korean ancestry cases	15q25.1	15	79777420	MTHFS	RPS12P25 - RNU6-667P	646985	106479862		25371	39929	rs166870-T	rs166870	0	166870	intergenic_variant	1	0.13	3E-7	6.522878745280337	(HR+ HER2-)	2.3	[1.67-3.15]	Affymetrix [2210580] (imputed)	N
2016-02-05	25867717	Song N	2015-04-13	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25867717	Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes.	Disease-free survival in breast cancer	1,732 Korean ancestry cases	1,494 Korean ancestry cases	10q21.1	10	53506471	PCDH15	RNA5SP318 - PCDH15	100873584	65217		48183	296300	rs10825036-G	rs10825036	0	10825036	intergenic_variant	1	0.32	4E-7	6.3979400086720375	(HR- HER2-)	2.26	[1.34-3.81]	Affymetrix [2210580] (imputed)	N
2016-07-20	26222057	Pander J	2015-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26222057	Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer.	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	256 cases treated with CAPOX-B plus cetuximab, 264 cases treated with CAPOX-B	NA	8p23.1	8	6781719	intergenic	AGPAT5 - LOC107986909	55326	107986909		20216	23295	rs2936519-A	rs2936519	0	2936519	intergenic_variant	1	NR	2E-7	6.698970004336019		1.8867927	[1.49-2.33]	Illumina [2850023] (imputed)	N
2016-07-20	26222057	Pander J	2015-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26222057	Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer.	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	256 cases treated with CAPOX-B plus cetuximab, 264 cases treated with CAPOX-B	NA	6p21.1	6	41053183	intergenic	TSPO2 - APOBEC2	222642	10930		8846	18	rs2073016-T	rs2073016	0	2073016	intron_variant	1	NR	4E-6	5.3979400086720375		1.62	[1.31-2]	Illumina [2850023] (imputed)	N
2016-07-20	26222057	Pander J	2015-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26222057	Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer.	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	256 cases treated with CAPOX-B plus cetuximab, 264 cases treated with CAPOX-B	NA	2q21.1	2	130967332	ARHGEF4	POTEI, ARHGEF4			653269, 50649			rs4377367-C	rs4377367	0	4377367	intron_variant	0	NR	6E-6	5.221848749616356		1.5873016	[1.32-1.92]	Illumina [2850023] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50851341	KLK3	LOC105372441 - KLK3	105372441	354		198	3574	rs2659124-T	rs2659124	0	2659124	upstream_gene_variant	1	0.854	1E-13	13.0		1.18	[1.13-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127119564	NR	PRNCR1 - LOC105375752	101867536	105375752		26969	20494	rs116041037-A	rs116041037	0	116041037	intergenic_variant	1	1.0E-4	6E-10	9.221848749616356	(African American)	2.67	[1.96-3.64]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127064901	NR	LOC105375751 - PCAT2	105375751	103164619		15450	7793	rs77541621-A	rs77541621	0	77541621	intergenic_variant	1	0.022	2E-26	25.69897000433602	(conditioned, EA)	2.0408163	[1.79-2.33]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127091724	NR	PRNCR1			101867536			rs72725879-T	rs72725879	0	72725879	non_coding_transcript_exon_variant	0	0.667	3E-8	7.522878745280337	(conditioned, East Asian)	1.92	[1.54-2.44]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - LOC105375754	727677	105375754		37305	145095	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1	0.14	9E-7	6.045757490560675	(East Asian)	1.83	[1.44-2.33]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q22.1	6	116888889	NR	RFX6			222546			rs339331-T	rs339331	0	339331	intron_variant	0	0.71	1E-6	6.0	(European)	1.13	[1.07-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.12	12	49282227	NR	TUBA1C - LOC101927267	84790	101927267		8889	10404	rs10875943-C	rs10875943	0	10875943	intergenic_variant	1	0.29	2E-6	5.698970004336019	(European)	1.12	[1.07-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50861367	NR	KLK3 - KLK2	354	3817		603	12066	rs2735839-G	rs2735839	0	2735839	upstream_gene_variant	1	0.85	2E-8	7.698970004336019	(European)	1.2	[1.13-1.28]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	1q21.3	1	150685811	NR	GOLPH3L			55204			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.21	1E-6	6.0	(European)	1.14	[1.08-1.20]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85567174	NR	GGCX - RN7SL126P	2677	106479268		5640	488	rs10187424-A	rs10187424	0	10187424	intron_variant	1	0.58	5E-6	5.301029995663981	(European)	1.11	[1.06-1.16]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27936944	NR	JAZF1			221895			rs10486567-G	rs10486567	0	10486567	intron_variant	0	0.77	3E-9	8.522878745280337	(European)	1.17	[1.11-1.23]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23668950	NR	LOC107986930			107986930			rs1512268-A	rs1512268	0	1512268	intergenic_variant	0	0.43	2E-12	11.698970004336019	(European)	1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	126999692	NR	LOC105375751			105375751			rs10086908-T	rs10086908	0	10086908	intron_variant	0	0.71	2E-10	9.698970004336019	(European)	1.17	[1.12-1.23]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127081052	NR	PRNCR1, PCAT2			101867536, 103164619			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0	0.21	5E-21	20.30102999566398	(European)	1.28	[1.21-1.34]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127094635	NR	PRNCR1 - LOC105375752	101867536	105375752		2040	45423	rs6983561-C	rs6983561	0	6983561	downstream_gene_variant	1	0.035	5E-19	18.30102999566398	(European)	1.61	[1.45-1.78]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127328663	NR	CASC8, CASC21			727677, 103021164			rs16902104-T	rs16902104	0	16902104	intron_variant	0	0.14	5E-10	9.301029995663981	(European)	1.21	[1.14-1.28]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127401060	NR	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.51	3E-24	23.522878745280337	(European)	1.25	[1.20-1.31]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - LOC105375754	727677	105375754		37305	145095	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1	0.099	2E-40	39.69897000433602	(European)	1.56	[1.46-1.67]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69227200	NR	LOC105369366 - LOC105369367	105369366	105369367		49193	1549	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1	0.52	8E-18	17.096910013008056	(European)	1.21	[1.16-1.26]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.13	12	52880120	NR	KRT78 - RPL7P41	196374	100271222		31126	5639	rs902774-A	rs902774	0	902774	TF_binding_site_variant	1	0.15	1E-7	7.0	(European)	1.17	[1.11-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37741165	NR	HNF1B			6928			rs7501939-C	rs7501939	0	7501939	intron_variant	0	0.6	1E-14	14.0	(European)	1.19	[1.14-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71112612	NR	CASC17			101928165			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.48	8E-9	8.096910013008056	(European)	1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	22q13.2	22	43104206	NR	RPS25P10 - BIK	100271372	638		11618	6542	rs5759167-G	rs5759167	0	5759167	regulatory_region_variant	1	0.51	5E-9	8.301029995663981	(European)	1.14	[1.09-1.19]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	10q11.22	10	46046326	NR	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.4	3E-18	17.522878745280337	(European)	1.21	[1.16-1.26]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37714971	NR	LOC105371754, HNF1B			105371754, 6928			rs11649743-G	rs11649743	0	11649743	intron_variant	0	0.81	1E-6	6.0	(European)	1.15	[1.09-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85578945	NR	VAMP8			8673			rs3731827-T	rs3731827	0	3731827	intron_variant	0	0.584	1E-9	9.0		1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27937744	NR	JAZF1			221895			rs7808935-T	rs7808935	0	7808935	intron_variant	0	0.766	3E-11	10.522878745280337		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23649749	NR	FAM60DP - LOC107986930	646721	107986930		14110	4795	rs142463603-A	rs142463603	1	13279749	regulatory_region_variant	1	0.417	4E-16	15.397940008672037		1.18	[1.13-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - LOC105375754	727677	105375754		37305	145095	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1	0.099	4E-45	44.39794000867204		1.54	[1.45-1.63]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	10q11.22	10	46046326	NR	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.401	7E-21	20.154901959985743		1.21	[1.16-1.25]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69244226	NR	LOC105369367 - LOC105369368	105369367	105369368		9290	3775	rs376592364-T	rs376592364	0	376592364	intergenic_variant	1	0.52	6E-20	19.221848749616356		1.2	[1.16-1.25]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls				NR							12:49672714-G	12:49672714	0			1	0.254	8E-9	8.096910013008056		1.14	[1.09-1.19]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls				NR							12:53309584-A	12:53309584	0			1	0.122	2E-14	13.698970004336019		1.25	[1.18-1.33]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37743574	NR	HNF1B			6928			rs11263763-A	rs11263763	0	11263763	intron_variant	0	0.519	5E-24	23.30102999566398		1.22	[1.18-1.28]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71111532	NR	CASC17			101928165			rs8071558-C	rs8071558	0	8071558	intron_variant	0	0.483	7E-11	10.154901959985743		1.14	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	22q13.2	22	43104206	NR	RPS25P10 - BIK	100271372	638		11618	6542	rs5759167-G	rs5759167	0	5759167	regulatory_region_variant	1	0.505	2E-9	8.698970004336019		1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69227200	NR	LOC105369366 - LOC105369367	105369366	105369367		49193	1549	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1	0.52	5E-19	18.30102999566398		1.2	[1.15-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.13	12	52880120	NR	KRT78 - RPL7P41	196374	100271222		31126	5639	rs902774-A	rs902774	0	902774	TF_binding_site_variant	1	0.15	9E-8	7.045757490560675		1.16	[1.10-1.23]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37741165	NR	HNF1B			6928			rs7501939-C	rs7501939	0	7501939	intron_variant	0	0.6	4E-15	14.397940008672037		1.17	[1.13-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71112612	NR	CASC17			101928165			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.48	2E-9	8.698970004336019		1.13	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q22.1	6	116888889	NR	RFX6			222546			rs339331-T	rs339331	0	339331	intron_variant	0	0.71	6E-7	6.221848749616356		1.12	[1.07-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27936944	NR	JAZF1			221895			rs10486567-G	rs10486567	0	10486567	intron_variant	0	0.77	3E-11	10.522878745280337		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23668950	NR	LOC107986930			107986930			rs1512268-A	rs1512268	0	1512268	intergenic_variant	0	0.43	4E-15	14.397940008672037		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127328663	NR	CASC8, CASC21			727677, 103021164			rs16902104-T	rs16902104	0	16902104	intron_variant	0	0.14	1E-9	9.0		1.18	[1.12-1.25]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	1q21.3	1	150685811	NR	GOLPH3L			55204			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.21	9E-6	5.045757490560675		1.12	[1.06-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85567174	NR	GGCX - RN7SL126P	2677	106479268		5640	488	rs10187424-A	rs10187424	0	10187424	intron_variant	1	0.58	3E-9	8.522878745280337		1.13	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	4q24	4	105140377	NR	LOC100288146 - TET2	100288146	54790		36383	5498	rs7679673-C	rs7679673	0	7679673	intron_variant	1	0.59	5E-8	7.301029995663981		1.12	[1.07-1.16]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	126999692	NR	LOC105375751			105375751			rs10086908-T	rs10086908	0	10086908	intron_variant	0	0.71	2E-12	11.698970004336019		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127081052	NR	PRNCR1, PCAT2			101867536, 103164619			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0	0.21	6E-21	20.221848749616356		1.25	[1.19-1.30]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127082911	NR	PRNCR1			101867536			rs13252298-A	rs13252298	0	13252298	non_coding_transcript_exon_variant	0	0.71	2E-6	5.698970004336019		1.11	[1.06-1.16]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127094635	NR	PRNCR1 - LOC105375752	101867536	105375752		2040	45423	rs6983561-C	rs6983561	0	6983561	downstream_gene_variant	1	0.035	6E-22	21.221848749616356		1.45	[1.34-1.56]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127401060	NR	CCAT2, CASC8			101805488, 727677			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.51	3E-27	26.522878745280337		1.25	[1.20-1.30]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.12	12	49282227	NR	TUBA1C - LOC101927267	84790	101927267		8889	10404	rs10875943-C	rs10875943	0	10875943	intergenic_variant	1	0.29	7E-8	7.154901959985743		1.12	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37714971	NR	LOC105371754, HNF1B			105371754, 6928			rs11649743-G	rs11649743	0	11649743	intron_variant	0	0.81	6E-7	6.221848749616356		1.14	[1.08-1.20]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50861367	NR	KLK3 - KLK2	354	3817		603	12066	rs2735839-G	rs2735839	0	2735839	upstream_gene_variant	1	0.85	6E-9	8.221848749616356		1.17	[1.11-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q25.3	6	160160512	SLC22A2, SLC22A1	SLC22A1 - SLC22A2	6580	6582		1311	56250	rs4646284-TG	rs4646284	0	4646284	downstream_gene_variant	1	0.298	1E-19	19.0		1.18	[1.14-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q25.3	6	160412632	SLC22A3	SLC22A3			6581			rs9364554-T	rs9364554	0	9364554	intron_variant	0	0.279	6E-12	11.221848749616356		1.14	[1.10-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-20	26222057	Pander J	2015-07-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26222057	Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer.	Progression free survival in metastatic colorectal cancer (treatment interaction)	256 cases treated with CAPOX-B plus cetuximab, 264 cases treated with CAPOX-B	NA	2q11.2	2	98688331	GnT-IVa	MGAT4A			11320			rs885036-A	rs885036	0	885036	intron_variant	0		2E-8	7.698970004336019		2.13	[1.64-2.78]	Illumina [2850023] (imputed)	N
2013-04-24	23354978	Rinella ES	2013-01-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls	203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols	10q26.13	10	121579461	FGFR2	FGFR2			2263			rs1078806-C	rs1078806	0	1078806	intron_variant	0	0.39	2E-6	5.698970004336019	(Pooled P value)	1.43	[NR]	Affymetrix [435632]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	1p36.23	1;1;1;1;1	8335381;8335500;8326670;8334176;8330828	SLC45A1	SLC45A1; SLC45A1; SLC45A1; SLC45A1; SLC45A1						rs2305016-?; rs7535752-?; rs9628987-?; rs12711517-?; rs2289731-?	rs2305016; rs7535752; rs9628987; rs12711517; rs2289731	0		intron_variant; missense_variant; intron_variant; intron_variant; synonymous_variant		NR	5E-6	5.301029995663981		1.23	[1.12-1.35]	Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	4q27	4;4	121200339;121205653	TNIP3	TNIP3; TNIP3						rs17435444-A; rs13116936-G	rs17435444; rs13116936	0		intron_variant; intron_variant		0.64	3E-7	6.522878745280337		1.23	[1.13-1.33]	Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	10p15.1	10;10;10	5630056;5628312;5623811		LOC107984199; LOC107984199; LOC102723629 - LOC107984199						rs4414128-?; rs2386661-?; rs17141741-?	rs4414128; rs2386661; rs17141741	0		upstream_gene_variant; upstream_gene_variant; upstream_gene_variant		NR	5E-6	5.301029995663981		1.27	[1.14-1.39]	Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	14q24.1	14;14;14;14;14;14	68497029;68506829;68507560;68505059;68500665;68508657		RAD51B; RAD51B; RAD51B; RAD51B; RAD51B; RAD51B						rs765899-?; rs757369-?; rs10132579-?; rs2842347-?; rs737387-?; rs2842346-?	rs765899; rs757369; rs10132579; rs2842347; rs737387; rs2842346	0		intron_variant; intron_variant; intron_variant; intron_variant; intron_variant; intron_variant		NR	2E-6	5.698970004336019		1.67	[1.35-2.08]	Illumina [1006480]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	1q32.1	1	204549714	LRRN2, PIK3C2B, MDM4	MDM4			4194			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.26	2E-12	11.698970004336019		1.14	[1.10-1.18]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	1q32.1	1	202218048	LGR6, UBE2T, PTPN7	LGR6			59352			rs6678914-?	rs6678914	0	6678914	intron_variant	0	0.59	1E-8	8.0		1.1	[1.06-1.13]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	2p24.1	2	19121042	intergenic	LOC105373455 - MIR4757	105373455	100616307		54972	227387	rs12710696-?	rs12710696	0	12710696	intron_variant	1	0.36	5E-8	7.301029995663981		1.1	[1.06-1.13]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	16q12.2	16	53821379	FTO, KIAA1752	FTO			79068			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	4E-8	7.3979400086720375		1.11	[1.07-1.15]	Illumina [NR]	N
2014-04-10	24143190	Low SK	2013-10-15	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls	2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls	10q26.13	10	121580797	FGFR2	FGFR2			2263			rs2981578-C	rs2981578	0	2981578	intron_variant	0	0.514	1E-12	12.0		1.225	[1.158-1.296]	Illumina [5335291] (imputed)	N
2014-04-10	24143190	Low SK	2013-10-15	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls	2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls	16q12.2	16	52601088	TOX3, LOC643714	CASC16			643714			rs12922061-T	rs12922061	0	12922061	intron_variant	0	0.241	4E-10	9.397940008672037		1.231	[1.153-1.314]	Illumina [5335291] (imputed)	N
2014-04-10	24143190	Low SK	2013-10-15	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls	2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls	16q12.1	16	52552429	TOX3, LOC643714	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.522	3E-11	10.522878745280337		1.213	[1.146-1.284]	Illumina [5335291] (imputed)	N
2014-04-10	24143190	Low SK	2013-10-15	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls	2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls	12p13.1	12	14257551	ATF7IP	GNAI2P1 - RPL30P11	2772	100271303		2065	99314	rs17221259-G	rs17221259	0	17221259	downstream_gene_variant	1	0.204	7E-6	5.154901959985743		1.252	[1.136-1.381]	Illumina [5335291] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	1p22.3	1	87313534	LMO4	LOC101927844 - LMO4	101927844	8543		62203	14934	rs12118297-G	rs12118297	0	12118297	intergenic_variant	1	0.62	4E-8	7.3979400086720375		1.1	[1.06-1.14]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	21q22.12	21	34738904	LINC00160	LOC107985515			107985515			rs16992204-C	rs16992204	0	16992204	upstream_gene_variant	0	0.12	5E-8	7.301029995663981		1.13	[1.07-1.18]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	6q25.1	6	151592978		CCDC170			80129			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.26	1E-6	6.0		1.15	[1.09-1.22]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	6q25.1	6	151627231		CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-A	rs2046210	0	2046210	intergenic_variant	1	0.35	7E-15	14.154901959985743		1.22	[1.16-1.29]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	10q26.13	10	121577821		FGFR2			2263			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.55	3E-11	10.522878745280337		1.19	[1.11-1.23]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	22q13.1	22	38962032		APOBEC3A			200315			rs12628403-C	rs12628403	0	12628403	intron_variant	0	0.27	4E-6	5.3979400086720375		1.17	[1.09-1.25]	Affymetrix, Illumina [668499] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	1p36.22	1	10503552	PEX14	PEX14			5195			rs10864459-?	rs10864459	0	10864459	intron_variant	0	0.69	5E-10	9.301029995663981		1.0526316	[1.01-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	1q32.1	1	202209914	LGR6	LGR6			59352			rs17489300-?	rs17489300	0	17489300	intron_variant	0	0.61	2E-8	7.698970004336019		1.0309278	[0.99-1.08] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	1q32.1	1	204549714	MDM4	MDM4			4194			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.28	8E-18	17.096910013008056		1.09	[1.05-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2p24.1	2	19121042	Intergenic	LOC105373455 - MIR4757	105373455	100616307		54972	227387	rs12710696-?	rs12710696	0	12710696	intron_variant	1	0.39	2E-6	5.698970004336019		1.01	[0.97-1.05] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2q14.2	2	120330606	INHBB	LOC105373584 - LOC105373989	105373584	105373989		11282	11844	rs11903787-?	rs11903787	0	11903787	downstream_gene_variant	1	0.74	7E-10	9.154901959985743		1.098901	[1.04-1.15] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	5p15.33	5	1279913	TERT	TERT			7015			rs2242652-?	rs2242652	0	2242652	intron_variant	0	0.22	8E-28	27.096910013008056		1.22	[1.16-1.28] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	5p15.33	5	1282204	TERT	TERT			7015			rs7726159-?	rs7726159	0	7726159	intron_variant	0	0.35	3E-8	7.522878745280337		1.07	[1.02-1.11] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	5p15.33	5	1297373	TERT	TERT - MIR4457	7015	100616235		1747	11937	rs2736108-?	rs2736108	0	2736108	upstream_gene_variant	1	0.71	3E-14	13.522878745280337		1.1235955	[1.08-1.16] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	6q25.1	6	151597721	ESR1	CCDC170			80129			rs12662670-?	rs12662670	0	12662670	intron_variant	0	0.09	1E-19	19.0		1.19	[1.11-1.27] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	6q25.1	6	151625017	ESR1	CCDC170 - ESR1	80129	2099		3824	29131	rs11155804-?	rs11155804	0	11155804	downstream_gene_variant	1	0.36	4E-28	27.397940008672037		1.15	[1.11-1.20] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-?	rs10995190	0	10995190	intron_variant	0	0.84	8E-6	5.096910013008056		1.010101	[0.96-1.06] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	10q25.2	10	113023044	TCF7L2	TCF7L2			6934			rs6585202-?	rs6585202	0	6585202	intron_variant	0	0.47	1E-9	9.0		1.1	[1.05-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	11p15.5	11	1880867	LSP1	LSP1			4046			rs4980383-?	rs4980383	0	4980383	non_coding_transcript_exon_variant	0	0.45	9E-9	8.045757490560675		1.07	[1.03-1.11] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	12p11.22	12	28021884	PTHLH	PTHLH - LOC105369710	5744	105369710		47697	39757	rs7297051-?	rs7297051	0	7297051	regulatory_region_variant	1	0.77	3E-20	19.522878745280337		1.1235955	[1.08-1.18] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-?	rs10771399	0	10771399	intergenic_variant	1	0.9	7E-18	17.154901959985743		1.1627907	[1.1-1.25] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	16q12.1	16	52565276	TOX3	CASC16			643714			rs4784227-?	rs4784227	0	4784227	intron_variant	0	0.26	6E-15	14.221848749616356		1.07	[1.02-1.12] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	16q12.2	16	53779455	FTO	FTO			79068			rs17817449-?	rs17817449	0	17817449	intron_variant	0	0.59	5E-8	7.301029995663981		1.0526316	[1.01-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	16q12.2	16	53821379	FTO	FTO			79068			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	2E-6	5.698970004336019		1.01	[0.97-1.06] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	19p13.11	19	17278895	MERIT40	BABAM1			29086			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	7E-21	20.154901959985743		1.17	[1.11-1.23] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	19p13.11	19	17283116	ADHB8	ANKLE1			126549			rs56069439-?	rs56069439	0	56069439	non_coding_transcript_exon_variant	0	0.3	1E-32	32.0		1.19	[1.14-1.24] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2p23.2	2	28896719	WDR43	WDR43			23160			rs67073037-?	rs67073037	0	67073037	intron_variant	0	0.8	5E-9	8.301029995663981		1.0869565	[1.04-1.15] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2q33.1	2	201071148	FAM126B, NDUFB3, CLK1, PPIL3	FAM126B			285172			rs114962751-?	rs114962751	0	114962751	intron_variant	0	0.02	7E-8	7.154901959985743		1.22	[1.05-1.42] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	13q22.1	13	73383544	KLF5, KLF12	RNY1P8 - MARK2P12	100873807	100421565		156284	24245	rs6562760-?	rs6562760	0	6562760	intergenic_variant	1	0.8	5E-10	9.301029995663981		1.1235955	[1.06-1.18] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	13q22.1	13	73232845	KLF12, KLF5	RNY1P8 - MARK2P12	100873807	100421565		5585	174944	rs12870942-?	rs12870942	0	12870942	intergenic_variant	1	0.3	4E-8	7.3979400086720375		1.06	[1.01-1.10] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2q35	2	217431785	NR	DIRC3			729582			rs16857609-?	rs16857609	0	16857609	intron_variant	0	0.26	7E-6	5.154901959985743		1.04	[1.00-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	5q33.3	5	158817075	NR	EBF1			1879			rs1432679-?	rs1432679	0	1432679	intron_variant	0	0.44	2E-6	5.698970004336019		1.04	[1.00-1.08] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	8p11.23	8	37000965	NR	RPL26P25 - LOC105379377	100270966	105379377		12467	65169	rs13365225-?	rs13365225	0	13365225	intergenic_variant	1	0.81	7E-6	5.154901959985743		1.0416667	[0.99-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	11q24.3	11	129591276	NR	RPS27P20 - LINC01395	100271581	101929557		53103	20840	rs11820646-?	rs11820646	0	11820646	upstream_gene_variant	1	0.62	9E-6	5.045757490560675		1.0752687	[1.03-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	12q22	12	95633983	NR	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-?	rs17356907	0	17356907	intron_variant	1	0.71	5E-7	6.301029995663981		1.0526316	[1-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	17q25.3	17	79807926	NR	CBX8 - LOC102723961	57332	102723961		10810	8017	rs745570-?	rs745570	0	745570	intergenic_variant	1	0.51	6E-6	5.221848749616356		1.0416667	[1-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	22q13.1	22	40480230	NR	MKL1			57591			rs6001930-?	rs6001930	0	6001930	intron_variant	0	0.11	2E-6	5.698970004336019		1.07	[1.01-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer	3962 African American cases, 711 African ancestry cases, 4,150 African ancestry controls, 624 African ancestry controls	1,984 African American cases, 2,939 African American controls	3q26.31	3	172550013	TNFSF10	TNFSF10 - LOC105374219	8743	105374219		26506	42844	rs13074711-T	rs13074711	0	13074711	intergenic_variant	1	0.69	2E-6	5.698970004336019		1.14	[1.08-1.21]	Illumina [16147413] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer	3962 African American cases, 711 African ancestry cases, 4,150 African ancestry controls, 624 African ancestry controls	1,984 African American cases, 2,939 African American controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.6	5E-6	5.301029995663981		1.13	[1.07-1.19]	Illumina [16147413] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	10q26.13	10	121586676	NR	FGFR2			2263			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.39	6E-9	8.221848749616356		1.17	[1.11-1.23]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	10q26.13	10	121592803	NR	FGFR2			2263			rs2981582-A	rs2981582	0	2981582	intron_variant	0	0.68	2E-8	7.698970004336019		1.18	[1.11-1.23]	Affymetrix, Illumina [668499] (imputed)	N
2008-06-16	18385738	Hung RJ	2008-04-03	Nature	www.ncbi.nlm.nih.gov/pubmed/18385738	A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.	Lung cancer	1,926 European ance other ancestry cases, 2,522 European and other ancestry controls	332 European ancestry cases, 462 European ancestry controls, 2,181 European and other ancestry cases, 4,290 European and other ancestry controls	15q25.1	15	78513681	CHRNA5, CHRNA3, PSMA4, LOC123688, CHRNB4	HYKK			123688			rs8034191-C	rs8034191	0	8034191	intron_variant	0	0.34	5E-20	19.30102999566398		1.3	[1.23-1.37]	Illumina [310023]	N
2013-01-18	23103227	Jin G	2012-10-25	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23103227	Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	2,331 Han Chinese ancestry lung cancer cases, 1,006 Han Chinese ancestry non-cardia gastric cancer cases, 2,031 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 4,006 Han Chinese ancestry controls	2,665 Han Chinese ancestry lung cancer cases, 3,330 Han Chinese ancestry non-cardia gastric cancer cases, 3,006 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 11,436 Han Chinese ancestry controls	6p21.1	6	40568389	LRFN2	LRFN2			57497			rs2494938-A	rs2494938	0	2494938	intron_variant	0	0.23	5E-9	8.301029995663981	(NCGC)	1.18	[1.12-1.25]	Affymetrix [NR]	N
2013-01-18	23103227	Jin G	2012-10-25	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23103227	Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	2,331 Han Chinese ancestry lung cancer cases, 1,006 Han Chinese ancestry non-cardia gastric cancer cases, 2,031 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 4,006 Han Chinese ancestry controls	2,665 Han Chinese ancestry lung cancer cases, 3,330 Han Chinese ancestry non-cardia gastric cancer cases, 3,006 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 11,436 Han Chinese ancestry controls	7p15.3	7	21544470	SP4, DNAH11	DNAH11			8701			rs2285947-A	rs2285947	0	2285947	intron_variant	0	0.27	1E-6	6.0	(NCGC)	1.14	[1.08-1.21]	Affymetrix [NR]	N
2013-01-18	23103227	Jin G	2012-10-25	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23103227	Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	2,331 Han Chinese ancestry lung cancer cases, 1,006 Han Chinese ancestry non-cardia gastric cancer cases, 2,031 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 4,006 Han Chinese ancestry controls	2,665 Han Chinese ancestry lung cancer cases, 3,330 Han Chinese ancestry non-cardia gastric cancer cases, 3,006 Han Chinese ancestry esophageal squamous-cell carcinoma cases, 11,436 Han Chinese ancestry controls	7p15.3	7	21544470	SP4, DNAH11	DNAH11			8701			rs2285947-A	rs2285947	0	2285947	intron_variant	0	0.27	3E-6	5.522878745280337	(ESCC)	1.14	[1.08-1.21]	Affymetrix [NR]	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	9p22.2	9	16915023	NR	BNC2 - LOC105375983	54796	105375983		44185	99049	rs3814113-?	rs3814113	0	3814113	intergenic_variant	1	0.68	4E-29	28.397940008672037	(All invasive)	1.21	[1.17-1.25]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	9p22.2	9	16915023	NR	BNC2 - LOC105375983	54796	105375983		44185	99049	rs3814113-?	rs3814113	0	3814113	intergenic_variant	1	0.68	4E-32	31.397940008672037	(Serious invasive)	1.28	[1.23-1.33]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q24.21	8	128531703	MYC	LINC00824			101927774			rs10088218-?	rs10088218	0	10088218	intron_variant	0	0.87	3E-12	11.522878745280337	(All invasive)	1.18	[1.13-1.24]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q24.21	8	128531703	NR	LINC00824			101927774			rs10088218-?	rs10088218	0	10088218	intron_variant	0	0.87	1E-17	17.0	(Serious invasive)	1.29	[1.21-1.36]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	2q31.1	2	176177905	NR	HAGLR			401022			rs2072590-?	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	0.32	5E-11	10.301029995663981	(All invasive)	1.11	[1.08-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	2q31.1	2	176177905	NR	HAGLR			401022			rs2072590-?	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	0.32	3E-10	9.522878745280337	(Serious invasive)	1.13	[1.09-1.18]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	3q25.31	3	156689208	NR	TIPARP			25976			rs7651446-?	rs7651446	0	7651446	intron_variant	0	0.05	2E-29	28.69897000433602	(All invasive)	1.44	[1.35-1.54]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	3q25.31	3	156689208	NR	TIPARP			25976			rs7651446-?	rs7651446	0	7651446	intron_variant	0	0.05	2E-34	33.69897000433602	(Serious invasive)	1.59	[1.48-1.71]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	19p13.11	19	17278895	NR	BABAM1			29086			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	2E-7	6.698970004336019	(All invasive)	1.11	[1.07-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	19p13.11	19	17278895	NR	BABAM1			29086			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	3E-14	13.522878745280337	(Serious invasive)	1.19	[1.14-1.25]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q21.32	17	48334138	NR	SKAP1			8631			rs9303542-?	rs9303542	0	9303542	intron_variant	0	0.27	6E-9	8.221848749616356	(All invasive)	1.12	[1.08-1.16]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q21.32	17	48334138	NR	SKAP1			8631			rs9303542-?	rs9303542	0	9303542	intron_variant	0	0.27	3E-10	9.522878745280337	(Serious invasive)	1.14	[1.09-1.18]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q21.13	8	81741409	CHMP4C, FABP5, PMP2, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16, FABP4	CHMP4C			92421			rs11782652-A	rs11782652	0	11782652	intron_variant	0	0.07	6E-9	8.221848749616356	(All invasive)	1.19	[1.12-1.26]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q21.13	8	81741409	CHMP4C, FABP5, PMP2, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16, FABP4	CHMP4C			92421			rs11782652-A	rs11782652	0	11782652	intron_variant	0	0.07	7E-10	9.154901959985743	(Serious invasive)	1.24	[1.16-1.33]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	10p12.31	10	21626690	NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1, MLLT10	MLLT10			8028			rs1243180-T	rs1243180	0	1243180	intron_variant	0	0.31	2E-8	7.698970004336019	(All invasive)	1.1	[1.06-1.13]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	10p12.31	10	21626690	NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1, MLLT10	MLLT10			8028			rs1243180-T	rs1243180	0	1243180	intron_variant	0	0.31	1E-7	7.0	(Serious invasive)	1.11	[1.07-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q12	17	37736525	HNF1B, ACACA, C17orf78, TADA2A, DUSP14, SYNRG, DDX52, TBC1D3F, TBC1D3, MRPL45, GPR179, SOCS7, ARHGAP23	HNF1B			6928			rs757210-G	rs757210	0	757210	intron_variant	0	0.37	8E-10	9.096910013008056	(Serious invasive)	1.12	[1.08-1.17]	Illumina [2508744] (imputed)	N
2011-05-27	21551455	Kanetsky PA	2011-05-06	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21551455	A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility.	Testicular cancer	349 European ancestry cases, 919 European ancestry controls	439 European ancestry cases, 960 European ancestry controls	9p24.3	9	845516	DMRT1	DMRT1			1761			rs7040024-A	rs7040024	0	7040024	intron_variant	0	NR	1E-11	11.0		1.7	[1.46-1.99]	Affymetrix [609482]	N
2011-05-27	21551455	Kanetsky PA	2011-05-06	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21551455	A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility.	Testicular cancer	349 European ancestry cases, 919 European ancestry controls	439 European ancestry cases, 960 European ancestry controls	9p24.3	9	863635	DMRT1	DMRT1			1761			rs755383-T	rs755383	0	755383	intron_variant	0	NR	9E-10	9.045757490560675		1.5	[1.32-1.71]	Affymetrix [609482]	N
2013-09-18	23555189	Chen Z	2013-04-01	Neoplasia	www.ncbi.nlm.nih.gov/pubmed/23555189	Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.	PCA3 expression level	1,371 European ancestry individuals	NA	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.41	1E-9	9.0		1.25	[1.18-1.32] unit increase	Illumina [3076666] (imputed)	N
2013-09-18	23555189	Chen Z	2013-04-01	Neoplasia	www.ncbi.nlm.nih.gov/pubmed/23555189	Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.	PCA3 expression level	1,371 European ancestry individuals	NA	19q13.33	19	50871711	KLK3, KLK2	KLK3 - KLK2	354	3817		10947	1722	rs10424878-A	rs10424878	0	10424878	intron_variant	1	0.40	1E-8	8.0		1.24	[1.17-1.31] unit increase	Illumina [3076666] (imputed)	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	1q22	1	156199819	SLC25A44	SLC25A44			9673			rs2072499-G	rs2072499	0	2072499	non_coding_transcript_exon_variant	0	0.35	3E-8	7.522878745280337		1.19	[1.08-1.30]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	1q24.1	1	165904155	UCK2	UCK2			7371			rs3790672-C	rs3790672	0	3790672	non_coding_transcript_exon_variant	0	0.28	2E-8	7.698970004336019		1.2	[1.09-1.33]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	3p24.3	3	16583541	DAZL	LINC00690 - DAZL	100996597	1618		42168	3251	rs10510452-A	rs10510452	0	10510452	downstream_gene_variant	1	0.69	1E-8	8.0		1.24	[1.12-1.37]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	4q24	4	103133529	CENPE	CENPE			1062			rs2720460-A	rs2720460	0	2720460	intron_variant	0	0.61	2E-10	9.698970004336019		1.24	[1.12-1.36]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	5q31.1	5	135030510	CATSPER3, PITX1	PITX1			5307			rs3805663-T	rs3805663	0	3805663	intron_variant	0	0.63	2E-8	7.698970004336019		1.25	[1.13-1.38]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	8q13.3	8	70064270	PRDM14	PRDM14			63978			rs7010162-G	rs7010162	0	7010162	intron_variant	0	0.61	5E-8	7.301029995663981		1.22	[1.11-1.34]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	16q12.1	16	50109033	HEATR3	HEATR3 - RPL10P14	55027	390729		1765	42186	rs8046148-G	rs8046148	0	8046148	intron_variant	1	0.79	4E-9	8.397940008672037		1.32	[1.17-1.48]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	17q22	17	58555182	RAD51C, TEX14	SEPT4-AS1			101927688			rs9905704-T	rs9905704	0	9905704	intron_variant	0	0.67	3E-9	8.522878745280337		1.21	[1.10-1.34]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	21q22.3	21	46270154	MCM3AP	MCM3AP			8888			rs2839186-T	rs2839186	0	2839186	intron_variant	0	0.46	1E-9	9.0		1.26	[1.15-1.38]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	5p15.33	5	1308437	TERT, CLPTM1L	TERT - MIR4457	7015	100616235		12811	873	rs4635969-T	rs4635969	0	4635969	downstream_gene_variant	1	0.2	5E-24	23.30102999566398		1.39	[1.25-1.54]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	5q31.3	5	142302223	SPRY4	LOC107986455 - SPRY4	107986455	81848		109105	8204	rs4624820-A	rs4624820	0	4624820	intergenic_variant	1	0.54	3E-31	30.522878745280337		1.52	[1.38-1.67]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	6p21.31	6	33574761	BAK1	BAK1			578			rs210138-G	rs210138	0	210138	intron_variant	0	0.19	2E-24	23.69897000433602		1.44	[1.30-1.61]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	9p24.3	9	863635	DMRT1	DMRT1			1761			rs755383-T	rs755383	0	755383	intron_variant	0	0.63	2E-26	25.69897000433602		1.38	[1.25-1.52]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	12p13.1	12	14500933	ATF7IP	ATF7IP			55729			rs2900333-C	rs2900333	0	2900333	3_prime_UTR_variant	0	0.62	1E-13	13.0		1.32	[1.20-1.46]	Illumina [307291]	N
2013-11-09	23666240	Ruark E	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666240	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.	Testicular germ cell tumor	986 European ancestry cases, 4,946 European ancestry controls	1,064 European ancestry cases, 10,082 European ancestry controls	12q21.32	12	88496894	KITLG	KITLG			4254			rs995030-G	rs995030	0	995030	3_prime_UTR_variant	0	0.8	2E-50	49.69897000433602		2.26	[1.95-2.61]	Illumina [307291]	N
2013-09-18	23555189	Chen Z	2013-04-01	Neoplasia	www.ncbi.nlm.nih.gov/pubmed/23555189	Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.	PCA3 expression level	1,371 European ancestry individuals	NA	9p21.2	9	27610659	C9orf72	CTAGE12P			392298			rs2889829-G	rs2889829	0	2889829	non_coding_transcript_exon_variant	0	0.64	2E-7	6.698970004336019		0.82	[0.75-0.89] unit increase	Illumina [3076666] (imputed)	N
2013-09-18	23555189	Chen Z	2013-04-01	Neoplasia	www.ncbi.nlm.nih.gov/pubmed/23555189	Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.	PCA3 expression level	1,371 European ancestry individuals	NA	8q24.23	8	137897476	FLJ45872	LOC401478			401478			rs62531686-C	rs62531686	0	62531686	intron_variant	0	0.3	8E-7	6.096910013008056		0.83	[0.76-0.90] unit increase	Illumina [3076666] (imputed)	N
2011-10-01	21896673	Chen D	2011-09-10	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21896673	Genome-wide association study of HPV seropositivity.	HPV seropositivity	1,286 European ancestry lung cancer cases, 679 European ancestry head and neck cancer cases, 811 European ancestry kidney cancer cases, 2,035 European ancestry controls	1,307 Hispanic head and neck cancer cases, 1,037 Hispanic controls	6p21.32	6	32697183	HLA-DQB1	HLA-DQB1 - MTCO3P1	3119	404026		30494	8961	rs9357152-G	rs9357152	0	9357152	intergenic_variant	1	0.33	1E-14	14.0				Illumina [316015]	N
2011-12-02	22037551	Shi Y	2011-10-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22037551	A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1.	Gastric cancer	1,006 Han Chinese ancestry cases, 2,273 Han Chinese ancestry controls	3,288 Han Chinese ancestry cases, 3,609 Han Chinese ancestry controls	3q13.31	3	114643917	ZBTB20	ZBTB20			26137			rs9841504-?	rs9841504	0	9841504	intron_variant	0	NR	2E-9	8.698970004336019		1.32	[1.20-1.45]	Affymetrix [555896]	N
2011-12-02	22037551	Shi Y	2011-10-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22037551	A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1.	Gastric cancer	1,006 Han Chinese ancestry cases, 2,273 Han Chinese ancestry controls	3,288 Han Chinese ancestry cases, 3,609 Han Chinese ancestry controls	5p13.1	5	40791782	PRKAA1, PTGER4	PRKAA1			5562			rs13361707-?	rs13361707	0	13361707	intron_variant	0	NR	8E-29	28.096910013008056		1.41	[1.32-1.49]	Affymetrix [555896]	N
2013-11-03	20350937	Takahashi M	2010-03-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/20350937	The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.	Thyroid cancer (Papillary, radiation-related)	401 European ancestry cases, 620 European ancestry controls	259 cases, 648 controls	9q22.33	9	97793827	TMOD1, C9orf97, NCBP1, XPA, HEMGN, KRT18P13, FOXE1, C9orf156	KRT18P13 - FOXE1	392371	2304		93026	59428	rs965513-A	rs965513	0	965513	intergenic_variant	1	NR	5E-12	11.301029995663981		1.65	[1.43-1.91]	Illumina [506840]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	20q13.33	20	60847915	intergenic	LOC105372700 - LOC100506470	105372700	100506470		39005	231149	rs4812219-?	rs4812219	0	4812219	intergenic_variant	1		7E-7	6.154901959985743	(overall survival)	3.27	[2.05-5.23]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	20p12.1	20	13248679	ISM1	ISM1, TASP1			140862, 55617			rs6105057-?	rs6105057	0	6105057	intron_variant	0		2E-6	5.698970004336019	(overall survival)	2.2	[1.59-3.04]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	5p12	5	45265666	HCN1	HCN1			348980			rs13180087-?	rs13180087	0	13180087	intron_variant	0		3E-6	5.522878745280337	(overall survival)	2.4	[1.66-3.46]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	Xq28	X	149380542	intergenic	AFF2 - LOC107985667	2334	107985667		379879	90362	rs17325431-?	rs17325431	0	17325431	intergenic_variant	1		3E-6	5.522878745280337	(overall survival)	2.47	[1.69-3.61]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	18q12.1	18	31461771	DSG3	DSG3			1830			rs3794924-?	rs3794924	0	3794924	intron_variant	0		4E-6	5.3979400086720375	(overall survival)	2.37	[1.65-3.43]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	1q31.2	1	192618733	intergenic	LOC105371664, LOC107985241			105371664, 107985241			rs10921219-?	rs10921219	0	10921219	intergenic_variant	0		4E-6	5.3979400086720375	(overall survival)	1.9	[1.44-2.49]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	14q32.2	14	96587587	intergenic	PAPOLA - RN7SKP108	10914	106480866		20471	50706	rs17280262-?	rs17280262	0	17280262	intergenic_variant	1		4E-6	5.3979400086720375	(overall survival)	2.66	[1.75-4.04]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	2q14.1	2	114456179	DPP10	DPP10			57628			rs17048372-?	rs17048372	0	17048372	intron_variant	0		6E-6	5.221848749616356	(overall survival)	2.17	[1.55-3.03]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	22q13.31	22	44200205	PARVG	PARVG			64098			rs139156-?	rs139156	0	139156	intron_variant	0		7E-6	5.154901959985743	(overall survival)	2.76	[1.77-4.29]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	14q32.2	14	96587587	intergenic	PAPOLA - RN7SKP108	10914	106480866		20471	50706	rs17280262-?	rs17280262	0	17280262	intergenic_variant	1		1E-7	7.0	(disease-free survival)	3.02	[2.00-4.55]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	15q13.3	15	33272281	intergenic	TMCO5B - LOC101928134	100652857	101928134		24726	31376	rs8035094-?	rs8035094	0	8035094	intergenic_variant	1		5E-6	5.301029995663981	(disease-free survival)	2.68	[1.75-4.09]	Illumina [729737]	N
2016-01-30	25866641	Xu W	2015-03-19	Biomark Res	www.ncbi.nlm.nih.gov/pubmed/25866641	A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.	Survival in colon cancer	334 European ancestry cases	NA	20p13	20	3756848	C20orf27	C20orf27			54976			rs658495-?	rs658495	0	658495	intron_variant	0		7E-6	5.154901959985743	(disease-free survival)	2.53	[1.69-3.78]	Illumina [729737]	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric cancer	2,500 European ancestry cases, 205,652 European ancestry controls (includes non-array genotyped, whole genome imputed individuals)	NA	1q22	1;1	155208991;155192276	MTX1, HCN3, MUC1	MTX1; THBS3; MUC1						rs760077-?; rs4072037-?	rs760077; rs4072037	0		missense_variant; splice_acceptor_variant		NR	2E-9	8.698970004336019		1.27	[NR]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric cancer	2,500 European ancestry cases, 205,652 European ancestry controls (includes non-array genotyped, whole genome imputed individuals)	NA	1q22	1	155215184	MTX1, HCN3, MUC1	GBAP1			2630			rs140081212-G	rs140081212	1	2990223	non_coding_transcript_exon_variant	0	0.646	8E-10	9.096910013008056		1.2658228	[1.18-1.37]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric cancer	2,500 European ancestry cases, 205,652 European ancestry controls (includes non-array genotyped, whole genome imputed individuals)	NA				intergenic							chr11:102118158-A	chr11:102118158-A	0			1	0.0015	3E-8	7.522878745280337		4.9	[2.79-8.62]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric cancer	2,500 European ancestry cases, 205,652 European ancestry controls (includes non-array genotyped, whole genome imputed individuals)	NA				intergenic							chr2:85874332-T	chr2:85874332	0			1	4.0E-4	1E-7	7.0		11.1	[4.53-27.19]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric cancer	2,500 European ancestry cases, 205,652 European ancestry controls (includes non-array genotyped, whole genome imputed individuals)	NA				ATM							chr11:107643195-T	chr11:107643195	0			1	0.0016	6E-7	6.221848749616356		4.27	[2.42-7.54]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric cancer	2,500 European ancestry cases, 205,652 European ancestry controls (includes non-array genotyped, whole genome imputed individuals)	NA				ATM							chr11:107629783-A	chr11:107629783	0			1	7.0E-4	3E-6	5.522878745280337		6.87	[3.07-15.37]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric cancer	2,500 European ancestry cases, 205,652 European ancestry controls (includes non-array genotyped, whole genome imputed individuals)	NA	8q24.3	8	142680513	PSCA	PSCA			8000			rs2294008-T	rs2294008	0	2294008	5_prime_UTR_variant	0	0.471	2E-7	6.698970004336019		1.21	[NR]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric cancer	2,500 European ancestry cases, 205,652 European ancestry controls (includes non-array genotyped, whole genome imputed individuals)	NA	5p13.1	5	40685693	PTGER4, TTC33, PRKAA1	PTGER4			5734			rs10036575-T	rs10036575	0	10036575	intron_variant	0	0.784	5E-6	5.301029995663981		1.2345679	[NR]	Illumina [~ 25000000] (imputed)	N
2014-04-02	24080446	Rudolph A	2013-11-04	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Breast cancer (menopausal hormone therapy interaction)	2,920 European ancestry cases	7,689 European ancestry cases, 9,266 European ancestry controls	13q12.3	13	28590646	POMP	LOC105370135 - EIF4A1P7	105370135	341784		6269	8171	rs9579199-?	rs9579199	0	9579199	intergenic_variant	1		8E-6	5.096910013008056		1.2048	[1.11-1.32]	Illumina [2500000] (imputed)	N
2014-04-02	24080446	Rudolph A	2013-11-04	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Breast cancer (menopausal hormone therapy interaction)	2,920 European ancestry cases	7,689 European ancestry cases, 9,266 European ancestry controls	16q23.3	16	81924693	PLCG2	PLCG2			5336			rs7192724-?	rs7192724	0	7192724	intron_variant	0		3E-6	5.522878745280337		1.24	[1.13-1.36]	Illumina [2500000] (imputed)	N
2017-03-24	27758888	Ingle JN	2016-10-10	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27758888	Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy.	Breast cancer-free interval (treatment with aromatase inhibitor)	6 African American recurrent cases, 134 African American controls without recurrence, 243 European ancestry recurrent cases, 4,216 European ancestry controls without recurrence, 3 Asian ancestry recurrent cases, 56 Asian ancestry controls without recurrence	NA	8q21.11	8	74567389	MIR2052HG, FLJ39080, LOC441355	MIR5681A - LOC105375904	100847058	105375904		18772	22751	rs13260300-?	rs13260300	0	13260300	intergenic_variant	1		2E-7	6.698970004336019		1.64	[1.35-2.00]	Illumina [~ 7400000] (imputed)	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p16.3	2	48974189	FSHR	FSHR			2492			rs2268363-?	rs2268363	0	2268363	intron_variant	0	0.18	5E-8	7.301029995663981		7.03	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p21	2	47012873	TTC7A	TTC7A			57217			rs10194115-?	rs10194115	0	10194115	intron_variant	0	0.07	5E-7	6.301029995663981		9.0	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	1p13.1	1	116927159	PTGFRN	PTGFRN			5738			rs2806864-?	rs2806864	0	2806864	intron_variant	0	0.15	6E-7	6.221848749616356		6.42	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xq11.2	X	65147139	KIAA1166	ZC3H12B			340554			rs7064929-?	rs7064929	0	7064929	intergenic_variant	0	0.17	7E-7	6.154901959985743		13.65	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	12q23.3	12	108373556	CMKLR1	CMKLR1 - LINC01498	1240	102723562		34208	85869	rs10861905-?	rs10861905	0	10861905	regulatory_region_variant	1	0.01	8E-7	6.096910013008056		33.95	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2q14.3	2	122533446	TSN	LOC105373593 - LOC107985943	105373593	107985943		28323	129033	rs1527243-?	rs1527243	0	1527243	intergenic_variant	1	0.43	1E-6	6.0		6.67	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	9p13.3	9	33283584	CHMP5	CHMP5 - LOC100862682	51510	100862682		1515	4648	rs12336160-?	rs12336160	0	12336160	downstream_gene_variant	1	0.09	1E-6	6.0		7.26	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p22.1	2	39720581	TMEM178	TMEM178A - THUMPD2	130733	80745		2618	15479	rs2716734-?	rs2716734	0	2716734	downstream_gene_variant	1	0.14	2E-6	5.698970004336019		5.97	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2q22.1	2	141038051	LRP1B	LRP1B			53353			rs10210358-?	rs10210358	0	10210358	intron_variant	0	0.31	2E-6	5.698970004336019		5.34	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	1p36.13	1	17967993	IGSF21	ACTL8 - LOC105376809	81569	105376809		140930	32477	rs16861326-?	rs16861326	0	16861326	intergenic_variant	1	0.02	2E-6	5.698970004336019		17.85	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xp22.11	X	22873960	DDX53	PTCHD1-AS			100873065			rs5925696-?	rs5925696	0	5925696	intron_variant	0	0.26	3E-6	5.522878745280337		12.52	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p22.2	2	38050689	FAM82A1	RMDN2			151393			rs6741148-?	rs6741148	0	6741148	intron_variant	0	0.33	4E-6	5.3979400086720375		5.2	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	9q22.32	9	94978992	C9orf3	C9orf3			84909			rs3802458-?	rs3802458	0	3802458	intron_variant	0	0.04	4E-6	5.3979400086720375		10.53	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	5q23.2	5	125030274	ZNF608	LOC105379158 - LOC101927421	105379158	101927421		34202	6557	rs6862844-?	rs6862844	0	6862844	intergenic_variant	1	0.09	4E-6	5.3979400086720375		6.72	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	1p36.21	1	15465931	ELA2A	CELA2A, LOC105376767			63036, 105376767			rs2901964-?	rs2901964	0	2901964	non_coding_transcript_exon_variant	0	0.37	5E-6	5.301029995663981		5.26	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2q14.2	2	120943713	GLI2	GLI2			2736			rs11122834-?	rs11122834	0	11122834	intron_variant	0	0.29	5E-6	5.301029995663981		4.93	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2q11.2	2	96835063	CNNM3	CNNM3			26505			rs9948-?	rs9948	0	9948	intron_variant	0	0.31	6E-6	5.221848749616356		4.9	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xq12	X	66386851	HEPH	LOC100128171 - GPR165P	100128171	392486		24986	51116	rs5965182-?	rs5965182	0	5965182	intergenic_variant	1	0.12	6E-6	5.221848749616356		11.73	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xp21.3	X	25835497	MAGEB18	LOC107985707			107985707			rs5944185-?	rs5944185	0	5944185	intergenic_variant	0	0.16	7E-6	5.154901959985743		10.5	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p24.1	2	21354871	APOB	LOC105374318			105374318			rs219553-?	rs219553	0	219553	intron_variant	0	0.42	7E-6	5.154901959985743		5.56	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	20p11.21	20	24077771	GGTLC1	LOC107985438 - LOC105372576	107985438	105372576		81227	13764	rs6049375-?	rs6049375	0	6049375	intergenic_variant	1	0.28	8E-6	5.096910013008056		4.84	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xp21.3	X	28214936	WDR42B	LOC105373152 - MIR6134	105373152	102465140		141753	280619	rs5971305-?	rs5971305	0	5971305	intergenic_variant	1	0.02	8E-6	5.096910013008056		33.69	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xp11.4	X	37995474	SYTL5	SYTL5			94122			rs872690-?	rs872690	0	872690	intron_variant	0	0.03	9E-6	5.045757490560675		11.78	[NR]	Affymetrix [512497]	N
2011-05-11	21483023	Wu X	2011-04-11	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21483023	Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	327 European ancestry individuals	735 European ancestry individuals	12q23.3	12	108305255	CMKLR1	CMKLR1			1240			rs1878022-?	rs1878022	0	1878022	intron_variant	0	NR	5E-7	6.301029995663981		1.33	[1.19-1.48]	Illumina [307260]	N
2011-06-03	21602798	Haiman CA	2011-05-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21602798	Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.	Prostate cancer	3,425 African American cases, 3,290 African American controls	1,500 African American/Afro-Caribbean cases, 1,908 African American/Afro-Caribbean controls, 344 Sub-Saharan African ancestry cases, 1,361 Sub-Saharan African ancestry controls	17q21.33	17	49359387	ZNF652	ZNF652			22834			rs7210100-?	rs7210100	0	7210100	intron_variant	0	0.05	3E-13	12.522878745280337		1.51	[1.35-1.69]	Illumina [10471986]	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	12p13.31	12	9228263	LOC642846, LOC728715	KLRG1			10219			rs10771431-A	rs10771431	0	10771431	downstream_gene_variant	0	0.444	2E-6	5.698970004336019		0.073	[0.042-0.104] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2p23.3	2	27375230	SLC4A1AP, GCKR	SNX17			9784			rs4665972-T	rs4665972	0	4665972	intron_variant	0	0.448	1E-6	6.0		0.08	[0.047-0.113] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	12p11.22	12	28003148	LOC100129646, PTHLH	PTHLH - LOC105369710	5744	105369710		28961	58493	rs12371778-G	rs12371778	0	12371778	intergenic_variant	1	0.091	1E-8	8.0		0.162	[0.11-0.22] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	8p11.23	8	36988591	KCNU1, ZNF703, MRPS7P1	RPL26P25 - LOC105379377	100270966	105379377		93	77543	rs7816345-T	rs7816345	0	7816345	upstream_gene_variant	1	0.194	2E-14	13.698970004336019		0.151	[0.11-0.19] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				FAM109B, NAGA, MKL1, WBP2NL							chr22:40779964-A	chr22:40779964	0			1	0.056	5E-7	6.301029995663981		0.187	[0.11-0.26] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				TBC1D22A, LOC100128818							chr22:45895495-T	chr22:45895495	0			1	0.199	7E-6	5.154901959985743		0.115	[0.064-0.166] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				DEFB112, TFAP2D							chr6:50202617-A	chr6:50202617	0			1	0.053	5E-6	5.301029995663981		0.174	[0.100-0.248] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	3p14.2	3	60777523	NPCDR1, PTPRG	FHIT			2272			rs11919041-T	rs11919041	0	11919041	intron_variant	0	0.287	2E-6	5.698970004336019		0.082	[0.049-0.115] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	3p14.2	3	62747691	CADPS	CADPS			8618			rs580384-C	rs580384	0	580384	intron_variant	0	0.089	4E-6	5.3979400086720375		0.124	[0.071-0.177] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	10q21.2	10	62427805	ADO, ZNF365, ALDH7A1P4	ZNF365			22891			rs7089814-C	rs7089814	0	7089814	intron_variant	0	0.375	3E-9	8.522878745280337		0.096	[0.065-0.127] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				NUFIP1P							chr6:67596834-A	chr6:67596834	0			1	0.0020	7E-6	5.154901959985743		1.008	[0.57-1.45] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	11q13.3	11	69328516	IFITM9P, CCND1	IFITM9P - LOC105369370	390218	105369370		24710	38309	rs7102705-A	rs7102705	0	7102705	intron_variant	1	0.211	5E-6	5.301029995663981		0.086	[0.049-0.123] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	4q13.3	4	74577305	EREG, AREGB, EPGN, AREG	LOC107986229			107986229			rs62314947-T	rs62314947	0	62314947	intron_variant	0	0.281	5E-8	7.301029995663981		0.101	[0.064-0.138] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	10q22.2	10	74943248	COMTD1, SPA17P1	KAT6B			23522			rs10466033-G	rs10466033	0	10466033	intron_variant	0	0.0080	6E-6	5.221848749616356		0.437	[0.25-0.63] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	13q31.3	13	92929538	GPC6	GPC5 - LOC105370317	2262	105370317		62301	103447	rs9523848-T	rs9523848	0	9523848	intergenic_variant	1	0.293	3E-6	5.522878745280337		0.081	[0.048-0.114] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	14q32.13	14	94329847	SERPINA6, CLMN	SERPINA6 - SERPINA2	866	390502		6496	34471	rs61280460-T	rs61280460	0	61280460	intergenic_variant	1	0.199	8E-7	6.096910013008056		0.095	[0.058-0.132] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	12q22	12	95633983	NEDD1, MIR135A2	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-G	rs17356907	0	17356907	intron_variant	1	0.296	1E-6	6.0		0.081	[0.048-0.114] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2q14.2	2	120487546	INHBB, GLI2, LOC84931	LINC01101 - LOC105373585	84931	105373585		21197	55312	rs4849887-T	rs4849887	0	4849887	intergenic_variant	1	0.113	3E-11	10.522878745280337		0.166	[0.12-0.22] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				TMCC1							chr3:130947635-A	chr3:130947635	0			1	0.0010	5E-7	6.301029995663981		2.299	[1.41-3.19] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	8q24.3	8	141530825	FLJ43860	LOC105375791 - MIR1302-7	105375791	100302147		16610	255417	rs7837045-A	rs7837045	0	7837045	regulatory_region_variant	1	0.22	5E-6	5.301029995663981		0.092	[0.053-0.131] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	6q25.1	6	151636579	ESR1, C6orf97	CCDC170 - ESR1	80129	2099		15386	17569	rs12173570-T	rs12173570	0	12173570	intergenic_variant	1	0.101	6E-11	10.221848749616356		0.171	[0.12-0.22] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				TLR3							chr4:187239569-T	chr4:187239569	0			1	0.013	6E-6	5.221848749616356		0.406	[0.23-0.58] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	1q32.1	1	201915824	ATP2B4	LMOD1			25802			rs2819348-C	rs2819348	0	2819348	intron_variant	0	0.318	3E-6	5.522878745280337		0.078	[0.045-0.111] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2q14.2	2	119755557	EPB41L5	LOC101927764			101927764			rs13401620-A	rs13401620	0	13401620	upstream_gene_variant	0	0.224	2E-6	5.698970004336019		0.095	[0.056-0.134] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2p14	2	64268493	RPL23AP37, LOC100128607	LOC100507006 - LOC105374768	100507006	105374768		15962	31378	rs1529102-A	rs1529102	0	1529102	intergenic_variant	1	0.495	6E-6	5.221848749616356		0.07	[0.041-0.099] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2p23.3	2	27519736	SLC4A1AP	GCKR			2646			rs780093-T	rs780093	0	780093	intron_variant	0	0.416	5E-6	5.301029995663981		0.072	[0.041-0.103] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2q31.2	2	178239571	TTN	OSBPL6			114880			rs34479159-C	rs34479159	0	34479159	intron_variant	0	0.19	6E-6	5.221848749616356		0.089	[0.050-0.128] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				LOC645207, GAP43							chr3:116704634-A	chr3:116704634	0			1	0.054	8E-6	5.096910013008056		0.165	[0.092-0.238] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	3p24.1	3	29167660	MESTP4, RBMS3	MESTP4 - RBMS3-AS3	131572	100873979		78044	96534	rs6549915-T	rs6549915	0	6549915	intron_variant	1	0.444	9E-6	5.045757490560675		0.078	[0.043-0.113] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	4q34.3	4	179462158	RPL19P8	LOC105377563 - LOC105377564	105377563	105377564		644832	502288	rs2716816-C	rs2716816	0	2716816	intron_variant	1	0.149	7E-6	5.154901959985743		0.098	[0.055-0.141] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	7p14.2	7	36912416	ELMO1	ELMO1			9844			rs10488023-G	rs10488023	0	10488023	intron_variant	0	0.142	8E-6	5.096910013008056		0.099	[0.056-0.142] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	11q24.2	11	126003207	KIRREL3	CDON			50937			rs7104745-G	rs7104745	0	7104745	intron_variant	0	0.458	6E-6	5.221848749616356		0.07	[0.039-0.101] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	13q13.3	13	35957411	FAM48A	DCLK1			9201			rs34065801-C	rs34065801	0	34065801	intron_variant	0	0.176	6E-6	5.221848749616356		0.096	[0.055-0.137] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	13q21.2	13	59379332	TDRD3	LOC105370222 - RNU7-88P	105370222	100873843		87900	100738	rs12585963-A	rs12585963	0	12585963	intergenic_variant	1	0.312	2E-6	5.698970004336019		0.08	[0.047-0.113] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	18q12.1	18	32399612	NOL4	GAREM			64762			rs58263042-C	rs58263042	0	58263042	intron_variant	0	0.061	9E-6	5.045757490560675		0.165	[0.092-0.238] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2q14.2	2	120332155	INHBB	LOC105373584 - LOC105373989	105373584	105373989		12831	10295	rs17625845-C	rs17625845	0	17625845	intergenic_variant	1	.205	5E-10	9.301029995663981		0.125	[.086-.164] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	22q12.1	22	28765019	MTFP1, LOC646513, SEC14L2, SDC4P, CHEK2	HSCB - CCDC117	150274	150275		7501	7655	rs4820792-T	rs4820792	0	4820792	intergenic_variant	1	.180	4E-7	6.3979400086720375		0.105	[0.065-.146] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	7q31.1	7	112002591	ZNF277	DOCK4			9732			rs61159171-T	rs61159171	0	61159171	intron_variant	0	0.348	6E-6	5.221848749616356		0.075	[0.042-0.108] cup size decrease	Illumina [7422970] (imputed)	N
2014-11-06	24737549	Yoon KA	2014-04-15	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24737549	Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer.	Non-small cell lung cancer (recurrence rate)	250 Korean ancestry cases	308 Korean ancestry cases	4q34.3	4	181276794	LINC00290	LOC101928679 - LOC107986205	101928679	107986205		11617	98980	rs1454694-C	rs1454694	0	1454694	intergenic_variant	1	0.21	9E-8	7.045757490560675		2.12	[1.61-2.79]	Affymetrix [308098]	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	3q13.2	3	113556777	WDR52-AS1, ATP6V1A, BOC, KIAA2018, MIR4446, NAA50, SIDT1, SPICE1, WDR52, WDR52-AS	SIDT1			54847			rs7611694-A	rs7611694	0	7611694	intron_variant	0	0.59	4E-13	12.397940008672037		1.1	[1.08-1.14]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	4q13.3	4	73483441	COX18, AFM, RASSF6, ALB, AFP, ANKRD17, LOC72804, LOC728040	AFM			173			rs1894292-G	rs1894292	0	1894292	intron_variant	0	0.52	5E-13	12.301029995663981		1.1	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	5q35.2	5	173512423	BOD1, FAM44B, LOC285593, STC2	LOC105377732			105377732			rs6869841-A	rs6869841	0	6869841	intergenic_variant	0	0.21	5E-8	7.301029995663981		1.07	[1.04-1.11]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6p21.32	6	32224554	CYP21A2, DOM3Z, FKBPL, HLA-DRB6, HCG23, LOC10029, ATF6B, LOC100293534, AGER, LOC100507547, MIR1236, PPT2, PPT2-EGF, HLA-DRA, PPT2-EGFL8, RNF5, RNF5P1, CFB, RDBP, TNXA, TNXB, HLA-DQB1, NOTCH4, SKIV2L, STK19, GPSM3, PBX2, LOC10050, EGFL8, AGPAT1, C2, C4A, PRRT1, BTNL2, C4B, HLA-DRB5, C6orf10, HLA-DRB1, CYP21A1P, HLA-DQA1	NOTCH4 - LOC101929163	4855	101929163		487	30619	rs3096702-A	rs3096702	0	3096702	upstream_gene_variant	1	0.4	5E-9	8.301029995663981		1.07	[1.04-1.10]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6q21	6	108963986	LACE1, LINC0022, LINC00222, ARMC2, SESN1, CEP57L1, FOXO3	ARMC2			84071			rs2273669-G	rs2273669	0	2273669	intron_variant	0	0.15	8E-9	8.096910013008056		1.07	[1.03-1.11]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6q25.2	6	153119944	RGS17, FBXO5, MTRF1L	RGS17			26575			rs1933488-A	rs1933488	0	1933488	intron_variant	0	0.59	4E-18	17.397940008672037		1.12	[1.09-1.15]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	7p15.3	7	20954872	SP8, ABCB5, RPL23P8	LINC01162			104355138			rs12155172-A	rs12155172	0	12155172	intron_variant	0	0.23	5E-13	12.301029995663981		1.11	[1.07-1.15]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	8p21.2	8	26034626	EBF2	EBF2			64641			rs11135910-A	rs11135910	0	11135910	intron_variant	0	0.16	8E-11	10.096910013008056		1.11	[1.07-1.16]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	10q24.32	10	102654464	CNNM2, CUEDC2, CYP17A1, FBXL15, LOC100505761, MIR146B, PSD, SFXN2, SUFU, TMEM180, ARL3, ACTR1A, AS3MT, TRIM8, C10orf32, C10orf32-AS3MT, WBP1L, C10orf95	LOC105378460, TRIM8			105378460, 81603			rs3850699-A	rs3850699	0	3850699	intron_variant	0	0.71	5E-10	9.301029995663981		1.1	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	11q22.2	11	102530930	MMP8, BIRC2, MMP10, MMP20, MMP27, MMP7, YAP1, BIRC3, TMEM123	MMP7 - MMP20	4316	9313		177	45905	rs11568818-A	rs11568818	0	11568818	upstream_gene_variant	1	0.56	2E-11	10.698970004336019		1.1	[1.06-1.14]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	12q24.21	12	114247766	TBX5, LOC255480	LOC105369996 - TBX5	105369996	6910		5586	106145	rs1270884-A	rs1270884	0	1270884	intergenic_variant	1	0.49	7E-11	10.154901959985743		1.07	[1.04-1.10]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	14q22.1	14	52905612	DDHD1, ERO1L, TXNDC16, FERMT2, GNPNAT1, GPR137C, PSMC6, STYX	FERMT2, LOC105370500			10979, 105370500			rs8008270-G	rs8008270	0	8008270	intron_variant	0	0.82	2E-14	13.698970004336019		1.12	[1.08-1.16]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	14q24.1	14	68660027	RAD51B, ZFP36L1, ACTN1	RAD51B			5890			rs7141529-G	rs7141529	0	7141529	intron_variant	0	0.5	3E-10	9.522878745280337		1.09	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	17p13.3	17	715725	DBIL5P, FAM57A, GEMIN4, GLOD4, NXN, RNMTL1, VPS53	VPS53 - FAM57A	55275	79850		869	16821	rs684232-G	rs684232	0	684232	intron_variant	1	0.36	5E-15	14.301029995663981		1.1	[1.07-1.14]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	17q21.32	17	49267824	NGFR, PHB, PHOSPHO1, HOXB13, PRAC, SPOP, ZNF652, ABI3, B4GALNT2, FLJ40194, GNGT2, IGF2BP1	FLJ40194 - MIR6129	124871	102465137		9159	20522	rs11650494-A	rs11650494	0	11650494	intergenic_variant	1	0.08	2E-9	8.698970004336019		1.15	[1.09-1.22]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	18q23	18	79013973	SALL3, ATP9B	LOC105372225			105372225			rs7241993-G	rs7241993	0	7241993	intergenic_variant	0	0.7	2E-9	8.698970004336019		1.09	[1.05-1.12]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	20q13.33	20	62440555	GTPBP5, HRH3, MIR1-1, MIR133A2, MIR4758, OSBPL2, RPS21, LAMA5, ADRM1, C20orf15, C20orf151, C20orf166, C20orf166-AS1, CABLES2, GATA5	LOC105372710			105372710			rs2427345-G	rs2427345	0	2427345	intron_variant	0	0.63	4E-8	7.3979400086720375		1.06	[1.03-1.1]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	20q13.33	20	63731211	STMN3, ZBTB46, ZGPAT, ABHD16B, ARFRP1, C20orf195, DNAJC5, EEF1A2, GMEB2, LIME1, LOC100505815, MIR1914, MIR647, MIR941-1, MIR941-2, MIR941-3, MIR941-4, PPDPF, PRIC285, PRPF6, PTK6, RTEL1, RTEL1-TN, RTEL1-TNFRSF6B, SAMD10, SRMS, TNFRSF6B, TPD52L2, UCKL1, SLC2A4RG, UCKL1-AS1, ZNF512B	ZGPAT			84619			rs6062509-A	rs6062509	0	6062509	intron_variant	0	0.7	4E-16	15.397940008672037		1.12	[1.09-1.16]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	Xp22.2	X	9846095	GPR143, LOC100288814, SHROOM2, TBL1X, WWC3	SHROOM2			357			rs2405942-A	rs2405942	0	2405942	intron_variant	0	0.79	2E-10	9.698970004336019		1.14	[1.09-1.2]	Illumina [~ 2600000] (imputed)	N
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	5p14.1	5	26389153	CDH9	RNU4-43P - CCNB3P1	106481185	100131678		376128	350600	rs969088-C	rs969088	0	969088	intron_variant	1	NR	2E-6	5.698970004336019	(Han Chinese)	1.43	[1.24-1.66]	NR [576351]	N
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	7q31.31	7	118351841	CFTR, ST7, WNT2	LOC102724495 - LOC105375471	102724495	105375471		28951	75199	rs41997-A	rs41997	0	41997	intron_variant	1	NR	4E-7	6.3979400086720375	(Han Chinese)	1.52	[1.28-1.79]	NR [576351]	N
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	9p21.3	9	23426273	HuB	LOC107987055 - LOC105369298	107987055	105369298		321098	56467	rs12000445-A	rs12000445	0	12000445	intron_variant	1	NR	7E-6	5.154901959985743	(Han Chinese)	1.49	[1.25-1.75]	NR [576351]	N
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	5p14.1	5	26389153	CDH9	RNU4-43P - CCNB3P1	106481185	100131678		376128	350600	rs969088-C	rs969088	0	969088	intron_variant	1	NR	3E-6	5.522878745280337	(Han Chinese + EA)	1.4	[1.22-1.61]	NR [576351]	N
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	14q24.3	14	78068563	NRXN3, SKIIP, SNW1, ALKBH1	NRXN3			9369			rs3850370-C	rs3850370	0	3850370	intergenic_variant	0	NR	4E-6	5.3979400086720375	(Han Chinese + EA)	1.31	[1.17-1.47]	NR [576351]	N
2014-11-06	24737549	Yoon KA	2014-04-15	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24737549	Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer.	Non-small cell lung cancer (recurrence rate)	250 Korean ancestry cases	308 Korean ancestry cases	4q34.3	4;4;4;4;4	181276794;181286665;181282098;181296074;181277326	LINC00290	LOC101928679 - LOC107986205; LOC101928679 - LOC107986205; LOC101928679 - LOC107986205; LOC101928679 - LOC107986205; LOC101928679 - LOC107986205						rs1454694-C; rs17241910-A; rs5012808-A; rs28431436-G; rs10019279-C	rs1454694; rs17241910; rs5012808; rs28431436; rs10019279	0		intergenic_variant; intergenic_variant; intergenic_variant; intergenic_variant; intergenic_variant		NR	4E-6	5.3979400086720375		2.09	[1.53-2.87]	Affymetrix [308098]	N
2013-05-09	23376709	Kerns SL	2013-01-31	J Urol	www.ncbi.nlm.nih.gov/pubmed/23376709	A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.	Urinary symptoms in response to radiotherapy in prostate cancer	346 European, African, Hispanic and Asian ancestry individuals	377 European, African, Hispanic and Asian ancestry individuals	9p21.2	9	27488094	IFNK, MOB3B	MOB3B			79817			rs17779457-?	rs17779457	0	17779457	intron_variant	0	0.25	7E-7	6.154901959985743	(at 2-3 yrs)	2.4	[1.1-3.6] unit increase	Affymetrix [613496]	N
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	19q13.2	19	41479679	ATP5SL, CEACAM21	PCAT19			100505495			rs11672691-G	rs11672691	0	11672691	intron_variant	0	NR	1E-8	8.0	(Aggressive)	1.11	[1.02-1.20]	Illumina [~ 2600000] (imputed)	N
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	19q13.2	19	41479679	ATP5SL, CEACAM21	PCAT19			100505495			rs11672691 -G	rs11672691	0	11672691	intron_variant	0	NR	2E-12	11.698970004336019	(All)	1.08	[1.04-1.12]	Illumina [~ 2600000] (imputed)	N
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	22q13.1	22	40040969	TNRC6B	LOC100130899 - TNRC6B	100130899	23112		4392	3848	rs11704416-C	rs11704416	0	11704416	3_prime_UTR_variant	1	NR	4E-6	5.3979400086720375	(Aggressive)	1.05	[0.96-1.15]	Illumina [~ 2600000] (imputed)	N
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	22q13.1	22	40040969	TNRC6B	LOC100130899 - TNRC6B	100130899	23112		4392	3848	rs11704416-C	rs11704416	0	11704416	3_prime_UTR_variant	1	NR	4E-7	6.3979400086720375	(All)	1.06	[1.02-1.10]	Illumina [~ 2600000] (imputed)	N
2016-07-27	26237429	Aminkeng F	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237429	A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.	Anthracycline-induced cardiotoxicity in childhood cancer	32 European ancestry cases with cardiotoxicity, 248 European ancestry cases without cardiotoxicity	22 European ancestry cases with cardiotoxicity, 74 European ancestry cases without cardiotoxicity, 2 African cases with cardiotoxicity, 9 African cases without cardiotoxicity, 5 Hispanic cases with cardiotoxicity, 18 Hispanic cases without cardiotoxicity, 8 East Asian cases with cardiotoxicity, 23 East Asian cases without cardiotoxicity, 4 Aboriginal Canadian cases with cardiotoxicity, 11 Aboriginal Canadian cases without cardiotoxicity	12q13.13	12	53211761	RARG	RARG			5916			rs2229774-A	rs2229774	0	2229774	missense_variant	0	0.076	8E-8	7.096910013008056	(EA)	5.4	[2.9-10.3]	Illumina [657694]	N
2016-07-27	26237429	Aminkeng F	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237429	A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.	Anthracycline-induced cardiotoxicity in childhood cancer	32 European ancestry cases with cardiotoxicity, 248 European ancestry cases without cardiotoxicity	22 European ancestry cases with cardiotoxicity, 74 European ancestry cases without cardiotoxicity, 2 African cases with cardiotoxicity, 9 African cases without cardiotoxicity, 5 Hispanic cases with cardiotoxicity, 18 Hispanic cases without cardiotoxicity, 8 East Asian cases with cardiotoxicity, 23 East Asian cases without cardiotoxicity, 4 Aboriginal Canadian cases with cardiotoxicity, 11 Aboriginal Canadian cases without cardiotoxicity	12q13.13	12	53211761	RARG	RARG			5916			rs2229774-A	rs2229774	0	2229774	missense_variant	0	0.064	6E-8	7.221848749616356		4.7	[2.7-8.3]	Illumina [657694]	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	1q21.3	1	154861707	ADAM15, ADAR, CKS1B, DCST1, DCST2, EFNA3, EFNA4, LOC10050, FLAD1, KCNN3, LENEP, LOC100505666, MIR4258, PBXIP1, DPM3, PYGO2, EFNA1, SHC1, SLC50A1, ZBTB7B, PMVK	KCNN3			3782			rs1218582-G	rs1218582	0	1218582	intron_variant	0	0.45	2E-8	7.698970004336019		1.06	[1.03-1.09]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	1q32.1	1	204549714	LRRN2, PIK3C2B, LOC127841, MDM4, PPP1R15B, PLEKHA6	MDM4			4194			rs4245739-A	rs4245739	0	4245739	3_prime_UTR_variant	0	0.75	2E-11	10.698970004336019		1.1	[1.05-1.14]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	2p25.1	2	9977740	C2orf48, CYS1, GRHL1, KLF11, MIR4261, RRM2, TAF1B	GRHL1			29841			rs11902236-A	rs11902236	0	11902236	intron_variant	0	0.27	3E-8	7.522878745280337		1.07	[1.03-1.10]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	2q37.3	2	241443449	BOK-AS1, DTYMK, FARP2, HDLBP, SEP2, STK25, THAP4, ANO7, ATG4B, BOK	FARP2			9855			rs3771570-A	rs3771570	0	3771570	3_prime_UTR_variant	0	0.15	5E-9	8.301029995663981		1.12	[1.08-1.17]	Illumina [~ 2600000] (imputed)	N
2016-10-12	26546620	Xu CF	2015-11-06	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/26546620	HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients With Cancer.	Response to Pazopanib in cancer (hepatotoxicity)	Up to 844 European ancestry cases, up to 325 Asian ancestry cases, up to 19 cases	Up to 811 European ancestry cases, up to 114 Asian ancestry cases, up to 77 cases	6p21.32	6	32184665	AGER	AGER			177			rs1800625 -G	rs1800625	0	1800625	upstream_gene_variant	0	NR	8E-9	8.096910013008056	(Time to ALT>3 x upper limit of normal event)	1.8	[1.5-2.1]	Illumina [6736730] (imputed)	N
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8;8;8;8;8;8;8;8;8;8;8;8;8;8	127081032;127115007;127072294;127063445;127069276;127068178;127125423;127081052;127081233;127075659;127110414;127071852;127080210;127104255	intergenic	PCAT2; PRNCR1; PRNCR1 - LOC105375752; LOC105375751 - PCAT2; LOC105375751 - PCAT2; LOC105375751 - PCAT2; LOC105375751 - PCAT2; PRNCR1 - LOC105375752; PCAT2; PRNCR1; PCAT2; PRNCR1; PCAT2; PRNCR1 - LOC105375752; LOC105375751 - PCAT2; PCAT2; PRNCR1; PRNCR1 - LOC105375752						rs1031588-G; rs1456305-T; rs6994316-A; rs1456314-G; rs7825414-G; rs17831626-T; rs7816535-G; rs1016343-T; rs1551510-G; rs6470494-T; rs1378897-G; rs6993569-G; rs1016342-C; rs1456306-C	rs1031588; rs1456305; rs6994316; rs1456314; rs7825414; rs17831626; rs7816535; rs1016343; rs1551510; rs6470494; rs1378897; rs6993569; rs1016342; rs1456306	0		non_coding_transcript_exon_variant; intergenic_variant; downstream_gene_variant; intergenic_variant; downstream_gene_variant; downstream_gene_variant; regulatory_region_variant; non_coding_transcript_exon_variant; non_coding_transcript_exon_variant; intron_variant; intergenic_variant; downstream_gene_variant; non_coding_transcript_exon_variant; intergenic_variant		0.022	3E-15	14.522878745280337	(EA)	2.1	[1.75-2.53]	Illumina [316515]	N
2017-01-16	27173062	Azad AK	2016-05-09	Cancer Epidemiol	www.ncbi.nlm.nih.gov/pubmed/27173062	A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways.	Survival in head and neck cancer	489 European ancestry cases, 26 Asian, African or First Nation ancestry cases	470 European ancestry cases, 57 Asian ancestry cases, 11 African American ancestry cases, 28 other ancestry cases	7q21.11	7	82417786	CACNA2D1	CACNA2D1			781			rs2299187-A	rs2299187	0	2299187	intron_variant	0	0.02	8E-6	5.096910013008056		3.26	[1.94-5.47]	Illumina [543873]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	16q22.1	16	70741552	VAC14	VAC14			55697			rs875858-?	rs875858	0	875858	intron_variant	0	NR	2E-8	7.698970004336019		3.6	[2.21-5.84]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	10q26.3	10	130032376	Intergenic	EBF3 - LINC00959	253738	387723		68102	31520	rs11017056-?	rs11017056	0	11017056	intergenic_variant	1	NR	4E-7	6.3979400086720375		2.61	[1.77-3.84]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	13q12.13	13	25800908	ATP8A2	ATP8A2			51761			rs1326116-?	rs1326116	0	1326116	intron_variant	0	NR	2E-6	5.698970004336019		2.77	[1.79-4.27]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	18p11.31	18	4772808	Intergenic	LOC105371968 - PPIAP14	105371968	5486		276415	229744	rs8089250-?	rs8089250	0	8089250	downstream_gene_variant	1	NR	2E-6	5.698970004336019		2.72	[1.78-4.17]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	2q36.3	2	225488082	KIAA1486	NYAP2			57624			rs6436559-?	rs6436559	0	6436559	intron_variant	0	NR	3E-6	5.522878745280337		3.34	[1.95-5.71]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	5p15.33	5	3727065	Intergenic	LOC107986399 - LOC105374625	107986399	105374625		108982	51282	rs1566691-?	rs1566691	0	1566691	intergenic_variant	1	NR	4E-6	5.3979400086720375		3.64	[2.03-6.52]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	11q25	11	132887775	OPCML	OPCML			4978			rs1027796-?	rs1027796	0	1027796	intron_variant	0	NR	4E-6	5.3979400086720375		2.38	[1.62-3.48]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	9q33.1	9	115509305	Intergenic	DEC1 - LOC105376235	50514	105376235		106661	87170	rs2213920-?	rs2213920	0	2213920	intergenic_variant	1	NR	5E-6	5.301029995663981		2.63	[1.70-4.06]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	2q36.3	2	228150003	SPHKAP	SPHKAP			80309			rs4438470-?	rs4438470	0	4438470	intron_variant	0	NR	5E-6	5.301029995663981		2.71	[1.73-4.25]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	2p25.2	2	6637697	Intergenic	LINC01246 - MIR7515HG	102800315	102800314		2991	11410	rs17815605-?	rs17815605	0	17815605	non_coding_transcript_exon_variant	1	NR	6E-6	5.221848749616356		2.886	[NR]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	5q31.1	5	136245971	TRPC7	TRPC7-AS2, TRPC7			106478968, 57113			rs11740657-?	rs11740657	0	11740657	intron_variant	0	NR	9E-6	5.045757490560675		2.776	[NR]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	10q21.3	10	66659088	CTNNA3	CTNNA3			29119			rs10997287-?	rs10997287	0	10997287	intron_variant	0	NR	9E-6	5.045757490560675		4.0816326	[NR]	Illumina [498081]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	112 lung cancer cases, 237 COPD cases	NA	9q34.11	9	129033082	FAM73B	SH3GLB2 - FAM73B	56904	84895		4729	3523	rs7042889-?	rs7042889	0	7042889	upstream_gene_variant	1		1E-7	7.0		0.136	[0.087-0.185] unit decrease	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	112 lung cancer cases, 237 COPD cases	NA	1q32.2	1	210316066	HHAT	RNASEH1P3 - HHAT	199827	55733		11248	11807	rs34585985-?	rs34585985	0	34585985	intergenic_variant	1		3E-7	6.522878745280337		0.121	[0.076-0.166] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	112 lung cancer cases, 237 COPD cases	NA	5p15.31	5	9557490	LOC100505806	SNHG18 - LOC101929359	100505806	101929359		7192	37298	rs17264034-?	rs17264034	0	17264034	intergenic_variant	1		6E-7	6.221848749616356		0.081	[0.052-0.110] unit decrease	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	112 lung cancer cases, 237 COPD cases	NA	5q12.3	5	65152843	ADAMTS	ADAMTS6			11174			rs6885147-?	rs6885147	0	6885147	intron_variant	0		3E-6	5.522878745280337		0.086	[0.051-0.121] unit decrease	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	112 lung cancer cases, 237 COPD cases	NA	5p15.1	5	16881981	MYO10	MYO10			4651			rs16869212-?	rs16869212	0	16869212	intron_variant	0		9E-6	5.045757490560675		0.079	[0.076-0.082] unit decrease	Affymetrix [418365]	N
2008-06-16	17529974	Stacey SN	2007-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529974	Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.	Breast cancer	1,599 European ancestry cases, 11,546 European ancestry controls	2,954 European ancestry cases, 5,967 European ancestry controls, Up to 561 Japanese ancestry cases, Up to 565 Japanese ancestry control, Up to 422 African American cases, Up to 448 African American controls, Up to 418 Hispanic cases, Up to 422 Hispanic controls, Up to 148 cases, Up to 293 controls	2q35	2	217041109	intergenic	LOC101928278, LOC105373874			101928278, 105373874			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.50	1E-13	13.0		1.2	[1.14-1.26]	Illumina [311524]	N
2008-06-16	17529974	Stacey SN	2007-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529974	Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.	Breast cancer	1,599 European ancestry cases, 11,546 European ancestry controls	2,954 European ancestry cases, 5,967 European ancestry controls, Up to 561 Japanese ancestry cases, Up to 565 Japanese ancestry control, Up to 422 African American cases, Up to 448 African American controls, Up to 418 Hispanic cases, Up to 422 Hispanic controls, Up to 148 cases, Up to 293 controls	16q12.1	16	52552429	TNRC9	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.27	6E-19	18.221848749616356		1.28	[1.21-1.35]	Illumina [311524]	N
2015-04-01	25038754	Cai Q	2014-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.	Breast cancer	2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls	5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls	1q32.1	1	203797203	ZC3H11A	ZC3H11A			9877			rs4951011-G	rs4951011	0	4951011	5_prime_UTR_variant	0	0.282	9E-9	8.045757490560675	(East Asian)	1.09	[1.06-1.12]	Affymetrix [up to 1930412] (imputed)	N
2015-04-01	25038754	Cai Q	2014-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.	Breast cancer	2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls	5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls	5q14.3	5	91436408	ARRDC3	ARRDC3-AS1 - RAB5CP2	100129716	133789		15693	40003	rs10474352-C	rs10474352	0	10474352	intron_variant	1	0.482	2E-9	8.698970004336019	(East Asian)	1.09	[1.06-1.12]	Affymetrix [up to 1930412] (imputed)	N
2015-04-01	25038754	Cai Q	2014-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.	Breast cancer	2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls	5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls	15q26.1	15	90968837	PRC1	PRC1, PRC1-AS1			9055, 100507118			rs2290203-G	rs2290203	0	2290203	intron_variant	0	0.504	4E-8	7.3979400086720375	(East Asian)	1.08	[1.05-1.11]	Affymetrix [up to 1930412] (imputed)	N
2015-04-01	25038754	Cai Q	2014-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.	Breast cancer	2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls	5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls	18q11.2	18	23196687	NR	CABLES1			91768			rs11082321-A	rs11082321	0	11082321	intron_variant	0	0.21	7E-7	6.154901959985743	(East Asian)	1.08	[NR]	Affymetrix [up to 1930412] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	12q22	12	94733833	intergenic	LOC105369914 - MIR492	105369914	574449		82735	100565	rs4761496-T	rs4761496	0	4761496	intergenic_variant	1	NR	5E-7	6.301029995663981		5.046	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	4p13	4	43211547	RP11-395F4.1	GRXCR1 - LOC105374432	389207	105374432		180889	11641	rs75790006-T	rs75790006	0	75790006	intron_variant	1	NR	1E-6	6.0		4.836	NR z-score increase	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA				intergenic							chr3:80136427-A	chr3:80136427	0			1	NR	1E-6	6.0		4.825	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA				HAPLN3							chr15:89432448-A	chr15:89432448	0			1	NR	2E-6	5.698970004336019		4.751	NR z-score increase	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA				intergenic							chr3:79848880-A	chr3:79848880	0			1	NR	2E-6	5.698970004336019		4.739	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	8p23.2	8	3372208	CSMD1	CSMD1			64478			rs17393453-A	rs17393453	0	17393453	intron_variant	0	NR	2E-6	5.698970004336019		4.734	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	6p22.3	6	15691547	intergenic	LOC102724520			102724520			rs59112743-A	rs59112743	0	59112743	regulatory_region_variant	0	NR	3E-6	5.522878745280337		4.699	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	17q23.2	17	61617277	intergenic	NACA2 - BRIP1	342538	83990		26075	61909	rs2040609-T	rs2040609	0	2040609	regulatory_region_variant	1	NR	3E-6	5.522878745280337		4.678	NR z-score increase	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	10q22.1	10	70616648	intergenic	PRF1 - ADAMTS14	5551	140766		13873	55870	rs80069861-A	rs80069861	0	80069861	intergenic_variant	1	NR	3E-6	5.522878745280337		4.664	NR z-score increase	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	10q22.1	10	70604089	PRF1	PRF1 - ADAMTS14	5551	140766		1314	68429	rs35401316-T	rs35401316	0	35401316	upstream_gene_variant	1	NR	3E-6	5.522878745280337		4.646	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	17q23.2	17	61650489	intergenic	NACA2 - BRIP1	342538	83990		59287	28697	rs11867566-A	rs11867566	0	11867566	intergenic_variant	1	NR	3E-6	5.522878745280337		4.643	NR z-score increase	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA				intergenic							chr2:49725708-T	chr2:49725708	0			1	NR	4E-6	5.3979400086720375		4.617	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	6p12.3	6	51243936	intergenic	FTH1P5 - LOC100422449	2509	100422449		330474	141365	rs9381952-A	rs9381952	0	9381952	intergenic_variant	1	NR	4E-6	5.3979400086720375		4.591	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	6p12.3	6	51240771	intergenic	FTH1P5 - LOC100422449	2509	100422449		327309	144530	rs10948606-T	rs10948606	0	10948606	intergenic_variant	1	NR	4E-6	5.3979400086720375		4.589	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA				PPP2R2C							chr4:6335966-T	chr4:6335966	0			1	NR	5E-6	5.301029995663981		4.571	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA				intergenic							chr2:49762165-A	chr2:49762165	0			1	NR	5E-6	5.301029995663981		4.568	NR z-score decrease	Affymetrix, Illumina [up to 9001799] (imputed)	N
2017-06-02	28081215	Pardo LM	2017-01-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28081215	Genome-Wide Association Studies of Multiple Keratinocyte Cancers.	Multiple keratinocyte cancers	2,106 European ancestry multiple keratinocyte cancer cases, 2,061 European ancestry single keratinocyte cancer cases, 135 European and unknown ancestry multiple keratinocyte cancer cases, 761 European and unknown ancestry single keratinocyte cancer cases	NA	6p12.3	6	51271160	intergenic	FTH1P5 - LOC100422449	2509	100422449		357698	114141	rs9370019-A	rs9370019	0	9370019	intergenic_variant	1	NR	5E-6	5.301029995663981		4.546	NR z-score increase	Affymetrix, Illumina [up to 9001799] (imputed)	N
2011-09-27	21866343	Ahn MJ	2011-08-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21866343	The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations.	Non-small cell lung cancer	445 Korean ancestry cases, 497 Korean ancestry controls	396 Korean ancestry cases, 998 Korean ancestry controls	18p11.22	18	10899030	APCDD1, NAPG, FAM38B	PIEZO2			63895			rs11080466-C	rs11080466	0	11080466	intron_variant	0	NR	1E-6	6.0		1.47	[1.27-1.72]	Affymetrix [474503]	N
2010-10-15	20876614	Yoon KA	2010-09-28	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/20876614	A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population.	Non-small cell lung cancer	621 Korean ancestry cases, 1,541 Korean ancestry controls	804 Korean ancestry cases, 1,470 Korean ancestry controls	17p13.2	17	6004123	NR	LOC339166 - WSCD1	339166	23302		73427	64983	rs9303196-T	rs9303196	0	9303196	intron_variant	1	0.07	8E-6	5.096910013008056		1.43	[1.14-1.82]	Affymetrix [246758]	N
2010-10-15	20876614	Yoon KA	2010-09-28	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/20876614	A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population.	Non-small cell lung cancer	621 Korean ancestry cases, 1,541 Korean ancestry controls	804 Korean ancestry cases, 1,470 Korean ancestry controls	18p11.31	18	7042912	NR	LAMA1			284217			rs16951095-C	rs16951095	0	16951095	non_coding_transcript_exon_variant	0	0.78	7E-6	5.154901959985743		1.3	[1.10-1.54]	Affymetrix [246758]	N
2010-10-15	20876614	Yoon KA	2010-09-28	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/20876614	A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population.	Non-small cell lung cancer	621 Korean ancestry cases, 1,541 Korean ancestry controls	804 Korean ancestry cases, 1,470 Korean ancestry controls	3q29	3	195137645	C3orf21	XXYLT1			152002			rs2131877-G	rs2131877	0	2131877	intron_variant	0	0.44	2E-8	7.698970004336019		1.3	[1.19-1.42]	Affymetrix [246758]	N
2010-12-09	21079520	Sato Y	2010-11-12	J Thorac Oncol	www.ncbi.nlm.nih.gov/pubmed/21079520	Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.	Non-small cell lung cancer (survival)	105 East Asian ancestry cases	NA	2q37.1	2	232561816	EIF4E2	EIF4E2			9470			rs1656402-?	rs1656402	0	1656402	intron_variant	0	NR	8E-8	7.096910013008056		2.38	[1.49-3.85] (AG)	Illumina [109365]	N
2010-12-09	21079520	Sato Y	2010-11-12	J Thorac Oncol	www.ncbi.nlm.nih.gov/pubmed/21079520	Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.	Non-small cell lung cancer (survival)	105 East Asian ancestry cases	NA	21q22.2	21	38801604	ETS2	LOC107985480 - ETS2	107985480	2114		12688	3703	rs1209950-T	rs1209950	0	1209950	upstream_gene_variant	1	NR	3E-7	6.522878745280337		4.96	[2.52-9.76] (CT)	Illumina [109365]	N
2010-12-09	21079520	Sato Y	2010-11-12	J Thorac Oncol	www.ncbi.nlm.nih.gov/pubmed/21079520	Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.	Non-small cell lung cancer (survival)	105 East Asian ancestry cases	NA	21q22.2	21	40043117	DSCAM	DSCAM			1826			rs9981861-G	rs9981861	0	9981861	intron_variant	0	NR	4E-6	5.3979400086720375		1.33	[0.82-2.15] (AG)	Illumina [109365]	N
2012-07-11	22532574	Stevens KN	2012-04-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22532574	Identification of a novel percent mammographic density locus at 12q24.	Percent mammographic density	1,241 European ancestry female individuals	9,126 European ancestry individuals	12q24.21	12	114430333	TBX5, TBX3	LOC105369998			105369998			rs1265507-?	rs1265507	0	1265507	regulatory_region_variant	0	NR	1E-8	8.0				Illumina [2510880]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	9p22.1	9	18930224	FAM154A	SAXO1			158297			rs1571228-?	rs1571228	0	1571228	intron_variant	0	NR	2E-7	6.698970004336019	(Dominant model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	2q34	2	210704998	CPS1	CPS1 - LOC107985978	1373	107985978		25891	315497	rs2371030-G	rs2371030	0	2371030	intergenic_variant	1	0.091	3E-6	5.522878745280337	(Additive model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	19p13.3	19	348743	MIER2	MIER2 - THEG	54531	51298		3950	13314	rs6510725-?	rs6510725	0	6510725	upstream_gene_variant	1	NR	3E-6	5.522878745280337	(Dominant model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	4q28.3	4	134859217	intergenic	LOC105377436 - LOC105377438	105377436	105377438		218643	73485	rs10029269-?	rs10029269	0	10029269	intergenic_variant	1	NR	4E-6	5.3979400086720375	(Dominant model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	6p21.31	6	34956087	ANKS1A	ANKS1A			23294			rs847845-?	rs847845	0	847845	intron_variant	0	NR	6E-6	5.221848749616356	(Dominant model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	14q24.3	14	74899026	DLST	DLST			1743			rs732765-G	rs732765	0	732765	intron_variant	0	0.257	7E-6	5.154901959985743	(Additive model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	2q22.1	2	137384594	THSD7B	THSD7B			80731			rs13405020-?	rs13405020	0	13405020	intron_variant	0	NR	7E-6	5.154901959985743	(Dominant model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	8q13.3	8	70255759	NCOA2	NCOA2			10499			rs2926702-T	rs2926702	0	2926702	intron_variant	0	0.572	7E-6	5.154901959985743	(Additive model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	16q21	16	61744191	CDH8	CDH8			1006			rs8048207-T	rs8048207	0	8048207	intron_variant	0	0.121	8E-6	5.096910013008056	(Additive model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	15q21.3	15	58382470	LIPC	LOC101928635			101928635			rs539901-G	rs539901	0	539901	intron_variant	0	0.109	8E-6	5.096910013008056	(Additive model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	13q33.1	13	101398739	NALCN	NALCN			259232			rs9557635-A	rs9557635	0	9557635	intron_variant	0	0.146	9E-6	5.045757490560675	(Additive model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	9q22.32	9	96335245	SLC35D2	SLC35D2			11046			rs6479272-T	rs6479272	0	6479272	intron_variant	0	0.086	9E-6	5.045757490560675	(Additive model)			Affymetrix [271817]	N
2013-01-25	23144319	Lee Y	2012-11-08	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/23144319	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	Non-small cell lung cancer	348 Korean ancestry cases	NA	2p23.3	2	26303551	GPR113	LOC105374334			105374334			rs6753473-G	rs6753473	0	6753473	upstream_gene_variant	0	0.052	4E-6	5.3979400086720375	(Additive model)			Affymetrix [271817]	N
2016-01-30	25823687	Cao S	2015-03-31	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/25823687	Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.	Platinum-induced myelosuppression in non-small cell lung cancer	328 Han Chinese ancestry cases	876 Han Chinese ancestry cases	2q24.3	2	163470244	FIGN	LOC107985829 - FIGN	107985829	55137		12789	132367	rs13014982-?	rs13014982	0	13014982	intergenic_variant	1		7E-6	5.154901959985743	(variant homozygote model)			Affymetrix [588732]	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	9p22.2	9	16915023	BNC2	BNC2 - LOC105375983	54796	105375983		44185	99049	rs3814113-G	rs3814113	0	3814113	intergenic_variant	1	0.32	6E-50	49.221848749616356		1.2658228	[1.22-1.32]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	8q24.21	8	128531703	CMYC	LINC00824			101927774			rs10088218-A	rs10088218	0	10088218	intron_variant	0	0.13	1E-20	20.0		1.2987013	[1.22-1.37]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	2q31.1	2	176177905	HOXD1	HAGLR			401022			rs2072590-A	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	0.68	9E-14	13.045757490560675		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	3q25.31	3	156689208	TIPARP	TIPARP			25976			rs7651446-A	rs7651446	0	7651446	intron_variant	0	0.05	6E-51	50.221848749616356		1.59	[1.48-1.70]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	19p13.11	19	17278895	BABAM1	BABAM1			29086			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.19	5E-14	13.301029995663981		1.18	[1.13-1.23]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q21.32	17	48334138	SKAP1	SKAP1			8631			rs9303542-G	rs9303542	0	9303542	intron_variant	0	0.27	5E-15	14.301029995663981		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	8q21.13	8	81741409	CHMP4C	CHMP4C			92421			rs11782652-G	rs11782652	0	11782652	intron_variant	0	0.07	3E-10	9.522878745280337			[1.16-1.32]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	10p12.31	10	21626690	MLLT10	MLLT10			8028			rs1243180-A	rs1243180	0	1243180	intron_variant	0	0.31	1E-9	9.0		1.1	[1.06-1.14]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q12	17	37736525	HNF1B	HNF1B			6928			rs757210-A	rs757210	0	757210	intron_variant	0	0.63	2E-8	7.698970004336019		1.11	[1.07-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-A	rs10069690	0	10069690	intron_variant	0	0.26	9E-9	8.045757490560675		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q21.31	17	46710944	PLEKHM1	NSF			4905			rs183211-A	rs183211	0	183211	intron_variant	0	0.24	2E-13	12.698970004336019		1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p36.12	1	22141722	WNT4	WNT4, LOC105376845			54361, 105376845			rs3820282-?	rs3820282	0	3820282	intron_variant	0	NR	2E-8	7.698970004336019		1.11	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p34.3	1	37616450	RSPO1	RSPO1			284654			rs12039431-?	rs12039431	0	12039431	intron_variant	0	NR	1E-8	8.0		1.07	[1.03-1.11]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	4q26	4	119028805	SYNPO2	SYNPO2			171024			rs17329882-?	rs17329882	0	17329882	intron_variant	0	NR	2E-8	7.698970004336019		1.09	[1.06-1.13]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	6p22.1	6	28518321	GPX6	GPX6 - GPX5	257202	2880		2528	7691	rs115344852-?	rs115344852	1	6456823	intron_variant	1	NR	6E-6	5.221848749616356		1.0638298	[1.03-1.1]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	16q21	16	58942687	intergenic	LOC105371296 - RPS27P27	105371296	100271585		59396	146150	rs8044477-?	rs8044477	0	8044477	intron_variant	1	NR	1E-8	8.0		1.1		Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p36.12	1	22141722	WNT4	WNT4, LOC105376845			54361, 105376845			rs3820282-?	rs3820282	0	3820282	intron_variant	0	NR	8E-8	7.096910013008056	(Serous)	1.12	[1.07-1.17]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p34.3	1	37616450	RSPO1	RSPO1			284654			rs12039431-?	rs12039431	0	12039431	intron_variant	0	NR	1E-11	11.0	(Serous)	1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	4q26	4	119028805	SYNPO2	SYNPO2			171024			rs17329882-?	rs17329882	0	17329882	intron_variant	0	NR	2E-8	7.698970004336019	(Serous)	1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	6p22.1	6	28518321	GPX6	GPX6 - GPX5	257202	2880		2528	7691	rs115344852-?	rs115344852	1	6456823	intron_variant	1	NR	3E-8	7.522878745280337	(Serous)	1.098901	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	16q21	16	58942687	intergenic	LOC105371296 - RPS27P27	105371296	100271585		59396	146150	rs8044477-?	rs8044477	0	8044477	intron_variant	1	NR	2E-7	6.698970004336019	(Serous)	1.1	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	1p31.3	1	67639770	intergenic	LOC105378780 - HNRNPCP9	105378780	100130196		49350	2943	rs344924-?	rs344924	0	344924	intergenic_variant	1	NR	3E-7	6.522878745280337	(Recessive model)	4.9	[2.70-9.0]	Affymetrix [334127]	N
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	2p24.1	2	19429543	intergenic	LOC101928196			101928196			rs13398721-?	rs13398721	0	13398721	intergenic_variant	0	NR	2E-7	6.698970004336019	(Recessive model)	7.1	[3.40-14.70]	Affymetrix [334127]	N
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	6q22.1	6	117450114	DCBLD1	RAP1BP3 - RNU6-253P	100132917	106480697		18061	7620	rs17635492-?	rs17635492	0	17635492	intron_variant	1	NR	4E-7	6.3979400086720375	(Dominant model)	7.6	[3.50-16.70]	Affymetrix [334127]	N
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	7p14.3	7	28974579	intergenic	TRIL - LOC100506497	9865	100506497		16166	5388	rs2018683-T	rs2018683	0	2018683	regulatory_region_variant	1	NR	8E-7	6.096910013008056	(Recessive model)	7.8	[3.4-17.7]	Affymetrix [334127]	N
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	13q32.1	13	95123178	ABCC4	ABCC4			10257			rs16950650-T	rs16950650	0	16950650	intron_variant	0	NR	2E-7	6.698970004336019	(Dominant model)	30.2	[8.4-109.0]	Affymetrix [334127]	N
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	14q32.13	14	95476110	C14orf49	SYNE3			161176			rs11622887-?	rs11622887	0	11622887	upstream_gene_variant	0	NR	3E-7	6.522878745280337	(Recessive model)	3.5	[2.20-5.60]	Affymetrix [334127]	N
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	16p12.3	16	16864058	intergenic	LOC100133127 - LOC441750	100133127	441750		322223	88445	rs7186128-G	rs7186128	0	7186128	intergenic_variant	1	NR	4E-7	6.3979400086720375	(Additive model)	2.5	[1.70-3.50]	Affymetrix [334127]	N
2015-04-17	25145502	Tang S	2014-08-22	Ann Surg Oncol	www.ncbi.nlm.nih.gov/pubmed/25145502	Genome-wide Association Study of Survival in Early-stage Non-Small Cell Lung Cancer.	Non-small cell lung cancer (survival)	354 Han Chinese ancestry cases	327 Han Chinese ancestry cases	4q26	4	113625548	CAMK2D	CAMK2D			817			rs10023113-A	rs10023113	0	10023113	intron_variant	0	NR	3E-7	6.522878745280337		2.3	[1.67-3.17]	Affymetrix [589102]	N
2015-04-17	25145502	Tang S	2014-08-22	Ann Surg Oncol	www.ncbi.nlm.nih.gov/pubmed/25145502	Genome-wide Association Study of Survival in Early-stage Non-Small Cell Lung Cancer.	Non-small cell lung cancer (survival)	354 Han Chinese ancestry cases	327 Han Chinese ancestry cases	4q34.3	4	182115761	NR	TENM3			55714			rs17305086-?	rs17305086	0	17305086	intron_variant	0	NR	6E-6	5.221848749616356		2.14	[1.54-2.98]	Affymetrix [589102]	N
2015-04-17	25145502	Tang S	2014-08-22	Ann Surg Oncol	www.ncbi.nlm.nih.gov/pubmed/25145502	Genome-wide Association Study of Survival in Early-stage Non-Small Cell Lung Cancer.	Non-small cell lung cancer (survival)	354 Han Chinese ancestry cases	327 Han Chinese ancestry cases	4q22.1	4	87750786	NR	LOC105377324 - CHCHD2P7	105377324	100874509		9373	34970	rs11733008-?	rs11733008	0	11733008	intergenic_variant	1	NR	3E-6	5.522878745280337		1.76	[1.39-2.23]	Affymetrix [589102]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	12q24.32	12	128297477	TMEM132C	TMEM132C			92293			rs11059635-G	rs11059635	0	11059635	intron_variant	0	0.67	2E-7	6.698970004336019	(Dominant)	6.63	[2.95-14.9]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	16q23.3	16	82612728	CDH13	LOC101928392 - CDH13	101928392	1012		37267	14066	rs3844412-A	rs3844412	0	3844412	intergenic_variant	1	0.11	4E-7	6.3979400086720375	(Dominant)	5.22	[2.67-10.2]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	5p15.2	5	14071948	TRIO	DNAH5 - TRIO	1767	7204		60119	71402	rs163818-C	rs163818	0	163818	intergenic_variant	1	0.02	6E-7	6.221848749616356	(Dominant)	11.5	[3.37-39.3]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	2p21	2	44478476	C2orf34	CAMKMT			79823			rs698813-C	rs698813	0	698813	intron_variant	0	0.52	1E-6	6.0	(Allelic)	4.27	[2.35-7.76]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	21q22.3	21	41672041	NCRNA00111	LOC105372813			105372813			rs2838088-A	rs2838088	0	2838088	intergenic_variant	0	0.12	1E-6	6.0	(Dominant)	4.48	[2.32-8.66]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	62 Japanese ancestry cases, 42 Japanese ancestry controls	NA	15q25.3	15	85919621	KLHL25	LOC105370953 - AGBL1	105370953	123624		18577	160014	rs4262906-C	rs4262906	0	4262906	intergenic_variant	1	0.31	7E-7	6.154901959985743	(Allelic)	4.36	[2.41-7.89]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	62 Japanese ancestry cases, 42 Japanese ancestry controls	NA	3q21.3	3	127231283	C3orf56	LOC101060159 - RNU6-1047P	101060159	106481511		7744	9685	rs4234284-T	rs4234284	0	4234284	regulatory_region_variant	1	0.23	3E-6	5.522878745280337	(Dominant)	3.01	[1.62-5.6]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	62 Japanese ancestry cases, 42 Japanese ancestry controls	NA	20p13	20	778672	C20orf54	SLC52A3 - FAM110A	113278	83541		2687	55025	rs6117615-C	rs6117615	0	6117615	upstream_gene_variant	1	0.24	7E-6	5.154901959985743	(Dominant)	3.89	[2.1-7.18]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	62 Japanese ancestry cases, 42 Japanese ancestry controls	NA	1p32.2	1	55647101	LOC100507652	RNU6-830P - LOC105378740	106480613	105378740		248481	136560	rs10443215-C	rs10443215	0	10443215	intron_variant	1	0.04	9E-6	5.045757490560675	(Allelic)	9.39	[2.77-31.8]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	9q31.2	9	106914612	ZNF462	ZNF462			58499			rs1858231-C	rs1858231	0	1858231	intron_variant	0	0.22	2E-6	5.698970004336019	(Allelic)	2.71	[1.79-4.12]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	11q14.2	11	86477110	ME3	ME3			10873			rs1870323-T	rs1870323	0	1870323	intron_variant	0	0.64	2E-6	5.698970004336019	(Allelic)	2.92	[1.87-4.57]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	15q25.3	15	85919621	KLHL25	LOC105370953 - AGBL1	105370953	123624		18577	160014	rs4262906-C	rs4262906	0	4262906	intergenic_variant	1	0.35	3E-6	5.522878745280337	(Allelic)	2.5	[1.71-3.67]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	5q14.3	5	86881956	RPL10AP9	LOC100505878 - RPL10AP9	100505878	728979		132184	2254	rs2471042-T	rs2471042	0	2471042	downstream_gene_variant	1	0.21	5E-6	5.301029995663981	(Dominant)	2.51	[1.64-3.81]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	10p14	10	8282926	LOC100507143	LINC00708 - LOC105376396	100507143	105376396		14621	99547	rs11255615-G	rs11255615	0	11255615	intergenic_variant	1	0.38	5E-6	5.301029995663981	(Allelic)	2.4	[1.65-3.53]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	5q14.3	5	86878330	RPL10AP9	LOC100505878 - RPL10AP9	100505878	728979		128558	5880	rs1493354-T	rs1493354	0	1493354	intergenic_variant	1	0.22	9E-6	5.045757490560675	(Dominant)	2.37	[1.56-3.6]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	18q21.33	18	63509033	SERPINB5	SERPINB5 - SERPINB12	5268	89777		3948	10131	rs2032224-A	rs2032224	0	2032224	downstream_gene_variant	1	0.62	9E-6	5.045757490560675	(Recessive)	2.16	[1.42-3.27]	Illumina [555600]	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	10q23.33	10	94306584	PLCE1, KIAA1516	PLCE1			51196			rs2274223-G	rs2274223	0	2274223	missense_variant	0	0.209	4E-18	17.397940008672037		1.35	[1.26-1.45]	Affymetrix, Illumina [7556215] (imputed)	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	2q33.1	2	201298088	CASP8, ALS2CR12	ALS2CR12			130540			rs13016963-A	rs13016963	0	13016963	intron_variant	0	0.283	4E-13	12.397940008672037		1.27	[1.19-1.33]	Affymetrix, Illumina [7556215] (imputed)	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	21q22.12	21	34985564	RUNX1	RUNX1			861			rs2014300-G	rs2014300	0	2014300	intron_variant	0	0.843	8E-9	8.096910013008056		1.28	[1.18-1.39]	Affymetrix, Illumina [7556215] (imputed)	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	22q12.1	22	28796682	CHEK2, CCDC117, XBP1	XBP1			7494			rs2239815-T	rs2239815	0	2239815	non_coding_transcript_exon_variant	0	0.387	4E-7	6.3979400086720375		1.16	[1.1-1.23]	Affymetrix, Illumina [7556215] (imputed)	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	5q11.2	5	59111944	PDE4D, PDE4DN2	PDE4D			5144			rs10052657-C	rs10052657	0	10052657	intron_variant	0	0.88	1E-6	6.0		1.25	[1.15-1.37]	Affymetrix, Illumina [7556215] (imputed)	N
2016-06-08	26129866	Hu N	2015-06-30	Gut	www.ncbi.nlm.nih.gov/pubmed/26129866	Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.	Gastric cancer	2,350 East Asian ancestry cases, 2,708 East Asian ancestry controls	7,408  East Asian ancestry cases, 7,548  East Asian ancestry controls	11q25	11	133242868	OPCML	OPCML			4978			rs4578395-C	rs4578395	0	4578395	intron_variant	0	0.092	2E-6	5.698970004336019		1.19	[1.11-1.28]	Illumina [556896]	N
2016-06-08	26129866	Hu N	2015-06-30	Gut	www.ncbi.nlm.nih.gov/pubmed/26129866	Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.	Gastric cancer	2,350 East Asian ancestry cases, 2,708 East Asian ancestry controls	7,408  East Asian ancestry cases, 7,548  East Asian ancestry controls	5p13.1	5	40790449	PRKAA1	PRKAA1			5562			rs10074991-G	rs10074991	0	10074991	intron_variant	0	0.483	5E-26	25.30102999566398		1.25	[1.2-1.3]	Illumina [556896]	N
2016-06-08	26129866	Hu N	2015-06-30	Gut	www.ncbi.nlm.nih.gov/pubmed/26129866	Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.	Gastric cancer	2,350 East Asian ancestry cases, 2,708 East Asian ancestry controls	7,408  East Asian ancestry cases, 7,548  East Asian ancestry controls	6p21.1	6	41037763	UNC5CL, TSPO2	UNC5CL			222643			rs2294693-C	rs2294693	0	2294693	intron_variant	0	0.238	7E-8	7.154901959985743		1.14	[1.09-1.20]	Illumina [556896]	N
2016-06-08	26129866	Hu N	2015-06-30	Gut	www.ncbi.nlm.nih.gov/pubmed/26129866	Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.	Non-cardia gastric cancer	1,027 East Asian ancestry cases, 2,708 East Asian ancestry controls	3,663  East Asian ancestry cases, 7,548  East Asian ancestry controls	6p21.1	6	41037763	UNC5CL, TSPO2	UNC5CL			222643			rs2294693-C	rs2294693	0	2294693	intron_variant	0	0.238	3E-8	7.522878745280337		1.18	[1.12-1.26]	Illumina [556896]	N
2016-06-08	26129866	Hu N	2015-06-30	Gut	www.ncbi.nlm.nih.gov/pubmed/26129866	Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.	Non-cardia gastric cancer	1,027 East Asian ancestry cases, 2,708 East Asian ancestry controls	3,663  East Asian ancestry cases, 7,548  East Asian ancestry controls	5p13.1	5	40790449	PRKAA1	PRKAA1			5562			rs10074991-G	rs10074991	0	10074991	intron_variant	0	0.483	2E-23	22.69897000433602		1.3	[1.23-1.37]	Illumina [556896]	N
2016-06-08	26129866	Hu N	2015-06-30	Gut	www.ncbi.nlm.nih.gov/pubmed/26129866	Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.	Gastric cancer	2,350 East Asian ancestry cases, 2,708 East Asian ancestry controls	7,408  East Asian ancestry cases, 7,548  East Asian ancestry controls	1q22	1	155192276	MUC1	MUC1			4582			rs4072037-A	rs4072037	0	4072037	splice_acceptor_variant	0	NR	7E-8	7.154901959985743		1.32	[1.19-1.45]	Illumina [556896]	N
2016-12-09	27008869	Chen MM	2016-03-23	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27008869	GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer.	Endometrial cancer	4,907 European ancestry cases, 11,945 European ancestry controls	NA	6q22.31	6	125688970	LOC643623	LOC105377986, LOC643623			105377986, 643623			rs2797160-?	rs2797160	0	2797160	intron_variant	0	0.578	4E-13	12.397940008672037		1.21	[NR]	Illumina [9486271] (imputed)	N
2016-12-09	27008869	Chen MM	2016-03-23	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27008869	GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer.	Endometrial cancer	4,907 European ancestry cases, 11,945 European ancestry controls	NA	13q22.1	13	73237742	KLF5	RNY1P8 - MARK2P12	100873807	100421565		10482	170047	rs9600103-?	rs9600103	0	9600103	intergenic_variant	1	0.722	4E-12	11.397940008672037		1.23	[NR]	Illumina [9486271] (imputed)	N
2016-12-09	27008869	Chen MM	2016-03-23	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27008869	GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer.	Endometrial cancer	4,907 European ancestry cases, 11,945 European ancestry controls	NA	6p22.3	6	21648854	SOX4, CASC15, CDKAL1	BOLA2P3 - CASC15	106480323	401237		46471	17590	rs1740828-?	rs1740828	0	1740828	intergenic_variant	1	0.516	2E-8	7.698970004336019		1.2	[NR]	Illumina [9486271] (imputed)	N
2016-12-09	27008869	Chen MM	2016-03-23	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27008869	GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer.	Endometrial cancer	4,907 European ancestry cases, 11,945 European ancestry controls	NA	17q12	17	37742390	HNF1B	HNF1B			6928			rs11651052-?	rs11651052	0	11651052	intron_variant	0	0.535	1E-8	8.0		1.16	[NR]	Illumina [9486271] (imputed)	N
2016-10-10	26701879	Wang Z	2015-12-23	Gut	www.ncbi.nlm.nih.gov/pubmed/26701879	Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.	Non-cardia gastric cancer	2,031 Han Chinese ancestry cases, 4,970 Han Chinese ancestry controls	3,564 Han Chinese ancestry cases, 4,637 Han Chinese ancestry controls	1q22	1	155192276	MUC1	MUC1			4582			rs4072037-T	rs4072037	0	4072037	splice_acceptor_variant	0	0.84	6E-17	16.221848749616356		1.3513513	[1.27-1.45]	Affymetrix, Illumina [6223896] (imputed)	N
2016-10-10	26701879	Wang Z	2015-12-23	Gut	www.ncbi.nlm.nih.gov/pubmed/26701879	Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.	Non-cardia gastric cancer	2,031 Han Chinese ancestry cases, 4,970 Han Chinese ancestry controls	3,564 Han Chinese ancestry cases, 4,637 Han Chinese ancestry controls	1q22	1	155515236	ASH1L	ASH1L			55870			rs80142782-T	rs80142782	0	80142782	intron_variant	0	0.93	2E-19	18.69897000433602		1.6129031	[1.45-1.79]	Affymetrix, Illumina [6223896] (imputed)	N
2016-10-10	26701879	Wang Z	2015-12-23	Gut	www.ncbi.nlm.nih.gov/pubmed/26701879	Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.	Non-cardia gastric cancer	2,031 Han Chinese ancestry cases, 4,970 Han Chinese ancestry controls	3,564 Han Chinese ancestry cases, 4,637 Han Chinese ancestry controls	5q14.3	5	89607147	lnc-POLR3G-4	LOC105379076			105379076			rs7712641-C	rs7712641	0	7712641	intron_variant	0	0.54	1E-11	11.0		1.1904762	[1.14-1.25]	Affymetrix, Illumina [6223896] (imputed)	N
2016-10-10	26701879	Wang Z	2015-12-23	Gut	www.ncbi.nlm.nih.gov/pubmed/26701879	Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.	Non-cardia gastric cancer	2,031 Han Chinese ancestry cases, 4,970 Han Chinese ancestry controls	3,564 Han Chinese ancestry cases, 4,637 Han Chinese ancestry controls	8q24.3	8	142680513	PSCA	PSCA			8000			rs2294008-T	rs2294008	0	2294008	5_prime_UTR_variant	0	0.26	6E-11	10.221848749616356		1.2	[1.15-1.28]	Affymetrix, Illumina [6223896] (imputed)	N
2016-10-10	26701879	Wang Z	2015-12-23	Gut	www.ncbi.nlm.nih.gov/pubmed/26701879	Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.	Non-cardia gastric cancer	2,031 Han Chinese ancestry cases, 4,970 Han Chinese ancestry controls	3,564 Han Chinese ancestry cases, 4,637 Han Chinese ancestry controls	2q37.1	2	234557214	intergenic	ARL4C - LOC105373936	10123	105373936		60161	38989	rs1108143-G	rs1108143	0	1108143	intergenic_variant	1	0.11	3E-7	6.522878745280337		1.23	[1.14-1.34]	Affymetrix, Illumina [6223896] (imputed)	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia)	303 Japanese ancestry cases, 880 Japanese ancestry controls	23 Japanese ancestry cases	2q23.3	2	152100897	CACNB4	CACNB4 - STAM2	785	10254		909	15904	rs3820706-G	rs3820706	0	3820706	intron_variant	1	0.57	2E-9	8.698970004336019	(Recessive)	2.38	[1.44-3.93]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia)	303 Japanese ancestry cases, 880 Japanese ancestry controls	23 Japanese ancestry cases	2q23.3	2	152124821	STAM2	STAM2			10254			rs16830728-T	rs16830728	0	16830728	intron_variant	0	0.59	3E-8	7.522878745280337	(Recessive)	3.61	[2.17-5.98]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia)	303 Japanese ancestry cases, 880 Japanese ancestry controls	23 Japanese ancestry cases	10q21.1	10	54444531	PCDH15	PCDH15			65217			rs7476422-G	rs7476422	0	7476422	intron_variant	0	0.82	3E-7	6.522878745280337	(Allelic)	2.06	[1.54-2.75]	Illumina [555600]	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	5q31.2	5	139481561	TMEM173	TMEM173			340061			rs7447927-C	rs7447927	0	7447927	synonymous_variant	0	0.54	8E-20	19.096910013008056		1.18	[1.14-1.22]	Affymetrix, Illumina [7556215] (imputed)	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	17p13.1	17	7654516	TP53, ATP1B2	ATP1B2			482			rs1642764-C	rs1642764	0	1642764	intron_variant	0	0.501	3E-13	12.522878745280337		1.14	[1.1-1.18]	Affymetrix, Illumina [7556215] (imputed)	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	6p21.32	6	32621489	HLA	HLA-DRB1 - LOC107986589	3123	107986589		31653	15699	rs35597309-A	rs35597309	0	35597309	intergenic_variant	1	0.072	1E-7	7.0		1.19	[1.12-1.27]	Affymetrix, Illumina [7556215] (imputed)	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	9p21.3	9	21997016	CDKN2B, CDKN2A	CDKN2B-AS1			100048912			rs61271866-A	rs61271866	0	61271866	intron_variant	0	0.190	7E-7	6.154901959985743		1.11	[1.07-1.16]	Affymetrix, Illumina [7556215] (imputed)	N
2015-04-16	25129146	Wu C	2014-08-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25129146	Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.	Esophageal squamous cell carcinoma	5,337 Han Chinese ancestry cases, 5,787 Han Chinese ancestry controls	9,654 Han Chinese ancestry cases, 10,058 Han Chinese ancestry  controls	8q24.22	8	132107714	NR	HHLA1 - KCNQ3	10086	3786		2449	13144	rs7822239-A	rs7822239	0	7822239	intron_variant	1	0.73	8E-6	5.096910013008056		1.1	[1.05-1.14]	Affymetrix, Illumina [7556215] (imputed)	N
2016-10-10	26701879	Wang Z	2015-12-23	Gut	www.ncbi.nlm.nih.gov/pubmed/26701879	Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.	Non-cardia gastric cancer	2,031 Han Chinese ancestry cases, 4,970 Han Chinese ancestry controls	3,564 Han Chinese ancestry cases, 4,637 Han Chinese ancestry controls	5p13.1	5	40791782	PRKAA1	PRKAA1			5562			rs13361707-C	rs13361707	0	13361707	intron_variant	0	0.503	1E-10	10.0		1.32	[0.88-1.43]	Affymetrix, Illumina [6223896] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial cancer	2,082 European ancestry endometrioid cases, 130 European ancestry cases,  9,544 European ancestry controls	4,553 European ancestry endometrioid cases, 972 European ancestry cases, 27,600 European ancestry controls	8q24.21	8	128525500	MYC	LINC00824			101927774			rs17232730-G	rs17232730	0	17232730	intron_variant	0	0.88	4E-7	6.3979400086720375		1.14	[1.07-1.2]	Illumina [up to 2300000] (imputed)	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Lung adenocarcinoma	739 African American cases, 3,601 African American controls	up to 311 African American cases, up to 1,137  African American controls	5p15.33	5	1287079	TERT	TERT			7015			rs2853677-C	rs2853677	0	2853677	intron_variant	0	0.273	1E-8	8.0		1.37	[1.23-1.53]	Illumina [1024001]	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial cancer	2,082 European ancestry endometrioid cases, 130 European ancestry cases,  9,544 European ancestry controls	4,553 European ancestry endometrioid cases, 972 European ancestry cases, 27,600 European ancestry controls	13q22.1	13	73240754	KLF12	RNY1P8 - MARK2P12	100873807	100421565		13494	167035	rs11841589-G	rs11841589	0	11841589	intergenic_variant	1	0.74	5E-11	10.301029995663981		1.15	[1.11-1.21]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial cancer	2,082 European ancestry endometrioid cases, 130 European ancestry cases,  9,544 European ancestry controls	4,553 European ancestry endometrioid cases, 972 European ancestry cases, 27,600 European ancestry controls	6q22.31	6	125695434	HEY2, NCOA7	LOC643623, LOC105377986			643623, 105377986			rs13328298-G	rs13328298	0	13328298	intron_variant	0	0.58	4E-10	9.397940008672037		1.13	[1.09-1.18]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial cancer	2,082 European ancestry endometrioid cases, 130 European ancestry cases,  9,544 European ancestry controls	4,553 European ancestry endometrioid cases, 972 European ancestry cases, 27,600 European ancestry controls	8q24.21	8	128587032	MYC	LINC00824 - LINC00977	101927774	728724		22353	629435	rs4733613-C	rs4733613	0	4733613	intergenic_variant	1	0.13	3E-9	8.522878745280337		1.1904762	[1.12-1.25]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial cancer	2,082 European ancestry endometrioid cases, 130 European ancestry cases,  9,544 European ancestry controls	4,553 European ancestry endometrioid cases, 972 European ancestry cases, 27,600 European ancestry controls	15q15.1	15	40029923	EIF2AK, BMF	EIF2AK4			440275			rs937213-C	rs937213	0	937213	intron_variant	0	0.42	2E-8	7.698970004336019		1.1111112	[1.08-1.16]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial cancer	2,082 European ancestry endometrioid cases, 130 European ancestry cases,  9,544 European ancestry controls	4,553 European ancestry endometrioid cases, 972 European ancestry cases, 27,600 European ancestry controls	14q32.33	14	104776883	AKT1, SIVA1	AKT1			207			rs2498796-A	rs2498796	0	2498796	non_coding_transcript_exon_variant	0	0.3	4E-8	7.3979400086720375		1.1235955	[1.08-1.18]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial cancer	2,082 European ancestry endometrioid cases, 130 European ancestry cases,  9,544 European ancestry controls	4,553 European ancestry endometrioid cases, 972 European ancestry cases, 27,600 European ancestry controls	17q12	17	37743574	HNF1B	HNF1B			6928			rs11263763-A	rs11263763	0	11263763	intron_variant	0	0.54	3E-19	18.522878745280337		1.2	[1.15-1.25]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial cancer	2,082 European ancestry endometrioid cases, 130 European ancestry cases,  9,544 European ancestry controls	4,553 European ancestry endometrioid cases, 972 European ancestry cases, 27,600 European ancestry controls	15q21.2	15	51245609	CYP19A1	CYP19A1			1588			rs2414098-C	rs2414098	0	2414098	intron_variant	0	0.62	5E-13	12.301029995663981		1.17	[1.13-1.23]	Illumina [up to 2300000] (imputed)	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in gastrointestinal cancer	204 cases	NA	10q26.2	10	127338145	DOCK1	DOCK1			1793			rs4751240-?	rs4751240	0	4751240	intron_variant	0		2E-8	7.698970004336019		0.1	[0.067-0.133] kg/m2 increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in gastrointestinal cancer	204 cases	NA	8p22	8	18870439	PSD3	PSD3			23362			rs3758141-?	rs3758141	0	3758141	intron_variant	0		7E-6	5.154901959985743		0.087	[0.050-0.124] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in gastrointestinal cancer	204 cases	NA	14q23.1	14	57844417	SLC35F4	SLC35F4			341880			rs927251-?	rs927251	0	927251	intron_variant	0		9E-6	5.045757490560675		0.083	[0.048-0.118] unit increase	Affymetrix [418365]	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	10q26.13	10	121425789	WDR11, FGFR2	RN7SKP167 - FGFR2	106479169	2263		14589	52541	rs10749415-?	rs10749415	0	10749415	intergenic_variant	1	0.95	9E-25	24.045757490560675	(conditional on Round 3 SNPs)	0.117	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50851141	KLK3	LOC105372441			105372441			rs11665748-?	rs11665748	0	11665748	upstream_gene_variant	0	0.65	3E-54	53.52287874528034	(conditional on Round 1 SNPs)	0.09	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	13q14.3	13	50871978	intergenic	DLEU7-AS1 - RNASEH2B-AS1	100874074	100874255		22073	10400	rs12429206-?	rs12429206	0	12429206	intron_variant	1	0.343	7E-8	7.154901959985743	(conditional on Round 3 SNPs)	0.031	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	11q24.3	11	129444288	intergenic	BARX2, LOC107984410			8538, 107984410			rs147520802-?	rs147520802	0	147520802	intron_variant	0	0.017	3E-6	5.522878745280337	(conditional on Round 4 SNPs)	0.109	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	8q24.21	8	127330621	MYC	CASC21, CASC8			103021164, 727677			rs17464492-?	rs17464492	0	17464492	intron_variant	0	0.71	2E-10	9.698970004336019	(conditional on Round 1 SNPs)	0.04	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	3q23	3	141414608	ZBTB38	ZBTB38			253461			rs1991431-?	rs1991431	0	1991431	intron_variant	0	0.43	3E-11	10.522878745280337	(conditional on Round 1 SNPs)	0.037	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	10q26.12	10	120915337	WDR11, FGFR2	LOC105378519			105378519			rs200367988-?	rs200367988	0	200367988	intergenic_variant	0	0.33	5E-18	17.30102999566398	(conditional on Round 1 SNPs)	0.051	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	10p12.1	10	27805490	ARMC4	ARMC4			55130			rs2492906-?	rs2492906	0	2492906	intergenic_variant	0	0.79	1E-8	8.0	(conditional on Round 1 SNPs)	0.037	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50845834	KLK3	LOC105372441			105372441			rs266849-A	rs266849	0	266849	intron_variant	0	0.79	4E-17	16.397940008672037	(conditional on Round 4 SNPs)	0.057	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50849681	KLK3	LOC105372441			105372441			rs266868-?	rs266868	0	266868	intron_variant	0	0.71	1E-14	14.0	(conditional on Round 3 SNPs)	0.046	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50870023	KLK2	KLK3 - KLK2	354	3817		9259	3410	rs2739472-?	rs2739472	0	2739472	intron_variant	1	0.56	8E-10	9.096910013008056	(conditional on Round 6 SNPs)	0.034	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	8p21.2	8	23609471	SLC25A37	RNU4-71P - FAM60DP	106481194	646721		9333	25404	rs4614003-?	rs4614003	0	4614003	intergenic_variant	1	0.296	1E-15	15.0	(conditional on Round 1 SNPs)	0.05	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	10q26.13	10	121572176	intergenic	FGFR2			2263			rs4752569-?	rs4752569	0	4752569	intron_variant	0	0.503	1E-11	11.0	(conditional on Round 2 SNPs)	0.038	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	8q24.21	8	127461280	intergenic	CASC8			727677			rs4871796-?	rs4871796	0	4871796	intron_variant	0	0.073	4E-6	5.3979400086720375	(conditional on Round 2 SNPs)	0.048	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	2p15	2	63050708	intergenic	OTX1			5013			rs58235267-?	rs58235267	0	58235267	intron_variant	0	0.471	6E-7	6.221848749616356	(conditional on Round 2 SNPs)	0.027	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	Xp22.2	X	16812550	TXLNG	TXLNG			55787			rs5969745-?	rs5969745	0	5969745	intron_variant	0	0.6	3E-13	12.522878745280337	(conditional on Round 1 SNPs)	0.03	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50876854	KLK2	KLK2			3817			rs6070-?	rs6070	0	6070	non_coding_transcript_exon_variant	0	0.65	4E-16	15.397940008672037	(conditional on Round5 SNPs	0.048	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50858126	KLK3	KLK3			354			rs61752561-?	rs61752561	0	61752561	missense_variant	0	0.97	2E-25	24.69897000433602	(conditional on Round 2 SNPs)	0.172	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	16q23.2	16	79821935	intergenic	LINC01229 - LOC105371357	101928248	105371357		20592	229416	rs66624999-?	rs66624999	0	66624999	intron_variant	1	0.864	2E-7	6.698970004336019	(conditional on Round 2 SNPs)	0.04	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	13q14.11	13	41321130	intergenic	NAA16			79612			rs74922337-?	rs74922337	0	74922337	intron_variant	0	0.917	2E-7	6.698970004336019	(conditional on Round 1 SNPs)	0.055	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	13q14.3	13	50507855	intergenic	DLEU1			10301			rs9596300-?	rs9596300	0	9596300	intron_variant	0	0.853	1E-8	8.0	(conditional on Round 1 SNPs)	0.045	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	1q32.1	1	205667206	SLC45A3	SLC45A3			85414			rs4951018-C	rs4951018	0	4951018	intron_variant	0	0.22	1E-8	8.0		0.0394282	[0.027-0.052] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	2p16.1	2	60532612	BCL11A	BCL11A			53335			rs2556375-G	rs2556375	0	2556375	intron_variant	0	0.17	6E-19	18.221848749616356		0.0652336	[0.051-0.08] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	4q32.1	4	156613097	PDGFC	LOC105377508 - LOC107986322	105377508	107986322		282496	9928	rs10023685-G	rs10023685	0	10023685	intergenic_variant	1	0.37	2E-9	8.698970004336019		0.0346789	[0.023-0.046] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	5p15.33	5	1356569	TERT, CLPTM1L	CLPTM1L - LINC01511	81037	100506791		11499	7013	rs37004-C	rs37004	0	37004	intron_variant	1	0.79	9E-13	12.045757490560675		0.0604747	[0.044-0.077] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	6p21.1	6	43742611	VEGFA	LOC100132242 - VEGFA	100132242	7422		35854	27598	rs6920449-T	rs6920449	0	6920449	upstream_gene_variant	1	0.16	6E-12	11.221848749616356		0.0529541	[0.038-0.068] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	8p21.2	8	23670998	NKX3-1	LOC107986930			107986930			rs13272392-T	rs13272392	0	13272392	intergenic_variant	0	0.43	4E-34	33.39794000867204		0.0685113	[0.057-0.08] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	8q24.21	8	127395198	MYC	CASC8			727677			rs10505477-A	rs10505477	0	10505477	intron_variant	0	0.49	7E-21	20.154901959985743		0.0525797	[0.042-0.064] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	9q33.1	9	117970471	TLR4	LOC105376243 - LOC105376246	105376243	105376246		93497	27177	rs6478343-C	rs6478343	0	6478343	intergenic_variant	1	0.82	2E-8	7.698970004336019		0.0415085	[0.027-0.056] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10p12.31	10	22292652	COMMD3, BMI1, SPAG6	RPL31P45 - COMMD3-BMI1	729308	100532731		25447	23731	rs116940348-A	rs116940348	0	116940348	intergenic_variant	1	0.03	1E-14	14.0		0.144017	[0.11-0.18] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.39	1E-50	50.0		0.0843414	[0.073-0.095] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	11p13	11	34761870	EHF, APIP	LOC102723568			102723568			rs4378355-C	rs4378355	0	4378355	intergenic_variant	0	0.39	2E-10	9.698970004336019		0.0368406	[0.025-0.048] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	11q22.2	11	102525876	MMP7	MMP7			4316			rs12285347-C	rs12285347	0	12285347	intron_variant	0	0.46	8E-12	11.096910013008056		0.038463	[0.027-0.049] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	12q24.21	12	114656455	TBX3	OSTF1P1 - TBX3	386654	6926		67656	13799	rs11067228-A	rs11067228	0	11067228	downstream_gene_variant	1	0.54	1E-14	14.0		0.0439143	[0.033-0.055] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	14q32.13	14	94631219	SERPINA3	SERPINA3 - ADIPOR1P2	12	390503		7166	2453	rs8023057-A	rs8023057	0	8023057	upstream_gene_variant	1	0.82	2E-15	14.698970004336019		0.06069	[0.046-0.076] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	16p13.3	16	4299110	GLIS2, TFAP4	TFAP4 - GLIS2	7023	84662		26110	15651	rs9921192-C	rs9921192	0	9921192	regulatory_region_variant	1	0.5	1E-9	9.0		0.0350975	[0.024-0.046] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q12	19	31614073	THEG5	THEG5 - RNA5SP471	100507527	100873714		20523	41283	rs11084596-T	rs11084596	0	11084596	intergenic_variant	1	0.61	1E-15	15.0		0.0475551	[0.036-0.059] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19	50858501	KLK3	KLK3			354			rs17632542-T	rs17632542	0	17632542	missense_variant	0	0.92	2E-340	339.69897000433605		0.435333	[0.41-0.46] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	Xp22.13	X	17802225	RAI2	RAI2			10742			rs16980679-G	rs16980679	0	16980679	intron_variant	0	0.95	3E-15	14.522878745280337		0.0765243	[0.058-0.096] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	Xp11.21	X	55910389	RRAGB	KLF8			11279			rs10855058-A	rs10855058	0	10855058	intron_variant	0	0.3	1E-8	8.0		0.0254562	[0.017-0.034] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	4q31.22	4	145953076	ZNF827	ZNF827 - LOC105377468	152485	105377468		14068	99310	rs56935123-AT	rs56935123	0	56935123	intergenic_variant	1	0.45	4E-9	8.397940008672037		0.0351137	[0.023-0.047] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	7p15.1	7	27936944	JAZF1	JAZF1			221895			rs10486567-G	rs10486567	0	10486567	intron_variant	0	0.76	4E-19	18.397940008672037		0.0575792	[0.045-0.07] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	9q33.2	9	120881149	PHF19	PHF19			26147			rs59482735-T	rs59482735	0	59482735	intron_variant	0	0.32	4E-9	8.397940008672037		0.0363711	[0.024-0.048] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.12	10	121289750	FGFR2	LINC01153 - LOC105378523	101927889	105378523		103784	1858	rs10886902-C	rs10886902	0	10886902	intergenic_variant	1	0.24	2E-53	52.69897000433602		0.100774	[0.088-0.114] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	13q14.3	13	50513307	DLEU1	DLEU1			10301			rs202346-A	rs202346	0	202346	intron_variant	0	0.25	3E-22	21.522878745280337		0.061691	[0.049-0.074] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	17q12	17	37737784	HNF1B	HNF1B			6928			rs11263761-A	rs11263761	0	11263761	intron_variant	0	0.51	6E-20	19.221848749616356		0.0515111	[0.04-0.063] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	1p22.3	1	87724354	LMO4	LOC107985518 - LOC107985519	107985518	107985519		93905	174279	rs6662386-C	rs6662386	0	6662386	intergenic_variant	1	0.44	7E-20	19.154901959985743		0.051711	[0.041-0.063] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	Xp22.11	X	24041058	EIF2S3, KLHL15	KLHL15 - EIF2S3	80311	1968		13872	13890	rs6627995-T	rs6627995	0	6627995	intergenic_variant	1	0.33	1E-13	13.0		0.0343829	[0.025-0.043] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.12	10;10	120915337;121289750	FGFR2, WDR11, 7SK	No mapped genes; LOC105378519; LINC01153 - LOC105378523						rs10749415-A; rs200367988-A; rs10886902-T	 rs10749415; rs200367988; rs10886902	0		intergenic_variant; intergenic_variant		0.148	4E-18	17.397940008672037		0.091	unit increase	Affymetrix [10109774] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	2p11.2	2	85567174	GGCX, VAMP8, VAMP5, RNF181	GGCX - RN7SL126P	2677	106479268		5640	488	rs10187424-A	rs10187424	0	10187424	intron_variant	1	0.59	3E-15	14.522878745280337		1.09	[1.06-1.12]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	2q37.3	2	237478585	intergenic	COL6A3 - LOC105373957	1293	105373957		43763	7115	rs7584330-C	rs7584330	0	7584330	intergenic_variant	1	0.22	3E-9	8.522878745280337		1.06	[1.02-1.09]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	3q23	3	141383991	ZBTB38	ZBTB38			253461			rs6763931-T	rs6763931	0	6763931	intron_variant	0	0.45	2E-8	7.698970004336019		1.04	[1.01-1.07]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	3q26.2	3	170412314	CLDN11, SKIL	SKIL - CLDN11	6498	5010		15465	6551	rs10936632-A	rs10936632	0	10936632	intron_variant	1	0.52	7E-22	21.154901959985743		1.11	[1.08-1.14]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	5p15.33	5	1279913	TERT	TERT			7015			rs2242652-G	rs2242652	0	2242652	intron_variant	0	0.81	3E-24	23.522878745280337		1.15	[1.11-1.19]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	5p12	5	44365443	FGF10	FGF10			2255			rs2121875-G	rs2121875	0	2121875	intron_variant	0	0.34	4E-8	7.3979400086720375		1.05	[1.02-1.08]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	6p21.33	6	31150734	CCHCR1	CCHCR1			54535			rs130067-G	rs130067	0	130067	missense_variant	0	0.21	3E-8	7.522878745280337		1.05	[1.02-1.09]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	12q13.12	12	49282227	PRPH	TUBA1C - LOC101927267	84790	101927267		8889	10404	rs10875943-C	rs10875943	0	10875943	intergenic_variant	1	0.31	7E-12	11.154901959985743		1.07	[1.04-1.10]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	Xq12	X	67801708	AR	BMI1P1 - OPHN1	100127902	4983		8659	240636	rs5919432-A	rs5919432	0	5919432	intergenic_variant	1	0.81	1E-8	8.0		1.06	[1.02-1.12]	NR [2600000] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	1q21.3	1	150685811	GOLPH3L	GOLPH3L			55204			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.22	6E-11	10.221848749616356	(EA)	1.1	[1.07-1.13]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	2p25.1	2	10570604	NOL10	LOC105373426 - NOL10	105373426	79954		23634	162	rs9287719-C	rs9287719	0	9287719	downstream_gene_variant	1	0.46	2E-8	7.698970004336019	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	4q13.3	4	72989536	COX18	LOC107986286, LOC105377273			107986286, 105377273			rs10009409-T	rs10009409	0	10009409	intergenic_variant	0	0.32	2E-10	9.698970004336019	(EA)	1.09	[1.06-1.12]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p24.2	6	11218797	NEDD9	NEDD9			4739			rs4713266-C	rs4713266	0	4713266	intron_variant	0	0.52	4E-8	7.3979400086720375	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p22.1	6	30105999	TRIM31	TRIM31, TRIM31-AS1			11074, 104533120			rs115457135-A	rs115457135	1	7767188	intron_variant	0	0.22	2E-8	7.698970004336019	(EA)	1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p21.32	6	32433162	HLA-DRB6	BTNL2 - HLA-DRA	56244	3122		24283	6680	rs115306967-G	rs115306967	1	3129859	intron_variant	1	0.65	3E-9	8.522878745280337	(EA)	1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	7p12.3	7	47397647	TNS3	TNS3			64759			rs56232506-A	rs56232506	0	56232506	intron_variant	0	0.45	2E-9	8.698970004336019	(EA)	1.07	[1.05-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	9p21.3	9	22041999	CDKN2B-AS1	CDKN2B-AS1			100048912			rs17694493-G	rs17694493	0	17694493	intron_variant	0	0.14	4E-8	7.3979400086720375	(EA)	1.1	[1.06-1.13]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	10q11.22	10	45587537	MARCH8	MARCH8			220972			rs76934034-T	rs76934034	0	76934034	intron_variant	0	0.91	5E-9	8.301029995663981	(EA)	1.14	[1.10-1.18]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	11q23.2	11	113936459	HTR3B	HTR3B			9177			rs11214775-G	rs11214775	0	11214775	intron_variant	0	0.71	3E-8	7.522878745280337	(EA)	1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	12q13.11	12	48025835	RP1-228P16.4	LOC105369750			105369750			rs80130819-A	rs80130819	0	80130819	upstream_gene_variant	0	0.91	4E-8	7.3979400086720375	(EA)	1.13	[1.08-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	14q24.2	14	70625539	TTC9	LOC101928075			101928075			rs8014671-G	rs8014671	0	8014671	intron_variant	0	0.59	1E-8	8.0	(EA)	1.07	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xp11.22	X	52867918	XAGE3	XAGE3			170626			rs2807031-C	rs2807031	0	2807031	intron_variant	0	0.18	9E-10	9.045757490560675	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xq13.1	X	70920000	SLC7A	TEX11 - SLC7A3	56159	84889		11283	5579	rs6625711-A	rs6625711	0	6625711	intergenic_variant	1	0.41	6E-12	11.221848749616356	(EA)	1.07	[1.05-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xq13.1	X	71188133	NLGN3, BCYRN1	LOC107985688			107985688			rs4844289-G	rs4844289	0	4844289	intron_variant	0	0.39	1E-9	9.0	(EA)	1.05	[1.04-1.07]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	20q13.13	20	50911385	ADNP	ADNP			23394			rs12480328-T	rs12480328	0	12480328	intron_variant	0	0.93	2E-7	6.698970004336019	(EA)	1.13	[1.08-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	21q22.3	21	41529494	TMPRSS2	TMPRSS2 - LOC105372809	7113	105372809		21336	23310	rs1041449-G	rs1041449	0	1041449	intron_variant	1	0.44	3E-7	6.522878745280337	(EA)	1.06	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	22q11.21	22	19770369	TBX1	TBX1			6899			rs2238776-G	rs2238776	0	2238776	intron_variant	0	0.8	2E-7	6.698970004336019	(EA)	1.09	[1.06-1.12]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	1p36.22	1	10496040	PEX14	PEX14			5195			rs636291-A	rs636291	0	636291	intron_variant	0	0.16	2E-8	7.698970004336019	(EA, early-onset)	1.18	[1.12-1.24]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	1q21.3	1	150685811	GOLPH3L	GOLPH3L			55204			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.22	3E-9	8.522878745280337		1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	2p25.1	2	10570604	NOL10	LOC105373426 - NOL10	105373426	79954		23634	162	rs9287719-C	rs9287719	0	9287719	downstream_gene_variant	1	0.46	3E-8	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	4q13.3	4	72989536	COX18	LOC107986286, LOC105377273			107986286, 105377273			rs10009409-T	rs10009409	0	10009409	intergenic_variant	0	0.32	2E-10	9.698970004336019		1.08	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p24.2	6	11218797	NEDD9	NEDD9			4739			rs4713266-C	rs4713266	0	4713266	intron_variant	0	0.52	3E-9	8.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p22.1	6	30105999	TRIM31	TRIM31, TRIM31-AS1			11074, 104533120			rs115457135-A	rs115457135	1	7767188	intron_variant	0	0.22	1E-7	7.0		1.07	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p21.32	6	32433162	HLA-DRB6	BTNL2 - HLA-DRA	56244	3122		24283	6680	rs115306967-G	rs115306967	1	3129859	intron_variant	1	0.65	9E-7	6.045757490560675		1.06	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	7p12.3	7	47397647	TNS3	TNS3			64759			rs56232506-A	rs56232506	0	56232506	intron_variant	0	0.45	9E-9	8.045757490560675		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	9p21.3	9	22041999	CDKN2B-AS1	CDKN2B-AS1			100048912			rs17694493-G	rs17694493	0	17694493	intron_variant	0	0.14	1E-6	6.0		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	10q11.22	10	45587537	MARCH8	MARCH8			220972			rs76934034-T	rs76934034	0	76934034	intron_variant	0	0.91	1E-8	8.0		1.13	[1.09-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	11q23.2	11	113936459	HTR3B	HTR3B			9177			rs11214775-G	rs11214775	0	11214775	intron_variant	0	0.71	5E-8	7.301029995663981		1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	12q13.11	12	48025835	RP1-228P16.4	LOC105369750			105369750			rs80130819-A	rs80130819	0	80130819	upstream_gene_variant	0	0.91	2E-9	8.698970004336019		1.14	[1.09-1.18]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	14q24.2	14	70625539	TTC9	LOC101928075			101928075			rs8014671-G	rs8014671	0	8014671	intron_variant	0	0.59	3E-7	6.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xp11.22	X	52867918	XAGE3	XAGE3			170626			rs2807031-C	rs2807031	0	2807031	intron_variant	0	0.18	3E-11	10.522878745280337		1.07	[1.05-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xq13.1	X	70920000	SLC7A	TEX11 - SLC7A3	56159	84889		11283	5579	rs6625711-A	rs6625711	0	6625711	intergenic_variant	1	0.41	6E-7	6.221848749616356		1.04	[1.03-1.06]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xq13.1	X	71188133	NLGN3, BCYRN1	LOC107985688			107985688			rs4844289-G	rs4844289	0	4844289	intron_variant	0	0.39	9E-8	7.045757490560675		1.04	[1.03-1.06]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	1q32.1	1	205788696	SLC41A1	LOC105371702 - SLC41A1	105371702	254428		5073	397	rs1775148-C	rs1775148	0	1775148	downstream_gene_variant	1	0.27	4E-8	7.3979400086720375		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6q14.1	6	75786165	MYO6	MYO6			4646			rs9443189-G	rs9443189	0	9443189	intron_variant	0	0.14	4E-8	7.3979400086720375		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	14q23.1	14	60655808	SIX1	SIX1 - SIX4	6495	51804		6319	53730	rs7153648-C	rs7153648	0	7153648	intron_variant	1	0.06	2E-9	8.698970004336019		1.11	[1.07-1.14]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	16q22.2	16	71657426	PHLPP2	PHLPP2			23035			rs12051443-A	rs12051443	0	12051443	intron_variant	0	0.34	3E-8	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	20q13.13	20	50911385	ADNP	ADNP			23394			rs12480328-T	rs12480328	0	12480328	intron_variant	0	0.93	5E-11	10.301029995663981		1.13	[1.10-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	21q22.3	21	41529494	TMPRSS2	TMPRSS2 - LOC105372809	7113	105372809		21336	23310	rs1041449-G	rs1041449	0	1041449	intron_variant	1	0.44	3E-8	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	22q11.21	22	19770369	TBX1	TBX1			6899			rs2238776-G	rs2238776	0	2238776	intron_variant	0	0.8	2E-8	7.698970004336019		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2009-06-14	19483681	Rapley EA	2009-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19483681	A genome-wide association study of testicular germ cell tumor.	Testicular germ cell tumor	730 cases, 1,435 controls	571 cases, 1,806 controls	1q24.1	1	165862412	intergenic	UCK2			7371			rs4657482-A	rs4657482	0	4657482	intron_variant	0	0.33	2E-6	5.698970004336019		1.14	[0.99-1.31]	Illumina [307666]	N
2009-06-14	19483681	Rapley EA	2009-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19483681	A genome-wide association study of testicular germ cell tumor.	Testicular germ cell tumor	730 cases, 1,435 controls	571 cases, 1,806 controls	4q24	4	103216633	intergenic	CENPE - LOC101929448	1062	101929448		18224	208409	rs4699052-C	rs4699052	0	4699052	intergenic_variant	1	0.61	2E-7	6.698970004336019		1.21	[1.05-1.39]	Illumina [307666]	N
2009-06-14	19483681	Rapley EA	2009-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19483681	A genome-wide association study of testicular germ cell tumor.	Testicular germ cell tumor	730 cases, 1,435 controls	571 cases, 1,806 controls	5q31.3	5	142302223	SPRY4	LOC107986455 - SPRY4	107986455	81848		109105	8204	rs4624820-A	rs4624820	0	4624820	intergenic_variant	1	0.54	3E-13	12.522878745280337		1.37	[1.19-1.58]	Illumina [307666]	N
2009-06-14	19483681	Rapley EA	2009-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19483681	A genome-wide association study of testicular germ cell tumor.	Testicular germ cell tumor	730 cases, 1,435 controls	571 cases, 1,806 controls	6p21.31	6	33574761	BAK1	BAK1			578			rs210138-G	rs210138	0	210138	intron_variant	0	0.20	1E-13	13.0		1.5	[1.28-1.75]	Illumina [307666]	N
2009-06-14	19483681	Rapley EA	2009-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19483681	A genome-wide association study of testicular germ cell tumor.	Testicular germ cell tumor	730 cases, 1,435 controls	571 cases, 1,806 controls	12q21.32	12	88496894	KITLG	KITLG			4254			rs995030-G	rs995030	0	995030	3_prime_UTR_variant	0	0.80	1E-31	31.0		2.55	[2.05-3.19]	Illumina [307666]	N
2009-06-14	19483681	Rapley EA	2009-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19483681	A genome-wide association study of testicular germ cell tumor.	Testicular germ cell tumor	730 cases, 1,435 controls	571 cases, 1,806 controls	12q21.32	12	88496894	KITLG	KITLG			4254			rs1508595-G	rs995030	0	995030	3_prime_UTR_variant	0	0.83	3E-30	29.522878745280337		2.69	[2.10-3.44]	Illumina [307666]	N
2011-04-29	21460395	Gu J	2011-04-02	Cancer Prev Res (Phila)	www.ncbi.nlm.nih.gov/pubmed/21460395	A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer.	Telomere length	459 individuals	1,160 individuals	20q12	20	39500359	DHX35	RN7SL680P - LOC102724950	106480380	102724950		150967	154964	rs6028466-?	rs6028466	0	6028466	intergenic_variant	1	NR	3E-7	6.522878745280337		0.19	[NR] unit increase	Illumina [312531]	N
2011-04-29	21460395	Gu J	2011-04-02	Cancer Prev Res (Phila)	www.ncbi.nlm.nih.gov/pubmed/21460395	A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer.	Telomere length	459 individuals	1,160 individuals	1p34.2	1	43179740	WDR65	LOC105378685, CFAP57			105378685, 149465			rs621559-?	rs621559	0	621559	intron_variant	0	NR	2E-6	5.698970004336019		0.16	[NR] unit increase	Illumina [312531]	N
2011-04-29	21460395	Gu J	2011-04-02	Cancer Prev Res (Phila)	www.ncbi.nlm.nih.gov/pubmed/21460395	A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer.	Telomere length	459 individuals	1,160 individuals	14q22.3	14	56058851	PELI2	LOC105370512 - LOC105370513	105370512	105370513		12036	36795	rs398652-?	rs398652	0	398652	intergenic_variant	1	NR	2E-6	5.698970004336019		0.12	[NR] unit increase	Illumina [312531]	N
2011-04-29	21460395	Gu J	2011-04-02	Cancer Prev Res (Phila)	www.ncbi.nlm.nih.gov/pubmed/21460395	A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer.	Telomere length	459 individuals	1,160 individuals	6q22.1	6	116765215	KPNA5	FAM162B			221303			rs654128-?	rs654128	0	654128	missense_variant	0	NR	3E-6	5.522878745280337		0.12	[NR] unit increase	Illumina [312531]	N
2014-03-02	23900074	Pooley KA	2013-07-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23900074	A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk.	Telomere length	2,240 European ancestry individuals	11,024 breast cancer cases, 15,065 controls	3q26.2	3	169810661	TERC	LRRC34			151827			rs10936601-?	rs10936601	0	10936601	intron_variant	0	0.27	4E-15	14.397940008672037		4.0E-4	[0.00029-0.00051] unit increase	Illumina, Perlegen [2448093] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Non-melanoma skin cancer	6,747 European ancestry individuals	2,078 European ancestry individuals	16q24.3	16	89919709	MC1R	MC1R			4157			rs1805007-C	rs1805007	0	1805007	missense_variant	0	NR	3E-10	9.522878745280337		0.34	[0.24-0.44] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	7p22.3	7	1929317	MAD1L1	MAD1L1			8379			rs12699477-C	rs12699477	0	12699477	intron_variant	0	0.38	6E-9	8.221848749616356		1.21	[1.14-1.29]	Illumina [NR]	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	16q12.1	16	50109033	HEATR3	HEATR3 - RPL10P14	55027	390729		1765	42186	rs8046148-?	rs8046148	0	8046148	intron_variant	1	NR	3E-6	5.522878745280337		1.2	[1.11-1.30]	Illumina [NR]	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	18q21.1	18	49583323	LIPG	LIPG			9388			rs9951026-?	rs9951026	0	9951026	intron_variant	0	NR	5E-6	5.301029995663981		1.22	[1.12-1.33]	Illumina [NR]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	10q24.2	10	98387303	PYROXD2	PYROXD2			84795			rs4345897-G	rs4345897	0	4345897	synonymous_variant	0	NR	2E-91	90.69897000433602	(Caprolactam)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	11q12.2	11	61803910	FADS1	FADS1			3992			rs174549-G	rs174549	0	174549	5_prime_UTR_variant	0	NR	2E-30	29.69897000433602	(Glycerolphosphocholine)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	2q34	2	210210185	ACADL	ACADL			33			rs3764913-T	rs3764913	0	3764913	non_coding_transcript_exon_variant	0	NR	4E-29	28.397940008672037	(2,6 dimethylheptanoyl carnitine)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	19p13.12	19	15879621	CYP4F2	CYP4F2			8529			rs2108622-T	rs2108622	0	2108622	missense_variant	0	NR	9E-24	23.045757490560675	(Glycerolphosphocholine)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	2q37.1	2	233759924	UGT1A8	UGT1A9, UGT1A5, UGT1A7, UGT1A, UGT1A8, UGT1A3, UGT1A10, UGT1A4, UGT1A6			54600, 54579, 54577, 7361, 54576, 54659, 54575, 54657, 54578			rs887829-T	rs887829	0	887829	intron_variant	0	NR	9E-25	24.045757490560675	(Bilirubin)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	7q21.3	7	95308945	PON1	PON1			5444			rs2057681-G	rs2057681	0	2057681	intron_variant	0	NR	7E-15	14.154901959985743	(C9H14Ona)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	15q21.3	15	58438954	LIPC	LOC101928694, LIPC			101928694, 3990			rs261342-C	rs261342	0	261342	intron_variant	0	NR	9E-13	12.045757490560675	(Glycerophospho-N-Palmitoyl Ethanolamine)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	12p12.1	12	21229685	SLCO1B1	SLCO1B1			10599			rs11045879-C	rs11045879	0	11045879	intron_variant	0	NR	5E-15	14.301029995663981	(Glycochenodeoxycholic acid 3-glucuronide)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	17q23.3	17	63492371	ACE	ACE			1636			rs4351-A	rs4351	0	4351	intron_variant	0	NR	9E-13	12.045757490560675	(Unknown)			Affymetrix [333722]	N
2015-11-21	25713168	Leng S	2015-02-23	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25713168	15q12 Variants, Sputum Gene Promoter Hypermethylation, and Lung Cancer Risk: A GWAS in Smokers.	Gene methylation in lung tissue	1,163 European ancestry smoker individuals	718 European ancestry smoker individuals	15q12	15	25539629	UBE3A	LOC105370737			105370737			rs73371737-A	rs73371737	0	73371737	intron_variant	0	0.11	3E-8	7.522878745280337		1.35	[1.21-1.50]	Illumina [1599980]	N
2015-11-21	25713168	Leng S	2015-02-23	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25713168	15q12 Variants, Sputum Gene Promoter Hypermethylation, and Lung Cancer Risk: A GWAS in Smokers.	Gene methylation in lung tissue	1,163 European ancestry smoker individuals	718 European ancestry smoker individuals	15q12	15	27078052	GABRG3	GABRG3			2567			rs7179575-C	rs7179575	0	7179575	intron_variant	0	0.64	4E-6	5.3979400086720375		1.2	[1.11-1.30]	Illumina [1599980]	N
2015-11-21	25713168	Leng S	2015-02-23	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25713168	15q12 Variants, Sputum Gene Promoter Hypermethylation, and Lung Cancer Risk: A GWAS in Smokers.	Gene methylation in lung tissue	1,163 European ancestry smoker individuals	718 European ancestry smoker individuals	15q12	15;15	27078052;25539629	UBE3A, GABRG3	GABRG3; LOC105370737						rs7179575-C; rs73371737-A	rs7179575; rs73371737	0		intron_variant; intron_variant		0.07	3E-9	8.522878745280337		1.57	[1.35-1.82]	Illumina [1599980]	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric adenocarcinoma (histologically verified)	2,043 European ancestry cases, 202,533 European ancestry controls	NA	1q22	1	155215184	MTX1, HCN3, MUC1	GBAP1			2630			rs140081212-G	rs140081212	1	2990223	non_coding_transcript_exon_variant	0	0.646	2E-8	7.698970004336019		1.2658228	[1.16-1.37]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric adenocarcinoma (histologically verified)	2,043 European ancestry cases, 202,533 European ancestry controls	NA				intergenic							chr11:102118158-A	chr11:102118158-A	0			1	0.0096	4E-7	6.3979400086720375		4.88	[2.65-8.98]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric adenocarcinoma (histologically verified)	2,043 European ancestry cases, 202,533 European ancestry controls	NA				intergenic							chr2:85874332-T	chr2:85874332	0			1	4.0E-4	8E-8	7.096910013008056		12.7	[5.03-32.08]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric adenocarcinoma (histologically verified)	2,043 European ancestry cases, 202,533 European ancestry controls	NA				ATM							chr11:107643195-T	chr11:107643195	0			1	0.0016	2E-7	6.698970004336019		4.84	[2.67-8.77]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric adenocarcinoma (histologically verified)	2,043 European ancestry cases, 202,533 European ancestry controls	NA				ATM							chr11:107629783-A	chr11:107629783	0			1	7.0E-4	1E-6	6.0		7.78	[3.38-17.91]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric adenocarcinoma (histologically verified)	2,043 European ancestry cases, 202,533 European ancestry controls	NA	20q12	20	41420939	CHD6	CHD6			84181			rs55864139-A	rs55864139	0	55864139	missense_variant	0	0.0029	7E-6	5.154901959985743		3.12	[1.9-5.11]	Illumina [~ 25000000] (imputed)	N
2016-07-14	26098866	Helgason H	2015-06-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26098866	Loss-of-function variants in ATM confer risk of gastric cancer.	Gastric adenocarcinoma (histologically verified)	2,043 European ancestry cases, 202,533 European ancestry controls	NA	8q24.3	8	142680513	PSCA	PSCA			8000			rs2294008-T	rs2294008	0	2294008	5_prime_UTR_variant	0	0.471	1E-6	6.0		1.21	[NR]	Illumina [~ 25000000] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Non-melanoma skin cancer	6,747 European ancestry individuals	2,078 European ancestry individuals	6p25.3	6	396321	IRF4	IRF4			3662			rs12203592-T	rs12203592	0	12203592	intron_variant	0	NR	7E-14	13.154901959985743		0.21	[0.15-0.27] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Non-melanoma skin cancer	6,747 European ancestry individuals	2,078 European ancestry individuals	6p25.3	6	471136	EXOC2, IRF4	LOC105374875			105374875			rs12202284-A	rs12202284	0	12202284	intergenic_variant	0	NR	5E-8	7.301029995663981		0.15	[0.091-0.209] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Non-melanoma skin cancer	6,747 European ancestry individuals	2,078 European ancestry individuals	14q22.1	14	51843386	GNG2	LOC101927598 - GNG2	101927598	54331		18367	3745	rs8015138-C	rs8015138	0	8015138	intron_variant	1	NR	7E-8	7.154901959985743		0.11	[0.071-0.149] unit decrease	Affymetrix, Illumina [7588169] (imputed)	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	1q24.1	1	165862412	UCK2	UCK2			7371			rs4657482-A	rs4657482	0	4657482	intron_variant	0	NR	6E-6	5.221848749616356		1.43	[1.22-1.67]	Illumina [NR]	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	6p21.31	6	33574761	BAK1	BAK1			578			rs210138-G	rs210138	0	210138	intron_variant	0	NR	3E-7	6.522878745280337		1.62	[1.35-1.95]	Illumina [NR]	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	12q21.32	12	88496894	KITLG	KITLG			4254			rs995030-A	rs995030	0	995030	3_prime_UTR_variant	0	NR	3E-13	12.522878745280337		2.3256	[1.85-2.94]	Illumina [NR]	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	9p24.3	9	863635	DMRT1	DMRT1			1761			rs755383-C	rs755383	0	755383	intron_variant	0	NR	4E-7	6.3979400086720375		1.5152	[1.3-1.79]	Illumina [NR]	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Smoking behaviour (cigarettes smoked per day)	up to 4737 African American individuals	NA	18q21.2	18	52471437	DCC	DCC			1630			rs1372626-?	rs1372626	0	1372626	intron_variant	0	NR	3E-6	5.522878745280337				Illumina [1024001]	N
2017-03-20	27393504	Zanetti KA	2016-05-13	Lung Cancer	www.ncbi.nlm.nih.gov/pubmed/27393504	Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.	Smoking status (current vs former)	2029 African American current smoker individuals,  1748 African American former smoker individuals	NA	6q25.1	6	151696556	ESR1	ESR1			2099			rs1293936-?	rs1293936	0	1293936	intron_variant	0	NR	5E-7	6.301029995663981		1.28	[1.16-1.41]	Illumina [1024001]	N
2017-06-01	28177523	Lin Y	2017-02-22	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/28177523	Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma.	Basal cell carcinoma	17,187 European ancestry cases, 287,054 European ancestry controls	NA	2q33.1	2	201258272	CASP8	CASP8			841			rs3769823-A	rs3769823	0	3769823	missense_variant	0	0.30	4E-18	17.397940008672037		1.12	[NR]	Affymetrix, Illumina [8262488] (imputed)	N
2017-06-01	28177523	Lin Y	2017-02-22	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/28177523	Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma.	Basal cell carcinoma	17,187 European ancestry cases, 287,054 European ancestry controls	NA	10q21.2	10	62637778	ZNF365	LOC105378327, ZNF365			105378327, 22891			rs16917546-C	rs16917546	0	16917546	intron_variant	0	0.37	3E-7	6.522878745280337		1.06	[NR]	Affymetrix, Illumina [8262488] (imputed)	N
2014-07-22	24220699	Gudmundsson J	2013-11-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24220699	A common variant at 8q24.21 is associated with renal cell cancer.	Renal cell carcinoma	1,505 European ancestry cases, 67,725 European ancestry controls	906 European ancestry cases, 3,772 European ancestry controls	8q24.21	8;8	127877125;127877126	MYC, PVT1	PVT1; PVT1; PVT1						rs6470588-C; rs35252396-CG; rs6470589-G	rs6470588; rs35252396; rs6470589	0		intron_variant; intron_variant; intron_variant		0.46	5E-11	10.301029995663981		1.27	[1.18-1.37]	Illumina [785863] (imputed)	N
2013-02-06	23184150	Henrion M	2012-11-25	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23184150	Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.	Renal cell carcinoma	2,215 European ancestry cases, 8,566 European ancestry controls	3,739 European ancestry cases, 8,786 European ancestry controls	2q22.3	2	144450626	ZEB2	ZEB2			9839			rs12105918-?	rs12105918	0	12105918	intron_variant	0	0.056	2E-8	7.698970004336019		1.45	[1.20-1.75]	Illumina [284377]	N
2013-02-06	23184150	Henrion M	2012-11-25	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23184150	Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.	Renal cell carcinoma	2,215 European ancestry cases, 8,566 European ancestry controls	3,739 European ancestry cases, 8,786 European ancestry controls	5p13.3	5	32000377	PDZD2	PDZD2			23037			rs10054504-?	rs10054504	0	10054504	intron_variant	0	0.11	8E-7	6.096910013008056		1.37	[1.19-1.58]	Illumina [284377]	N
2015-11-12	25826619	Henrion MY	2015-03-31	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25826619	Common Variation at 1q24.1 (ALDH9A1) Is a Potential Risk Factor for Renal Cancer.	Renal cell carcinoma	2,215 Western European ancestry cases, 8,566 Western European ancestry controls	2,844 European ancestry cases, 7,270 European ancestry controls	2p21	2	46325462	EPAS1	EPAS1			2034			rs4953345-A	rs4953345	0	4953345	intron_variant	0	NR	5E-10	9.301029995663981	(Western European)	1.25	[1.17-1.33]	Illumina [up to 12182133] (imputed)	N
2015-11-12	25826619	Henrion MY	2015-03-31	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25826619	Common Variation at 1q24.1 (ALDH9A1) Is a Potential Risk Factor for Renal Cancer.	Renal cell carcinoma	2,215 Western European ancestry cases, 8,566 Western European ancestry controls	2,844 European ancestry cases, 7,270 European ancestry controls	2q22.3	2	144452349	ZEB2	ZEB2			9839			rs72858496-T	rs72858496	0	72858496	intron_variant	0	NR	2E-7	6.698970004336019	(Western European)	1.46	[1.32-1.60]	Illumina [up to 12182133] (imputed)	N
2015-11-12	25826619	Henrion MY	2015-03-31	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25826619	Common Variation at 1q24.1 (ALDH9A1) Is a Potential Risk Factor for Renal Cancer.	Renal cell carcinoma	2,215 Western European ancestry cases, 8,566 Western European ancestry controls	2,844 European ancestry cases, 7,270 European ancestry controls	11q13.3	11	69423355	AX746803, AK094674	LOC105369370 - LOC102724265	105369370	102724265		50843	2316	rs11263654-C	rs11263654	0	11263654	upstream_gene_variant	1	NR	1E-9	9.0	(Western European)	1.53	[1.39-1.67]	Illumina [up to 12182133] (imputed)	N
2014-04-02	24080446	Rudolph A	2013-11-04	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Lobular breast cancer (menopausal hormone therapy interaction)	541 European ancestry cases	676 European ancestry cases, 9,266 European ancestry controls	3q13.33	3	119542528	CD80	CD80			941			rs7648642-?	rs7648642	0	7648642	intron_variant	0		5E-6	5.301029995663981		1.5625	[1.28-1.89]	Illumina [2500000] (imputed)	N
2014-04-02	24080446	Rudolph A	2013-11-04	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Lobular breast cancer (menopausal hormone therapy interaction)	541 European ancestry cases	676 European ancestry cases, 9,266 European ancestry controls	17q12	17	34662519	TMEM132E	TMEM132E - LOC105371740	124842	105371740		23201	62990	rs11654964-?	rs11654964	0	11654964	intergenic_variant	1		3E-6	5.522878745280337		1.67	[1.35-2.06]	Illumina [2500000] (imputed)	N
2016-12-07	26908436	Siiskonen SJ	2016-02-12	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26908436	A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants.	Squamous cell carcinoma	745 European ancestry cases, 12,805 European ancestry controls	531 European ancestry cases, 551 European ancestry controls	16q24.3	16	89961218	DEF8	DEF8			54849			rs8063761-T	rs8063761	0	8063761	intron_variant	0	NR	2E-9	8.698970004336019		1.34	[1.22-1.47]	Affymetrix [2392512] (imputed)	N
2016-12-07	26908436	Siiskonen SJ	2016-02-12	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26908436	A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants.	Squamous cell carcinoma	745 European ancestry cases, 12,805 European ancestry controls	531 European ancestry cases, 551 European ancestry controls	6q26	6	161680146	PARK2	PARK2			5071			rs9689649-C	rs9689649	0	9689649	intron_variant	0	0.22	3E-6	5.522878745280337		1.38	[1.21-1.58]	Affymetrix [2392512] (imputed)	N
2016-12-07	26908436	Siiskonen SJ	2016-02-12	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26908436	A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants.	Squamous cell carcinoma	745 European ancestry cases, 12,805 European ancestry controls	531 European ancestry cases, 551 European ancestry controls	20q11.23	20	37388937	SRC	SRC			6714			rs754626-G	rs754626	0	754626	intron_variant	0	0.25	1E-6	6.0		1.32	[1.18-1.47]	Affymetrix [2392512] (imputed)	N
2016-12-07	26908436	Siiskonen SJ	2016-02-12	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26908436	A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants.	Squamous cell carcinoma	745 European ancestry cases, 12,805 European ancestry controls	531 European ancestry cases, 551 European ancestry controls	8q24.22	8	133471452	ST3GAL1	ST3GAL1			6482			rs9643297-G	rs9643297	0	9643297	intron_variant	0	0.31	8E-6	5.096910013008056		1.32	[1.17-1.50]	Affymetrix [2392512] (imputed)	N
2016-12-07	26908436	Siiskonen SJ	2016-02-12	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26908436	A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants.	Squamous cell carcinoma	745 European ancestry cases, 12,805 European ancestry controls	531 European ancestry cases, 551 European ancestry controls	5q12.3	5	65959844	ERBB2IP	ERBB2IP			55914			rs17247181-T	rs17247181	0	17247181	intron_variant	0	0.1	4E-6	5.3979400086720375		1.4	[1.21-1.62]	Affymetrix [2392512] (imputed)	N
2011-11-24	22037553	Haiman CA	2011-10-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22037553	A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.	Breast cancer	1,004 African American cases, 2,745 African American controls,1,718 European ancestry cases, 3,670 European ancestry controls	2,292 European ancestry cases, 16,901 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	1E-10	10.0		1.18	[1.13-1.25]	Illumina [3154485] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q31.1	2	173348166	CDCA7	LOC100289479 - CDCA7	100289479	83879		9705	5851	rs1550623-A	rs1550623	0	1550623	intron_variant	1	0.84	3E-8	7.522878745280337		1.06	[1.03-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5q11.2	5	59041654	PDE4D	PDE4D			5144			rs1353747-T	rs1353747	0	1353747	intron_variant	0	0.905	3E-8	7.522878745280337		1.09	[1.05-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8q21.13	8	75505702	HNF4G	HNF4G			3174			rs2943559-G	rs2943559	0	2943559	intron_variant	0	0.07	6E-15	14.221848749616356		1.13	[1.09-1.17	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10p12.31	10	22026914	DNAJC1	DNAJC1 - ADIPOR1P1	64215	645220		23146	137662	rs11814448-C	rs11814448	0	11814448	intergenic_variant	1	0.02	9E-16	15.045757490560675		1.26	[1.18-1.35]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	18q11.2	18	26990703	CHST9	CHST9			83539			rs1436904-T	rs1436904	0	1436904	intron_variant	0	0.6	3E-8	7.522878745280337		1.04	[1.02-1.06]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2012-11-30	22976474	Siddiq A	2012-09-13	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls	562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls	20q11.22	20	34000289	RALY, EIF2S2, ASIP	RALY			22913			rs2284378-T	rs2284378	0	2284378	intron_variant	0	0.31	1E-8	8.0		1.16	[1.10-1.22]	Illumina [2608509] (imputed)	N
2012-11-30	22976474	Siddiq A	2012-09-13	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls	562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls	6q14.1	6	81483392	FAM46A, C6orf37	LOC105377871			105377871			rs17530068-C	rs17530068	0	17530068	intergenic_variant	0	0.24	3E-7	6.522878745280337		1.16	[1.10-1.23]	Illumina [2608509] (imputed)	N
2012-11-30	22976474	Siddiq A	2012-09-13	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls	562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls	19p13.11	19	17282085	NR	ANKLE1			126549			rs8100241-G	rs8100241	0	8100241	missense_variant	0	NR	4E-8	7.3979400086720375		1.14	[NR]	Illumina [2608509] (imputed)	N
2012-11-30	22976474	Siddiq A	2012-09-13	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls	562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls	6q25.1	6	151666222	NR	ESR1			2099			rs9383938-T	rs9383938	0	9383938	intron_variant	0	NR	2E-10	9.698970004336019		1.28	[NR]	Illumina [2608509] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	1p36.22	1	10506158	PEX14	PEX14			5195			rs616488-A	rs616488	0	616488	intron_variant	0	0.67	2E-10	9.698970004336019		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	1p13.2	1	113905767	BCL2L15, AP4B1, DCLRE1B, HIPK1, PTPN22	DCLRE1B			64858			rs11552449-T	rs11552449	0	11552449	missense_variant	0	0.17	2E-8	7.698970004336019		1.07	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q14.2	2	120487546	intergenic	LINC01101 - LOC105373585	84931	105373585		21197	55312	rs4849887-C	rs4849887	0	4849887	intergenic_variant	1	0.902	4E-11	10.397940008672037		1.1	[1.06-1.14]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q31.1	2	172108243	METAP1D, DLX1, DLX2	DLX2-AS1			104326193			rs2016394-G	rs2016394	0	2016394	intron_variant	0	0.52	1E-8	8.0		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q35	2	217431785	DIRC3	DIRC3			729582			rs16857609-T	rs16857609	0	16857609	intron_variant	0	0.26	1E-15	15.0		1.08	[1.06-1.10]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	3p26.1	3	4700592	ITPR1, EGOT	ITPR1			3708			rs6762644-G	rs6762644	0	6762644	intron_variant	0	0.4	2E-12	11.698970004336019		1.07	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	3p24.1	3	30641447	TGFBR2	TGFBR2			7048			rs12493607-C	rs12493607	0	12493607	intron_variant	0	0.35	2E-8	7.698970004336019		1.06	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	4q24	4	105163621	TET2	TET2			54790			rs9790517-T	rs9790517	0	9790517	intron_variant	0	0.23	4E-8	7.3979400086720375		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	4q34.1	4	174925275	ADAM29	ADAM29			11086			rs6828523-C	rs6828523	0	6828523	intron_variant	0	0.87	4E-16	15.397940008672037		1.11	[1.09-1.15]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5q11.2	5	58888234	RAB3C	RAB3C - PDE4D	115827	5144		28840	80804	rs10472076-C	rs10472076	0	10472076	intergenic_variant	1	0.38	3E-8	7.522878745280337		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5q33.3	5	158817075	EBF1	EBF1			1879			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.43	2E-14	13.698970004336019		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	6p25.3	6	1318643	FOXQ1	FOXQ1 - LINC01394	94234	106144586		3885	2566	rs11242675-T	rs11242675	0	11242675	downstream_gene_variant	1	0.61	7E-9	8.154901959985743		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	6p23	6	13722291	RANBP9	RANBP9 - MCUR1	10048	63933		10709	64258	rs204247-G	rs204247	0	204247	intergenic_variant	1	0.43	8E-9	8.096910013008056		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	7q35	7	144377836	ARHGEF5, NOBOX	ARHGEF5			7984			rs720475-G	rs720475	0	720475	intron_variant	0	0.75	7E-11	10.154901959985743		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8p12	8	29652100	intergenic	RPL17P33 - LINC00589	646909	619351		19417	69159	rs9693444-A	rs9693444	0	9693444	intergenic_variant	1	0.32	9E-14	13.045757490560675		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8q21.13	8	75318066	intergenic	HIGD1AP6 - PKMP4	100874436	106480443		15492	58643	rs6472903-T	rs6472903	0	6472903	intron_variant	1	0.82	2E-17	16.69897000433602		1.1	[1.08-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8q24.21	8	128182395	MYC, MIR1208	MIR1208 - RN7SKP226	100302281	106480903		32207	38109	rs11780156-T	rs11780156	0	11780156	regulatory_region_variant	1	0.16	3E-11	10.522878745280337		1.07	[1.04-1.10]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	9q31.2	9	107543834	intergenic	LOC105376206 - LOC105376205	105376206	105376205		28619	22955	rs10759243-A	rs10759243	0	10759243	upstream_gene_variant	1	0.39	1E-8	8.0		1.06	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10p12.31	10	21744013	DNAJC1, MLLT10	LOC107984214			107984214			rs7072776-A	rs7072776	0	7072776	downstream_gene_variant	0	0.29	4E-14	13.397940008672037		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q25.2	10	113014168	TCF7L2	TCF7L2			6934			rs7904519-G	rs7904519	0	7904519	intron_variant	0	0.46	3E-8	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q26.12	10	121334387	intergenic	LOC105378523 - RN7SKP167	105378523	106479169		11442	76529	rs11199914-C	rs11199914	0	11199914	intergenic_variant	1	0.68	2E-8	7.698970004336019		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	11q13.1	11	65815595	DKFZp761E198, OVOL1, SNX32, CFL1, MUS81	OVOL1 - SNX32	5017	254122		18376	18041	rs3903072-G	rs3903072	0	3903072	regulatory_region_variant	1	0.53	9E-12	11.045757490560675		1.05	[1.04-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	11q24.3	11	129591276	intergenic	RPS27P20 - LINC01395	100271581	101929557		53103	20840	rs11820646-C	rs11820646	0	11820646	upstream_gene_variant	1	0.59	1E-9	9.0		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	12p13.1	12	14260997	intergenic	GNAI2P1 - RPL30P11	2772	100271303		5511	95868	rs12422552-C	rs12422552	0	12422552	regulatory_region_variant	1	0.26	4E-8	7.3979400086720375		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	12q22	12	95633983	NTN4	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-A	rs17356907	0	17356907	intron_variant	1	0.7	2E-22	21.69897000433602		1.1	[1.08-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	13q13.1	13	32398489	BRCA2, N4BP2L1, N4BP2L2	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.0080	5E-8	7.301029995663981		1.26	[1.14-1.39]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	14q13.3	14	36663564	PAX9, SLC25A21	PAX9			5083			rs2236007-G	rs2236007	0	2236007	intron_variant	0	0.79	2E-13	12.698970004336019		1.08	[1.05-1.1]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	14q24.1	14	68193711	RAD51L1	RAD51B			5890			rs2588809-T	rs2588809	0	2588809	intron_variant	0	0.16	1E-10	10.0		1.08	[1.05-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	14q32.11	14	91374725	CCDC88C	CCDC88C			440193			rs941764-G	rs941764	0	941764	intron_variant	0	0.34	4E-10	9.397940008672037		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	16q12.2	16	53779455	FTO, MIR1972-2	FTO			79068			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.6	6E-14	13.221848749616356		1.08	[1.05-1.1]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	16q23.2	16	80616908	CDYL2	CDYL2			124359			rs13329835-G	rs13329835	0	13329835	intron_variant	0	0.22	2E-16	15.698970004336019		1.08	[1.05-1.10]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	18q11.2	18	26757460	intergenic	PCAT18 - LOC105372035	728606	105372035		53822	65353	rs527616-G	rs527616	0	527616	intron_variant	1	0.62	2E-10	9.698970004336019		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	19p13.11	19	18460331	SSBP4, ISYNA1, ELL	ELL			8178			rs4808801-A	rs4808801	0	4808801	intron_variant	0	0.65	5E-15	14.301029995663981		1.08	[1.05-1.1]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	19q13.31	19	43782361	C19orf61, KCNN4, LYPD5, ZNF283	KCNN4 - LOC107987268	3783	107987268		222	1931	rs3760982-A	rs3760982	0	3760982	upstream_gene_variant	1	0.46	2E-10	9.698970004336019		1.06	[1.04-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	22q12.2	22	29225488	EMID1, RHBDD3, EWSR1, CHEK2	EMID1			129080			rs132390-C	rs132390	0	132390	intron_variant	0	0.036	3E-9	8.522878745280337		1.12	[1.07-1.18]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	22q13.1	22	40480230	MKL1	MKL1			57591			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.11	9E-19	18.045757490560675		1.12	[1.09-1.16]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	1p11.2	1	121538815	intergenic	EMBP1			647121			rs11249433-G	rs11249433	0	11249433	intron_variant	0	0.4	2E-26	25.69897000433602		1.09	[1.07-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q35	2	217041109	intergenic	LOC101928278, LOC105373874			101928278, 105373874			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.51	2E-57	56.69897000433602		1.14	[1.11-1.16]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	3p24.1	3	27374522	SLC4A7	SLC4A7			9497			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	2E-30	29.69897000433602		1.1	[1.08-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	7E-9	8.154901959985743		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5p12	5	44706396	intergenic	LOC102723839 - RN7SL383P	102723839	106479363		196114	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	0.25	2E-37	36.69897000433602		1.13	[1.10-1.15]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5q11.2	5	56736057	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-C	rs889312	0	889312	regulatory_region_variant	1	0.28	3E-36	35.52287874528034		1.12	[1.10-1.15]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	6q14.1	6	81483392	intergenic	LOC105377871			105377871			rs17530068-G	rs17530068	0	17530068	intergenic_variant	0	0.22	8E-9	8.096910013008056		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	6q25.1	6	151592978	ESR1	CCDC170			80129			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.07	2E-21	20.69897000433602		1.16	[1.12-1.21]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8q24.21	8	127343372	intergenic	CASC21, CASC8			103021164, 727677			rs13281615-G	rs13281615	0	13281615	intron_variant	0	0.41	1E-27	27.0		1.09	[1.07-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	9p21.3	9	22062135	CDKN2A, CDKN2B	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.17	6E-8	7.221848749616356		1.06	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	9q31.2	9	108126198	intergenic	LOC105376214			105376214			rs865686-T	rs865686	0	865686	intergenic_variant	0	0.62	1E-34	34.0		1.12	[1.1-1.14]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-G	rs10995190	0	10995190	intron_variant	0	0.84	1E-36	36.0		1.16	[1.14-1.19]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q22.3	10	79081391	ZMIZ1	ZMIZ1			57178			rs704010-T	rs704010	0	704010	intron_variant	0	0.38	7E-22	21.154901959985743		1.08	[1.06-1.10]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q26.13	10	121577821	FGFR2	FGFR2			2263			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.4	2E-170	169.69897000433602		1.27	[1.24-1.29]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	11p15.5	11	1887776	LSP1	LSP1			4046			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.31	2E-11	10.698970004336019		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	11q13.3	11	69513996	intergenic	LINC01488 - CCND1	101928292	595		20453	127109	rs614367-T	rs614367	0	614367	intergenic_variant	1	0.15	2E-63	62.69897000433602		1.21	[1.18-1.24]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.88	8E-31	30.096910013008056		1.16	[1.14-1.2]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	12q24.21	12	115398717	intergenic	LOC105370003			105370003			rs1292011-A	rs1292011	0	1292011	regulatory_region_variant	0	0.58	9E-22	21.045757490560675		1.09	[1.06-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	14q24.1	14	68567965	RAD51L1	RAD51B			5890			rs999737-C	rs999737	0	999737	intron_variant	0	0.77	3E-19	18.522878745280337		1.09	[1.06-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	2E-114	113.69897000433602		1.24	[1.21-1.27]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	17q22	17	54979110	COX11	STXBP4			252983			rs6504950-G	rs6504950	0	6504950	intron_variant	0	0.72	2E-13	12.698970004336019		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	21q21.1	21	15148511	NRIP1	LOC107985483 - LOC105372739	107985483	105372739		26075	40082	rs2823093-G	rs2823093	0	2823093	intergenic_variant	1	0.73	7E-16	15.154901959985743		1.09	[1.06-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2015-01-21	24880342	Wang Y	2014-06-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24880342	Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.	Lung cancer	3,442 European ancestry adenocarcinoma cases, 3,275 European ancestry squamous cell carcinoma cases, 4,631 cases, up to 15,861 controls	3,589 European ancestry adenocarcinoma cases, 3,202 European ancestry squamous cell carcinoma cases, 3,455 cases, up to 38,295 controls	13q13.1	13	32398489	BRCA2, FRY	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.0105	5E-20	19.30102999566398	(Squamous cell carcinoma)	2.47	[2.03-3.00]	Illumina [8900000] (imputed)	N
2015-01-21	24880342	Wang Y	2014-06-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24880342	Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.	Lung cancer	3,442 European ancestry adenocarcinoma cases, 3,275 European ancestry squamous cell carcinoma cases, 4,631 cases, up to 15,861 controls	3,589 European ancestry adenocarcinoma cases, 3,202 European ancestry squamous cell carcinoma cases, 3,455 cases, up to 38,295 controls	22q12.1	22	28725099	CHEK2	CHEK2			11200			rs17879961-A	rs17879961	0	17879961	missense_variant	0	0.9975	1E-13	13.0	(Squamous cell carcinoma)	2.63	[2.04-3.33]	Illumina [8900000] (imputed)	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	1,085 cancer cases, 237 COPD cases	NA	3q25.1	3	152136326	LOC401093	LOC107986047 - LOC101928166	107986047	101928166		166827	23138	rs188981-?	rs188981	0	188981	intron_variant	1		7E-6	5.154901959985743		0.025	unit decrease	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	1,085 cancer cases, 237 COPD cases	NA	16q22.2	16	72128203	PMFBP1	PMFBP1			83449			rs8044868-?	rs8044868	0	8044868	intron_variant	0		8E-6	5.096910013008056		0.029	[0.017-0.041] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	1,085 cancer cases, 237 COPD cases	NA	20p11.21	20	23851958	CST5	CST2 - CST5	1470	1473		25283	23977	rs11698834-?	rs11698834	0	11698834	intergenic_variant	1		9E-6	5.045757490560675		0.034	[0.018-0.050] unit decrease	Affymetrix [418365]	N
2011-04-13	21437268	McKay JD	2011-03-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21437268	A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium.	Oral cavity and pharyngeal cancer	2,091 European ancestry cases, 8,334 European ancestry controls	6,574 European ancestry cases, 7,892 European ancestry controls	4q23	4	99318162	ADH1B	ADH1B			125			rs1229984-T	rs1229984	0	1229984	missense_variant	0	0.94	1E-20	20.0		1.56	[1.41-1.69]	Illumina [294620]	N
2011-04-13	21437268	McKay JD	2011-03-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21437268	A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium.	Oral cavity and pharyngeal cancer	2,091 European ancestry cases, 8,334 European ancestry controls	6,574 European ancestry cases, 7,892 European ancestry controls	4q23	4	99420704	ADH7	ADH7			131			rs971074-G	rs971074	0	971074	synonymous_variant	0	NR	9E-17	16.045757490560675		1.33	[1.25-1.43]	Illumina [294620]	N
2011-04-13	21437268	McKay JD	2011-03-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21437268	A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium.	Oral cavity and pharyngeal cancer	2,091 European ancestry cases, 8,334 European ancestry controls	6,574 European ancestry cases, 7,892 European ancestry controls	4q23	4	99353129	ADH1C	ADH1C - LOC102723576	126	102723576		84	25726	rs1789924-C	rs1789924	0	1789924	upstream_gene_variant	1	NR	3E-7	6.522878745280337		1.12	[1.07-1.17]	Illumina [294620]	N
2011-04-13	21437268	McKay JD	2011-03-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21437268	A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium.	Oral cavity and pharyngeal cancer	2,091 European ancestry cases, 8,334 European ancestry controls	6,574 European ancestry cases, 7,892 European ancestry controls	4q21.23	4	83453327	HEL308, ADH, FAM175A	HELQ			113510			rs1494961-C	rs1494961	0	1494961	missense_variant	0	0.49	1E-8	8.0		1.12	[1.08-1.17]	Illumina [294620]	N
2011-04-13	21437268	McKay JD	2011-03-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21437268	A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium.	Oral cavity and pharyngeal cancer	2,091 European ancestry cases, 8,334 European ancestry controls	6,574 European ancestry cases, 7,892 European ancestry controls	12q24.13	12	112083644	ALDH2	NAA25			80018			rs4767364-A	rs4767364	0	4767364	intron_variant	0	0.29	2E-8	7.698970004336019		1.13	[1.08-1.18]	Illumina [294620]	N
2011-05-24	21499250	Spurdle AB	2011-04-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21499250	Genome-wide association study identifies a common variant associated with risk of endometrial cancer.	Endometrial cancer	1,265 European ancestry cases, 5,190 European ancestry controls	3,957 European ancestry cases, 6,886 European ancestry controls	17q12	17	37738049	HNF1B	HNF1B			6928			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.52	7E-10	9.154901959985743		1.19	[1.12-1.27]	Illumina [519655]	N
2011-05-24	21499250	Spurdle AB	2011-04-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21499250	Genome-wide association study identifies a common variant associated with risk of endometrial cancer.	Endometrial cancer	1,265 European ancestry cases, 5,190 European ancestry controls	3,957 European ancestry cases, 6,886 European ancestry controls	1p34.3	1	35222214	SFPQ	SFPQ - ZMYM4	6421	9202		29053	46480	rs673604-?	rs673604	0	673604	intergenic_variant	1	NR	6E-6	5.221848749616356		1.21	[1.12-1.32]	Illumina [519655]	N
2012-01-14	22180457	Kiyotani K	2011-12-16	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22180457	A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.	Response to tamoxifen in breast cancer	240 Japanese ancestry female cases	222 Japanese ancestry female cases	10q22.3	10	76397814	C10orf11	C10orf11			83938			rs10509373-C	rs10509373	0	10509373	intron_variant	0	0.024	6E-9	8.221848749616356		4.51	[2.72-7.51]	Illumina [470796]	N
2009-11-09	19836008	Landi MT	2009-10-15	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19836008	A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.	Lung adenocarcinoma	5,739 European ancestry cases, 5,848 European ancestry controls	7,561 European ancestry cases, 13,818 European ancestry controls	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-G	rs2736100	0	2736100	intron_variant	0	0.50	2E-10	9.698970004336019		1.12	[1.08-1.16]	Illumina [515922]	N
2009-11-09	19836008	Landi MT	2009-10-15	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19836008	A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.	Lung adenocarcinoma	5,739 European ancestry cases, 5,848 European ancestry controls	7,561 European ancestry cases, 13,818 European ancestry controls	15q25.1	15	78601997	CHRNA5, CHRNA3	CHRNA3			1136			rs1051730-T	rs1051730	0	1051730	synonymous_variant	0	0.35	2E-51	50.69897000433602		1.31	[1.27-1.36]	Illumina [515922]	N
2009-11-09	19836008	Landi MT	2009-10-15	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19836008	A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.	Lung adenocarcinoma	5,739 European ancestry cases, 5,848 European ancestry controls	7,561 European ancestry cases, 13,818 European ancestry controls	5p15.33	5	1342599	CLPTM1L	CLPTM1L			81037			rs31489-C	rs31489	0	31489	intron_variant	0	0.59	2E-10	9.698970004336019		1.12	[1.09-1.16]	Illumina [515922]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	2q36.3	2	228777706	intergenic	RPL7L1P10 - RPL17P14	106480729	100270941		23920	226180	rs11679180-?	rs11679180	0	11679180	intergenic_variant	1	NR	3E-6	5.522878745280337	(European, All type I)			Illumina [873935]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	10q26.2	10	126158100	ADAM12	ADAM12			8038			rs12778749-?	rs12778749	0	12778749	intron_variant	0	NR	9E-6	5.045757490560675	(European, All type I)			Illumina [873935]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	9p21.1	9	28587996	LINGO2	LINGO2, LOC105376004			158038, 105376004			rs2891316-?	rs2891316	0	2891316	intron_variant	0	NR	9E-6	5.045757490560675	(European, All type I)			Illumina [873935]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	6q22.31	6	125701456	LOC643623	LOC643623, LOC105377986			643623, 105377986			rs1777220-?	rs1777220	0	1777220	intron_variant	0	NR	2E-6	5.698970004336019	(European, All type I)			Illumina [873935]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	22q13.32	22	48345986	intergenic	LOC105373080 - LOC105373081	105373080	105373081		4251	5354	rs4407-?	rs4407	0	4407	intergenic_variant	1	NR	3E-6	5.522878745280337	(European, Endometroid subtype)			Illumina [873935]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	10q26.2	10	126158100	ADAM12	ADAM12			8038			rs12778749-?	rs12778749	0	12778749	intron_variant	0	NR	8E-6	5.096910013008056	(European, Endometroid subtype)			Illumina [873935]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	6q27	6	166922663	LOC100131869, RNASET2	RPS6KA2-AS1 - RNASET2	100861523	8635		17594	6846	rs9459805-?	rs9459805	0	9459805	intron_variant	1	NR	8E-6	5.096910013008056	(European, Endometroid subtype)			Illumina [873935]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	3p14.3	3	54983722	CACNA2D3	CACNA2D3			55799			rs3773582-?	rs3773582	0	3773582	intron_variant	0	NR	8E-6	5.096910013008056	(European, Endometroid subtype)			Illumina [873935]	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	17q22	17	58555182	C17orf47, RAD51C, PPM1E, SEPT4, TRIM37, SKA2, TEX14	SEPT4-AS1			101927688			rs9905704-T	rs9905704	0	9905704	intron_variant	0	0.68	4E-13	12.397940008672037		1.27	[1.18-1.33]	Illumina [NR]	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	16q23.1	16	74636560	RFWD3, GLG1, MLKL	RFWD3			55159			rs4888262-C	rs4888262	0	4888262	synonymous_variant	0	0.458	5E-12	11.301029995663981		1.26	[1.18-1.34]	Illumina [NR]	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	4q22.3	4	94303661	SMARCAD1, HPGDS	HPGDS			27306			rs17021463-T	rs17021463	0	17021463	intron_variant	0	0.42	1E-8	8.0		1.19	[1.12-1.26]	Illumina [NR]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	1p36.31	1	5853561	NPHP4	MIR4417 - MIR4689	100616489	100616421		289418	9111	rs548726-?	rs548726	0	548726	intergenic_variant	1	NR	5E-7	6.301029995663981				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	5q33.3	5	159477305	IL12B	LOC285627 - LOC105377685	285627	105377685		11029	27638	rs12657996-?	rs12657996	0	12657996	intron_variant	1	NR	9E-6	5.045757490560675				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	7p21.3	7	12351693	TMEM106B	VWDE			221806			rs6967385-?	rs6967385	0	6967385	missense_variant	0	NR	6E-6	5.221848749616356				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	10q21.2	10	61547717	TMEM26	TMEM26-AS1 - C10orf107	101928781	219621		54284	115210	rs2787702-?	rs2787702	0	2787702	intergenic_variant	1	NR	9E-6	5.045757490560675				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	10q21.2	10	61589009	C10orf107	TMEM26-AS1 - C10orf107	101928781	219621		95576	73918	rs1350172-?	rs1350172	0	1350172	regulatory_region_variant	1	NR	4E-7	6.3979400086720375				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	10q22.1	10	69503508	TSPAN15	TSPAN15			23555			rs1227969-?	rs1227969	0	1227969	intron_variant	0	NR	6E-7	6.221848749616356				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	11q24.1	11	121333892	SC5DL	SC5D - BMPR1APS2	6309	100533800		20482	27761	rs4936613-?	rs4936613	0	4936613	intergenic_variant	1	NR	6E-6	5.221848749616356				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	15q26.3	15	100711514	ASB7	ASB7 - LOC105371024	140460	105371024		59813	4538	rs184234-?	rs184234	0	184234	upstream_gene_variant	1	NR	1E-6	6.0				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	16p11.2	16	29895225	SEZ6L2	SEZ6L2			26470			rs4787484-?	rs4787484	0	4787484	intron_variant	0	NR	1E-6	6.0				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	17q21.31	17	43987619	PYY	PYY			5697			rs9895585-?	rs9895585	0	9895585	intron_variant	0	NR	9E-6	5.045757490560675				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	19p12	19	24039984	ZNF254	ZNF254			9534			rs7260598-?	rs7260598	0	7260598	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	21q22.3	21	41855386	PRDM15	PRDM15			63977			rs915832-?	rs915832	0	915832	intron_variant	0	NR	7E-6	5.154901959985743				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (placlitaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	Xq27.1	X	139035247	FGF13	FGF13			2258			rs10521792-?	rs10521792	0	10521792	intron_variant	0	NR	2E-7	6.698970004336019				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	1p31.1	1	82589116	TTLL7	ADGRL2 - LOC105378814	23266	105378814		596378	32357	rs10874322-?	rs10874322	0	10874322	intergenic_variant	1	NR	2E-6	5.698970004336019				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	1q43	1	237457939	RYR2	RYR2			6262			rs1478912-?	rs1478912	0	1478912	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	1q44	1	247051576	ZNF670	ZNF670-ZNF695, ZNF670			100533111, 93474			rs4925540-?	rs4925540	0	4925540	intron_variant	0	NR	2E-6	5.698970004336019				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	2q12.1	2	104542180	POU3F3	LINC01102 - LOC105373524	150568	105373524		29423	38641	rs17624523-?	rs17624523	0	17624523	intergenic_variant	1	NR	8E-6	5.096910013008056				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	3p25.1	3	14439270	SLC6A6	SLC6A6			6533			rs6790433-?	rs6790433	0	6790433	intron_variant	0	NR	1E-6	6.0				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	5p13.1	5	42288491	GHR	LOC101926960 - GHR	101926960	2690		113146	135284	rs11748684-?	rs11748684	0	11748684	intergenic_variant	1	NR	3E-6	5.522878745280337				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	7q21.11	7	82102130	CACNA2D1	CACNA2D1			781			rs258671-?	rs258671	0	258671	intron_variant	0	NR	1E-6	6.0				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	9p24.3	9	1456797	intergenic	LOC102723803			102723803			rs1412259-?	rs1412259	0	1412259	regulatory_region_variant	0	NR	4E-6	5.3979400086720375				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	11p15.3	11	12050956	DKK3	LOC105376554			105376554			rs923175-?	rs923175	0	923175	intron_variant	0	NR	7E-6	5.154901959985743				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	11q14.3	11	89769208	TRIM49	UBTFL2 - TRIM64DP	120126	727828		15228	7773	rs2130017-?	rs2130017	0	2130017	upstream_gene_variant	1	NR	8E-6	5.096910013008056				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	17q21.33	17	50211709	COL1A1	COL1A1 - LOC105371820	1277	105371820		10061	1923	rs2586502-?	rs2586502	0	2586502	intron_variant	1	NR	1E-6	6.0				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	18q11.2	18	24556605	HRH4	EIF4A3P1 - LOC729950	390843	729950		33697	71577	rs12954803-?	rs12954803	0	12954803	intergenic_variant	1	NR	8E-6	5.096910013008056				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	18q21.1	18	48289046	KIAA0427	ZBTB7C			201501			rs1944582-?	rs1944582	0	1944582	intron_variant	0	NR	4E-6	5.3979400086720375				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	19p12	19	24172691	ZNF254	HAVCR1P1 - LOC105376906	100101266	105376906		9244	3347413	rs11668609-?	rs11668609	0	11668609	intergenic_variant	1	NR	3E-6	5.522878745280337				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA				OSCAR							rs10423754-?	rs10423754	0	10423754	intron_variant	1	NR	9E-6	5.045757490560675				Affymetrix, Illumina [~ 1300000]	N
2012-12-06	23006423	Niu N	2012-09-24	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/23006423	Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.	Response to taxane treatment (docetaxel)	96 African American lymphoblastoid cell lines, 96 European ancestry lymphoblastoid cell lines, 96 Han Chinese ancestry lymphoblastoid cell lines	NA	20p12.1	20	16555769	C20orf23	KIF16B			55614			rs6044112-?	rs6044112	0	6044112	intron_variant	0	NR	7E-7	6.154901959985743				Affymetrix, Illumina [~ 1300000]	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	1q32.1	1	205673662	SLC45A3	SLC45A3			85414			rs2153904-C	rs2153904	0	2153904	intron_variant	0	0.5	1E-13	13.0		0.13	[0.091-0.169] unit decrease	Affymetrix [2163106] (imputed)	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	1q32.1	1	205787356	SLC41A1	LOC105371702 - SLC41A1	105371702	254428		3733	1737	rs6679073-C	rs6679073	0	6679073	downstream_gene_variant	1	0.5	4E-15	14.397940008672037		0.15	[0.11-0.19] unit decrease	Affymetrix [2163106] (imputed)	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	10q11.22	10	46052478	MSMB	MSMB - RPL23AP61	4477	728484		6209	10772	rs4631830-C	rs4631830	0	4631830	regulatory_region_variant	1	0.45	7E-11	10.154901959985743		0.12	[0.081-0.159] unit increase	Affymetrix [2163106] (imputed)	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	19q13.33	19	50842312	KLK3, KLK15	LOC105372441			105372441			rs2659051-G	rs2659051	0	2659051	intron_variant	0	0.66	9E-21	20.045757490560675		0.2	[0.16-0.24] unit decrease	Affymetrix [2163106] (imputed)	N
2016-06-08	26129866	Hu N	2015-06-30	Gut	www.ncbi.nlm.nih.gov/pubmed/26129866	Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.	Cardia gastric cancer	1,189 East Asian ancestry cases,  2,708 East Asian ancestry controls	3,738  East Asian ancestry cases,  7,548  East Asian ancestry controls	5p13.1	5	40790449	PRKAA1	PRKAA1			5562			rs10074991-G	rs10074991	0	10074991	intron_variant	0	0.483	7E-12	11.154901959985743		1.2048193	[1.14-1.27]	Illumina [556896]	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	1q32.1	1	205756218	NUCKS1, RAB7L1	NUCKS1 - RAB29	64710	8934		5974	11768	rs823123-G	rs823123	0	823123	intergenic_variant	1	0.16	5E-13	12.301029995663981		0.19	[0.13-0.25] unit increase	Affymetrix [2163106] (imputed)	N
2013-11-07	23666239	Chung CC	2013-05-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23666239	Meta-analysis identifies four new loci associated with testicular germ cell tumor.	Testicular germ cell tumor	582 European ancestry male cases, 1,056 European ancestry male controls	3,560 European ancestry male cases, 8,510 European ancestry male controls	5q31.3	5	142302223	SPRY4	LOC107986455 - SPRY4	107986455	81848		109105	8204	rs4624820-G	rs4624820	0	4624820	intergenic_variant	1	NR	8E-10	9.096910013008056		1.6393	[1.39-1.89]	Illumina [NR]	N
2014-05-12	24096698	De Vivo I	2013-10-06	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/24096698	Genome-wide association study of endometrial cancer in E2C2.	Endometrial cancer	up to 2,695 European ancestry cases, up to 2,777 European ancestry controls	up to 3,235 cases, up to 12,059 controls	22q13.32	22	48345986	intergenic	LOC105373080 - LOC105373081	105373080	105373081		4251	5354	rs4407-?	rs4407	0	4407	intergenic_variant	1	NR	2E-6	5.698970004336019	(Endometroid subtype)			Illumina [873935]	N
2014-02-04	21946351	Stacey SN	2011-09-25	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21946351	A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.	Basal cell carcinoma	2,121 European ancestry cases, 39,614 European ancestry controls	2,506 European and other ancestry cases, 15,101 European and other ancestry controls	17p13.1	17	7668434	TP53	TP53			7157			rs78378222-C	rs78378222	0	78378222	3_prime_UTR_variant	0	NR	2E-20	19.69897000433602		2.16	[1.83-2.54]	Illumina [~ 16000000] (imputed)	N
2014-02-11	19151717	Rafnar T	2009-01-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19151717	Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.	Basal cell carcinoma	1,505 European ancestry cases, 28,890 European ancestry controls	1,060 European ancestry cases, 515 European ancestry controls	5p15.33	5	1321972	TERT, CLPTM1L	CLPTM1L			81037			rs401681-C	rs401681	0	401681	intron_variant	0	0.56	4E-12	11.397940008672037		1.25	[1.18-1.34]	Illumina [302140]	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Adenocarcinoma	Up to 5,744 Chinese ancestry cases, up to 4,817 Chinese ancestry controls, up to 1,133 Japanese ancestry cases, up to 1,460 Japanese ancestry controls	Up to 4,647 Chinese ancestry cases, up to 4,099 Chinese ancestry controls, up to 1,231 Japanese ancestry cases, up to 2,947 Japanese ancestry controls	6p21.1	6	41525674	DQ141194	FOXP4-AS1			101060264			rs7741164-A	rs7741164	0	7741164	intron_variant	0	0.308	1E-12	12.0		1.18	[1.13-1.24]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Adenocarcinoma	Up to 5,744 Chinese ancestry cases, up to 4,817 Chinese ancestry controls, up to 1,133 Japanese ancestry cases, up to 1,460 Japanese ancestry controls	Up to 4,647 Chinese ancestry cases, up to 4,099 Chinese ancestry controls, up to 1,231 Japanese ancestry cases, up to 2,947 Japanese ancestry controls	9p21.3	9	22160088	Intergenic	CDKN2B-AS1 - DMRTA1	100048912	63951		38991	286753	rs72658409-?	rs72658409	0	72658409	intergenic_variant	1	0.927	2E-9	8.698970004336019		1.2987013	[1.19-1.41]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Adenocarcinoma	Up to 5,744 Chinese ancestry cases, up to 4,817 Chinese ancestry controls, up to 1,133 Japanese ancestry cases, up to 1,460 Japanese ancestry controls	Up to 4,647 Chinese ancestry cases, up to 4,099 Chinese ancestry controls, up to 1,231 Japanese ancestry cases, up to 2,947 Japanese ancestry controls	12q13.13	12	51955287	ACVR1B	ACVR1B			91			rs11610143-?	rs11610143	0	11610143	intron_variant	0	0.685	2E-9	8.698970004336019		1.1363636	[1.09-1.19]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Adenocarcinoma	Up to 5,744 Chinese ancestry cases, up to 4,817 Chinese ancestry controls, up to 1,133 Japanese ancestry cases, up to 1,460 Japanese ancestry controls	Up to 4,647 Chinese ancestry cases, up to 4,099 Chinese ancestry controls, up to 1,231 Japanese ancestry cases, up to 2,947 Japanese ancestry controls	17q25.3	17	78169467	SYNGR2	SYNGR2			9144			rs3794742-?	rs3794742	0	3794742	intron_variant	0	0.483	1E-6	6.0		1.098901	[1.06-1.15]	Affymetrix, Illumina [7564751] (imputed)	N
2016-11-16	26732429	Wang Z	2016-01-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/26732429	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.	Adenocarcinoma	Up to 5,744 Chinese ancestry cases, up to 4,817 Chinese ancestry controls, up to 1,133 Japanese ancestry cases, up to 1,460 Japanese ancestry controls	Up to 4,647 Chinese ancestry cases, up to 4,099 Chinese ancestry controls, up to 1,231 Japanese ancestry cases, up to 2,947 Japanese ancestry controls	8p22	8	17650455	Intergenic	MTUS1			57509			rs4921799-?	rs4921799	0	4921799	intron_variant	0	0.171	3E-6	5.522878745280337		1.1235955		Affymetrix, Illumina [7564751] (imputed)	N
2017-03-20	27492634	Du Y	2016-08-01	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/27492634	Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.	Small intestine neuroendocrine tumor	293 European ancestry cases, 4,542 European ancestry controls, up to 241 controls	NA	12q23.1	12	96098670	ELK3, LTA4H	LOC105369923			105369923			rs2540513-?	rs2540513	0	2540513	downstream_gene_variant	0	NR	3E-9	8.522878745280337		1.87	[NR]	Affymetrix [613218]	N
2017-03-20	27492634	Du Y	2016-08-01	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/27492634	Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.	Bronchial neuroendocrine tumor	128 European ancestry cases, 4,542 European ancestry controls	NA	10p11.21	10	35955481	intergenic	LOC105376495 - LOC107984222	105376495	107984222		56518	88924	rs10827565-?	rs10827565	0	10827565	intergenic_variant	1	NR	1E-11	11.0		2.992	NR	Affymetrix [613218]	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40847202	CYP2A6	CYP2A6			1548			rs56113850-T	rs56113850	0	56113850	intron_variant	0	NR	1E-50	50.0		0.3644	[0.32-0.41] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40864271	CYP2A6, CYP2A7	CYP2A6 - CYP2A7	1548	1549		13824	11168	rs113029345-C	rs113029345	1	3875150	intron_variant	1	NR	1E-41	41.0		0.3592	[0.31-0.41] unit increase	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40913389	CYP2G1P, CYP2B7P1	LOC107985299 - CYP2B7P	107985299	1556		7774	10876	rs76935404-T	rs76935404	0	76935404	upstream_gene_variant	1	NR	1E-25	25.0		0.2489	[0.2-0.29] unit increase	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40911822	CYP2G1P, CYP2B7P1	LOC107985299 - CYP2B7P	107985299	1556		6207	12443	rs10425738-G	rs10425738	0	10425738	upstream_gene_variant	1	NR	1E-24	24.0		0.2425	[0.2-0.29] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40827379	RAB4B-EGLN2, CYP2A6	CYP2F2P - CYP2A6	171427	1548		606	16159	rs11878604-C	rs11878604	0	11878604	intron_variant	1	NR	7E-24	23.154901959985743		0.276	[0.22-0.33] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40866570	CYP2A6, CYP2A7	CYP2A6 - CYP2A7	1548	1549		16123	8869	rs7247903-G	rs7247903	0	7247903	intron_variant	1	NR	1E-21	21.0		0.3222	[0.26-0.39] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40840863	RAB4B-EGLN2, CYP2A6	CYP2F2P - CYP2A6	171427	1548		14090	2675	rs2316205-C	rs2316205	0	2316205	non_coding_transcript_exon_variant	1	NR	4E-14	13.397940008672037		0.1786	[0.13-0.22] unit increase	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40878770	CYP2A7	CYP2A7			1549			rs4079366-T	rs4079366	0	4079366	missense_variant	0	NR	8E-14	13.096910013008056		0.1854	[0.14-0.23] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40901969	CYP2G1P, CYP2B7P1	LOC107985299			107985299			rs73931391-G	rs73931391	0	73931391	downstream_gene_variant	0	NR	2E-12	11.698970004336019		0.5852	[0.42-0.75] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40818275	RAB4B-EGLN2, CYP2A6	CYP2T1P - CYP2F2P	171523	171427		6883	202	rs2545770-A	rs2545770	0	2545770	intron_variant	1	NR	4E-11	10.397940008672037		0.2012	[0.14-0.26] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40811274	RAB4B-EGLN2, CYP2A6	CYP2T1P			171523			rs185308415-G	rs185308415	0	185308415	non_coding_transcript_exon_variant	0	NR	3E-9	8.522878745280337		0.3344	[0.22-0.44] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	41032173	CYP2B6, CYP2A13	CYP2A7P1 - CYP2G2P	1550	83757		3910	18279	rs76617915-A	rs76617915	0	76617915	upstream_gene_variant	1	NR	2E-8	7.698970004336019		0.6151	[0.4-0.83] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	19q13.2	19	40824274	RAB4B-EGLN2, CYP2A6	CYP2F2P			171427			rs7507400-T	rs7507400	0	7507400	intron_variant	0	NR	4E-8	7.3979400086720375		0.1679	[0.11-0.23] unit decrease	Illumina [11892802] (imputed)	N
2017-02-19	27488534	Patel YM	2016-08-03	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27488534	Novel Association of Genetic Markers Affecting CYP2A6 activity and Lung Cancer Risk.	nicotine metabolite ratio in current smokers	437 European ancestry individuals, 364 African American individuals, 453 Latino individuals, 674 Japanese American individuals, 311 Native Hawaiian ancestry individuals	NA	8q22.1	8	97581926	TSPYL5, MTDH	LOC105375657 - RPS2P33	105375657	286150		62573	42240	rs2045966-G	rs2045966	0	2045966	intergenic_variant	1	NR	3E-8	7.522878745280337		0.2483	[0.16-0.34] unit increase	Illumina [11892802] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial endometrioid carcinoma	2,082 European ancestry cases, 9,544 European ancestry controls	4,553 European ancestry cases, 27,600 European ancestry controls	13q22.1	13	73240754	KLF12	RNY1P8 - MARK2P12	100873807	100421565		13494	167035	rs11841589-G	rs11841589	0	11841589	intergenic_variant	1	0.74	6E-10	9.221848749616356		1.16	[1.10-1.21]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial endometrioid carcinoma	2,082 European ancestry cases, 9,544 European ancestry controls	4,553 European ancestry cases, 27,600 European ancestry controls	6q22.31	6	125695434	HEY2, NCOA7	LOC643623, LOC105377986			643623, 105377986			rs13328298-G	rs13328298	0	13328298	intron_variant	0	0.58	1E-11	11.0		1.15	[1.11-1.20]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial endometrioid carcinoma	2,082 European ancestry cases, 9,544 European ancestry controls	4,553 European ancestry cases, 27,600 European ancestry controls	8q24.21	8	128587032	MYC	LINC00824 - LINC00977	101927774	728724		22353	629435	rs4733613-C	rs4733613	0	4733613	intergenic_variant	1	0.13	8E-9	8.096910013008056		1.1904762	[1.12-1.27]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial endometrioid carcinoma	2,082 European ancestry cases, 9,544 European ancestry controls	4,553 European ancestry cases, 27,600 European ancestry controls	15q15.1	15	40029923	EIF2AK, BMF	EIF2AK4			440275			rs937213-C	rs937213	0	937213	intron_variant	0	0.42	2E-7	6.698970004336019		1.1111112	[1.06-1.16]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial endometrioid carcinoma	2,082 European ancestry cases, 9,544 European ancestry controls	4,553 European ancestry cases, 27,600 European ancestry controls	14q32.33	14	104776883	AKT1, SIVA1	AKT1			207			rs2498796-A	rs2498796	0	2498796	non_coding_transcript_exon_variant	0	0.3	4E-8	7.3979400086720375		1.1363636	[1.09-1.18]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial endometrioid carcinoma	2,082 European ancestry cases, 9,544 European ancestry controls	4,553 European ancestry cases, 27,600 European ancestry controls	17q12	17	37743574	HNF1B	HNF1B			6928			rs11263763-A	rs11263763	0	11263763	intron_variant	0	0.54	7E-17	16.154901959985743		1.2	[1.15-1.25]	Illumina [up to 2300000] (imputed)	N
2017-01-13	27135401	Cheng TH	2016-05-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27135401	Five endometrial cancer risk loci identified through genome-wide association analysis.	Endometrial endometrioid carcinoma	2,082 European ancestry cases, 9,544 European ancestry controls	4,553 European ancestry cases, 27,600 European ancestry controls	15q21.2	15	51245609	CYP19A1	CYP19A1			1588			rs2414098-C	rs2414098	0	2414098	intron_variant	0	0.62	2E-13	12.698970004336019		1.18	[1.13-1.23]	Illumina [up to 2300000] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	4p16.1	4	6274903	WFS1	WFS1			7466			rs62283056-C	rs62283056	0	62283056	intron_variant	0	NR	5E-8	7.301029995663981		5.438	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43088349	intergenic	LOC107985876 - RNU6-242P	107985876	106481254		18693	3039	rs62137541-T	rs62137541	0	62137541	downstream_gene_variant	1	NR	1E-7	7.0		5.28	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43091570	intergenic	RNU6-242P - LOC100506047	106481254	100506047		76	4300	rs7562946-A	rs7562946	0	7562946	upstream_gene_variant	1	NR	4E-7	6.3979400086720375		5.053	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	8p23.1	8	11427626	FAM167A	FAM167A-AS1, FAM167A			83656, 83648			rs12156238-C	rs12156238	0	12156238	intron_variant	0	NR	5E-7	6.301029995663981		5.032	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43092840	intergenic	RNU6-242P - LOC100506047	106481254	100506047		1346	3030	rs3179891-A	rs3179891	0	3179891	upstream_gene_variant	1	NR	5E-7	6.301029995663981		5.026	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43088710	intergenic	LOC107985876 - RNU6-242P	107985876	106481254		19054	2678	rs7578467-T	rs7578467	0	7578467	downstream_gene_variant	1	NR	5E-7	6.301029995663981		5.019	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	10q26.3	10	128974127	intergenic	LOC728327 - LOC107984279	728327	107984279		57839	266258	rs10829534-T	rs10829534	0	10829534	intergenic_variant	1	NR	5E-6	5.301029995663981		4.582	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	1p31.1	1	76987908	ST6GALNAC5	ST6GALNAC5			81849			rs2143582-T	rs2143582	0	2143582	intron_variant	0	NR	5E-6	5.301029995663981		4.554	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	4q13.1	4	60987687	intergenic	MIR548AG1 - LOC105377249	100616450	105377249		65003	156001	rs13148643-T	rs13148643	0	13148643	intergenic_variant	1	NR	5E-6	5.301029995663981		4.554	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	5q15	5	97197765	intergenic	RIOK2 - YTHDF1P1	55781	402220		14464	170822	rs1000083-T	rs1000083	0	1000083	intron_variant	1	NR	5E-6	5.301029995663981		4.55	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43093990	intergenic	RNU6-242P - LOC100506047	106481254	100506047		2496	1880	rs12615153-T	rs12615153	0	12615153	upstream_gene_variant	1	NR	6E-6	5.221848749616356		4.529	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	3p26.3	3	2005081	intergenic	RPL21P17 - RN7SKP144	727810	106479159		98912	83896	rs13067896-A	rs13067896	0	13067896	intergenic_variant	1	NR	7E-6	5.154901959985743		4.494	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	3p26.3	3	2002712	intergenic	RPL21P17 - RN7SKP144	727810	106479159		96543	86265	rs35367356-A	rs35367356	0	35367356	intergenic_variant	1	NR	7E-6	5.154901959985743		4.492	z score decrease	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	12q24.22	12	116702884	intergenic	MAP1LC3B2 - C12orf49	643246	79794		126264	10436	rs10850703-A	rs10850703	0	10850703	non_coding_transcript_exon_variant	1	NR	8E-6	5.096910013008056		4.472	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	11p15.4	11	3128167	OSBPL5	OSBPL5			114879			rs1466045-A	rs1466045	0	1466045	intron_variant	0	NR	8E-6	5.096910013008056		4.46	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	6p22.2	6	26293110	intergenic	TRX-CAT1-3 - TRR-TCG4-1	7210	7232		6513	6567	rs7746807-A	rs7746807	0	7746807	intergenic_variant	1	NR	8E-6	5.096910013008056		4.46	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	5q35.2	5	176485993	UBXD8	FAF2			23197			rs3888233-A	rs3888233	0	3888233	intron_variant	0	NR	9E-6	5.045757490560675		4.451	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	4q13.1	4	60971415	intergenic	MIR548AG1 - LOC105377249	100616450	105377249		48731	172273	rs1906073-A	rs1906073	0	1906073	intergenic_variant	1	NR	9E-6	5.045757490560675		4.438	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	12q13.13	12	51216581	POU6F1	POU6F1			5463			rs7399018-T	rs7399018	0	7399018	intron_variant	0	NR	9E-6	5.045757490560675		4.438	z score increase	Illumina [5060354] (imputed)	N
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	3p26.3	3	2006661	intergenic	RPL21P17 - RN7SKP144	727810	106479159		100492	82316	rs73807529-A	rs73807529	0	73807529	intergenic_variant	1	NR	9E-6	5.045757490560675		4.435	z score decrease	Illumina [5060354] (imputed)	N
2017-06-27	28292921	Boldry EJ	2017-03-14	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28292921	Genetic Determinants of 1,3-Butadiene Metabolism and Detoxification in Three Populations of Smokers with Different Risks of Lung Cancer.	Urinary 1,3-butadiene metabolite levels in smokers	327 African American individuals, 349 Japanese American individuals, 396 European ancestry individuals	NA				GSTT1							rs6004031-?	rs6004031	0	6004031		1	NR	1E-23	23.0	(MHBMA)			Illumina [11892802] (imputed)	N
2017-06-27	28292921	Boldry EJ	2017-03-14	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28292921	Genetic Determinants of 1,3-Butadiene Metabolism and Detoxification in Three Populations of Smokers with Different Risks of Lung Cancer.	Urinary 1,3-butadiene metabolite levels in smokers	327 African American individuals, 349 Japanese American individuals, 396 European ancestry individuals	NA	22q11.23	22	23897951	GSTT1	MIF-AS1			284889			rs5760092-?	rs5760092	0	5760092	intron_variant	0	NR	3E-9	8.522878745280337	(MHBMA, AA)			Illumina [11892802] (imputed)	N
2017-06-27	28292921	Boldry EJ	2017-03-14	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28292921	Genetic Determinants of 1,3-Butadiene Metabolism and Detoxification in Three Populations of Smokers with Different Risks of Lung Cancer.	Urinary 1,3-butadiene metabolite levels in smokers	327 African American individuals, 349 Japanese American individuals, 396 European ancestry individuals	NA				GSTT1							rs6004031-?	rs6004031	0	6004031		1	NR	5E-9	8.301029995663981	(MHBMA, Japanese)			Illumina [11892802] (imputed)	N
2017-06-27	28292921	Boldry EJ	2017-03-14	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28292921	Genetic Determinants of 1,3-Butadiene Metabolism and Detoxification in Three Populations of Smokers with Different Risks of Lung Cancer.	Urinary 1,3-butadiene metabolite levels in smokers	327 African American individuals, 349 Japanese American individuals, 396 European ancestry individuals	NA				GSTT1							rs72617242-?	rs72617242	0	72617242	upstream_gene_variant	1	NR	1E-14	14.0	(MHBMA, EA)			Illumina [11892802] (imputed)	N
2011-11-09	22010048	Wu X	2011-10-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22010048	A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.	Renal cell carcinoma	894 European ancestry cases, 1,516 European ancestry controls	3,772 European ancestry cases, 8,505 European ancestry controls	12p11.23	12	26300350	ITPR2	LOC105369705			105369705			rs718314-?	rs718314	0	718314	intron_variant	0	NR	9E-10	9.045757490560675		1.19	[1.13-1.26]	Illumina [533191]	N
2011-11-09	22010048	Wu X	2011-10-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22010048	A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.	Renal cell carcinoma	894 European ancestry cases, 1,516 European ancestry controls	3,772 European ancestry cases, 8,505 European ancestry controls	11q13.3	11	69419726	NR	LOC105369370 - LOC102724265	105369370	102724265		47214	5945	rs4980785-?	rs4980785	0	4980785	downstream_gene_variant	1	NR	2E-6	5.698970004336019				Illumina [533191]	N
2011-11-09	22010048	Wu X	2011-10-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22010048	A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.	Renal cell carcinoma	894 European ancestry cases, 1,516 European ancestry controls	3,772 European ancestry cases, 8,505 European ancestry controls	6q22.31	6	118486684	NR	CEP85L, LOC105377971			387119, 105377971			rs25422-?	rs25422	0	25422	intron_variant	0	NR	5E-6	5.301029995663981				Illumina [533191]	N
2012-05-16	22472174	Xiao Y	2012-04-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22472174	SSBP2 variants are associated with survival in glioblastoma patients.	Glioblastoma	315 European ancestry cases	434 European ancestry cases	5q14.1	5	81423306	SSBP2	SSBP2			23635			rs7732320-T	rs7732320	0	7732320	intron_variant	0	0.11	1E-6	6.0		1.64	[1.34-2.00]	Illumina [314635]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	116 Japanese ancestry cases, 108 Japanese ancestry controls	NA	13q12.3	13	30740318	ALOX5AP	ALOX5AP			241			rs3885907-G	rs3885907	0	3885907	intron_variant	0	0.18	1E-6	6.0	(Dominant)	2.66	[1.71-4.13]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	116 Japanese ancestry cases, 108 Japanese ancestry controls	NA	1p21.3	1	94615889	LOC100130235	LOC105378861			105378861			rs4474258-A	rs4474258	0	4474258	non_coding_transcript_exon_variant	0	0.43	5E-6	5.301029995663981	(Recessive)	1.89	[1.29-2.75]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	116 Japanese ancestry cases, 108 Japanese ancestry controls	NA	10p13	10	13625731	PRPF18	PRPF18			8559			rs7089227-G	rs7089227	0	7089227	intron_variant	0	0.41	7E-6	5.154901959985743	(Dominant)	1.99	[1.37-2.90]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	1q21.2	1	147548685	BCL9	BCL9			607			rs594206-A	rs594206	0	594206	intron_variant	0	0.78	6E-7	6.221848749616356	(Dominant)	36.3	[4.58-287]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	1p31.1	1	70421416	CTH	CTH			1491			rs672203-A	rs672203	0	672203	intron_variant	0	0.52	2E-6	5.698970004336019	(Dominant)	5.33	[2.59-11.0]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	9p24.2	9	2203938	SMARCA2	LOC107987043			107987043			rs6475600-C	rs6475600	0	6475600	intergenic_variant	0	0.63	2E-6	5.698970004336019	(Allelic)	7.78	3.25-18.6]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	4p15.31	4	18864546	LCORL	LOC105374510 - LOC107986263	105374510	107986263		27483	103950	rs6845621-C	rs6845621	0	6845621	intergenic_variant	1	0.20	2E-6	5.698970004336019	(Allelic)	5.53	[2.61-11.7]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	9q33.3	9	123933491	DENND1A	DENND1A - LOC105376267	57706	105376267		3333	62581	rs10818894-G	rs10818894	0	10818894	upstream_gene_variant	1	0.70	2E-6	5.698970004336019	(Dominant)	10.4	[3.56-30.1]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	8p23.2	8	5017650	LOC100129861	CSMD1 - RSL24D1P7	64478	100129861		22615	53639	rs10112481-A	rs10112481	0	10112481	intergenic_variant	1	0.22	4E-6	5.3979400086720375	(Allelic)	5.12	[2.46-10.6]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	18q22.1	18	65231430	CDH7	LOC105372168 - LOC107985128	105372168	107985128		87223	192598	rs637644-G	rs637644	0	637644	intergenic_variant	1	0.80	7E-6	5.154901959985743	(Allelic)	32.5	[4.08-259]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	16q23.3	16	83292454	CDH13	CDH13			1012			rs11644424-T	rs11644424	0	11644424	intron_variant	0	0.44	8E-6	5.096910013008056	(Dominant)	3.32	[1.71-6.44]	Illumina [555600]	N
2013-04-17	23341777	Dong J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23341777	Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese.	Squamous cell carcinoma	833 Han Chinese ancestry cases, 3,094 Han Chinese ancestry controls	2,223 Han Chinese ancestry cases, 6,409 Han Chinese ancestry controls	12q23.1	12	100426307	SLC17A8, NR1H4, SCYL2, GAS2L3	SLC17A8 - NR1H4	246213	9971		4248	47466	rs12296850-A	rs12296850	0	12296850	downstream_gene_variant	1	0.744	1E-10	10.0		1.28	[1.19-1.39]	Affymetrix [570009]	N
2016-03-24	25987243	Parham LR	2015-05-19	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/25987243	Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.	Lapatinib-induced hepatotoxicity	775 European ancestry treated breast cancer cases, 236 East Asian ancestry treated breast cancer cases, 247 treated breast cancer cases	NA	8q21.13	8	80146584	TPD52	TPD52			7163			rs7828135-?	rs7828135	0	7828135	intron_variant	0	NR	5E-8	7.301029995663981	(Maximum ALT, Conditioned on HLA- DRB1*07:01)			Illumina [1085881]	N
2016-03-24	25987243	Parham LR	2015-05-19	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/25987243	Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.	Lapatinib-induced hepatotoxicity	775 European ancestry treated breast cancer cases, 236 East Asian ancestry treated breast cancer cases, 247 treated breast cancer cases	NA				HLA-DRB1							HLA-DRB1*07:01	HLA-DRB1*07:01	0			1	NR	8E-11	10.096910013008056	(case/control)			Illumina [1085881]	N
2016-03-24	25987243	Parham LR	2015-05-19	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/25987243	Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.	Lapatinib-induced hepatotoxicity	775 European ancestry treated breast cancer cases, 236 East Asian ancestry treated breast cancer cases, 247 treated breast cancer cases	NA				HLA-DRB1							HLA-DRB1*07:01	HLA-DRB1*07:01	0			1	NR	2E-18	17.69897000433602	(Maximum ALT)			Illumina [1085881]	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	5p13.2	5	33951588	SLC45A2	SLC45A2			51151			rs16891982-?	rs16891982	0	16891982	missense_variant	0	0.55	3E-28	27.522878745280337		1.923077	[1.69-2.13]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	6p25.3	6	396321	IRF4	IRF4			3662			rs12203592-T	rs12203592	0	12203592	intron_variant	0	0.17	8E-97	96.09691001300806		1.56	[1.49-1.62]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	11q14.3	11	89284793	TYR	LOC107984363, TYR			107984363, 7299			rs1126809-A	rs1126809	0	1126809	missense_variant	0	0.28	2E-20	19.69897000433602		1.19	[1.15-1.24]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	15q13.1	15	28165345	HERC2	HERC2			8924			rs12916300-?	rs12916300	0	12916300	intron_variant	0	0.74	3E-9	8.522878745280337		1.1363636	[1.09-1.18]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	16q24.3	16	89960104	DEF8, MC1R	DEF8			54849			rs4268748-C	rs4268748	0	4268748	intron_variant	0	0.26	2E-44	43.69897000433602		1.33	[1.28-1.39]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	20q11.22	20	34077942	RALY	RALY			22913			rs6059655-A	rs6059655	0	6059655	intron_variant	0	0.08	9E-21	20.045757490560675		1.32	[1.24-1.39]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	3p13	3	71433933	FOXP1	FOXP1			27086			rs62246017-A	rs62246017	0	62246017	intron_variant	0	0.33	1E-8	8.0		1.11	[1.07-1.16]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	3q28	3	189487243	TPRG1, TP63	LOC105374270 - LOC107986169	105374270	107986169		8937	2988	rs6791479-T	rs6791479	0	6791479	intergenic_variant	1	0.43	1E-11	11.0		1.13	[1.09-1.16]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	6p21.32	6	32641081	HLA-DQA1	LOC107986589, HLA-DQA1			107986589, 3117			rs4455710-T	rs4455710	0	4455710	intron_variant	0	0.38	2E-18	17.69897000433602		1.17	[1.13-1.21]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	9p22.2	9	16913838	BNC2, CNTLN	BNC2 - LOC105375983	54796	105375983		43000	100234	rs74664507-?	rs74664507	1	11445081	intergenic_variant	1	0.56	8E-9	8.096910013008056		1.1111112	[1.08-1.15]	Affymetrix [9610468] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	16q24.3	16	89669749	SPATA33	SPATA33			124045			rs35063026-T	rs35063026	0	35063026	3_prime_UTR_variant	0	NR	1E-20	20.0	(adjusted for rs4268748)	1.33	[1.26-1.42]	Affymetrix [9610468] (imputed)	N
2015-01-21	24880342	Wang Y	2014-06-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24880342	Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.	Lung cancer	3,442 European ancestry adenocarcinoma cases, 3,275 European ancestry squamous cell carcinoma cases, 4,631 cases, up to 15,861 controls	3,589 European ancestry adenocarcinoma cases, 3,202 European ancestry squamous cell carcinoma cases, 3,455 cases, up to 38,295 controls	3q28	3	189639813	TP63	TP63			8626			rs13314271-T	rs13314271	0	13314271	intron_variant	0	0.49	7E-10	9.154901959985743	(Adenocarcinoma)	1.13	[1.09-1.18]	Illumina [8900000] (imputed)	N
2016-11-17	26829030	Asgari MM	2016-01-29	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/26829030	Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.	Squamous cell carcinoma	6,891 European ancestry cases, 54,566 European ancestry controls	810 European ancestry cases,  5,600 European ancestry controls	15q13.1	15	28088564	OCA2	OCA2			4948			rs149906873-A	rs149906873	1	79974247	intron_variant	0	NR	6E-10	9.221848749616356	(adjusted for rs16891982, rs12203592, rs1126809, rs12916300, rs4268748, rs6059655, rs62246017, rs6791479, rs4455710, rs74664507	1.31	NR	Affymetrix [9610468] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.13, 10q26.12	10;10;10	121425789;120915337;121289750	FGFR2, WDR11, 7SK	RN7SKP167 - FGFR2; LOC105378519; LINC01153 - LOC105378523						rs10749415-G; rs200367988-G; rs10886902-T	rs10749415; rs200367988; rs10886902	0		intergenic_variant; intergenic_variant; intergenic_variant		0.025	3E-11	10.522878745280337		0.168	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.13, 10q26.12	10;10;10	121425789;120915337;121289750	FGFR2, WDR11, 7SK	RN7SKP167 - FGFR2; LOC105378519; LINC01153 - LOC105378523						rs10749415-A; rs200367988-G; rs10886902-T	rs10749415; rs200367988; rs10886902	0		intergenic_variant; intergenic_variant; intergenic_variant		0.491	1E-35	35.0		0.089	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.13, 10q26.12	10;10;10	121425789;120915337;121289750	FGFR2, WDR11, 7SK	RN7SKP167 - FGFR2; LOC105378519; LINC01153 - LOC105378523						rs10749415-A; rs200367988-A; rs10886902-C	rs10749415; rs200367988; rs10886902	0		intergenic_variant; intergenic_variant; intergenic_variant		0.078	4E-43	42.39794000867204		0.206	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-T; rs6070-T; rs11665748-G; rs17632542-G; rs266849-C; rs266868-G; rs61752561-G	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.042	9E-186	185.04575749056067		0.506	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-C; rs6070-T; rs11665748-G; rs17632542-G; rs266849-T; rs266868-A; rs61752561-A	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.204	2E-111	110.69897000433602		0.211	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-C; rs6070-A; rs11665748-G; rs17632542-G; rs266849-T; rs266868-A; rs61752561-A	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.107	8E-17	16.096910013008056		0.109	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-T; rs6070-A; rs11665748-G; rs17632542-G; rs266849-C; rs266868-G; rs61752561-G	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.01	1E-85	85.0		0.856	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-C; rs6070-T; rs11665748-A; rs17632542-G; rs266849-T; rs266868-A; rs61752561-A	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.059	4E-9	8.397940008672037		0.1	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-C; rs6070-T; rs11665748-A; rs17632542-A; rs266849-T; rs266868-A; rs61752561-A	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.024	1E-7	7.0		0.124	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-T; rs6070-T; rs11665748-G; rs17632542-G; rs266849-T; rs266868-G; rs61752561-G	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.029	8E-10	9.096910013008056		0.153	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-T; rs6070-A; rs11665748-G; rs17632542-G; rs266849-T; rs266868-G; rs61752561-G	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.02	3E-11	10.522878745280337		0.201	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50870023;50876854;50851141;50858501;50845834;50849681;50858126	KLK3, KLK2	KLK3 - KLK2; KLK2; LOC105372441; KLK3; LOC105372441; LOC105372441; KLK3						rs2739472-C; rs6070-T; rs11665748-G; rs17632542-G; rs266849-C; rs266868-A; rs61752561-G	rs2739472; rs6070; rs11665748; rs17632542; rs266849; rs266868; rs61752561	0		intron_variant; non_coding_transcript_exon_variant; upstream_gene_variant; missense_variant; intron_variant; intron_variant; missense_variant		0.011	2E-45	44.69897000433602		0.494	unit decrease	Affymetrix [10109774] (imputed)	N
2011-01-15	21131975	Purdue MP	2010-12-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21131975	Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.	Renal cell carcinoma	3,772 European ancestry cases, 8,505 European ancestry controls	2,198 European ancestry cases, 4,918 European ancestry controls	2p21	2	46310465	EPAS1	EPAS1			2034			rs7579899-?	rs7579899	0	7579899	intron_variant	0	0.40	2E-9	8.698970004336019		1.15	[1.10-1.21]	Illumina [586069]	N
2011-01-15	21131975	Purdue MP	2010-12-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21131975	Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.	Renal cell carcinoma	3,772 European ancestry cases, 8,505 European ancestry controls	2,198 European ancestry cases, 4,918 European ancestry controls	11q13.3	11	69424973	intergenic	LOC105369370 - LOC102724265	105369370	102724265		52461	698	rs7105934-?	rs7105934	0	7105934	upstream_gene_variant	1	0.93	8E-14	13.096910013008056		1.45	[1.32-1.61]	Illumina [586069]	N
2011-01-15	21131975	Purdue MP	2010-12-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21131975	Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.	Renal cell carcinoma	3,772 European ancestry cases, 8,505 European ancestry controls	2,198 European ancestry cases, 4,918 European ancestry controls	12q24.31	12	124836304	SCARB1	SCARB1			949			rs4765623-?	rs4765623	0	4765623	intron_variant	0	0.34	3E-8	7.522878745280337		1.15	[1.09-1.20]	Illumina [586069]	N
2011-01-15	21131975	Purdue MP	2010-12-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21131975	Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.	Renal cell carcinoma	3,772 European ancestry cases, 8,505 European ancestry controls	2,198 European ancestry cases, 4,918 European ancestry controls	3q26.31	3	171790673	PP13439	PLD1			5337			rs9839909-?	rs9839909	0	9839909	intron_variant	0	0.66	3E-6	5.522878745280337	(dominant)	1.2	[1.11-1.32]	Illumina [586069]	N
2009-06-14	19478819	Ng CC	2009-05-29	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19478819	A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma.	Nasopharyngeal carcinoma	111 Malaysian Chinese ancestry cases, 260 Malaysian Chinese ancestry controls	168 Malaysian Chinese ancestry cases, 252 Malaysian Chinese ancestry controls	3p22.2	3	37477054	ITGA9	ITGA9			3680			rs189897-A	rs189897	0	189897	intron_variant	0	0.09	7E-8	7.154901959985743		3.18	[1.94-5.21]	Illumina [533048]	N
2011-08-06	21787189	Nyberg F	2011-07-01	Pharmacogenomics	www.ncbi.nlm.nih.gov/pubmed/21787189	Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data.	Interstitial lung disease	80 Japanese ancestry cases, 194 Japanese ancestry controls	NA	5q33.1	5	151964997	intergenic	LOC101927115			101927115			rs170020-C	rs170020	0	170020	intron_variant	0	NR	4E-6	5.3979400086720375		2.96	[1.80-.5.00]	Illumina, Perlegen [465816]	N
2011-08-06	21787189	Nyberg F	2011-07-01	Pharmacogenomics	www.ncbi.nlm.nih.gov/pubmed/21787189	Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data.	Interstitial lung disease	80 Japanese ancestry cases, 194 Japanese ancestry controls	NA	1q23.2	1	159783393	DUSP23	DUSP23 - LOC105371464	54935	105371464		847	17088	rs4233356-T	rs4233356	0	4233356	downstream_gene_variant	1	NR	9E-6	5.045757490560675		2.51	[1.64-3.84]	Illumina, Perlegen [465816]	N
2011-01-11	21139019	Walsh KM	2010-12-07	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/21139019	A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.	Ileal carcinoids	239 European ancestry cases, 107 European ancestry controls	NA	20p12.1	20	16330665	KIF16B	KIF16B			55614			rs2208059-?	rs2208059	0	2208059	intron_variant	0	NR	4E-7	6.3979400086720375		2.42	[1.72-3.42]	Illumina [308330]	N
2011-01-11	21139019	Walsh KM	2010-12-07	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/21139019	A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.	Ileal carcinoids	239 European ancestry cases, 107 European ancestry controls	NA	5q23.3	5	128186851	SLC12A2	SLC12A2			6558			rs10089-?	rs10089	0	10089	3_prime_UTR_variant	0	NR	2E-6	5.698970004336019		2.56	[1.79-3.70]	Illumina [308330]	N
2011-01-11	21139019	Walsh KM	2010-12-07	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/21139019	A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.	Ileal carcinoids	239 European ancestry cases, 107 European ancestry controls	NA	3q28	3	192179429	FGF12	FGF12			2257			rs975121-?	rs975121	0	975121	intron_variant	0	NR	7E-6	5.154901959985743		2.17	[1.55-3.03]	Illumina [308330]	N
2011-01-11	21139019	Walsh KM	2010-12-07	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/21139019	A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.	Ileal carcinoids	239 European ancestry cases, 107 European ancestry controls	NA	6p22.3	6	20694653	CDKAL1	CDKAL1			54901			rs2206734-?	rs2206734	0	2206734	intron_variant	0	NR	8E-6	5.096910013008056		3.45	[2.08-5.56]	Illumina [308330]	N
2011-01-13	21160077	Gudmundsson J	2010-12-15	Sci Transl Med	www.ncbi.nlm.nih.gov/pubmed/21160077	Genetic correction of PSA values using sequence variants associated with PSA levels.	Serum prostate-specific antigen levels	7,538 European ancestry individuals	2,373 European ancestry individuals	5p15.33	5	1321972	TERT	CLPTM1L			81037			rs401681-C	rs401681	0	401681	intron_variant	0	0.55	1E-10	10.0		7.0	[NR] % increase	Illumina [304070]	N
2011-01-13	21160077	Gudmundsson J	2010-12-15	Sci Transl Med	www.ncbi.nlm.nih.gov/pubmed/21160077	Genetic correction of PSA values using sequence variants associated with PSA levels.	Serum prostate-specific antigen levels	7,538 European ancestry individuals	2,373 European ancestry individuals	10q26.12	10	121274035	FGFR2	LINC01153 - LOC105378523	101927889	105378523		88069	17573	rs10788160-A	rs10788160	0	10788160	intergenic_variant	1	0.31	5E-15	14.301029995663981		10.2	[NR] % increase	Illumina [304070]	N
2011-01-13	21160077	Gudmundsson J	2010-12-15	Sci Transl Med	www.ncbi.nlm.nih.gov/pubmed/21160077	Genetic correction of PSA values using sequence variants associated with PSA levels.	Serum prostate-specific antigen levels	7,538 European ancestry individuals	2,373 European ancestry individuals	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.39	7E-13	12.154901959985743		9.2	[NR] % increase	Illumina [304070]	N
2011-01-13	21160077	Gudmundsson J	2010-12-15	Sci Transl Med	www.ncbi.nlm.nih.gov/pubmed/21160077	Genetic correction of PSA values using sequence variants associated with PSA levels.	Serum prostate-specific antigen levels	7,538 European ancestry individuals	2,373 European ancestry individuals	12q24.21	12	114656455	TBX3	OSTF1P1 - TBX3	386654	6926		67656	13799	rs11067228-A	rs11067228	0	11067228	downstream_gene_variant	1	0.56	2E-11	10.698970004336019		8.3	[NR] % increase	Illumina [304070]	N
2011-01-13	21160077	Gudmundsson J	2010-12-15	Sci Transl Med	www.ncbi.nlm.nih.gov/pubmed/21160077	Genetic correction of PSA values using sequence variants associated with PSA levels.	Serum prostate-specific antigen levels	7,538 European ancestry individuals	2,373 European ancestry individuals	17q12	17	37738049	HNF1B	HNF1B			6928			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.52	6E-11	10.221848749616356		9.4	[NR] % increase	Illumina [304070]	N
2011-01-13	21160077	Gudmundsson J	2010-12-15	Sci Transl Med	www.ncbi.nlm.nih.gov/pubmed/21160077	Genetic correction of PSA values using sequence variants associated with PSA levels.	Serum prostate-specific antigen levels	7,538 European ancestry individuals	2,373 European ancestry individuals	19q13.33	19	50858501	KLK3	KLK3			354			rs17632542-T	rs17632542	0	17632542	missense_variant	0	0.91	3E-46	45.52287874528034		39.1	[NR] % increase	Illumina [304070]	N
2011-01-13	21160077	Gudmundsson J	2010-12-15	Sci Transl Med	www.ncbi.nlm.nih.gov/pubmed/21160077	Genetic correction of PSA values using sequence variants associated with PSA levels.	Serum prostate-specific antigen levels	7,538 European ancestry individuals	2,373 European ancestry individuals	19q13.33	19	50845834	NR	LOC105372441			105372441			rs266849-A	rs266849	0	266849	intron_variant	0	0.83	6E-10	9.221848749616356				Illumina [304070]	N
2015-04-22	21278746	Lindstrom S	2011-01-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21278746	Common variants in ZNF365 are associated with both mammographic density and breast cancer risk.	Percent mammographic density	4,877 European ancestry females	1,145 European ancestry females, 1,690 females	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-A	rs10995190	0	10995190	intron_variant	0	0.15	1E-9	9.0		0.18	[0.12-0.25] % decrease	Affymetrix, Illumina [> 2000000] (imputed)	N
2011-07-13	21700618	Nan H	2011-06-23	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21700618	Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma.	Basal cell carcinoma	2,045 European ancestry cases, 6,013 European ancestry controls	1,426 cases, 4,845 controls	16q24.3	16	89919709	MC1R	MC1R			4157			rs1805007-T	rs1805007	0	1805007	missense_variant	0	0.07	4E-17	16.397940008672037		1.55	[1.45-1.66]	Affymetrix, Illumina [2318094] (imputed)	N
2011-07-13	21700618	Nan H	2011-06-23	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21700618	Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma.	Basal cell carcinoma	2,045 European ancestry cases, 6,013 European ancestry controls	1,426 cases, 4,845 controls	6p25.3	6	475489	EXOC2	LOC105374875			105374875			rs12210050-T	rs12210050	0	12210050	intergenic_variant	0	0.17	1E-9	9.0		1.24	[1.17-1.31]	Affymetrix, Illumina [2318094] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Eye color	3871 European ancestry individuals	2,496 European ancestry individuals	1q32.3	1	212953223	VASH2	VASH2			79805			rs3002288-A	rs3002288	0	3002288	intron_variant	0	NR	7E-8	7.154901959985743	(Brown eye color)	0.22	[0.14-0.30] unit decrease	Affymetrix, Illumina [2469762] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Eye color	3871 European ancestry individuals	2,496 European ancestry individuals	5p15.31	5	6767199	POLS	LOC102724943			102724943			rs12520016-G	rs12520016	0	12520016	intron_variant	0	NR	9E-7	6.045757490560675	(Intermediate/Green eye color)	0.42	[0.26-0.58] unit increase	Affymetrix, Illumina [2469762] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Sunburns	9,283 European ancestry individuals	4,236 European ancestry individuals	11q25	11	131481074	NTM	NTM			50863			rs12421680-A	rs12421680	0	12421680	intron_variant	0	NR	6E-6	5.221848749616356		0.41	[0.23-0.59] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Hair color	7,070 European ancestry individuals	4,155 European ancestry individuals	13q22.3	13	77807011	EDNRB	SLAIN1 - EDNRB-AS1	122060	100505518		42769	11926	rs975739-G	rs975739	0	975739	intergenic_variant	1	NR	2E-14	13.698970004336019		0.08	[0.060-0.100] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Eye color	3871 European ancestry individuals	2,496 European ancestry individuals	15q13.1	15	27951675	OCA2	OCA2			4948			rs7173419-T	rs7173419	0	7173419	intron_variant	0	NR	1E-7	7.0	(Brown eye color)	0.33	[0.21-0.45] unit increase	Affymetrix, Illumina [2469762] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Eye color	3871 European ancestry individuals	2,496 European ancestry individuals	15q13.1	15	28120472	HERC2	HERC2			8924			rs12913832-A	rs12913832	0	12913832	intron_variant	0	NR	1E-177	177.0	(Brown eye color)	2.82	[2.62-3.02] unit increase	Affymetrix, Illumina [2469762] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Tanning	9,678 European ancestry individuals		6p25.3	6	396321	IRF4	IRF4			3662			rs12203592-C	rs12203592	0	12203592	intron_variant	0	NR	3E-23	22.522878745280337		0.35	[0.29-0.41] unit decrease	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Tanning	9,678 European ancestry individuals		11q14.3	11	89284793	TYR	LOC107984363, TYR			107984363, 7299			rs1126809-G	rs1126809	0	1126809	missense_variant	0	NR	5E-21	20.30102999566398		0.12	[0.10-0.14] unit decrease	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Tanning	9,678 European ancestry individuals		15q13.1	15	28120472	HERC2	HERC2			8924			rs12913832-G	rs12913832	0	12913832	intron_variant	0	NR	1E-22	22.0		0.14	[0.12-0.16] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Tanning	9,678 European ancestry individuals		16q24.3	16	89919709	MC1R	MC1R			4157			rs1805007-C	rs1805007	0	1805007	missense_variant	0	NR	1E-65	65.0		0.39	[0.35-0.43] unit decrease	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Hair color	7,070 European ancestry individuals	4,155 European ancestry individuals	6p25.3	6	396321	IRF4	IRF4			3662			rs12203592-C	rs12203592	0	12203592	intron_variant	0	NR	1E-28	28.0		0.35	[0.29-0.41] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Hair color	7,070 European ancestry individuals	4,155 European ancestry individuals	12q21.33	12	88934558	KITLG	LOC105369887 - LOC728084	105369887	728084		150274	76568	rs12821256-C	rs12821256	0	12821256	regulatory_region_variant	1	NR	7E-19	18.154901959985743		0.18	[0.14-0.22] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Hair color	7,070 European ancestry individuals	4,155 European ancestry individuals	14q32.12	14	92307319	SLC24A4	LOC105370627			105370627			rs12896399-G	rs12896399	0	12896399	intergenic_variant	0	NR	2E-36	35.69897000433602		0.16	[0.14-0.18] unit decrease	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Hair color	7,070 European ancestry individuals	4,155 European ancestry individuals	15q13.1	15	28120472	HERC2	HERC2			8924			rs12913832-G	rs12913832	0	12913832	intron_variant	0	NR	1E-167	167.0		0.39	[0.37-0.41] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Hair color	7,070 European ancestry individuals	4,155 European ancestry individuals	16q24.3	16	89919709	MC1R	MC1R			4157			rs1805007-C	rs1805007	0	1805007	missense_variant	0	NR	3E-9	8.522878745280337		0.16	[0.10-0.22] unit decrease	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Tanning	9,678 European ancestry individuals		20q11.22	20	34141638	ASIP	RPS2P1 - ASIP	140755	434		18296	44855	rs4911414-G	rs4911414	0	4911414	intergenic_variant	1	NR	4E-9	8.397940008672037		0.07	[0.050-0.090] unit decrease	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Sunburns	9,283 European ancestry individuals	4,236 European ancestry individuals	6p25.3	6	396321	IRF4	IRF4			3662			rs12203592-T	rs12203592	0	12203592	intron_variant	0	NR	2E-6	5.698970004336019		1.13	[0.66-1.60] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Sunburns	9,283 European ancestry individuals	4,236 European ancestry individuals	11q14.3	11	89284793	TYR	LOC107984363, TYR			107984363, 7299			rs1126809-G	rs1126809	0	1126809	missense_variant	0	NR	2E-8	7.698970004336019		0.6	[0.38-0.82] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Sunburns	9,283 European ancestry individuals	4,236 European ancestry individuals	16q24.3	16	89919709	MC1R	MC1R			4157			rs1805007-C	rs1805007	0	1805007	missense_variant	0	NR	2E-19	18.69897000433602		1.66	[1.31-2.01] unit increase	Affymetrix, Illumina [7588169] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Eye color	3871 European ancestry individuals	2,496 European ancestry individuals	9p23	9	12672097	TYRP1	RNU2-47P - TYRP1	106480672	7306		371646	21288	rs1408799-C	rs1408799	0	1408799	intergenic_variant	1	NR	5E-7	6.301029995663981	(Blue eye color)	0.27	[0.17-0.37] unit decrease	Affymetrix, Illumina [2469762] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Eye color	3871 European ancestry individuals	2,496 European ancestry individuals	14q32.12	14	92307319	SLC24A4	LOC105370627			105370627			rs12896399-G	rs12896399	0	12896399	intergenic_variant	0	NR	4E-11	10.397940008672037	(Blue eye color)	0.33	[0.23-0.43] unit increase	Affymetrix, Illumina [2469762] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Eye color	3871 European ancestry individuals	2,496 European ancestry individuals	15q13.1	15	28120472	HERC2	HERC2			8924			rs12913832-G	rs12913832	0	12913832	intron_variant	0	NR	1E-158	158.0	(Blue eye color)	2.84	[2.62-3.06] unit decrease	Affymetrix, Illumina [2469762] (imputed)	N
2013-08-10	23548203	Zhang M	2013-04-01	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23548203	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	Eye color	3871 European ancestry individuals	2,496 European ancestry individuals	14q32.12	14	92307319	SLC24A4	LOC105370627			105370627			rs12896399-G	rs12896399	0	12896399	intergenic_variant	0	NR	3E-7	6.522878745280337	(Intermediate/Green eye color)	0.27	[0.17-0.37] unit decrease	Affymetrix, Illumina [2469762] (imputed)	N
2014-12-11	24919509	Terao C	2014-06-11	J Med Genet	www.ncbi.nlm.nih.gov/pubmed/24919509	A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population.	Prostate-specific antigen levels	1,086 Japanese ancestry males	1,302 Japanese ancestry males	1q32.1	1	205669336	SLC45A3	SLC45A3			85414			rs16856139-?	rs16856139	0	16856139	intron_variant	0	NR	2E-11	10.698970004336019		0.084	[0.059-0.109] unit increase	Illumina [303283]	N
2014-12-11	24919509	Terao C	2014-06-11	J Med Genet	www.ncbi.nlm.nih.gov/pubmed/24919509	A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population.	Prostate-specific antigen levels	1,086 Japanese ancestry males	1,302 Japanese ancestry males	19q13.33	19	50860142	KLK3	KLK3			354			rs1058205-?	rs1058205	0	1058205	3_prime_UTR_variant	0	NR	8E-21	20.096910013008056		0.085	[0.067-0.103] unit increase	Illumina [303283]	N
2013-03-27	23359319	Jin G	2013-01-01	Neoplasia	www.ncbi.nlm.nih.gov/pubmed/23359319	Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.	Prostate-specific antigen levels	3,192 European ancestry individuals	1,722 European ancestry individuals	12p13.1	12	14434367	ATF7IP	ATF7IP			55729			rs3213764-G	rs3213764	0	3213764	missense_variant	0	0.467	2E-9	8.698970004336019		0.049	% increase	Illumina [642584]	N
2013-03-27	23359319	Jin G	2013-01-01	Neoplasia	www.ncbi.nlm.nih.gov/pubmed/23359319	Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.	Prostate-specific antigen levels	3,192 European ancestry individuals	1,722 European ancestry individuals	19q13.33	19	50889862	KLK2, KLKP1	KLKP1			606293			rs1354774-G	rs1354774	0	1354774	intron_variant	0	0.343	6E-20	19.221848749616356		0.058	% increase	Illumina [642584]	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	1p35.2	1	30842746	intergenic	LOC105378622 - RN7SKP91	105378622	106480861		8300	1079	rs4949316-G	rs4949316	0	4949316	upstream_gene_variant	1	NR	9E-6	5.045757490560675		0.2127	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	1q31.1	1	187442910	intergenic	LINC01036 - LINC01037	104169671	106144535		82666	718	rs2244067-T	rs2244067	0	2244067	upstream_gene_variant	1	NR	7E-6	5.154901959985743		0.2142	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	1q32.3	1	213661300	intergenic	LOC105372912			105372912			rs4655303-T	rs4655303	0	4655303	intergenic_variant	0	NR	5E-6	5.301029995663981		0.2187	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	2p22.3	2	35437731	intergenic	LOC100130842 - MIR548AD	100130842	100616475		218127	33674	rs13402855-C	rs13402855	0	13402855	intergenic_variant	1	NR	2E-6	5.698970004336019		0.2262	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	6q27	6	167988248	HGC6.1.1, MLLT4, KIF25, HGC6.3	HGC6.3 - KIF25-AS1	100128124	100505879		11309	5939	rs2843012-A	rs2843012	0	2843012	downstream_gene_variant	1	NR	6E-6	5.221848749616356		0.218	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	8p23.2	8	5369580	intergenic	LOC107986907 - RPL23AP54	107986907	100271466		223733	106929	rs77265424-G	rs77265424	0	77265424	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.2223	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	8p23.2	8	6295398	intergenic	LOC105377797 - LOC100287015	105377797	100287015		229278	108158	rs6559140-A	rs6559140	0	6559140	intergenic_variant	1	NR	7E-6	5.154901959985743		0.2159	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	8q24.13	8	121694051	intergenic	LOC105375732 - MRPS36P3	105375732	347704		9309	397419	rs279612-G	rs279612	0	279612	intron_variant	1	NR	7E-6	5.154901959985743		0.2138	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	9q21.13	9	76050860	PCSK5	PCSK5			5125			rs7047865-G	rs7047865	0	7047865	intron_variant	0	NR	5E-6	5.301029995663981		0.2188	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	11q24.3	11	128946326	TP53AIP1, ARHGAP32, 5S_rRNA	TP53AIP1 - ARHGAP32	63970	9743		2093	18734	rs11221522-A	rs11221522	0	11221522	upstream_gene_variant	1	NR	5E-7	6.301029995663981		0.2412	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	13q31.3	13	91080516	intergenic	BRK1P2 - LINC00380	100874492	101930747		56565	6738	rs61970269-T	rs61970269	0	61970269	intergenic_variant	1	NR	3E-6	5.522878745280337		0.2234	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	16q23.1	16	78301147	WWOX	WWOX			51741			rs78867184-G	rs78867184	0	78867184	intron_variant	0	NR	9E-6	5.045757490560675		0.213	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA)	up to 398 European ancestry individuals	NA	17p13.3	17	2241899	SMG6, SRR, AJ276246	SMG6			23293			rs11078884-C	rs11078884	0	11078884	intron_variant	0	NR	3E-6	5.522878745280337		0.2234	unit increase	Illumina [5767231] (imputed)	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	18q23	18	78897779	intergenic	LOC105372221 - LOC105372224	105372221	105372224		256542	10833	rs9951602-A	rs9951602	0	9951602	intergenic_variant	1	0.189	9E-6	5.045757490560675	(IGF1 bound )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	4q35.2	4	186236880	KLKB1	KLKB1			3818			rs3733402-G	rs3733402	0	3733402	missense_variant	0	0.337	9E-8	7.045757490560675	(IGF1 free )	0.04	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	3q11.2	3	96963418	EPHA6	EPHA6			285220			rs7650621-C	rs7650621	0	7650621	intron_variant	0	0.0060	2E-6	5.698970004336019	(IGF1 free )	0.04	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	9p21.1	9	28359784	LINGO2	LINGO2			158038			rs16912725-A	rs16912725	0	16912725	intron_variant	0	0.0040	2E-6	5.698970004336019	(IGF1 free )	0.04	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	12q23.3	12	104424414	CHST11	LOC105369949			105369949			rs11112046-A	rs11112046	0	11112046	intergenic_variant	0	0.179	3E-6	5.522878745280337	(IGF1 free )	0.02	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	5q35.2	5	175355116	DRD1	ARL2BPP6 - DRD1	100874421	1812		63864	85556	rs251925-A	rs251925	0	251925	intergenic_variant	1	0.285	5E-6	5.301029995663981	(IGF1 free )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	7q22.1	7	100342684	PMS2L1	STAG3L5P-PVRIG2P-PILRB			101752399			rs13228694-A	rs13228694	0	13228694	intron_variant	0	0.043	6E-6	5.221848749616356	(IGF1 free )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	3p12.1	3	84153052	intergenic	LOC105377188 - LINC00971	105377188	440970		100175	485353	rs4522784-C	rs4522784	0	4522784	intergenic_variant	1	0.01	7E-6	5.154901959985743	(IGF1 free )	0.04	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	12p13.33	12	1947197	DCP1B	DCP1B			196513			rs10505725-A	rs10505725	0	10505725	intron_variant	0	0.28	8E-6	5.096910013008056	(IGF1 free )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	20p12.1	20	15196934	MACROD2	MACROD2			140733			rs199307-G	rs199307	0	199307	5_prime_UTR_variant	0	0.241	8E-6	5.096910013008056	(IGF1 free )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	3q11.2	3	96609983	RPL18AP8	RNU6-1094P - MTRNR2L12	106480047	100463498		1066	7203	rs6796026-A	rs6796026	0	6796026	upstream_gene_variant	1	0.0080	8E-6	5.096910013008056	(IGF1 free )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	4q21.23	4	83800661	MAG1, AGPAT9	LOC105377315			105377315			rs4693646-A	rs4693646	0	4693646	intron_variant	0	0.407	9E-6	5.045757490560675	(IGF1 free )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	15q26.1	15	89624877	C15orf42	TICRR			90381			rs894157-G	rs894157	0	894157	missense_variant	0	0.273	9E-6	5.045757490560675	(IGF1 free )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	12p13.32	12	4196717	CCND2	LOC105369612			105369612			rs12827476-A	rs12827476	0	12827476	intergenic_variant	0	0.452	9E-6	5.045757490560675	(IGF1 free )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	17p11.2	17	17164868	MPRIP	MPRIP			23164			rs61744862-A	rs61744862	0	61744862	missense_variant	0	0.041	7E-8	7.154901959985743	(IGFBP-3 )	0.04	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	20q13.33	20	61933124	CDH4	CDH4			1002			rs6061910-A	rs6061910	0	6061910	splice_region_variant	0	0.063	1E-7	7.0	(IGFBP-3 )	0.04	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	12q13.2	12	56080359	ERBB3	ERBB3			2065			rs34379766-A	rs34379766	0	34379766	missense_variant	0	0.064	5E-7	6.301029995663981	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	20q13.12	20	44742679	KCNK15, WISP2, RIMS4	KCNK15-AS1			106144538			rs11696845-A	rs11696845	0	11696845	intron_variant	0	0.355	5E-7	6.301029995663981	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	14q23.1	14	58899597	LOC440181	LINC01500			102723742			rs405460-A	rs405460	0	405460	intron_variant	0	0.418	6E-7	6.221848749616356	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	13q34	13	110137885	COL4A1	LOC101927712			101927712			rs641862-G	rs641862	0	641862	regulatory_region_variant	0	0.062	7E-7	6.154901959985743	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	16p13.13	16	11128381	CLEC16A	CLEC16A			23274			rs78394940-A	rs78394940	0	78394940	intron_variant	0	0.063	9E-7	6.045757490560675	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	6p21.1	6	44772212	SUPT3H	LOC101929770			101929770			rs1342371-A	rs1342371	0	1342371	intergenic_variant	0	0.088	2E-6	5.698970004336019	(IGF1 bound )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	5q12.1	5	59801097	PDE4D	PDE4D			5144			rs2963826-A	rs2963826	0	2963826	intron_variant	0	0.325	2E-6	5.698970004336019	(IGF1 bound )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	15q15.1	15	40240667	PAK6	PAK6, BUB1B-PAK6			56924, 106821730			rs4924439-A	rs4924439	0	4924439	synonymous_variant	0	0.051	1E-6	6.0	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	20p12.3	20	6770442	BMP2	BMP2			650			rs2273074-A	rs2273074	0	2273074	missense_variant	0	0.043	1E-6	6.0	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	1p36.21	1	15744515	TMEM82	TMEM82			388595			rs59905655-A	rs59905655	0	59905655	missense_variant	0	0.043	2E-6	5.698970004336019	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	10q26.11	10	119206827	GRK5	PRDX3 - GRK5	10935	2869		27962	858	rs1397615-A	rs1397615	0	1397615	upstream_gene_variant	1	0.044	2E-6	5.698970004336019	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	8q24.3	8	143720286	MAPK15	MAPK15			225689			rs35925379-A	rs35925379	0	35925379	missense_variant	0	0.052	2E-6	5.698970004336019	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	11q24.2	11	125407598	PKNOX2	PKNOX2			63876			rs7112365-A	rs7112365	0	7112365	intron_variant	0	0.07	2E-6	5.698970004336019	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	2q14.1	2	113132796	IL1RN	IL1RN			3557			rs4252023-A	rs4252023	0	4252023	synonymous_variant	0	0.058	2E-6	5.698970004336019	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	10q11.21	10	43260306	RASGEF1A	RASGEF1A			221002			rs28461806-G	rs28461806	0	28461806	intron_variant	0	0.049	2E-6	5.698970004336019	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	7p12.3	7	46713893	EPS15P1	LOC730338 - EPS15P1	730338	55380		16771	67997	rs700750-A	rs700750	0	700750	intron_variant	1	0.487	3E-6	5.522878745280337	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	8p23.1	8	8719869	CLDN23	CLDN23 - MFHAS1	137075	9258		15762	63485	rs13256369-G	rs13256369	0	13256369	downstream_gene_variant	1	0.413	3E-6	5.522878745280337	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	11q23.1	11	111540883	LAYN	LAYN			143903			rs11213935-A	rs11213935	0	11213935	missense_variant	0	0.078	4E-6	5.3979400086720375	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	19p13.13	19	13135154	NACC1	NACC1			112939			rs10408126-A	rs10408126	0	10408126	intron_variant	0	0.034	4E-6	5.3979400086720375	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	16p13.3	16	2057112	TSC2	TSC2			7249			rs45502703-G	rs45502703	0	45502703	missense_variant	0	0.052	5E-6	5.301029995663981	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	1p36.32	1	2521540	PANK4	PANK4			55229			rs12073504-G	rs12073504	0	12073504	3_prime_UTR_variant	0	0.033	5E-6	5.301029995663981	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	12q24.23	12	118016864	RFC5	RFC5			5985			rs5745796-A	rs5745796	0	5745796	missense_variant	0	0.032	5E-6	5.301029995663981	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	3p21.31	3	48466176	TREX1	TREX1			11277			rs3135940-A	rs3135940	0	3135940	splice_region_variant	0	0.045	6E-6	5.221848749616356	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	19p13.3	19	3613474	C19orf29	CACTIN, CACTIN-AS1			58509, 404665			rs12977510-A	rs12977510	0	12977510	missense_variant	0	0.046	6E-6	5.221848749616356	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	7p11.2	7	54607180	RPL31P35	VSTM2A-OT1 - RNU6-1125P	285878	106480061		35454	13845	rs679830-A	rs679830	0	679830	intergenic_variant	1	0.116	6E-6	5.221848749616356	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	9q34.11	9	128713304	PKN3	PKN3			29941			rs72758841-G	rs72758841	0	72758841	missense_variant	0	0.036	6E-6	5.221848749616356	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	7q11.23	7	73580146	TBL2	TBL2 - MLXIPL	26608	51085		1463	13048	rs12666883-A	rs12666883	0	12666883	upstream_gene_variant	1	0.033	6E-6	5.221848749616356	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	18p11.31	18	3879739	DLGAP1	DLGAP1-AS3, DLGAP1			201477, 9229			rs76205593-C	rs76205593	0	76205593	missense_variant	0	0.07	7E-6	5.154901959985743	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	4q31.3	4	152975008	FHDC1	FHDC1			85462			rs77708442-A	rs77708442	0	77708442	missense_variant	0	0.032	8E-6	5.096910013008056	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	16q22.1	16	70471456	FUK	FUK			197258			rs11861805-T	rs11861805	0	11861805	intron_variant	0	0.049	8E-6	5.096910013008056	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	15q21.1	15	45642671	SQRDL	SQRDL			58472			rs607541-C	rs607541	0	607541	intron_variant	0	0.464	8E-6	5.096910013008056	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	16p13.3	16	3728336	CREBBP	CREBBP			1387			rs3751845-A	rs3751845	0	3751845	synonymous_variant	0	0.053	9E-6	5.045757490560675	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	2p25.1	2	11618305	GREB1	GREB1			9687			rs73175262-A	rs73175262	0	73175262	missense_variant	0	0.053	9E-6	5.045757490560675	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2015-06-24	25353672	Fernandez-Navarro P	2014-10-29	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/25353672	Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21.	Mammographic density	239 European ancestry low mammographic density females, 239 European ancestry high mammographic density females	NA	2p25.1	2	9683741	NR	LOC101926982 - RNU4-73P	101926982	106481195		18033	56902	rs4669418-A	rs4669418	0	4669418	intron_variant	1	0.597	9E-6	5.045757490560675		1.86	[1.41-2.47]	Illumina [575374]	N
2015-06-24	25353672	Fernandez-Navarro P	2014-10-29	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/25353672	Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21.	Mammographic density	239 European ancestry low mammographic density females, 239 European ancestry high mammographic density females	NA	2p13.3	2	70642341	NR	TGFA - ADD2	7039	119		88326	14443	rs6733938-G	rs6733938	0	6733938	intron_variant	1	0.155	5E-6	5.301029995663981		2.38	[1.61-3.45]	Illumina [575374]	N
2015-06-24	25353672	Fernandez-Navarro P	2014-10-29	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/25353672	Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21.	Mammographic density	239 European ancestry low mammographic density females, 239 European ancestry high mammographic density females	NA	2q11.2	2	99743888	NR	AFF3			3899			rs7601137-T	rs7601137	0	7601137	intron_variant	0	0.848	9E-6	5.045757490560675		2.32	[1.58-3.41]	Illumina [575374]	N
2015-06-24	25353672	Fernandez-Navarro P	2014-10-29	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/25353672	Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21.	Mammographic density	239 European ancestry low mammographic density females, 239 European ancestry high mammographic density females	NA	4q21.3	4	86211618	NR	LOC101929064, MAPK10			101929064, 5602			rs2904090-C	rs2904090	0	2904090	intron_variant	0	0.185	8E-6	5.096910013008056		2.22	[1.54-3.13]	Illumina [575374]	N
2015-06-24	25353672	Fernandez-Navarro P	2014-10-29	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/25353672	Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21.	Mammographic density	239 European ancestry low mammographic density females, 239 European ancestry high mammographic density females	NA	6p21.2	6	38432363	NR	BTBD9			114781			rs4565302-C	rs4565302	0	4565302	intron_variant	0	0.09	5E-6	5.301029995663981		2.94	[1.79-5.00]	Illumina [575374]	N
2015-07-15	25411163	Maitland ML	2014-11-19	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/25411163	Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of pazopanib.	Serum VEGFR2 concentration	736 Old Order Amish	NA	4q12	4	53810801	FIP1L1, PDGFRA, KIT, KDR	LOC100506444 - LOC100129728	100506444	100129728		76443	116392	rs725344-T	rs725344	0	725344	intron_variant	1	0.12	5E-25	24.30102999566398		1.32	[NR] ng/mL decrease	Affymetrix [549310]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	18q12.3	18	42357544	PIK3C3	LINC00907			284260			rs9304270-A	rs9304270	0	9304270	intron_variant	0	0.122	2E-6	5.698970004336019	(C-peptide )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	14q32.13	14	94505905	SERPINA12	SERPINA12			145264			rs11627075-A	rs11627075	0	11627075	intron_variant	0	0.046	3E-6	5.522878745280337	(C-peptide )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	13q12.11	13	21241730	ESRRAP2	LINC01046 - LOC105370105	103689843	105370105		6526	18283	rs17064136-A	rs17064136	0	17064136	intergenic_variant	1	0.037	4E-6	5.3979400086720375	(C-peptide )	0.04	[NR] ng/mL increase	Illumina [899892]	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	12q12	12	40373560	LRRK2	LOC105369736			105369736			rs10467147-A	rs10467147	0	10467147	downstream_gene_variant	0	0.196	5E-6	5.301029995663981	(C-peptide )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	9q34.2	9	133256074	ABO	ABO			28			rs8176741-?	rs8176741	0	8176741	synonymous_variant	0		2E-24	23.69897000433602				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19q13.33	19	48641533	CA11	CA11, SEC1P			770, 653677			rs11880333-?	rs11880333	0	11880333	intron_variant	0		5E-12	11.301029995663981				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19q13.33	19	48633394	DBP	DBP			1628			rs12608544-?	rs12608544	0	12608544	3_prime_UTR_variant	0		2E-12	11.698970004336019				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	21q22.3	21	41326980	FAM3B	FAM3B			54097			rs441810-?	rs441810	0	441810	intron_variant	0		2E-8	7.698970004336019				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19q13.33	19	48613847	FAM83E	FAM83E			54854			rs433852-?	rs433852	0	433852	intron_variant	0		5E-8	7.301029995663981				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19q13.33	19	48751247	FUT1	FUT1			2523			rs2071699-?	rs2071699	0	2071699	missense_variant	0		3E-10	9.522878745280337				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19q13.33	19	48703374	FUT2	FUT2, LOC105447645			2524, 105447645			rs1047781-?	rs1047781	0	1047781	missense_variant	0		1E-56	56.0				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19p13.3	19	5841345	FUT6	FUT6 - FUT3	2528	2525		1592	1543	rs3760775-?	rs3760775	0	3760775	upstream_gene_variant	1		8E-19	18.096910013008056				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	9q34.2	9	133279786	intergenic	ABO - LCN1P2	28	653163		4572	37719	rs7030248-?	rs7030248	0	7030248	upstream_gene_variant	1		4E-15	14.397940008672037				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19q13.33	19	48615114	RPL18	FAM83E - RPL18	54854	6141		273	213	rs2292342-?	rs2292342	0	2292342	upstream_gene_variant	1		7E-12	11.154901959985743				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19q13.33	19	48592021	SULT2B1	SULT2B1			6820			rs3786749-?	rs3786749	0	3786749	intron_variant	0		1E-10	10.0				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19q13.33	19	48649698	intergenic	SEC1P			653677			rs8111500-?	rs8111500	0	8111500	intron_variant	0	NR	4E-9	8.397940008672037				Illumina [709211] (imputed)	N
2015-01-14	24941225	Liang Y	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24941225	Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.	Elevated serum carcinoembryonic antigen levels	1,999 Chinese ancestry individuals	NA	19p13.3	19	5851790	FUT3	LOC101928844			101928844			rs2306969-?	rs2306969	0	2306969	intron_variant	0	NR	3E-8	7.522878745280337				Illumina [709211] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	6p25.3	6	396321	IRF4	IRF4			3662			rs12203592-T	rs12203592	0	12203592	intron_variant	0	0.17	2E-152	151.69897000433602		1.48	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	16q24.3	16	89919709	MC1R	MC1R			4157			rs1805007-T	rs1805007	0	1805007	missense_variant	0	0.07	3E-63	62.52287874528034		1.4	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	6p25.3	6	475489	EXOC2	LOC105374875			105374875			rs12210050-T	rs12210050	0	12210050	intergenic_variant	0	0.17	1E-51	51.0		1.25	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	20p13	20	2302811	TGM3	TGM3			7053			rs214785-C	rs214785	0	214785	intron_variant	0	0.18	8E-33	32.096910013008056		1.19	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	5p13.2	5	33946466	SLC45A2	SLC45A2			51151			rs35407-G	rs35407	0	35407	3_prime_UTR_variant	0	0.96	5E-27	26.30102999566398		1.59	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	20q11.22	20	34077942	RALY	RALY			22913			rs6059655-A	rs6059655	0	6059655	intron_variant	0	0.07	3E-26	25.522878745280337		1.24	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	1p36.13	1	17418040	RCC2	RCC2			55920			rs57142672-G	rs57142672	0	57142672	intron_variant	0	0.34	1E-23	23.0		1.13	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	10p14	10	8894035	GATA3	LOC105376400 - LOC105755953	105376400	105755953		224233	3954	rs73635312-G	rs73635312	0	73635312	upstream_gene_variant	1	0.84	3E-23	22.522878745280337		1.19	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	11q14.3	11	89284793	TYR	LOC107984363, TYR			107984363, 7299			rs1126809-A	rs1126809	0	1126809	missense_variant	0	0.28	3E-19	18.522878745280337		1.12	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	5p15.33	5	1325475	CLPTM1L	CLPTM1L			81037			rs421284-T	rs421284	0	421284	non_coding_transcript_exon_variant	0	0.56	1E-18	18.0		1.11	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	2q33.1	2	201300483	ALS2CR12	ALS2CR12			130540			rs2080303-T	rs2080303	0	2080303	intron_variant	0	0.32	7E-19	18.154901959985743		1.13	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	1q42.13	1	228843990	RHOU	LOC100421842 - LOC105373143	100421842	105373143		67125	104722	rs61824911-G	rs61824911	0	61824911	intergenic_variant	1	0.28	1E-14	14.0		1.11	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	15q13.1	15	28165345	OCA2	HERC2			8924			rs12916300-T	rs12916300	0	12916300	intron_variant	0	0.71	8E-17	16.096910013008056		1.15	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	8q22.2	8	99992792	RGS22	RGS22			26166			rs141115006-C	rs141115006	1	28798718	intron_variant	0	0.83	2E-15	14.698970004336019		1.14	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	8q21.13	8	76562310	ZFHX4	LOC107986952			107986952			rs10093547-G	rs10093547	0	10093547	intron_variant	0	0.94	5E-15	14.301029995663981		1.22	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	9p21.3	9	22054691	CDKN2B	CDKN2B-AS1			100048912			rs7874604-T	rs7874604	0	7874604	intron_variant	0	0.54	5E-13	12.301029995663981		1.1	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	12q13.13	12	52519884	KRT5	KRT5			3852			rs11170164-T	rs11170164	0	11170164	missense_variant	0	0.08	1E-15	15.0		1.19	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	17p13.1	17	7668434	TP53	TP53			7157			rs78378222-G	rs78378222	0	78378222	3_prime_UTR_variant	0	0.01	2E-10	9.698970004336019		1.41	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	7q32.3	7	130900794	KLF14	LINC-PINT			378805			rs157935-T	rs157935	0	157935	intron_variant	0	0.71	5E-6	5.301029995663981		1.06	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	3p13	3	71572518	FOXP1	FOXP1			27086			rs2116709-A	rs2116709	0	2116709	non_coding_transcript_exon_variant	0	0.6	2E-17	16.69897000433602		1.1111112	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	9p22.2	9	16884588	BNC2	BNC2 - LOC105375983	54796	105375983		13750	129484	rs10810657-A	rs10810657	0	10810657	intergenic_variant	1	0.59	2E-17	16.69897000433602		1.1111112	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	3q28	3	188374758	LPP	LPP			4026			rs191177147-T	rs191177147	1	62291440	intron_variant	0	0.39	1E-14	14.0		1.11	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	7q22.1	7	101775373	CUX1	MYL10 - CUX1	93408	1523		146077	40531	rs73183643-G	rs73183643	0	73183643	intergenic_variant	1	0.76	2E-13	12.698970004336019		1.1111112	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	8q21.13	8	80477556	ZBTB10	LOC105375922 - LOC105375921	105375922	105375921		26505	6690	rs11993814-C	rs11993814	0	11993814	intergenic_variant	1	0.74	9E-11	10.045757490560675		1.09	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	21q22.3	21	41668857	LINC00111	LOC107985478 - LOC105372813	107985478	105372813		370	92	rs2776353-A	rs2776353	0	2776353	intergenic_variant	1	0.67	2E-12	11.698970004336019		1.1	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	19p13.3	19	4837475	PLIN3	TICAM1 - PLIN3	148022	10226		5733	859	rs10425559-G	rs10425559	0	10425559	upstream_gene_variant	1	0.6	3E-8	7.522878745280337		1.08	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	7p12.3	7	47403036	TNS3	TNS3			64759			rs7776701-C	rs7776701	0	7776701	intron_variant	0	0.52	4E-8	7.3979400086720375		1.06	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	10q24.33	10	103920874	OBFC1	OBFC1 - LOC102724351	79991	102724351		2587	16773	rs7907606-G	rs7907606	0	7907606	upstream_gene_variant	1	0.17	5E-9	8.301029995663981		1.1	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	6q27	6	166981146	MIR3939	LOC105378120 - MIR3939	105378120	100500857		5710	16661	rs4710154-T	rs4710154	0	4710154	intron_variant	1	0.32	1E-8	8.0		1.08	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	6p22.3	6	22056694	CASC15	CASC15			401237			rs2294214-C	rs2294214	0	2294214	splice_region_variant	0	0.32	3E-8	7.522878745280337		1.07	[NR]	Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	6p25.3	6	396321	IRF4	IRF4			3662			rs12203592-T	rs12203592	0	12203592	intron_variant	0	0.17	3E-111	110.52287874528034		1.62		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	16q24.3	16	89919709	MC1R	MC1R			4157			rs1805007-T	rs1805007	0	1805007	missense_variant	0	0.07	9E-39	38.045757490560675		1.46		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	5p13.2	5	33946466	SLC45A2	SLC45A2			51151			rs35407-G	rs35407	0	35407	3_prime_UTR_variant	0	0.96	1E-13	13.0		1.6949153		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	11q14.3	11	89284793	TYR	LOC107984363, TYR			107984363, 7299			rs1126809-A	rs1126809	0	1126809	missense_variant	0	0.28	3E-14	13.522878745280337		1.16		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	20q11.22	20	34077942	RALY-ASIP	RALY			22913			rs6059655-A	rs6059655	0	6059655	intron_variant	0	0.07	3E-14	13.522878745280337		1.27		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	15q13.1	15	27985172	OCA2	OCA2			4948			rs1800407-T	rs1800407	0	1800407	missense_variant	0	0.07	9E-9	8.045757490560675		1.2		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	9q34.3	9	136462535	SEC16A	SEC16A			9919			rs57994353-C	rs57994353	0	57994353	intron_variant	0	0.3	8E-9	8.096910013008056		1.12		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	9p22.2	9	16884588	BNC2, CNTLN	BNC2 - LOC105375983	54796	105375983		13750	129484	rs10810657-A	rs10810657	0	10810657	intergenic_variant	1	0.59	1E-8	8.0		1.1111112		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	11q23.3	11	116019561	CADM1, BUD13	RPL15P15 - LOC105369513	100128347	105369513		68760	13513	rs74899442-C	rs74899442	0	74899442	intergenic_variant	1	0.01	9E-9	8.045757490560675		2.13		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	2p22.3	2	35111498	NR	LOC105374461 - LOC107985808	105374461	107985808		111310	47586	rs192481803-T	rs192481803	0	192481803	intron_variant	1	0.01	5E-8	7.301029995663981		1.9		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	7p21.1	7	17095084	AHR	LOC107986771 - LOC107986772	107986771	107986772		53963	4720	rs117132860-A	rs117132860	0	117132860	regulatory_region_variant	1	0.02	4E-8	7.3979400086720375		1.48		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	3q28	3	188370330	LPP	LPP			4026			rs11715549-G	rs11715549	0	11715549	intron_variant	0	0.46	1E-7	7.0		1.1		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-01-31	27436580	Cui Q	2016-07-19	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27436580	An Extended Genome-Wide Association Study Identifies Novel Susceptibility Loci for Nasopharyngeal Carcinoma.	Nasopharyngeal carcinoma	1,583 Southern Chinese ancestry cases, 2,979 Southern Chinese ancestry controls	5,463 Southern Chinese ancestry cases, 5,591 Southern Chinese ancestry controls	5p15.33	5	1321972	TERT, CLPTM1L	CLPTM1L			81037			rs401681-?	rs401681	0	401681	intron_variant	0	0.67	3E-14	13.522878745280337		1.22	[1.15-1.28]	Illumina [463250]	N
2017-01-31	27436580	Cui Q	2016-07-19	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27436580	An Extended Genome-Wide Association Study Identifies Novel Susceptibility Loci for Nasopharyngeal Carcinoma.	Nasopharyngeal carcinoma	1,583 Southern Chinese ancestry cases, 2,979 Southern Chinese ancestry controls	5,463 Southern Chinese ancestry cases, 5,591 Southern Chinese ancestry controls	16p13.13	16	10870261	CIITA	LOC105371080, CIITA			105371080, 4261			rs6498114-?	rs6498114	0	6498114	intron_variant	0	0.54	4E-9	8.397940008672037		1.15	[1.10-1.20]	Illumina [463250]	N
2017-01-31	27436580	Cui Q	2016-07-19	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27436580	An Extended Genome-Wide Association Study Identifies Novel Susceptibility Loci for Nasopharyngeal Carcinoma.	Nasopharyngeal carcinoma	1,583 Southern Chinese ancestry cases, 2,979 Southern Chinese ancestry controls	5,463 Southern Chinese ancestry cases, 5,591 Southern Chinese ancestry controls	4q31.21	4	143328617	NR	USP38 - LOC107986316	84640	107986316		104743	6860	rs300890-A	rs300890	0	300890	intron_variant	1	NR	9E-6	5.045757490560675		1.127	1.069-1.187	Illumina [463250]	N
2017-02-24	27424798	Chahal HS	2016-07-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27424798	Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.	cutaneous squamous cell carcinoma	6,579 European ancestry cases, 280,558 European ancestry controls	825 European ancestry cases, 11,518 European ancestry controls	8q23.3	8	115565487	TRPS1	TRPS1			7227			rs199816436-?	rs199816436	0	199816436	intron_variant	0	0.44	1E-6	6.0		1.1		Affymetrix, Illumina [at least 560000] (imputed)	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	237 COPD cases, 204 GI cancer cases	NA	10q26.2	10	127338145	DOCK1	DOCK1			1793			rs4751240-?	rs4751240	0	4751240	intron_variant	0		9E-10	9.045757490560675		0.1	[0.071-0.129] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	237 COPD cases, 204 GI cancer cases	NA	3q25.2	3	152872973	P2RY1	LOC107986146 - HMGN2P13	107986146	100289682		2433	194196	rs9847124-?	rs9847124	0	9847124	intergenic_variant	1		6E-7	6.221848749616356		0.07	[0.17-0.45] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	237 COPD cases, 204 GI cancer cases	NA	4p16.2	4	5709641	EVC2	EVC2 - EVC	132884	2121		93	1556	rs3774854-?	rs3774854	0	3774854	upstream_gene_variant	1		1E-6	6.0		0.05	[0.028-0.072] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	237 COPD cases, 204 GI cancer cases	NA	9p23	9	9799050	PTPRD	PTPRD			5789			rs10120246-?	rs10120246	0	10120246	intron_variant	0		4E-6	5.3979400086720375		0.08	[0.049-0.111] unit increase	Affymetrix [418365]	N
2009-11-09	19836008	Landi MT	2009-10-15	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19836008	A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.	Lung adenocarcinoma	5,739 European ancestry cases, 5,848 European ancestry controls	7,561 European ancestry cases, 13,818 European ancestry controls	6p21.33	6	31652743	APOM, BAT3	APOM, BAG6			55937, 7917			rs3117582-C	rs3117582	0	3117582	intron_variant	0	0.10	5E-12	11.301029995663981		1.22	[1.15-1.29]	Illumina [515922]	N
2009-11-09	19836008	Landi MT	2009-10-15	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19836008	A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.	Lung adenocarcinoma	5,739 European ancestry cases, 5,848 European ancestry controls	7,561 European ancestry cases, 13,818 European ancestry controls	6p22.1	6	28808340	TRNAA-UGC	TRF-GAA3-1 - TRA-AGC6-1	100189170	100189042		435	3732	rs4324798-A	rs4324798	0	4324798	regulatory_region_variant	1	0.09	2E-8	7.698970004336019		1.16	[1.09-1.24]	Illumina [515922]	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	2p22.2	2	38049406	CYP1B1, RMDN2	RMDN2			151393			rs6750047-A	rs6750047	0	6750047	intron_variant	0	0.43	7E-9	8.154901959985743		0.092	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	6p22.3	6	21163688	CDKAL1	CDKAL1			54901			rs6914598-C	rs6914598	0	6914598	intron_variant	0	0.32	4E-8	7.3979400086720375		0.1	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	7p21.1	7	16944656	AGR3	LOC100131425 - LOC105375170	100131425	105375170		55768	43719	rs1636744-T	rs1636744	0	1636744	intergenic_variant	1	0.40	7E-9	8.154901959985743		0.091	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	9q31.2	9	106298549	TMEM38B, RAD23B, TAL2, ZNF462, KLF4	LOC105376201 - MIR8081	105376201	102465995		257187	302379	rs10739221-T	rs10739221	0	10739221	intron_variant	1	0.24	7E-11	10.154901959985743		0.12	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	10q24.33	10	103909085	OBFC1, SH3PXD2A	OBFC1			79991			rs2995264-G	rs2995264	0	2995264	intron_variant	0	0.088	2E-9	8.698970004336019		0.16	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	11q13.3	11	69552350	CCND1	LINC01488 - CCND1	101928292	595		58807	88755	rs498136-A	rs498136	0	498136	intergenic_variant	1	0.32	2E-12	11.698970004336019		0.12	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	15q13.1	15	28090674	OCA2	OCA2			4948			rs4778138-G	rs4778138	0	4778138	intron_variant	0	0.16	2E-11	10.698970004336019		0.17	[NR] unit decrease	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	2p15	2	63550724	WDPCP	WDPCP			51057			rs186133190-C	rs186133190	0	186133190	intron_variant	0	0.015	1E-6	6.0		0.44	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	3q26.2	3	169763483	TERC	SDHDP3 - TERC	29771	7012		52905	1127	rs12696304-G	rs12696304	0	12696304	downstream_gene_variant	1	0.27	3E-7	6.522878745280337		0.092	[NR] unit decrease	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	7q31.33	7	124756591	GPR37, POT1	GPR37			2861			rs4731207-A	rs4731207	0	4731207	intron_variant	0	0.5	5E-7	6.301029995663981		0.079	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	7q32.3	7	131070053	LINC-PINT	LINC-PINT			378805			rs4731742-G	rs4731742	0	4731742	intron_variant	0	0.3	4E-7	6.3979400086720375		0.12	[NR] unit decrease	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	9q31.2	9	107936435	KLF4	LOC101926973			101926973			rs7041168-G	rs7041168	0	7041168	intergenic_variant	0	0.47	6E-7	6.221848749616356		0.081	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	11q13.3	11	69152181	TPCN2, CCND1	LOC107984345, LOC338694			107984345, 338694			rs2290419-G	rs2290419	0	2290419	intron_variant	0	0.044	3E-7	6.522878745280337		0.18	[NR] unit decrease	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	12p13.1	12	12922268	GPRC5A	MIR614 - KIAA1467	693199	57613		6350	5412	rs2111398-G	rs2111398	0	2111398	downstream_gene_variant	1	0.43	3E-7	6.522878745280337		0.087	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	16q22.1	16	68762843	CDH1	CDH1			999			rs35158985-G	rs35158985	0	35158985	intron_variant	0	0.3	3E-7	6.522878745280337		0.095	[NR] unit increase	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-06-02	26237428	Law MH	2015-08-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26237428	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.	Cutaneous malignant melanoma	12,874 European ancestry cases, 23,203 European ancestry controls	785 European ancestry cases, 791 European ancestry controls, 2,331 cases, 2,415 controls	20q13.33	20	63638397	RTEL1	LOC100505771 - STMN3	100505771	50861		9573	1308	rs75691080-T	rs75691080	0	75691080	downstream_gene_variant	1	0.095	1E-6	6.0		0.16	[NR] unit decrease	Affymetrix, Illumina [at least 1569314] (imputed)	N
2016-10-10	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioblastoma	1,783 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	12q23.3	12	106419124	POLR3B	POLR3B			55703			rs3851634-T	rs3851634	0	3851634	intron_variant	0	0.7	3E-9	8.522878745280337		1.2345679	[1.15-1.32]	Illumina [at least 8427548] (imputed)	N
2016-10-10	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioblastoma	1,783 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	5p15.33	5	1283640	NR	TERT			7015			rs72709458-T	rs72709458	0	72709458	intron_variant	0	NR	6E-24	23.221848749616356		1.68	[1.52-1.86]	Illumina [at least 8427548] (imputed)	N
2016-10-10	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioblastoma	1,783 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	7p11.2	7	55080382	NR	EGFR			1956			rs59060240-T	rs59060240	0	59060240	intron_variant	0	NR	4E-9	8.397940008672037		1.4084507	[1.25-1.59]	Illumina [at least 8427548] (imputed)	N
2016-10-10	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioblastoma	1,783 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	7p11.2	7	54848587	NR	LOC100996654 - LOC643168	100996654	643168		43618	84794	rs75061358-G	rs75061358	0	75061358	intergenic_variant	1	NR	6E-11	10.221848749616356		1.59	[1.39-1.83]	Illumina [at least 8427548] (imputed)	N
2016-10-10	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioblastoma	1,783 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	9p21.3	9	22066213	NR	CDKN2B-AS1			100048912			rs145929329-ATT	rs145929329	0	145929329	intron_variant	0	NR	5E-12	11.301029995663981		1.35	[1.24-1.47]	Illumina [at least 8427548] (imputed)	N
2016-10-10	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioblastoma	1,783 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	17p13.1	17	7675353	NR	TP53			7157			rs35850753-T	rs35850753	0	35850753	5_prime_UTR_variant	0	NR	4E-12	11.397940008672037		2.79	[2.09-3.72]	Illumina [at least 8427548] (imputed)	N
2016-10-10	26424050	Kinnersley B	2015-10-01	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26424050	Genome-wide association study identifies multiple susceptibility loci for glioma.	Glioblastoma	1,783 Northern European ancestry cases, 7,435 Northern European ancestry controls	up to 1,490 European ancestry cases, up to 1,723 European ancestry controls	20q13.33	20	63689615	NR	RTEL1-TNFRSF6B, RTEL1			100533107, 51750			rs6062302-C	rs6062302	0	6062302	synonymous_variant	0	NR	1E-13	13.0		1.4285715	[1.3-1.56]	Illumina [at least 8427548] (imputed)	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	1q44	1	247702471	RP11-634B7.4	LOC105373274			105373274			rs3862188-G	rs3862188	0	3862188	intron_variant	0	0.28	3E-8	7.522878745280337		1.87	[1.50-2.33]	Illumina [714494]	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	17q25.3	17	77598082	NR	LOC100507351 - LOC107985079	100507351	107985079		33058	68894	rs1972597-G	rs1972597	0	1972597	intergenic_variant	1	0.36	1E-7	7.0		1.61	[1.35-1.93]	Illumina [714494]	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	12q24.22	12	117072747	NR	TESC			54997			rs11068315-A	rs11068315	0	11068315	intron_variant	0	0.8	2E-6	5.698970004336019		2.06	[1.53-2.77]	Illumina [714494]	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	2p23.1	2	30666058	NR	CAPN13			92291			rs12464483-A	rs12464483	0	12464483	regulatory_region_variant	0	0.15	2E-6	5.698970004336019		1.7	[1.37-2.12]	Illumina [714494]	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	16q21	16	62453185	NR	CDH8 - LOC105371306	1006	105371306		416350	226072	rs1834077-A	rs1834077	0	1834077	intergenic_variant	1	0.39	3E-6	5.522878745280337		1.63	[1.33-2.01]	Illumina [714494]	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	2q11.2	2	102090719	NR	IL1R1			3554			rs10199359-G	rs10199359	0	10199359	intron_variant	0	0.18	3E-6	5.522878745280337		1.64	[1.33-2.02]	Illumina [714494]	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	6p12.2	6	52270696	NR	MCM3			4172			rs3789775-A	rs3789775	0	3789775	intron_variant	0	0.13	3E-6	5.522878745280337		1.8	[1.40-2.30]	Illumina [714494]	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	1q41	1	216684671	NR	ESRRG			2104			rs4085154-?	rs4085154	0	4085154	intron_variant	0	0.55	4E-6	5.3979400086720375		1.5873016	[1.3-1.92]	Illumina [714494]	N
2017-03-16	27670397	Reyes-Gibby CC	2016-09-27	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/27670397	Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.	Pre-treatment pain in head and neck squamous cell carcinoma	148 European ancestry cases, 810 European ancestry controls	58 European ancestry cases, 352 European ancestry controls	9q33.2	9	120963648	NR	C5			727			rs17612-?	rs17612	0	17612	missense_variant	0	0.26	5E-6	5.301029995663981		4.347826	[2.27-7.69]	Illumina [714494]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	11q24.1	11	123009573	BSX, HSPA8	BSX - LOC341056	390259	341056		27902	7993	rs12420422	rs12420422	0	12420422	intergenic_variant	1	NR	5E-10	9.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	12p13.33	12	3060327	NR	TEAD4 - RPL13AP24	7004	100271603		19651	11219	rs12310617	rs12310617	0	12310617	intergenic_variant	1	NR	2E-6	5.698970004336019				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	2p25.1	2	9956965	NR	GRHL1			29841			rs16867253	rs16867253	0	16867253	intron_variant	0	NR	6E-7	6.221848749616356				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	2q22.3	2	146120964	NR	LOC105373666 - RNU7-2P	105373666	100147745		239353	24192	rs222826	rs222826	0	222826	intergenic_variant	1	NR	5E-10	9.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	14q32.12	14	92945686	ITPK1	ITPK1			3705			rs4905014	rs4905014	0	4905014	intron_variant	0	NR	5E-16	15.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	3q21.1	3	123019460	SEMA5B	SEMA5B			54437			rs7632505	rs7632505	0	7632505	intron_variant	0	NR	8E-22	21.096910013008056				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	16q22.3	16	72963084	NR	ZFHX3			463			rs7190256	rs7190256	0	7190256	intron_variant	0	NR	5E-10	9.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	17p13.1	17	7718146	NR	DNAH2			146754			rs3803802	rs3803802	0	3803802	5_prime_UTR_variant	0	NR	5E-6	5.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	7p21.1	7	19177581	NR	FERD3L - LOC107986773	222894	107986773		32160	123054	rs17140821	rs17140821	0	17140821	regulatory_region_variant	1	NR	5E-7	6.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	18p11.22	18	8522684	NR	THEMIS3P - AKR1B1P6	100420484	100129769		8843	22965	rs8082812	rs8082812	0	8082812	intergenic_variant	1	NR	6E-64	63.221848749616356				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	9p21.3	9	22125348	NR	CDKN2B-AS1 - DMRTA1	100048912	63951		4251	321493	rs1333048	rs1333048	0	1333048	downstream_gene_variant	1	NR	1E-6	6.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	21q22.3	21	41463567	TMPRSS2	MX1 - TMPRSS2	4599	7113		4353	984	rs460976	rs460976	0	460976	downstream_gene_variant	1	NR	1E-8	8.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	10p12.1	10	26969741	ANKRD26	ANKRD26			22852			rs7081476	rs7081476	0	7081476	intergenic_variant	0	NR	2E-8	7.698970004336019				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases and mortality	9,618 European ancestry individuals	19,796 European ancestry individuals	10q25.2	10	112996282	NR	TCF7L2			6934			rs4506565	rs4506565	0	4506565	intron_variant	0	NR	2E-9	8.698970004336019				Affymetrix [NR]	N
2008-09-16	18385739	Thorgeirsson TE	2008-04-03	Nature	www.ncbi.nlm.nih.gov/pubmed/18385739	A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.	Nicotine dependence	10,995 European ancestry individuals	4,848 European ancestry individuals	15q25.1	15	78601997	CHRNA5, CHRNA3, CHRNB4	CHRNA3			1136			rs1051730-T	rs1051730	0	1051730	synonymous_variant	0	0.35	6E-20	19.221848749616356		0.1	[0.08-0.12] cigarettes per day increase	Illumina [306207]	N
2008-06-18	18488026	Brown KM	2008-05-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18488026	Common sequence variants on 20q11.22 confer melanoma susceptibility.	Melanoma	864 European ancestry cases, 864 European ancestry controls	1,230 European ancestry cases, 1,251 European ancestry controls	20q11.22	20	34583968	CDC91L1	PIGU			128869			rs910873-T	rs910873	0	910873	intron_variant	0	0.09	1E-15	15.0		1.75	[1.53-2.01]	Illumina [535150]	N
2008-11-12	18849993	Stacey SN	2008-10-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18849993	Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits.	Basal cell carcinoma	930 European ancestry cases, 33,117 European ancestry controls	1,216 European ancestry cases, 2,844 European ancestry controls	1p36.13	1	17395867	RCC2, ARHGEF10L, PADI4, PADI6	PADI6			353238			rs7538876-A	rs7538876	0	7538876	intron_variant	0	0.35	4E-12	11.397940008672037		1.28	[1.19-1.37]	Illumina [304083]	N
2008-11-12	18849993	Stacey SN	2008-10-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18849993	Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits.	Basal cell carcinoma	930 European ancestry cases, 33,117 European ancestry controls	1,216 European ancestry cases, 2,844 European ancestry controls	1q42.13	1	228862088	RHOU	LOC100421842 - LOC105373143	100421842	105373143		85223	86624	rs801114-G	rs801114	0	801114	downstream_gene_variant	1	0.33	6E-12	11.221848749616356		1.28	[1.19-1.37]	Illumina [304083]	N
2009-09-04	19664746	Tse KP	2009-08-05	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19664746	Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.	Nasopharyngeal carcinoma	277 Han Chinese ancestry cases, 285 Han Chinese ancestry controls	635 Han Chinese ancestry cases, 1,640 Han Chinese ancestry controls	6p22.1	6	29950322	HLA-A	HLA-A - HCG4P4	3105	353002		4438	4883	rs2517713-A	rs2517713	0	2517713	intron_variant	1	0.62	4E-20	19.397940008672037		1.88	[1.65-2.15]	Illumina [480365]	N
2009-09-04	19664746	Tse KP	2009-08-05	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19664746	Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.	Nasopharyngeal carcinoma	277 Han Chinese ancestry cases, 285 Han Chinese ancestry controls	635 Han Chinese ancestry cases, 1,640 Han Chinese ancestry controls	6p22.1	6	29643654	GABBR1	SUMO2P1 - MOG	285829	4340		7150	13327	rs29232-A	rs29232	0	29232	intergenic_variant	1	0.46	9E-17	16.045757490560675		1.67	[1.48-1.88]	Illumina [480365]	N
2009-09-04	19664746	Tse KP	2009-08-05	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/19664746	Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.	Nasopharyngeal carcinoma	277 Han Chinese ancestry cases, 285 Han Chinese ancestry controls	635 Han Chinese ancestry cases, 1,640 Han Chinese ancestry controls	6p22.1	6	29702484	HLA-F	ZFP57 - ZDHHC20P1	346171	100048907		21334	5657	rs3129055-G	rs3129055	0	3129055	regulatory_region_variant	1	0.31	7E-11	10.154901959985743		1.51	[1.34-1.71]	Illumina [480365]	N
2009-09-28	19729612	Paterson AD	2009-09-03	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/19729612	Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin.	Soluble E-selectin levels	685 European ancestry individuals with type 1 diabetes	477 European ancestry individuals	9q34.2	9	133278724	ABO	ABO - LCN1P2	28	653163		3510	38781	rs579459-C	rs579459	0	579459	upstream_gene_variant	1	0.20	1E-29	29.0				Illumina [~ 841000]	N
2011-08-12	21757650	Debette S	2011-07-14	Circ Res	www.ncbi.nlm.nih.gov/pubmed/21757650	Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.	Vascular endothelial growth factor levels	3,527 European ancestry individuals	1,727 European ancestry individuals	6p21.1	6	43957789	MRPL14, MGC45491	LINC01512 - LOC101929705	100132354	101929705		19582	37934	rs4513773-G	rs4513773	0	4513773	intergenic_variant	1	0.47	1E-584	584.0				Affymetrix [2540233] (imputed)	N
2011-08-12	21757650	Debette S	2011-07-14	Circ Res	www.ncbi.nlm.nih.gov/pubmed/21757650	Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.	Vascular endothelial growth factor levels	3,527 European ancestry individuals	1,727 European ancestry individuals	8q23.1	8	105569300	ZFPM2, LRP12	ZFPM2			23414			rs6993770-T	rs6993770	0	6993770	intron_variant	0	0.32	5E-23	22.30102999566398				Affymetrix [2540233] (imputed)	N
2011-08-12	21757650	Debette S	2011-07-14	Circ Res	www.ncbi.nlm.nih.gov/pubmed/21757650	Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.	Vascular endothelial growth factor levels	3,527 European ancestry individuals	1,727 European ancestry individuals	9p24.2	9	2691186	KCNV2, VLDLR	LOC105375957 - KCNV2	105375957	169522		23210	26340	rs10738760-A	rs10738760	0	10738760	intergenic_variant	1	0.49	1E-39	39.0				Affymetrix [2540233] (imputed)	N
2011-08-12	21757650	Debette S	2011-07-14	Circ Res	www.ncbi.nlm.nih.gov/pubmed/21757650	Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.	Vascular endothelial growth factor levels	3,527 European ancestry individuals	1,727 European ancestry individuals	6p21.1	6	43929990	MGC45491, VEGF	LINC01512			100132354			rs9472155-T	rs9472155	0	9472155	intergenic_variant	0	0.22	2E-26	25.69897000433602				Affymetrix [2540233] (imputed)	N
2010-09-15	20700438	Hsiung CA	2010-08-05	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20700438	The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia.	Lung adenocarcinoma	584 East Asian ancestry cases, 585 East Asian ancestry controls	2,184 East Asian ancestry cases, 2,515 East Asian ancestry controls	5p15.33	5	1286401	TERT, CLPTM1L	TERT			7015			rs2736100-G	rs2736100	0	2736100	intron_variant	0	0.39	2E-22	21.69897000433602		1.46	[1.35-1.57]	Illumina [457504]	N
2010-10-07	20871597	Miki D	2010-09-26	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20871597	Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations.	Lung adenocarcinoma	1,004 Japanese ancestry cases, 1,900 Japanese ancestry controls	1,094 East Asian ancestry cases, 9,148 East Asian ancestry controls	3q28	3	189665394	TP63	TP63			8626			rs10937405-C	rs10937405	0	10937405	intron_variant	0	0.67	7E-12	11.154901959985743		1.31	[1.22-1.42]	Illumina [432024]	N
2010-10-07	20871597	Miki D	2010-09-26	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20871597	Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations.	Lung adenocarcinoma	1,004 Japanese ancestry cases, 1,900 Japanese ancestry controls	1,094 East Asian ancestry cases, 9,148 East Asian ancestry controls	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-C	rs2736100	0	2736100	intron_variant	0	0.39	3E-11	10.522878745280337		1.27	[1.19-1.37]	Illumina [432024]	N
2011-02-22	21216879	Kaplan RC	2011-01-07	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21216879	A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.	Insulin-like growth factors	10,280 European ancestry individuals	NA	7p12.3	7	45968511	IGFBP3	LOC102723446			102723446			rs11977526-A	rs11977526	0	11977526	upstream_gene_variant	0	0.41	3E-101	100.52287874528034	(IGFBP-3)			Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-02-22	21216879	Kaplan RC	2011-01-07	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21216879	A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.	Insulin-like growth factors	10,280 European ancestry individuals	NA	7p12.3	7	46713955	TNS3	LOC730338 - EPS15P1	730338	55380		16833	67935	rs700752-G	rs700752	0	700752	intron_variant	1	0.65	4E-21	20.397940008672037	(IGFBP-3)			Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-02-22	21216879	Kaplan RC	2011-01-07	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21216879	A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.	Insulin-like growth factors	10,280 European ancestry individuals	NA	7p12.3	7	46713955	TNS3	LOC730338 - EPS15P1	730338	55380		16833	67935	rs700752-G	rs700752	0	700752	intron_variant	1	0.65	5E-9	8.301029995663981	(IGF-I)			Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-02-22	21216879	Kaplan RC	2011-01-07	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21216879	A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.	Insulin-like growth factors	10,280 European ancestry individuals	NA	4p16.1	4	7218206	SORCS2	SORCS2			57537			rs4234798-T	rs4234798	0	4234798	intron_variant	0	0.39	5E-10	9.301029995663981	(IGFBP-3)			Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-02-22	21216879	Kaplan RC	2011-01-07	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21216879	A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.	Insulin-like growth factors	10,280 European ancestry individuals	NA	16p13.3	16	1788835	NUBP2, IGFALS	NUBP2			10101			rs1065656-G	rs1065656	0	1065656	3_prime_UTR_variant	0	0.68	1E-11	11.0	(IGFBP-3)			Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-02-22	21216879	Kaplan RC	2011-01-07	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21216879	A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.	Insulin-like growth factors	10,280 European ancestry individuals	NA	7p21.3	7	7843692	RPA3	UMAD1			729852			rs7780564-C	rs7780564	0	7780564	intron_variant	0	0.55	4E-7	6.3979400086720375	(IGF-I)			Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-02-22	21216879	Kaplan RC	2011-01-07	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21216879	A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.	Insulin-like growth factors	10,280 European ancestry individuals	NA	10q22.1	10	72089881	SPOCK2	SPOCK2 - ASCC1	9806	51008		849	6151	rs1245541-G	rs1245541	0	1245541	upstream_gene_variant	1	0.61	5E-7	6.301029995663981	(IGF-I)			Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-02-22	21216879	Kaplan RC	2011-01-07	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21216879	A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.	Insulin-like growth factors	10,280 European ancestry individuals	NA	6q21	6	108666981	FOXO3	FOXO3			2309			rs2153960-A	rs2153960	0	2153960	intron_variant	0	0.69	5E-7	6.301029995663981	(IGF-I)			Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-07-13	21700618	Nan H	2011-06-23	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21700618	Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma.	Basal cell carcinoma	2,045 European ancestry cases, 6,013 European ancestry controls	1,426 cases, 4,845 controls	13q32.3	13	99389484	UBAC2	UBAC2 - CCR12P	337867	100133168		2985	18442	rs7335046-G	rs7335046	0	7335046	downstream_gene_variant	1	0.12	3E-8	7.522878745280337		1.26	[1.18-1.34]	Affymetrix, Illumina [2318094] (imputed)	N
2011-07-20	21706340	Teerlink C	2011-06-26	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21706340	A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q.	Melanoma	156 European ancestry cases from 34 high-risk families, 2,150 European ancestry controls	NA	10q25.1	10	105756594	NR	LOC101927549			101927549			rs17119461-?	rs17119461	0	17119461	intergenic_variant	0	0.04	7E-12	11.154901959985743		8.4	[4.20-17.0]	Illumina [491227]	N
2012-05-25	22511988	Jylhava J	2012-04-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22511988	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	Circulating cell-free DNA	1,841 individuals	NA	2q37.1	2	233763993	UGT1A1	UGT1A10, UGT1A5, UGT1A7, UGT1A9, UGT1A3, UGT1A4, UGT1A8, UGT1A, UGT1A1, UGT1A6			54575, 54579, 54577, 54600, 54659, 54657, 54576, 7361, 54658, 54578			rs6742078-T	rs6742078	0	6742078	intron_variant	0	0.60	2E-23	22.69897000433602		0.3358	[0.27-0.40] ug/ml increase	Illumina [2543887] (imputed)	N
2014-03-18	23996088	Migliorini G	2013-08-30	Blood	www.ncbi.nlm.nih.gov/pubmed/23996088	Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.	Acute lymphoblastic leukemia (B-cell precursor)	1,658 European ancestry child cases, 4,723 European ancestry controls	1,449 European ancestry child cases, 1,488 European ancestry controls	10q21.2	10	61961417	ARID5B	ARID5B			84159			rs7090445-?	rs7090445	0	7090445	intron_variant	0	NR	5E-54	53.30102999566398				Illumina [382776] (imputed)	N
2014-03-18	23996088	Migliorini G	2013-08-30	Blood	www.ncbi.nlm.nih.gov/pubmed/23996088	Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.	Acute lymphoblastic leukemia (B-cell precursor)	1,658 European ancestry child cases, 4,723 European ancestry controls	1,449 European ancestry child cases, 1,488 European ancestry controls	9p21.3	9	21984662	CDKN2A/B	CDKN2A			1029			rs3731217-?	rs3731217	0	3731217	intron_variant	0	NR	2E-8	7.698970004336019				Illumina [382776] (imputed)	N
2014-03-18	23996088	Migliorini G	2013-08-30	Blood	www.ncbi.nlm.nih.gov/pubmed/23996088	Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.	Acute lymphoblastic leukemia (B-cell precursor)	1,658 European ancestry child cases, 4,723 European ancestry controls	1,449 European ancestry child cases, 1,488 European ancestry controls	14q11.2	14	23119848	CEBPE	CEBPE - SLC7A8	1053	23428		237	5447	rs2239633-?	rs2239633	0	2239633	upstream_gene_variant	1	NR	1E-16	16.0				Illumina [382776] (imputed)	N
2014-03-18	23996088	Migliorini G	2013-08-30	Blood	www.ncbi.nlm.nih.gov/pubmed/23996088	Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.	Acute lymphoblastic leukemia (B-cell precursor)	1,658 European ancestry child cases, 4,723 European ancestry controls	1,449 European ancestry child cases, 1,488 European ancestry controls	7p12.2	7	50402283	IKZF1	IKZF1			10320			rs11980379-?	rs11980379	0	11980379	3_prime_UTR_variant	0	NR	3E-33	32.52287874528034				Illumina [382776] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	20p13	20	2301324	TGM3	LOC105372503, TGM3			105372503, 7053			rs214782-G	rs214782	0	214782	intron_variant	0	0.17	6E-17	16.221848749616356		1.29	[1.22-1.37]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	8q22.2	8	100012277	RGS22	RGS22			26166			rs7006527-?	rs7006527	0	7006527	intron_variant	0	0.86	9E-13	12.045757490560675		1.3	[1.22-1.41]	Illumina [38500000] (imputed)	N
2010-03-17	20147318	Qi L	2010-02-22	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/20147318	Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes.	E-selectin levels	501 European ancestry type 2 diabetes female cases, 504 European ancestry female controls	518 European ancestry female individuals	9q34.2	9	133278431	ABO	ABO - LCN1P2	28	653163		3217	39074	rs651007-T	rs651007	0	651007	upstream_gene_variant	1	0.22	2E-82	81.69897000433602		17.23	[NR] ng/ml decrease	Affymetrix [721316]	N
2010-06-14	20512145	Bei JX	2010-05-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20512145	A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.	Nasopharyngeal carcinoma	1,583 Chinese ancestry cases, 1,894 Chinese ancestry controls	3,507 Chinese ancestry cases, 3,063 Chinese ancestry controls, 284  Chinese ancestry trios	6p22.1	6	29938914	HLA-A	HLA-U - HCG4P5	352965	353003		4034	1998	rs2860580-?	rs2860580	0	2860580	intron_variant	1	0.62	5E-67	66.30102999566398		1.72	[1.61-1.82]	Illumina [464328]	N
2010-06-14	20512145	Bei JX	2010-05-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20512145	A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.	Nasopharyngeal carcinoma	1,583 Chinese ancestry cases, 1,894 Chinese ancestry controls	3,507 Chinese ancestry cases, 3,063 Chinese ancestry controls, 284  Chinese ancestry trios	6p21.33	6	31295974	HLA-C, HLA-B	LOC105375015			105375015			rs2894207-?	rs2894207	0	2894207	intron_variant	0	0.82	3E-33	32.52287874528034		1.64	[1.52-1.75]	Illumina [464328]	N
2010-06-14	20512145	Bei JX	2010-05-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20512145	A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.	Nasopharyngeal carcinoma	1,583 Chinese ancestry cases, 1,894 Chinese ancestry controls	3,507 Chinese ancestry cases, 3,063 Chinese ancestry controls, 284  Chinese ancestry trios	6p21.32	6	32624960	HLA-DQ, HLA-DR	HLA-DRB1 - LOC107986589	3123	107986589		35124	12228	rs28421666-?	rs28421666	0	28421666	upstream_gene_variant	1	0.88	2E-18	17.69897000433602		1.49	[1.37-1.64]	Illumina [464328]	N
2010-06-14	20512145	Bei JX	2010-05-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20512145	A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.	Nasopharyngeal carcinoma	1,583 Chinese ancestry cases, 1,894 Chinese ancestry controls	3,507 Chinese ancestry cases, 3,063 Chinese ancestry controls, 284  Chinese ancestry trios	13q12.12	13	23631056	TNFRSF19	TNFRSF19			55504			rs9510787-G	rs9510787	0	9510787	intron_variant	0	0.37	2E-9	8.698970004336019		1.2	[1.10-1.30]	Illumina [464328]	N
2010-06-14	20512145	Bei JX	2010-05-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20512145	A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.	Nasopharyngeal carcinoma	1,583 Chinese ancestry cases, 1,894 Chinese ancestry controls	3,507 Chinese ancestry cases, 3,063 Chinese ancestry controls, 284  Chinese ancestry trios	3q26.2	3	169364845	MDS1, EVI1	MECOM			2122			rs6774494-?	rs6774494	0	6774494	intron_variant	0	0.35	1E-8	8.0		1.19	[1.12-1.27]	Illumina [464328]	N
2010-06-14	20512145	Bei JX	2010-05-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20512145	A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.	Nasopharyngeal carcinoma	1,583 Chinese ancestry cases, 1,894 Chinese ancestry controls	3,507 Chinese ancestry cases, 3,063 Chinese ancestry controls, 284  Chinese ancestry trios	9p21.3	9	22043927	CDKN2B, CDNK2A	CDKN2B-AS1			100048912			rs1412829-?	rs1412829	0	1412829	intron_variant	0	0.89	5E-7	6.301029995663981		1.28	[1.18-1.41]	Illumina [464328]	N
2010-06-14	20512145	Bei JX	2010-05-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20512145	A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.	Nasopharyngeal carcinoma	1,583 Chinese ancestry cases, 1,894 Chinese ancestry controls	3,507 Chinese ancestry cases, 3,063 Chinese ancestry controls, 284  Chinese ancestry trios	13q12.12	13	23553071	TNFRSF19	LINC00327 - TNFRSF19	100506697	55504		65607	17177	rs1572072-?	rs1572072	0	1572072	intergenic_variant	1	0.74	1E-8	8.0		1.19	[1.11-1.27]	Illumina [464328]	N
2012-09-20	22797724	Shiraishi K	2012-07-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22797724	A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.	Lung adenocarcinoma	1,695 Japanese ancestry cases, 5,333 Japanese ancestry controls	4,334 Japanese ancestry cases, 8,202 Japanese ancestry controls	5p15.33	5	1287079	TERT	TERT			7015			rs2853677-C	rs2853677	0	2853677	intron_variant	0	0.30	3E-40	39.52287874528034		1.41	[1.32-1.50]	Illumina [538166]	N
2012-09-20	22797724	Shiraishi K	2012-07-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22797724	A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.	Lung adenocarcinoma	1,695 Japanese ancestry cases, 5,333 Japanese ancestry controls	4,334 Japanese ancestry cases, 8,202 Japanese ancestry controls	3q28	3	189665394	TP63	TP63			8626			rs10937405-C	rs10937405	0	10937405	intron_variant	0	0.67	7E-17	16.154901959985743		1.25	[1.19-1.32]	Illumina [538166]	N
2012-09-20	22797724	Shiraishi K	2012-07-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22797724	A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.	Lung adenocarcinoma	1,695 Japanese ancestry cases, 5,333 Japanese ancestry controls	4,334 Japanese ancestry cases, 8,202 Japanese ancestry controls	17q24.2	17	67902693	BPTF	BPTF			2186			rs7216064-A	rs7216064	0	7216064	intron_variant	0	0.707	7E-11	10.154901959985743		1.2	[1.13-1.26]	Illumina [538166]	N
2012-09-20	22797724	Shiraishi K	2012-07-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22797724	A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.	Lung adenocarcinoma	1,695 Japanese ancestry cases, 5,333 Japanese ancestry controls	4,334 Japanese ancestry cases, 8,202 Japanese ancestry controls	6p21.32	6	32400310	BTNL2	LOC101929163, BTNL2			101929163, 56244			rs3817963-G	rs3817963	0	3817963	intron_variant	0	0.318	3E-10	9.522878745280337		1.18	[1.12-1.24]	Illumina [538166]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	1q23.3	1	160776286	intergenic	LOC105371470			105371470			rs576523-?	rs576523	0	576523	intron_variant	0	NR	2E-7	6.698970004336019				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	1q21.2	1	148892307	PDE4DIP	PDE4DIP			9659			rs2863344-?	rs2863344	0	2863344	intron_variant	0	NR	2E-6	5.698970004336019				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	1p31.1	1	75304940	SLC44A5	SLC44A5			204962			rs1249675-?	rs1249675	0	1249675	intron_variant	0	NR	7E-6	5.154901959985743				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	2q14.2	2	121054648	intergenic	LOC105373587			105373587			rs4848143-?	rs4848143	0	4848143	intergenic_variant	0	NR	9E-6	5.045757490560675				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	3p14.2	3	59368432	intergenic	LOC105377110			105377110			rs6771019-?	rs6771019	0	6771019	intergenic_variant	0	NR	2E-6	5.698970004336019				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	3q26.1	3	163116513	intergenic	RPS6P4 - LINC01192	100131548	647107		359	60730	rs9824150-?	rs9824150	0	9824150	intron_variant	1	NR	7E-6	5.154901959985743				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	4q32.3	4	166534341	intergenic	TLL1 - SPOCK3	7092	50859		429163	199043	rs11941399-?	rs11941399	0	11941399	intergenic_variant	1	NR	1E-6	6.0				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	4q22.3	4	94232198	SMARCAD1	SMARCAD1			56916			rs3106136-?	rs3106136	0	3106136	intron_variant	0	NR	7E-6	5.154901959985743				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	5p15.31	5	7649747	MTRR, ADCY2	ADCY2			108			rs4702484-?	rs4702484	0	4702484	intron_variant	0	NR	6E-7	6.221848749616356				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	6p21.33	6	31440488	intergenic	MICA - HLA-X	100507436	267016		25173	21358	rs2524276-?	rs2524276	0	2524276	intron_variant	1	NR	6E-6	5.221848749616356				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	6q14.1	6	76581082	LOC643281	LOC105377860			105377860			rs12198063-?	rs12198063	0	12198063	intron_variant	0	NR	8E-6	5.096910013008056				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA				intergenic							rs361433-?	rs361433	0	361433	upstream_gene_variant	1	NR	9E-7	6.045757490560675				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	7p21.3	7	10325096	intergenic	LOC105375150 - HSPA8P8	105375150	100287551		109363	126140	rs2882834-?	rs2882834	0	2882834	intergenic_variant	1	NR	1E-6	6.0				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	7p15.3	7	21183171	intergenic	LINC01162 - RN7SL542P	104355138	106479419		160023	32366	rs6971109-?	rs6971109	0	6971109	intergenic_variant	1	NR	7E-6	5.154901959985743				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	10p15.2	10	3616727	intergenic	LOC105376360			105376360			rs705469-?	rs705469	0	705469	intergenic_variant	0	NR	7E-6	5.154901959985743				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	10q23.1	10	80617834	SH2D4B	SH2D4B			387694			rs6586111-?	rs6586111	0	6586111	intron_variant	0	NR	7E-6	5.154901959985743				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	10p15.2	10	3625534	intergenic	LOC105376360			105376360			rs705471-?	rs705471	0	705471	intergenic_variant	0	NR	7E-6	5.154901959985743				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	11p15.2	11	16018629	SOX6	SOX6			55553			rs16932455-?	rs16932455	0	16932455	intron_variant	0	NR	2E-6	5.698970004336019				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	13q12.11	13	20162077	intergenic	GJA3 - LOC107984553	2700	107984553		750	16933	rs6490525-?	rs6490525	0	6490525	upstream_gene_variant	1	NR	4E-6	5.3979400086720375				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	18q12.2	18	35517996	intergenic	INO80C - GALNT1	125476	2589		20005	63070	rs9953852-?	rs9953852	0	9953852	intergenic_variant	1	NR	3E-6	5.522878745280337				NR [~ 2000000]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	19p12	19	21773334	intergenic	ZNF100 - BRI3BPP1	163227	100129976		5706	27146	rs8101143-?	rs8101143	0	8101143	intron_variant	1	NR	2E-7	6.698970004336019				NR [~ 2000000]	N
2013-11-15	23719583	Kerns SL	2013-05-26	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/23719583	Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.	Adverse response to radiation therapy	79 European, African, Asian, and Hispanic ancestry cases, 241 European, African, Asian, and Hispanic ancestry controls	107 European, African, Asian, and Hispanic ancestry cases, 671 European, African, Asian, and Hispanic ancestry controls	4q28.3	4	137213427	LOC646316, PCDH18	LOC105377441			105377441			rs10519410-?	rs10519410	0	10519410	upstream_gene_variant	0	0.20	1E-6	6.0		1.5	[1.0-2.3]	Affymetrix [614453]	N
2013-11-15	23719583	Kerns SL	2013-05-26	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/23719583	Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.	Adverse response to radiation therapy	79 European, African, Asian, and Hispanic ancestry cases, 241 European, African, Asian, and Hispanic ancestry controls	107 European, African, Asian, and Hispanic ancestry cases, 671 European, African, Asian, and Hispanic ancestry controls	7q21.3	7	97388483	ACN9, TAC1	LOC105375416			105375416			rs10255878-?	rs10255878	0	10255878	intergenic_variant	0	0.14	4E-6	5.3979400086720375		5.2	[1.9-14.5]	Affymetrix [614453]	N
2013-11-15	23719583	Kerns SL	2013-05-26	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/23719583	Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.	Adverse response to radiation therapy	79 European, African, Asian, and Hispanic ancestry cases, 241 European, African, Asian, and Hispanic ancestry controls	107 European, African, Asian, and Hispanic ancestry cases, 671 European, African, Asian, and Hispanic ancestry controls	11q21	11	93058934	MTNR1B, SLC36A4	RPL26P31 - SLC36A4	100271469	120103		6060	85237	rs7120482-?	rs7120482	0	7120482	intergenic_variant	1	0.29	5E-8	7.301029995663981		3.1	[1.7-5.6]	Affymetrix [614453]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	13q12.11	13	20476436	CRYL1	CRYL1			51084			rs7989332-G	rs7989332	0	7989332	intron_variant	0	0.738	5E-6	5.301029995663981	(Allelic model)	2.056	[1.507-2.806]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	5p13.2	5	35799892	SPEF2	SPEF2, LOC105374724			79925, 105374724			rs3822735-G	rs3822735	0	3822735	intron_variant	0	0.752	2E-6	5.698970004336019	(Dominant model)	2.062	[1.500-2.834]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	15q21.3	15	55657884	PRTG	PRTG			283659			rs11071200-T	rs11071200	0	11071200	intron_variant	0	0.008	9E-7	6.045757490560675	(Dominant model)	8.241	[2.888-23.520]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	3p14.1	3	66475539	LRIG1	LRIG1			26018			rs3845905-G	rs3845905	0	3845905	intron_variant	0	0.828	6E-6	5.221848749616356	(Allelic model)	2.433	[1.645-3.598]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	16q23.3	16	81741193	CMIP	LOC105369213			105369213			rs12446319-A	rs12446319	0	12446319	intron_variant	0	0.143	9E-6	5.045757490560675	(Allelic model)	2.026	[1.48-2.774]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	6q14.1	6	76556471	LOC100131680	LOC105377860			105377860			rs4235898-A	rs4235898	0	4235898	intron_variant	0	0.74	1E-6	6.0	(Allelic model)	1.718	[1.377-2.142]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	14q31.3	14	86435710	LOC100421119	LOC105370607 - LOC283585	105370607	283585		78070	470068	rs12882718-T	rs12882718	0	12882718	intergenic_variant	1	0.643	6E-6	5.221848749616356	(Dominant model)	1.555	[1.283-1.884]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	6q21	6	105881180	PRDM1	LOC105377923			105377923			rs9386485-T	rs9386485	0	9386485	intergenic_variant	0	0.492	3E-6	5.522878745280337	(Allelic model)	1.524	[1.279-1.817]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	4q31.3	4	153453832	KIAA0922	MND1 - KIAA0922	84057	23240		38735	12514	rs6817170-G	rs6817170	0	6817170	intergenic_variant	1	0.286	9E-6	5.045757490560675	(Allelic model)	1.517	[1.264-1.822]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	2q32.3	2	195501166	LOC391470	LOC105376755			105376755			rs4591358-C	rs4591358	0	4591358	intron_variant	0	0.215	7E-6	5.154901959985743	(Allelic model)	1.578	[1.297-1.92]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	218 Japanese ancestry cases, 364 Japanese controls	NA	6q21	6	105881180	PRDM1	LOC105377923			105377923			rs9386485-T	rs9386485	0	9386485	intergenic_variant	0	0.477	1E-6	6.0	(Allelic model)	1.821	[1.429-2.32]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	218 Japanese ancestry cases, 364 Japanese controls	NA	9p13.3	9	35648953	SIT1	LOC101926948 - SIT1	101926948	27240		1477	345	rs3138083-A	rs3138083	0	3138083	upstream_gene_variant	1	0.117	4E-6	5.3979400086720375	(Allelic model)	2.136	[1.551-2.942]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	218 Japanese ancestry cases, 364 Japanese controls	NA	2p24.1	2	20135948	RPS16P2	LOC107985807 - RPS16P2	107985807	402069		9928	19625	rs4666360-C	rs4666360	0	4666360	regulatory_region_variant	1	0.114	3E-6	5.522878745280337	(Dominant model)	2.136	[1.546-2.95]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	218 Japanese ancestry cases, 364 Japanese controls	NA	15q24.2	15	75157333	RPL36AP45	LOC107987225 - RPL36AP45	107987225	441727		1797	29318	rs4886670-A	rs4886670	0	4886670	intergenic_variant	1	0.229	7E-6	5.154901959985743	(Allelic model)	1.835	[1.412-2.383]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	218 Japanese ancestry cases, 364 Japanese controls	NA	5q35.1	5	172844004	ERGIC1	ERGIC1			57222			rs792975-T	rs792975	0	792975	intron_variant	0	0.519	8E-6	5.096910013008056	(Allelic model)	1.746	[1.366-2.232]	Illumina [733202]	N
2012-10-16	22864933	O'Donnell PH	2012-01-03	Cancer	www.ncbi.nlm.nih.gov/pubmed/22864933	Identification of novel germline polymorphisms governing capecitabine sensitivity.	Capecitabine sensitivity	Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines	NA	5p15.31	5	7649747	MTRR, ADCY2	ADCY2			108			rs4702484-?	rs4702484	0	4702484	intron_variant	0	NR	5E-8	7.301029995663981	(EA)			NR [~ 2000000]	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	20p13	20	2239664	TGM3	LOC388780 - TGM3	388780	7053		3010	56303	rs59586681-T	rs59586681	0	59586681	intergenic_variant	1	0.61	3E-9	8.522878745280337		1.16	[1.11-1.22]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	1p36.13	1	17395867	RCC2, PADI6	PADI6			353238			rs7538876-A	rs7538876	0	7538876	intron_variant	0		7E-14	13.154901959985743		1.25	[1.18-1.32]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	1q42.13	1	228862088	RHOU	LOC100421842 - LOC105373143	100421842	105373143		85223	86624	rs801114-G	rs801114	0	801114	downstream_gene_variant	1		2E-13	12.698970004336019		1.25	[1.17-1.32]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	5p15.33	5	1321972	TERT	CLPTM1L			81037			rs401681-C	rs401681	0	401681	intron_variant	0		2E-12	11.698970004336019		1.23	[1.16-1.30]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	12q13.13	12	52519884	KRT5	KRT5			3852			rs11170164-T	rs11170164	0	11170164	missense_variant	0		3E-6	5.522878745280337		1.25	[1.14-1.37]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	9p21.3	9	22034720	CDKN2A, CDKN2B	CDKN2B-AS1			100048912			rs2151280-G	rs2151280	0	2151280	intron_variant	0		3E-10	9.522878745280337		1.2	[1.14-1.27]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	7q32.3	7	130900794	KLF14	LINC-PINT			378805			rs157935-T	rs157935	0	157935	intron_variant	0		9E-11	10.045757490560675		1.23	[1.15-1.31]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	17p13.1	17	7668434	TP53	TP53			7157			rs78378222-G	rs78378222	0	78378222	3_prime_UTR_variant	0		4E-22	21.397940008672037		2.24	[1.90-2.64]	Illumina [38500000] (imputed)	N
2014-10-02	24403052	Stacey SN	2014-01-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24403052	Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.	Basal cell carcinoma	4,208 European ancestry cases, 109,408 European ancestry controls	up to 1,480 European ancestry cases, up to 4,610 European ancestry controls	8q22.2	8	100012277	RGS22	RGS22			26166			rs7006527-?	rs7006527	0	7006527	intron_variant	0		9E-10	9.045757490560675		1.2987	[1.2-1.43]	Illumina [38500000] (imputed)	N
2013-03-06	23209447	Tang M	2012-11-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23209447	The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.	Nasopharyngeal carcinoma	up to 1,405 Han Chinese ancestry cases, up to 2,650 Han Chinese ancestry controls	356 Han Chinese ancestry cases, 629 Han Chinese ancestry controls				HLA							A*11:01-?	A*11:01	0			1	NR	2E-19	18.69897000433602	(NPC vs. Control)	1.69	[1.52-1.89]	Affymetrix [591458]	N
2013-03-06	23209447	Tang M	2012-11-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23209447	The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.	Nasopharyngeal carcinoma	up to 1,405 Han Chinese ancestry cases, up to 2,650 Han Chinese ancestry controls	356 Han Chinese ancestry cases, 629 Han Chinese ancestry controls				HLA							*A 11:01-?	A*11:01	0			1	NR	2E-16	15.698970004336019	(NPC vs. EP Controls)	1.75	[1.54-2]	Affymetrix [591458]	N
2013-03-06	23209447	Tang M	2012-11-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23209447	The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.	Nasopharyngeal carcinoma	up to 1,405 Han Chinese ancestry cases, up to 2,650 Han Chinese ancestry controls	356 Han Chinese ancestry cases, 629 Han Chinese ancestry controls				HLA							A*11:01-?	A*11:01	0			1	NR	3E-14	13.522878745280337	(NPC vs. EN Controls)	1.64	[1.45-1.89]	Affymetrix [591458]	N
2013-03-06	23209447	Tang M	2012-11-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23209447	The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.	Nasopharyngeal carcinoma	up to 1,405 Han Chinese ancestry cases, up to 2,650 Han Chinese ancestry controls	356 Han Chinese ancestry cases, 629 Han Chinese ancestry controls				HLA							B*38:02-?	B*38:02	0			1	NR	7E-11	10.154901959985743	(NPC vs. Control)	1.67	[1.43-1.94]	Affymetrix [591458]	N
2013-03-06	23209447	Tang M	2012-11-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23209447	The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.	Nasopharyngeal carcinoma	up to 1,405 Han Chinese ancestry cases, up to 2,650 Han Chinese ancestry controls	356 Han Chinese ancestry cases, 629 Han Chinese ancestry controls				HLA							B*38:02-?	B*38:02	0			1	NR	2E-10	9.698970004336019	(NPC vs. EP Controls)	1.88	[1.55-2.28]	Affymetrix [591458]	N
2013-03-06	23209447	Tang M	2012-11-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23209447	The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.	Nasopharyngeal carcinoma	up to 1,405 Han Chinese ancestry cases, up to 2,650 Han Chinese ancestry controls	356 Han Chinese ancestry cases, 629 Han Chinese ancestry controls				HLA							B*55:02-?	B*55:02	0			1	NR	5E-10	9.301029995663981	(NPC vs. EN Controls)	3.85	[2.5-5.88]	Affymetrix [591458]	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	2q36.3	2	227227319	BC035052, AK056332, COL4A3	COL4A3, LOC654841			1285, 654841			rs35212277-A	rs35212277	0	35212277	intron_variant	0		9E-6	5.045757490560675		0.2664	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	3p12.3	3	77603591	ROBO2	ROBO2			6092			rs73114594-A	rs73114594	0	73114594	intron_variant	0		7E-6	5.154901959985743		0.272	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	4p13	4	43318490	intergenic	LOC105374434, LOC105374433			105374434, 105374433			rs2006970-C	rs2006970	0	2006970	intergenic_variant	0		9E-6	5.045757490560675		0.2674	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	6p21.1	6	41994933	CCND3	CCND3			896			rs9357377-A	rs9357377	0	9357377	intron_variant	0		5E-6	5.301029995663981		0.2747	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	9p22.3	9	16000237	intergenic	CCDC171			203238			rs79156074-T	rs79156074	0	79156074	intron_variant	0		2E-6	5.698970004336019		0.2824	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	10q26.2	10	126134582	ADAM12	ADAM12			8038			rs1278329-G	rs1278329	0	1278329	intron_variant	0		8E-6	5.096910013008056		0.2671	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	11q23.3	11	115528028	intergenic	LOC105369511 - FTLP7	105369511	441623		7808	10690	rs7483296-T	rs7483296	0	7483296	downstream_gene_variant	1		8E-7	6.096910013008056		0.2927	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	14q21.1	14	38214056	SSTR1, CLEC14A	SSTR1 - CLEC14A	6751	161198		993	39944	rs11622412-T	rs11622412	0	11622412	downstream_gene_variant	1		5E-8	7.301029995663981		0.323	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	18p11.22	18	10766427	PIEZO2	PIEZO2			63895			rs2865126-A	rs2865126	0	2865126	intron_variant	0		8E-6	5.096910013008056		0.2663	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	Xp21.3	X	26351782	intergenic	LOC100422209 - LOC100418721	100422209	100418721		5671	145154	rs6526555-C	rs6526555	0	6526555	intergenic_variant	1		5E-6	5.301029995663981		0.2804	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (5-HIAA/ MHPG Ratio)	up to 398 European ancestry individuals	NA	Xq24	X	117735951	intergenic	LOC100420957 - KLHL13	100420957	90293		335870	161862	rs5910235-G	rs5910235	0	5910235	intergenic_variant	1		7E-6	5.154901959985743		0.2785	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	3p14.2	3	62126467	PTPRG, ID2B	PTPRG			5793			rs35593266-A	rs35593266	0	35593266	intron_variant	0		5E-6	5.301029995663981		0.2196	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	3q21.2	3	125874014	intergenic	LOC101927056, ENPP7P4			101927056, 100421816			rs71327718-G	rs71327718	0	71327718	intron_variant	0		7E-6	5.154901959985743		0.2152	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	5p13.2	5	35461098	intergenic	PRLR - SPEF2	5618	79925		230509	156675	rs284737-C	rs284737	0	284737	intergenic_variant	1		8E-6	5.096910013008056		0.2134	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	6q25.1	6	150059748	ULBP3	PHBP1 - ULBP3	5246	79465		15437	1298	rs78546022-G	rs78546022	0	78546022	downstream_gene_variant	1		4E-6	5.3979400086720375		0.2221	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	9q34.11	9	129587318	BC037833	LOC105376292 - NTMT1	105376292	28989		4632	21566	rs73628692-T	rs73628692	0	73628692	downstream_gene_variant	1		7E-6	5.154901959985743		0.2144	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	11p13	11	31863373	RCN1, DKFZp686K1684	DKFZp686K1684			440034			rs11031492-G	rs11031492	0	11031492	intron_variant	0		4E-6	5.3979400086720375		0.2196	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	12q13.11	12	47421189	intergenic	LOC107984528 - LOC100288129	107984528	100288129		51107	41898	rs1881744-A	rs1881744	0	1881744	downstream_gene_variant	1		2E-6	5.698970004336019		0.228	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	12q23.1	12	99510762	ANKS1B	ANKS1B			56899			rs1961649-T	rs1961649	0	1961649	intron_variant	0		3E-6	5.522878745280337		0.2234	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA/5-HIAA ratio)	up to 398 European ancestry individuals	NA	16p13.3	16	3719580	TRAP1, CREBBP	TRAP1 - CREBBP	10131	1387		1983	5474	rs56240109-G	rs56240109	0	56240109	upstream_gene_variant	1		5E-6	5.301029995663981		0.219	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	1q41	1	222071916	intergenic	LOC107985307 - FAM183EP	107985307	107403081		12509	130791	rs10863681-G	rs10863681	0	10863681	intergenic_variant	1		6E-6	5.221848749616356		0.2262	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	2p23.3	2	26027030	U6, RAB10	UQCRHP2 - TRMT112P6	729769	391358		31759	1003	rs68184094-A	rs68184094	0	68184094	downstream_gene_variant	1		4E-6	5.3979400086720375		0.2298	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	3p25.3	3	11583940	VGLL4	VGLL4			9686			rs6802119-C	rs6802119	0	6802119	intron_variant	0		8E-6	5.096910013008056		0.2221	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	4q22.1	4	90480460	FAM190A	CCSER1			401145			rs187200046-T	rs187200046	0	187200046	intron_variant	0		4E-6	5.3979400086720375		0.2293	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	6q15	6	92487582	intergenic	LOC107986625 - LOC105377896	107986625	105377896		153290	97322	rs13207034-A	rs13207034	0	13207034	intergenic_variant	1		1E-6	6.0		0.2425	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	6p22.3	6	21454922	intergenic	CDKAL1 - LINC00581	54901	100874531		222518	31139	rs9460635-C	rs9460635	0	9460635	intergenic_variant	1		7E-6	5.154901959985743		0.2238	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	8p12	8	29137505	KIF13B, AF086219	KIF13B			23303			rs13251954-A	rs13251954	0	13251954	intron_variant	0		2E-6	5.698970004336019		0.2357	unit decrease	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	8q13.3	8	70227095	NCOA2	NCOA2			10499			rs72663955-G	rs72663955	0	72663955	intron_variant	0		6E-6	5.221848749616356		0.2246	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	8q22.1	8	95093809	C8orf38	NDUFAF6			137682			rs4590408-G	rs4590408	0	4590408	intron_variant	0		6E-6	5.221848749616356		0.2255	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	20q12	20	40810843	intergenic	LOC101927098 - RNA5SP484	101927098	100873726		93411	43276	rs4812466-T	rs4812466	0	4812466	intergenic_variant	1		6E-6	5.221848749616356		0.2258	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	21q21.3	21	26773870	intergenic	CYYR1 - ADAMTS1	116159	9510		200466	62417	rs2830487-A	rs2830487	0	2830487	intergenic_variant	1		5E-7	6.301029995663981		0.2494	unit increase	Illumina [5767231] (imputed)	N
2013-04-04	23319000	Luykx JJ	2013-01-15	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23319000	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	Metabolite levels (HVA-5-HIAA Factor score)	up to 398 European ancestry individuals	NA	22q12.3	22	34975259	intergenic	ISX-AS1			101926957			rs9619497-A	rs9619497	0	9619497	intergenic_variant	0		5E-6	5.301029995663981		0.2273	unit increase	Illumina [5767231] (imputed)	N
2013-04-09	23251661	Comuzzie AG	2012-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23251661	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	Obesity-related traits	815 Hispanic children from 263 families	NA	6p21.32	6	32195971	GPSM3, NOTCH4	NOTCH4			4855			rs13215567-A	rs13215567	0	13215567	synonymous_variant	0	0.049	1E-6	6.0	(IGFBP-3 )	0.03	[NR] ng/mL increase	Illumina [899892]	N
2013-03-22	23269536	Sun J	2012-12-27	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23269536	Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.	Prostate-specific antigen levels	1,999 Chinese ancestry males	1,496 Chinese ancestry males	1q32.1	1	205669094	SLC45A3, NUCKS1, RAB7L1, SLC41A1, FLJ32569	SLC45A3			85414			rs12409639-A	rs12409639	0	12409639	intron_variant	0	0.11	2E-19	18.69897000433602		0.2	[NR] % increase	Illumina [> 709211] (imputed)	N
2013-03-22	23269536	Sun J	2012-12-27	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23269536	Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.	Prostate-specific antigen levels	1,999 Chinese ancestry males	1,496 Chinese ancestry males	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	4477	728484		57	16924	rs10993994-T	rs10993994	0	10993994	upstream_gene_variant	1	0.50	5E-17	16.30102999566398		0.12	[NR] % increase	Illumina [> 709211] (imputed)	N
2013-03-22	23269536	Sun J	2012-12-27	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23269536	Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.	Prostate-specific antigen levels	1,999 Chinese ancestry males	1,496 Chinese ancestry males	19q13.33	19	50861367	KLK3	KLK3 - KLK2	354	3817		603	12066	rs2735839-G	rs2735839	0	2735839	upstream_gene_variant	1	0.58	6E-37	36.221848749616356		0.19	[NR] % increase	Illumina [> 709211] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	4q13.3	4	74554070	AREG	LOC107986229			107986229			rs10034692-A	rs10034692	0	10034692	intron_variant	0	0.74	2E-10	9.698970004336019		0.16	[0.1-0.22] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	4q13.3	4	74618075	AREG	LOC107986229 - BTC	107986229	685		32977	126684	rs12642133-A	rs12642133	0	12642133	intergenic_variant	1	0.3	8E-10	9.096910013008056				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	5q23.2	5	123118610	PRDM6	PRDM6			93166			rs186749-A	rs186749	0	186749	intron_variant	0	0.28	3E-7	6.522878745280337				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	6q25.1	6	151625494	ESR1	CCDC170 - ESR1	80129	2099		4301	28654	rs12665607-A	rs12665607	0	12665607	downstream_gene_variant	1	0.08	2E-8	7.698970004336019		0.17	[0.092-0.248] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	7q21.11	7	78285026	MAGI2	MAGI2			9863			rs798336-T	rs798336	0	798336	intron_variant	0	0.88	2E-6	5.698970004336019				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-A	rs10995190	0	10995190	intron_variant	0	0.16	1E-16	16.0		0.24	[0.18-0.30] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	11p15.5	11	1887776	LSP1, TNNT3	LSP1			4046			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.66	1E-10	10.0		0.14	[0.081-0.199] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	12p12.1	12	26293692	intergenic	LOC105369705			105369705			rs11836164-T	rs11836164	0	11836164	intron_variant	0	0.77	1E-7	7.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	12q23.2	12	102618116	IGF1	LOC105369944			105369944			rs703556-A	rs703556	0	703556	intergenic_variant	0	0.98	4E-10	9.397940008672037		0.41	[0.25-0.57] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	20p12.2	20	11016263	C20orf187	C20orf187			728434			rs6104691-A	rs6104691	0	6104691	intergenic_variant	0	0.34	1E-6	6.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	22q13.1	22	38232300	TMEM184B, PLA2G6	TMEM184B			25829			rs7289126-A	rs7289126	0	7289126	intron_variant	0	0.4	3E-8	7.522878745280337		0.11	[0.071-0.149] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	22q13.1	22	40382227	SGSM3, MKL1, TNRC6B	SGSM3, LOC107985538, ADSL			27352, 107985538, 158			rs17001868-A	rs17001868	0	17001868	intron_variant	0	0.92	2E-13	12.698970004336019		0.18	[0.12-0.24] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	6p25.1	6	6751826	intergenic	LOC101928004			101928004			rs1294438-T	rs1294438	0	1294438	regulatory_region_variant	0	0.34	1E-6	6.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	7p12.3	7	46905209	intergenic	EPS15P1 - LOC105375267	55380	105375267		121689	64481	rs2190016-T	rs2190016	0	2190016	intron_variant	1	0.62	3E-6	5.522878745280337				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	8p11.23	8	36988591	intergenic	RPL26P25 - LOC105379377	100270966	105379377		93	77543	rs7816345-T	rs7816345	0	7816345	upstream_gene_variant	1	0.18	2E-23	22.69897000433602		0.24	[0.18-0.30] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	9p13.3	9	35758581	intergenic	NPR2			4882			rs10814275-A	rs10814275	0	10814275	upstream_gene_variant	0	0.95	6E-7	6.221848749616356				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q21.1	10	51695802	PRKG1, CSTF2T	CSTF2T, PRKG1			23283, 5592			rs14168-A	rs14168	0	14168	3_prime_UTR_variant	0	0.94	3E-6	5.522878745280337				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q21.2	10	62459241	ZNF365	ZNF365			22891			rs12220488-A	rs12220488	0	12220488	intron_variant	0	0.55	8E-7	6.096910013008056				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q25.1	10	107620506	intergenic	RNA5SP326 - LOC101927573	100873592	101927573		158837	69047	rs10884482-T	rs10884482	0	10884482	intergenic_variant	1	0.07	6E-8	7.221848749616356				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	14q12	14	26201719	intergenic	LOC107984700 - CYB5AP5	107984700	100289051		363187	6243	rs1546939-T	rs1546939	0	1546939	intergenic_variant	1	0.37	9E-6	5.045757490560675				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	5q23.2	5	123118610	PRDM6	PRDM6			93166			rs186749-A	rs186749	0	186749	intron_variant	0	0.28	3E-9	8.522878745280337		0.1	[0.061-0.139] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	8p11.23	8	36988591	intergenic	RPL26P25 - LOC105379377	100270966	105379377		93	77543	rs7816345-T	rs7816345	0	7816345	upstream_gene_variant	1	0.18	5E-8	7.301029995663981		0.08	[0.041-0.119] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	9q31.2	9	107621302	intergenic	LOC105376205			105376205			rs1110403-A	rs1110403	0	1110403	intergenic_variant	0	0.58	7E-6	5.154901959985743				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q21.2	10	62498069	ZNF365	ZNF365			22891			rs10509168-T	rs10509168	0	10509168	intron_variant	0	0.41	1E-9	9.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	22q13.1	22	38232300	TMEM184B, PLA2G6	TMEM184B			25829			rs7289126-A	rs7289126	0	7289126	intron_variant	0	0.4	5E-9	8.301029995663981		0.1	[0.061-0.139] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-26	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Nicotine glucouronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	4q13.2	4	68820054	UGT2B10	UGT2B10			7365			rs116224959-G	rs116224959	1	835315	intron_variant	0	NR	3E-43	42.52287874528034		0.1193	[NR] unit increase	Illumina [11892802] (imputed)	N
2015-06-26	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Nicotine glucouronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	7q21.3	7	96505669	SHFM1	LOC105375411			105375411			rs4132568-A	rs4132568	0	4132568	intron_variant	0	NR	3E-8	7.522878745280337		0.0343	[NR] unit decrease	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	4q13.2	4	68807835	UGT2B10	LOC100422026 - LOC100422189	100422026	100422189		20159	6160	rs115765562-C	rs115765562	1	34100980	regulatory_region_variant	1	NR	2E-155	154.69897000433602		0.1833	[NR] unit increase	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	4q13.2	4	68803498	UGT2B10	LOC100422026 - LOC100422189	100422026	100422189		15822	10497	rs141360540-G	rs141360540	1	10028938	intergenic_variant	1	NR	6E-91	90.22184874961636		0.1587	[NR] unit decrease	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	4q13.2	4	68803670	UGT2B10	LOC100422026 - LOC100422189	100422026	100422189		15994	10325	rs115219551-A	rs115219551	1	9997650	intergenic_variant	1	NR	2E-50	49.69897000433602		0.0941	[NR] unit decrease	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	4q13.2	4	68816753	UGT2B10	UGT2B10			7365			rs294777-A	rs294777	0	294777	intron_variant	0	NR	6E-48	47.221848749616356		0.1905	[NR] unit increase	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	4q12	4	57282220	OC255130	IGFBP7-AS1 - RPS26P24	255130	100271113		76921	70779	rs6832720-A	rs6832720	0	6832720	intergenic_variant	1	NR	7E-9	8.154901959985743		0.0585	[NR] unit decrease	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	4q13.2	4	66207425	LOC100144602	LOC728048 - MIR1269A	728048	100302177		112739	69399	rs1115363-A	rs1115363	0	1115363	intergenic_variant	1	NR	7E-9	8.154901959985743		0.0974	[NR] unit increase	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	7q11.21	7	66580525	LOC493754, KCTD7	LOC493754			493754			rs6952407-A	rs6952407	0	6952407	intron_variant	0	NR	5E-9	8.301029995663981		0.033	[NR] unit increase	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	9q31.2	9	108111500	KLF4, ACTL7B	LOC105376214			105376214			rs60634637-T	rs60634637	0	60634637	intergenic_variant	0	NR	2E-8	7.698970004336019		0.0942	[NR] unit increase	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	10p13	10	14591025	FAM107B	FAM107B			83641			rs4750535-C	rs4750535	0	4750535	intron_variant	0	NR	3E-10	9.522878745280337		0.0999	[NR] unit increase	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	11p15.2	11	16538083	SOX6	AKR1B1P3 - RN7SL188P	729347	106479290		53374	38768	rs4287304-C	rs4287304	0	4287304	intron_variant	1	NR	3E-9	8.522878745280337		0.1028	[NR] unit decrease	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	14q23.2	14	62580965	KCNH5	LOC105370529 - ATP5A1P4	105370529	100129782		75152	23148	rs76513344-C	rs76513344	0	76513344	intergenic_variant	1	NR	2E-9	8.698970004336019		0.0995	[NR] unit decrease	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	15q26.3	15	100533239	CERS3, LASS3	CERS3			204219			rs80332023-C	rs80332023	0	80332023	intron_variant	0	NR	3E-8	7.522878745280337		0.12	[NR] unit decrease	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	15q26.2	15	96911650	7SK, SPATA8	RN7SKP181 - LOC105371004	106479176	105371004		69266	159402	rs60283548-C	rs60283548	0	60283548	intergenic_variant	1	NR	4E-8	7.3979400086720375		0.1327	[NR] unit decrease	Illumina [11892802] (imputed)	N
2015-06-25	25293881	Patel Y	2014-10-07	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/25293881	The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations.	Cotinine glucuronidation	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	NA	19q13.31	19	43429573	TEX101, LYPD3	TEX101 - LYPD3	83639	27076		10958	31221	rs34705275-A	rs34705275	0	34705275	intergenic_variant	1	NR	4E-8	7.3979400086720375		0.0337	[NR] unit increase	Illumina [11892802] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	2p24.3	2	16280877	MYCN, FAM49A	LOC105373443 - LOC107985855	105373443	107985855		75923	74115	rs57244888-T	rs57244888	0	57244888	intergenic_variant	1	0.898	5E-12	11.301029995663981		1.32	[1.22-1.43]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	2q33.1	2	201350769	ALS2CR12, CASP8, CASP10	ALS2CR12			130540			rs13014235-C	rs13014235	0	13014235	missense_variant	0	0.456	2E-9	8.698970004336019		1.15	[1.10-1.20]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	8q21.13	8	76566304	ZFHX4, ZFHX4-AS1	LOC107986952			107986952			rs28727938-C	rs28727938	0	28727938	intron_variant	0	0.938	4E-12	11.397940008672037		1.43	[1.30-1.59]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	10p14	10	8894035	GATA3, RP11-428L9.1, RP11-428L9.2	LOC105376400 - LOC105755953	105376400	105755953		224233	3954	rs73635312-G	rs73635312	0	73635312	upstream_gene_variant	1	0.874	2E-16	15.698970004336019		1.35	[1.25-1.45]	Illumina [24988228] (imputed)	N
2015-11-17	25877299	Kristiansen W	2015-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25877299	Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.	Testicular germ cell tumor	1,326 European ancestry cases, 6,687 European ancestry controls	710 European ancestry case-parent triads, 289 European ancestry cases, 290 European ancestry controls	17q12	17	37741165	HNF1B	HNF1B			6928			rs7501939-C	rs7501939	0	7501939	intron_variant	0	0.624	1E-9	9.0		1.28	[1.19-1.39]	Illumina [610240]	N
2015-11-17	25877299	Kristiansen W	2015-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25877299	Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.	Testicular germ cell tumor	1,326 European ancestry cases, 6,687 European ancestry controls	710 European ancestry case-parent triads, 289 European ancestry cases, 290 European ancestry controls	19p12	19	23966743	intergenic	LOC100505851 - RNA5-8SP4	100505851	100873572		8813	37615	rs2195987-T	rs2195987	0	2195987	intergenic_variant	1	0.782	3E-8	7.522878745280337		1.32	[1.19-1.45]	Illumina [610240]	N
2015-11-17	25877299	Kristiansen W	2015-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25877299	Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.	Testicular germ cell tumor	1,326 European ancestry cases, 6,687 European ancestry controls	710 European ancestry case-parent triads, 289 European ancestry cases, 290 European ancestry controls	1q22	1	156199819	SLC20A44	SLC25A44			9673			rs2072499-G	rs2072499	0	2072499	non_coding_transcript_exon_variant	0	0.354	3E-7	6.522878745280337		1.22	[NR]	Illumina [610240]	N
2015-11-17	25877299	Kristiansen W	2015-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25877299	Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.	Testicular germ cell tumor	1,326 European ancestry cases, 6,687 European ancestry controls	710 European ancestry case-parent triads, 289 European ancestry cases, 290 European ancestry controls	1q24.1	1	165904155	UCK2	UCK2			7371			rs3790672-C	rs3790672	0	3790672	non_coding_transcript_exon_variant	0	0.281	2E-7	6.698970004336019		1.23	[NR]	Illumina [610240]	N
2015-11-17	25877299	Kristiansen W	2015-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25877299	Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.	Testicular germ cell tumor	1,326 European ancestry cases, 6,687 European ancestry controls	710 European ancestry case-parent triads, 289 European ancestry cases, 290 European ancestry controls	4q24	4	103133529	CENPE	CENPE			1062			rs2720460-A	rs2720460	0	2720460	intron_variant	0	0.594	6E-12	11.221848749616356		1.32	[NR]	Illumina [610240]	N
2015-11-17	25877299	Kristiansen W	2015-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25877299	Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.	Testicular germ cell tumor	1,326 European ancestry cases, 6,687 European ancestry controls	710 European ancestry case-parent triads, 289 European ancestry cases, 290 European ancestry controls	17q22	17	58555182	TEX14	SEPT4-AS1			101927688			rs9905704-T	rs9905704	0	9905704	intron_variant	0	0.708	4E-6	5.3979400086720375		1.23	[NR]	Illumina [610240]	N
2015-11-17	25877299	Kristiansen W	2015-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25877299	Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.	Testicular germ cell tumor	1,326 European ancestry cases, 6,687 European ancestry controls	710 European ancestry case-parent triads, 289 European ancestry cases, 290 European ancestry controls	21q22.3	21	46270154	MCM3AP	MCM3AP			8888			rs2839186-T	rs2839186	0	2839186	intron_variant	0	0.443	3E-6	5.522878745280337		1.23	[NR]	Illumina [610240]	N
2015-11-17	25877299	Kristiansen W	2015-04-15	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/25877299	Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.	Testicular germ cell tumor	1,326 European ancestry cases, 6,687 European ancestry controls	710 European ancestry case-parent triads, 289 European ancestry cases, 290 European ancestry controls	3p24.3	3	16583541	DAZL	LINC00690 - DAZL	100996597	1618		42168	3251	rs10510452-A	rs10510452	0	10510452	downstream_gene_variant	1	0.729	3E-9	8.522878745280337		1.32	[NR]	Illumina [610240]	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	1p36.13	1	17395867	RCC2, PADI6	PADI6			353238			rs7538876-A	rs7538876	0	7538876	intron_variant	0	0.356	8E-17	16.096910013008056		1.25	[NR]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	1q42.13	1	228862088	RHOU	LOC100421842 - LOC105373143	100421842	105373143		85223	86624	rs801114-G	rs801114	0	801114	downstream_gene_variant	1	0.33	8E-14	13.096910013008056		1.23	[NR]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	5p15.33	5	1321972	TERT	CLPTM1L			81037			rs401681-C	rs401681	0	401681	intron_variant	0	0.546	9E-13	12.045757490560675		1.21	[NR]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	12q13.13	12	52519884	KRT5	KRT5			3852			rs11170164-T	rs11170164	0	11170164	missense_variant	0	0.087	9E-9	8.045757490560675		1.29	[NR]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	9p21.3	9	22034720	CDKN2A, CDKN2B	CDKN2B-AS1			100048912			rs2151280-G	rs2151280	0	2151280	intron_variant	0	0.532	9E-11	10.045757490560675		1.19	[NR]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	7q32.3	7	130900794	KLF14	LINC-PINT			378805			rs157935-T	rs157935	0	157935	intron_variant	0	0.675	4E-20	19.397940008672037		1.21	[NR]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	17p13.1	17	7668434	TP53	TP53			7157			rs78378222-G	rs78378222	0	78378222	3_prime_UTR_variant	0	0.018	1E-20	20.0		2.07	[NR]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	20p13	20	2301324	TGM3	LOC105372503, TGM3			105372503, 7053			rs214782-G	rs214782	0	214782	intron_variant	0	0.171	2E-13	12.698970004336019		1.28	[NR]	Illumina [24988228] (imputed)	N
2015-11-21	25855136	Stacey SN	2015-04-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25855136	New basal cell carcinoma susceptibility loci.	Basal cell carcinoma	4,572 European ancestry cases, 266,358 European ancestry controls	up to 956 European ancestry cases, up to 4,214 European ancestry controls, 526 cases, 528 controls	8q22.2	8	100012277	RGS22	RGS22			26166			rs7006527-A	rs7006527	0	7006527	intron_variant	0	0.858	2E-12	11.698970004336019		1.32	[NR]	Illumina [24988228] (imputed)	N
2016-07-18	26183928	Leng S	2015-07-16	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/26183928	Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.	MGMT methylation in smokers	296  European ancestry individuals with MGMT methylation, 867 European ancestry individuals without MGMT methylation	107 European and Hispanic individuals with MGMT methylation, 323 European and Hispanic individuals without MGMT methylation	10q26.3	10	129467281	MGMT	MGMT			4255			rs16906252-?	rs16906252	0	16906252	synonymous_variant	0	NR	4E-31	30.397940008672037				Illumina [1599980]	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q14.1	2	113215368	PAX8	LOC107985935 - PAX8	107985935	7849		828	629	rs752590-?	rs752590	0	752590	intron_variant	1	0.21	3E-8	7.522878745280337		1.34	[1.21-1.49]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q31.1	2	176172583	HOXD3	HOXD3			3232			rs711830-?	rs711830	0	711830	3_prime_UTR_variant	0	0.32	8E-12	11.096910013008056		1.3	[1.20-1.40]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	19q13.2	19	39242112	IFNL3, IFNL4	LOC107985266 - IFNL3	107985266	282617		4128	1424	rs688187-?	rs688187	0	688187	upstream_gene_variant	1	0.68	7E-13	12.154901959985743		1.4925373	[1.33-1.67]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q14.1	2	113258824	PAX8	PAX8-AS1, PAX8			654433, 7849			rs72831838-?	rs72831838	0	72831838	intron_variant	0	0.14	8E-7	6.096910013008056	(Invasive Only)	1.39	[1.22-1.58]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q31.1	2	176172583	HOXD3	HOXD3			3232			rs711830-?	rs711830	0	711830	3_prime_UTR_variant	0	0.32	8E-7	6.096910013008056	(Invasive Only)	1.26	[1.15-1.39]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	19q13.2	19	39242112	IFNL3, IFNL4	LOC107985266 - IFNL3	107985266	282617		4128	1424	rs688187-?	rs688187	0	688187	upstream_gene_variant	1	0.68	1E-8	8.0	(Invasive Only)	1.4084507	[1.25-1.59]	Illumina [15504273] (imputed)	N
2016-07-18	26183928	Leng S	2015-07-16	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/26183928	Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.	MGMT methylation in smokers	296  European ancestry individuals with MGMT methylation, 867 European ancestry individuals without MGMT methylation	107 European and Hispanic individuals with MGMT methylation, 323 European and Hispanic individuals without MGMT methylation	15q15.2	15	42725228	STARD9, CDAN1, TTBK2, UBR1	CDAN1			146059			rs16957091-G	rs16957091	0	16957091	synonymous_variant	0	0.23	3E-7	6.522878745280337		1.7	[1.39-2.07]	Illumina [1599980]	N
2016-07-18	26183928	Leng S	2015-07-16	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/26183928	Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.	MGMT methylation in smokers	296  European ancestry individuals with MGMT methylation, 867 European ancestry individuals without MGMT methylation	107 European and Hispanic individuals with MGMT methylation, 323 European and Hispanic individuals without MGMT methylation	17q24.3	17	69121547	ABCA6, ABCA10	ABCA6			23460			rs997781-A	rs997781	0	997781	intron_variant	0	0.29	2E-7	6.698970004336019		1.63	[1.36-1.95]	Illumina [1599980]	N
2015-10-24	25569183	Vijai J	2015-01-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25569183	A genome-wide association study of marginal zone lymphoma shows association to the HLA region.	Marginal zone lymphoma	825 European ancestry cases, 6,221 European ancestry controls	456 European ancestry cases, 906 European ancestry controls	6p21.32	6	32402810	BTNL2	LOC101929163, BTNL2			101929163, 56244			rs9461741-C	rs9461741	0	9461741	intron_variant	0	0.018	4E-15	14.397940008672037		2.66	[2.08-3.39]	Illumina [611856]	N
2015-10-24	25569183	Vijai J	2015-01-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25569183	A genome-wide association study of marginal zone lymphoma shows association to the HLA region.	Marginal zone lymphoma	825 European ancestry cases, 6,221 European ancestry controls	456 European ancestry cases, 906 European ancestry controls	6p21.33	6	31368124	HLA-B, TCF19	DHFRP2 - RNU6-283P	729816	106479692		1159	2010	rs2922994-G	rs2922994	0	2922994	upstream_gene_variant	1	0.113	2E-9	8.698970004336019		1.64	[1.39-1.92]	Illumina [611856]	N
2015-10-24	25569183	Vijai J	2015-01-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25569183	A genome-wide association study of marginal zone lymphoma shows association to the HLA region.	Marginal zone lymphoma	825 European ancestry cases, 6,221 European ancestry controls	456 European ancestry cases, 906 European ancestry controls	14q23.1	14	61262775	intergenic	LOC105378182 - TMEM30B	105378182	161291		145630	14595	rs76788097-G	rs76788097	0	76788097	intron_variant	1	0.062	2E-6	5.698970004336019		1.53	[1.28-1.82]	Illumina [611856]	N
2015-10-24	25569183	Vijai J	2015-01-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25569183	A genome-wide association study of marginal zone lymphoma shows association to the HLA region.	Marginal zone lymphoma	825 European ancestry cases, 6,221 European ancestry controls	456 European ancestry cases, 906 European ancestry controls	2p24.1	2	20935927	intergenic	LOC101928271 - APOB	101928271	338		74266	65502	rs76588427-A	rs76588427	0	76588427	intergenic_variant	1	0.017	3E-6	5.522878745280337		2.05	[1.52-2.76]	Illumina [611856]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	8q22.1	8	97269961	TSPYL5	LOC101927066			101927066			rs1864729-?	rs1864729	0	1864729	downstream_gene_variant	0	0.098	3E-8	7.522878745280337		1.589	[1.35-1.871] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	2p11.2	2	85478554	NR	RN7SL251P - RPSAP22	106480990	100270874		35763	12371	rs11688246-?	rs11688246	0	11688246	intergenic_variant	1	0.052	1E-7	7.0		1.832	[1.469-2.285] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	14q23.2	14	62501677	NR	LOC105370529			105370529			rs4902141-?	rs4902141	0	4902141	intergenic_variant	0	0.026	1E-7	7.0		2.161	[1.629-2.867] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	1p35.1	1	33463157	NR	PHC2 - TLR12P	1912	100131451		32140	3092	rs12565140-?	rs12565140	0	12565140	upstream_gene_variant	1	0.136	3E-7	6.522878745280337		1.425	[1.247-1.629] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	1p31.1	1	80445429	NR	HMGB1P18 - HNRNPA1P64	646526	100129325		161260	5519	rs12118390-?	rs12118390	0	12118390	intergenic_variant	1	0.022	3E-7	6.522878745280337		2.253	[1.658-3.06] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	4q22.3	4	94694618	NR	PDLIM5 - BMPR1B-AS1	10611	100507012		26391	49050	rs4699587-?	rs4699587	0	4699587	intron_variant	1	0.048	5E-7	6.301029995663981		1.763	[1.416-2.194] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	10q11.21	10	44539224	NR	RPL9P21 - EIF2AP4	728374	100874401		124022	267219	rs7072122-?	rs7072122	0	7072122	intergenic_variant	1	0.051	6E-7	6.221848749616356		1.73	[1.397-2.141] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	12q22	12	94289428	NR	CEP83, PLXNC1			51134, 10154			rs4761470-?	rs4761470	0	4761470	intron_variant	0	0.177	6E-7	6.221848749616356		1.375	[1.214-1.556] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	5q15	5	97740844	NR	LOC391813 - LOC105379098	391813	105379098		1944	345022	rs10515260-?	rs10515260	0	10515260	downstream_gene_variant	1	0.035	6E-7	6.221848749616356		1.913	[1.485-2.463] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	3q26.33	3	182133496	NR	LOC105374242 - LOC105374243	105374242	105374243		105788	16029	rs16832889-?	rs16832889	0	16832889	intron_variant	1	0.011	1E-6	6.0		3.085	[1.965-4.844] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	2p16.3	2	52284656	NR	LOC730100			730100			rs17042688-?	rs17042688	0	17042688	intron_variant	0	0.038	1E-6	6.0		1.911	[1.474-2.476] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	11q24.2	11	126160720	NR	LOC105369591 - RPUSD4	105369591	84881		20082	41374	rs10501858-?	rs10501858	0	10501858	non_coding_transcript_exon_variant	1	0.091	1E-6	6.0		1.539	[1.295-1.829] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	2q11.2	2	101413184	NR	RFX8			731220			rs12620464-?	rs12620464	0	12620464	intron_variant	0	0.143	1E-6	6.0		1.397	[1.221-1.579] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	20p12.3	20	8723905	NR	PLCB1			23236			rs6077414-?	rs6077414	0	6077414	intron_variant	0	0.092	1E-6	6.0		1.466	[1.257-1.711] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	1p31.3	1	65049850	NR	LOC107983962, JAK1			107983962, 3716			rs478665-?	rs478665	0	478665	intergenic_variant	0	0.05	1E-6	6.0		1.772	[1.407-2.233] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	21q22.2	21	40331020	NR	DSCAM			1826			rs727333-?	rs727333	0	727333	intron_variant	0	0.081	1E-6	6.0		1.542	[1.295-1.837] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	3q29	3	194004541	NR	LOC647323 - LOC285389	647323	285389		882	915	rs724767-?	rs724767	0	724767	intron_variant	1	0.115	2E-6	5.698970004336019		1.436	[1.241-1.663] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	1p36.11	1	27405147	NR	WASF2			10163			rs11548323-?	rs11548323	0	11548323	3_prime_UTR_variant	0	0.17	2E-6	5.698970004336019		1.396	[1.219-1.598] unit increase	Illumina [563945]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	3p14.3	3	58041470	FLNB	FLNB			2317			rs1623879-G	rs1623879	0	1623879	intron_variant	0	0.321	4E-6	5.3979400086720375	(Recessive model)	1.669	[1.297-2.148]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	15q24.1	15	74839978	ULK3	ULK3			25989			rs936229-G	rs936229	0	936229	intron_variant	0	0.595	4E-6	5.3979400086720375	(Dominant model)	1.685	[1.302-2.18]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	8p23.2	8	4247625	CSMD1	CSMD1			64478			rs1714746-G	rs1714746	0	1714746	intron_variant	0	0.435	7E-6	5.154901959985743	(Recessive model)	1.61	[1.261-2.056]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	1p13.3	1	108850215	AKNAD1	AKNAD1			254268			rs1277203-A	rs1277203	0	1277203	intron_variant	0	0.626	9E-6	5.045757490560675	(Recessive model)	1.615	[1.243-2.098]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	17p12	17	12874085	RICH2	ARHGAP44			9912			rs11651483-C	rs11651483	0	11651483	intron_variant	0	0.665	3E-7	6.522878745280337	(Recessive model)	1.357	[1.12-1.643]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	13q31.3	13	92436398	GPC5	GPC5			2262			rs4771859-G	rs4771859	0	4771859	intron_variant	0	0.709	1E-6	6.0	(Recessive model)	1.328	[1.088-1.623]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	1q41	1	216542978	ESRRG	ESRRG			2104			rs12145418-T	rs12145418	0	12145418	intron_variant	0	0.274	2E-6	5.698970004336019	(Recessive model)	1.331	[1.104-1.604]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	16q23.1	16	77294998	ADAMTS18	ADAMTS18			170692			rs12935229-A	rs12935229	0	12935229	synonymous_variant	0	0.182	4E-6	5.3979400086720375	(Recessive model)	1.495	[1.214-1.84]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	12q24.31	12	122146362	MLXIP	MLXIP			22877			rs1043763-T	rs1043763	0	1043763	3_prime_UTR_variant	0	0.574	7E-6	5.154901959985743	(Dominant model)	1.496	[1.248-1.795]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	14q32.2	14	97521520	LOC100129345	LOC101929241			101929241			rs8022296-G	rs8022296	0	8022296	intron_variant	0	0.608	7E-6	5.154901959985743	(Recessive model)	1.269	[1.058-1.521]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	218 Japanese ancestry cases, 364 Japanese controls	NA	1p22.2	1	89559960	LRRC8B	LRRC8B			23507			rs922106-T	rs922106	0	922106	intron_variant	0	0.202	9E-7	6.045757490560675	(Recessive model)	1.679	[1.277-2.207]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	218 Japanese ancestry cases, 364 Japanese controls	NA	8q22.2	8	98009781	MATN2	MATN2			4147			rs2444896-T	rs2444896	0	2444896	intron_variant	0	0.603	2E-6	5.698970004336019	(Dominant model)	1.754	[1.355-2.269]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	218 Japanese ancestry cases, 364 Japanese controls	NA	17p13.1	17	9971888	GAS7	GAS7			8522			rs3786094-C	rs3786094	0	3786094	intron_variant	0	0.422	6E-6	5.221848749616356	(Recessive model)	1.531	[1.206-1.944]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	168 Japanese ancestry cases, 335 Japanese ancestry controls	NA	16p12.2	16	22877865	HS3ST2	HS3ST2			9956			rs2519974-T	rs2519974	0	2519974	intron_variant	0	0.381	4E-6	5.3979400086720375	(Dominant model)	1.647	[1.264-2.146]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	168 Japanese ancestry cases, 335 Japanese ancestry controls	NA	1q31.3	1	198500032	ATP6V1G3	LOC105371677			105371677			rs10922438-T	rs10922438	0	10922438	intergenic_variant	0	0.106	6E-6	5.221848749616356	(Allelic model)	2.301	[1.608-3.293]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	168 Japanese ancestry cases, 335 Japanese ancestry controls	NA	19p13.3	19	6475602	DENND1C	DENND1C			79958			rs3745571-T	rs3745571	0	3745571	3_prime_UTR_variant	0	0.67	8E-6	5.096910013008056	(Dominant model)	1.73	[1.276-2.345]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	15q24.2	15	75157333	RPL36AP45	LOC107987225 - RPL36AP45	107987225	441727		1797	29318	rs4886670-A	rs4886670	0	4886670	intergenic_variant	1	0.227	1E-6	6.0	(Allelic model)	1.605	[1.330-1.937]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	19q12	19	30446936	ZNF536	ZNF536			9745			rs33428-G	rs33428	0	33428	intron_variant	0	0.403	3E-6	5.522878745280337	(Dominant model)	1.375	[1.160-1.629]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	14q11.2	14	22468664	TRA	TRA, LOC105370401			6955, 105370401			rs12589282-G	rs12589282	0	12589282	intron_variant	0	0.437	4E-6	5.3979400086720375	(Recessive model)	1.48	[1.25-1.752]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	3p14.1	3	66475539	LRIG1	LRIG1			26018			rs3845905-G	rs3845905	0	3845905	intron_variant	0	0.85	4E-6	5.3979400086720375	(Allelic model)	1.894	[1.433-2.503]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	5q35.1	5	170115596	FOXI1	FOXI1 - KRT18P41	2299	345430		5871	25008	rs1895302-C	rs1895302	0	1895302	intergenic_variant	1	0.478	7E-6	5.154901959985743	(Dominant model)	1.34	[1.132-1.587]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	1p36.12	1	21511262	ALPL	ALPL			249			rs16825455-T	rs16825455	0	16825455	intron_variant	0	0.605	9E-6	5.045757490560675	(Dominant model)	1.425	[1.193-1.702]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	7p21.1	7	16822225	AGR2	AGR2 - LOC100287613	10551	100287613		17111	27766	rs10253216-T	rs10253216	0	10253216	intron_variant	1	0.468	2E-7	6.698970004336019	(Dominant model)	1.478	[1.155-1.891]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	4q13.1	4	62558371	LOC644534	HMGN1P11 - EXOC5P1	644534	644548		46802	258455	rs11944965-T	rs11944965	0	11944965	intergenic_variant	1	0.678	2E-6	5.698970004336019	(Dominant model)	1.986	[1.475-2.676]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	18q23	18	76776324	ZNF236	CCND3P2 - LOC100131655	106480307	100131655		24483	18408	rs2406342-T	rs2406342	0	2406342	intergenic_variant	1	0.475	2E-6	5.698970004336019	(Dominant model)	1.697	[1.323-2.177]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	20p12.3	20	7771719	SFRS13AP2	LOC105372518 - SRSF10P2	105372518	171472		46723	59782	rs6077251-T	rs6077251	0	6077251	intergenic_variant	1	0.153	3E-6	5.522878745280337	(Allelic model)	2.065	[1.537-2.773]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	8p21.1	8	27882900	SCARA5	SCARA5			286133			rs11774576-A	rs11774576	0	11774576	intron_variant	0	0.581	3E-6	5.522878745280337	(Dominant model)	1.699	[1.307-2.208]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	11p15.1	11	18800490	PTPN5	PTPN5 - LOC100420123	84867	100420123		7769	35715	rs4627050-G	rs4627050	0	4627050	intergenic_variant	1	0.649	4E-6	5.3979400086720375	(Allelic model)	1.932	[1.452-2.572]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	1p13.3	1	107760300	VAV3	VAV3			10451			rs12142335-A	rs12142335	0	12142335	intron_variant	0	0.004	8E-6	5.096910013008056	(Dominant model)	9.713	[3.175-29.71]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	184 Japanese ancestry cases, 459 Japanese ancestry controls	NA	12p13.31	12	6332835	TNFRSF1A	TNFRSF1A			7132			rs4149639-C	rs4149639	0	4149639	intron_variant	0	0.047	7E-6	5.154901959985743	(Allelic model)	2.763	[1.781-4.287]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	184 Japanese ancestry cases, 459 Japanese ancestry controls	NA	19p12	19	20218302	LOC100421704	LOC105372310, LOC105372311			105372310, 105372311			rs1654260-A	rs1654260	0	1654260	intron_variant	0	0.488	8E-6	5.096910013008056	(Allelic model)	1.749	[1.365-2.24]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	184 Japanese ancestry cases, 459 Japanese ancestry controls	NA	6q16.1	6	98048076	MIR2113	MIR2113 - EIF4EBP2P3	100302164	100190924		23455	130584	rs2505059-G	rs2505059	0	2505059	intron_variant	1	0.398	5E-6	5.301029995663981	(Allelic model)	1.765	[1.383-2.252]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	184 Japanese ancestry cases, 459 Japanese ancestry controls	NA	2q33.1	2	199773786	LOC348751	FTCDNL1, LOC107985974			348751, 107985974			rs12615435-T	rs12615435	0	12615435	intron_variant	0	0.773	4E-6	5.3979400086720375	(Allelic model)	2.214	[1.555-3.154]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	184 Japanese ancestry cases, 459 Japanese ancestry controls	NA	5q33.3	5	158997383	EBF1	EBF1			1879			rs10040979-G	rs10040979	0	10040979	intron_variant	0	0.618	5E-7	6.301029995663981	(Recessive model)	1.452	[1.12-1.883]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	184 Japanese ancestry cases, 459 Japanese ancestry controls	NA	1p31.3	1	68168241	LOC100289178	WLS, GNG12-AS1			79971, 100289178			rs1367448-C	rs1367448	0	1367448	intron_variant	0	0.526	5E-6	5.301029995663981	(Dominant model)	1.554	[1.212-1.993]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	83 Japanese ancestry cases, 66 Japanese ancestry controls	NA	15q24.3	15	77872364	LOC100302666	LINGO1 - CSPG4P13	84894	100302666		51464	6274	rs11857176-A	rs11857176	0	11857176	regulatory_region_variant	1	0.515	8E-7	6.096910013008056	(Recessive model)	1.8	[1.127-2.874]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	83 Japanese ancestry cases, 66 Japanese ancestry controls	NA	2p25.3	2	773278	LOC339822	LOC105373480 - LOC105373392	105373480	105373392		18943	1264	rs4380275-G	rs4380275	0	4380275	intergenic_variant	1	0.152	5E-6	5.301029995663981	(Recessive model)	3.604	[2.041-6.365]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	83 Japanese ancestry cases, 66 Japanese ancestry controls	NA	11q14.2	11	86703240	ME3	LOC107984427			107984427			rs2512987-T	rs2512987	0	2512987	intron_variant	0	0.417	7E-6	5.154901959985743	(Allelic model)	2.985	[1.855-4.803]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	83 Japanese ancestry cases, 370 Japanese ancestry controls	NA	12p13.31	12	6332835	TNFRSF1A	TNFRSF1A			7132			rs4149639-C	rs4149639	0	4149639	intron_variant	0	0.042	3E-7	6.522878745280337	(Allelic model)	4.443	[2.571-7.677]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	83 Japanese ancestry cases, 370 Japanese ancestry controls	NA	13q12.2	13	27786350	GSX1	LOC105370129 - GSX1	105370129	219409		46217	6293	rs1923834-G	rs1923834	0	1923834	intergenic_variant	1	0.77	5E-6	5.301029995663981	(Dominant model)	3.236	[1.823-5.744]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	83 Japanese ancestry cases, 370 Japanese ancestry controls	NA	10q26.13	10	124456270	LHPP	NKX1-2 - LHPP	390010	64077		6289	5502	rs908366-A	rs908366	0	908366	intergenic_variant	1	0.328	7E-6	5.154901959985743	(Allelic model)	2.199	[1.564-3.092]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	83 Japanese ancestry cases, 370 Japanese ancestry controls	NA	5p15.32	5	5407701	KIAA0947	LOC101929200			101929200			rs2964475-C	rs2964475	0	2964475	intergenic_variant	0	0.415	4E-6	5.3979400086720375	(Allelic model)	2.248	[1.592-3.174]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	83 Japanese ancestry cases, 370 Japanese ancestry controls	NA	3q27.3	3	187999098	LOC100505844	LOC107986166			107986166			rs1553091-G	rs1553091	0	1553091	intron_variant	0	0.358	7E-6	5.154901959985743	(Recessive model)	1.48	[1.053-2.08]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	294 Japanese ancestry cases, 2,249 Japanese ancestry controls	NA	18p11.31	18	4539085	LOC284215	LOC105371968 - PPIAP14	105371968	5486		42692	463467	rs7228133-C	rs7228133	0	7228133	intergenic_variant	1	0.686	2E-6	5.698970004336019	(Recessive model)	1.255	[1.034-1.522]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	294 Japanese ancestry cases, 2,249 Japanese ancestry controls	NA	21q21.2	21	25454202	NCRNA00158	CYP2C63P - LOC105372753	107063541	105372753		7821	39327	rs8127977-A	rs8127977	0	8127977	intergenic_variant	1	0.722	2E-6	5.698970004336019	(Dominant model)	1.587	[1.282-1.966]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	294 Japanese ancestry cases, 2,249 Japanese ancestry controls	NA	12q13.13	12	53925943	HOXC13	LOC107984525 - HOXC13-AS	107984525	100874366		26891	9385	rs894734-G	rs894734	0	894734	intergenic_variant	1	0.776	4E-6	5.3979400086720375	(Dominant model)	1.619	[1.279-2.05]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	294 Japanese ancestry cases, 2,249 Japanese ancestry controls	NA	13q12.11	13	22179954	LOC100506622	LOC105370108 - LINC00540	105370108	100506622		24369	30331	rs9580312-G	rs9580312	0	9580312	intron_variant	1	0.409	8E-6	5.096910013008056	(Dominant model)	1.33	[1.12-1.581]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	294 Japanese ancestry cases, 2,249 Japanese ancestry controls	NA	21q21.1	21	18109036	CHODL	CHODL			140578			rs2055011-C	rs2055011	0	2055011	intron_variant	0	0.143	9E-6	5.045757490560675	(Recessive model)	1.347	[1.075-1.686]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	294 Japanese ancestry cases, 2,249 Japanese ancestry controls	NA	12q24.31	12	124409638	NCOR2	NCOR2			9612			rs12582168-C	rs12582168	0	12582168	intron_variant	0	0.256	9E-6	5.045757490560675	(Dominant model)	1.454	[1.21-1.748]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	177 Japanese ancestry cases, 952 Japanese ancestry controls	NA	2q36.1	2	224078968	SERPINE2	SERPINE2 - LOC100420435	5270	100420435		39649	91749	rs6740660-G	rs6740660	0	6740660	intergenic_variant	1	0.894	4E-6	5.3979400086720375	(Allelic model)	3.386	[1.87-6.131]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	177 Japanese ancestry cases, 952 Japanese ancestry controls	NA	4p14	4	36025125	LOC651644	ARAP2			116984			rs1567482-G	rs1567482	0	1567482	intron_variant	0	0.875	6E-6	5.221848749616356	(Allelic model)	2.846	[1.716-4.719]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	177 Japanese ancestry cases, 952 Japanese ancestry controls	NA	7p21.3	7	12673445	LOC100505995	SCIN - LOC105375157	85477	105375157		19842	591	rs10488226-A	rs10488226	0	10488226	intergenic_variant	1	0.107	3E-6	5.522878745280337	(Dominant model)	2.026	[1.50-2.737]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	177 Japanese ancestry cases, 952 Japanese ancestry controls	NA	2q32.3	2	191600872	OBFC2A	LOC107985833 - NABP1	107985833	64859		52372	77200	rs6706693-A	rs6706693	0	6706693	intergenic_variant	1	0.219	9E-6	5.045757490560675	(Recessive model)	1.743	[1.362-2.232]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	80 Japanese ancestry cases, 226 Japanese ancestry controls	NA	18q23	18	77893443	LOC100421527	RNA5SP461 - LINC01029	100873705	101927715		29876	77851	rs9961113-C	rs9961113	0	9961113	intergenic_variant	1	0.403	1E-6	6.0	(Allelic model)	2.473	[1.706-3.584]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	80 Japanese ancestry cases, 226 Japanese ancestry controls	NA	22q12.2	22	30757289	OSBP2	OSBP2			23762			rs9609078-T	rs9609078	0	9609078	intron_variant	0	0.009	4E-6	5.3979400086720375	(Allelic model)	10.89	[3.528-33.61]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	80 Japanese ancestry cases, 226 Japanese ancestry controls	NA	5q11.2	5	59417854	PDE4D	PDE4D			5144			rs2547917-A	rs2547917	0	2547917	intron_variant	0	0.212	3E-6	5.522878745280337	(Recessive model)	1.997	[1.345-2.965]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	80 Japanese ancestry cases, 226 Japanese ancestry controls	NA	15q25.3	15	84872155	ALPK3	ALPK3			57538			rs12900463-C	rs12900463	0	12900463	3_prime_UTR_variant	0	0.115	4E-6	5.3979400086720375	(Recessive model)	2.154	[1.342-3.457]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	80 Japanese ancestry cases, 226 Japanese ancestry controls	NA	5q35.2	5	174198151	HMP19	HMP19 - LOC105377737	51617	105377737		88972	39764	rs6863418-A	rs6863418	0	6863418	intron_variant	1	0.055	7E-6	5.154901959985743	(Dominant model)	3.623	[2.042-6.429]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	147 Japanese ancestry cases, 233 Japanese ancestry controls	NA	13q33.2	13	105944370	LOC728192	LINC00343 - RNA5SP38	144920	100873370		182574	211002	rs488248-T	rs488248	0	488248	intergenic_variant	1	0.795	3E-6	5.522878745280337	(Allelic model)	2.896	[1.802-4.665]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	147 Japanese ancestry cases, 233 Japanese ancestry controls	NA	7q31.32	7	123119926	SLC13A1	SLC13A1			6561			rs4727963-C	rs4727963	0	4727963	intron_variant	0	0.618	1E-6	6.0	(Dominant model)	2.094	[1.505-2.914]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	147 Japanese ancestry cases, 233 Japanese ancestry controls	NA	9q33.2	9	121758981	DAB2IP	DAB2IP			153090			rs3747851-T	rs3747851	0	3747851	synonymous_variant	0	0.176	6E-7	6.221848749616356	(Allelic model)	2.377	[1.693-3.339]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	147 Japanese ancestry cases, 233 Japanese ancestry controls	NA	6q22.33	6	129687300	ARHGAP18	ARHGAP18			93663			rs12660691-A	rs12660691	0	12660691	intron_variant	0	0.819	4E-6	5.3979400086720375	(Allelic model)	3.199	[1.899-5.391]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	147 Japanese ancestry cases, 233 Japanese ancestry controls	NA	14q31.3	14	87274681	GALC	LOC105370608 - LOC105370610	105370608	105370610		240541	69965	rs1756650-G	rs1756650	0	1756650	intergenic_variant	1	0.162	2E-6	5.698970004336019	(Recessive model)	1.386	[0.954-2.014]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	147 Japanese ancestry cases, 233 Japanese ancestry controls	NA	18q22.1	18	64503491	LOC284294	LOC284294 - LOC105372166	284294	105372166		79890	34609	rs4553720-T	rs4553720	0	4553720	intergenic_variant	1	0.281	7E-6	5.154901959985743	(Recessive model)	1.547	[1.131-2.116]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	106 Japanese ancestry cases, 187 Japanese ancestry controls	NA	7p21.3	7	12055340	TMEM106B	THSD7A - TMEM106B	221981	54664		223142	155882	rs1035147-T	rs1035147	0	1035147	intergenic_variant	1	0.877	4E-6	5.3979400086720375	(Allelic model)	7.294	[2.587-20.559]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	106 Japanese ancestry cases, 187 Japanese ancestry controls	NA	5q21.2	5	104872312	RAB9P1	RNU6-334P - LOC105379111	106479714	105379111		91923	99988	rs10074959-T	rs10074959	0	10074959	intron_variant	1	0.237	1E-6	6.0	(Recessive model)	1.524	[1.048-2.217]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	106 Japanese ancestry cases, 187 Japanese ancestry controls	NA	1p21.3	1	99123823	LOC100129620	LOC100129620			100129620			rs303386-A	rs303386	0	303386	intron_variant	0	0.444	4E-6	5.3979400086720375	(Dominant)	1.766	[1.256-2.483]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	106 Japanese ancestry cases, 187 Japanese ancestry controls	NA	14q22.3	14	55765082	RPL13AP3	KTN1 - RPL13AP3	3895	645683		80498	1163	rs7494275-C	rs7494275	0	7494275	intron_variant	1	0.406	9E-6	5.045757490560675	(Recessive model)	1.732	[1.232-2.433]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	106 Japanese ancestry cases, 187 Japanese ancestry controls	NA	3p26.1	3	6968394	GRM7	GRM7			2917			rs480409-G	rs480409	0	480409	intron_variant	0	0.348	9E-6	5.045757490560675	(Recessive model)	1.842	[1.307-2.596]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	59 Japanese ancestry cases, 155 Japanese ancestry controls	NA	6p25.2	6	3836964	FAM50B	FAM50B			26240			rs17318866-G	rs17318866	0	17318866	intron_variant	0	0.79	1E-6	6.0	(Allelic model)	7.559	[2.689-21.263]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	59 Japanese ancestry cases, 155 Japanese ancestry controls	NA	2p22.1	2	41046491	LOC729984	LOC105374497 - HNRNPA1P57	105374497	101060039		76224	109665	rs17027130-C	rs17027130	0	17027130	intergenic_variant	1	0.387	3E-6	5.522878745280337	(Allelic model)	2.865	[1.844-4.452]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	59 Japanese ancestry cases, 155 Japanese ancestry controls	NA	1p21.3	1	99123823	LOC100129620	LOC100129620			100129620			rs303386-A	rs303386	0	303386	intron_variant	0	0.429	4E-6	5.3979400086720375	(Dominant model)	2.238	[1.448-3.46]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	54 Japanese ancestry cases, 39 Japanese ancestry controls	NA	20p12.2	20	10202869	LOC100131208	SNAP25-AS1			100131208			rs6039763-A	rs6039763	0	6039763	intron_variant	0	0.09	2E-6	5.698970004336019	(Dominant model)	5.966	[2.502-14.23]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	54 Japanese ancestry cases, 39 Japanese ancestry controls	NA	1p33	1	47632734	LOC388630	ATP6V0E1P4 - LOC107984953	100874504	107984953		81984	55764	rs2506991-G	rs2506991	0	2506991	intergenic_variant	1	0.269	2E-6	5.698970004336019	(Recessive model)	3.948	[2.101-7.418]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	54 Japanese ancestry cases, 39 Japanese ancestry controls	NA	2p16.3	2	49487883	FSHR	LOC105374595 - RPL7P13	105374595	130728		117969	390729	rs12987465-A	rs12987465	0	12987465	intergenic_variant	1	0.359	7E-6	5.154901959985743	(Recessive model)	2.597	[1.424-4.737]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	54 Japanese ancestry cases, 39 Japanese ancestry controls	NA	7p21.1	7	20216082	MACC1	MACC1			346389			rs3095008-T	rs3095008	0	3095008	intron_variant	0	0.846	9E-6	5.045757490560675	(Dominant model)			Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	9q34.2	9	134233655	RXRA	LOC107987039 - LOC105376310	107987039	105376310		5449	60275	rs10785877-T	rs10785877	0	10785877	intergenic_variant	1	0.66	7E-7	6.154901959985743	(Allelic model)	2.58	[1.766-3.769]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	1p36.21	1	15013464	RP1-21O18.1	KAZN			23254			rs6429703-T	rs6429703	0	6429703	intron_variant	0	0.078	8E-6	5.096910013008056	(Allelic model)	2.942	[1.802-4.804]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	12q22	12	95096472	FGD6	FGD6			55785			rs12310399-A	rs12310399	0	12310399	intron_variant	0	0.567	2E-7	6.698970004336019	(Recessive model)	1.852	[1.329-2.58]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	19q12	19	28375689	LOC100420587	LOC107985269 - LOC100420587	107985269	100420587		58329	59699	rs995834-C	rs995834	0	995834	intron_variant	1	0.425	1E-6	6.0	(Dominant model)	1.871	[1.364-2.566]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	1p22.2	1	89557237	LRRC8B	LRRC8B			23507			rs922107-G	rs922107	0	922107	intron_variant	0	0.211	3E-6	5.522878745280337	(Recessive model)	1.788	[1.25-2.558]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	7p14.1	7	37522765	LOC442668	ELMO1 - NECAP1P1	9844	442668		73356	60090	rs1425132-T	rs1425132	0	1425132	intergenic_variant	1	0.666	5E-6	5.301029995663981	(Recessive model)	1.43	[1.013-2.017]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	22q12.3	22	36121884	APOL3	LOC102723507			102723507			rs1476029-A	rs1476029	0	1476029	intergenic_variant	0	0.015	8E-6	5.096910013008056	(Allelic model)	6.426	[2.429-17.00]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	106 Japanese ancestry cases, 187 Japanese ancestry controls	NA	5q21.2	5	104863359	RAB9P1	RNU6-334P - LOC105379111	106479714	105379111		82970	108941	rs1632744-T	rs1632744	0	1632744	intron_variant	1	0.258	5E-6	5.301029995663981	(Recessive model)	1.387	[0.959-2.007]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	147 Japanese ancestry cases, 233 Japanese ancestry controls	NA	2q21.1	2	129276439	LOC151121	LOC151121 - LOC105373613	151121	105373613		2548	165786	rs837841-T	rs837841	0	837841	upstream_gene_variant	1	0.662	8E-6	5.096910013008056	(Recessive model)	1.279	[0.930-1.759]	Illumina [733202]	N
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	371 Japanese ancestry cases, 825 Japanese ancestry controls	NA	7p21.1	7	17045697	LOC100131425	LOC107986771 - LOC107986772	107986771	107986772		4576	54107	rs6961860-G	rs6961860	0	6961860	intergenic_variant	1	0.495	5E-6	5.301029995663981	(Recessive model)	1.283	[1.078-1.527]	Illumina [733202]	N
2014-03-18	23996088	Migliorini G	2013-08-30	Blood	www.ncbi.nlm.nih.gov/pubmed/23996088	Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.	Acute lymphoblastic leukemia (B-cell precursor)	1,658 European ancestry child cases, 4,723 European ancestry controls	1,449 European ancestry child cases, 1,488 European ancestry controls	10p12.2	10	22550699	PIP4K2A	PIP4K2A			5305			rs10828317-T	rs10828317	1	2230469	missense_variant	0	0.68	2E-9	8.698970004336019		1.23	[1.15-1.32]	Illumina [382776] (imputed)	N
2014-03-18	23996088	Migliorini G	2013-08-30	Blood	www.ncbi.nlm.nih.gov/pubmed/23996088	Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.	Acute lymphoblastic leukemia (B-cell precursor)	1,658 European ancestry child cases, 4,723 European ancestry controls	1,449 European ancestry child cases, 1,488 European ancestry controls	10p14	10	8062245	GATA3	GATA3			2625			rs3824662-T	rs3824662	0	3824662	intron_variant	0	0.17	9E-12	11.045757490560675		1.31	[1.21-1.41]	Illumina [382776] (imputed)	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Esophageal adenocarcinoma	1,516 European ancestry cases, 3,209 European ancestry controls	874 European ancestry cases, 6,911 European ancestry controls	3p13	3	70879779	FOXP1	RNU6-281P - FOXP1	106481267	27086		71327	74935	rs2687201-T	rs2687201	0	2687201	regulatory_region_variant	1	0.303	6E-7	6.221848749616356		1.2	[1.12-1.29]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Esophageal adenocarcinoma	1,516 European ancestry cases, 3,209 European ancestry controls	874 European ancestry cases, 6,911 European ancestry controls	4q22.1	4	87478958	NR	SPARCL1			8404			rs4610302-G	rs4610302	0	4610302	intron_variant	0	0.59	4E-6	5.3979400086720375		1.1765	[1.1-1.27]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Esophageal adenocarcinoma	1,516 European ancestry cases, 3,209 European ancestry controls	874 European ancestry cases, 6,911 European ancestry controls	6q11.1	6	61285855	NR	RBBP4P3 - KHDRBS2	730180	202559		411212	256824	rs2342002-T	rs2342002	0	2342002	intergenic_variant	1	0.214	9E-7	6.045757490560675		1.22	[1.13-1.33]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Esophageal adenocarcinoma	1,516 European ancestry cases, 3,209 European ancestry controls	874 European ancestry cases, 6,911 European ancestry controls	7p14.1	7	43247240	NR	HECW1			23072			rs17172185-T	rs17172185	0	17172185	intron_variant	0	0.946	5E-6	5.301029995663981		1.4706	[1.25-1.75]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Esophageal adenocarcinoma	1,516 European ancestry cases, 3,209 European ancestry controls	874 European ancestry cases, 6,911 European ancestry controls	9q22.32	9	93953746	BARX1	BARX1			56033			rs11789015-A	rs11789015	0	11789015	intron_variant	0	0.717	2E-7	6.698970004336019		1.2346	[1.14-1.33]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Esophageal adenocarcinoma	1,516 European ancestry cases, 3,209 European ancestry controls	874 European ancestry cases, 6,911 European ancestry controls	9q22.32	9	94096129	PTPDC1	PTPDC1			138639			rs6479527-C	rs6479527	0	6479527	intron_variant	0	0.511	2E-6	5.698970004336019		1.1765	[1.1-1.27]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Esophageal adenocarcinoma	1,516 European ancestry cases, 3,209 European ancestry controls	874 European ancestry cases, 6,911 European ancestry controls	16q24.1	16	86430089	FOXF1	LINC00917 - LOC401864	732275	401864		84410	4755	rs2178146-A	rs2178146	0	2178146	downstream_gene_variant	1	0.587	4E-6	5.3979400086720375		1.1765	[1.1-1.27]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Esophageal adenocarcinoma	1,516 European ancestry cases, 3,209 European ancestry controls	874 European ancestry cases, 6,911 European ancestry controls	19p13.11	19	18692362	CRTC1	CRTC1			23373			rs10419226-A	rs10419226	0	10419226	intron_variant	0	0.456	8E-7	6.096910013008056		1.19	[1.11-1.27]	Illumina [922031]	N
2017-02-10	27501781	Shiraishi K	2016-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27501781	Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.	EGFR mutation-positive lung adenocarcinoma	663 Japanese ancestry cases, 4,367 Japanese ancestry controls	2,510 Japanese ancestry cases, 10,791 Japanese ancestry controls	5p15.33	5	1286401	TERT	TERT			7015			rs2736100-G	rs2736100	0	2736100	intron_variant	0	0.387	2E-31	30.69897000433602		1.42	[1.34-1.50]	Illumina [NR] (imputed)	N
2017-02-10	27501781	Shiraishi K	2016-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27501781	Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.	EGFR mutation-positive lung adenocarcinoma	663 Japanese ancestry cases, 4,367 Japanese ancestry controls	2,510 Japanese ancestry cases, 10,791 Japanese ancestry controls	6p21.32	6	33091097	HLA-DPB1	HLA-DPB1 - HLA-DPA2	3115	646702		1401	385	rs2179920-A	rs2179920	0	2179920	downstream_gene_variant	1	0.165	5E-17	16.30102999566398		1.36	[1.27-1.47]	Illumina [NR] (imputed)	N
2017-02-10	27501781	Shiraishi K	2016-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27501781	Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.	EGFR mutation-positive lung adenocarcinoma	663 Japanese ancestry cases, 4,367 Japanese ancestry controls	2,510 Japanese ancestry cases, 10,791 Japanese ancestry controls	6p21.32	6	32400310	BTNL2	LOC101929163, BTNL2			101929163, 56244			rs3817963-G	rs3817963	0	3817963	intron_variant	0	0.316	1E-16	16.0		1.29	[1.21-1.37]	Illumina [NR] (imputed)	N
2017-02-10	27501781	Shiraishi K	2016-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27501781	Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.	EGFR mutation-positive lung adenocarcinoma	663 Japanese ancestry cases, 4,367 Japanese ancestry controls	2,510 Japanese ancestry cases, 10,791 Japanese ancestry controls	3q28	3	189639152	TP63	TP63			8626			rs7636839-A	rs7636839	0	7636839	intron_variant	0	0.479	9E-13	12.045757490560675		1.23	[1.16-1.30]	Illumina [NR] (imputed)	N
2017-02-10	27501781	Shiraishi K	2016-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27501781	Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.	EGFR mutation-positive lung adenocarcinoma	663 Japanese ancestry cases, 4,367 Japanese ancestry controls	2,510 Japanese ancestry cases, 10,791 Japanese ancestry controls	17q24.2	17	67902693	BPTF	BPTF			2186			rs7216064-A	rs7216064	0	7216064	intron_variant	0	0.706	2E-12	11.698970004336019		1.27	[1.19-1.35]	Illumina [NR] (imputed)	N
2017-02-10	27501781	Shiraishi K	2016-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27501781	Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.	EGFR mutation-positive lung adenocarcinoma	663 Japanese ancestry cases, 4,367 Japanese ancestry controls	2,510 Japanese ancestry cases, 10,791 Japanese ancestry controls	6p21.1	6	41522750	FOXP4	LINC01276 - FOXP4-AS1	103106903	101060264		2898	1145	rs2495239-A	rs2495239	0	2495239	intron_variant	1	0.382	4E-9	8.397940008672037		1.19	[1.12-1.26]	Illumina [NR] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Esophageal adenocarcinoma	4,112 European ancestry cases, 17,159 European ancestry controls	NA	7q31.2	7	117400063	ASZ1	ASZ1			136991			rs2188554-A	rs2188554	0	2188554	intron_variant	0		6E-9	8.221848749616356		1.2322	[1.16-1.3]	Illumina [13074274] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Esophageal adenocarcinoma	4,112 European ancestry cases, 17,159 European ancestry controls	NA	6q11.1	6	61681634	KHDRBS2	KHDRBS2			202559			rs76014404-T	rs76014404	0	76014404	intron_variant	0		2E-8	7.698970004336019		1.2102	[1.14-1.28]	Illumina [13074274] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Esophageal adenocarcinoma	4,112 European ancestry cases, 17,159 European ancestry controls	NA	3q27.1	3	184065565	HTR3C	HTR3C - 5-HT3C2	170572	389180		4892	17607	rs9823696-A	rs9823696	0	9823696	downstream_gene_variant	1		2E-8	7.698970004336019		1.1715	[1.12-1.23]	Illumina [13074274] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Esophageal adenocarcinoma	4,112 European ancestry cases, 17,159 European ancestry controls	NA	5p15.33	5	668194	TPPP, CEP72	LOC101929895, TPPP			101929895, 11076			rs75783973-A	rs75783973	0	75783973	intron_variant	0		2E-8	7.698970004336019		1.3303	[1.23-1.43]	Illumina [13074274] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Esophageal adenocarcinoma	4,112 European ancestry cases, 17,159 European ancestry controls	NA	2p24.1	2	20679060	GDF7, C2orf43	GDF7 - C2orf43	151449	60526		7570	3429	rs7255-T	rs7255	0	7255	3_prime_UTR_variant	1		4E-8	7.3979400086720375		1.1654	[1.11-1.22]	Illumina [13074274] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	6p21.32	6	32717158	HLA-DQA2	MTCO3P1 - LOC102725019	404026	102725019		10355	1009	rs9275642-C	rs9275642	0	9275642	upstream_gene_variant	1	0.79	2E-12	11.698970004336019		1.1235955	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	6p21.33	6	31356838	HLA-B	HLA-B			3106			rs1050529-C	rs1050529	0	1050529	missense_variant	0	0.75	3E-9	8.522878745280337		1.11	[NR]	Illumina [at least 560000] (imputed)	N
2017-03-11	27539887	Chahal HS	2016-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27539887	Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.	Basal cell carcinoma	12.945 European ancestry cases, 274,252 European ancestry controls	4,242 European ancestry cases, 12,802 European ancestry controls	6p21.33	6	31857135	NEU1	C6orf48 - NEU1	50854	4758		17369	1917	rs9267650-T	rs9267650	0	9267650	upstream_gene_variant	1	0.05	1E-8	8.0		1.17	[NR]	Illumina [at least 560000] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	5q14.3	5	88884379	MEF2C	MEF2C-AS1, MEF2C			101929423, 4208			rs114694170-T	rs114694170	0	114694170	non_coding_transcript_exon_variant	0	0.96	1E-11	11.0		0.15	[0.1-0.2] unit decrease	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	6p21.1	6	43736681	VEGFA, MRPS18A	LOC100132242 - VEGFA	100132242	7422		29924	33528	rs34528081-T	rs34528081	0	34528081	intron_variant	1	0.6	2E-17	16.69897000433602		0.09	[0.07-0.11] unit decrease	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	6p21.1	6	43957870	LOC100132354	LINC01512 - LOC101929705	100132354	101929705		19663	37853	rs6921438-A	rs6921438	0	6921438	intergenic_variant	1	0.46	2E-1449	1448.698970004336		0.64	[0.62-0.66] unit decrease	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	6p21.1	6	43979661	C6orf223	LINC01512 - LOC101929705	100132354	101929705		41454	16062	rs1740073-T	rs1740073	0	1740073	intergenic_variant	1	0.36	4E-17	16.397940008672037		0.09	[0.07-0.11] unit increase	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	8q23.1	8	105569300	ZFPM2	ZFPM2			23414			rs6993770-A	rs6993770	0	6993770	intron_variant	0	0.7	4E-55	54.39794000867204		0.16	[0.14-0.18] unit increase	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	9p24.2	9	2621145	AS1, VLDLR	VLDLR-AS1			401491			rs7043199-A	rs7043199	0	7043199	intron_variant	0	0.21	4E-14	13.397940008672037		0.1	[0.075-0.125] unit decrease	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	9p24.2	9	2692583	KCNV2, VLDLR	LOC105375957 - KCNV2	105375957	169522		24607	24943	rs2375981-C	rs2375981	0	2375981	intergenic_variant	1	0.54	9E-99	98.04575749056067		0.21	[0.19-0.23] unit increase	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	10q21.3	10	63306426	JMJD1C	JMJD1C			221037			rs10761741-T	rs10761741	0	10761741	intron_variant	0	0.43	3E-19	18.522878745280337		0.08	[0.062-0.098] unit increase	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	16q24.2	16	88502423	ZFPM1	ZFPM1			161882			rs4782371-T	rs4782371	0	4782371	intron_variant	0	0.67	1E-9	9.0		0.07	[0.048-0.092] unit decrease	Affymetrix, Illumina [6705861] (imputed)	N
2016-12-01	26910538	Choi SH	2016-02-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26910538	Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.	Vascular endothelial growth factor levels	9541 European ancestry individuals, 1,115 Cilento (founder/genetic isolated) individuals, 897 Ogliastran (founder/genetic isolated) individuals, 1,759 Val Borbera (founder/genetic isolated) individuals	2,141 European ancestry individuals, 659 Sorbian (founder/genetic isolated) individuals	18q22.3	18	75203596	ZADH2	ZADH2			284273			rs2639990-T	rs2639990	0	2639990	intron_variant	0	0.91	6E-10	9.221848749616356		0.11	[0.075-0.145] unit increase	Affymetrix, Illumina [6705861] (imputed)	N
2017-01-31	27436580	Cui Q	2016-07-19	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27436580	An Extended Genome-Wide Association Study Identifies Novel Susceptibility Loci for Nasopharyngeal Carcinoma.	Nasopharyngeal carcinoma	1,583 Southern Chinese ancestry cases, 2,979 Southern Chinese ancestry controls	5,463 Southern Chinese ancestry cases, 5,591 Southern Chinese ancestry controls	6p22.1	6	29938914	NR	HLA-U - HCG4P5	352965	353003		4034	1998	rs2860580-?	rs2860580	0	2860580	intron_variant	1	0.62	3E-31	30.522878745280337		1.89	[1.69-2.13]	Illumina [463250]	N
2017-01-31	27436580	Cui Q	2016-07-19	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27436580	An Extended Genome-Wide Association Study Identifies Novel Susceptibility Loci for Nasopharyngeal Carcinoma.	Nasopharyngeal carcinoma	1,583 Southern Chinese ancestry cases, 2,979 Southern Chinese ancestry controls	5,463 Southern Chinese ancestry cases, 5,591 Southern Chinese ancestry controls	6p21.33	6	31295974	NR	LOC105375015			105375015			rs2894207-?	rs2894207	0	2894207	intron_variant	0	0.84	2E-19	18.69897000433602		1.96	[1.69-2.27]	Illumina [463250]	N
2017-01-31	27436580	Cui Q	2016-07-19	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27436580	An Extended Genome-Wide Association Study Identifies Novel Susceptibility Loci for Nasopharyngeal Carcinoma.	Nasopharyngeal carcinoma	1,583 Southern Chinese ancestry cases, 2,979 Southern Chinese ancestry controls	5,463 Southern Chinese ancestry cases, 5,591 Southern Chinese ancestry controls	6p21.32	6	32624960	NR	HLA-DRB1 - LOC107986589	3123	107986589		35124	12228	rs28421666-?	rs28421666	0	28421666	upstream_gene_variant	1	0.87	1E-10	10.0		1.64	[1.43-1.92]	Illumina [463250]	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	16q24.3	16	89919709	MC1R	MC1R			4157			rs1805007-T	rs1805007	0	1805007	missense_variant	0	0.07	4E-37	36.39794000867204		1.5	[1.41-1.59]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	5p13.2	5	33946466	SLC45A2	SLC45A2			51151			rs35407-G	rs35407	0	35407	3_prime_UTR_variant	0	0.97	3E-19	18.522878745280337		2.0833335	[1.79-2.44]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	20q11.22	20	34077942	RALY, ASIP	RALY			22913			rs6059655-A	rs6059655	0	6059655	intron_variant	0	0.07	5E-23	22.30102999566398		1.38	[1.29-1.47]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	9p21.3	9	21805208	MTAP	MTAP			4507			rs201131773-?	rs201131773	0	201131773	intron_variant	0	0.48	3E-17	16.522878745280337		1.19	[1.15-1.24]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	6p25.3	6	421281	IRF4, EXOC2	IRF4 - LOC105374875	3662	105374875		9838	29732	rs62389423-A	rs62389423	0	62389423	regulatory_region_variant	1	0.14	9E-14	13.045757490560675		1.24	[1.17-1.31]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	5p15.33	5	1284538	TERT	TERT			7015			rs139996880-A	rs139996880	0	139996880	intron_variant	0	0.16	7E-12	11.154901959985743		1.26	[1.18-1.34]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	11q14.3	11	89277878	TYR	TYR, LOC107984363			7299, 107984363			rs1393350-A	rs1393350	0	1393350	intron_variant	0	0.27	4E-13	12.397940008672037		1.17	[1.12-1.22]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	21q22.3	21	41374154	MX2	MX2			4600			rs45430-T	rs45430	0	45430	intron_variant	0	0.66	3E-8	7.522878745280337		1.1235955	[1.08-1.16]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	5p15.1	5	17453974	BASP1	LOC102723526			102723526			rs187843643-T	rs187843643	0	187843643	intron_variant	0	0.01	4E-8	7.3979400086720375		1.96	[1.54-2.48]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	5p13.2	5	33951588	SLC45A2	SLC45A2			51151			rs16891982-?	rs16891982	0	16891982	missense_variant	0	0.96	1E-23	23.0		2.3809524	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	22q13.1	22	38148291	PLA2G6	PLA2G6			8398			rs2284063-?	rs2284063	0	2284063	non_coding_transcript_exon_variant	0	0.64	2E-9	8.698970004336019		1.2048193	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	15q13.1	15	28090674	OCA2	OCA2			4948			rs4778138-?	rs4778138	0	4778138	intron_variant	0	0.85	2E-11	10.698970004336019		1.1904762	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	9p21.3	9	21816529	MTAP, CDKN2A	MTAP			4507			rs7023329-?	rs7023329	0	7023329	intron_variant	0	0.5	7E-9	8.154901959985743		1.1627907	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	11q22.3	11	108304735	ATM	ATM			472			rs1801516-?	rs1801516	0	1801516	missense_variant	0	0.86	3E-9	8.522878745280337		1.1363636	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	1q21.3	1	150887995	ARNT	LOC100996521			100996521			rs7412746-T	rs7412746	0	7412746	intron_variant	0	0.47	9E-11	10.045757490560675		1.15	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	2q33.1	2	201298088	CASP8	ALS2CR12			130540			rs13016963-A	rs13016963	0	13016963	intron_variant	0	0.38	9E-10	9.045757490560675		1.14	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	2p22.2	2	38049406	RMDN2, CYP1B1	RMDN2			151393			rs6750047-A	rs6750047	0	6750047	intron_variant	0	0.28	7E-9	8.154901959985743		1.1	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	6p22.3	6	21163688	CDKAL1	CDKAL1			54901			rs6914598-C	rs6914598	0	6914598	intron_variant	0	0.31	4E-8	7.3979400086720375		1.1	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	7p21.1	7	16944656	AGR3	LOC100131425 - LOC105375170	100131425	105375170		55768	43719	rs1636744-T	rs1636744	0	1636744	intergenic_variant	1	0.41	7E-9	8.154901959985743		1.1	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	9q31.2	9	106298549	TMEM38B, RAD23B, TAL2	LOC105376201 - MIR8081	105376201	102465995		257187	302379	rs10739221-T	rs10739221	0	10739221	intron_variant	1	0.24	7E-11	10.154901959985743		1.13	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	10q24.33	10	103909085	OBFC1	OBFC1			79991			rs2995264-G	rs2995264	0	2995264	intron_variant	0	0.1	2E-9	8.698970004336019		1.17	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	11q13.3	11	69552350	CCND1	LINC01488 - CCND1	101928292	595		58807	88755	rs498136-A	rs498136	0	498136	intergenic_variant	1	0.36	2E-12	11.698970004336019		1.12	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	16q24.3	16	89689495	MC1R	CDK10			8558			rs258322-A	rs258322	0	258322	intron_variant	0	0.09	3E-27	26.522878745280337		1.67	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	16q24.3	16	90000528	AFG3L1P	AFG3L1P			172			rs4785763-A	rs4785763	0	4785763	non_coding_transcript_exon_variant	0	0.33	6E-22	21.221848749616356		1.32	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	16q12.2	16	54080912	FTO	FTO			79068			rs16953002-A	rs16953002	0	16953002	intron_variant	0	0.17	4E-12	11.397940008672037		1.16	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	16q24.3	16	89689495	CDK10	CDK10			8558			rs258322-A	rs258322	0	258322	intron_variant	0	0.09	2E-8	7.698970004336019		1.67	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	20q11.22	20	34989186	MYH7B	MYH7B, LOC107985393			57644, 107985393			rs1885120-C	rs1885120	0	1885120	intron_variant	0	0.07	2E-18	17.69897000433602		1.55	[NR]	Illumina [at least 560000] (imputed)	N
2017-06-06	28212542	Ransohoff KJ	2017-02-09	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/28212542	Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.	Melanoma	4,842 European ancestry cases, 286,565 European ancestry controls	1,804 European ancestry cases, 1,026 European ancestry controls	20q11.22	20	34583968	PIGU	PIGU			128869			rs910873-A	rs910873	0	910873	intron_variant	0	0.08	1E-15	15.0		1.75	[NR]	Illumina [at least 560000] (imputed)	N
2016-07-11	26084801	Mirabello L	2015-06-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26084801	A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma.	Metastasis at diagnosis in osteosarcoma	122 European ancestry cases with metastasis, 419 European ancestry cases without metastasis	43 European ancestry cases with metastasis, 22 African ancestry cases with metastasis, 40 Brazilian ancestry cases with metastasis, 183 European ancestry cases without metastasis, 39 African ancestry cases without metastasis, 67 Brazilian ancestry cases without metastasis	9p23	9	14190288	NFIB	NFIB			4781			rs7034162-A	rs7034162	0	7034162	intron_variant	0	0.11	3E-8	7.522878745280337	(EA)	2.62	[1.86-3.68]	Illumina [447040]	N
2016-07-11	26084801	Mirabello L	2015-06-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26084801	A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma.	Metastasis at diagnosis in osteosarcoma	122 European ancestry cases with metastasis, 419 European ancestry cases without metastasis	43 European ancestry cases with metastasis, 22 African ancestry cases with metastasis, 40 Brazilian ancestry cases with metastasis, 183 European ancestry cases without metastasis, 39 African ancestry cases without metastasis, 67 Brazilian ancestry cases without metastasis	9p23	9	14190288	NFIB	NFIB			4781			rs7034162-A	rs7034162	0	7034162	intron_variant	0	0.1	1E-9	9.0		2.43	[1.83-3.24]	Illumina [447040]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	11q12.2	11	61803311	NR	FADS1			3992			rs174547	rs174547	0	174547	intron_variant	0	NR	7E-25	24.154901959985743				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	11q23.3	11	116778201	NR	ZPR1			8882			rs964184	rs964184	0	964184	3_prime_UTR_variant	0	NR	2E-108	107.69897000433602				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	11q23.3	11	117037567	NR	SIK3			23387			rs7115242	rs7115242	0	7115242	intron_variant	0	NR	1E-9	9.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	11q24.1	11	123009573	NR	BSX - LOC341056	390259	341056		27902	7993	rs12420422	rs12420422	0	12420422	intergenic_variant	1	NR	2E-7	6.698970004336019				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	12p13.33	12	3060327	NR	TEAD4 - RPL13AP24	7004	100271603		19651	11219	rs12310617	rs12310617	0	12310617	intergenic_variant	1	NR	2E-7	6.698970004336019				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	12q21.33	12	89656726	NR	ATP2B1			490			rs12579302	rs12579302	0	12579302	intron_variant	0	NR	4E-7	6.3979400086720375				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	12q24.31	12	122479003	NR	ZCCHC8			55596			rs12369179	rs12369179	0	12369179	intron_variant	0	NR	8E-7	6.096910013008056				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	14q32.12	14	92945686	ITPK1	ITPK1			3705			rs4905014	rs4905014	0	4905014	intron_variant	0	NR	9E-15	14.045757490560675				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	15q21.3	15	58435126	NR	LIPC, LOC101928694			3990, 101928694			rs261332	rs261332	0	261332	non_coding_transcript_exon_variant	0	NR	2E-35	34.69897000433602				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	16q12.2	16	53786615	NR	FTO			79068			rs9939609	rs9939609	0	9939609	intron_variant	0	NR	1E-14	14.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	16q13	16	56956804	NR	HERPUD1 - CETP	9709	1071		12923	5119	rs247617	rs247617	0	247617	regulatory_region_variant	1	NR	1E-149	149.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	16q22.3	16	72963084	NR	ZFHX3			463			rs7190256	rs7190256	0	7190256	intron_variant	0	NR	3E-11	10.522878745280337				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	18p11.22	18	8522684	NR	THEMIS3P - AKR1B1P6	100420484	100129769		8843	22965	rs8082812	rs8082812	0	8082812	intergenic_variant	1	NR	5E-67	66.30102999566398				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	19p13.11	19	19296909	NR	SUGP1			57794			rs10401969	rs10401969	0	10401969	intron_variant	0	NR	4E-11	10.397940008672037				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	19q13.32	19	44919689	NR	APOC1 - APOC1P1	341	342		340	7114	rs4420638	rs4420638	0	4420638	downstream_gene_variant	1	NR	1E-22	22.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	19q13.32	19	44744370	NR	BCL3			602			rs4803750	rs4803750	0	4803750	upstream_gene_variant	0	NR	1E-13	13.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	1p13.3	1	109275684	NR	CELSR2			1952			rs629301	rs629301	0	629301	3_prime_UTR_variant	0	NR	1E-49	49.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	2p25.1	2	9956965	NR	GRHL1			29841			rs16867253	rs16867253	0	16867253	intron_variant	0	NR	3E-6	5.522878745280337				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	2p24.1	2	21065449	NR	APOB - TDRD15	338	100129278		21376	58483	rs562338	rs562338	0	562338	intergenic_variant	1	NR	5E-21	20.30102999566398				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	2p24.1	2	21176344	NR	TDRD15 - LOC105374317	100129278	105374317		29019	44787	rs478442	rs478442	0	478442	intergenic_variant	1	NR	4E-16	15.397940008672037				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	2p23.3	2	27263727	NR	SLC30A3			7781			rs6759518	rs6759518	0	6759518	intron_variant	0	NR	8E-10	9.096910013008056				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	2p23.3	2	27412596	NR	PPM1G - NRBP1	5496	29959		2913	15194	rs1728918	rs1728918	0	1728918	upstream_gene_variant	1	NR	1E-31	31.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	2p23.3	2	27518370	NR	GCKR			2646			rs780094	rs780094	0	780094	intron_variant	0	NR	4E-91	90.39794000867204				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	2q22.3	2	146120964	NR	LOC105373666 - RNU7-2P	105373666	100147745		239353	24192	rs222826	rs222826	0	222826	intergenic_variant	1	NR	8E-7	6.096910013008056				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	2q35	2	215086907	NR	ABCA12			26154			rs940274	rs940274	0	940274	intron_variant	0	NR	4E-6	5.3979400086720375				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	3q21.1	3	123019460	SEMA5B	SEMA5B			54437			rs7632505	rs7632505	0	7632505	intron_variant	0	NR	7E-19	18.154901959985743				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	4q24	4	102363708	NR	RN7SL728P - LOC105377621	106481857	105377621		15017	54894	rs13114738	rs13114738	0	13114738	intron_variant	1	NR	8E-8	7.096910013008056				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	4q25	4	110810780	NR	PITX2 - MIR297	5308	100126354		168657	49802	rs6533530	rs6533530	0	6533530	intergenic_variant	1	NR	1E-7	7.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	4q31.1	4	139829967	MAML3	MAML3			55534			rs1869717	rs1869717	0	1869717	intron_variant	0	NR	5E-8	7.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	5q13.3	5	75329662	NR	ANKRD31 - HMGCR	256006	3156		92765	6672	rs7703051	rs7703051	0	7703051	intron_variant	1	NR	9E-12	11.045757490560675				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	5q13.3	5	75463358	NR	COL4A3BP			10087			rs4704221	rs4704221	0	4704221	intron_variant	0	NR	2E-8	7.698970004336019				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	5q13.3	5	75584065	NR	POLK			51426			rs5744680	rs5744680	0	5744680	intron_variant	0	NR	3E-8	7.522878745280337				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	5q13.3	5	75701931	NR	POC5			134359			rs10057967	rs10057967	0	10057967	intron_variant	0	NR	3E-6	5.522878745280337				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	7p21.1	7	19177581	NR	FERD3L - LOC107986773	222894	107986773		32160	123054	rs17140821	rs17140821	0	17140821	regulatory_region_variant	1	NR	5E-7	6.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	7q11.23	7	73462836	NR	BAZ1B			9031			rs2074755	rs2074755	0	2074755	non_coding_transcript_exon_variant	0	NR	1E-17	17.0				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	7q11.23	7	73637727	NR	MLXIPL - VPS37D	51085	155382		13184	27619	rs799165	rs799165	0	799165	intergenic_variant	1	NR	9E-15	14.045757490560675				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	8p21.3	8	20008763	NR	LPL - LOC105379311	4023	105379311		41504	69951	rs765547	rs765547	0	765547	intergenic_variant	1	NR	2E-44	43.69897000433602				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	8q24.13	8	125466108	NR	TRIB1 - LOC105375746	10221	105375746		27703	56323	rs2980853	rs2980853	0	2980853	upstream_gene_variant	1	NR	3E-18	17.522878745280337				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	9p21.3	9	22125504	NR	CDKN2B-AS1 - DMRTA1	100048912	63951		4407	321337	rs1333049	rs1333049	0	1333049	downstream_gene_variant	1	NR	9E-8	7.045757490560675				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	20q12	20	41147406	NR	PLCG1			5335			rs760762	rs760762	0	760762	intron_variant	0	NR	7E-7	6.154901959985743				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	20q12	20	41322165	NR	ZHX3 - LOC100130936	23051	100130936		4559	8957	rs2866611	rs2866611	0	2866611	upstream_gene_variant	1	NR	6E-7	6.221848749616356				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	21q22.3	21	41463567	NR	MX1 - TMPRSS2	4599	7113		4353	984	rs460976	rs460976	0	460976	downstream_gene_variant	1	NR	4E-6	5.3979400086720375				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	10p12.1	10	26969741	NR	ANKRD26			22852			rs7081476	rs7081476	0	7081476	intergenic_variant	0	NR	5E-6	5.301029995663981				Affymetrix [NR]	N
2017-05-15	27790247	He L	2016-11-03	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27790247	Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.	Age-related diseases, mortality and associated endophenotypes	9,618 European ancestry individuals	19,796 European ancestry individuals	10q25.2	10	112996282	NR	TCF7L2			6934			rs4506565	rs4506565	0	4506565	intron_variant	0	NR	8E-17	16.096910013008056				Affymetrix [NR]	N
2017-02-15	28090565	Tsai EA	2016-05-26	Cell Mol Gastroenterol Hepatol	www.ncbi.nlm.nih.gov/pubmed/28090565	THBS2 Is a Candidate Modifier of Liver Disease Severity in Alagille Syndrome.	Liver disease severity in Alagille syndrome	97 European ancestry mild cases, 64 European ancestry severe cases	NA	6q27	6	169268903	THBS2	THBS2 - VTA1P1	7058	106481708		14789	27568	rs7382539-?	rs7382539	0	7382539	intergenic_variant	1	NR	2E-6	5.698970004336019				Illumina [579677]	N
2017-02-15	28090565	Tsai EA	2016-05-26	Cell Mol Gastroenterol Hepatol	www.ncbi.nlm.nih.gov/pubmed/28090565	THBS2 Is a Candidate Modifier of Liver Disease Severity in Alagille Syndrome.	Liver disease severity in Alagille syndrome	97 European ancestry mild cases, 64 European ancestry severe cases	NA	9q33.2	9	119810618	NR	LOC105376250 - LOC107987122	105376250	107987122		286536	60323	rs944961-?	rs944961	0	944961	intergenic_variant	1	NR	2E-6	5.698970004336019				Illumina [579677]	N
2009-07-16	19578364	Bishop DT	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578364	Genome-wide association study identifies three loci associated with melanoma risk.	Melanoma	1,539 European ancestry cases, 3,917 European ancestry controls	2,312 European ancestry cases, 1,867 European ancestry controls	9p21.3	9	21816529	CDKN2A	MTAP			4507			rs7023329-A	rs7023329	0	7023329	intron_variant	0	0.50	4E-7	6.3979400086720375		1.18	[1.10-1.25]	Illumina [~ 317000]	N
2009-07-16	19578364	Bishop DT	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578364	Genome-wide association study identifies three loci associated with melanoma risk.	Melanoma	1,539 European ancestry cases, 3,917 European ancestry controls	2,312 European ancestry cases, 1,867 European ancestry controls	11q14.3	11	89277878	TYR	TYR, LOC107984363			7299, 107984363			rs1393350-A	rs1393350	0	1393350	intron_variant	0	0.27	2E-14	13.698970004336019		1.29	[1.21-1.38]	Illumina [~ 317000]	N
2009-07-16	19578364	Bishop DT	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578364	Genome-wide association study identifies three loci associated with melanoma risk.	Melanoma	1,539 European ancestry cases, 3,917 European ancestry controls	2,312 European ancestry cases, 1,867 European ancestry controls	16q24.3	16	89689495	MC1R	CDK10			8558			rs258322-A	rs258322	0	258322	intron_variant	0	0.09	3E-27	26.522878745280337		1.67	[1.52-1.83]	Illumina [~ 317000]	N
2009-07-16	19578364	Bishop DT	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578364	Genome-wide association study identifies three loci associated with melanoma risk.	Melanoma	1,539 European ancestry cases, 3,917 European ancestry controls	2,312 European ancestry cases, 1,867 European ancestry controls	16q24.3	16	90000528	MC1R	AFG3L1P			172			rs4785763-A	rs4785763	0	4785763	non_coding_transcript_exon_variant	0	0.32	6E-22	21.221848749616356		1.36	[1.28-1.45]	Illumina [~ 317000]	N
2009-07-16	19578364	Bishop DT	2009-07-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19578364	Genome-wide association study identifies three loci associated with melanoma risk.	Melanoma	1,539 European ancestry cases, 3,917 European ancestry controls	2,312 European ancestry cases, 1,867 European ancestry controls	22q13.1	22	38148291	intergenic	PLA2G6			8398			rs2284063-?	rs2284063	0	2284063	non_coding_transcript_exon_variant	0	0.37	2E-9	8.698970004336019		1.2	[1.14-1.28]	Illumina [~ 317000]	N
2011-10-07	21926416	Amos CI	2011-09-22	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21926416	Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.	Melanoma	1,804 European ancestry cases, 1,026 European ancestry controls	6,483 European and Middle East/North African ancestry cases, 23,324 European and Middle East/North African ancestry controls	1q21.3	1	150989393	ANXA9	ANXA9			8416			rs1722784-?	rs1722784	0	1722784	intron_variant	0	NR	2E-6	5.698970004336019		1.12	[NR]	Illumina [818977]	N
2011-11-02	21983785	Macgregor S	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983785	Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3.	Melanoma	2,168 European ancestry cases, 4,387 European ancestry controls	5,193 European ancestry cases, 15,144 European ancestry controls	1q21.3	1	150887995	ARNT, SETDB1, LASS2, ANXA9, MCL1, CTSK	LOC100996521			100996521			rs7412746-T	rs7412746	0	7412746	intron_variant	0	0.55	9E-11	10.045757490560675		1.15	[NR]	Illumina [5480804] (imputed)	N
2011-11-02	21983785	Macgregor S	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983785	Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3.	Melanoma	2,168 European ancestry cases, 4,387 European ancestry controls	5,193 European ancestry cases, 15,144 European ancestry controls	1q42.12	1	226376990	PARP1	PARP1			142			rs3219090-C	rs3219090	0	3219090	intron_variant	0	0.67	9E-8	7.045757490560675		1.15	[NR]	Illumina [5480804] (imputed)	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	2q33.1	2	201298088	CASP8	ALS2CR12			130540			rs13016963-A	rs13016963	0	13016963	intron_variant	0	0.37	9E-10	9.045757490560675		1.14	[1.09-1.19]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	11q22.3	11	108304735	ATM	ATM			472			rs1801516-?	rs1801516	0	1801516	missense_variant	0	0.87	3E-9	8.522878745280337		1.19	[1.12-1.27]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	21q22.3	21	41374154	MX2	MX2			4600			rs45430-?	rs45430	0	45430	intron_variant	0	0.61	3E-9	8.522878745280337		1.14	[1.09-1.18]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	5p15.33	5	1321972	TERT, CLPTM1L	CLPTM1L			81037			rs401681-A	rs401681	0	401681	intron_variant	0	0.46	3E-8	7.522878745280337		1.2	[1.12-1.28]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	5p13.2	5	33955221	SLC45A2	SLC45A2			51151			rs35390-?	rs35390	0	35390	intron_variant	0	0.98	2E-7	6.698970004336019		2.78	[1.89-4.35]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	9p21.3	9	21816529	MTAP, CDKN2A	MTAP			4507			rs7023329-?	rs7023329	0	7023329	intron_variant	0	0.51	7E-9	8.154901959985743		1.2	[1.14-1.28]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	11q14.3	11	89277878	TYR	TYR, LOC107984363			7299, 107984363			rs1393350-A	rs1393350	0	1393350	intron_variant	0	0.28	2E-13	12.698970004336019		1.3	[1.21-1.39]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	16q24.3	16	89689495	MC1R	CDK10			8558			rs258322-A	rs258322	0	258322	intron_variant	0	0.11	3E-27	26.522878745280337		1.7	[1.54-1.87]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	6q23.2	6	134577318	ASIP	LOC101928304 - FAM8A6P	101928304	114182		37313	25824	rs2284378-G	rs228437	0	228437	intron_variant	1	0.33	1E-7	7.0		1.21	[1.13-1.29]	Illumina [594997]	N
2011-12-10	21983787	Barrett JH	2011-10-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21983787	Genome-wide association study identifies three new melanoma susceptibility loci.	Melanoma	2,804 European ancestry cases, 7,618 European ancestry controls	5,551 European ancestry cases, 7,449 European ancestry controls	22q13.1	22	38149612	PLA2G6	PLA2G6			8398			rs6001027-?	rs6001027	0	6001027	non_coding_transcript_exon_variant	0	0.65	2E-6	5.698970004336019		1.18	[1.09-1.27]	Illumina [594997]	N
2011-12-20	22120009	Broderick P	2011-11-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22120009	Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.	Multiple myeloma	1,675 European ancestry cases, 5,903 European ancestry controls	169 European ancestry cases, 927 European ancestry controls	7p15.3	7	21898622	DNAH11	DNAH11			8701			rs4487645-C	rs4487645	0	4487645	intron_variant	0	0.65	3E-14	13.522878745280337		1.38	[1.28-1.50]	Illumina [422839]	N
2011-12-20	22120009	Broderick P	2011-11-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22120009	Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.	Multiple myeloma	1,675 European ancestry cases, 5,903 European ancestry controls	169 European ancestry cases, 927 European ancestry controls	3p22.1	3	41883906	ULK4	ULK4			54986			rs1052501-G	rs1052501	0	1052501	missense_variant	0	0.16	2E-8	7.698970004336019		1.32	[1.20-1.45]	Illumina [422839]	N
2011-12-20	22120009	Broderick P	2011-11-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22120009	Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.	Multiple myeloma	1,675 European ancestry cases, 5,903 European ancestry controls	169 European ancestry cases, 927 European ancestry controls	2p23.3	2	25436375	DTNB	LOC101929272, DTNB			101929272, 1838			rs6746082-A	rs6746082	0	6746082	intron_variant	0	0.79	4E-7	6.3979400086720375		1.29	[1.17-1.42]	Illumina [422839]	N
2011-05-26	21471979	Kumar V	2011-04-07	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21471979	Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility.	Large B-cell lymphoma	74 Japanese ancestry cases, 934 Japanese ancestry controls	325 Japanese ancestry cases, 3,309 Japanese ancestry controls	13q12.2	13	27623299	LNX2	POLR1D			51082			rs7097-?	rs7097	0	7097	3_prime_UTR_variant	0	NR	7E-6	5.154901959985743		1.44	[1.23-1.67]	Illumina [444361]	N
2011-05-26	21471979	Kumar V	2011-04-07	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21471979	Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility.	Large B-cell lymphoma	74 Japanese ancestry cases, 934 Japanese ancestry controls	325 Japanese ancestry cases, 3,309 Japanese ancestry controls	14q32.32	14	103018488	CDC42BPB	CDC42BPB			9578			rs751837-?	rs751837	0	751837	intron_variant	0	NR	3E-7	6.522878745280337		3.51	[2.13-5.88]	Illumina [444361]	N
2012-03-10	22327514	Postel-Vinay S	2012-02-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22327514	Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma.	Ewing sarcoma	Up to 427 European ancestry cases, up to 4,352 European ancestry controls	661 European ancestry cases, 1,299 European ancestry controls	1p36.22	1	10986798	TARDBP	C1orf127 - CFL1P6	148345	390996		4761	3012	rs9430161-G	rs9430161	0	9430161	upstream_gene_variant	1	0.79	1E-20	20.0		2.2	[1.77-2.72]	NR [286966]	N
2012-03-10	22327514	Postel-Vinay S	2012-02-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22327514	Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma.	Ewing sarcoma	Up to 427 European ancestry cases, up to 4,352 European ancestry controls	661 European ancestry cases, 1,299 European ancestry controls	10q21.3	10	62820815	EGR2, ADO, ZNF365	EGR2 - LOC107984012	1959	107984012		1648	72345	rs224278-C	rs224278	0	224278	intron_variant	1	0.58	4E-17	16.397940008672037		1.66	[1.42-1.93]	NR [286966]	N
2012-03-10	22327514	Postel-Vinay S	2012-02-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22327514	Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma.	Ewing sarcoma	Up to 427 European ancestry cases, up to 4,352 European ancestry controls	661 European ancestry cases, 1,299 European ancestry controls	15q15.1	15	40047293	BMF, SRP14, EIF2AK4	SRP14-AS1			100131089			rs4924410-A	rs4924410	0	4924410	intron_variant	0	0.27	7E-9	8.154901959985743		1.46	[1.23-1.74]	NR [286966]	N
2014-03-01	23903356	Hayes MG	2013-07-31	Diabetes	www.ncbi.nlm.nih.gov/pubmed/23903356	Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies.	Glycemic traits (pregnancy)	1,367 European ancestry individuals, 817 Hispanic individuals, 1,075 Afro-Caribbean individuals, 1,178 Thai ancestry individuals	2,798 European ancestry individuals, 228 French Canadian founder population individuals	8p23.1	8	9326086	PPP1R3B	LOC157273			157273			rs4841132-G	rs4841132	0	4841132	non_coding_transcript_exon_variant	0	0.91	5E-15	14.301029995663981	(FCP)	0.0294	[NR] unit decrease	Illumina [up to 945994] (imputed)	N
2013-11-29	23727862	Savage SA	2013-06-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23727862	Genome-wide association study identifies two susceptibility loci for osteosarcoma.	Osteosarcoma	694 European ancestry cases, 2,703 European ancestry controls	247 European ancestry cases, 550 European ancestry controls	6p21.31	6	34068669	GRM4	GRM4			2914			rs1906953-A	rs1906953	0	1906953	intron_variant	0	NR	8E-9	8.096910013008056		1.57	[1.35-1.83]	Illumina [698968]	N
2013-11-29	23727862	Savage SA	2013-06-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23727862	Genome-wide association study identifies two susceptibility loci for osteosarcoma.	Osteosarcoma	694 European ancestry cases, 2,703 European ancestry controls	247 European ancestry cases, 550 European ancestry controls	13q14.3	13	50620269	AJ412031	DLEU1 - LOC107984568	10301	107984568		91626	62642	rs573666-G	rs573666	0	573666	intron_variant	1	NR	9E-6	5.045757490560675		1.3	[1.16-1.47]	Illumina [698968]	N
2013-11-29	23727862	Savage SA	2013-06-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23727862	Genome-wide association study identifies two susceptibility loci for osteosarcoma.	Osteosarcoma	694 European ancestry cases, 2,703 European ancestry controls	247 European ancestry cases, 550 European ancestry controls	10p15.1	10	5762568	C10orf18, GDI2	FAM208B			54906			rs2797501-A	rs2797501	0	2797501	missense_variant	0	NR	8E-6	5.096910013008056		1.61	[1.30-1.96]	Illumina [698968]	N
2013-11-29	23727862	Savage SA	2013-06-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23727862	Genome-wide association study identifies two susceptibility loci for osteosarcoma.	Osteosarcoma	694 European ancestry cases, 2,703 European ancestry controls	247 European ancestry cases, 550 European ancestry controls	2p25.2	2	6321289	intergenic	LOC105373401 - LINC01247	105373401	101929390		8147	44721	rs7591996-C	rs7591996	0	7591996	intron_variant	1	NR	1E-8	8.0		1.39	[1.23-1.54]	Illumina [698968]	N
2013-11-29	23727862	Savage SA	2013-06-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23727862	Genome-wide association study identifies two susceptibility loci for osteosarcoma.	Osteosarcoma	694 European ancestry cases, 2,703 European ancestry controls	247 European ancestry cases, 550 European ancestry controls	15q26.3	15	100188458	ADAMTS17	ADAMTS17			170691			rs2086452-C	rs2086452	0	2086452	intron_variant	0	NR	1E-6	6.0		1.35	[1.19-1.52]	Illumina [698968]	N
2013-11-29	23727862	Savage SA	2013-06-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23727862	Genome-wide association study identifies two susceptibility loci for osteosarcoma.	Osteosarcoma	694 European ancestry cases, 2,703 European ancestry controls	247 European ancestry cases, 550 European ancestry controls	5q12.3	5	65151950	ADAMTS6	ADAMTS6			11174			rs17206779-G	rs17206779	0	17206779	splice_region_variant	0	NR	5E-7	6.301029995663981		1.33	[1.19-1.47]	Illumina [698968]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		11q13.3	11	69648142	CCND1	CCND1			595			rs603965-G	rs603965	1	9344	splice_region_variant	0	0.56	8E-11	10.096910013008056	(t11;14 vs. controls)	1.82	[1.52-2.19]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		10q24.1	10	96880089	NR	LCOR			84458			rs17112190-A	rs17112190	0	17112190	intron_variant	0	0.11	9E-7	6.045757490560675	(t11;14 vs. controls)	1.8	[1.42-2.27]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		16q23.3	16	82753448	NR	CDH13			1012			rs8056064-G	rs8056064	0	8056064	intron_variant	0	0.15	2E-6	5.698970004336019	(t11;14 vs. controls)	1.68	[1.36-2.08]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		2p23.3	2	25410373	NR	DTNB			1838			rs10180663-A	rs10180663	0	10180663	intron_variant	0	0.69	2E-6	5.698970004336019	(t11;14 vs. controls)	1.64	[1.34-2.02]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		13q14.2	13	48892795	NR	LOC107984559			107984559			rs1449572-A	rs1449572	0	1449572	regulatory_region_variant	0	0.14	8E-6	5.096910013008056	(t4;14 vs. controls)	1.73	[1.36-2.21]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		14q22.3	14	57140349	NR	LOC440180 - EXOC5	440180	10640		97648	62127	rs7144018-G	rs7144018	0	7144018	intron_variant	1	0.1	9E-6	5.045757490560675	(t4;14 vs. controls)	1.85	[1.41-2.44]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		3q13.33	3	121435346	NR	POLQ			10721			rs6800901-A	rs6800901	0	6800901	intron_variant	0	0.34	2E-6	5.698970004336019	(Any IgH translocation vs. controls)	1.31	[1.17-1.47]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		3q26.2	3	169759718	NR	SDHDP3 - TERC	29771	7012		49140	4892	rs12638862-A	rs12638862	0	12638862	downstream_gene_variant	1	0.74	2E-6	5.698970004336019	(Any IgH translocation vs. controls)	1.37	[1.20-1.56]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		8q12.1	8	59633105	NR	LOC105375859 - LOC107986889	105375859	107986889		12907	126943	rs4737547-G	rs4737547	0	4737547	intergenic_variant	1	0.42	3E-6	5.522878745280337	(Any IgH translocation vs. controls)	1.3	[1.17-1.45]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		1q21.3	1	153668351	NR	ILF2			3608			rs7536700-A	rs7536700	0	7536700	intron_variant	0	0.07	4E-6	5.3979400086720375	(Any IgH translocation vs. controls)	1.53	[1.28-1.84]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		2p23.3	2	25390277	NR	DTNB			1838			rs7577599-A	rs7577599	0	7577599	intron_variant	0	0.81	6E-6	5.221848749616356	(Any IgH translocation vs. controls)	1.43	[1.22-1.67]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		15q13.1	15	28243742	NR	HERC2			8924			rs8028689-G	rs8028689	0	8028689	intron_variant	0	0.05	7E-6	5.154901959985743	(Any IgH translocation vs. controls)	1.65	[1.33-2.05]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		4q34.1	4	173734763	NR	LOC107986203 - LOC101928478	107986203	101928478		35780	161953	rs4521323-C	rs4521323	0	4521323	intergenic_variant	1	0.56	9E-6	5.045757490560675	(Any IgH translocation vs. controls)	1.28	[1.15-1.43]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		4q34.3	4	180047278	NR	LOC105377564			105377564			rs1994816-A	rs1994816	0	1994816	intergenic_variant	0	0.14	5E-7	6.301029995663981	(non t11;14 and t4;14 IgH translocations vs. controls)	1.76	[1.41-2.20]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		10q22.1	10	71007652	NR	LOC105378351 - UNC5B	105378351	219699		1900	204883	rs10509328-G	rs10509328	0	10509328	intergenic_variant	1	0.09	1E-6	6.0	(non t11;14 and t4;14 IgH translocations vs. controls)	1.86	[1.45-2.39]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		18q22.1	18	67284976	NR	RPL31P9 - DSEL	619464	92126		147218	221606	rs8099213-A	rs8099213	0	8099213	intergenic_variant	1	0.35	5E-6	5.301029995663981	(non t11;14 and t4;14 IgH translocations vs. controls)	1.52	[1.27-1.81]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		6q23.2	6	131242437	NR	AKAP7			9465			rs4629710-A	rs4629710	0	4629710	intron_variant	0	0.2	6E-6	5.221848749616356	(non t11;14 and t4;14 IgH translocations vs. controls)	1.6	[1.31-1.96]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		10p15.1	10	4634004	NR	RNU6-163P - LINC00704	106479638	100216001		118947	16181	rs7086888-G	rs7086888	0	7086888	intergenic_variant	1	0.07	8E-6	5.096910013008056	(non t11;14 and t4;14 IgH translocations vs. controls)	1.87	[1.42-2.46]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		22q13.1	22	39123191	NR	COX5BP7 - CBX7	1336	23492		2627	7581	rs139371-G	rs139371	0	139371	intron_variant	1	0.46	9E-6	5.045757490560675	(non t11;14 and t4;14 IgH translocations vs. controls)	1.5	[1.26-1.80]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		1q21.3	1	153668351	NR	ILF2			3608			rs7536700-A	rs7536700	0	7536700	intron_variant	0	0.07	9E-6	5.045757490560675	(non t11;14 and t4;14 IgH translocations vs. controls)	1.86	[1.42-2.46]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		11q13.3	11	69648142	CCND1	CCND1			595			rs603965-G	rs603965	1	9344	splice_region_variant	0	0.55	2E-11	10.698970004336019	(t11;14 vs non t11;14)	1.95	[1.61-2.38]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		5p14.3	5	22812155	NR	CDH12			1010			rs780179-G	rs780179	0	780179	intron_variant	0	0.48	9E-7	6.045757490560675	(t11;14 vs non t11;14)	1.59	[1.32-1.92]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		16q24.3	16	89404838	NR	ANKRD11			29123			rs2086824-A	rs2086824	0	2086824	intron_variant	0	0.51	2E-6	5.698970004336019	(t11;14 vs non t11;14)	1.58	[1.31-1.91]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		2q31.1	2	173640196	NR	LOC107985961			107985961			rs13028485-A	rs13028485	0	13028485	intergenic_variant	0	0.06	2E-6	5.698970004336019	(t11;14 vs non t11;14)	2.17	[1.57-2.99]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (IgH translocation)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		16q24.3	16	89382255	NR	ANKRD11			29123			rs3096299-G	rs3096299	0	3096299	intron_variant	0	0.45	4E-6	5.3979400086720375	(t11;14 vs non t11;14)	1.54	[1.28-1.86]	Illumina [414804] (imputed)	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		11q13.3	11	69642525	NR	CCND1			595			rs1352075-A	rs1352075	0	1352075	intron_variant	0	0.44	2E-6	5.698970004336019	(HD vs. non-HD)	1.42	[1.23-1.64]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		5q35.2	5	174350517	NR	LINC01411			101928176			rs12659144-G	rs12659144	0	12659144	intron_variant	0	0.12	3E-6	5.522878745280337	(HD vs. non-HD)	1.67	[1.35-2.07]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		3q26.2	3	169198452	NR	MECOM			2122			rs9864370-G	rs9864370	0	9864370	intron_variant	0	0.05	9E-6	5.045757490560675	(HD vs. non-HD)	2.04	[1.49-2.80]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		11p15.1	11	21875334	NR	LOC102723370			102723370			rs11026318-A	rs11026318	0	11026318	intergenic_variant	0	0.07	9E-6	5.045757490560675	(Non-HD without IgH translocations vs. controls)	2.33	[1.60-3.38]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		3p22.1	3	41744517	NR	ULK4			54986			rs6599175-G	rs6599175	0	6599175	intron_variant	0	0.16	1E-9	9.0	(HD vs. controls)	1.48	[1.30-1.68]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		7p15.3	7	21898622	NR	DNAH11			8701			rs4487645-C	rs4487645	0	4487645	intron_variant	0	0.65	1E-9	9.0	(HD vs. controls)	1.43	[1.27-1.60]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		22q13.1	22	39123191	NR	COX5BP7 - CBX7	1336	23492		2627	7581	rs139371-A	rs139371	0	139371	intron_variant	1	0.46	2E-9	8.698970004336019	(HD vs. controls)	1.37	[1.24-1.52]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		1p32.3	1	53909897	NR	DIO1			1733			rs2235544-A	rs2235544	0	2235544	intron_variant	0	0.46	6E-7	6.221848749616356	(HD vs. controls)	1.3	[1.17-1.44]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		17q21.1	17	40023239	NR	MED24			9862			rs2302777-A	rs2302777	0	2302777	synonymous_variant	0	0.62	8E-7	6.096910013008056	(HD vs. controls)	1.31	[1.18-1.46]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		8p23.1	8	9935152	NR	MIR124-1 - LOC105379235	406907	105379235		31680	48157	rs2055729-G	rs2055729	0	2055729	intergenic_variant	1	0.33	8E-7	6.096910013008056	(HD vs. controls)	1.3	[1.17-1.45]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		14q21.1	14	42934256	NR	YWHAQP1 - TUBBP3	319121	326106		126235	340712	rs11157317-A	rs11157317	0	11157317	intergenic_variant	1	0.25	9E-6	5.045757490560675	(HD vs. controls)	1.29	[1.15-1.44]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		3p22.1	3	41954644	NR	ULK4			54986			rs2272007-A	rs2272007	0	2272007	missense_variant	0	0.16	2E-9	8.698970004336019	(HD vs. controls)	1.47	[1.30-1.67]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		8p23.1	8	9744189	NR	TNKS			8658			rs12545912-C	rs12545912	0	12545912	intron_variant	0	0.24	7E-6	5.154901959985743	(HD vs. controls)	1.3	[1.16-1.45]	Illumina [414804]	N
2013-08-02	23502783	Weinhold N	2013-03-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23502783	The CCND1 c.870G&gt;A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	Multiple myeloma (hyperdiploidy)	up to 1,660 European ancestry cases, 7,306 European ancestry controls		8p23.1	8	9538022	NR	LOC100420404 - TNKS	100420404	8658		81196	17207	rs6601327-G	rs6601327	0	6601327	intergenic_variant	1	0.37	8E-6	5.096910013008056	(HD vs. controls)	1.27	[1.14-1.41]	Illumina [414804]	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma	2,194 European ancestry cases, 222,555 European ancestry controls	586 European ancestry cases, 2,111 European ancestry controls	5q15	5	95907227	ELL2	ELL2			22936			rs56219066-T	rs56219066	0	56219066	intron_variant	0	0.711	1E-9	9.0		1.25	[1.16-1.34]	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma	2,194 European ancestry cases, 222,555 European ancestry controls	586 European ancestry cases, 2,111 European ancestry controls	22q12.3	22	35303589	TOM1	TOM1			10043			rs138740-C	rs138740	0	138740	intron_variant	0	0.415	6E-8	7.221848749616356		1.18	[1.11-1.25]	Illumina [12100000] (imputed)	N
2016-04-21	26015512	Komatsu M	2015-05-26	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/26015512	Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.	Paclitaxel-induced cytotoxicity	57 Japanese ancestry lymphoblastoid cell lines, 59 Han Chinese ancestry lymphoblastoid cell lines	77 European ancestry lymphoblastoid cell lines, 87 Yoruban ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines	10p15.3	10	2818886	intergenic	LOC105376350 - LOC105376352	105376350	105376352		200179	157525	rs11595500-?	rs11595500	0	11595500	intergenic_variant	1	NR	4E-8	7.3979400086720375		0.212	[NR] unit decrease	NR [~ 4600000] (imputed)	N
2016-04-21	26015512	Komatsu M	2015-05-26	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/26015512	Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.	Paclitaxel-induced cytotoxicity	57 Japanese ancestry lymphoblastoid cell lines, 59 Han Chinese ancestry lymphoblastoid cell lines	77 European ancestry lymphoblastoid cell lines, 87 Yoruban ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines	5q23.3	5	130312328	intergenic	CHSY3 - LOC105379171	337876	105379171		125691	25081	rs264124-?	rs264124	0	264124	intergenic_variant	1	NR	7E-7	6.154901959985743		0.146	[NR] unit increase	NR [~ 4600000] (imputed)	N
2016-04-21	26015512	Komatsu M	2015-05-26	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/26015512	Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.	Paclitaxel-induced cytotoxicity	57 Japanese ancestry lymphoblastoid cell lines, 59 Han Chinese ancestry lymphoblastoid cell lines	77 European ancestry lymphoblastoid cell lines, 87 Yoruban ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines	17p13.2	17	6423425	AIPL1	LOC105371509 - AIPL1	105371509	23746		48378	312	rs3892315-?	rs3892315	0	3892315	intron_variant	1	NR	9E-7	6.045757490560675		0.207	[NR] unit increase	NR [~ 4600000] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9q33.1	9	116202676	NR	PAPPA			5069			rs1003858-?	rs1003858	0	1003858	intron_variant	0	NR	2E-7	6.698970004336019	(AA)	1.5177	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q23.1	10	85725660	NR	GRID1			2894			rs10159528-?	rs10159528	0	10159528	intron_variant	0	NR	8E-6	5.096910013008056	(AA)	0.3793	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11p15.1	11	21935412	NR	LOC102723370			102723370			rs111561475-?	rs111561475	0	111561475	intergenic_variant	0	NR	2E-6	5.698970004336019	(AA)	1.3324	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20q12	20	40956071	NR	RNA5SP484 - LOC100128988	100873726	100128988		101842	24690	rs115299670-?	rs115299670	0	115299670	intergenic_variant	1	NR	7E-6	5.154901959985743	(AA)	0.5975	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q23.33	10	92804854	NR	HHEX - EXOC6	3087	54536		109203	21977	rs117582141-?	rs117582141	0	117582141	intergenic_variant	1	NR	1E-6	6.0	(AA)	1.4321	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q29	3	197538563	NR	BDH1			622			rs11919456-?	rs11919456	0	11919456	intron_variant	0	NR	7E-7	6.154901959985743	(AA)	0.3125	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4p15.1	4	29168543	NR	LOC102723764 - LOC105374561	102723764	105374561		154059	45741	rs139214349-?	rs139214349	0	139214349	intron_variant	1	NR	6E-8	7.221848749616356	(AA)	1.3527	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	14q11.2	14	24034912	NR	DHRS4L1			728635			rs140436982-?	rs140436982	0	140436982	upstream_gene_variant	0	NR	5E-6	5.301029995663981	(AA)	1.4246	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	22q11.21	22	18899301	NR	LOC100996432 - DGCR6	100996432	8214		4870	6922	rs144073979-?	rs144073979	0	144073979	upstream_gene_variant	1	NR	1E-6	6.0	(AA)	0.8925	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q37.3	2	238918088	NR	TWIST2 - FLJ43879	117581	401039		7540	1214	rs144363312-?	rs144363312	0	144363312	downstream_gene_variant	1	NR	3E-6	5.522878745280337	(AA)	1.5622	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12q24.22	12	117624269	NR	KSR2			283455			rs144850704-?	rs144850704	0	144850704	intron_variant	0	NR	1E-6	6.0	(AA)	0.7013	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7q35	7	147919701	NR	CNTNAP2			26047			rs146883444-?	rs146883444	0	146883444	intron_variant	0	NR	6E-6	5.221848749616356	(AA)	1.4347	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16q22.2	16	72191288	NR	PMFBP1 - LOC105371341	83449	105371341		17380	11196	rs16970670-?	rs16970670	0	16970670	intergenic_variant	1	NR	4E-6	5.3979400086720375	(AA)	1.0285	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3p13	3	70210551	NR	LOC107986096			107986096			rs17006842-?	rs17006842	0	17006842	intron_variant	0	NR	4E-6	5.3979400086720375	(AA)	0.9617	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q11.2	2	100730839	NR	LOC105375310			105375310			rs182466621-?	rs182466621	0	182466621	intergenic_variant	0	NR	8E-7	6.096910013008056	(AA)	1.3747	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q34.2	4	176297102	NR	ASB5 - SPCS3	140458	60559		19531	22837	rs183073101-?	rs183073101	0	183073101	regulatory_region_variant	1	NR	6E-6	5.221848749616356	(AA)	0.8703	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q32.3	4	167451282	NR	RN7SL776P - PHBP14	106479503	100873751		50520	197148	rs191069440-?	rs191069440	0	191069440	intergenic_variant	1	NR	6E-7	6.221848749616356	(AA)	0.9699	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9q21.12	9	71226002	NR	TRPM3			80036			rs2309891-?	rs2309891	0	2309891	intron_variant	0	NR	3E-7	6.522878745280337	(AA)	0.3754	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17p13.1	17	10208841	NR	GAS7 - RPS27AP1	8522	103911		10290	49872	rs28452431-?	rs28452431	0	28452431	regulatory_region_variant	1	NR	7E-6	5.154901959985743	(AA)	0.352	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q24.22	8	133627845	NR	ST3GAL1 - LOC105375773	6482	105375773		55391	35916	rs2945731-?	rs2945731	0	2945731	intergenic_variant	1	NR	2E-6	5.698970004336019	(AA)	1.2332	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6q13	6	73429655	NR	MB21D1			115004			rs311671-?	rs311671	0	311671	intron_variant	0	NR	5E-6	5.301029995663981	(AA)	0.493	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11p15.1	11	21687041	NR	LOC107984320			107984320			rs34402840-?	rs34402840	0	34402840	intergenic_variant	0	NR	9E-7	6.045757490560675	(AA)	1.5785	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7p12.1	7	51636695	NR	ROBO2P1 - LOC105375278	106480790	105375278		36122	71277	rs35493220-?	rs35493220	0	35493220	intergenic_variant	1	NR	6E-7	6.221848749616356	(AA)	1.1798	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8p23.1	8	10829027	NR	PINX1			54984			rs35660623-?	rs35660623	0	35660623	intron_variant	0	NR	5E-6	5.301029995663981	(AA)	0.5385	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q23.3	5	129188192	NR	LOC102723654			102723654			rs35757618-?	rs35757618	0	35757618	intergenic_variant	0	NR	2E-6	5.698970004336019	(AA)	1.1564	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	19q13.43	19	57291543	NR	ZNF460			10794			rs36032958-?	rs36032958	0	36032958	synonymous_variant	0	NR	5E-6	5.301029995663981	(AA)	1.1962	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12q24.21	12	114366775	NR	TBX5			6910			rs3782464-?	rs3782464	0	3782464	intron_variant	0	NR	7E-6	5.154901959985743	(AA)	0.3457	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6q23.2	6	133287530	NR	EYA4			2070			rs454953-?	rs454953	0	454953	intron_variant	0	NR	4E-6	5.3979400086720375	(AA)	0.2799	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2p15	2	61245497	NR	USP34			9736			rs4671400-?	rs4671400	0	4671400	intron_variant	0	NR	5E-6	5.301029995663981	(AA)	0.805	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18p11.32	18	2507426	NR	LOC105371961 - METTL4	105371961	64863		136309	30099	rs4797996-?	rs4797996	0	4797996	intergenic_variant	1	NR	2E-6	5.698970004336019	(AA)	0.3058	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11q13.5	11	76556433	NR	C11orf30 - LOC101928813	56946	101928813		3532	51718	rs55904328-?	rs55904328	0	55904328	downstream_gene_variant	1	NR	6E-8	7.221848749616356	(AA)	0.4203	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q11.2	5	58227651	NR	LOC105378983 - LOC105378984	105378983	105378984		8751	162617	rs55966191-?	rs55966191	0	55966191	intergenic_variant	1	NR	5E-7	6.301029995663981	(AA)	1.042	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q35.1	4	185351567	NR	SNX25			83891			rs61731371-?	rs61731371	0	61731371	synonymous_variant	0	NR	3E-6	5.522878745280337	(AA)	1.4609	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20p12.3	20	8294998	NR	PLCB1			23236			rs62195918-?	rs62195918	0	62195918	intron_variant	0	NR	5E-6	5.301029995663981	(AA)	0.3458	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q37.1	2	231879093	NR	GAMTP1 - MIR1471	391491	100302126		68693	13149	rs6714205-?	rs6714205	0	6714205	intergenic_variant	1	NR	2E-7	6.698970004336019	(AA)	0.3626	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6p22.3	6	19235878	NR	LOC101928519 - LOC105374961	101928519	105374961		55398	81174	rs6931743-?	rs6931743	0	6931743	intergenic_variant	1	NR	2E-6	5.698970004336019	(AA)	0.9262	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9p21.1	9	28024196	NR	LINGO2			158038			rs72724928-?	rs72724928	0	72724928	intron_variant	0	NR	9E-7	6.045757490560675	(AA)	1.5217	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q11.1	5	50324716	NR	HCN1 - EMB	348980	133418		4628598	71476	rs72749828-?	rs72749828	0	72749828	intergenic_variant	1	NR	2E-6	5.698970004336019	(AA)	0.8801	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q25.1	3	151426056	NR	MED12L			116931			rs73869064-?	rs73869064	0	73869064	intron_variant	0	NR	3E-6	5.522878745280337	(AA)	0.3879	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	15q25.3	15	87214547	NR	LOC105370955 - LOC107984735	105370955	107984735		35972	94086	rs75676075-?	rs75676075	0	75676075	intergenic_variant	1	NR	7E-6	5.154901959985743	(AA)	0.5371	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10p12.2	10	24068862	NR	KIAA1217			56243			rs75984653-?	rs75984653	0	75984653	intron_variant	0	NR	7E-6	5.154901959985743	(AA)	1.2881	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	13q12.12	13	23847637	NR	MIPEP			4285			rs76248362-?	rs76248362	0	76248362	intron_variant	0	NR	5E-6	5.301029995663981	(AA)	1.3521	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17q12	17	37529428	NR	SYNRG			11276			rs763512-?	rs763512	0	763512	intron_variant	0	NR	6E-6	5.221848749616356	(AA)	0.3996	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q21.1	4	77425223	NR	LOC105377295 - CXCL13	105377295	10563		14289	86530	rs7669806-?	rs7669806	0	7669806	intron_variant	1	NR	7E-6	5.154901959985743	(AA)	0.4845	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4p14	4	37181024	NR	LOC101928721 - MIR4801	101928721	100616435		46956	60886	rs7678296-?	rs7678296	0	7678296	intergenic_variant	1	NR	7E-6	5.154901959985743	(AA)	0.4535	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q13.1	4	64356524	NR	TECRL			253017			rs7698280-?	rs7698280	0	7698280	intron_variant	0	NR	5E-6	5.301029995663981	(AA)	0.3344	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q21.2	10	59904437	NR	CCDC6			8030			rs77329626-?	rs77329626	0	77329626	intron_variant	0	NR	8E-6	5.096910013008056	(AA)	1.4476	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8p11.21	8	41125666	NR	RNU6-356P - LOC105379771	106479724	105379771		92668	46663	rs77924284-?	rs77924284	0	77924284	intergenic_variant	1	NR	3E-7	6.522878745280337	(AA)	0.5406	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q21.1	18	50490517	NR	RPLP0P11 - MAPK4	647094	5596		31658	69264	rs77990856-?	rs77990856	0	77990856	intergenic_variant	1	NR	5E-11	10.301029995663981	(AA)	1.9734	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20q13.31	20	57280737	NR	LOC105372687			105372687			rs78404372-?	rs78404372	0	78404372	intron_variant	0	NR	7E-7	6.154901959985743	(AA)	0.8275	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17q25.3	17	82566308	NR	FOXK2			3607			rs78461346-?	rs78461346	0	78461346	intron_variant	0	NR	8E-6	5.096910013008056	(AA)	1.2145	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12p13.1	12	13383212	NR	LINC01559 - RNA5SP353	283422	100873613		6467	57672	rs78791096-?	rs78791096	0	78791096	intron_variant	1	NR	8E-6	5.096910013008056	(AA)	0.5516	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6q25.3	6	158910228	NR	C6orf99			100130967			rs78995442-?	rs78995442	0	78995442	non_coding_transcript_exon_variant	0	NR	5E-6	5.301029995663981	(AA)	0.6532	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17q25.3	17	79309121	NR	RBFOX3			146713			rs79211555-?	rs79211555	0	79211555	intron_variant	0	NR	3E-8	7.522878745280337	(AA)	1.6521	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q36.1	2	223197727	NR	LOC105373905 - LOC105373906	105373905	105373906		83053	5329	rs79351035-?	rs79351035	0	79351035	intron_variant	1	NR	7E-6	5.154901959985743	(AA)	0.8247	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7p14.3	7	29416664	NR	CHN2			1124			rs79489058-?	rs79489058	0	79489058	intron_variant	0	NR	5E-6	5.301029995663981	(AA)	1.3914	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18p11.22	18	10592716	NR	NAPG - LOC105371990	8774	105371990		39947	3130	rs8098600-?	rs8098600	0	8098600	upstream_gene_variant	1	NR	8E-6	5.096910013008056	(AA)	0.3827	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q23.1	5	117367334	NR	LOC105379139			105379139			rs10070219-?	rs10070219	0	10070219	intergenic_variant	0	NR	7E-6	5.154901959985743	(EA)	0.3481	[0.2-0.5] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9p23	9	10060843	NR	PTPRD			5789			rs10958852-?	rs10958852	0	10958852	intron_variant	0	NR	3E-7	6.522878745280337	(EA)	0.8906	[0.55-1.23] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11q14.2	11	88441800	NR	LOC101929174 - GRM5-AS1	101929174	100873989		13608	62776	rs11019935-?	rs11019935	0	11019935	intergenic_variant	1	NR	3E-7	6.522878745280337	(EA)	0.8885	[0.55-1.22] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8p22	8	13035349	NR	KIAA1456 - RNU6-842P	57604	106481447		5572	9001	rs113367091-?	rs113367091	0	113367091	downstream_gene_variant	1	NR	3E-6	5.522878745280337	(EA)	0.8257	[0.48-1.17] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17p13.1	17	8885434	NR	PIK3R5			23533			rs114619297-?	rs114619297	0	114619297	intron_variant	0	NR	5E-6	5.301029995663981	(EA)	1.3777	[0.79-1.96] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q13.3	5	76053677	NR	SV2C			22987			rs117041666-?	rs117041666	0	117041666	intergenic_variant	0	NR	2E-6	5.698970004336019	(EA)	1.1009	[0.65-1.55] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10p11.23	10	30288009	NR	LOC101929279 - RNU6-598P	101929279	106479830		55319	11560	rs12220014-?	rs12220014	0	12220014	intergenic_variant	1	NR	4E-6	5.3979400086720375	(EA)	0.6201	[0.36-0.88] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3p21.31	3	49475886	NR	DAG1			1605			rs142316462-?	rs142316462	0	142316462	intron_variant	0	NR	3E-6	5.522878745280337	(EA)	0.6756	[0.4-0.96] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q12.1	18	33861956	NR	NOL4			8715			rs142429341-?	rs142429341	0	142429341	intron_variant	0	NR	4E-6	5.3979400086720375	(EA)	0.3124	[0.18-0.44] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q31.2	2	178090295	NR	PDE11A			50940			rs145244554-?	rs145244554	0	145244554	intron_variant	0	NR	5E-6	5.301029995663981	(EA)	0.6734	[0.39-0.96] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q32.3	2	194286481	NR	HNRNPA1P47 - LOC101927406	100287191	101927406		97972	57788	rs150734725-?	rs150734725	0	150734725	intergenic_variant	1	NR	6E-6	5.221848749616356	(EA)	1.4012	[0.8-2] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7q32.3	7	132133338	NR	PLXNA4			91584			rs182006024-?	rs182006024	0	182006024	intron_variant	0	NR	4E-6	5.3979400086720375	(EA)	0.6284	[0.36-0.89] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q21.3	8	86114530	NR	ATP6V0D2			245972			rs183497284-?	rs183497284	0	183497284	intron_variant	0	NR	7E-6	5.154901959985743	(EA)	1.3425	[0.77-1.92] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16q12.2	16	53342547	NR	RNA5SP427 - LOC100996483	100873678	100996483		4976	11975	rs2080364-?	rs2080364	0	2080364	downstream_gene_variant	1	NR	2E-6	5.698970004336019	(EA)	0.2572	[0.15-0.36] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12p13.31	12	6006558	NR	VWF			7450			rs2532859-?	rs2532859	0	2532859	intron_variant	0	NR	2E-6	5.698970004336019	(EA)	0.2726	[0.16-0.38] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q35.1	5	171470204	NR	LOC105377721			105377721			rs3097847-?	rs3097847	0	3097847	intergenic_variant	0	NR	2E-6	5.698970004336019	(EA)	0.4669	[0.28-0.65] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16q21	16	66549802	NR	TK2			7084			rs3743714-?	rs3743714	0	3743714	5_prime_UTR_variant	0	NR	7E-6	5.154901959985743	(EA)	0.4757	[0.27-0.68] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7q21.11	7	78053573	NR	MAGI2			9863			rs3807766-?	rs3807766	0	3807766	intron_variant	0	NR	4E-6	5.3979400086720375	(EA)	0.2122	[0.12-0.3] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7p14.1	7	40322235	NR	SUGCT			79783			rs3857747-?	rs3857747	0	3857747	intron_variant	0	NR	1E-6	6.0	(EA)	0.2401	[0.15-0.33] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11p15.4	11	4803398	NR	OR52Y1P - OR52R1	81240	119695		9137	35	rs61880854-?	rs61880854	0	61880854	intron_variant	1	NR	2E-6	5.698970004336019	(EA)	0.5821	[0.34-0.82] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18p11.21	18	14010932	NR	RPL36AP49 - LOC100128776	284230	100128776		90952	42974	rs71363185-?	rs71363185	0	71363185	downstream_gene_variant	1	NR	5E-6	5.301029995663981	(EA)	0.3871	[0.22-0.55] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q21.1	18	49157384	NR	DYM			54808			rs72923818-?	rs72923818	0	72923818	intron_variant	0	NR	1E-6	6.0	(EA)	0.4612	[0.28-0.65] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	22q11.21	22	20967502	NR	AIFM3			150209			rs73164810-?	rs73164810	0	73164810	intron_variant	0	NR	7E-7	6.154901959985743	(EA)	0.4181	[0.26-0.58] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20q13.2	20	55616161	NR	LOC105372676			105372676			rs73625555-?	rs73625555	0	73625555	intergenic_variant	0	NR	2E-6	5.698970004336019	(EA)	1.0117	[0.6-1.43] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6q24.1	6	140127710	NR	LOC100507477 - LOC105378025	100507477	105378025		33989	12902	rs75402058-?	rs75402058	0	75402058	intergenic_variant	1	NR	7E-6	5.154901959985743	(EA)	0.9986	[0.57-1.43] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17q11.2	17	28362619	NR	TMEM199			147007			rs756766-?	rs756766	0	756766	3_prime_UTR_variant	0	NR	7E-6	5.154901959985743	(EA)	0.5607	[0.32-0.8] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q15	5	95184169	NR	LOC105379085, MCTP1			105379085, 79772			rs75927821-?	rs75927821	0	75927821	intron_variant	0	NR	4E-6	5.3979400086720375	(EA)	0.3466	[0.2-0.49] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9q21.33	9	84765758	NR	NTRK2			4915			rs77362122-?	rs77362122	0	77362122	intron_variant	0	NR	7E-6	5.154901959985743	(EA)	0.4737	[0.27-0.68] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3p26.1	3	4993129	NR	LOC105376934			105376934			rs78745845-?	rs78745845	0	78745845	intergenic_variant	0	NR	3E-6	5.522878745280337	(EA)	1.0382	[0.61-1.47] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q13.12	3	106575615	NR	LOC101929485			101929485			rs79757846-?	rs79757846	0	79757846	intergenic_variant	0	NR	4E-6	5.3979400086720375	(EA)	0.9748	[0.57-1.38] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q32	5	149428439	NR	MIR143HG			728264			rs78823151-?	rs78823151	0	78823151	non_coding_transcript_exon_variant	0	NR	8E-6	5.096910013008056	(EA)	0.6201	[0.35-0.89] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7p14.1	7	40442213	NR	SUGCT			79783			rs2329775-?	rs2329775	0	2329775	intron_variant	0	NR	5E-6	5.301029995663981	(EA)	0.2225	[0.13-0.32] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11q12.2	11	61717684	NR	DAGLA			747			rs10488693-?	rs10488693	0	10488693	intron_variant	0	NR	7E-8	7.154901959985743	(Japanese)	0.8403	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11p12	11	36485319	NR	TRAF6			7189			rs10501157-?	rs10501157	0	10501157	downstream_gene_variant	0	NR	7E-9	8.154901959985743	(Japanese)	0.8987	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p12.2	16	23738456	NR	ERN2 - CHP2	10595	63928		24956	16171	rs11642421-?	rs11642421	0	11642421	intergenic_variant	1	NR	1E-7	7.0	(Japanese)	0.5307	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q12.2	18	37727857	NR	LOC102724417			102724417			rs12458491-?	rs12458491	0	12458491	intergenic_variant	0	NR	2E-9	8.698970004336019	(Japanese)	0.8417	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q22.1	2	137168337	NR	THSD7B			80731			rs13019227-?	rs13019227	0	13019227	intron_variant	0	NR	3E-8	7.522878745280337	(Japanese)	0.7808	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p12.2	16	22939292	NR	HS3ST2 - USP31	9956	57478		22954	122115	rs138450362-?	rs138450362	0	138450362	intergenic_variant	1	NR	5E-8	7.301029995663981	(Japanese)	1.0668	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	13q21.33	13	70783858	NR	LOC105370255			105370255			rs139612726-?	rs139612726	0	139612726	intergenic_variant	0	NR	8E-8	7.096910013008056	(Japanese)	0.8006	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q23	3	139171721	NR	BPESC1 - PISRT1	60467	140464		46554	61271	rs140701484-?	rs140701484	0	140701484	intron_variant	1	NR	1E-8	8.0	(Japanese)	0.9447	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12p13.33	12	691668	NR	LOC105369597, LOC101929432			105369597, 101929432			rs145863439-?	rs145863439	0	145863439	intergenic_variant	0	NR	2E-7	6.698970004336019	(Japanese)	0.9962	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11p12	11	36769135	NR	LOC107984326			107984326			rs1474107-?	rs1474107	0	1474107	intergenic_variant	0	NR	5E-10	9.301029995663981	(Japanese)	1.0047	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q22.3	3	138783216	NR	PIK3CB			5291			rs149005978-?	rs149005978	0	149005978	intron_variant	0	NR	2E-11	10.698970004336019	(Japanese)	1.0831	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11q12.1	11	59362639	NR	OR5BR1P - OR5AN1	81201	390195		28554	1820	rs149914843-?	rs149914843	0	149914843	upstream_gene_variant	1	NR	3E-9	8.522878745280337	(Japanese)	1.3074	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q12.2	18	37566243	NR	CELF4 - LOC107985118	56853	107985118		191	70961	rs150664883-?	rs150664883	0	150664883	upstream_gene_variant	1	NR	5E-9	8.301029995663981	(Japanese)	0.4318	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	14q13.1	14	33029670	NR	NPAS3			64067			rs17455969-?	rs17455969	0	17455969	intron_variant	0	NR	1E-7	7.0	(Japanese)	1.1128	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	13q12.3	13	30895528	NR	TEX26-AS1			100507064			rs17534004-?	rs17534004	0	17534004	intron_variant	0	NR	2E-8	7.698970004336019	(Japanese)	0.8173	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q25.33	3	159723391	NR	IQCJ-SCHIP1, SCHIP1			100505385, 29970			rs17807116-?	rs17807116	0	17807116	intron_variant	0	NR	2E-8	7.698970004336019	(Japanese)	1.0307	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11q12.3	11	62374219	NR	ASRGL1			80150			rs184485201-?	rs184485201	0	184485201	intron_variant	0	NR	2E-7	6.698970004336019	(Japanese)	0.9188	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	19p13.2	19	11623811	NR	VN2R12P - ZNF887P	100033400	100419709		2587	24537	rs187568415-?	rs187568415	0	187568415	downstream_gene_variant	1	NR	2E-8	7.698970004336019	(Japanese)	0.9328	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11q12.3	11	62196458	NR	SCGB1D1 - SCGB2A1	10648	4246		2921	12210	rs189478926-?	rs189478926	0	189478926	downstream_gene_variant	1	NR	5E-9	8.301029995663981	(Japanese)	0.8474	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20p13	20	552161	NR	CSNK2A1 - TCF15	1457	6939		8323	51832	rs204664-?	rs204664	0	204664	intergenic_variant	1	NR	9E-8	7.045757490560675	(Japanese)	0.5462	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q12.2	18	37505770	NR	CELF4			56853			rs41475954-?	rs41475954	0	41475954	intron_variant	0	NR	4E-9	8.397940008672037	(Japanese)	0.6178	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	13q32.3	13	100082270	NR	ASNSP3 - LOC105370333	100423061	105370333		18653	3761	rs59876823-?	rs59876823	0	59876823	downstream_gene_variant	1	NR	7E-9	8.154901959985743	(Japanese)	0.9446	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8p12	8	31469533	NR	LOC101929492 - LOC105379360	101929492	105379360		68410	66141	rs7004520-?	rs7004520	0	7004520	intergenic_variant	1	NR	2E-7	6.698970004336019	(Japanese)	0.5201	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	15q15.1	15	42040418	NR	PLA2G4E			123745			rs7172971-?	rs7172971	0	7172971	intron_variant	0	NR	1E-8	8.0	(Japanese)	0.8034	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p12.2	16	23050620	NR	HS3ST2 - USP31	9956	57478		134282	10787	rs72772480-?	rs72772480	0	72772480	intergenic_variant	1	NR	2E-7	6.698970004336019	(Japanese)	0.6071	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12q21.32	12	86858583	NR	MGAT4C - LOC105369878	25834	105369878		19584	183333	rs75750649-?	rs75750649	0	75750649	intergenic_variant	1	NR	3E-8	7.522878745280337	(Japanese)	0.8691	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q21.2	10	59930437	NR	CCDC6 - LINC01553	8030	283025		23781	27780	rs75768999-?	rs75768999	0	75768999	intergenic_variant	1	NR	2E-9	8.698970004336019	(Japanese)	0.6094	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q32.1	2	183692132	NR	CACYBPP2 - LOC105373775	644877	105373775		84013	357102	rs77731990-?	rs77731990	0	77731990	intergenic_variant	1	NR	3E-8	7.522878745280337	(Japanese)	1.1807	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q12.2	18	37456867	NR	CELF4			56853			rs79828856-?	rs79828856	0	79828856	intron_variant	0	NR	8E-8	7.096910013008056	(Japanese)	0.6584	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q26.13	10	125227554	NR	MRPS21P6 - LOC105378541	359770	105378541		60458	963	rs9422860-?	rs9422860	0	9422860	regulatory_region_variant	1	NR	1E-7	7.0	(Japanese)	0.6912	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q35.1	5	173223484	NR	BNIP1 - RPL7AP33	662	391850		59097	2293	rs10440708-?	rs10440708	0	10440708	downstream_gene_variant	1	NR	8E-8	7.096910013008056	(Latino)	1.502	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4p15.33	4	12025243	NR	LOC107986179 - LOC107986180	107986179	107986180		83483	99284	rs113991851-?	rs113991851	0	113991851	intergenic_variant	1	NR	1E-7	7.0	(Latino)	1.3931	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6p22.1	6	29318457	NR	LOC105375005			105375005			rs114114977-?	rs114114977	1	73407446	intergenic_variant	0	NR	3E-7	6.522878745280337	(Latino)	0.8824	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q21.1	4	77975394	NR	HMGB1P44 - HNRNPA1P56	100130279	391670		10864	12115	rs114622739-?	rs114622739	0	114622739	intergenic_variant	1	NR	2E-7	6.698970004336019	(Latino)	1.3251	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q13.31	3	113931599	NR	GRAMD1C			54762			rs114780919-?	rs114780919	0	114780919	intron_variant	0	NR	8E-8	7.096910013008056	(Latino)	1.7019	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p13.13	16	12381345	NR	SNX29			92017			rs116383923-?	rs116383923	1	111209267	intron_variant	0	NR	3E-9	8.522878745280337	(Latino)	1.4764	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p13.12	16	12883205	NR	RPL35AP34 - SHISA9	100271641	729993		1665	18414	rs11864332-?	rs11864332	0	11864332	downstream_gene_variant	1	NR	3E-9	8.522878745280337	(Latino)	1.1289	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9q22.32	9	96081777	NR	LOC158435			158435			rs12346945-?	rs12346945	0	12346945	intergenic_variant	0	NR	2E-7	6.698970004336019	(Latino)	1.3995	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17q24.3	17	70665494	NR	CALM2P1 - LOC105371884	100128390	105371884		423116	145977	rs12602300-?	rs12602300	0	12602300	intergenic_variant	1	NR	1E-7	7.0	(Latino)	0.7551	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12q13.2	12	56014530	NR	LOC105369781, IKZF4			105369781, 64375			rs137948794-?	rs137948794	0	137948794	intron_variant	0	NR	2E-8	7.698970004336019	(Latino)	0.8728	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q25.1	10	105647558	NR	LOC107984266			107984266			rs144529734-?	rs144529734	0	144529734	intergenic_variant	0	NR	6E-8	7.221848749616356	(Latino)	1.301	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q14.3	5	84778474	NR	LOC105379059 - LOC100289244	105379059	100289244		203696	221144	rs144704329-?	rs144704329	0	144704329	intergenic_variant	1	NR	2E-7	6.698970004336019	(Latino)	1.5768	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q26.2	3	167952807	NR	LINC01330 - LOC107986039	646168	107986039		28796	3492	rs145242450-?	rs145242450	0	145242450	downstream_gene_variant	1	NR	1E-7	7.0	(Latino)	1.6001	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q29	3	194517169	NR	LINC00884 - RNU6-1101P	401106	106480050		28624	16334	rs147484948-?	rs147484948	0	147484948	non_coding_transcript_exon_variant	1	NR	1E-7	7.0	(Latino)	1.2626	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20q13.2	20	55624691	NR	LOC105372676			105372676			rs188674761-?	rs188674761	0	188674761	intergenic_variant	0	NR	2E-7	6.698970004336019	(Latino)	1.1179	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q24.11	8	117639150	NR	LOC105375721			105375721			rs189087047-?	rs189087047	0	189087047	intergenic_variant	0	NR	8E-8	7.096910013008056	(Latino)	1.6762	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20p12.2	20	9650739	NR	PAK7			57144			rs2224610-?	rs2224610	0	2224610	intron_variant	0	NR	3E-7	6.522878745280337	(Latino)	1.3171	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9p21.3	9	24560579	NR	IZUMO3 - RMRPP5	100129669	106481874		14649	344890	rs2805062-?	rs2805062	0	2805062	intron_variant	1	NR	1E-10	10.0	(Latino)	1.3293	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q32.1	2	183628013	NR	CACYBPP2 - LOC105373775	644877	105373775		19894	421221	rs34395537-?	rs34395537	0	34395537	intergenic_variant	1	NR	8E-10	9.096910013008056	(Latino)	1.7295	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p13.12	16	12665652	NR	CPPED1			55313			rs58144239-?	rs58144239	0	58144239	intron_variant	0	NR	1E-9	9.0	(Latino)	1.2211	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p13.13	16	10504450	NR	RNU6-633P - EMP2	106481381	2013		8077	23972	rs58376408-?	rs58376408	0	58376408	intergenic_variant	1	NR	2E-9	8.698970004336019	(Latino)	1.3522	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	15q25.3	15	88327931	NR	LOC105370958 - LOC105370959	105370958	105370959		5654	17011	rs62024303-?	rs62024303	0	62024303	intergenic_variant	1	NR	3E-7	6.522878745280337	(Latino)	1.2385	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9q22.32	9	96267007	NR	HSD17B3			3293			rs7042315-?	rs7042315	0	7042315	intron_variant	0	NR	6E-8	7.221848749616356	(Latino)	1.4753	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q29	3	195778256	NR	MUC4			4585			rs73085315-?	rs73085315	0	73085315	intron_variant	0	NR	2E-10	9.698970004336019	(Latino)	1.4698	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	13q21.31	13	63164591	NR	LOC105370234 - LINC00376	105370234	104355293		253046	18510	rs73505772-?	rs73505772	0	73505772	intergenic_variant	1	NR	3E-7	6.522878745280337	(Latino)	1.3909	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6p21.1	6	41264814	NR	TREML5P - TREM1	221438	54210		15225	2571	rs74851542-?	rs74851542	0	74851542	downstream_gene_variant	1	NR	2E-7	6.698970004336019	(Latino)	1.1461	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	21q22.12	21	34941487	NR	RUNX1			861			rs75030518-?	rs75030518	0	75030518	intron_variant	0	NR	2E-7	6.698970004336019	(Latino)	1.4514	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p13.2	16	7882576	NR	LOC105371069			105371069			rs75728418-?	rs75728418	0	75728418	intergenic_variant	0	NR	1E-7	7.0	(Latino)	1.2847	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q22.3	3	138884041	NR	PIK3CB - ATP5G1P3	5291	646619		49103	5114	rs7637688-?	rs7637688	0	7637688	intergenic_variant	1	NR	7E-8	7.154901959985743	(Latino)	0.6713	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q22.1	10	71964198	NR	PSAP - CHST3	5660	9469		112823	164	rs76409888-?	rs76409888	0	76409888	upstream_gene_variant	1	NR	1E-7	7.0	(Latino)	1.7704	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p13.13	16	11688193	NR	TXNDC11			51061			rs9924009-?	rs9924009	0	9924009	intron_variant	0	NR	3E-7	6.522878745280337	(Latino)	1.0391	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9p21.3	9	24431794	NR	LOC100419692 - LOC105375994	100419692	105375994		475350	99487	rs118043898-?	rs118043898	0	118043898	intergenic_variant	1	NR	5E-8	7.301029995663981	(Latino)	1.6762	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5p14.1	5	27460098	NR	LOC105374695 - LINC01021	105374695	643401		46460	12194	rs10077887-?	rs10077887	0	10077887	intergenic_variant	1	NR	8E-6	5.096910013008056	(Native Hawaiian)	0.5383	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	15q23	15	71814833	NR	NR2E3			10002			rs113441626-?	rs113441626	0	113441626	3_prime_UTR_variant	0	NR	8E-8	7.096910013008056	(Native Hawaiian)	1.3074	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	15q23	15	72206596	NR	PKM			5315			rs113920924-?	rs113920924	0	113920924	non_coding_transcript_exon_variant	0	NR	9E-6	5.045757490560675	(Native Hawaiian)	1.0445	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7q31.2	7	117299233	NR	LOC105375467, WNT2			105375467, 7472			rs114167782-?	rs114167782	0	114167782	intron_variant	0	NR	2E-7	6.698970004336019	(Native Hawaiian)	1.2727	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	14q32.13	14	95627510	NR	LOC105370643 - TCL6	105370643	27004		36520	23668	rs115169421-?	rs115169421	0	115169421	intron_variant	1	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.9626	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q11.1	8	46494994	NR	CYP4F44P - HSPA8P13	106480733	106480803		2954067	54095	rs117044419-?	rs117044419	0	117044419	intergenic_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.7395	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11p14.3	11	23670881	NR	RPS2P38 - LOC105376593	196188	105376593		149642	58106	rs117285774-?	rs117285774	0	117285774	intergenic_variant	1	NR	6E-6	5.221848749616356	(Native Hawaiian)	1.5042	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	19p12	19	20452485	NR	LOC105372317			105372317			rs117403524-?	rs117403524	0	117403524	intron_variant	0	NR	5E-6	5.301029995663981	(Native Hawaiian)	1.3757	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q11.1	8	46331989	NR	CYP4F44P - HSPA8P13	106480733	106480803		2791062	217100	rs117933211-?	rs117933211	0	117933211	intergenic_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	1.0044	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6q16.3	6	100057472	NR	MCHR2-AS1			728012			rs12209443-?	rs12209443	0	12209443	intron_variant	0	NR	6E-6	5.221848749616356	(Native Hawaiian)	0.6219	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	14q22.1	14	51607489	NR	FRMD6			122786			rs12879264-?	rs12879264	0	12879264	intron_variant	0	NR	9E-6	5.045757490560675	(Native Hawaiian)	0.2555	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	13q14.11	13	42717153	NR	TNFSF11 - FAM216B	8600	144809		109140	64397	rs1323612-?	rs1323612	0	1323612	intergenic_variant	1	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.6004	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	19q13.42	19	54650073	NR	VN1R105P - LILRB4	100288264	11006		1208	12451	rs139806220-?	rs139806220	0	139806220	intron_variant	1	NR	5E-8	7.301029995663981	(Native Hawaiian)	1.187	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q23.1	8	105443330	NR	ZFPM2			23414			rs142507408-?	rs142507408	0	142507408	intron_variant	0	NR	2E-6	5.698970004336019	(Native Hawaiian)	1.6373	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12p12.3	12	19368705	NR	PLEKHA5			54477			rs143970033-?	rs143970033	0	143970033	intron_variant	0	NR	9E-8	7.045757490560675	(Native Hawaiian)	1.0142	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17p13.1	17	9172427	NR	NTN1, LOC101928266			9423, 101928266			rs144460277-?	rs144460277	0	144460277	intron_variant	0	NR	6E-7	6.221848749616356	(Native Hawaiian)	1.2032	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8p23.3	8	1351712	NR	LOC286083 - LOC105379585	286083	105379585		49105	21576	rs144606178-?	rs144606178	0	144606178	intron_variant	1	NR	6E-6	5.221848749616356	(Native Hawaiian)	0.5584	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9q21.13	9	74792899	NR	TRPM6			140803			rs144773862-?	rs144773862	0	144773862	intron_variant	0	NR	6E-6	5.221848749616356	(Native Hawaiian)	1.1625	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12q24.23	12	118006065	NR	KSR2 - RFC5	283455	5985		37507	10636	rs146238395-?	rs146238395	0	146238395	intergenic_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	1.1114	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6q24.1	6	140517337	NR	MIR3668 - LOC105378027	100500879	105378027		312011	21517	rs146383502-?	rs146383502	0	146383502	intergenic_variant	1	NR	5E-7	6.301029995663981	(Native Hawaiian)	1.2123	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4p13	4	43888423	NR	RN7SL193P - LOC402175	106480493	402175		24874	10492	rs148386737-?	rs148386737	0	148386737	intergenic_variant	1	NR	2E-6	5.698970004336019	(Native Hawaiian)	1.2238	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16q21	16	65627613	NR	LINC00922 - LOC107984823	283867	107984823		51313	182427	rs151011520-?	rs151011520	0	151011520	intron_variant	1	NR	1E-6	6.0	(Native Hawaiian)	1.5544	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q27	4	121999890	NR	LOC102724158 - RN7SL335P	102724158	106480375		10168	87618	rs17643636-?	rs17643636	0	17643636	intergenic_variant	1	NR	2E-6	5.698970004336019	(Native Hawaiian)	1.1347	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9p13.3	9	33995448	NR	UBAP2			55833			rs180850064-?	rs180850064	0	180850064	non_coding_transcript_exon_variant	0	NR	1E-6	6.0	(Native Hawaiian)	1.3692	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	21q22.3	21	41474608	NR	TMPRSS2			7113			rs183026840-?	rs183026840	0	183026840	intron_variant	0	NR	9E-6	5.045757490560675	(Native Hawaiian)	0.8436	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3p21.31	3	44285656	NR	TOPAZ1			375337			rs184952719-?	rs184952719	0	184952719	intron_variant	0	NR	7E-6	5.154901959985743	(Native Hawaiian)	1.2616	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q23.3	2	153086712	NR	LOC105373691 - ATP5F1P4	105373691	100422514		58426	72226	rs186826000-?	rs186826000	0	186826000	intergenic_variant	1	NR	8E-6	5.096910013008056	(Native Hawaiian)	1.2102	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6p22.1	6	29904733	NR	HLA-T - DDX39BP1	352964	100048904		5786	1814	rs189370103-?	rs189370103	0	189370103	intron_variant	1	NR	8E-6	5.096910013008056	(Native Hawaiian)	1.0607	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p13.3	16	5984142	NR	RBFOX1			54715			rs191076832-?	rs191076832	0	191076832	intron_variant	0	NR	6E-6	5.221848749616356	(Native Hawaiian)	1.1977	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q26.2	3	170285775	NR	PRKCI			5584			rs191153365-?	rs191153365	0	191153365	intron_variant	0	NR	3E-6	5.522878745280337	(Native Hawaiian)	1.2581	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7q21.3	7	95994998	NR	DYNC1I1			1780			rs1988399-?	rs1988399	0	1988399	intron_variant	0	NR	7E-6	5.154901959985743	(Native Hawaiian)	0.2318	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11p15.1	11	21024881	NR	NELL1			4745			rs35295995-?	rs35295995	0	35295995	intron_variant	0	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.8108	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20q13.12	20	45878897	NR	ZSWIM3			140831			rs4812973-?	rs4812973	0	4812973	3_prime_UTR_variant	0	NR	8E-6	5.096910013008056	(Native Hawaiian)	0.4476	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q31.2	5	136997105	NR	SPOCK1			6695			rs6876032-?	rs6876032	0	6876032	intron_variant	0	NR	8E-6	5.096910013008056	(Native Hawaiian)	0.4158	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q11.2	5	57547358	NR	LOC102724122 - LINCR-0003	102724122	100996645		11888	22984	rs6895539-?	rs6895539	0	6895539	intergenic_variant	1	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.805	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11q24.3	11	128222597	NR	LOC105369564			105369564			rs71479994-?	rs71479994	0	71479994	intron_variant	0	NR	9E-6	5.045757490560675	(Native Hawaiian)	0.8798	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q26.3	10	132408041	NR	PWWP2B			170394			rs74383458-?	rs74383458	0	74383458	intron_variant	0	NR	9E-6	5.045757490560675	(Native Hawaiian)	0.9857	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	19p13.3	19	2522673	NR	GNG7			2788			rs74407240-?	rs74407240	0	74407240	intron_variant	0	NR	9E-6	5.045757490560675	(Native Hawaiian)	0.705	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q23	18	79568615	NR	NFATC1 - LOC284240	4772	284240		39292	5090	rs75000611-?	rs75000611	0	75000611	intergenic_variant	1	NR	7E-7	6.154901959985743	(Native Hawaiian)	0.995	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	13q32.3	13	99804258	NR	LOC101927437, CLYBL			101927437, 171425			rs75327846-?	rs75327846	0	75327846	intron_variant	0	NR	1E-6	6.0	(Native Hawaiian)	0.9315	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7p22.3	7	1752760	NR	ELFN1 - MAD1L1	392617	8379		4806	63032	rs76720445-?	rs76720445	0	76720445	downstream_gene_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.7911	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q11.1	8	46141196	NR	CYP4F44P - HSPA8P13	106480733	106480803		2600269	407893	rs76794758-?	rs76794758	0	76794758	intergenic_variant	1	NR	8E-7	6.096910013008056	(Native Hawaiian)	1.1364	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6q24.1	6	140195831	NR	RNA5SP220 - MIR3668	100873480	100500879		37137	9421	rs76846186-?	rs76846186	0	76846186	intergenic_variant	1	NR	2E-8	7.698970004336019	(Native Hawaiian)	1.4779	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	22q13.31	22	44075243	NR	PARVB			29780			rs77206040-?	rs77206040	0	77206040	intron_variant	0	NR	4E-6	5.3979400086720375	(Native Hawaiian)	1.2408	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q22.1	2	141257677	NR	LRP1B			53353			rs77455689-?	rs77455689	0	77455689	intron_variant	0	NR	4E-6	5.3979400086720375	(Native Hawaiian)	1.1204	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12q12	12	43590425	NR	LOC400026 - EEF1A1P17	400026	401717		18254	56501	rs77464658-?	rs77464658	0	77464658	intergenic_variant	1	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.9525	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q11.1	8	46035004	NR	CYP4F44P - HSPA8P13	106480733	106480803		2494077	514085	rs77583023-?	rs77583023	0	77583023	intergenic_variant	1	NR	1E-6	6.0	(Native Hawaiian)	1.125	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3p13	3	71987769	NR	RN7SL271P - LOC105377157	106479321	105377157		160298	5500	rs77673554-?	rs77673554	0	77673554	regulatory_region_variant	1	NR	8E-6	5.096910013008056	(Native Hawaiian)	0.9345	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18p11.31	18	6894476	NR	ARHGAP28			79822			rs77741790-?	rs77741790	0	77741790	intron_variant	0	NR	4E-6	5.3979400086720375	(Native Hawaiian)	0.3788	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q31.2	5	137107558	NR	SPOCK1			6695			rs79987496-?	rs79987496	0	79987496	intron_variant	0	NR	2E-7	6.698970004336019	(Native Hawaiian)	1.1521	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4p14	4	36440352	NR	MIR1255B1 - LOC105374400	100313806	105374400		13924	55863	rs80127210-?	rs80127210	0	80127210	intergenic_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.94	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12q21.1	12	72224079	NR	TRHDE			29953			rs11179118-?	rs11179118	0	11179118	intron_variant	0	NR	2E-6	5.698970004336019		0.3063	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q35.2	4	188259805	NR	LOC105377607 - RPL7AP27	105377607	152663		76853	89513	rs112226039-?	rs112226039	0	112226039	intergenic_variant	1	NR	7E-8	7.154901959985743		0.1868	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8p23.3	8	1027436	NR	ERICH1-AS1			619343			rs113660214-?	rs113660214	0	113660214	intron_variant	0	NR	2E-6	5.698970004336019		0.5166	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2p21	2	44833338	NR	LOC105374573 - LOC100130502	105374573	100130502		10938	87742	rs114059891-?	rs114059891	0	114059891	intergenic_variant	1	NR	2E-6	5.698970004336019		0.52	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20p12.3	20	8915129	NR	PLCB1 - LOC105372522	23236	105372522		30218	47070	rs115205687-?	rs115205687	0	115205687	intron_variant	1	NR	1E-6	6.0		0.4923	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	17q25.1	17	73788236	NR	LINC00469, LOC400620			283982, 400620			rs116885154-?	rs116885154	0	116885154	intron_variant	0	NR	4E-7	6.3979400086720375		0.4672	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7p21.3	7	12935930	NR	LOC105375158			105375158			rs11980091-?	rs11980091	0	11980091	intron_variant	0	NR	2E-6	5.698970004336019		0.4696	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	9p21.3	9	23035988	NR	LOC107987055			107987055			rs12375901-?	rs12375901	0	12375901	intron_variant	0	NR	2E-7	6.698970004336019		0.5435	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	19p13.2	19	10879653	NR	CARM1			10498			rs12710258-?	rs12710258	0	12710258	intron_variant	0	NR	6E-7	6.221848749616356		0.1876	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	Xp22.13	X	19186106	NR	ADGRG2 - PDHA1	10149	5160		63150	157787	rs139545172-?	rs139545172	0	139545172	intergenic_variant	1	NR	3E-7	6.522878745280337		0.3328	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	Xq27.3	X	143165510	NR	RN7SKP81 - RN7SKP149	106480858	106479161		74833	31842	rs139618469-?	rs139618469	0	139618469	intergenic_variant	1	NR	4E-7	6.3979400086720375		0.4553	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	13q12.11	13	19216443	NR	PSPC1P1, LOC105370099			642395, 105370099			rs142980497-?	rs142980497	1	2765205	intron_variant	0	NR	8E-7	6.096910013008056		0.143	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10p12.31	10	21405290	NR	RNMTL1P1 - LOC105376445	100420295	105376445		10699	9497	rs143362648-?	rs143362648	0	143362648	intergenic_variant	1	NR	5E-7	6.301029995663981		0.5559	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	6q22.1	6	115097886	NR	LOC105377960 - LOC105377961	105377960	105377961		44406	374622	rs145880548-?	rs145880548	0	145880548	intergenic_variant	1	NR	9E-7	6.045757490560675		0.4797	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3p25.3	3	9988607	NR	EMC3, EMC3-AS1			55831, 442075			rs146559718-?	rs146559718	1	496348	intron_variant	0	NR	1E-6	6.0		0.2043	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q26.31	3	171403444	NR	TNIK			23043			rs150394119-?	rs150394119	0	150394119	intron_variant	0	NR	9E-7	6.045757490560675		0.3226	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	10q25.2	10	112050671	NR	LOC107984268, LOC105378486			107984268, 105378486			rs150400940-?	rs150400940	0	150400940	intergenic_variant	0	NR	7E-7	6.154901959985743		0.3888	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	20p11.21	20	23918358	NR	CST5 - CSTP1	1473	1480		38615	413	rs1741629-?	rs1741629	0	1741629	downstream_gene_variant	1	NR	2E-7	6.698970004336019		0.389	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	19p13.11	19	17184193	NR	MYO9B			4650			rs188493101-?	rs188493101	0	188493101	intron_variant	0	NR	1E-6	6.0		0.6195	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q32.3	2	193827587	NR	LOC107985834 - LOC105373815	107985834	105373815		96706	122079	rs191228972-?	rs191228972	0	191228972	intergenic_variant	1	NR	1E-6	6.0		0.6347	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	21q22.11	21	31028811	NR	LOC105372775 - LOC105372774	105372775	105372774		9621	1284	rs28456019-?	rs28456019	0	28456019	intergenic_variant	1	NR	1E-6	6.0		0.1685	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7q11.23	7	76307732	NR	HSPB1 - YWHAG	3315	7532		3435	19059	rs2908197-?	rs2908197	0	2908197	downstream_gene_variant	1	NR	2E-6	5.698970004336019		0.1227	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	18q22.3	18	71607335	NR	LOC107985179			107985179			rs35815903-?	rs35815903	0	35815903	intergenic_variant	0	NR	3E-7	6.522878745280337		0.3674	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q24	4	103999322	NR	LOC105377349			105377349			rs41427747-?	rs41427747	0	41427747	intron_variant	0	NR	6E-7	6.221848749616356		0.3337	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2q22.1	2	141414797	NR	LRP1B			53353			rs4954702-?	rs4954702	0	4954702	intron_variant	0	NR	1E-6	6.0		0.1077	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	12q15	12	69004009	NR	CPM - LOC107984471	1368	107984471		40769	3650	rs57514780-?	rs57514780	0	57514780	intergenic_variant	1	NR	1E-7	7.0		0.3512	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q29	3	195192301	NR	XXYLT1			152002			rs57827131-?	rs57827131	0	57827131	intron_variant	0	NR	1E-6	6.0		0.2498	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q35.1	5	172111740	NR	STK10			6793			rs60188314-?	rs60188314	0	60188314	intron_variant	0	NR	1E-6	6.0		0.4404	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8q24.23	8	138596475	NR	COL22A1			169044			rs61496269-?	rs61496269	0	61496269	intron_variant	0	NR	2E-6	5.698970004336019		0.397	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5q34	5	162680373	NR	LOC105377698 - ARL2BPP5	105377698	100874420		19442	81460	rs6874604-?	rs6874604	0	6874604	intergenic_variant	1	NR	2E-7	6.698970004336019		0.4952	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	14q32.32	14	103210903	NR	LINC00605 - RPL21P13	100131366	319144		21875	30549	rs71417845-?	rs71417845	0	71417845	downstream_gene_variant	1	NR	1E-6	6.0		0.52	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2p14	2	67026490	NR	LOC105374785 - LOC102800447	105374785	102800447		10021	59956	rs72904859-?	rs72904859	0	72904859	intergenic_variant	1	NR	4E-7	6.3979400086720375		0.4346	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q24	3	147808253	NR	LOC102724145 - LOC100507461	102724145	100507461		49492	269906	rs72995528-?	rs72995528	0	72995528	intergenic_variant	1	NR	6E-7	6.221848749616356		0.5172	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3p26.1	3	7878962	NR	GRM7 - LOC101927394	2917	101927394		135930	73843	rs73130949-?	rs73130949	0	73130949	intergenic_variant	1	NR	2E-6	5.698970004336019		0.5089	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q25.1	3	151426056	NR	MED12L			116931			rs73869064-?	rs73869064	0	73869064	intron_variant	0	NR	5E-7	6.301029995663981		0.3537	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	4q31.23	4	148653597	NR	LOC107986195, LOC105377483			107986195, 105377483			rs75764011-?	rs75764011	0	75764011	intergenic_variant	0	NR	3E-7	6.522878745280337		0.2708	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	5p15.33	5	2664364	NR	LOC100506858 - LOC107986398	100506858	107986398		352163	32810	rs75778424-?	rs75778424	0	75778424	intergenic_variant	1	NR	2E-6	5.698970004336019		0.3107	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	8p21.3	8	20091687	NR	LOC105379311			105379311			rs77913157-?	rs77913157	0	77913157	intron_variant	0	NR	6E-7	6.221848749616356		0.352	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	11q22.3	11	104170883	NR	PDGFD - RNA5SP348	80310	100873610		6584	81696	rs7930114-?	rs7930114	0	7930114	intergenic_variant	1	NR	2E-6	5.698970004336019		0.4242	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	19q13.42	19	55662011	NR	U2AF2			11338			rs79546472-?	rs79546472	0	79546472	non_coding_transcript_exon_variant	0	NR	1E-6	6.0		0.375	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	3q29	3	195429768	NR	ACAP2			23527			rs79900979-?	rs79900979	0	79900979	intron_variant	0	NR	7E-8	7.154901959985743		0.447	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	7q31.32	7	122631261	NR	CADPS2			93664			rs80261602-?	rs80261602	0	80261602	intron_variant	0	NR	1E-6	6.0		0.3507	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	16p13.3	16	2867326	NR	LOC101929566			101929566			rs9925432-?	rs9925432	0	9925432	intron_variant	0	NR	4E-7	6.3979400086720375		0.1098	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-14	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxypropylmercapturic acid levels in smokers	362 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 438 European ancestry current smoker individuals, 449 Latino current smoker individuals, 704 Japanese ancestry current smoker individuals	NA	2p14	2	67015977	NR	LOC105374785			105374785			rs11886159-?	rs11886159	0	11886159	intergenic_variant	0	NR	4E-7	6.3979400086720375		0.4335	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	18q21.1	18	50490517	NR	RPLP0P11 - MAPK4	647094	5596		31658	69264	rs77990856-?	rs77990856	0	77990856	intergenic_variant	1	NR	4E-11	10.397940008672037	(AA)	1.7919	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5q22.3	5	114906794	NR	LOC101927078 - TRIM36	101927078	55521		133381	217968	rs142034933-?	rs142034933	0	142034933	intergenic_variant	1	NR	5E-10	9.301029995663981	(AA)	1.3274	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8p23.1	8	10767736	NR	PINX1, LOC102723313			54984, 102723313			rs13271456-?	rs13271456	0	13271456	intron_variant	0	NR	3E-9	8.522878745280337	(AA)	1.3337	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.2	X	17027288	NR	REPS2			9185			rs143049324-?	rs143049324	0	143049324	intron_variant	0	NR	6E-9	8.221848749616356	(AA)	1.2848	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.11	X	22890680	NR	PTCHD1-AS			100873065			rs73198917-?	rs73198917	0	73198917	intron_variant	0	NR	1E-9	9.0	(AA)	1.5266	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17q25.3	17	79309121	NR	RBFOX3			146713			rs79211555-?	rs79211555	0	79211555	intron_variant	0	NR	3E-9	8.522878745280337	(AA)	1.5956	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p16.3	2	50521617	NR	NRXN1			9378			rs1014667-?	rs1014667	0	1014667	intron_variant	0	NR	9E-8	7.045757490560675	(AA)	1.7115	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.2	X	15234130	NR	LOC102724092			102724092			rs112827279-?	rs112827279	0	112827279	downstream_gene_variant	0	NR	5E-8	7.301029995663981	(AA)	1.0337	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p22.3	2	32021126	NR	DPY30			84661			rs139157003-?	rs139157003	0	139157003	intron_variant	0	NR	7E-8	7.154901959985743	(AA)	1.6118	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4p15.1	4	29168543	NR	LOC102723764 - LOC105374561	102723764	105374561		154059	45741	rs139214349-?	rs139214349	0	139214349	intron_variant	1	NR	1E-8	8.0	(AA)	1.2786	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16q21	16	59753666	NR	DUXAP11 - APOOP5	106481741	644649		97330	466	rs1392502-?	rs1392502	0	1392502	intron_variant	1	NR	1E-8	8.0	(AA)	0.8419	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q37.3	2	238918088	NR	TWIST2 - FLJ43879	117581	401039		7540	1214	rs144363312-?	rs144363312	0	144363312	downstream_gene_variant	1	NR	2E-8	7.698970004336019	(AA)	1.6807	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.32	X	93801889	NR	FAM133A - RNU6-332P	286499	106481284		89615	201926	rs149432766-?	rs149432766	0	149432766	intergenic_variant	1	NR	4E-8	7.3979400086720375	(AA)	1.3762	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.11	X	23322339	NR	PTCHD1-AS - PTCHD1	100873065	139411		29193	12031	rs150798856-?	rs150798856	0	150798856	intergenic_variant	1	NR	8E-8	7.096910013008056	(AA)	1.3265	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	18q12.3	18	44422774	NR	LINC01478			101927921			rs182599614-?	rs182599614	0	182599614	intron_variant	0	NR	7E-8	7.154901959985743	(AA)	1.4306	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq13.1	X	72109657	NR	NHSL2			340527			rs191209518-?	rs191209518	0	191209518	intron_variant	0	NR	3E-8	7.522878745280337	(AA)	1.2269	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8q24.22	8	133627845	NR	ST3GAL1 - LOC105375773	6482	105375773		55391	35916	rs2945731-?	rs2945731	0	2945731	intergenic_variant	1	NR	2E-8	7.698970004336019	(AA)	1.3036	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11p15.1	11	21687041	NR	LOC107984320			107984320			rs34402840-?	rs34402840	0	34402840	intergenic_variant	0	NR	9E-8	7.045757490560675	(AA)	1.5485	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5q11.2	5	58227651	NR	LOC105378983 - LOC105378984	105378983	105378984		8751	162617	rs55966191-?	rs55966191	0	55966191	intergenic_variant	1	NR	9E-8	7.045757490560675	(AA)	0.9971	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16q23.1	16	76430039	NR	CNTNAP4			85445			rs58296637-?	rs58296637	0	58296637	intron_variant	0	NR	2E-8	7.698970004336019	(AA)	1.6165	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8q21.13	8	80550062	NR	ZBTB10 - RPSAP47	65986	389672		23797	8732	rs72689705-?	rs72689705	0	72689705	intergenic_variant	1	NR	5E-8	7.301029995663981	(AA)	0.7981	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.11	X	22417389	NR	PTCHD1-AS			100873065			rs113288656-?	rs113288656	0	113288656	intron_variant	0	NR	2E-7	6.698970004336019	(AA)	1.1184	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16q23.1	16	79006207	NR	WWOX			51741			rs113496184-?	rs113496184	0	113496184	intron_variant	0	NR	2E-7	6.698970004336019	(AA)	1.256	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p12	2	81068213	NR	LOC105374827 - LOC100287912	105374827	100287912		113206	125926	rs113626797-?	rs113626797	0	113626797	intergenic_variant	1	NR	5E-7	6.301029995663981	(AA)	1.4247	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16q23.3	16	82814603	NR	CDH13, LOC101928446			1012, 101928446			rs12598815-?	rs12598815	0	12598815	intron_variant	0	NR	1E-7	7.0	(AA)	1.2435	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	78678436	NR	LOC107985670			107985670			rs139306621-?	rs139306621	0	139306621	intergenic_variant	0	NR	2E-7	6.698970004336019	(AA)	0.9347	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	19q13.2	19	41800015	NR	CEACAM3			1084			rs140520053-?	rs140520053	0	140520053	intron_variant	0	NR	5E-7	6.301029995663981	(AA)	1.6277	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11p13	11	36265280	NR	LDLRAD3 - COMMD9	143458	29099		33144	7012	rs149502810-?	rs149502810	0	149502810	downstream_gene_variant	1	NR	3E-7	6.522878745280337	(AA)	1.9023	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	9q34.11	9	129127015	NR	PPP2R4			5524			rs17481720-?	rs17481720	0	17481720	intron_variant	0	NR	4E-7	6.3979400086720375	(AA)	1.2771	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	19q13.31	19	44401857	NR	ZNF285 - ZNF229	26974	7772		246	24394	rs17657696-?	rs17657696	0	17657696	intron_variant	1	NR	4E-7	6.3979400086720375	(AA)	1.0923	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q11.2	2	100730839	NR	LOC105375310			105375310			rs182466621-?	rs182466621	0	182466621	intergenic_variant	0	NR	2E-7	6.698970004336019	(AA)	1.2926	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p12	2	80930411	NR	LOC105374827			105374827			rs1826411-?	rs1826411	0	1826411	intergenic_variant	0	NR	2E-7	6.698970004336019	(AA)	1.4592	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q24.1	2	154955880	NR	LOC105373696			105373696			rs183369189-?	rs183369189	0	183369189	intergenic_variant	0	NR	2E-7	6.698970004336019	(AA)	0.8502	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp11.3	X	44070843	NR	LOC643167 - EFHC2	643167	80258		39725	75411	rs191792526-?	rs191792526	0	191792526	intergenic_variant	1	NR	4E-7	6.3979400086720375	(AA)	1.4223	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5p15.31	5	9356944	NR	SEMA5A			9037			rs2463505-?	rs2463505	0	2463505	intron_variant	0	NR	3E-7	6.522878745280337	(AA)	1.1143	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6q13	6	73429655	NR	MB21D1			115004			rs311671-?	rs311671	0	311671	intron_variant	0	NR	4E-7	6.3979400086720375	(AA)	0.4928	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5q23.3	5	129188192	NR	LOC102723654			102723654			rs35757618-?	rs35757618	0	35757618	intergenic_variant	0	NR	3E-7	6.522878745280337	(AA)	1.1154	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4q35.1	4	185351567	NR	SNX25			83891			rs61731371-?	rs61731371	0	61731371	synonymous_variant	0	NR	5E-7	6.301029995663981	(AA)	1.4202	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	9p23	9	9142493	NR	PTPRD			5789			rs62529502-?	rs62529502	0	62529502	intron_variant	0	NR	2E-7	6.698970004336019	(AA)	1.2801	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8q24.3	8	142672278	NR	PSCA			8000			rs72690918-?	rs72690918	0	72690918	intron_variant	0	NR	1E-7	7.0	(AA)	1.5694	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16q22.2	16	72171772	NR	PMFBP1			83449			rs72791114-?	rs72791114	0	72791114	5_prime_UTR_variant	0	NR	2E-7	6.698970004336019	(AA)	1.1381	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q25.2	15	81413409	NR	TMC3-AS1			101929655			rs74249803-?	rs74249803	0	74249803	intron_variant	0	NR	4E-7	6.3979400086720375	(AA)	1.8701	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	13q12.12	13	23857670	NR	MIPEP			4285			rs74657221-?	rs74657221	0	74657221	intron_variant	0	NR	1E-7	7.0	(AA)	1.4229	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q33.3	2	206713131	NR	DYTN			391475			rs75358501-?	rs75358501	0	75358501	intron_variant	0	NR	3E-7	6.522878745280337	(AA)	0.8915	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq28	X	154153041	NR	OPN1LW			5956			rs79866052-?	rs79866052	1	5986963	missense_variant	0	NR	2E-7	6.698970004336019	(AA)	0.6455	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	9p23	9	10060843	NR	PTPRD			5789			rs10958852-?	rs10958852	0	10958852	intron_variant	0	NR	2E-6	5.698970004336019	(EA)	0.6831	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11q14.2	11	88441800	NR	LOC101929174 - GRM5-AS1	101929174	100873989		13608	62776	rs11019935-?	rs11019935	0	11019935	intergenic_variant	1	NR	3E-7	6.522878745280337	(EA)	0.7379	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	9q33.3	9	124191361	NR	LOC107987037 - NEK6	107987037	10783		107024	66245	rs111873027-?	rs111873027	0	111873027	intergenic_variant	1	NR	2E-6	5.698970004336019	(EA)	0.9778	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q14.3	2	128919841	NR	LOC101927881 - LOC151121	101927881	151121		51114	322332	rs115944785-?	rs115944785	0	115944785	intergenic_variant	1	NR	2E-6	5.698970004336019	(EA)	0.402	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p14.1	3	68747005	NR	FAM19A4			151647			rs11708245-?	rs11708245	0	11708245	intron_variant	0	NR	1E-7	7.0	(EA)	0.1938	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10p12.31	10	20013643	NR	PLXDC2			84898			rs12218391-?	rs12218391	0	12218391	intron_variant	0	NR	2E-6	5.698970004336019	(EA)	0.2158	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q25.3	10	116258452	NR	GFRA1			2674			rs140018268-?	rs140018268	0	140018268	intron_variant	0	NR	2E-6	5.698970004336019	(EA)	0.6172	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q31.3	2	181451520	NR	LOC101927156 - ITGA4	101927156	3676		51967	5372	rs147084229-?	rs147084229	0	147084229	intergenic_variant	1	NR	8E-7	6.096910013008056	(EA)	0.7441	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16p11.1	16	35616247	NR	C1QL1P1 - KIF18BP1	106480353	642683		40753	22387	rs149133508-?	rs149133508	0	149133508	intergenic_variant	1	NR	5E-7	6.301029995663981	(EA)	1.4324	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q32.3	2	194286481	NR	HNRNPA1P47 - LOC101927406	100287191	101927406		97972	57788	rs150734725-?	rs150734725	0	150734725	intergenic_variant	1	NR	3E-7	6.522878745280337	(EA)	1.3024	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p26.1	3	4751322	NR	EGOT, ITPR1			100126791, 3708			rs17041333-?	rs17041333	0	17041333	non_coding_transcript_exon_variant	0	NR	3E-8	7.522878745280337	(EA)	0.8959	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	7p13	7	44809836	NR	PPIA - LOC105375260	5478	105375260		6713	12158	rs185203327-?	rs185203327	0	185203327	intron_variant	1	NR	8E-7	6.096910013008056	(EA)	0.6381	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4q13.3	4	72634350	NR	ADAMTS3 - HNRNPA1P67	9508	728019		65551	172837	rs189962344-?	rs189962344	0	189962344	intergenic_variant	1	NR	2E-6	5.698970004336019	(EA)	0.9147	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16p11.2	16	35143453	NR	LOC105371197			105371197			rs190542424-?	rs190542424	0	190542424	upstream_gene_variant	0	NR	4E-7	6.3979400086720375	(EA)	1.3492	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10p12.2	10	23782077	NR	KIAA1217			56243			rs192858301-?	rs192858301	0	192858301	intron_variant	0	NR	5E-7	6.301029995663981	(EA)	1.1652	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	20p11.1	20	26102121	NR	FAM182A - NCOR1P1	284800	149934		15204	1295	rs193078978-?	rs193078978	0	193078978	downstream_gene_variant	1	NR	2E-6	5.698970004336019	(EA)	0.3087	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10p14	10	7175017	NR	SFMBT2			57713			rs2497442-?	rs2497442	0	2497442	intron_variant	0	NR	2E-6	5.698970004336019	(EA)	0.9057	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16q24.1	16	86336274	NR	LINC00917			732275			rs2696842-?	rs2696842	0	2696842	intron_variant	0	NR	2E-6	5.698970004336019	(EA)	0.4964	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	7p15.3	7	24474482	NR	LOC107986777 - RNU6-1103P	107986777	106480051		29080	62850	rs28459952-?	rs28459952	0	28459952	intergenic_variant	1	NR	2E-6	5.698970004336019	(EA)	0.4564	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5q35.1	5	171470204	NR	LOC105377721			105377721			rs3097847-?	rs3097847	0	3097847	intergenic_variant	0	NR	1E-6	6.0	(EA)	0.3852	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6q22.33	6	127568185	NR	SOGA3 - C6orf58	387104	352999		48830	8989	rs4897220-?	rs4897220	0	4897220	intron_variant	1	NR	2E-6	5.698970004336019	(EA)	0.1952	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11p15.4	11	4803398	NR	OR52Y1P - OR52R1	81240	119695		9137	35	rs61880854-?	rs61880854	0	61880854	intron_variant	1	NR	5E-7	6.301029995663981	(EA)	0.5055	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p26.1	3	4614354	NR	ITPR1			3708			rs72622154-?	rs72622154	0	72622154	intron_variant	0	NR	3E-6	5.522878745280337	(EA)	0.3942	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17q11.2	17	33158862	NR	ASIC2			40			rs72819126-?	rs72819126	0	72819126	intron_variant	0	NR	1E-6	6.0	(EA)	0.5993	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3q23	3	140147632	NR	CLSTN2			64084			rs76347219-?	rs76347219	0	76347219	intron_variant	0	NR	7E-7	6.154901959985743	(EA)	0.9717	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	1p21.3	1	96910288	NR	PTBP2 - DPYD	58155	1806		95239	167455	rs76620758-?	rs76620758	0	76620758	intergenic_variant	1	NR	2E-6	5.698970004336019	(EA)	0.6556	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	13q33.3	13	108904171	NR	MYO16			23026			rs78553789-?	rs78553789	0	78553789	intron_variant	0	NR	6E-7	6.221848749616356	(EA)	0.6956	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4p15.1	4	30256624	NR	LOC100130674 - PCDH7	100130674	5099		248273	463754	rs80205050-?	rs80205050	0	80205050	intergenic_variant	1	NR	6E-7	6.221848749616356	(EA)	0.7611	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q26.3	15	98618223	NR	FAM169B - IRAIN	283777	104472848		103841	27640	rs8035887-?	rs8035887	0	8035887	intergenic_variant	1	NR	4E-7	6.3979400086720375	(EA)	0.6866	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA				NR							GA012297-?	GA012297	0			1	NR	4E-7	6.3979400086720375	(Japanese)	0.6818	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11p11.2	11	48152460	NR	PTPRJ			5795			rs10838809-?	rs10838809	0	10838809	intron_variant	0	NR	3E-6	5.522878745280337	(Japanese)	0.3947	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q26.1	15	92188429	NR	SLCO3A1 - LOC107987227	28232	107987227		15994	88573	rs11074046-?	rs11074046	0	11074046	intron_variant	1	NR	2E-6	5.698970004336019	(Japanese)	0.4693	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4q28.1	4	123994124	NR	LINC01091 - LOC105377407	285419	105377407		63761	37985	rs112000748-?	rs112000748	0	112000748	intergenic_variant	1	NR	1E-6	6.0	(Japanese)	0.2719	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3q29	3	195864852	NR	TNK2			10188			rs114951929-?	rs114951929	0	114951929	intron_variant	0	NR	5E-7	6.301029995663981	(Japanese)	0.7627	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6q21	6	110815877	NR	AMD1, CDK19			262, 23097			rs117178387-?	rs117178387	0	117178387	non_coding_transcript_exon_variant	0	NR	1E-6	6.0	(Japanese)	0.5797	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	12p12.3	12	16026437	NR	DERA			51071			rs12423382-?	rs12423382	0	12423382	intron_variant	0	NR	3E-6	5.522878745280337	(Japanese)	0.487	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q25.2	15	84680172	NR	SEC11A			23478			rs12440825-?	rs12440825	0	12440825	intron_variant	0	NR	1E-6	6.0	(Japanese)	0.6862	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17q24.2	17	68578976	NR	FAM20A, LOC105371873			54757, 105371873			rs12453524-?	rs12453524	0	12453524	intron_variant	0	NR	4E-6	5.3979400086720375	(Japanese)	0.6306	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q36.3	2	228861490	NR	RPL7L1P10 - RPL17P14	106480729	100270941		107704	142396	rs12996281-?	rs12996281	0	12996281	intron_variant	1	NR	1E-6	6.0	(Japanese)	0.5723	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p14.2	3	63251134	NR	SYNPR			132204			rs13098482-?	rs13098482	0	13098482	intron_variant	0	NR	4E-7	6.3979400086720375	(Japanese)	0.683	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p23.1	2	30275787	NR	LBH - LOC102723594	81606	102723594		15754	17248	rs13406665-?	rs13406665	0	13406665	intron_variant	1	NR	3E-6	5.522878745280337	(Japanese)	0.4538	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	18q21.33	18	63326888	NR	BCL2 - KDSR	596	2531		7110	848	rs139419907-?	rs139419907	0	139419907	downstream_gene_variant	1	NR	3E-6	5.522878745280337	(Japanese)	0.762	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6q21	6	110625136	NR	CDK19			23097			rs139429326-?	rs139429326	0	139429326	intron_variant	0	NR	2E-6	5.698970004336019	(Japanese)	0.5905	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6q27	6	166915656	NR	RPS6KA2-AS1 - RNASET2	100861523	8635		10587	13853	rs143050142-?	rs143050142	0	143050142	intron_variant	1	NR	8E-7	6.096910013008056	(Japanese)	0.9785	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17q24.2	17	68350415	NR	ARSG			22901			rs143323161-?	rs143323161	0	143323161	intron_variant	0	NR	3E-6	5.522878745280337	(Japanese)	0.6027	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	20q13.33	20	62315753	NR	LAMA5			3911			rs147619472-?	rs147619472	0	147619472	intron_variant	0	NR	4E-6	5.3979400086720375	(Japanese)	0.6915	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10p13	10	12440908	NR	CAMK1D			57118			rs147729365-?	rs147729365	0	147729365	intron_variant	0	NR	4E-7	6.3979400086720375	(Japanese)	0.7133	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3q22.1	3	132145292	NR	CPNE4			131034			rs148258131-?	rs148258131	0	148258131	intron_variant	0	NR	2E-6	5.698970004336019	(Japanese)	0.7519	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q13.1	15	28515160	NR	ABCB10P4 - GOLGA8G	100132289	283768		6367	4451	rs150848999-?	rs150848999	0	150848999	downstream_gene_variant	1	NR	4E-6	5.3979400086720375	(Japanese)	0.2222	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10p11.1	10	38472310	NR	SEPT14P10 - LOC107984177	107105352	107984177		12048	6937	rs180858466-?	rs180858466	0	180858466	intergenic_variant	1	NR	3E-6	5.522878745280337	(Japanese)	0.8521	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3q29	3	196101256	NR	TFRC - LINC00885	7037	401109		19095	41380	rs181104541-?	rs181104541	0	181104541	intergenic_variant	1	NR	2E-6	5.698970004336019	(Japanese)	0.542	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16p11.2	16	32866115	NR	LOC107984808 - BCAP31P2	107984808	100194426		7172	3868	rs1820772-?	rs1820772	0	1820772	upstream_gene_variant	1	NR	2E-7	6.698970004336019	(Japanese)	0.6803	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8q12.2	8	60680319	NR	CHD7			55636			rs187025166-?	rs187025166	0	187025166	intron_variant	0	NR	4E-6	5.3979400086720375	(Japanese)	0.8255	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17p12	17	14811500	NR	LOC105371545 - LOC107984977	105371545	107984977		9227	23127	rs189798510-?	rs189798510	0	189798510	intergenic_variant	1	NR	2E-7	6.698970004336019	(Japanese)	0.5677	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6p25.1	6	6911218	NR	LOC105374902 - RN7SL554P	105374902	106479423		12650	27388	rs2249382-?	rs2249382	0	2249382	intron_variant	1	NR	1E-7	7.0	(Japanese)	0.298	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	18q12.2	18	37505770	NR	CELF4			56853			rs41475954-?	rs41475954	0	41475954	intron_variant	0	NR	1E-6	6.0	(Japanese)	0.4614	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p25.1	2	9601406	NR	YWHAQ			10971			rs55883249-?	rs55883249	0	55883249	intron_variant	0	NR	2E-7	6.698970004336019	(Japanese)	0.6204	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q23.31	10	90392443	NR	LOC105378426 - LOC101926942	105378426	101926942		215738	10078	rs58616815-?	rs58616815	0	58616815	intergenic_variant	1	NR	2E-6	5.698970004336019	(Japanese)	0.3566	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	18p11.21	18	13298944	NR	LDLRAD4			753			rs62097350-?	rs62097350	0	62097350	intron_variant	0	NR	2E-6	5.698970004336019	(Japanese)	0.3644	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q25.1	15	79635252	NR	LOC390617 - LOC390618	390617	390618		74579	32937	rs7177026-?	rs7177026	0	7177026	intergenic_variant	1	NR	3E-6	5.522878745280337	(Japanese)	0.1442	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17q24.3	17	70210256	NR	KCNJ2 - CALM2P1	3759	100128390		30212	31051	rs72863877-?	rs72863877	0	72863877	intergenic_variant	1	NR	2E-6	5.698970004336019	(Japanese)	0.7501	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	13q14.3	13	54019582	NR	LINC00558 - LINC00458	100861552	100507428		143463	104742	rs73197788-?	rs73197788	0	73197788	intergenic_variant	1	NR	2E-6	5.698970004336019	(Japanese)	0.7369	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	14q32.12	14	93970393	NR	ASB2			51676			rs79797842-?	rs79797842	0	79797842	intron_variant	0	NR	5E-9	8.301029995663981	(Japanese)	0.9475	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11p15.1	11	20492179	NR	PRMT3			10196			rs80315173-?	rs80315173	0	80315173	intron_variant	0	NR	4E-7	6.3979400086720375	(Japanese)	0.6257	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17q25.3	17	82284247	NR	CSNK1D - LOC101929511	1453	101929511		10505	5799	rs8072599-?	rs8072599	0	8072599	intergenic_variant	1	NR	2E-6	5.698970004336019	(Japanese)	0.7355	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p24.3	3	22972467	NR	RANP7 - SALL4P5	100874192	100130785		67129	17274	rs822203-?	rs822203	0	822203	intergenic_variant	1	NR	3E-6	5.522878745280337	(Japanese)	0.1429	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q25.3	15	84833784	NR	ALPK3			57538			rs891288-?	rs891288	0	891288	intron_variant	0	NR	6E-7	6.221848749616356	(Japanese)	0.7142	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	18p11.31	18	7172525	NR	SLC25A51P2 - LRRC30	645423	339291		36644	58614	rs9675861-?	rs9675861	0	9675861	intergenic_variant	1	NR	1E-6	6.0	(Japanese)	0.395	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4q35.2	4	188094248	NR	TRIML2			205860			rs10031466-?	rs10031466	0	10031466	intron_variant	0	NR	1E-6	6.0	(Latino)	0.2396	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5q21.3	5	106409915	NR	RNA5SP189 - LOC345571	100873451	345571		486807	6184	rs111346824-?	rs111346824	0	111346824	intergenic_variant	1	NR	3E-6	5.522878745280337	(Latino)	0.8801	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	13q14.11	13	40214229	NR	LINC00548			400123			rs111834582-?	rs111834582	0	111834582	intron_variant	0	NR	3E-6	5.522878745280337	(Latino)	1.2451	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p14.3	3	58470270	NR	PDHB - LOC107986092	5162	107986092		36418	1104	rs112208829-?	rs112208829	0	112208829	intergenic_variant	1	NR	3E-6	5.522878745280337	(Latino)	1.0368	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8q22.1	8	95280875	NR	C8orf37-AS1			100616530			rs112505062-?	rs112505062	0	112505062	intron_variant	0	NR	4E-6	5.3979400086720375	(Latino)	0.3738	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	21q21.1	21	18756591	NR	LOC101927797			101927797			rs112643338-?	rs112643338	0	112643338	intron_variant	0	NR	4E-6	5.3979400086720375	(Latino)	1.1442	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p15	2	61424393	NR	USP34			9736			rs115219852-?	rs115219852	0	115219852	intron_variant	0	NR	7E-7	6.154901959985743	(Latino)	1.184	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	13q21.31	13	62709905	NR	LINC00448			100874176			rs116571008-?	rs116571008	0	116571008	intron_variant	0	NR	7E-7	6.154901959985743	(Latino)	1.0121	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	18q23	18	79412316	NR	NFATC1			4772			rs116989867-?	rs116989867	0	116989867	intron_variant	0	NR	2E-6	5.698970004336019	(Latino)	1.4136	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q25.3	15	86265638	NR	AGBL1			123624			rs11858486-?	rs11858486	0	11858486	intron_variant	0	NR	4E-6	5.3979400086720375	(Latino)	0.3081	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	12q24.22	12	117495695	NR	KSR2			283455			rs137949660-?	rs137949660	0	137949660	intron_variant	0	NR	1E-6	6.0	(Latino)	0.9133	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq26.3	X	134944139	NR	RNU6-616P - LOC340581	106479838	340581		25723	5410	rs137986605-?	rs137986605	0	137986605	intergenic_variant	1	NR	8E-8	7.096910013008056	(Latino)	0.6545	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq26.3	X	136051802	NR	SLC9A6 - GAPDHP67	10479	2609		4533	26075	rs150889544-?	rs150889544	0	150889544	downstream_gene_variant	1	NR	3E-6	5.522878745280337	(Latino)	0.8548	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q22.3	2	146327302	NR	LOC105373667			105373667			rs16855418-?	rs16855418	0	16855418	intergenic_variant	0	NR	4E-6	5.3979400086720375	(Latino)	0.8124	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	21q22.13	21	37299116	NR	DSCR3 - DYRK1A	10311	1859		30992	66674	rs16994935-?	rs16994935	0	16994935	intergenic_variant	1	NR	2E-6	5.698970004336019	(Latino)	0.6174	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17q11.2	17	28927882	NR	PHF12, LOC101927018			57649, 101927018			rs184910283-?	rs184910283	0	184910283	intron_variant	0	NR	3E-6	5.522878745280337	(Latino)	1.0577	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4p14	4	39250206	NR	WDR19			57728			rs185013096-?	rs185013096	1	13435366	intron_variant	0	NR	2E-6	5.698970004336019	(Latino)	0.9424	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8q24.11	8	117639150	NR	LOC105375721			105375721			rs189087047-?	rs189087047	0	189087047	intergenic_variant	0	NR	3E-6	5.522878745280337	(Latino)	1.3249	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11q13.4	11	71813131	NR	ALG1L9P			285407			rs190164515-?	rs190164515	0	190164515	intron_variant	0	NR	4E-6	5.3979400086720375	(Latino)	0.7365	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	14q31.1	14	81564777	NR	SEL1L - LINC01467	6400	101928559		30913	40570	rs190480000-?	rs190480000	0	190480000	intergenic_variant	1	NR	1E-6	6.0	(Latino)	0.9245	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	7q22.3	7	107652218	NR	LOC105375443 - SLC26A4-AS1	105375443	286002		6876	4298	rs2395909-?	rs2395909	0	2395909	downstream_gene_variant	1	NR	2E-6	5.698970004336019	(Latino)	0.2462	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q32.1	2	183628013	NR	CACYBPP2 - LOC105373775	644877	105373775		19894	421221	rs34395537-?	rs34395537	0	34395537	intergenic_variant	1	NR	3E-7	6.522878745280337	(Latino)	1.3226	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q25.1	10	107773994	NR	LOC101927573 - LINC01435	101927573	103695365		60482	97582	rs4285805-?	rs4285805	0	4285805	intron_variant	1	NR	3E-6	5.522878745280337	(Latino)	0.2418	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	9p24.1	9	8897187	NR	PTPRD			5789			rs60250264-?	rs60250264	0	60250264	intron_variant	0	NR	2E-6	5.698970004336019	(Latino)	1.3059	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q11.2	2	100975599	NR	NPAS2, LOC101927142			4862, 101927142			rs60866311-?	rs60866311	0	60866311	non_coding_transcript_exon_variant	0	NR	9E-7	6.045757490560675	(Latino)	0.7469	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p21	2	47009297	NR	TTC7A			57217			rs61571577-?	rs61571577	0	61571577	intron_variant	0	NR	5E-7	6.301029995663981	(Latino)	1.1768	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q22.3	2	144303564	NR	GTDC1			79712			rs62169186-?	rs62169186	0	62169186	intron_variant	0	NR	3E-6	5.522878745280337	(Latino)	0.7196	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	7p14.1	7	43187042	NR	HECW1			23072			rs73099645-?	rs73099645	0	73099645	intron_variant	0	NR	1E-6	6.0	(Latino)	0.6507	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p12	2	82125373	NR	RN7SL201P - RNU6-685P	106481830	106479868		157999	143239	rs73939615-?	rs73939615	0	73939615	intergenic_variant	1	NR	1E-6	6.0	(Latino)	1.2363	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p16.1	2	55798738	NR	LOC107985811 - EFEMP1	107985811	2202		25819	67224	rs74760234-?	rs74760234	0	74760234	intergenic_variant	1	NR	4E-7	6.3979400086720375	(Latino)	1.2083	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	14q24.2	14	72756121	NR	DPF3			8110			rs75575287-?	rs75575287	0	75575287	intron_variant	0	NR	3E-6	5.522878745280337	(Latino)	1.0865	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q14.3	2	128271828	NR	HS6ST1			9394			rs7561107-?	rs7561107	0	7561107	intron_variant	0	NR	3E-6	5.522878745280337	(Latino)	1.0082	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q25.2	10	112626980	NR	VTI1A			143187			rs76124550-?	rs76124550	0	76124550	intron_variant	0	NR	1E-6	6.0	(Latino)	1.0661	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5p13.2	5	35441618	NR	PRLR - SPEF2	5618	79925		211029	176155	rs76632111-?	rs76632111	0	76632111	intergenic_variant	1	NR	7E-9	8.154901959985743	(Latino)	1.2071	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4p16.2	4	4677180	NR	STX18-AS1			100507266			rs7675915-?	rs7675915	0	7675915	intron_variant	0	NR	3E-8	7.522878745280337	(Latino)	0.6309	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p23.1	2	30763879	NR	CAPN13			92291			rs78355147-?	rs78355147	0	78355147	intron_variant	0	NR	5E-7	6.301029995663981	(Latino)	0.9913	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	13q21.31	13	62933349	NR	LOC105370234 - LINC00376	105370234	104355293		21804	249752	rs79340079-?	rs79340079	0	79340079	intergenic_variant	1	NR	3E-6	5.522878745280337	(Latino)	0.8904	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6p24.3	6	8664924	NR	LOC100506207			100506207			rs80011011-?	rs80011011	0	80011011	intergenic_variant	0	NR	3E-7	6.522878745280337	(Latino)	1.3328	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8q24.22	8	132904554	NR	TG			7038			rs80018415-?	rs80018415	0	80018415	intron_variant	0	NR	8E-7	6.096910013008056	(Latino)	0.6193	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q25.1	10	106655006	NR	SORCS1, LOC105378473			114815, 105378473			rs978571-?	rs978571	0	978571	intron_variant	0	NR	3E-6	5.522878745280337	(Latino)	0.7898	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	17q21.2	17	40882989	NR	LOC105371777, KRT20			105371777, 54474			rs9912181-?	rs9912181	0	9912181	intron_variant	0	NR	2E-6	5.698970004336019	(Latino)	0.6894	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10p14	10	7028608	NR	LOC105376387			105376387			rs9943451-?	rs9943451	0	9943451	regulatory_region_variant	0	NR	3E-6	5.522878745280337	(Latino)	1.1339	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p24.1	2	19581401	NR	LOC105373460 - LOC105373459	105373460	105373459		60501	6719	rs10856789-?	rs10856789	0	10856789	intergenic_variant	1	NR	1E-7	7.0	(Native Hawaiian)	1.1678	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	21q22.3	21	46298882	NR	YBEY			54059			rs112591243-?	rs112591243	0	112591243	downstream_gene_variant	0	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.6857	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11q12.1	11	58564369	NR	LPXN			9404			rs112960054-?	rs112960054	0	112960054	intron_variant	0	NR	1E-6	6.0	(Native Hawaiian)	0.6103	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11q12.1	11	58315137	NR	OR10Q2P - OR5BC1P	81345	81208		22366	2503	rs113196862-?	rs113196862	0	113196862	downstream_gene_variant	1	NR	7E-7	6.154901959985743	(Native Hawaiian)	0.6231	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q26.2	10	126973570	NR	DOCK1			1793			rs115536975-?	rs115536975	0	115536975	intron_variant	0	NR	3E-7	6.522878745280337	(Native Hawaiian)	1.0725	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6p21.1	6	45633613	NR	RUNX2			860			rs117787235-?	rs117787235	0	117787235	intron_variant	0	NR	2E-6	5.698970004336019	(Native Hawaiian)	0.679	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11q23.3	11	119749203	NR	LOC102724301 - LOC390255	102724301	390255		9580	72009	rs117807646-?	rs117807646	0	117807646	intergenic_variant	1	NR	4E-6	5.3979400086720375	(Native Hawaiian)	0.7472	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6q21	6	108441002	NR	LACE1			246269			rs117914390-?	rs117914390	0	117914390	intron_variant	0	NR	4E-6	5.3979400086720375	(Native Hawaiian)	1.2612	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	9q22.32	9	94595859	NR	FBP2 - FBP1	8789	2203		2027	7274	rs117926975-?	rs117926975	0	117926975	upstream_gene_variant	1	NR	2E-6	5.698970004336019	(Native Hawaiian)	1.202	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp11.1	X	58297412	NR	KRT8P17 - LOC653588	392479	653588		311081	4481711	rs12854631-?	rs12854631	0	12854631	intergenic_variant	1	NR	1E-6	6.0	(Native Hawaiian)	0.8076	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.13	X	18194062	NR	BEND2			139105			rs137948999-?	rs137948999	0	137948999	intron_variant	0	NR	4E-6	5.3979400086720375	(Native Hawaiian)	0.8279	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq22.3	X	106804838	NR	TBC1D8B			54885			rs140267713-?	rs140267713	0	140267713	intron_variant	0	NR	2E-6	5.698970004336019	(Native Hawaiian)	0.8404	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq22.1	X	100959983	NR	LOC286453 - ARL13A	286453	392509		2447	9028	rs140386998-?	rs140386998	0	140386998	downstream_gene_variant	1	NR	6E-7	6.221848749616356	(Native Hawaiian)	0.7379	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.33	X	4117086	NR	RPL24P9 - LOC101928201	100129487	101928201		163480	510114	rs143011308-?	rs143011308	0	143011308	intergenic_variant	1	NR	4E-7	6.3979400086720375	(Native Hawaiian)	0.8601	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq22.3	X	106254643	NR	MUM1L1 - LOC107178920	139221	107178920		45682	72789	rs144773023-?	rs144773023	0	144773023	intergenic_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.8408	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	78206936	NR	LOC107985669			107985669			rs146228471-?	rs146228471	1	5913653	intergenic_variant	0	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.832	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.31	X	91548679	NR	PABPC5 - SERBP1P4	140886	100132591		110095	11759	rs146414513-?	rs146414513	0	146414513	intergenic_variant	1	NR	7E-7	6.154901959985743	(Native Hawaiian)	0.8791	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.31	X	7839126	NR	STS - VCX	412	26609		484483	3136	rs146514374-?	rs146514374	0	146514374	upstream_gene_variant	1	NR	1E-7	7.0	(Native Hawaiian)	1.0285	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	14q21.3	14	50173277	NR	SOS2			6655			rs147168872-?	rs147168872	0	147168872	intron_variant	0	NR	9E-7	6.045757490560675	(Native Hawaiian)	1.1117	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	79047973	NR	P2RY10 - P2RY10P2	27334	449518		84246	36955	rs147428850-?	rs147428850	0	147428850	intergenic_variant	1	NR	8E-7	6.096910013008056	(Native Hawaiian)	0.8192	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16p13.2	16	10278663	NR	LOC105371078 - ATF7IP2	105371078	80063		26020	107392	rs147774538-?	rs147774538	0	147774538	regulatory_region_variant	1	NR	4E-6	5.3979400086720375	(Native Hawaiian)	1.0415	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp11.22	X	54017674	NR	PHF8			23133			rs148215758-?	rs148215758	0	148215758	synonymous_variant	0	NR	2E-7	6.698970004336019	(Native Hawaiian)	1.1057	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p14.3	3	54463747	NR	CACNA2D3			55799			rs149422347-?	rs149422347	0	149422347	intron_variant	0	NR	2E-6	5.698970004336019	(Native Hawaiian)	1.482	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	15q22.2	15	60395052	NR	ANXA2			302			rs16942556-?	rs16942556	0	16942556	intron_variant	0	NR	3E-6	5.522878745280337	(Native Hawaiian)	1.1184	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp22.33	X	4330060	NR	RPL24P9 - LOC101928201	100129487	101928201		376454	297140	rs17219051-?	rs17219051	0	17219051	intergenic_variant	1	NR	6E-7	6.221848749616356	(Native Hawaiian)	0.8015	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	6p12.3	6	48448376	NR	RBMXP1 - LOC107986602	3186	107986602		233407	76058	rs180781551-?	rs180781551	0	180781551	intergenic_variant	1	NR	6E-7	6.221848749616356	(Native Hawaiian)	1.2508	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.31	X	91399614	NR	LOC107985700 - PABPC5-AS1	107985700	102724167		85328	15289	rs181551482-?	rs181551482	0	181551482	intergenic_variant	1	NR	4E-6	5.3979400086720375	(Native Hawaiian)	0.7179	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	79674625	NR	LOC105373282 - TBX22	105373282	50945		220637	340105	rs181869920-?	rs181869920	0	181869920	intergenic_variant	1	NR	9E-11	10.045757490560675	(Native Hawaiian)	1.3873	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq13.1	X	71404945	NR	TAF1			6872			rs182705894-?	rs182705894	0	182705894	intron_variant	0	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.8778	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp11.21	X	56034817	NR	KLF8			11279			rs183056377-?	rs183056377	0	183056377	intergenic_variant	0	NR	4E-7	6.3979400086720375	(Native Hawaiian)	0.8009	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q23.3	2	153086712	NR	LOC105373691 - ATP5F1P4	105373691	100422514		58426	72226	rs186826000-?	rs186826000	0	186826000	intergenic_variant	1	NR	3E-7	6.522878745280337	(Native Hawaiian)	1.2654	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q21.2	10	59770640	NR	MRLN - CCDC6	100507027	8030		17195	18107	rs187296392-?	rs187296392	0	187296392	intergenic_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	1.1487	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	78854563	NR	RPL7P54 - MIR4328	100271146	100422932		90589	46631	rs188085108-?	rs188085108	0	188085108	regulatory_region_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.7341	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p11.1	3	90405245	NR	HSPE1P19 - LOC101930420	106481675	101930420		143537	968377	rs189894228-?	rs189894228	0	189894228	intergenic_variant	1	NR	1E-6	6.0	(Native Hawaiian)	1.0929	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	76826573	NR	MIR325HG			101928469			rs191870197-?	rs191870197	0	191870197	intron_variant	0	NR	1E-6	6.0	(Native Hawaiian)	0.9067	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	14q13.1	14	34027246	NR	LOC102724945			102724945			rs191936903-?	rs191936903	0	191936903	intron_variant	0	NR	3E-6	5.522878745280337	(Native Hawaiian)	1.1003	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq13.3	X	76601629	NR	MAGEE1 - RNA5SP508	57692	100873559		170276	53380	rs192657641-?	rs192657641	1	5938601	intergenic_variant	1	NR	1E-6	6.0	(Native Hawaiian)	0.9198	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	13q21.32	13	66468960	NR	PCDH9			5101			rs2027099-?	rs2027099	0	2027099	intron_variant	0	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.2073	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16p13.11	16	16542330	NR	LOC100133127 - LOC441750	100133127	441750		495	410173	rs2316394-?	rs2316394	0	2316394	upstream_gene_variant	1	NR	4E-7	6.3979400086720375	(Native Hawaiian)	1.283	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	77090709	NR	LOC105373254 - LOC100130843	105373254	100130843		9504	283503	rs4644421-?	rs4644421	0	4644421	intergenic_variant	1	NR	1E-6	6.0	(Native Hawaiian)	0.9434	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	7q36.3	7	157441725	NR	DNAJB6 - LOC101927914	10049	101927914		24286	24506	rs4716734-?	rs4716734	0	4716734	intergenic_variant	1	NR	2E-6	5.698970004336019	(Native Hawaiian)	0.5754	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	7q21.11	7	82372901	NR	CACNA2D1			781			rs4732446-?	rs4732446	0	4732446	intron_variant	0	NR	5E-6	5.301029995663981	(Native Hawaiian)	1.0501	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xp11.3	X	44460694	NR	EFHC2 - LOC100533618	80258	100533618		117017	6755	rs55952756-?	rs55952756	0	55952756	intergenic_variant	1	NR	2E-6	5.698970004336019	(Native Hawaiian)	0.7218	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	79276916	NR	LOC107985690 - KIF4CP	107985690	347363		26820	46383	rs5912268-?	rs5912268	0	5912268	intergenic_variant	1	NR	9E-7	6.045757490560675	(Native Hawaiian)	0.8072	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq22.3	X	106354763	NR	LOC107178920 - LOC105373306	107178920	105373306		25073	110511	rs5916984-?	rs5916984	0	5916984	intergenic_variant	1	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.8342	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq13.3	X	76197175	NR	PBDC1 - LOC100216356	51260	100216356		18865	25462	rs5937507-?	rs5937507	0	5937507	intergenic_variant	1	NR	2E-8	7.698970004336019	(Native Hawaiian)	1.2018	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq13.3	X	76414569	NR	LDHBP2 - MAGEE1	3947	57692		78659	13084	rs5938548-?	rs5938548	0	5938548	intergenic_variant	1	NR	2E-7	6.698970004336019	(Native Hawaiian)	1.0852	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq24	X	119130439	NR	KIAA1210			57481			rs5957117-?	rs5957117	0	5957117	intron_variant	0	NR	6E-7	6.221848749616356	(Native Hawaiian)	0.9688	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq25	X	128918288	NR	RPL32P35 - LOC392539	100271393	392539		79447	122236	rs5975063-?	rs5975063	0	5975063	intergenic_variant	1	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.9373	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3q11.1	3	93972003	NR	PROS1			5627			rs60136336-?	rs60136336	0	60136336	intron_variant	0	NR	2E-6	5.698970004336019	(Native Hawaiian)	0.7505	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	20q13.12	20	45661494	NR	WFDC11			259239			rs6065855-?	rs6065855	0	6065855	intron_variant	0	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.6644	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16p13.3	16	1434454	NR	LOC105371045, CCDC154			105371045, 645811			rs61743495-?	rs61743495	0	61743495	missense_variant	0	NR	3E-6	5.522878745280337	(Native Hawaiian)	0.9229	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq21.1	X	78340040	NR	CYSLTR1 - HMGN1P34	10800	100874447		12349	179553	rs62612828-?	rs62612828	0	62612828	intergenic_variant	1	NR	1E-6	6.0	(Native Hawaiian)	0.9761	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4p14	4	37660910	NR	RELL1			768211			rs6531565-?	rs6531565	0	6531565	intron_variant	0	NR	6E-7	6.221848749616356	(Native Hawaiian)	0.5136	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q26.3	10	132408041	NR	PWWP2B			170394			rs74383458-?	rs74383458	0	74383458	intron_variant	0	NR	4E-6	5.3979400086720375	(Native Hawaiian)	0.9327	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p26.3	3	751144	NR	LINC01266			101927215			rs74427637-?	rs74427637	0	74427637	intron_variant	0	NR	2E-6	5.698970004336019	(Native Hawaiian)	1.2837	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	7q21.12	7	87244761	NR	TMEM243 - TP53TG1	79161	11257		24158	80586	rs74464075-?	rs74464075	0	74464075	intergenic_variant	1	NR	1E-6	6.0	(Native Hawaiian)	1.3228	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	Xq11.1	X	62727259	NR	KRT8P17 - LOC653588	392479	653588		4740928	51864	rs7473757-?	rs7473757	0	7473757	intergenic_variant	1	NR	4E-6	5.3979400086720375	(Native Hawaiian)	0.7668	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	14q32.33	14	105261860	NR	BRF1			2972			rs76752037-?	rs76752037	0	76752037	intron_variant	0	NR	5E-6	5.301029995663981	(Native Hawaiian)	0.826	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10q22.1	10	69881082	NR	COL13A1			1305			rs77040403-?	rs77040403	0	77040403	intron_variant	0	NR	4E-6	5.3979400086720375	(Native Hawaiian)	0.7427	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	21q21.1	21	16189964	NR	MIR99AHG			388815			rs78211511-?	rs78211511	0	78211511	intron_variant	0	NR	3E-7	6.522878745280337	(Native Hawaiian)	1.0443	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5q13.3	5	74359173	NR	LINC01333 - LINC01331	101929082	104310351		30816	10203	rs80337801-?	rs80337801	0	80337801	intergenic_variant	1	NR	3E-7	6.522878745280337	(Native Hawaiian)	0.9711	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	12q24.21	12	115179836	NR	LOC102723639 - LOC105370003	102723639	105370003		74598	193675	rs55922880-?	rs55922880	0	55922880	intergenic_variant	1	NR	1E-9	9.0		0.4066	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3q29	3	195429768	NR	ACAP2			23527			rs79900979-?	rs79900979	0	79900979	intron_variant	0	NR	6E-9	8.221848749616356		0.4281	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	20p12.3	20	8915129	NR	PLCB1 - LOC105372522	23236	105372522		30218	47070	rs115205687-?	rs115205687	0	115205687	intron_variant	1	NR	4E-8	7.3979400086720375		0.4891	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	8q22.1	8	95279813	NR	C8orf37-AS1			100616530			rs55821258-?	rs55821258	0	55821258	intron_variant	0	NR	2E-8	7.698970004336019		0.2167	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5q35.1	5	172111740	NR	STK10			6793			rs60188314-?	rs60188314	0	60188314	intron_variant	0	NR	1E-8	8.0		0.4624	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	1p32.1	1	59655756	NR	FGGY			55277			rs72666268-?	rs72666268	0	72666268	intron_variant	0	NR	6E-8	7.221848749616356		0.3331	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4p16.2	4	4677180	NR	STX18-AS1			100507266			rs7675915-?	rs7675915	0	7675915	intron_variant	0	NR	3E-8	7.522878745280337		0.3501	[NR] unit increase	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	1q24.3	1	171387110	NR	FMO4 - GM2AP2	2329	100287900		45026	5138	rs10912872-?	rs10912872	0	10912872	intergenic_variant	1	NR	3E-8	7.522878745280337		0.1102	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p22.1	3	39950732	NR	MYRIP			25924			rs112364629-?	rs112364629	0	112364629	intron_variant	0	NR	6E-7	6.221848749616356		0.4197	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3q29	3	195298691	NR	ACAP2			23527			rs140333256-?	rs140333256	0	140333256	intron_variant	0	NR	1E-7	7.0		0.4046	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	9p23	9	13475447	NR	LOC105375977			105375977			rs150066336-?	rs150066336	0	150066336	intron_variant	0	NR	2E-7	6.698970004336019		0.6169	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	11p14.3	11	22503808	NR	LOC105376588			105376588			rs1514092-?	rs1514092	0	1514092	downstream_gene_variant	0	NR	3E-7	6.522878745280337		0.264	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p25.3	3	8822123	NR	LOC107986061			107986061			rs17049612-?	rs17049612	0	17049612	intron_variant	0	NR	6E-7	6.221848749616356		0.3986	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p15	2	62589884	NR	LOC105374764			105374764			rs17576670-?	rs17576670	0	17576670	downstream_gene_variant	0	NR	6E-7	6.221848749616356		0.3445	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4p16.3	4	597684	NR	PDE6B			5158			rs35476224-?	rs35476224	0	35476224	intergenic_variant	0	NR	1E-7	7.0		0.3139	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	5q34	5	162680373	NR	LOC105377698 - ARL2BPP5	105377698	100874420		19442	81460	rs6874604-?	rs6874604	0	6874604	intergenic_variant	1	NR	3E-7	6.522878745280337		0.4305	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	10p12.31	10	22089029	NR	DNAJC1 - ADIPOR1P1	64215	645220		85261	75547	rs72810761-?	rs72810761	0	72810761	intergenic_variant	1	NR	7E-7	6.154901959985743		0.3118	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	4q21.22	4	82591688	NR	LOC442113 - LINC00575	442113	439934		9993	21425	rs72909131-?	rs72909131	0	72909131	intergenic_variant	1	NR	7E-7	6.154901959985743		0.5037	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	3p26.1	3	7878962	NR	GRM7 - LOC101927394	2917	101927394		135930	73843	rs73130949-?	rs73130949	0	73130949	intergenic_variant	1	NR	2E-7	6.698970004336019		0.4934	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	20p13	20	1420847	NR	LOC105372497 - NSFL1C	105372497	55968		9701	21315	rs73584251-?	rs73584251	0	73584251	regulatory_region_variant	1	NR	4E-7	6.3979400086720375		0.4242	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2q22.2	2	143097365	NR	MTND4P22, ARHGAP15			100873244, 55843			rs73962318-?	rs73962318	0	73962318	non_coding_transcript_exon_variant	0	NR	6E-7	6.221848749616356		0.3471	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	2p11.2	2	86613946	NR	RNF103, RNF103-CHMP3, LOC105374845			7844, 100526767, 105374845			rs745109-?	rs745109	0	745109	non_coding_transcript_exon_variant	0	NR	8E-7	6.096910013008056		0.155	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-07-13	26053186	Park SL	2015-06-08	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26053186	Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	361 African American current smoker individuals, 329 Native Hawaiian ancestry current smoker individuals, 440 European ancestry current smoker individuals, 452 Latino current smoker individuals, 702 Japanese ancestry current smoker individuals	NA	16p12.3	16	19263230	NR	LOC105371114, SYT17			105371114, 51760			rs75774303-?	rs75774303	0	75774303	intron_variant	0	NR	5E-7	6.301029995663981		0.4062	[NR] unit decrease	Illumina [up to 11892802] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma	2,194 European ancestry cases, 222,555 European ancestry controls	586 European ancestry cases, 2,111 European ancestry controls	2p23.3	2	25889649	DTNB, ASXL2	NDUFB4P4 - KIF3C	107075092	3797		2443	36937	rs12986445-A	rs12986445	0	12986445	upstream_gene_variant	1	0.74	3E-6	5.522878745280337		0.18	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma	2,194 European ancestry cases, 222,555 European ancestry controls	586 European ancestry cases, 2,111 European ancestry controls	3p22.1	3	41786808	ULK4	ULK4			54986			rs73071352-G	rs73071352	0	73071352	intron_variant	0	0.14	5E-7	6.301029995663981		0.24	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma	2,194 European ancestry cases, 222,555 European ancestry controls	586 European ancestry cases, 2,111 European ancestry controls	6p21.33	6	31277183	PSORS1C2, HLA	USP8P1			100287272			rs6919908-T	rs6919908	0	6919908	non_coding_transcript_exon_variant	0	0.23	4E-10	9.397940008672037		0.25	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma	2,194 European ancestry cases, 222,555 European ancestry controls	586 European ancestry cases, 2,111 European ancestry controls	7p15.3	7	21888461	CDCA7L, DNAH11	DNAH11			8701			rs57104699-C	rs57104699	0	57104699	intron_variant	0	0.66	4E-8	7.3979400086720375		0.2	unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma	2,194 European ancestry cases, 222,555 European ancestry controls	586 European ancestry cases, 2,111 European ancestry controls	17p11.2	17	16916785	TNFRSF13B	LOC101929105 - TBC1D27	101929105	96597		34173	5987	rs57968458-A	rs57968458	0	57968458	intergenic_variant	1	0.098	6E-11	10.221848749616356		0.36	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma	2,194 European ancestry cases, 222,555 European ancestry controls	586 European ancestry cases, 2,111 European ancestry controls	22q13.1	22	39167908	CBX7	FUNDC2P4 - PDGFB	100127979	5155		11812	55451	rs34101942-?	rs34101942	0	34101942	intergenic_variant	1	NR	3E-7	6.522878745280337		0.18	[NR] unit increase	Illumina [12100000] (imputed)	N
2013-06-11	23455637	Iles MM	2013-03-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23455637	A variant in FTO shows association with melanoma risk not due to BMI.	Melanoma	1,353 European ancestry cases, 3,566 European ancestry controls	12,313 European ancestry cases, Up to 55,667 European ancestry controls	16q12.2	16	54080912	FTO	FTO			79068			rs16953002-A	rs16953002	0	16953002	intron_variant	0	0.17	4E-12	11.397940008672037		1.16	[1.11-1.20]	Illumina [2600000] (imputed)	N
2014-03-13	23955597	Chubb D	2013-08-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23955597	Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.	Multiple myeloma	2,335 European ancestry cases, 7,306 European ancestry controls	2,357 European ancestry cases, 3,684 European ancestry controls	2q37.1	2	231311828	NR	ARMC9			80210			rs7580717-G	rs7580717	0	7580717	intron_variant	0		5E-6	5.301029995663981		1.131	[NR]	Illumina [414804]	N
2014-03-13	23955597	Chubb D	2013-08-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23955597	Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.	Multiple myeloma	2,335 European ancestry cases, 7,306 European ancestry controls	2,357 European ancestry cases, 3,684 European ancestry controls	3q26.2	3	169774313	MYNN, TERC	MYNN			55892			rs10936599-G	rs10936599	0	10936599	synonymous_variant	0	0.8	9E-14	13.045757490560675		1.256	[1.18-1.33]	Illumina [414804]	N
2014-03-13	23955597	Chubb D	2013-08-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23955597	Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.	Multiple myeloma	2,335 European ancestry cases, 7,306 European ancestry controls	2,357 European ancestry cases, 3,684 European ancestry controls	6p21.33	6	31139481	PSORS1C1, CCHCR1, TCF19, POU5F1, CDSN	PSORS1C1			170679			rs2285803-A	rs2285803	0	2285803	intron_variant	0	0.32	1E-10	10.0		1.192	[1.13-1.26]	Illumina [414804]	N
2014-03-13	23955597	Chubb D	2013-08-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23955597	Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.	Multiple myeloma	2,335 European ancestry cases, 7,306 European ancestry controls	2,357 European ancestry cases, 3,684 European ancestry controls	10q25.2	10	110277217	NR	MXI1			4601			rs11195062-A	rs11195062	0	11195062	intron_variant	0		3E-6	5.522878745280337		1.132	[NR]	Illumina [414804]	N
2014-03-13	23955597	Chubb D	2013-08-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23955597	Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.	Multiple myeloma	2,335 European ancestry cases, 7,306 European ancestry controls	2,357 European ancestry cases, 3,684 European ancestry controls	17p11.2	17	16945825	TNFRSF13B	TNFRSF13B			23495			rs4273077-G	rs4273077	0	4273077	intron_variant	0	0.12	8E-9	8.096910013008056		1.255	[1.16-1.36]	Illumina [414804]	N
2014-03-13	23955597	Chubb D	2013-08-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23955597	Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.	Multiple myeloma	2,335 European ancestry cases, 7,306 European ancestry controls	2,357 European ancestry cases, 3,684 European ancestry controls	22q13.1	22	39146287	CBX7	CBX7			23492			rs877529-A	rs877529	0	877529	intron_variant	0	0.51	8E-16	15.096910013008056		1.228	[1.17-1.29]	Illumina [414804]	N
2014-03-01	23903356	Hayes MG	2013-07-31	Diabetes	www.ncbi.nlm.nih.gov/pubmed/23903356	Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies.	Glycemic traits (pregnancy)	1,367 European ancestry individuals, 817 Hispanic individuals, 1,075 Afro-Caribbean individuals, 1,178 Thai ancestry individuals	2,798 European ancestry individuals, 228 French Canadian founder population individuals	2p23.3	2	27508073	GCKR	GCKR			2646			rs1260326-T	rs1260326	0	1260326	missense_variant	0	0.409	6E-11	10.221848749616356	(FCP)	0.0116	[NR] unit decrease	Illumina [up to 945994] (imputed)	N
2014-03-01	23903356	Hayes MG	2013-07-31	Diabetes	www.ncbi.nlm.nih.gov/pubmed/23903356	Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies.	Glycemic traits (pregnancy)	1,367 European ancestry individuals, 817 Hispanic individuals, 1,075 Afro-Caribbean individuals, 1,178 Thai ancestry individuals	2,798 European ancestry individuals, 228 French Canadian founder population individuals	21q22.3	21	41211811	BACE2, PLAC4, C21orf130, FAM3B	BACE2			25825			rs6517656-G	rs6517656	0	6517656	intron_variant	0	0.839	6E-16	15.221848749616356	(FCP)	0.0402	[NR] unit increase	Illumina [up to 945994] (imputed)	N
2015-01-21	24980573	Song F	2014-06-30	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24980573	Identification of a melanoma susceptibility locus and somatic mutation in TET2.	Melanoma	494 European ancestry cases, 5,628 European ancestry controls	5,383 European ancestry cases, 13,033 European ancestry controls	3p21.2	3	51341843	DOCK3	DOCK3			1795			rs1031925-?	rs1031925	0	1031925	intron_variant	0		8E-6	5.096910013008056		1.15	[1.08-1.22]	Affymetrix, Illumina [1579307] (imputed)	N
2015-01-21	24980573	Song F	2014-06-30	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24980573	Identification of a melanoma susceptibility locus and somatic mutation in TET2.	Melanoma	494 European ancestry cases, 5,628 European ancestry controls	5,383 European ancestry cases, 13,033 European ancestry controls	3q26.2	3	169747154	ACTRT3	SDHDP3 - TERC	29771	7012		36576	17456	rs13097028-?	rs13097028	0	13097028	intergenic_variant	1		7E-7	6.154901959985743		1.1236	[1.08-1.18]	Affymetrix, Illumina [1579307] (imputed)	N
2015-01-21	24980573	Song F	2014-06-30	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24980573	Identification of a melanoma susceptibility locus and somatic mutation in TET2.	Melanoma	494 European ancestry cases, 5,628 European ancestry controls	5,383 European ancestry cases, 13,033 European ancestry controls	4q24	4	105218230	TET2	TET2, TET2-AS1			54790, 104384744			rs4698934-?	rs4698934	0	4698934	intron_variant	0		8E-7	6.096910013008056		1.18	[1.10-1.25]	Affymetrix, Illumina [1579307] (imputed)	N
2015-01-21	24980573	Song F	2014-06-30	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24980573	Identification of a melanoma susceptibility locus and somatic mutation in TET2.	Melanoma	494 European ancestry cases, 5,628 European ancestry controls	5,383 European ancestry cases, 13,033 European ancestry controls	6q12	6	64722390	EYS	EYS			346007			rs1889497-?	rs1889497	0	1889497	intron_variant	0		2E-6	5.698970004336019		1.1494	[1.09-1.22]	Affymetrix, Illumina [1579307] (imputed)	N
2015-01-21	24980573	Song F	2014-06-30	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24980573	Identification of a melanoma susceptibility locus and somatic mutation in TET2.	Melanoma	494 European ancestry cases, 5,628 European ancestry controls	5,383 European ancestry cases, 13,033 European ancestry controls	11q14.3	11	89272085	TYR	TYR, LOC107984363			7299, 107984363			rs1847134-?	rs1847134	0	1847134	intron_variant	0		6E-8	7.221848749616356		1.25	[1.15-1.35]	Affymetrix, Illumina [1579307] (imputed)	N
2015-01-21	24980573	Song F	2014-06-30	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24980573	Identification of a melanoma susceptibility locus and somatic mutation in TET2.	Melanoma	494 European ancestry cases, 5,628 European ancestry controls	5,383 European ancestry cases, 13,033 European ancestry controls	16q24.3	16	89689495	MC1R	CDK10			8558			rs258322-A	rs258322	0	258322	intron_variant	0		2E-9	8.698970004336019		1.5	[1.31-1.71]	Affymetrix, Illumina [1579307] (imputed)	N
2015-06-08	25194280	Wei Q	2014-09-07	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25194280	Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.	Laryngeal squamous cell carcinoma	993 Chinese ancestry cases, 1,995 Chinese ancestry controls	2,398 Chinese ancestry cases, 2,804 Chinese ancestry controls	11q12.2	11	61803910	FADS1, FADS2, FADS3, FEN1	FADS1			3992			rs174549-?	rs174549	0	174549	5_prime_UTR_variant	0	0.59	1E-20	20.0		1.37	[1.28-1.47]	Affymetrix [662108]	N
2015-06-08	25194280	Wei Q	2014-09-07	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25194280	Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.	Laryngeal squamous cell carcinoma	993 Chinese ancestry cases, 1,995 Chinese ancestry controls	2,398 Chinese ancestry cases, 2,804 Chinese ancestry controls	6q16.1	6	92812416	EPHA7	LOC107986533 - ATF1P1	107986533	100128159		87074	74851	rs9445023-?	rs9445023	0	9445023	intergenic_variant	1	0.88	7E-7	6.154901959985743		1.32	[1.18-1.47]	Affymetrix [662108]	N
2015-06-08	25194280	Wei Q	2014-09-07	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25194280	Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.	Laryngeal squamous cell carcinoma	993 Chinese ancestry cases, 1,995 Chinese ancestry controls	2,398 Chinese ancestry cases, 2,804 Chinese ancestry controls	5q14.3	5	83523300	VCAN	VCAN			1462			rs310518-?	rs310518	0	310518	intron_variant	0	0.79	7E-8	7.154901959985743		1.27	[1.16-1.37]	Affymetrix [662108]	N
2015-06-08	25194280	Wei Q	2014-09-07	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25194280	Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.	Laryngeal squamous cell carcinoma	993 Chinese ancestry cases, 1,995 Chinese ancestry controls	2,398 Chinese ancestry cases, 2,804 Chinese ancestry controls	6p21.33	6	31600692	AIF1, HLA	NCR3 - UQCRHP1	259197	100130756		7668	10391	rs2857595-?	rs2857595	0	2857595	intergenic_variant	1	0.50	2E-15	14.698970004336019		1.3	[1.22-1.39]	Affymetrix [662108]	N
2015-06-08	25194280	Wei Q	2014-09-07	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25194280	Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.	Laryngeal squamous cell carcinoma	993 Chinese ancestry cases, 1,995 Chinese ancestry controls	2,398 Chinese ancestry cases, 2,804 Chinese ancestry controls	16p13.2	16	9344835	GRIN2A	LOC101927026			101927026			rs40129-?	rs40129	0	40129	intergenic_variant	0	0.25	4E-7	6.3979400086720375		1.21	[1.12–1.30]	Affymetrix [662108]	N
2015-06-08	25194280	Wei Q	2014-09-07	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25194280	Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.	Laryngeal squamous cell carcinoma	993 Chinese ancestry cases, 1,995 Chinese ancestry controls	2,398 Chinese ancestry cases, 2,804 Chinese ancestry controls	12q24.21	12	114147775	TBX5	LOC105369995 - LOC105369996	105369995	105369996		34286	90447	rs10492336-?	rs10492336	0	10492336	intergenic_variant	1	0.82	4E-14	13.397940008672037		1.41	[1.30-1.54]	Affymetrix [662108]	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	2p24.1	2	20679060	LDAH, GDF7	GDF7 - C2orf43	151449	60526		7570	3429	rs7255-T	rs7255	0	7255	3_prime_UTR_variant	1		9E-11	10.045757490560675		1.14	[1.09-1.18]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	15q21.3	15	58069827	ALDH1A2	ALDH1A2 - LOC101928635	8854	101928635		3904	36782	rs2464469-G	rs2464469	0	2464469	intron_variant	1		5E-10	9.301029995663981		1.12	[1.09-1.18]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	7q31.2	7	117616658	CFTR	CFTR			1080			rs17451754-G	rs17451754	0	17451754	intron_variant	0		5E-10	9.301029995663981		1.19	[1.12-1.25]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	8p23.1	8	10210563	MSRA	MSRA			4482			rs17749155-A	rs17749155	0	17749155	intron_variant	0		5E-10	9.301029995663981		1.18	[1.12-1.24]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	8p23.1	8	11578007	BLK, LINC00208	LINC00208			83655			rs10108511-T	rs10108511	0	10108511	intron_variant	0		2E-9	8.698970004336019		1.12	[1.08-1.16]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	3p13	3	70880832	FOXP1	RNU6-281P - FOXP1	106481267	27086		72380	73882	rs2687202-T	rs2687202	0	2687202	regulatory_region_variant	1		2E-9	8.698970004336019		1.13	[1.08-1.17]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	12q24.21	12	114235918	LOC105369996, TBX5	LOC105369995 - LOC105369996	105369995	105369996		122429	2304	rs1247942-G	rs1247942	0	1247942	downstream_gene_variant	1		2E-9	8.698970004336019		1.12	[1.09-1.16]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	6q11.1	6	61485463	KHDRBS2, MTRNR2L9	RBBP4P3 - KHDRBS2	730180	202559		610820	57216	rs62423175-A	rs62423175	0	62423175	intergenic_variant	1		3E-9	8.522878745280337		1.17	[1.11-1.23]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	5p15.33	5	662977	TPPP, CEP72	CEP72, TPPP			55722, 11076			rs9918259-T	rs9918259	0	9918259	3_prime_UTR_variant	0		3E-9	8.522878745280337		1.2	[1.13-1.27]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	6p22.1	6	29388554	MHC	OR5V1			81696			rs9257809-A	rs9257809	0	9257809	intron_variant	0		6E-9	8.221848749616356		1.23	[1.14-1.31]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	9q22.33	9	97548219	TMOD1	TMOD1			7111			rs7852462-C	rs7852462	0	7852462	intron_variant	0		2E-8	7.698970004336019		1.12	[1.08-1.16]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	2q33.1	2	199180316	SATB2	LOC100419513 - SATB2	100419513	23314		70228	89184	rs139606545-G	rs139606545	1	13397172	intergenic_variant	1		2E-8	7.698970004336019		1.11	[1.08-1.16]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	16q24.1	16	86363229	LOC732275, FOXF1	LINC00917 - LOC401864	732275	401864		17550	71615	rs1979654-G	rs1979654	0	1979654	regulatory_region_variant	1		3E-8	7.522878745280337		1.11	[1.08-1.16]	Illumina [11951684] (imputed)	N
2017-03-13	27527254	Gharahkhani P	2016-08-12	Lancet Oncol	www.ncbi.nlm.nih.gov/pubmed/27527254	Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.	Barrett's esophagus  or Esophageal adenocarcinoma	6,167 European ancestry Barrett's oesophagus cases, 4,112 European ancestry esophageal adenocarcinoma cases, 17,159 European ancestry controls	NA	19p13.11	19	18693485	CRTC1	CRTC1			23373			rs199620551-TG	rs199620551	0	199620551	intron_variant	0		5E-8	7.301029995663981		1.11	[1.08-1.15]	Illumina [11951684] (imputed)	N
2012-01-27	22086417	Cozen W	2011-11-15	Blood	www.ncbi.nlm.nih.gov/pubmed/22086417	A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.	Nodular sclerosis Hodgkin lymphoma	393 European ancestry cases, 3,315 European ancestry controls	113 European ancestry cases, 214 European ancestry controls	6p21.32	6;6;6;6;6	32460508;32604474;32142202;32415331;32416944	HLA-DQB1, HLA-DRB1	HLA-DRB9 - HLA-DRB5; HLA-DRB1 - LOC107986589; FKBPL - PRRT1; BTNL2 - HLA-DRA; BTNL2 - HLA-DRA						rs6903608-T; rs2858870-C; rs204999-G; rs9268528-A; rs9268542-A	rs6903608; rs2858870; rs204999; rs9268528; rs9268542	0		intron_variant; intron_variant; intergenic_variant; regulatory_region_variant; intergenic_variant		NR	8E-18	17.096910013008056		2.5	[NR]	Illumina [705591]	N
2012-01-27	22086417	Cozen W	2011-11-15	Blood	www.ncbi.nlm.nih.gov/pubmed/22086417	A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.	Nodular sclerosis Hodgkin lymphoma	393 European ancestry cases, 3,315 European ancestry controls	113 European ancestry cases, 214 European ancestry controls	6p21.32	6;6;6;6;6	32460508;32604474;32142202;32415331;32416944	HLA-DQB1, HLA-DRB1	HLA-DRB9 - HLA-DRB5; HLA-DRB1 - LOC107986589; FKBPL - PRRT1; BTNL2 - HLA-DRA; BTNL2 - HLA-DRA						rs6903608-C; rs2858870-T; rs204999-A; rs9268528-G; rs9268542-G	rs6903608; rs2858870; rs204999; rs9268528; rs9268542	0		intron_variant; intron_variant; intergenic_variant; regulatory_region_variant; intergenic_variant		NR	2E-7	6.698970004336019		1.7	[NR]	Illumina [705591]	N
2017-03-24	27694927	Vijayakrishnan J	2016-10-03	Leukemia	www.ncbi.nlm.nih.gov/pubmed/27694927	A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.	Acute lymphoblastic leukemia in childhood (B cell precursor)	1,658 European ancestry child cases, 7,224 European ancestry controls	1,109 child cases, 1,412 European ancestry child cases, 2,085 controls, 1,479 European ancestry controls	12q23.1	12	96218984	ELK3	ELK3			2004			rs4762284-T	rs4762284	0	4762284	intron_variant	0	0.3	8E-9	8.096910013008056		1.19	[1.12–1.26]	Illumina [11700000] (imputed)	N
2017-03-24	27694927	Vijayakrishnan J	2016-10-03	Leukemia	www.ncbi.nlm.nih.gov/pubmed/27694927	A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.	Acute lymphoblastic leukemia in childhood (B cell precursor)	1,658 European ancestry child cases, 7,224 European ancestry controls	1,109 child cases, 1,412 European ancestry child cases, 2,085 controls, 1,479 European ancestry controls	10q26.13	10	124604740	LHPP	LHPP			64077			rs35837782-G	rs35837782	0	35837782	intron_variant	0	0.62	1E-11	11.0		1.21	[1.15–1.28]	Illumina [11700000] (imputed)	N
2012-02-23	22286212	Urayama KY	2012-01-27	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/22286212	Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.	Hodgkin's lymphoma	1,200 European ancestry cases, 6,417 European ancestry controls	563 European ancestry cases, 613 European ancestry controls	6p21.33	6	31479019	MICB	HCG26 - LOC102725068	352961	102725068		6611	899	rs2248462-?	rs2248462	0	2248462	downstream_gene_variant	1	NR	7E-16	15.154901959985743	(Total cHL)	1.64	[1.45-1.85]	Illumina [502514]	N
2012-02-23	22286212	Urayama KY	2012-01-27	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/22286212	Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.	Hodgkin's lymphoma	1,200 European ancestry cases, 6,417 European ancestry controls	563 European ancestry cases, 613 European ancestry controls	6p21.32	6	32465390	HLA-DRA	HLA-DRB9 - HLA-DRB5	3132	3127		5301	51953	rs2395185-?	rs2395185	0	2395185	intron_variant	1	NR	4E-31	30.397940008672037	(Total cHL)	1.82	[1.67-2.00]	Illumina [502514]	N
2012-02-23	22286212	Urayama KY	2012-01-27	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/22286212	Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.	Hodgkin's lymphoma	1,200 European ancestry cases, 6,417 European ancestry controls	563 European ancestry cases, 613 European ancestry controls	5q15	5	96766240	ERAP1	ERAP1, CAST			51752, 831			rs27524-?	rs27524	0	27524	intron_variant	0	NR	7E-6	5.154901959985743	(Total cHL)	1.22	[1.11-1.33]	Illumina [502514]	N
2012-02-23	22286212	Urayama KY	2012-01-27	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/22286212	Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.	Hodgkin's lymphoma	1,200 European ancestry cases, 6,417 European ancestry controls	563 European ancestry cases, 613 European ancestry controls	5q31.1	5	132660272	IL13	IL13			3596			rs20541-?	rs20541	0	20541	missense_variant	0	NR	1E-8	8.0	(EBV-negative cHL)	1.47	[1.29-1.68]	Illumina [502514]	N
2013-07-26	23512250	Xu H	2013-03-19	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23512250	Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.	Acute lymphoblastic leukemia (childhood)	972 European ancestry cases, 1,386 European ancestry controls, 89 African American cases, 1,363 African American controls, 305 Hispanic cases, 1,008 Hispanic controls	574 European ancestry cases, 2,601 European ancestry controls, 128 African American cases, 1,075 African American controls, 143 Hispanic cases, 640 Hispanic controls	7p12.2	7	50405553	DDC, GRB10, IKZF1	IKZF1 - RNU6-1091P	10320	106480637		452	29827	rs6964969-C	rs6964969	0	6964969	downstream_gene_variant	1	0.28	2E-29	28.69897000433602		1.67	[1.53-1.83]	Affymetrix [709059]	N
2013-07-26	23512250	Xu H	2013-03-19	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23512250	Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.	Acute lymphoblastic leukemia (childhood)	972 European ancestry cases, 1,386 European ancestry controls, 89 African American cases, 1,363 African American controls, 305 Hispanic cases, 1,008 Hispanic controls	574 European ancestry cases, 2,601 European ancestry controls, 128 African American cases, 1,075 African American controls, 143 Hispanic cases, 640 Hispanic controls	10q21.2	10	61963818	ARID5B	ARID5B			84159			rs10821936-C	rs10821936	1	10821936	intron_variant	0	0.33	6E-46	45.221848749616356		1.86	[1.71-2.03]	Affymetrix [709059]	N
2013-07-26	23512250	Xu H	2013-03-19	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/23512250	Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.	Acute lymphoblastic leukemia (childhood)	972 European ancestry cases, 1,386 European ancestry controls, 89 African American cases, 1,363 African American controls, 305 Hispanic cases, 1,008 Hispanic controls	574 European ancestry cases, 2,601 European ancestry controls, 128 African American cases, 1,075 African American controls, 143 Hispanic cases, 640 Hispanic controls	14q11.2	14	23116124	CEBPE	LOC107984665 - CEBPE	107984665	1053		10320	1182	rs4982731-C	rs4982731	0	4982731	downstream_gene_variant	1	0.28	9E-12	11.045757490560675		1.36	[1.24-1.48]	Affymetrix [709059]	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	5q15	5	95907227	ELL2	ELL2			22936			rs56219066-T	rs56219066	0	56219066	intron_variant	0	0.711	2E-10	9.698970004336019		1.24	[1.16-1.33]	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	22q12.3	22	35303589	TOM1	TOM1			10043			rs138740-C	rs138740	0	138740	intron_variant	0	0.415	3E-7	6.522878745280337		1.16	[1.10-1.23]	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	2p23.3	2	25889649	DTNB, ASXL2	NDUFB4P4 - KIF3C	107075092	3797		2443	36937	rs12986445-A	rs12986445	0	12986445	upstream_gene_variant	1	0.74	5E-6	5.301029995663981		0.17	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	3p22.1	3	41786808	ULK4	ULK4			54986			rs73071352-G	rs73071352	0	73071352	intron_variant	0	NR	3E-8	7.522878745280337		0.25	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	3q26.2	3	169800667	MYNN, LRRC34	LRRC34			151827			rs6793295-T	rs6793295	0	6793295	missense_variant	0	0.74	7E-6	5.154901959985743		0.16	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	6p21.33	6	31277183	PSORS1C2, HLA	USP8P1			100287272			rs6919908-T	rs6919908	0	6919908	non_coding_transcript_exon_variant	0	0.23	6E-10	9.221848749616356		0.23	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	7p15.3	7	21888461	DNAH11, CDCA7L	DNAH11			8701			rs57104699-C	rs57104699	0	57104699	intron_variant	0	0.66	2E-8	7.698970004336019		0.19	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	17p11.2	17	16916785	TNFRSF13B	LOC101929105 - TBC1D27	101929105	96597		34173	5987	rs57968458-A	rs57968458	0	57968458	intergenic_variant	1	0.098	3E-10	9.522878745280337		0.33	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-03-24	26007630	Swaminathan B	2015-05-26	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26007630	Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.	Multiple myeloma and monoclonal gammopathy	2,194 European ancestry multiple myeloma cases, 251 European ancestry monoclonal gammopathy cases, 294,390 European ancestry controls	586 European ancestry multiple myeloma cases, 2,111 European ancestry controls	22q13.1	22	39167908	CBX7	FUNDC2P4 - PDGFB	100127979	5155		11812	55451	rs34101942-?	rs34101942	0	34101942	intergenic_variant	1	NR	9E-6	5.045757490560675		0.15	[NR] unit increase	Illumina [12100000] (imputed)	N
2016-06-10	26198393	Ziv E	2015-07-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26198393	Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.	Multiple myeloma (survival)	469 European ancestry cases, 25 African American cases, 27 Latino cases, 24 cases	1090 European ancestry cases	16p13.11	16	15880785	MYH11, FOPNL, ABCC1, ABCC6	FOPNL			123811			rs72773978-T	rs72773978	0	72773978	intron_variant	0	0.051	7E-9	8.154901959985743		1.93	[1.54-2.41]	Affymetrix, Illumina [6026834] (imputed)	N
2015-06-26	25261932	Cerhan JR	2014-09-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Diffuse large B cell lymphoma	3,857 European ancestry cases, 7,666 European ancestry controls	1,359 European ancestry cases, 4,557 European ancestry controls	2p23.3	2	24471603	NCOA1, ITSN2	LOC105374329 - NCOA1	105374329	8648		8449	20447	rs79480871-T	rs79480871	0	79480871	intergenic_variant	1	0.062	4E-8	7.3979400086720375		1.34	[1.21-1.49]	Illumina [8363971] (imputed)	N
2015-06-26	25261932	Cerhan JR	2014-09-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Diffuse large B cell lymphoma	3,857 European ancestry cases, 7,666 European ancestry controls	1,359 European ancestry cases, 4,557 European ancestry controls	6p25.3	6	484453	EXOC2	LOC105374875 - EXOC2	105374875	55770		7841	685	rs116446171-G	rs116446171	0	116446171	downstream_gene_variant	1	0.019	2E-21	20.69897000433602		2.2	[1.87-2.59]	Illumina [8363971] (imputed)	N
2015-06-26	25261932	Cerhan JR	2014-09-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Diffuse large B cell lymphoma	3,857 European ancestry cases, 7,666 European ancestry controls	1,359 European ancestry cases, 4,557 European ancestry controls	6p21.33	6	31355013	HLA-B	HLA-B			3106			rs2523607-A	rs2523607	0	2523607	non_coding_transcript_exon_variant	0	0.120	2E-10	9.698970004336019		1.32	[1.21-1.44]	Illumina [8363971] (imputed)	N
2015-06-26	25261932	Cerhan JR	2014-09-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Diffuse large B cell lymphoma	3,857 European ancestry cases, 7,666 European ancestry controls	1,359 European ancestry cases, 4,557 European ancestry controls	6p21.1	6	41654359	NR	MDFI - NPM1P51	4188	100130606		113	12451	rs45483501-C	rs45483501	0	45483501	downstream_gene_variant	1	0.875	8E-6	5.096910013008056		1.22	[1.11-1.33]	Illumina [8363971] (imputed)	N
2015-06-26	25261932	Cerhan JR	2014-09-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Diffuse large B cell lymphoma	3,857 European ancestry cases, 7,666 European ancestry controls	1,359 European ancestry cases, 4,557 European ancestry controls	8q24.21	8	128064327	MYC, PVT1	PVT1			5820			rs13255292-T	rs13255292	0	13255292	intron_variant	0	0.321	1E-12	12.0		1.22	[1.15-1.29]	Illumina [8363971] (imputed)	N
2015-06-26	25261932	Cerhan JR	2014-09-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Diffuse large B cell lymphoma	3,857 European ancestry cases, 7,666 European ancestry controls	1,359 European ancestry cases, 4,557 European ancestry controls	8q24.21	8	128257220	MYC, PVT1	RN7SKP226 - LINC00824	106480903	101927774		36468	148049	rs4733601-A	rs4733601	0	4733601	intergenic_variant	1	0.477	4E-11	10.397940008672037		1.19	[1.12-1.25]	Illumina [8363971] (imputed)	N
2015-06-26	25261932	Cerhan JR	2014-09-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Diffuse large B cell lymphoma	3,857 European ancestry cases, 7,666 European ancestry controls	1,359 European ancestry cases, 4,557 European ancestry controls	5q31.3	5	141655607	ARAP3	ARAP3			64411			rs79464052-C	rs79464052	0	79464052	intron_variant	0	0.056	6E-8	7.221848749616356		1.34	[1.21-1.49]	Illumina [8363971] (imputed)	N
2015-06-26	25261932	Cerhan JR	2014-09-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Diffuse large B cell lymphoma	3,857 European ancestry cases, 7,666 European ancestry controls	1,359 European ancestry cases, 4,557 European ancestry controls	3q13.33	3	122098766	CD86	CD86			942			rs2681416-A	rs2681416	0	2681416	intron_variant	0	0.311	8E-8	7.096910013008056		1.16	[1.10-1.23]	Illumina [8363971] (imputed)	N
2016-09-28	26460308	Ghesquieres H	2015-10-12	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/26460308	Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	852 European ancestry cases	685 European ancestry cases	5q23.2	5	122582513	ARGFXP1, SNCAIP, SNX2	LOC101927357			101927357			rs7712513-C	rs7712513	0	7712513	intergenic_variant	0	0.35	2E-7	6.698970004336019		1.39	[1.23-1.57]	Illumina [> 552942] (imputed)	N
2016-09-28	26460308	Ghesquieres H	2015-10-12	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/26460308	Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	852 European ancestry cases	685 European ancestry cases	6q21	6	113750518	LOC100652953, MARCKS, HDAC2	LOC101927686 - RPL30P8	101927686	100132053		100443	79304	rs7765004-C	rs7765004	0	7765004	intergenic_variant	1	0.33	7E-7	6.154901959985743		1.38	[1.22-1.57]	Illumina [> 552942] (imputed)	N
2017-05-11	28317148	Campo C	2017-01-01	Hematol Oncol	www.ncbi.nlm.nih.gov/pubmed/28317148	Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients.	Bortezomib-induced peripheral neuropathy in multiple myeloma	102 European ancestry cases and 544 European ancestry controls.	NR	4q34.3	4	181371930	TENM3, RP11-665C14.2	LOC101928679 - LOC107986205	101928679	107986205		106753	3844	rs6552496-C	rs6552496	0	6552496	intergenic_variant	1	NR	8E-6	5.096910013008056		2.0	[1.46-2.76]	Illumina [NR] (imputed)	N
2017-05-11	28317148	Campo C	2017-01-01	Hematol Oncol	www.ncbi.nlm.nih.gov/pubmed/28317148	Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients.	Bortezomib-induced peripheral neuropathy in multiple myeloma	102 European ancestry cases and 544 European ancestry controls.	NR	5q14.1	5	79890115	RP11-168A11.1	LOC105379048			105379048			rs12521798-A	rs12521798	0	12521798	intergenic_variant	0	NR	4E-6	5.3979400086720375		2.76	[1.73-4.38]	Illumina [NR] (imputed)	N
2017-05-11	28317148	Campo C	2017-01-01	Hematol Oncol	www.ncbi.nlm.nih.gov/pubmed/28317148	Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients.	Bortezomib-induced peripheral neuropathy in multiple myeloma	102 European ancestry cases and 544 European ancestry controls.	NR	16q23.3	16	83591958	CDH13	CDH13			1012			rs8060632-A	rs8060632	0	8060632	intron_variant	0	NR	2E-6	5.698970004336019		2.31	[1.61-3.32]	Illumina [NR] (imputed)	N
2017-05-11	28317148	Campo C	2017-01-01	Hematol Oncol	www.ncbi.nlm.nih.gov/pubmed/28317148	Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients.	Bortezomib-induced peripheral neuropathy in multiple myeloma	102 European ancestry cases and 544 European ancestry controls.	NR	18q21.2	18	52420925	DCC	DCC			1630			rs17748074-A	rs17748074	0	17748074	intron_variant	0	NR	9E-6	5.045757490560675		1.96	[1.45-2.65]	Illumina [NR] (imputed)	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in chronic obstructive pulmonary disease	237 cases	NA	3p26.2	3	2943458	CNTN4	CNTN4			152330			rs41526344-?	rs41526344	0	41526344	intron_variant	0		4E-8	7.3979400086720375		0.13	[0.083-0.177] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in chronic obstructive pulmonary disease	237 cases	NA	13q14.11	13	40395301	LINC00598	LINC00598			646982			rs1751857-?	rs1751857	0	1751857	intron_variant	0		4E-7	6.3979400086720375		0.11	[0.069-0.151] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in chronic obstructive pulmonary disease	237 cases	NA	5q32	5	147679452	JAKMIP2	LOC101927012, JAKMIP2			101927012, 9832			rs17107133-?	rs17107133	0	17107133	intron_variant	0		2E-6	5.698970004336019		0.1	[0.059-0.141] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in chronic obstructive pulmonary disease	237 cases	NA	1q32.2	1	210316066	HHAT	RNASEH1P3 - HHAT	199827	55733		11248	11807	rs34585985-?	rs34585985	0	34585985	intergenic_variant	1		3E-6	5.522878745280337		0.12	[0.071-0.169] unit increase	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in chronic obstructive pulmonary disease	237 cases	NA	20p12.2	20	10501124	C20orf94	SLX4IP			128710			rs677673-?	rs677673	0	677673	intron_variant	0		6E-6	5.221848749616356		0.092	[0.053-0.131] unit decrease	Affymetrix [418365]	N
2017-05-30	28044437	McDonald MN	2017-01-02	J Cachexia Sarcopenia Muscle	www.ncbi.nlm.nih.gov/pubmed/28044437	Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.	Body mass index (change over time) in chronic obstructive pulmonary disease	237 cases	NA	12q24.23	12	117858119	KSR2	KSR2			283455			rs10507285-?	rs10507285	0	10507285	intron_variant	0		8E-6	5.096910013008056		0.075	[0.042-0.108] unit increase	Affymetrix [418365]	N
2011-06-01	21540461	Kim DH	2011-05-03	Blood	www.ncbi.nlm.nih.gov/pubmed/21540461	A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.	Chronic myeloid leukemia	201 Korean ancestry cases, 497 Korean ancestry controls	237 Korean ancestry cases, 1,000 Korean ancestry controls, 232 European ancestry cases, 576 European ancestry controls	6q25.1	6	151586613	AKAP12, ZBTB2, MTHFD1L, RMND1, C6orf211, ESR1, C6orf97	CCDC170			80129			rs4869742-T	rs4869742	0	4869742	intron_variant	0	0.77	2E-6	5.698970004336019		1.67	[1.35-2.04]	Affymetrix [456522]	N
2011-06-01	21540461	Kim DH	2011-05-03	Blood	www.ncbi.nlm.nih.gov/pubmed/21540461	A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.	Chronic myeloid leukemia	201 Korean ancestry cases, 497 Korean ancestry controls	237 Korean ancestry cases, 1,000 Korean ancestry controls, 232 European ancestry cases, 576 European ancestry controls	17q11.1	17	27214252	WSB1, FAM27L	LOC105371703 - LOC105371704	105371703	105371704		125011	15932	rs4795519-C	rs4795519	0	4795519	intergenic_variant	1	0.48	1E-12	12.0		1.85	[1.56-2.17]	Affymetrix [456522]	N
2008-09-03	18758461	Di Bernardo MC	2008-08-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18758461	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	505 European ancestry cases, 1,438 European ancestry controls	1,024 European ancestry cases, 1,677 European ancestry controls	6p25.3	6	411064	IRF4	IRF4			3662			rs872071-G	rs872071	0	872071	3_prime_UTR_variant	0	0.54	2E-20	19.69897000433602		1.54	[1.41- 1.69]	Illumina [345665]	N
2008-09-03	18758461	Di Bernardo MC	2008-08-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18758461	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	505 European ancestry cases, 1,438 European ancestry controls	1,024 European ancestry cases, 1,677 European ancestry controls	15q23	15	69726651	intergenic	PCAT29 - LOC107984788	104472713	107984788		30901	24368	rs7176508-A	rs7176508	0	7176508	regulatory_region_variant	1	0.37	5E-12	11.301029995663981		1.37	[1.26-1.50]	Illumina [345665]	N
2008-09-03	18758461	Di Bernardo MC	2008-08-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18758461	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	505 European ancestry cases, 1,438 European ancestry controls	1,024 European ancestry cases, 1,677 European ancestry controls	2q37.1	2	230226508	SP140, SP110	SP140			11262			rs13397985-G	rs13397985	0	13397985	intron_variant	0	0.19	6E-10	9.221848749616356		1.41	[1.26-1.57]	Illumina [345665]	N
2008-09-03	18758461	Di Bernardo MC	2008-08-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18758461	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	505 European ancestry cases, 1,438 European ancestry controls	1,024 European ancestry cases, 1,677 European ancestry controls	11q24.1	11	123490689	GRAMD1B	GRAMD1B			57476			rs735665-A	rs735665	0	735665	intron_variant	0	0.21	4E-12	11.397940008672037		1.45	[1.31-1.61]	Illumina [345665]	N
2008-09-03	18758461	Di Bernardo MC	2008-08-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18758461	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	505 European ancestry cases, 1,438 European ancestry controls	1,024 European ancestry cases, 1,677 European ancestry controls	2q13	2	111039881	ACOXL, BCL2L11	ACOXL			55289			rs17483466-G	rs17483466	0	17483466	intron_variant	0	0.20	2E-10	9.698970004336019		1.39	[1.25-1.53]	Illumina [345665]	N
2008-09-03	18758461	Di Bernardo MC	2008-08-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18758461	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	505 European ancestry cases, 1,438 European ancestry controls	1,024 European ancestry cases, 1,677 European ancestry controls	19q13.32	19	46704397	PRKD2, STRN4	PRKD2			25865			rs11083846-A	rs11083846	0	11083846	splice_region_variant	0	0.22	4E-9	8.397940008672037		1.35	[1.22-1.49]	Illumina [345665]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	10p12.33	10	17346144	ST8SIA6	ST8SIA6			338596			rs359312-T	rs359312	0	359312	intron_variant	0	NR	9E-8	7.045757490560675		3.91	[1.52-10.10]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	4q31.21	4	141788570	IL15	IL15 - INPP4B	3600	8821		54583	234590	rs17007695-C	rs17007695	0	17007695	intergenic_variant	1	NR	9E-7	6.045757490560675		2.67	[1.53-4.68]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	2q33.1	2	200157231	C2orf47	LOC105373833 - SPATS2L	105373833	26010		66817	148650	rs1569175-T	rs1569175	0	1569175	intergenic_variant	1	NR	9E-7	6.045757490560675		2.73	[1.52-4.93]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	20q13.12	20	47579861	NCOA3	NCOA3			8202			rs6125048-T	rs6125048	0	6125048	intron_variant	0	NR	2E-6	5.698970004336019		2.73	[1.08-6.88]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	7p14.1	7	37226747	ELMO1	ELMO1			9844			rs4723619-C	rs4723619	0	4723619	intron_variant	0	NR	3E-6	5.522878745280337		3.01	[1.50-6.03]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	7p21.2	7	14406292	DGKB	DGKB			1607			rs6971925-T	rs6971925	0	6971925	intron_variant	0	NR	3E-6	5.522878745280337		13.91	[2.72-70.92]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	10q26.12	10	121141109	intergenic	LOC105378522			105378522			rs2901286-A	rs2901286	0	2901286	intergenic_variant	0	NR	4E-6	5.3979400086720375		4.66	[1.58-13.7]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	11p15.1	11	20540973	intergenic	PRMT3 - LOC105376584	10196	105376584		30112	19095	rs7128311-C	rs7128311	0	7128311	intergenic_variant	1	NR	5E-6	5.301029995663981		13.9	[2.72-71.1]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	6q25.3	6	155608667	intergenic	LOC105378068 - RNU7-152P	105378068	106479081		82649	46296	rs35229355-T	rs35229355	0	35229355	intergenic_variant	1	NR	5E-6	5.301029995663981		7.24	[2.46-21.30]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	5p13.2	5	36137518	LMBRD2	LMBRD2			92255			rs267759-A	rs267759	0	267759	intron_variant	0	NR	7E-6	5.154901959985743		3.23	[1.52-6.87]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	10p14	10	8108750	intergenic	LOC105376395 - PRPF38AP1	105376395	389935		11169	52510	rs10508343-A	rs10508343	0	10508343	intergenic_variant	1	NR	8E-6	5.096910013008056		3.81	[1.40-10.40]	Affymetrix [476796]	N
2009-02-26	19176441	Yang JJ	2009-01-28	JAMA	www.ncbi.nlm.nih.gov/pubmed/19176441	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	Response to treatment for acute lymphoblastic leukemia	356 European ancestry cases, 53 Black cases, 78 cases	NA	11q21	11	96266936	MAML2	MAML2			84441			rs7115578-A	rs7115578	0	7115578	intron_variant	0	NR	8E-6	5.096910013008056		1.86	[1.23-2.79]	Affymetrix [476796]	N
2009-08-21	19620980	Skibola CF	2009-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19620980	Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma.	Follicular lymphoma	189 European ancestry cases, 592 European controls	456 European ancestry cases, 2,785 European ancestry controls	6p21.33	6	31106253	STG, PSORS1	HCG22 - C6orf15	285834	29113		46363	4970	rs6457327-C	rs6457327	0	6457327	downstream_gene_variant	1	0.62	5E-11	10.301029995663981		1.69	[1.43-2.00]	Illumina [~ 500000]	N
2009-09-04	19684604	Papaemmanuil E	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684604	Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	907 European ancestry cases, 2,398 European ancestry controls	NA	7p12.2	7	50402906	IKZF1	IKZF1			10320			rs4132601-C	rs4132601	0	4132601	3_prime_UTR_variant	0	0.28	1E-19	19.0		1.69	[1.58-1.81]	Illumina [291473]	N
2009-09-04	19684604	Papaemmanuil E	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684604	Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	907 European ancestry cases, 2,398 European ancestry controls	NA	10q21.2	10	61992400	ARID5B	ARID5B			84159			rs7089424-C	rs7089424	0	7089424	intron_variant	0	0.34	7E-19	18.154901959985743		1.65	[1.54-1.76]	Illumina [291473]	N
2009-09-04	19684604	Papaemmanuil E	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684604	Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	907 European ancestry cases, 2,398 European ancestry controls	NA	14q11.2	14	23119848	CEBPE	CEBPE - SLC7A8	1053	23428		237	5447	rs2239633-G	rs2239633	0	2239633	upstream_gene_variant	1	0.52	3E-7	6.522878745280337		1.34	[1.22-1.45]	Illumina [291473]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	10q21.2	10	61963818	ARID5B	ARID5B			84159			rs10821936-C	rs10821936	1	10821936	intron_variant	0	0.34	1E-15	15.0		1.91	[1.60-2.20]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	7p12.2	7	50398606	DDC, IKZF1	IKZF1			10320			rs11978267-G	rs11978267	0	11978267	intron_variant	0	0.27	8E-11	10.096910013008056		1.69	[1.40-1.90]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	12q24.22	12	116564853	KRTHB5	MAP1LC3B2			643246			rs2089222-A	rs2089222	0	2089222	intron_variant	0	0.03	8E-8	7.096910013008056		2.26	[1.60-3.0]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	6q24.1	6	140848688	intergenic	LOC102723724			102723724			rs11155133-G	rs11155133	0	11155133	intron_variant	0	0.01	3E-7	6.522878745280337		3.62	[2.10-6.00]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	19q13.31	19	44007237	ZNF230	ZNF230			7773			rs2191566-G	rs2191566	0	2191566	intron_variant	0	0.28	4E-7	6.3979400086720375		1.52	[1.20-1.70]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	1q43	1	237103303	RYR2	RYR2			6262			rs7554607-A	rs7554607	0	7554607	intron_variant	0	0.56	2E-6	5.698970004336019		1.49	[1.20-1.70]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	2q36.1	2	223053265	KCNE4	KCNE4			23704			rs12621643-T	rs12621643	0	12621643	missense_variant	0	0.28	3E-6	5.522878745280337		1.48	[1.20-1.70]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	1p31.1	1	76306643	SIAT7C	ST6GALNAC3			256435			rs10873876-T	rs10873876	0	10873876	intron_variant	0	0.15	4E-6	5.3979400086720375		1.55	[1.20-1.80]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	3q26.32	3	178712151	KCNMB2	KCNMB2, KCNMB2-AS1			10242, 104797538			rs9290663-T	rs9290663	0	9290663	intron_variant	0	0.13	6E-6	5.221848749616356		1.58	[1.20-1.90]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	1q31.3	1	196875463	intergenic	LOC100996886			100996886			rs6428370-G	rs6428370	0	6428370	intron_variant	0	0.32	7E-6	5.154901959985743		1.43	[1.20-1.60]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	1q44	1	247526230	OR2C3	GCSAML, GCSAML-AS1			148823, 148824			rs1881797-C	rs1881797	0	1881797	intron_variant	0	0.18	7E-6	5.154901959985743		1.52	[1.20-1.80]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	12p13.32	12	4315956	C12orf5	CCND2 - C12orf5	894	57103		10600	5237	rs10849033-G	rs10849033	0	10849033	intron_variant	1	0.02	9E-6	5.045757490560675		2.55	[1.60-3.80]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	18p11.32	18	2498055	intergenic	LOC105371961 - METTL4	105371961	64863		126938	39470	rs1879352-C	rs1879352	0	1879352	intergenic_variant	1	0.16	9E-6	5.045757490560675		1.53	[1.20-1.80]	Affymetrix [307944]	N
2009-09-11	19684603	Trevino LR	2009-08-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19684603	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	317 European ancestry cases, 17,958 European ancestry controls	NA	10p11.21	10	34529060	PARD3	PARD3			56288			rs563507-A	rs563507	0	563507	intron_variant	0	0.04	9E-6	5.045757490560675		2.0	[1.40-2.70]	Affymetrix [307944]	N
2010-09-07	20639881	Conde L	2010-07-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20639881	Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.	Follicular lymphoma	681 European ancestry cases, 750 European ancestry controls	up to 3,164 European ancestry cases, 6,208 European ancestry controls	6p21.32	6	32697643	HLA-DQB1	HLA-DQB1 - MTCO3P1	3119	404026		30954	8501	rs10484561-G	rs10484561	0	10484561	intergenic_variant	1	0.11	1E-29	29.0	(FL)	1.95	[1.72-2.22]	Illumina [312768]	N
2010-09-07	20639881	Conde L	2010-07-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20639881	Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.	Follicular lymphoma	681 European ancestry cases, 750 European ancestry controls	up to 3,164 European ancestry cases, 6,208 European ancestry controls	11q24.1	11	123490689	intergenic	GRAMD1B			57476			rs735665-T	rs735665	0	735665	intron_variant	0	0.21	4E-9	8.397940008672037	(CLL/SLL)	1.81	[1.50-2.20]	Illumina [312768]	N
2010-09-07	20639881	Conde L	2010-07-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20639881	Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.	Follicular lymphoma	681 European ancestry cases, 750 European ancestry controls	up to 3,164 European ancestry cases, 6,208 European ancestry controls	6p21.33	6	31106253	C6orf15	HCG22 - C6orf15	285834	29113		46363	4970	rs6457327-C	rs6457327	0	6457327	downstream_gene_variant	1	0.56	7E-6	5.154901959985743	(FL)	1.47	[1.27-1.72]	Illumina [312768]	N
2011-01-03	21037568	Enciso-Mora V	2010-10-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21037568	A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).	Hodgkin's lymphoma	589 European ancestry cases, 5,199 European ancestry controls	2,057 European ancestry cases, 3,416 European ancestry controls	2p16.1	2	60839531	REL	RN7SL632P - LINC01185	106481095	400957		7602	8229	rs1432295-G	rs1432295	0	1432295	intron_variant	1	0.40	2E-8	7.698970004336019		1.22	[1.14-1.30]	Illumina [504374]	N
2011-01-03	21037568	Enciso-Mora V	2010-10-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21037568	A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).	Hodgkin's lymphoma	589 European ancestry cases, 5,199 European ancestry controls	2,057 European ancestry cases, 3,416 European ancestry controls	6p21.32	6	32460508	HLA-DRA	HLA-DRB9 - HLA-DRB5	3132	3127		419	56835	rs6903608-G	rs6903608	0	6903608	intron_variant	1	0.27	3E-50	49.52287874528034		1.7	[1.58-1.82]	Illumina [504374]	N
2011-01-03	21037568	Enciso-Mora V	2010-10-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21037568	A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).	Hodgkin's lymphoma	589 European ancestry cases, 5,199 European ancestry controls	2,057 European ancestry cases, 3,416 European ancestry controls	8q24.21	8	128180025	PVT1	MIR1208 - RN7SKP226	100302281	106480903		29837	40479	rs2019960-G	rs2019960	0	2019960	intergenic_variant	1	0.23	1E-13	13.0		1.33	[1.23-1.44]	Illumina [504374]	N
2011-01-03	21037568	Enciso-Mora V	2010-10-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21037568	A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).	Hodgkin's lymphoma	589 European ancestry cases, 5,199 European ancestry controls	2,057 European ancestry cases, 3,416 European ancestry controls	10p14	10	8051071	GATA3	GATA3-AS1, GATA3			399717, 2625			rs501764-C	rs501764	0	501764	non_coding_transcript_exon_variant	0	0.19	7E-8	7.154901959985743		1.25	[1.15-1.36]	Illumina [504374]	N
2011-01-12	21131588	Slager SL	2010-12-03	Blood	www.ncbi.nlm.nih.gov/pubmed/21131588	Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.	Chronic lymphocytic leukemia	407 European ancestry cases, 296 European ancestry controls	252 European ancestry cases, 965 European ancestry controls	16q24.1	16	85910833	IRF8	IRF8			3394			rs391525-?	rs391525	0	391525	intron_variant	0	0.66	3E-9	8.522878745280337		1.56	[1.35-1.82]	Affymetrix [827777]	N
2011-01-12	21131588	Slager SL	2010-12-03	Blood	www.ncbi.nlm.nih.gov/pubmed/21131588	Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.	Chronic lymphocytic leukemia	407 European ancestry cases, 296 European ancestry controls	252 European ancestry cases, 965 European ancestry controls	6p21.32	6	32610305	HLA-DRB5	HLA-DRB1 - LOC107986589	3123	107986589		20469	26883	rs674313-T	rs674313	0	674313	upstream_gene_variant	1	0.26	7E-9	8.154901959985743		1.69	[1.41-2.01]	Affymetrix [827777]	N
2011-01-12	21131588	Slager SL	2010-12-03	Blood	www.ncbi.nlm.nih.gov/pubmed/21131588	Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.	Chronic lymphocytic leukemia	407 European ancestry cases, 296 European ancestry controls	252 European ancestry cases, 965 European ancestry controls	6p21.32	6	32638979	HLA-DQA1	LOC107986589, HLA-DQA1			107986589, 3117			rs9272535-A	rs9272535	0	9272535	missense_variant	0	0.27	9E-8	7.045757490560675		1.61	[1.35-1.92]	Affymetrix [827777]	N
2011-01-03	21037568	Enciso-Mora V	2010-10-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21037568	A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).	Hodgkin's lymphoma	589 European ancestry cases, 5,199 European ancestry controls	2,057 European ancestry cases, 3,416 European ancestry controls	8q24.21	8	128063586	PVT1	PVT1			5820			rs2608053-G	rs2608053	0	2608053	intron_variant	0	0.52	1E-7	7.0		1.2	[1.12-1.28]	Illumina [504374]	N
2011-01-12	21131588	Slager SL	2010-12-03	Blood	www.ncbi.nlm.nih.gov/pubmed/21131588	Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.	Chronic lymphocytic leukemia	407 European ancestry cases, 296 European ancestry controls	252 European ancestry cases, 965 European ancestry controls	6p25.3	6	417727	NR	IRF4 - LOC105374875	3662	105374875		6284	33286	rs9378805-C	rs9378805	0	9378805	intergenic_variant	1	0.49	2E-6	5.698970004336019		1.38	[1.20-1.58]	Affymetrix [827777]	N
2011-05-25	21533074	Smedby KE	2011-04-21	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21533074	GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.	Follicular lymphoma	379 European ancestry cases, 791 European ancestry controls	1,049 European ancestry cases, 3,952 European ancestry controls	6p21.32	6	32696681	HLA-DQB1	HLA-DQB1 - MTCO3P1	3119	404026		29992	9463	rs2647012-G	rs2647012	0	2647012	intergenic_variant	1	0.56	2E-21	20.69897000433602		1.56	[1.43-1.72]	Illumina [298168]	N
2012-08-07	22700719	Slager SL	2012-06-13	Blood	www.ncbi.nlm.nih.gov/pubmed/22700719	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,121 European ancestry cases, 3,745 European ancestry controls	861 European ancestry cases, 2,033 European ancestry controls	6p21.31	6	33579060	BAK1	BAK1			578			rs210142-C	rs210142	0	210142	intron_variant	0	0.70	9E-16	15.045757490560675		1.4	[1.25-1.57]	Affymetrix, Illumina [~ 1500000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	3q26.2	3	169774313	MYNN	MYNN			55892			rs10936599-C	rs10936599	0	10936599	synonymous_variant	0		2E-9	8.698970004336019		1.26	[1.17-1.35]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	4q26	4	113762688	CAMK2D	CAMK2D - LOC105377375	817	105377375		761	108841	rs6858698-C	rs6858698	0	6858698	upstream_gene_variant	1		3E-9	8.522878745280337		1.31	[1.20-1.44]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	5p15.33	5	1344343	CLPTM1L	CLPTM1L			81037			rs31490-A	rs31490	0	31490	splice_region_variant	0		2E-7	6.698970004336019		1.18	[1.11-1.26]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	6q25.2	6	154157305	IPCEF1	IPCEF1, OPRM1			26034, 4988			rs2236256-C	rs2236256	0	2236256	3_prime_UTR_variant	0		2E-10	9.698970004336019		1.23	[1.15-1.30]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	7q31.33	7	124822607	POT1	POT1			25913			rs17246404-C	rs17246404	0	17246404	3_prime_UTR_variant	0		3E-8	7.522878745280337		1.22	[1.14-1.31]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	2p22.2	2	37240121	PRKD3, QPCT	NDUFAF7			55471			rs2041840-C	rs2041840	0	2041840	intron_variant	0	0.62	9E-6	5.045757490560675		1.2	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	2q13	2	111114320	ACOXL, BCL2L11	ACOXL, LOC400997			55289, 400997			rs1439287-A	rs1439287	0	1439287	intron_variant	0	0.48	5E-15	14.301029995663981		1.37	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	2q37.1	2	230226508	SP140, SP110	SP140			11262			rs13397985-G	rs13397985	0	13397985	intron_variant	0	0.19	5E-13	12.301029995663981		1.43	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	6p25.3	6	411064	IRF4	IRF4			3662			rs872071-G	rs872071	0	872071	3_prime_UTR_variant	0	0.51	3E-16	15.522878745280337		1.39	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	6p21.32	6	32289789	HLA	LOC101929163			101929163			rs926070-A	rs926070	0	926070	intron_variant	0		4E-8	7.3979400086720375	0.66	1.27	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	6p21.31	6	33572432	BAK1	RN7SL26P - BAK1	106479234	578		31432	114	rs210134-G	rs210134	0	210134	intron_variant	1	0.68	3E-6	5.522878745280337		1.31	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	8q24.21	8	127175774	POU5F1B	LOC105375752 - CASC19	105375752	103021165		6256	12011	rs2466024-A	rs2466024	0	2466024	intergenic_variant	1	0.41	3E-6	5.522878745280337		1.21	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	10q23.31	10	88990206	ACTA, FAS	ACTA2, FAS			59, 355			rs1800682-A	rs1800682	0	1800682	intron_variant	0	0.54	2E-8	7.698970004336019		1.25	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	11p15.5	11	2301599	C11orf21, TSPAN32	TSPAN32, C11orf21			10077, 29125			rs11022157-A	rs11022157	0	11022157	non_coding_transcript_exon_variant	0	0.36	3E-6	5.522878745280337		1.22	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	11q24.1	11	123490689	SCN3B, GRAMD1B	GRAMD1B			57476			rs735665-A	rs735665	0	735665	intron_variant	0	0.19	4E-24	23.397940008672037		1.64	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	15q15.1	15	40121915	BUB1B, BMF	BMF - MTND5P37	90427	107133493		13031	11856	rs8023845-G	rs8023845	0	8023845	intergenic_variant	1	0.78	2E-6	5.698970004336019		1.27	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	15q21.3	15	56090097	NEDD4, RFX7	CD24P2 - RFX7	936	64864		16009	436	rs16976734-G	rs16976734	0	16976734	3_prime_UTR_variant	1	0.11	4E-7	6.3979400086720375		1.36	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	15q23	15	69726651	RPLP1	PCAT29 - LOC107984788	104472713	107984788		30901	24368	rs7176508-A	rs7176508	0	7176508	regulatory_region_variant	1	0.38	8E-18	17.096910013008056		1.42	[NR]	Illumina [450000] (imputed)	N
2014-06-19	24292274	Speedy HE	2013-12-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24292274	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,739 European ancestry cases, 5,199 European ancestry controls	1,144 European ancestry cases, 3,151 European ancestry controls	16q24.1	16	85922065	IRF8	IRF8			3394			rs1044873-C	rs1044873	0	1044873	3_prime_UTR_variant	0	0.61	1E-9	9.0		1.29	[NR]	Illumina [450000] (imputed)	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	18q11.2	18	22074176	NR	LOC102724208 - RNU6ATAC20P	102724208	106480541		23017	56427	rs4800353-T	rs4800353	0	4800353	intergenic_variant	1	0.864	3E-7	6.522878745280337		1.22	[1.14-1.32]	Illumina [922031]	N
2014-05-13	24149102	Frampton M	2013-10-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24149102	Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.	Hodgkin's lymphoma	1,465 European ancestry cases, 6,417 European ancestry controls	1,071 European ancestry cases, 953 cases, 1,853 controls	2p16.1	2	60839531	NR	RN7SL632P - LINC01185	106481095	400957		7602	8229	rs1432295-G	rs1432295	0	1432295	intron_variant	1	0.4	1E-6	6.0		1.24	[NR]	Illumina [296129]	N
2014-05-13	24149102	Frampton M	2013-10-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24149102	Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.	Hodgkin's lymphoma	1,465 European ancestry cases, 6,417 European ancestry controls	1,071 European ancestry cases, 953 cases, 1,853 controls	10p14	10	8051071	NR	GATA3-AS1, GATA3			399717, 2625			rs501764-C	rs501764	0	501764	non_coding_transcript_exon_variant	0	0.19	4E-10	9.397940008672037		1.39	[NR]	Illumina [296129]	N
2014-05-13	24149102	Frampton M	2013-10-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24149102	Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.	Hodgkin's lymphoma	1,465 European ancestry cases, 6,417 European ancestry controls	1,071 European ancestry cases, 953 cases, 1,853 controls	8q24.21	8	128180025	NR	MIR1208 - RN7SKP226	100302281	106480903		29837	40479	rs2019960-G	rs2019960	0	2019960	intergenic_variant	1	0.23	6E-10	9.221848749616356		1.37	[NR]	Illumina [296129]	N
2014-05-13	24149102	Frampton M	2013-10-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24149102	Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.	Hodgkin's lymphoma	1,465 European ancestry cases, 6,417 European ancestry controls	1,071 European ancestry cases, 953 cases, 1,853 controls	6p21.32	6	32460508	NR	HLA-DRB9 - HLA-DRB5	3132	3127		419	56835	rs6903608-G	rs6903608	0	6903608	intron_variant	1	0.27	5E-27	26.30102999566398		1.62	[NR]	Illumina [296129]	N
2012-08-07	22700719	Slager SL	2012-06-13	Blood	www.ncbi.nlm.nih.gov/pubmed/22700719	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,121 European ancestry cases, 3,745 European ancestry controls	861 European ancestry cases, 2,033 European ancestry controls	2q13	2	111039881	NR	ACOXL			55289			rs17483466-?	rs17483466	0	17483466	intron_variant	0	0.80	5E-9	8.301029995663981		1.43	[1.27-1.61]	Affymetrix, Illumina [~ 1500000] (imputed)	N
2012-08-07	22700719	Slager SL	2012-06-13	Blood	www.ncbi.nlm.nih.gov/pubmed/22700719	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,121 European ancestry cases, 3,745 European ancestry controls	861 European ancestry cases, 2,033 European ancestry controls	2q37.1	2	230226508	NR	SP140			11262			rs13397985-?	rs13397985	0	13397985	intron_variant	0	0.81	2E-7	6.698970004336019		1.39	[1.23-1.59]	Affymetrix, Illumina [~ 1500000] (imputed)	N
2012-08-07	22700719	Slager SL	2012-06-13	Blood	www.ncbi.nlm.nih.gov/pubmed/22700719	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,121 European ancestry cases, 3,745 European ancestry controls	861 European ancestry cases, 2,033 European ancestry controls	2q37.3	2	241431686	NR	FARP2			9855			rs757978-T	rs757978	0	757978	missense_variant	0	0.26	3E-6	5.522878745280337		1.46	[1.25-1.72]	Affymetrix, Illumina [~ 1500000] (imputed)	N
2012-08-07	22700719	Slager SL	2012-06-13	Blood	www.ncbi.nlm.nih.gov/pubmed/22700719	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,121 European ancestry cases, 3,745 European ancestry controls	861 European ancestry cases, 2,033 European ancestry controls	6p25.3	6	411064	NR	IRF4			3662			rs872071-G	rs872071	0	872071	3_prime_UTR_variant	0	0.53	8E-14	13.096910013008056		1.47	[1.33-1.63]	Affymetrix, Illumina [~ 1500000] (imputed)	N
2012-08-07	22700719	Slager SL	2012-06-13	Blood	www.ncbi.nlm.nih.gov/pubmed/22700719	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,121 European ancestry cases, 3,745 European ancestry controls	861 European ancestry cases, 2,033 European ancestry controls	11q24.1	11	123490689	NR	GRAMD1B			57476			rs735665-A	rs735665	0	735665	intron_variant	0	0.20	3E-12	11.522878745280337		1.52	[1.35-1.72]	Affymetrix, Illumina [~ 1500000] (imputed)	N
2012-08-07	22700719	Slager SL	2012-06-13	Blood	www.ncbi.nlm.nih.gov/pubmed/22700719	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,121 European ancestry cases, 3,745 European ancestry controls	861 European ancestry cases, 2,033 European ancestry controls	15q23	15	69726651	NR	PCAT29 - LOC107984788	104472713	107984788		30901	24368	rs7176508-A	rs7176508	0	7176508	regulatory_region_variant	1	0.37	3E-11	10.522878745280337		1.42	[1.28-1.58]	Affymetrix, Illumina [~ 1500000] (imputed)	N
2012-08-07	22700719	Slager SL	2012-06-13	Blood	www.ncbi.nlm.nih.gov/pubmed/22700719	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	1,121 European ancestry cases, 3,745 European ancestry controls	861 European ancestry cases, 2,033 European ancestry controls	16q24.1	16	85942053	NR	LOC107984811 - LOC105371388	107984811	105371388		5202	3326	rs305061-?	rs305061	0	305061	intergenic_variant	1	0.73	9E-8	7.045757490560675		1.33	[1.2-1.49]	Affymetrix, Illumina [~ 1500000] (imputed)	N
2013-12-05	23749188	Tan DE	2013-06-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23749188	Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population.	B cell non-Hodgkin lymphoma	253 Singaporean Chinese ancestry cases, 1,438 Singaporean Chinese ancestry controls	1,175 Han Chinese ancestry cases, 5,492 Han Chinese ancestry controls	3q27.3	3	187931631	BCL6, LPP	LOC105374265			105374265			rs6773854-C	rs6773854	0	6773854	downstream_gene_variant	0	0.21	3E-13	12.522878745280337		1.44	[1.31-1.59]	Illumina [550946]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	10q23.31	10	88999967	ACTA2, FAS	FAS			355			rs4406737-G	rs4406737	0	4406737	intron_variant	0	0.57	1E-14	14.0		1.27	[1.19-1.33]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	18q21.33	18	63126316	BCL2	BCL2			596			rs4987855-G	rs4987855	0	4987855	3_prime_UTR_variant	0	0.91	3E-12	11.522878745280337		1.47	[1.32-1.61]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	11p15.5	11	2289922	TSPAN32	ASCL2 - C11orf21	430	29125		18970	6355	rs7944004-T	rs7944004	0	7944004	intergenic_variant	1	0.49	2E-10	9.698970004336019		1.2	[1.13-1.27]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	4q25	4	108095668	LEF1	LEF1			51176			rs898518-A	rs898518	0	898518	intron_variant	0	0.59	4E-10	9.397940008672037		1.2	[1.14-1.27]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	2q33.1	2	201246657	CASP8, CASP10	CASP8			841			rs3769825-T	rs3769825	0	3769825	intron_variant	0	0.45	3E-9	8.522878745280337		1.19	[1.12-1.25]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	9p21.3	9	22206988	AS1, CDKN2B	CDKN2B-AS1 - DMRTA1	100048912	63951		85891	239853	rs1679013-C	rs1679013	0	1679013	intron_variant	1	0.52	1E-8	8.0		1.19	[1.12-1.27]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	18q21.32	18	59955055	PMAIP1	LOC105372151 - NFE2L3P1	105372151	642996		3735	12753	rs4368253-C	rs4368253	0	4368253	intergenic_variant	1	0.69	3E-8	7.522878745280337		1.19	[1.12-1.27]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	2q13	2	110858527	ACOXL, BCL2L11	ACOXL			55289			rs13401811-G	rs13401811	0	13401811	intron_variant	0	0.81	2E-18	17.69897000433602		1.41	[1.30-1.52]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	8q22.3	8	102566646	ODF1, KLF10	ODF1 - POU5F1P2	4956	100129512		5629	54590	rs2511714-G	rs2511714	0	2511714	intergenic_variant	1	0.41	5E-8	7.301029995663981		1.19	[1.12-1.27]	Illumina [549934]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	14q22.1	14	50936813	PYGL	PYGL			5836			rs7142143-C	rs7142143	0	7142143	intron_variant	0	0.01	7E-9	8.154901959985743		3.61	[2.34-5.57]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	3p22.1	3	39805581	MYRIP	LOC105377039 - MYRIP	105377039	25924		2677	3333	rs17079534-A	rs17079534	0	17079534	upstream_gene_variant	1	0.005	2E-7	6.698970004336019		4.07	[2.40-6.87]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	2q23.3	2	149601110	LOC642340	LOC101929231			101929231			rs10170236-C	rs10170236	0	10170236	intron_variant	0	0.256	4E-6	5.3979400086720375		1.45	[1.24-1.69]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1p31.3	1	66303417	PDE4B	PDE4B			5142			rs6683977-C	rs6683977	0	6683977	intron_variant	0	0.449	5E-6	5.301029995663981		1.41	[1.22-1.64]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	2q23.2	2	149540704	intergenic	LYPD6 - MMADHC	130574	27249		66556	28929	rs7578361-C	rs7578361	0	7578361	intergenic_variant	1	0.276	8E-6	5.096910013008056		1.4	[1.21-1.63]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	7q34	7	140002794	TBXAS1	TBXAS1			6916			rs17837497-A	rs17837497	0	17837497	intron_variant	0	0.016	2E-6	5.698970004336019		2.34	[1.65-3.31]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	7q21.11	7	78702149	MAGI2	MAGI2			9863			rs1496766-C	rs1496766	0	1496766	intron_variant	0	0.014	5E-6	5.301029995663981		2.84	[1.81-4.44]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	18q12.3	18	43011119	RIT2	RIT2			6014			rs9958208-A	rs9958208	0	9958208	intron_variant	0	0.099	5E-6	5.301029995663981		1.62	[1.32-1.99]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	10q22.1	10	70281049	NPFFR1	NPFFR1			64106			rs41322152-C	rs41322152	0	41322152	intron_variant	0	0.012	8E-6	5.096910013008056		2.52	[1.68-3.79]	Affymetrix [444044]	N
2012-12-06	23007406	Yang JJ	2012-09-24	Blood	www.ncbi.nlm.nih.gov/pubmed/23007406	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	1,268 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1,267 European, South Asian, East Asian, African American/Afro-Caribbean, Hispanic and other ancestry cases	1p31.3	1	66296783	PDE4B	PDE4B			5142			rs546784-A	rs546784	0	546784	intron_variant	0	0.457	9E-6	5.045757490560675		1.4	[1.20-1.62]	Affymetrix [444044]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	3q28	3	189683987	TP63	TP63			8626			rs17505102-C	rs17505102	0	17505102	intron_variant	0	0.15	3E-8	7.522878745280337	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	11q12.1	11	56408195	OR8U8	OR5AL2P - OR5AL1	79476	79482		13546	4502	rs1945213-C	rs1945213	0	1945213	upstream_gene_variant	1	0.31	9E-11	10.045757490560675	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	11p11.2	11	48093537	PTPRJ	PTPRJ			5795			rs3942852-C	rs3942852	0	3942852	intron_variant	0	0.22	5E-7	6.301029995663981	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	14q24.3	14	76237008	C14orf118	LOC105370575			105370575			rs7156960-G	rs7156960	0	7156960	intron_variant	0	0.48	4E-6	5.3979400086720375	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	8p21.3	8	19793650	INTS10	LOC107986920 - INTS10	107986920	55174		14682	23499	rs920590-C	rs920590	0	920590	regulatory_region_variant	1	0.31	6E-9	8.221848749616356	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	4q13.1	4	58637561	intergenic	LOC107986228 - LOC105377672	107986228	105377672		47318	138861	rs282708-A	rs282708	0	282708	intergenic_variant	1	0.4	5E-6	5.301029995663981	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	1p13.3	1	110716148	KCNA3	LOC107985174			107985174			rs343604-T	rs343604	0	343604	intergenic_variant	0	0.08	1E-6	6.0	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	8q23.1	8	107960070	RSPO2	RSPO2			340419			rs630662-A	rs630662	0	630662	intron_variant	0	0.29	2E-6	5.698970004336019	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	1p31.3	1	66223426	PDE4B	PDE4B			5142			rs17423910-G	rs17423910	0	17423910	intron_variant	0	0.17	6E-6	5.221848749616356	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	6q24.2	6	143337875	AIG1	AIG1			51390			rs6901152-T	rs6901152	0	6901152	intron_variant	0	0.43	5E-6	5.301029995663981	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	4q32.1	4	158523162	RXFP1	RXFP1			59350			rs936094-C	rs936094	0	936094	intron_variant	0	0.17	1E-6	6.0	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	3p14.3	3	55773227	ERC2	ERC2			26059			rs6445754-C	rs6445754	0	6445754	intron_variant	0	0.22	5E-6	5.301029995663981	(ETV6-RUNX1 positive, Northern European)			Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	10q21.2	10	61963818	ARID5B	ARID5B			84159			rs10821936-C	rs10821936	0	10821936	intron_variant	0	0.31	1E-11	11.0	(ETV6-RUNX1 positive)	1.42	[1.29 - 1.58]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	7p12.2	7	50398606	IKZF1	IKZF1			10320			rs11978267-G	rs11978267	0	11978267	intron_variant	0	0.27	9E-11	10.045757490560675	(ETV6-RUNX1 positive)	1.43	[1.28 - 1.59]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	14q11.2	14	23119848	CEBPE	CEBPE - SLC7A8	1053	23428		237	5447	rs2239633-C	rs2239633	0	2239633	upstream_gene_variant	1	0.5	2E-8	7.698970004336019	(ETV6-RUNX1 positive)	1.3333333	[1.2-1.49]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	7p12.2	7	50498129	DDC	DDC			1644			rs2167364-G	rs2167364	0	2167364	intron_variant	0	0.31	2E-7	6.698970004336019	(ETV6-RUNX1 positive)	1.32	[1.19 - 1.46]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	7p12.2	7	50402906	IKZF1	IKZF1			10320			rs4132601-G	rs4132601	0	4132601	3_prime_UTR_variant	0	0.27	8E-13	12.096910013008056		1.43	[1.30 - 1.58]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	7p12.2	7	50498129	DDC	DDC			1644			rs2167364-G	rs2167364	0	2167364	intron_variant	0	0.31	2E-8	7.698970004336019		1.32	[1.20 - 1.45]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	10q21.2	10	61963818	ARID5B	ARID5B			84159			rs10821936-C	rs10821936	0	10821936	intron_variant	0	0.31	4E-15	14.397940008672037		1.46	[1.33 - 1.60]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	14q11.2	14	23119848	CEBPE	CEBPE - SLC7A8	1053	23428		237	5447	rs2239633-C	rs2239633	0	2239633	upstream_gene_variant	1	0.5	4E-10	9.397940008672037		1.3513513	[1.22-1.47]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	6q14.1	6	77080091	intergenic	LOC101928570			101928570			rs7738636-A	rs7738636	0	7738636	intergenic_variant	0	0.76	6E-6	5.221848749616356		1.2658228	[1.15-1.41]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	11q12.1	11	56408195	OR8U8	OR5AL2P - OR5AL1	79476	79482		13546	4502	rs1945213-G	rs1945213	0	1945213	upstream_gene_variant	1	0.69	3E-8	7.522878745280337		1.2987013	[1.19-1.43]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	4q13.1	4	58637561	intergenic	LOC107986228 - LOC105377672	107986228	105377672		47318	138861	rs282708-A	rs282708	0	282708	intergenic_variant	1	0.41	8E-6	5.096910013008056		1.23	[1.12-1.35 ]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	3q28	3	189683987	TP63	TP63			8626			rs17505102-G	rs17505102	0	17505102	intron_variant	0	0.85	2E-8	7.698970004336019		1.4705882	[1.28-1.67]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	14q24.3	14	76237008	C14orf118	LOC105370575			105370575			rs7156960-C	rs7156960	0	7156960	intron_variant	0	0.53	3E-6	5.522878745280337		1.2195122	[1.12-1.33]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	3q28	3	189683987	TP63	TP63			8626			rs17505102-G	rs17505102	0	17505102	intron_variant	0	0.85	9E-9	8.045757490560675	(ETV6-RUNX1 positive)	1.5873016	[1.33-1.92]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	11q12.1	11	56408195	OR8U8	OR5AL2P - OR5AL1	79476	79482		13546	4502	rs1945213-G	rs1945213	0	1945213	upstream_gene_variant	1	0.69	4E-8	7.3979400086720375	(ETV6-RUNX1 positive)	1.2820514	[1.14-1.45]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	11p11.2	11	48093537	PTPRJ	PTPRJ			5795			rs3942852-T	rs3942852	0	3942852	intron_variant	0	0.78	1E-6	6.0	(ETV6-RUNX1 positive)	1.2987013	[1.12-1.47]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	14q24.3	14	76237008	C14orf118	LOC105370575			105370575			rs7156960-C	rs7156960	0	7156960	intron_variant	0	0.52	1E-6	6.0	(ETV6-RUNX1 positive)	1.2048193	[1.09-1.33]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	15q26.1	15	92114143	SLCO3A1	SLCO3A1			28232			rs207954-C	rs207954	0	207954	intron_variant	0	0.72	1E-6	6.0	(ETV6-RUNX1 positive)	1.25	[1.08-1.43]	Affymetrix [355750]	N
2015-05-08	22076464	Ellinghaus E	2011-11-11	Leukemia	www.ncbi.nlm.nih.gov/pubmed/22076464	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	Acute lymphoblastic leukemia (childhood)	419 European ancestry ETV6-RUNX1 positive cases, 474 European ancestry controls	951 European ancestry ETV6-RUNX1 positive cases, 326 European ancestry ETV6-RUNX1 negative cases, 3,061 European ancestry controls	8p21.3	8	19793650	INTS10	LOC107986920 - INTS10	107986920	55174		14682	23499	rs920590-C	rs920590	0	920590	regulatory_region_variant	1	0.31	2E-6	5.698970004336019	(ETV6-RUNX1 positive)	1.19	[1.07 - 1.33 ]	Affymetrix [355750]	N
2015-07-27	25468567	Perez-Andreu V	2014-12-02	Blood	www.ncbi.nlm.nih.gov/pubmed/25468567	A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.	Acute lymphoblastic leukemia (adolescents and young adults)	99 European ancestry cases, 1,381 European ancestry controls, 15 African American cases, 1,363 African American controls, 76 Hispanic cases, 1,008 Hispanic controls, 118 other ancestry cases, 2,909 other ancestry controls	72 European ancestry cases, 3,667 European ancestry controls, 9 African American cases, 1,076 African American controls, 34 Hispanic cases, 501 Hispanic controls, 47 other ancestry cases, 511 other ancestry controls	10p14	10	8062245	GATA3	GATA3			2625			rs3824662-A	rs3824662	0	3824662	intron_variant	0	0.20	3E-10	9.522878745280337		1.77	[1.48-2.12]	Affymetrix [635297]	N
2015-06-13	25310577	Evans TJ	2014-10-13	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25310577	Confirmation of Childhood Acute Lymphoblastic Leukemia Variants, ARID5B and IKZF1, and Interaction with Parental Environmental Exposures.	Acute lymphoblastic leukemia (childhood)	358 European ancestry cases, 1,192 European ancestry controls	441 European ancestry cases, 1,542 European ancestry controls	10q21.2	10	61963136	ARID5B	ARID5B			84159			rs4245595-C	rs4245595	0	4245595	intron_variant	0	0.34	2E-9	8.698970004336019		1.63	[1.38–1.93]	Illumina [7162141] (imputed)	N
2015-06-13	25310577	Evans TJ	2014-10-13	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25310577	Confirmation of Childhood Acute Lymphoblastic Leukemia Variants, ARID5B and IKZF1, and Interaction with Parental Environmental Exposures.	Acute lymphoblastic leukemia (childhood)	358 European ancestry cases, 1,192 European ancestry controls	441 European ancestry cases, 1,542 European ancestry controls	7p12.2	7	50410929	IKZF1	IKZF1 - RNU6-1091P	10320	106480637		5828	24451	rs1110701-G	rs1110701	0	1110701	regulatory_region_variant	1	0.28	7E-9	8.154901959985743		1.69	[1.42–2.02]	Illumina [7162141] (imputed)	N
2016-02-24	25987655	Fernandez CA	2015-05-18	Blood	www.ncbi.nlm.nih.gov/pubmed/25987655	Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.	Asparaginase hypersensitivity in acute lymphoblastic leukemia	3,126 child cases	182 child cases	6p21.32	6	32172710	AGPAT1	AGPAT1			10554			rs3130284-C	rs3130284	0	3130284	intron_variant	0	NR	7E-6	5.154901959985743		1.464		Affymetrix [NR]	N
2015-11-21	25710658	Diouf B	2015-02-24	JAMA	www.ncbi.nlm.nih.gov/pubmed/25710658	Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	53 European ancestry cases with peripheral neuropathy, 156 cases without peripheral neuropathy, 10 African ancestry cases with peripheral neuropathy, 33 African ancestry cases without peripheral neuropathy, 1 Asian ancestry case with peripheral neuropathy, 1 Asian ancestry case without peripheral neuropathy, 14 Hispanic cases with peripheral neuropathy, 30 Hispanic cases without peripheral neuropathy, 8 cases with peripheral neuropathy, 15 cases without peripheral neuropathy	NA	5p15.33	5	609978	CEP72	LOC100996325, LOC105374608			100996325, 105374608			rs924607-T	rs924607	0	924607	intron_variant	0	NR	6E-9	8.221848749616356		2.43	[1.70-3.49]	Affymetrix [1576016] (imputed)	N
2015-11-21	25710658	Diouf B	2015-02-24	JAMA	www.ncbi.nlm.nih.gov/pubmed/25710658	Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	53 European ancestry cases with peripheral neuropathy, 156 cases without peripheral neuropathy, 10 African ancestry cases with peripheral neuropathy, 33 African ancestry cases without peripheral neuropathy, 1 Asian ancestry case with peripheral neuropathy, 1 Asian ancestry case without peripheral neuropathy, 14 Hispanic cases with peripheral neuropathy, 30 Hispanic cases without peripheral neuropathy, 8 cases with peripheral neuropathy, 15 cases without peripheral neuropathy	NA	2p14	2	67075611	ETAA1	LOC105374785 - LOC102800447	105374785	102800447		59142	10835	rs17032980-?	rs17032980	0	17032980	intergenic_variant	1	NR	1E-8	8.0		3.17	[1.95-5.17]	Affymetrix [1576016] (imputed)	N
2015-11-21	25710658	Diouf B	2015-02-24	JAMA	www.ncbi.nlm.nih.gov/pubmed/25710658	Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	53 European ancestry cases with peripheral neuropathy, 156 cases without peripheral neuropathy, 10 African ancestry cases with peripheral neuropathy, 33 African ancestry cases without peripheral neuropathy, 1 Asian ancestry case with peripheral neuropathy, 1 Asian ancestry case without peripheral neuropathy, 14 Hispanic cases with peripheral neuropathy, 30 Hispanic cases without peripheral neuropathy, 8 cases with peripheral neuropathy, 15 cases without peripheral neuropathy	NA	11q14.3	11	92245852	MTNR1B	FAT3			120114			rs12786200-?	rs12786200	0	12786200	intergenic_variant	0	NR	3E-8	7.522878745280337		4.35	[2.50-7.69]	Affymetrix [1576016] (imputed)	N
2015-11-21	25710658	Diouf B	2015-02-24	JAMA	www.ncbi.nlm.nih.gov/pubmed/25710658	Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	53 European ancestry cases with peripheral neuropathy, 156 cases without peripheral neuropathy, 10 African ancestry cases with peripheral neuropathy, 33 African ancestry cases without peripheral neuropathy, 1 Asian ancestry case with peripheral neuropathy, 1 Asian ancestry case without peripheral neuropathy, 14 Hispanic cases with peripheral neuropathy, 30 Hispanic cases without peripheral neuropathy, 8 cases with peripheral neuropathy, 15 cases without peripheral neuropathy	NA	9p21.1	9	32867483	TMEM215	LOC107987060 - APTX	107987060	54840		24578	16389	rs4463516-?	rs4463516	0	4463516	intron_variant	1	NR	3E-8	7.522878745280337		2.89	[1.90-4.39]	Affymetrix [1576016] (imputed)	N
2015-11-21	25710658	Diouf B	2015-02-24	JAMA	www.ncbi.nlm.nih.gov/pubmed/25710658	Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	53 European ancestry cases with peripheral neuropathy, 156 cases without peripheral neuropathy, 10 African ancestry cases with peripheral neuropathy, 33 African ancestry cases without peripheral neuropathy, 1 Asian ancestry case with peripheral neuropathy, 1 Asian ancestry case without peripheral neuropathy, 14 Hispanic cases with peripheral neuropathy, 30 Hispanic cases without peripheral neuropathy, 8 cases with peripheral neuropathy, 15 cases without peripheral neuropathy	NA	8q22.1	8	95011854	NDUFAF6	NDUFAF6			137682			rs7818688-?	rs7818688	0	7818688	intron_variant	0	NR	4E-8	7.3979400086720375		4.26	[2.45-7.42]	Affymetrix [1576016] (imputed)	N
2016-02-24	25987655	Fernandez CA	2015-05-18	Blood	www.ncbi.nlm.nih.gov/pubmed/25987655	Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.	Asparaginase hypersensitivity in acute lymphoblastic leukemia	3,126 child cases	182 child cases	20q13.2	20	51419700	NFATC2	NFATC2			4773			rs6021191 -T	rs6021191	0	6021191	intron_variant	0		4E-8	7.3979400086720375		3.109		Affymetrix [NR]	N
2016-02-24	25987655	Fernandez CA	2015-05-18	Blood	www.ncbi.nlm.nih.gov/pubmed/25987655	Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.	Asparaginase hypersensitivity in acute lymphoblastic leukemia	3,126 child cases	182 child cases	6p21.32	6	32584318	HLA-DRB1	HLA-DRB1			3123			rs17885382 -T	rs17885382	0	17885382	missense_variant	0		3E-6	5.522878745280337		1.627		Affymetrix [NR]	N
2016-02-24	25987655	Fernandez CA	2015-05-18	Blood	www.ncbi.nlm.nih.gov/pubmed/25987655	Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.	Asparaginase hypersensitivity in acute lymphoblastic leukemia	3,126 child cases	182 child cases	9q34.3	9	138043623	CACNA1B	LOC101928786, CACNA1B			101928786, 774			rs7865267 -T	rs7865267	0	7865267	intron_variant	0		3E-6	5.522878745280337		2.012		Affymetrix [NR]	N
2016-02-24	25987655	Fernandez CA	2015-05-18	Blood	www.ncbi.nlm.nih.gov/pubmed/25987655	Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.	Asparaginase hypersensitivity in acute lymphoblastic leukemia	3,126 child cases	182 child cases	6p21.32	6	32154695	PPT2	PPT2-EGFL8, PPT2			100532746, 9374			rs3096696 -A	rs3096696	0	3096696	missense_variant	0		4E-6	5.3979400086720375		1.478		Affymetrix [NR]	N
2016-02-24	25987655	Fernandez CA	2015-05-18	Blood	www.ncbi.nlm.nih.gov/pubmed/25987655	Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.	Asparaginase hypersensitivity in acute lymphoblastic leukemia	3,126 child cases	182 child cases	7q21.3	7	94008313	BET1	LOC107986820			107986820			rs10260824 -C	rs10260824	0	10260824	intron_variant	0		5E-6	5.301029995663981		1.749		Affymetrix [NR]	N
2016-02-24	25987655	Fernandez CA	2015-05-18	Blood	www.ncbi.nlm.nih.gov/pubmed/25987655	Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.	Asparaginase hypersensitivity in acute lymphoblastic leukemia	3,126 child cases	182 child cases	17p13.2	17	5489769	DERL2	MIS12			79003			rs1805465 -T	rs1805465	0	1805465	3_prime_UTR_variant	0		6E-6	5.221848749616356		2.339		Affymetrix [NR]	N
2016-02-24	25987655	Fernandez CA	2015-05-18	Blood	www.ncbi.nlm.nih.gov/pubmed/25987655	Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.	Asparaginase hypersensitivity in acute lymphoblastic leukemia	3,126 child cases	182 child cases	10q25.1	10	106677881	SORCS1	SORCS1			114815			rs821931 -G	rs821931	0	821931	intron_variant	0		9E-6	5.045757490560675		1.587		Affymetrix [NR]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	2q13	2	111039881	ACOXL	ACOXL			55289			rs17483466-G	rs17483466	0	17483466	intron_variant	0	0.2	4E-17	16.397940008672037		1.37	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	2q37.1	2	230226508	SP140	SP140			11262			rs13397985-G	rs13397985	0	13397985	intron_variant	0	0.18	1E-22	22.0		1.45	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	2q37.3	2	241431686	FARP2	FARP2			9855			rs757978-A	rs757978	0	757978	missense_variant	0	0.11	1E-7	7.0		1.29	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	6p25.3	6	411064	IRF4	IRF4			3662			rs872071-G	rs872071	0	872071	3_prime_UTR_variant	0	0.51	6E-20	19.221848749616356		1.33	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	6p21.32	6	32658495	HLA	HLA-DQA1 - HLA-DQB1	3117	3119		3649	969	rs9273363-A	rs9273363	0	9273363	upstream_gene_variant	1	0.27	2E-10	9.698970004336019		1.24	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	6p21.31	6	33579060	BAK1	BAK1			578			rs210142-C	rs210142	0	210142	intron_variant	0	0.72	5E-8	7.301029995663981		1.22	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	8q24.21	8	127198984	MYC	CASC19 - CCAT1	103021165	100507056		1357	8398	rs2466035-C	rs2466035	0	2466035	intron_variant	1	0.31	2E-8	7.698970004336019		1.21	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	11q24.1	11	123490689	SCN3B	GRAMD1B			57476			rs735665-A	rs735665	0	735665	intron_variant	0	0.19	4E-39	38.39794000867204		1.62	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	15q21.3	15	56483399	MNS1, RFXDC2	LOC105370831			105370831			rs11636802-G	rs11636802	0	11636802	intergenic_variant	0	0.11	2E-13	12.698970004336019		1.41	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	15q23	15	69726651	RPLP1	PCAT29 - LOC107984788	104472713	107984788		30901	24368	rs7176508-A	rs7176508	0	7176508	regulatory_region_variant	1	0.39	1E-17	17.0		1.32	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	16q24.1	16	85894208	IRF8	RPL10AP12 - IRF8	401863	3394		77641	4960	rs391023-G	rs391023	0	391023	upstream_gene_variant	1	0.63	5E-17	16.30102999566398		1.33	[NR]	Illumina [549934]	N
2014-01-07	23770605	Berndt SI	2013-06-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23770605	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	2,179 European ancestry cases, 6,221 European ancestry controls	1,709 European ancestry cases, 6,318 European ancestry controls	18q21.33	18	63126688	BCL2	BCL2			596			rs4987852-?	rs4987852	0	4987852	3_prime_UTR_variant	0	NR	8E-11	10.096910013008056		1.41	[NR]	Illumina [549934]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	3p13	3	70879779	FOXP1	RNU6-281P - FOXP1	106481267	27086		71327	74935	rs2687201-T	rs2687201	0	2687201	regulatory_region_variant	1	0.303	5E-9	8.301029995663981		1.18	[1.12-1.25]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	3q26.2	3	168007561	NR	LOC107986152			107986152			rs7632500-C	rs7632500	0	7632500	downstream_gene_variant	0	0.038	1E-6	6.0		1.37	[1.21-1.55]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	6q11.1	6	61285855	NR	RBBP4P3 - KHDRBS2	730180	202559		411212	256824	rs2342002-T	rs2342002	0	2342002	intergenic_variant	1	0.214	7E-6	5.154901959985743		1.15	[1.08-1.23]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	7q36.2	7	153574792	NR	LOC107986750 - DPP6	107986750	1804		50561	173194	rs11771429-G	rs11771429	0	11771429	intergenic_variant	1	0.816	8E-6	5.096910013008056		1.1905	[1.1-1.28]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	9q22.32	9	93953746	BARX1	BARX1			56033			rs11789015-A	rs11789015	0	11789015	intron_variant	0	0.717	1E-9	9.0		1.2048	[1.14-1.27]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	15q21.3	15	57960908	NR	ALDH1A2			8854			rs3784262-A	rs3784262	0	3784262	intron_variant	0	0.54	7E-7	6.154901959985743		1.1364	[1.09-1.2]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	16q24.1	16	86430089	FOXF1	LINC00917 - LOC401864	732275	401864		84410	4755	rs2178146-A	rs2178146	0	2178146	downstream_gene_variant	1	0.587	1E-6	6.0		1.1364	[1.09-1.2]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	19p13.11	19	18692362	CRTC1	CRTC1			23373			rs10419226-A	rs10419226	0	10419226	intron_variant	0	0.456	4E-10	9.397940008672037		1.18	[1.12-1.24]	Illumina [922031]	N
2014-04-10	24121790	Levine DM	2013-10-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24121790	A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	3,928 European ancestry cases, 3,207 European ancestry controls	1,636 European ancestry cases, 6,911 European ancestry controls	19q13.32	19	44738850	NR	LOC107985305 - BCL3	107985305	602		13642	3771	rs2927438-C	rs2927438	0	2927438	regulatory_region_variant	1	0.778	2E-6	5.698970004336019		1.1628	[1.1-1.25]	Illumina [922031]	N
2014-05-13	24149102	Frampton M	2013-10-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24149102	Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.	Hodgkin's lymphoma	1,465 European ancestry cases, 6,417 European ancestry controls	1,071 European ancestry cases, 953 cases, 1,853 controls	3p24.1	3	27723132	EOMES	EOMES - LOC105377007	8320	105377007		417	74456	rs3806624-G	rs3806624	0	3806624	upstream_gene_variant	1	0.45	1E-12	12.0		1.26	[1.18-1.34]	Illumina [296129]	N
2014-05-13	24149102	Frampton M	2013-10-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24149102	Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.	Hodgkin's lymphoma	1,465 European ancestry cases, 6,417 European ancestry controls	1,071 European ancestry cases, 953 cases, 1,853 controls	6q23.3	6	135093866	HBS1L, MYB	LOC107986647 - LOC105378010	107986647	105378010		35130	12979	rs7745098-G	rs7745098	0	7745098	intron_variant	1	0.48	3E-9	8.522878745280337		1.21	[1.14-1.29]	Illumina [296129]	N
2015-02-06	24920014	Cozen W	2014-06-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24920014	A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.	Hodgkin's lymphoma	1,816 European ancestry cases, 7,877 European ancestry controls	1,281 European ancestry cases, 3,218 European ancestry controls	2p16.1	2	60816699	REL	PAPOLG - RN7SL632P	64895	106481095		14613	14965	rs13034020-G	rs13034020	0	13034020	intergenic_variant	1	0.16	3E-6	5.522878745280337		1.28	[1.16–1.43]	Affymetrix, Illumina [1004829] (imputed)	N
2015-02-06	24920014	Cozen W	2014-06-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24920014	A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.	Hodgkin's lymphoma	1,816 European ancestry cases, 7,877 European ancestry controls	1,281 European ancestry cases, 3,218 European ancestry controls	5q31.1	5	132662721	IL13	IL13 - IL4	3596	3565		1612	11265	rs2069757-A	rs2069757	0	2069757	intron_variant	1	0.07	2E-11	10.698970004336019		1.59	[1.39–1.82]	Affymetrix, Illumina [1004829] (imputed)	N
2015-02-06	24920014	Cozen W	2014-06-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24920014	A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.	Hodgkin's lymphoma	1,816 European ancestry cases, 7,877 European ancestry controls	1,281 European ancestry cases, 3,218 European ancestry controls	6p21.32	6	32460508	HLA class II, HLA class I	HLA-DRB9 - HLA-DRB5	3132	3127		419	56835	rs6903608-C	rs6903608	0	6903608	intron_variant	1	0.30	7E-31	30.154901959985743		1.64	[1.51–1.78]	Affymetrix, Illumina [1004829] (imputed)	N
2015-02-06	24920014	Cozen W	2014-06-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24920014	A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.	Hodgkin's lymphoma	1,816 European ancestry cases, 7,877 European ancestry controls	1,281 European ancestry cases, 3,218 European ancestry controls	8q24.21	8	128180025	intergenic	MIR1208 - RN7SKP226	100302281	106480903		29837	40479	rs2019960-C	rs2019960	0	2019960	intergenic_variant	1	0.22	7E-8	7.154901959985743		1.3	[1.18–1.43]	Affymetrix, Illumina [1004829] (imputed)	N
2015-02-06	24920014	Cozen W	2014-06-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24920014	A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.	Hodgkin's lymphoma	1,816 European ancestry cases, 7,877 European ancestry controls	1,281 European ancestry cases, 3,218 European ancestry controls	10p14	10	8068061	GATA3	GATA3			2625			rs444929-C	rs444929	0	444929	intron_variant	0	0.21	3E-6	5.522878745280337		1.26	[1.15–1.39]	Affymetrix, Illumina [1004829] (imputed)	N
2015-02-06	24920014	Cozen W	2014-06-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24920014	A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.	Hodgkin's lymphoma	1,816 European ancestry cases, 7,877 European ancestry controls	1,281 European ancestry cases, 3,218 European ancestry controls	19p13.3	19	1650135	TCF3	TCF3			6929			rs1860661-?	rs1860661	0	1860661	intron_variant	0	NR	4E-10	9.397940008672037		1.23	[1.16-1.32]	Affymetrix, Illumina [1004829] (imputed)	N
2015-02-06	24920014	Cozen W	2014-06-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/24920014	A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.	Hodgkin's lymphoma	1,816 European ancestry cases, 7,877 European ancestry controls	1,281 European ancestry cases, 3,218 European ancestry controls	3q23	3	140450815	CLSTN2	LOC105374132, CLSTN2			105374132, 64084			rs6439924-?	rs6439924	0	6439924	intron_variant	0	0.16	8E-7	6.096910013008056		1.23	[1.13-1.33]	Affymetrix, Illumina [1004829] (imputed)	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	6p21.32	6	32476767	HLA	HLA-DRB9 - HLA-DRB5	3132	3127		16678	40576	rs12195582-T	rs12195582	0	12195582	upstream_gene_variant	1	0.465	5E-100	99.30102999566398		1.78	[1.69-1.88]	Illumina [up to 21554489]	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	11q23.3	11	118871133	CXCR5	SETP16 - CXCR5	649925	643		36568	12633	rs4938573-C	rs4938573	0	4938573	regulatory_region_variant	1	0.204	6E-20	19.221848749616356		1.34	[1.26-1.43]	Illumina [up to 21554489]	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	11q24.3	11	128622844	ETS1	LOC105369568 - LOC101929538	105369568	101929538		598	58396	rs4937362-T	rs4937362	0	4937362	upstream_gene_variant	1	0.456	7E-11	10.154901959985743		1.19	[1.13-1.25]	Illumina [up to 21554489]	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	3q28	3	188582114	LPP	LPP			4026			rs6444305-G	rs6444305	0	6444305	intron_variant	0	0.276	1E-10	10.0		1.21	[1.14-1.28]	Illumina [up to 21554489]	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	18q21.33	18	63115978	BCL2	LOC105372161 - BCL2	105372161	596		17835	7368	rs17749561-G	rs17749561	0	17749561	intergenic_variant	1	0.91	8E-10	9.096910013008056		1.34	[1.22-1.47]	Illumina [up to 21554489]	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	8q24.21	8	128064205	PVT1	PVT1			5820			rs13254990-T	rs13254990	0	13254990	intron_variant	0	0.315	1E-8	8.0		1.18	[1.11-1.24]	Illumina [up to 21554489]	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	17q25.3	17	82447676	C17orf62	C17orf62			79415			rs3751913-C	rs3751913	0	3751913	non_coding_transcript_exon_variant	0	0.121	2E-7	6.698970004336019		1.23	[1.14-1.33]	Illumina [up to 21554489]	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	3q13.33	3	122098766	CD86	CD86			942			rs2681416-A	rs2681416	0	2681416	intron_variant	0	0.311	2E-7	6.698970004336019		1.16	[1.09-1.22]	Illumina [up to 21554489]	N
2015-05-18	25279986	Skibola CF	2014-10-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/25279986	Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.	Follicular lymphoma	2,728 European ancestry cases, 7,758 European ancestry controls	1,795 European ancestry cases, 5,586 European ancestry controls	18q12.3	18	45285245	SLC14A2	SLC14A2			8170			rs11082438-G	rs11082438	0	11082438	intron_variant	0	0.936	4E-7	6.3979400086720375		1.33	[1.19-1.48]	Illumina [up to 21554489]	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	2p22.2	2	37368946	QPCT	QPCT			25797			rs3770745-T	rs3770745	0	3770745	intron_variant	0	0.229	1E-7	7.0		1.22	[1.14-1.32]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	2q13	2	111074216	ACOXL	ACOXL			55289			rs58055674-C	rs58055674	0	58055674	intron_variant	0	0.173	5E-20	19.30102999566398		1.44	[1.33-1.56]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	2q33.1	2	201044792	FAM126B, CASP8	FAM126B			285172			rs13015798-A	rs13015798	0	13015798	intron_variant	0	0.673	3E-8	7.522878745280337		1.2048193	[1.14-1.3]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	4q25	4	108105258	LEF1	LEF1			51176			rs2003869-G	rs2003869	0	2003869	intron_variant	0	0.567	1E-7	7.0		1.19	[1.11-1.26]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	5p15.33	5	1284538	TERT	TERT			7015			rs139996880-A	rs139996880	0	139996880	intron_variant	0	0.165	6E-8	7.221848749616356		1.29	[1.18-1.42]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	6p25.3	6	409119	IRF4	IRF4			3662			rs9391997-G	rs9391997	0	9391997	3_prime_UTR_variant	0	0.494	9E-22	21.045757490560675		1.35	[1.27-1.43]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	6p21.32	6	32600569	HLA-DQB1, HLA-DRB1, HLA-DRB5	HLA-DRB1 - LOC107986589	3123	107986589		10733	36619	rs9270750-A	rs9270750	0	9270750	intron_variant	1	0.543	6E-16	15.221848749616356		1.32	[1.23-1.41]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	8q22.3	8	102566646	ODF1	ODF1 - POU5F1P2	4956	100129512		5629	54590	rs2511714-G	rs2511714	0	2511714	intergenic_variant	1	0.391	2E-7	6.698970004336019		1.19	[1.11-1.27]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	8q24.21	8	127183089	CASC19	LOC105375752 - CASC19	105375752	103021165		13571	4696	rs140099016-C	rs140099016	1	113952129	downstream_gene_variant	1	0.294	2E-12	11.698970004336019		1.28	[1.19-1.37]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	9p21.3	9	22336997	DMRTA1, CDKN2B-AS1	CDKN2B-AS1 - DMRTA1	100048912	63951		215900	109844	rs1359742-G	rs1359742	0	1359742	intergenic_variant	1	0.499	7E-9	8.154901959985743		1.2048193	[1.12-1.28]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	10q23.31	10	88999967	ACTA2, FAS	FAS			355			rs4406737-G	rs4406737	0	4406737	intron_variant	0	0.57	9E-14	13.045757490560675		1.27	[1.19-1.35]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	11p15.5	11	2299865	C11orf21	TSPAN32, C11orf21			10077, 29125			rs2521269-C	rs2521269	0	2521269	intron_variant	0	0.45799999999999996	4E-8	7.3979400086720375		1.1904762	[1.12-1.27]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	11q24.1	11	123484683	GRAMD1B	GRAMD1B			57476			rs35923643-G	rs35923643	0	35923643	intron_variant	0	0.196	2E-40	39.69897000433602		1.66	[1.54-1.79]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	15q15.1	15	40111456	BMF	BMF - MTND5P37	90427	107133493		2572	22315	rs8024033-C	rs8024033	0	8024033	upstream_gene_variant	1	0.514	3E-10	9.522878745280337		1.2195122	[1.14-1.3]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	15q21.3	15	56488569	MNS1, RFX7	LOC105370831			105370831			rs72742684-T	rs72742684	0	72742684	intergenic_variant	0	0.108	2E-13	12.698970004336019		1.43	[1.30-1.58]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	15q23	15	69697166	PCAT29	PCAT29 - LOC107984788	104472713	107984788		1416	53853	rs2052702-A	rs2052702	0	2052702	downstream_gene_variant	1	0.386	4E-18	17.397940008672037		1.3157895	[1.23-1.41]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	16q24.1	16	85895015	IRF8	RPL10AP12 - IRF8	401863	3394		78448	4153	rs391855-A	rs391855	0	391855	upstream_gene_variant	1	0.5660000000000001	1E-22	22.0		1.369863	[1.28-1.45]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	18q21.32	18	59955055	PMAIP1	LOC105372151 - NFE2L3P1	105372151	642996		3735	12753	rs4368253-C	rs4368253	0	4368253	intergenic_variant	1	0.677	8E-7	6.096910013008056		1.18	[1.11-1.26]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	18q21.33	18	63126261	BCL2	BCL2			596			rs4987856-C	rs4987856	0	4987856	3_prime_UTR_variant	0	0.906	4E-11	10.397940008672037		1.4492754	[1.3-1.61]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	3p24.1	3	27736288	EOMES	EOMES - LOC105377007	8320	105377007		13573	61300	rs9880772-T	rs9880772	0	9880772	intergenic_variant	1	0.465	3E-11	10.522878745280337		1.19	[1.13-1.25]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	6p25.2	6	2969044	SERPINB6	SERPINB6			5269			rs73718779-A	rs73718779	0	73718779	intron_variant	0	0.11	2E-8	7.698970004336019		1.26	[1.16-1.36]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	3q28	3	188397894	LPP	LPP			4026			rs9815073-C	rs9815073	0	9815073	intron_variant	0	0.651	4E-8	7.3979400086720375		1.18	[1.11-1.25]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	2q13	2	111150685	BCL2L11	BCL2L11			10018			rs9308731-A	rs9308731	0	9308731	intron_variant	0	0.537	1E-11	11.0		1.19	[1.13-1.26]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	4q24	4	101816093	BANK1	BANK1			55024			rs10028805-G	rs10028805	0	10028805	intron_variant	0	0.624	7E-8	7.154901959985743		1.16	[1.10-1.22]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	3p22.2	3	39149538	CSRNP1	CSRNP1			64651			rs1274963-T	rs1274963	0	1274963	intron_variant	0	0.208	2E-7	6.698970004336019		1.18	[1.11-1.25]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	5q14.1	5	78888580	NR	ARSB			411			rs6893857-C	rs6893857	0	6893857	intron_variant	0	0.183	2E-6	5.698970004336019		1.17	[1.10-1.25]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	20q13.32	20	58831013	NR	GNAS-AS1			149775			rs76473307-A	rs76473307	0	76473307	intron_variant	0	0.97	7E-6	5.154901959985743		1.4285715	[1.22-1.67]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	11q24.1	11	123497625	NR	GRAMD1B			57476			rs2953196-G	rs2953196	0	2953196	intron_variant	0	0.756	5E-16	15.301029995663981		1.3	[1.22-1.38]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	2q37.3	2	241253433	NR	HDLBP			3069			rs7578199-T	rs7578199	0	7578199	missense_variant	0	0.745	8E-8	7.096910013008056		1.1764705	[1.11-1.25]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	2q37.1	2	230179539	NR	SP110			3431			rs2396718-C	rs2396718	0	2396718	intron_variant	0	0.094	2E-7	6.698970004336019		1.27	[1.16-1.38]	Affymetrix, Illumina [~ 8500000] (imputed)	N
2017-02-10	27564568	Liu C	2016-08-26	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/27564568	A Genome-wide Approach Validates that Thiopurine Methyltransferase Activity is a Monogenic Pharmacogenomic Trait.	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	up to 407 European ancestry cases, up to 138 African ancestry cases, up to 251 Hispanic cases, up to 57 Asian ancestry cases, up to 110 other ancestry cases	NA	6p22.3	6	18130687	TPMT	TPMT			7172			rs1142345-?	rs1142345	0	1142345	missense_variant	0	NR	9E-61	60.045757490560675		7.69	unit decrease	Affymetrix, Illumina [9000000] (imputed)	N
2016-12-15	26956414	Berndt SI	2016-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26956414	Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.	Chronic lymphocytic leukemia	3,100 European ancestry cases, 7,667 European ancestry controls	1,958 cases,  5,530 controls	6p22.1	6	30072307	NR	RNF39			80352			rs115819718-A	rs115819718	1	9393989	intron_variant	0	0.278	5E-6	5.301029995663981		1.14	1.08-1.21	Affymetrix, Illumina [~ 8500000] (imputed)	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	3p14.2	3	60951377	FHIT	FHIT			2272			rs9849262-T	rs9849262	0	9849262	intron_variant	0	0.01	8E-6	5.096910013008056		1.4	[0.81-1.99]	Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	7q32.2	7	130269008	CPA2	CPA2			1358			rs199695765-T	rs199695765	0	199695765	stop_gained	0	0.0	2E-8	7.698970004336019		6.6		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	19q13.41	19	52582594	ZNF701	ZNF701			55762			rs144556038-T	rs144556038	0	144556038	stop_gained	0	3.0E-4	2E-6	5.698970004336019		3.6		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	16q23.1	16	77367618	ADAMTS18	ADAMTS18			170692			rs112141546-T	rs112141546	0	112141546	missense_variant	0	3.0E-4	4E-10	9.397940008672037		3.3		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	1p34.2	1	43363065	CDC20	CDC20			991			rs45461499-A	rs45461499	0	45461499	missense_variant	0	0.002	4E-9	8.397940008672037		4.6		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	4q22.3	4	94573377	PDLIM5	PDLIM5			10611			rs200495769-T	rs200495769	0	200495769	missense_variant	0	2.0E-4	3E-7	6.522878745280337		5.7		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	3p25.1	3	14761602	C3orf20	C3orf20			84077			rs141708090-T	rs141708090	0	141708090	missense_variant	0	2.0E-4	6E-7	6.221848749616356		3.6		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA				NTF4							9:49564629-T	9:49564629	0			1	0.0	7E-7	6.154901959985743		5.1		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	8q21.11	8	73071865	C8orf84	SBSPON			157869			rs201734206-T	rs201734206	0	201734206	missense_variant	0	0.0	2E-6	5.698970004336019		4.9		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	2q23.3	2	151677702	NEB	NEB			4703			rs202124287-T	rs202124287	0	202124287	missense_variant	0	0.0	4E-6	5.3979400086720375		4.8		Affymetrix [at least 751455]	N
2016-12-22	27114598	Liu C	2016-04-25	J Clin Oncol	www.ncbi.nlm.nih.gov/pubmed/27114598	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	46 European ancestry cases with pancreatitis, 3,023 European ancestry cases without pancreatitis, 11 Black cases with pancreatitis, 339 Black cases without pancreatitis, 46 Hispanic cases with pancreatitis, 1,131 Hispanic cases without pancreatitis, 1 Asian ancestry case with pancreatitis, 98 Asian ancestry cases without pancreatitis, 13 cases with with pancreatitis, 477 cases without pancreatitis	NA	16q23.1	16	77367618	HOGA1	ADAMTS18			170692			rs112141546-T	rs112141546	0	112141546	missense_variant	0	3.0E-4	1E-6	6.0		3.5		Affymetrix [at least 751455]	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	2p22.2	2	37376658	QPCT, PRKD3	LOC107985868			107985868			rs888096 -A	rs888096	0	888096	downstream_gene_variant	0	NR	5E-8	7.301029995663981		1.15	[1.09-1.21]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	2q13	2	111074216	ACOXL, BCL2L11	ACOXL			55289			rs58055674-C	rs58055674	0	58055674	intron_variant	0	NR	2E-27	26.69897000433602		1.41	[1.32-1.5]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	2q33.1	2	201159226	CASP10, CASP8	CFLAR			8837			rs7558911-A	rs7558911	0	7558911	intron_variant	0	NR	5E-11	10.301029995663981		1.18	[1.12-1.24]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	2q37.1	2	230289297	SP110, SP140	SP140			11262			rs34004493-G	rs34004493	0	34004493	intron_variant	0	NR	4E-32	31.397940008672037		1.39	[1.31-1.47]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	2q37.3	2	241355498	FARP2	SEPT2 - FARP2	4735	9855		1471	751	rs3755397-G	rs3755397	0	3755397	upstream_gene_variant	1	NR	9E-12	11.045757490560675		1.32	[1.22-1.43]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	3p24.1	3	27736288	EOMES	EOMES - LOC105377007	8320	105377007		13573	61300	rs9880772 -A	rs9880772	0	9880772	intergenic_variant	1	NR	2E-9	8.698970004336019		1.16	[1.11-1.22]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	4q25	4	108104709	LEF1	LEF1			51176			rs7690934 -C	rs7690934	0	7690934	intron_variant	0	NR	6E-9	8.221848749616356		1.16	[1.11-1.22]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	5p15.33	5	1285859	TERT	TERT			7015			rs7705526 -A	rs7705526	0	7705526	intron_variant	0	NR	6E-10	9.221848749616356		1.18	[1.12-1.25]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	6p25.3	6	412802	IRF4	IRF4 - LOC105374875	3662	105374875		1359	38211	rs9392504-A	rs9392504	0	9392504	downstream_gene_variant	1	NR	1E-28	28.0		1.33	[1.26-1.4]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	6p21.32	6	32610350	HLA	HLA-DRB1 - LOC107986589	3123	107986589		20514	26838	rs9271176 -G	rs9271176	0	9271176	upstream_gene_variant	1	NR	3E-20	19.522878745280337		1.29	[1.22-1.36]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	7q31.33	7	124752458	POT1	GPR37			2861			rs2267708-T	rs2267708	0	2267708	intron_variant	0	NR	9E-9	8.045757490560675		1.16	[1.1-1.22]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	8q24.21	8	127188726	POU5F1B	CASC19			103021165			rs2466029-G	rs2466029	0	2466029	intron_variant	0	NR	7E-16	15.154901959985743		1.23	[1.17-1.3]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	9p21.3	9	22206988	CDKN2B-AS1	CDKN2B-AS1 - DMRTA1	100048912	63951		85891	239853	rs1679013 -C	rs1679013	0	1679013	intron_variant	1	NR	2E-8	7.698970004336019		1.16	[1.1-1.22]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	10q23.31	10	88992261	ACTA, FAS	FAS-AS1, FAS			100302740, 355			rs6586163-A	rs6586163	0	6586163	intron_variant	0	NR	1E-15	15.0		1.23	[1.17-1.29]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	11p15.5	11	2300420	C11orf21, TSPAN32	TSPAN32, C11orf21			10077, 29125			rs2651823-A	rs2651823	0	2651823	intron_variant	0	NR	5E-11	10.301029995663981		1.18	[1.13-1.25]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	11q24.1	11	123484683	SCN3B, GRAMD1B	GRAMD1B			57476			rs35923643-G	rs35923643	0	35923643	intron_variant	0	NR	4E-58	57.39794000867204		1.63	[1.53-1.72]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	12q24.13	12	112943571	OAS3	OAS3			4940			rs6489882-G	rs6489882	0	6489882	intron_variant	0	NR	5E-8	7.301029995663981		1.16	[1.1-1.22]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	15q15.1	15	40111456	BMF, BUB1B	BMF - MTND5P37	90427	107133493		2572	22315	rs8024033-C	rs8024033	0	8024033	upstream_gene_variant	1	NR	7E-19	18.154901959985743		1.26	[1.2-1.32]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	15q23	15	69728186	RPLP1	PCAT29 - LOC107984788	104472713	107984788		32436	22833	rs11637565-G	rs11637565	0	11637565	intergenic_variant	1	NR	2E-31	30.69897000433602		1.35	[1.28-1.42]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	16q24.1	16	85895015	IRF8	RPL10AP12 - IRF8	401863	3394		78448	4153	rs391855-A	rs391855	0	391855	upstream_gene_variant	1	NR	1E-28	28.0		1.34	[1.27-1.41]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	18q21.33	18	63121512	BCL2	LOC105372161 - BCL2	105372161	596		23369	1834	rs77551289-A	rs77551289	0	77551289	downstream_gene_variant	1	NR	2E-11	10.698970004336019		1.37	[1.25-1.5]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	19q13.32	19	46673495	PRKD2, STRN4	DACT3-AS1			100506068			rs874460-C	rs874460	0	874460	non_coding_transcript_exon_variant	0	NR	3E-8	7.522878745280337		1.24	[1.15-1.34]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	4q24	4	101819845	BANK1	BANK1			55024			rs71597109-C	rs71597109	0	71597109	intron_variant	0	0.69	1E-10	10.0		1.17	[1.11-1.22]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	1p36.11	1	23617245	MDS2	LOC107984928 - MDS2	107984928	259283		14943	10089	rs34676223-C	rs34676223	0	34676223	intron_variant	1	0.71	5E-13	12.301029995663981		1.19	[1.14-1.25]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	6p21.31	6	34648545	C6orf106	C6orf106			64771			rs3800461-C	rs3800461	0	3800461	intron_variant	0	0.11	2E-8	7.698970004336019		1.2	[1.13-1.28]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	11q23.2	11	113646481	TMPRSS5	LOC107984390			107984390			rs61904987-T	rs61904987	0	61904987	intergenic_variant	0	0.12	2E-11	10.698970004336019		1.24	[1.16-1.32]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	18q21.1	18	50317164	MBD1, CXXC1	CXXC1 - RNA5SP458	30827	106479016		28842	1838	rs1036935-A	rs1036935	0	1036935	upstream_gene_variant	1	0.22	3E-8	7.522878745280337		1.15	[1.10-1.21]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	19p13.3	19	4069121	ZBTB7A, PIAS4, LRF	ZBTB7A - MAP2K2	51341	5605		2176	21200	rs7254272-A	rs7254272	0	7254272	upstream_gene_variant	1	0.18	5E-8	7.301029995663981		1.17	[1.10-1.23]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	22q13.33	22	50532837	SCO2, ODF3B, TYMP, NCAPH2	ODF3B - LOC102724608	440836	102724608		258	8546	rs140522-T	rs140522	0	140522	upstream_gene_variant	1	0.32	3E-9	8.522878745280337		1.15	[1.10-1.20]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	1q42.13	1	228744549	RHOU	RHOU			58480			rs41271473-G	rs41271473	0	41271473	3_prime_UTR_variant	0	0.79	1E-10	10.0		1.19	[1.13-1.26]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	4q35.1	4	184333619	LOC728175, IRF2	LOC107986242 - LOC728175	107986242	728175		14903	7412	rs57214277-T	rs57214277	0	57214277	regulatory_region_variant	1	0.41	4E-8	7.3979400086720375		1.13	[1.08-1.18]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	3q28	3	188411006	LPP	LPP			4026			rs73192661-C	rs73192661	0	73192661	intron_variant	0	NR	5E-6	5.301029995663981		1.14	[1.08-1.2]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	4q26	4	113777540	CAMK2D	CAMK2D - LOC105377375	817	105377375		15613	93989	rs1476569-G	rs1476569	0	1476569	intergenic_variant	1	NR	6E-10	9.221848749616356		1.18	[1.12-1.25]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	6p21.31	6	33579153	BAK1	BAK1			578			rs210143-C	rs210143	0	210143	intron_variant	0	NR	6E-16	15.221848749616356		1.26	[1.19-1.33]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	6q25.2	6	154150090	IPCEF1	OPRM1			4988			rs4869818-G	rs4869818	0	4869818	intron_variant	0	NR	4E-8	7.3979400086720375		1.15	[1.09-1.21]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	8q22.3	8	102565637	ODF1	ODF1 - POU5F1P2	4956	100129512		4620	55599	rs2511713-G	rs2511713	0	2511713	downstream_gene_variant	1	NR	6E-8	7.221848749616356		1.17	[1.1-1.23]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-08	28165464	Law PJ	2017-02-06	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28165464	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.	Chronic lymphocytic leukemia	4,478 European ancestry cases and 13,213 European ancestry controls.	1,722 European ancestry cases and 4,385 European ancestry controls.	15q21.3	15	56485493	RFX7, NEDD4	LOC105370831			105370831			rs142215530-G	rs142215530	0	142215530	intergenic_variant	0	NR	2E-18	17.69897000433602		1.39	[1.29-1.5]	Affymetrix, Illumina [> 10000000] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	22q13.31	22	43928847	PNPLA3	PNPLA3			80339			rs738409-G	rs738409	0	738409	missense_variant	0		3E-8	7.522878745280337		1.29	[1.04-1.58]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2q14.2	2	118661291	EN1	LOC101927709 - LOC107985816	101927709	107985816		58325	172409	rs144104656-G	rs144104656	0	144104656	regulatory_region_variant	1		2E-7	6.698970004336019		8.04	[1.36-47.52]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	22q12.3	22	31829377	DEPDC5	DEPDC5			9681			rs147481775-A	rs147481775	0	147481775	intron_variant	0		6E-7	6.221848749616356		4.66	[1.22-17.88]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	13q13.3	13	38041119	TRPC4	LOC101929077			101929077			rs74709575 -C	rs74709575	0	74709575	intron_variant	0		1E-6	6.0		4.52	[1.19-17.19]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	17q25.3	17	80288362	RNF213	RNF213			57674			rs17857135 -T	rs17857135	0	17857135	missense_variant	0		2E-6	5.698970004336019		1.2820514	[1.03-1.59]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	12q14.1	12	61914884	FAM19A2	FAM19A2			338811			rs112769843-C	rs112769843	0	112769843	intron_variant	0		2E-6	5.698970004336019		1.8518518	[1.06-3.12]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	20p11.21	20	23001450	SSTR4	LOC101929707			101929707			rs11696756-A	rs11696756	0	11696756	intergenic_variant	0		3E-6	5.522878745280337		1.39	[1.03-1.86]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	6q27	6	170610382	PDCD2	PDCD2 - LOC107986677	5134	107986677		25690	2229	rs12530134 -A	rs12530134	0	12530134	intergenic_variant	1		4E-6	5.3979400086720375		1.36	[1.03-1.80]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	9q34.11	9	130022496	FNBP1	FNBP1			23048			rs117483095-T	rs117483095	0	117483095	intron_variant	0		4E-6	5.3979400086720375		1.62	[1.05-2.50]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2q37.3	2	238593191	ASB1	LINC01107 - LOC105373963	151171	105373963		37692	118309	rs113941845-A	rs113941845	0	113941845	intergenic_variant	1		4E-6	5.3979400086720375		1.24	[1.02-1.51]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	7p21.1	7	17203933	AHR	LOC107986772, LOC101927609			107986772, 101927609			rs145145722-T	rs145145722	0	145145722	upstream_gene_variant	0		4E-6	5.3979400086720375		2.3809524	[1.09-5.26]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	11q21	11	93676282	KIAA1731	CEP295			85459			rs11020478-G	rs11020478	0	11020478	intron_variant	0		4E-6	5.3979400086720375		1.21	[1.02-1.43]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2q31.2	2	177553847	TTC30B	TTC30B - TTC30A	150737	92104		1051	60451	rs1348850-A	rs1348850	0	1348850	intron_variant	1		4E-6	5.3979400086720375		1.22	[1.02-1.46]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	9q22.2	9	89595680	GADD45G	LOC105376137 - LOC105376139	105376137	105376139		38577	3103	rs7024024-A	rs7024024	0	7024024	intergenic_variant	1		4E-6	5.3979400086720375		1.2195122	[1.02-1.47]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2p25.1	2	11641492	GREB1	GREB1			9687			rs149940960-T	rs149940960	0	149940960	3_prime_UTR_variant	0		4E-6	5.3979400086720375		6.25	[1.18-33.33]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	12q14.1	12	57807682	TSFM	AVIL			10677			rs143969105-G	rs143969105	0	143969105	missense_variant	0		4E-6	5.3979400086720375		8.68	[1.21-62.08]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	14q12	14	27284333	Intergenic	RPS27AP4 - LOC728755	326323	728755		25141	31484	rs75870332-A	rs75870332	0	75870332	intron_variant	1		5E-6	5.301029995663981		1.51	[1.04-2.19]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	6p22.3	6	20759346	CDKAL1	CDKAL1			54901			rs58800477-G	rs58800477	0	58800477	intron_variant	0		5E-6	5.301029995663981		4.1	[1.13-14.91]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	9p21.2	9	26228660	LOC100506422	LOC107987027 - LOC105375999	107987027	105375999		81044	117510	rs149850605-T	rs149850605	0	149850605	intergenic_variant	1		5E-6	5.301029995663981		6.09	[1.16-31.9]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	22q13.31	22	43928850	PNPLA3	PNPLA3			80339			rs738408-T	rs738408	0	738408	synonymous_variant	0		2E-7	6.698970004336019	(EA)	1.36	[1.05-1.77]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	5q35.2	5	174435441	MSX2	LINC01411			101928176			rs34531324-T	rs34531324	0	34531324	intron_variant	0		9E-7	6.045757490560675	(EA)	1.29	[1.03-1.61]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	3p24.3	3	20984460	VENTXP7	LOC107986068 - LOC105376987	107986068	105376987		30253	56788	rs73188336-T	rs73188336	0	73188336	intron_variant	1		2E-6	5.698970004336019	(EA)	4.23	[1.16-15.4]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	20p11.21	20	23001450	SSTR4	LOC101929707			101929707			rs11696756-A	rs11696756	0	11696756	intergenic_variant	0		2E-6	5.698970004336019	(EA)	1.51	[1.04-2.17]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	12q14.1	12	57807682	TSFM	AVIL			10677			rs143969105-G	rs143969105	0	143969105	missense_variant	0		4E-6	5.3979400086720375	(EA)	9.04	[1.23-66.26]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	3p22.1	3	42691976	KBTBD5	KLHL40			131377			rs123509-T	rs123509	0	123509	missense_variant	0		5E-6	5.301029995663981	(EA)	1.3	[1.02-1.65]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	17p13.1	17	10319145	MYH13	MYH13, LOC107985004			8735, 107985004			rs61745304-A	rs61745304	0	61745304	missense_variant	0		5E-6	5.301029995663981	(EA)	2.66	[1.09-6.50]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	6q25.1	6	150804007	PLEKHG1	PLEKHG1			57480			rs10046301-C	rs10046301	0	10046301	intron_variant	0		6E-6	5.221848749616356	(EA)	1.42	[1.03-1.95]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2q37.3	2	239001819	HDAC4	FLJ43879 - HDAC4	401039	9759		75550	46349	rs3935695-C	rs3935695	0	3935695	intergenic_variant	1		7E-6	5.154901959985743	(EA)	1.27	[1.02-1.59]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2q33.2	2	203434784	ABI2	RAPH1			65059			rs77589546-G	rs77589546	0	77589546	3_prime_UTR_variant	0		7E-6	5.154901959985743	(EA)	2.34	[1.07-5.11]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2q12.1	2	104651032	Intergenic	LOC105373525 - LOC105373526	105373525	105373526		65675	8305	rs7607659-T	rs7607659	0	7607659	intergenic_variant	1		7E-6	5.154901959985743	(EA)	2.95	[1.09-7.98]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	9q21.31	9	79932131	TLE4	LINC01507			101927477			rs267585-T	rs267585	0	267585	intergenic_variant	0		8E-6	5.096910013008056	(EA)	1.39	[1.03-1.88]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	1q31.3	1	196902587	CFHR2	CFHR4			10877			rs145744152-C	rs145744152	0	145744152	synonymous_variant	0		9E-6	5.045757490560675	(EA)	2.75	[1.08-6.97]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	1p36.11	1	26811902	PIGV	PIGV - RN7SL165P	55650	106479281		13499	2920	rs12748152-C	rs12748152	0	12748152	upstream_gene_variant	1		1E-8	8.0	(AA)	6.25	[1.47-25]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2p25.1	2	11641492	GREB1	GREB1			9687			rs149940960-T	rs149940960	0	149940960	3_prime_UTR_variant	0		2E-8	7.698970004336019	(AA)	6.666666	[1.49-25]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	5q15	5	96700607	CAST	CAST			831			rs72772090-G	rs72772090	0	72772090	intron_variant	0		4E-7	6.3979400086720375	(AA)	5.263158	[1.3-20]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	1p12	1	119714487	PHGDH	PHGDH			26227			rs637868-C	rs637868	0	637868	intron_variant	0		4E-7	6.3979400086720375	(AA)	1.5384616	[1.08-2.22]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	3p22.3	3	34149739	PDCD6IP	LOC105377024 - LOC101928114	105377024	101928114		267983	9407	rs6550253-A	rs6550253	0	6550253	intergenic_variant	1		9E-7	6.045757490560675	(AA)	2.95	[1.17-7.45]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	1q43	1	238128048	MTRNR2L11	YWHAQP9 - LOC105373220	101290508	105373220		19458	195040	rs6684897-G	rs6684897	0	6684897	intergenic_variant	1		9E-7	6.045757490560675	(AA)	1.8867927	[1.1-3.23]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	6q23.3	6	138018697	PERP	LOC105378021			105378021			rs4896310-A	rs4896310	0	4896310	intergenic_variant	0		1E-6	6.0	(AA)	2.11	[1.11-4.03]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	1q23.3	1	162767290	DDR2	DDR2			4921			rs143928882-C	rs143928882	0	143928882	synonymous_variant	0		2E-6	5.698970004336019	(AA)	7.692308	[1.32-50]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	3q21.3	3	127621197	MCM2	MCM2, LOC107986126			4171, 107986126			rs144122212-T	rs144122212	0	144122212	missense_variant	0		2E-6	5.698970004336019	(AA)	7.692308	[1.32-50]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	20q13.13	20	49374264	KCNB1	LOC105372649, KCNB1			105372649, 3745			rs142605642-C	rs142605642	0	142605642	synonymous_variant	0		2E-6	5.698970004336019	(AA)	7.692308	[1.32-50]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	22q12.2	22	31590150	SFI1	SFI1			9814			rs116783514-C	rs116783514	0	116783514	intron_variant	0		2E-6	5.698970004336019	(AA)	4.09	[1.19-13.99]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	19q13.12	19	36341148	ZFP14	ZFP14			57677			rs75094162-T	rs75094162	0	75094162	synonymous_variant	0		2E-6	5.698970004336019	(AA)	2.9411764	[1.15-7.14]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	2p13.1	2	74395262	DCTN1	DCTN1-AS1 - C2orf81	100189589	388963		1381	18914	rs146058206-A	rs146058206	0	146058206	3_prime_UTR_variant	1		2E-6	5.698970004336019	(AA)	9.02	[1.31-62.00]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	9q31.1	9	103849449	SMC2	RNA5SP291 - LOC105376192	100873544	105376192		159872	67132	rs114440645-G	rs114440645	0	114440645	intergenic_variant	1		2E-6	5.698970004336019	(AA)	9.02	[1.31-62.00]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	10p13	10	13373961	SEPHS1	SEPHS1 - LOC105376419	22929	105376419		25663	9050	rs61610071-G	rs61610071	0	61610071	intergenic_variant	1		2E-6	5.698970004336019	(AA)	9.02	[1.31-62.00]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	12q24.33	12	129452215	TMEM132D	TMEM132D			121256			rs4759570-A	rs4759570	0	4759570	intron_variant	0		2E-6	5.698970004336019	(AA)	9.02	[1.31-62.00]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	1p35.3	1	28334563	MED18	MED18			54797			rs139242087-T	rs139242087	0	139242087	missense_variant	0		3E-6	5.522878745280337	(AA)	8.55	[1.30-56.03]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	1p36.11	1	26854576	ZDHHC18	ZDHHC18			84243			rs41307935-C	rs41307935	0	41307935	3_prime_UTR_variant	0		1E-7	7.0	(AA)	4.5454545	[1.33-16.67]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	3q22.1	3	132198152	CPNE4	CPNE4			131034			rs9836270-A	rs9836270	0	9836270	intron_variant	0		2E-6	5.698970004336019	(Hispanic)	1.98	[1.11-3.53]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	15q26.2	15	96565598	SPATA8	LOC105371001 - LOC105371002	105371001	105371002		13901	123715	rs2139953-A	rs2139953	0	2139953	intergenic_variant	1		5E-6	5.301029995663981	(Hispanic)	2.0	[1.1-3.7]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	6q14.1	6	76693087	IMPG1	LOC100131680 - LOC105377861	100131680	105377861		29688	5703	rs11753479-G	rs11753479	0	11753479	intergenic_variant	1		5E-6	5.301029995663981	(Hispanic)	2.3255813	[1.11-4.76]	Affymetrix, Illumina [NR] (imputed)	N
2017-06-27	28090653	Liu Y	2017-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28090653	Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	up to 488 European ancestry cases, up to 111 African American cases, up to 60 Hispanic cases, up to 56 other ancestry cases	NA	1p35.1	1	34012883	CSMD2	CSMD2			114784			rs4653367-G	rs4653367	0	4653367	intron_variant	0		7E-6	5.154901959985743	(Hispanic)	2.0408163	[1.09-3.85]	Affymetrix, Illumina [NR] (imputed)	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p23	6	14636732	JARID2, RNF182	LOC101928354			101928354			rs707824-T	rs707824	0	707824	intergenic_variant	0	NR	6E-7	6.221848749616356	(NHL)	1.33	[1.17-1.47]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p21.32	6	32614112	HLA-DRB5, HLA-DQA1	HLA-DRB1 - LOC107986589	3123	107986589		24276	23076	rs4530903-T	rs4530903	0	4530903	upstream_gene_variant	1	NR	3E-6	5.522878745280337	(LYM)	1.29	[1.16-1.43]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p21.32	6	32614112	HLA-DRB5, HLA-DQA1	HLA-DRB1 - LOC107986589	3123	107986589		24276	23076	rs4530903-T	rs4530903	0	4530903	upstream_gene_variant	1	NR	2E-8	7.698970004336019	(NHL)	1.37	[1.23-1.54]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	11q12.1	11	58292720	LPXN	OR10Q2P			81345			rs12289961-T	rs12289961	0	12289961	non_coding_transcript_exon_variant	0	NR	4E-8	7.3979400086720375	(LYM)	1.29	[1.17-1.40]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	11q12.1	11	58292720	LPXN	OR10Q2P			81345			rs12289961-T	rs12289961	0	12289961	non_coding_transcript_exon_variant	0	NR	1E-7	7.0	(NHL)	1.29	[1.17-1.42]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	11q12.1	11	58580292	ZFP91-CNTF	ZFP91, ZFP91-CNTF			80829, 386607			rs948562-G	rs948562	0	948562	intron_variant	0	NR	6E-7	6.221848749616356	(LYM)	1.29	[1.16-1.43]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	11q12.1	11	58580292	ZFP91-CNTF	ZFP91, ZFP91-CNTF			80829, 386607			rs948562-G	rs948562	0	948562	intron_variant	0	NR	3E-7	6.522878745280337	(NHL)	1.32	[1.18-1.46]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p21.32	6	32700559	HLA-DQA2, HLA-DQB1	HLA-DQB1 - MTCO3P1	3119	404026		33870	5585	rs2647046-?	rs2647046	0	2647046	regulatory_region_variant	1	NR	2E-6	5.698970004336019	(NHL)	1.25	[1.14-1.37]	Affymetrix [530583]	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	1p31.3	1	67203951	IL23R	IL23R			149233			rs11580078-G	rs11580078	0	11580078	intron_variant	0	0.43	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	1p13.2	1	113761186	PTPN22	PHTF1 - RSBN1	10745	54665		1298	646	rs6679677-A	rs6679677	0	6679677	upstream_gene_variant	1	0.09	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	1q24.3	1	172869708	TNFSF18	LOC105371618 - AIMP1P2	105371618	100873064		31921	16239	rs34884278-C	rs34884278	0	34884278	intron_variant	1	0.3	4E-7	6.3979400086720375				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	1q31.3	1	197406337	CRB1	CRB1			23418			rs6689858-C	rs6689858	0	6689858	intron_variant	0	0.29	2E-7	6.698970004336019				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	1q32.1	1	206760172	IL10	LOC105372877 - IL10	105372877	3586		7770	7431	rs55705316-G	rs55705316	0	55705316	intergenic_variant	1	0.14	1E-6	6.0				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	2q12.1	2	102464132	IL18R1	IL18RAP - SLC9A4	8807	389015		11564	9150	rs2075184-T	rs2075184	0	2075184	intergenic_variant	1	0.23	9E-8	7.045757490560675				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	2q37.1	2	233276621	ATG16L1	ATG16L1			55054			rs36001488-C	rs36001488	0	36001488	intron_variant	0	0.48	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	2q37.3	2	240624322	GPR35	GPR35			2859			rs4676410-A	rs4676410	0	4676410	intron_variant	0	0.19	2E-7	6.698970004336019				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	3p21.31	3	49534707	DAG1	DAG1			1605			rs4625-G	rs4625	0	4625	3_prime_UTR_variant	0	0.31	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	4q27	4	122639784	IL21	IL21-AS1			100996941			rs62324212-A	rs62324212	0	62324212	intron_variant	0	0.42	3E-8	7.522878745280337				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	5p13.1	5	40487168	PTGER4	LOC105374736 - LOC105374737	105374736	105374737		159517	112782	rs7725052-C	rs7725052	0	7725052	regulatory_region_variant	1	0.43	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	5q11.2	5	56148856	ANKRD55	ANKRD55			79722			rs7731626-A	rs7731626	0	7731626	intron_variant	0	0.39	1E-10	10.0				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	5q15	5	96888176	ERAP2	ERAP2, ERAP1			64167, 51752			rs4869313-T	rs4869313	0	4869313	intron_variant	0	0.42	9E-8	7.045757490560675				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	5q31.1	5	132475490	IL5	C5orf56			441108			rs11741255-A	rs11741255	0	11741255	intron_variant	0	0.42	2E-9	8.698970004336019				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	5q33.3	5	159402286	IL12B	LOC285626 - LOC285627	285626	285627		39452	46270	rs755374-T	rs755374	0	755374	intron_variant	1	0.32	2E-10	9.698970004336019				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	9p24.1	9	4981866	JAK2	HNRNPA1P41 - JAK2	100128701	3717		35904	3220	rs36051895-T	rs36051895	0	36051895	upstream_gene_variant	1	0.29	9E-8	7.045757490560675				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	9q32	9	114790969	TNFSF15	TNFSF15			9966			rs4246905-T	rs4246905	0	4246905	missense_variant	0	0.28	1E-8	8.0				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	9q34.3	9	136369144	CARD9	CARD9			64170			rs11145763-C	rs11145763	0	11145763	intron_variant	0	0.4	3E-8	7.522878745280337				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	10p15.1	10	6056986	IL2RA	IL2RA			3559			rs706778-T	rs706778	0	706778	intron_variant	0	0.41	6E-9	8.221848749616356				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	10q21.2	10	62679011	ZNF365	ZNF365 - ALDH7A1P4	22891	544		7000	61979	rs10822050-C	rs10822050	0	10822050	intergenic_variant	1	0.39	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	10q22.3	10	79287626	ZMIZ1	ZMIZ1			57178			rs1250563-C	rs1250563	0	1250563	intron_variant	0	0.29	1E-8	8.0				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	10q24.2	10	99538694	NKX2-3	NKX2-3 - SLC25A28	159296	81894		2170	71824	rs1332099-T	rs1332099	0	1332099	downstream_gene_variant	1	0.46	9E-11	10.045757490560675				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	11p15.5	11	2146620	INS	IGF2-AS, IGF2, INS-IGF2			51214, 3481, 723961			rs17885785-T	rs17885785	0	17885785	non_coding_transcript_exon_variant	0	0.2	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	12q12	12	40366829	LRRK2	LOC105369736, LRRK2			105369736, 120892			rs17466626-G	rs17466626	0	17466626	non_coding_transcript_exon_variant	0	0.02	3E-10	9.522878745280337				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	12q13.2	12	56002984	SUOX	SUOX			6821			rs1689510-C	rs1689510	0	1689510	non_coding_transcript_exon_variant	0	0.31	4E-9	8.397940008672037				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	15q22.33	15	67171953	SMAD3	SMAD3			4088			rs72743477-G	rs72743477	0	72743477	intron_variant	0	0.21	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	16p12.1	16	28329624	SBK1	SBK1 - LOC105369182	388228	105369182		5775	11700	rs12598357-G	rs12598357	0	12598357	intergenic_variant	1	0.39	4E-9	8.397940008672037				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	16p11.2	16	28835925	ATXN2L	ATXN2L			11273			rs12928404-C	rs12928404	0	12928404	splice_region_variant	0	0.38	6E-7	6.221848749616356				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	16q12.1	16	50634166	NOD2	NKD1			85407			rs117372389-T	rs117372389	0	117372389	3_prime_UTR_variant	0	0.02	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	17q21.1	17	39883866	IKZF3	ZPBP2 - GSDMB	124626	55876		5970	20729	rs12232497-C	rs12232497	0	12232497	intergenic_variant	1	0.45	3E-7	6.522878745280337				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	19p13.2	19	10476920	TYK2	PDE4A - KEAP1	5141	9817		7289	9200	rs62131887-T	rs62131887	0	62131887	intergenic_variant	1	0.28	4E-7	6.3979400086720375				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	19q13.33	19	48703728	FUT2	LOC105447645, FUT2			105447645, 2524			rs602662-G	rs602662	0	602662	missense_variant	0	0.49	5E-8	7.301029995663981				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	20q13.33	20	63637985	TNFRSF6B	LOC100505771 - STMN3	100505771	50861		9161	1720	rs2738774-A	rs2738774	0	2738774	downstream_gene_variant	1	0.32	9E-7	6.045757490560675				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	21q22.2	21	39094644	PSMG1	LOC107985484 - RPL23AP12	107985484	391282		10111	32911	rs2836882-A	rs2836882	0	2836882	regulatory_region_variant	1	0.27	5E-8	7.301029995663981				Illumina [7347414] (imputed)	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p21.32	6	32762235	HLA-DQB2	HLA-DQB2			3120			rs7453920-?	rs7453920	0	7453920	intron_variant	0	NR	5E-6	5.301029995663981	(LYM)	1.19	[1.11-1.3]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p21.32	6	32614112	HLA-DRB5, HLA-DQA1	HLA-DRB1 - LOC107986589	3123	107986589		24276	23076	rs4530903-T	rs4530903	0	4530903	upstream_gene_variant	1	NR	3E-12	11.522878745280337	(FL)	1.93	[NR]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p21.32	6	32461866	BTLN2, HLA-DRA, HLA-DRB5, HLA-DRB1	HLA-DRB9 - HLA-DRB5	3132	3127		1777	55477	rs9268853-C	rs9268853	0	9268853	intron_variant	1	NR	2E-10	9.698970004336019	(FL)	1.56	[NR]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p21.32	6	32700323	HLA-DQA2, HLA-DQB1	HLA-DQB1 - MTCO3P1	3119	404026		33634	5821	rs2647045-?	rs2647045	0	2647045	intergenic_variant	1	NR	4E-10	9.397940008672037	(FL)	1.69	[NR]	Affymetrix [530583]	N
2013-04-17	23349640	Vijai J	2013-01-17	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23349640	Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.	Lymphoma	275 Follicular non-Hodgkin's Lymphoma cases, 269 diffuse large B-cell non-Hodgkin's Lymphoma cases, 198 other non-Hodgkin's Lymphoma cases, 202 Hodgkin's Lymphoma cases, 4,044 controls	202 European ancestry Follicular non-Hodgkin's Lymphoma cases, 367 European ancestry diffuse large B-cell non-Hodgkin's Lymphoma cases, 577 European ancestry other non-Hodgkin's Lymphoma cases, 99 European ancestry Hodgkin's Lymphoma cases, 2,596 European ancestry controls	6p21.32	6	32774091	HLA-DQB2, TAP2	HLA-DQB2 - HLA-DOB	3120	3112		10538	38672	rs2621416-G	rs2621416	0	2621416	intergenic_variant	1	NR	2E-9	8.698970004336019	(FL)	1.57	[NR]	Affymetrix [530583]	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	1p31.1	1	81771892	LPHN2	ADGRL2			23266			rs2066363-C	rs2066363	0	2066363	intron_variant	0	0.34	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	2p25.3	2	2944140	TSSC1	LINC01250			101927554			rs114846446-A	rs114846446	0	114846446	intron_variant	0	0.01	2E-7	6.698970004336019				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	4p16.2	4	4990640	CYTL1	LOC101928306 - CYTL1	101928306	54360		1969	23946	rs7672495-C	rs7672495	0	7672495	intergenic_variant	1	0.18	1E-7	7.0				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	4q35.1	4	182824168	TNM3	TENM3 - LOC105377576	55714	105377576		21144	46957	rs7660520-A	rs7660520	0	7660520	intergenic_variant	1	0.26	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	8q24.23	8	137124061	intergenic	RNU6-144P - LOC107986905	106481222	107986905		18604	14792	rs7831697-G	rs7831697	0	7831697	intergenic_variant	1	0.25	5E-7	6.301029995663981				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	9p23	9	12785074	LURAP1L	LURAP1L-AS1, LURAP1L			101929467, 286343			rs7042370-T	rs7042370	0	7042370	intron_variant	0	0.43	1E-7	7.0				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	9q34.11	9	129894985	FNBP1	FNBP1			23048			rs10988542-C	rs10988542	0	10988542	intron_variant	0	0.08	7E-7	6.154901959985743				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	10p11.21	10	37303610	ANKRD30A	RN7SL314P - LOC101929498	106481836	101929498		5921	1353	rs7100025-G	rs7100025	0	7100025	intron_variant	1	0.34	8E-11	10.096910013008056				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	13q33.3	13	106410694	EFNB2	LINC00460 - RPL35P9	728192	100873796		32902	15063	rs11839053-C	rs11839053	0	11839053	intergenic_variant	1	0.02	1E-6	6.0				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	16q12.1	16	50270338	ADCY7	ADCY7			113			rs77150043-T	rs77150043	0	77150043	intron_variant	0	0.23	6E-9	8.221848749616356				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	Xq26.3	X	136583619	CD40LG	RNU6-320P - LINC00892	106480570	100128420		274	55924	rs2807264-C	rs2807264	0	2807264	downstream_gene_variant	1	0.21	1E-8	8.0				Illumina [7347414] (imputed)	N
2016-08-31	26301688	Li YR	2015-08-24	Nat Med	www.ncbi.nlm.nih.gov/pubmed/26301688	Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.	Pediatric autoimmune diseases	97 European ancestry thyroiditis cases, 107 European ancestry ankylosing spondylitis cases, 100 European ancestry psoriasis cases, 173 European ancestry celiac disease cases, 254 European ancestry systemic lupus erythematosus cases, 308 European ancestry common variable inmunodeficiency cases, 865 European ancestry ulcerative colitis cases, 1,086 European ancestry Type 1 diabetes cases, 1,123  European ancestry juvenile idiopathic arthritis cases, 1,922  European ancestry Crohn's disease cases, 10,718 European ancestry controls	NA	Xq26.3	X	136949968	RBMX	LOC100289184 - LOC100420958	100289184	100420958		1835	11949	rs12863738-T	rs12863738	0	12863738	intron_variant	1	0.17	6E-8	7.221848749616356				Illumina [7347414] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	2p23.3	2	25406569	DTNB	DTNB			1838			rs6546149-G	rs6546149	0	6546149	intron_variant	0	NR	6E-10	9.221848749616356				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	2q13	2	111098716	BCL2L11	LOC400997, ACOXL			400997, 55289			rs12711846-G	rs12711846	0	12711846	non_coding_transcript_exon_variant	0	NR	3E-14	13.522878745280337				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	3p24.1	3	27736288	EOMES	EOMES - LOC105377007	8320	105377007		13573	61300	rs9880772-A	rs9880772	0	9880772	intergenic_variant	1	NR	7E-9	8.154901959985743				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	3p22.1	3	41709497	ULK4	ULK4			54986			rs6763508-C	rs6763508	0	6763508	intron_variant	0	NR	8E-12	11.096910013008056				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	3q26.2	3	169759718	TERC	SDHDP3 - TERC	29771	7012		49140	4892	rs12638862-A	rs12638862	0	12638862	downstream_gene_variant	1	NR	2E-11	10.698970004336019				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	6p25.3	6	442357	IRF4	IRF4 - LOC105374875	3662	105374875		30914	8656	rs9392017-G	rs9392017	0	9392017	intergenic_variant	1	NR	6E-9	8.221848749616356				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	6p21.31	6	33579153	BAK1	BAK1			578			rs210143-C	rs210143	0	210143	intron_variant	0	NR	7E-12	11.154901959985743				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	11q24.1	11	123524538	GRAMD1B	GRAMD1B			57476			rs4525246-C	rs4525246	0	4525246	intron_variant	0	NR	3E-14	13.522878745280337				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	2q37.1	2	230279864	SP110	SP140			11262			rs149207840-TCCTCCTG	rs149207840	0	149207840	intron_variant	0	NR	1E-7	7.0				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	3q28	3	188236626	LPP	LPP			4026			rs4459895-C	rs4459895	0	4459895	intron_variant	0	NR	2E-7	6.698970004336019				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	5q15	5	95896837	ELL2	ELL2			22936			rs2546191-A	rs2546191	0	2546191	intron_variant	0	NR	4E-7	6.3979400086720375				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	8q24.21	8	128102971	PVT1	PVT1 - MIR1208	5820	100302281		1718	47145	rs2720680-G	rs2720680	0	2720680	downstream_gene_variant	1	NR	7E-8	7.154901959985743				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	15q15.1	15	40099764	BMF	BMF			90427			rs35603048-T	rs35603048	0	35603048	intron_variant	0	NR	4E-7	6.3979400086720375				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	16q24.1	16	85951755	IRF8	LOC105371388 - LOC105371389	105371388	105371389		2120	96073	rs4240807-C	rs4240807	0	4240807	intergenic_variant	1	NR	7E-7	6.154901959985743				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	1p35.2	1	31389925	NR	LOC105378623 - LOC107985470	105378623	107985470		95	390	rs148297606-C	rs148297606	0	148297606	intergenic_variant	1	NR	4E-6	5.3979400086720375				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	12q21.1	12	74276187	NR	LOC100507377			100507377			rs181181503-C	rs181181503	0	181181503	intron_variant	0	NR	3E-7	6.522878745280337				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	13q21.2	13	60686390	NR	LINC00378			101926930			rs1576377-C	rs1576377	0	1576377	intron_variant	0	NR	4E-6	5.3979400086720375				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	19p13.11	19	16161878	NR	CIB3			117286			rs73005220-G	rs73005220	0	73005220	intron_variant	0	NR	1E-6	6.0				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	22q13.33	22	50511648	NCAPH2	NCAPH2			29781			rs131821-AT	rs131821	0	131821	intron_variant	0	NR	7E-8	7.154901959985743				Illumina [10806625] (imputed)	N
2017-05-30	28112199	Law PJ	2017-01-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28112199	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	1,842 European ancestry chronic lymphocytic leukemia cases, 1,465 European ancestry Hodgkin lymphoma cases, 3,790 European ancestry multiple myeloma cases, 7,324 European ancestry controls	NA	3q22.3	3	136870707	NCK1	NCK1			4690			rs11715604	rs11715604	0	11715604	intron_variant	0	NR	2E-9	8.698970004336019				Illumina [10806625] (imputed)	N
